
<html lang="en"     class="pb-page"  data-request-id="760f2347-3a35-4c60-8a6c-1fe2294e2521"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.1c00115;requestedJournal:journal:jmcmar;issue:issue:10.1021/jmcmar.2021.64.issue-11;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery" /></meta><meta name="dc.Creator" content="Jiyun  Sun" /></meta><meta name="dc.Creator" content="Zhiwei  Xiao" /></meta><meta name="dc.Creator" content="Ahmed  Haider" /></meta><meta name="dc.Creator" content="Catherine  Gebhard" /></meta><meta name="dc.Creator" content="Hao  Xu" /></meta><meta name="dc.Creator" content="Hai-Bin  Luo" /></meta><meta name="dc.Creator" content="Han-Ting  Zhang" /></meta><meta name="dc.Creator" content="Lee  Josephson" /></meta><meta name="dc.Creator" content="Lu  Wang" /></meta><meta name="dc.Creator" content="Steven H.  Liang" /></meta><meta name="dc.Description" content="Cyclic nucleotide phosphodiesterases (PDEs) control the intracellular concentrations of cAMP and cGMP in virtually all mammalian cells. Accordingly, the PDE family regulates a myriad of physiologic..." /></meta><meta name="Description" content="Cyclic nucleotide phosphodiesterases (PDEs) control the intracellular concentrations of cAMP and cGMP in virtually all mammalian cells. Accordingly, the PDE family regulates a myriad of physiologic..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 27, 2021" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00115" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00115" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00115" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00115" /></link>
        
    
    

<title>Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00115" /></meta><meta property="og:title" content="Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0019.jpeg" /></meta><meta property="og:description" content="Cyclic nucleotide phosphodiesterases (PDEs) control the intracellular concentrations of cAMP and cGMP in virtually all mammalian cells. Accordingly, the PDE family regulates a myriad of physiological functions, including cell proliferation, differentiation and apoptosis, gene expression, central nervous system function, and muscle contraction. Along this line, dysfunction of PDEs has been implicated in neurodegenerative disorders, coronary artery diseases, chronic obstructive pulmonary disease, and cancer development. To date, 11 PDE families have been identified; however, their distinct roles in the various pathologies are largely unexplored and subject to contemporary research efforts. Indeed, there is growing interest for the development of isoform-selective PDE inhibitors as potential therapeutic agents. Similarly, the evolving knowledge on the various PDE isoforms has channeled the identification of new PET probes, allowing isoform-selective imaging. This review highlights recent advances in PDE-targeted PET tracer development, thereby focusing on efforts to assess disease-related PDE pathophysiology and to support isoform-selective drug discovery." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00115"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00115">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00115&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00115&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00115&amp;href=/doi/10.1021/acs.jmedchem.1c00115" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 7083-7109</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02091" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.1c00154" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Jiyun Sun</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jiyun Sun</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jiyun++Sun">Jiyun Sun</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhiwei Xiao</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhiwei Xiao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhiwei++Xiao">Zhiwei Xiao</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ahmed Haider</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ahmed Haider</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ahmed++Haider">Ahmed Haider</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Catherine Gebhard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Catherine Gebhard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Nuclear Medicine, University Hospital Zurich, Raemistrasse 100, Zurich 8006, Switzerland</div><div class="loa-info-affiliations-info">Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, Schlieren 8952, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Catherine++Gebhard">Catherine Gebhard</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hao Xu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hao Xu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, 613 West Huangpu Road, Tianhe District, Guangzhou 510630, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hao++Xu">Hao Xu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hai-Bin Luo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hai-Bin Luo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 510006, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hai-Bin++Luo">Hai-Bin Luo</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-2163-0509" title="Orcid link">https://orcid.org/0000-0002-2163-0509</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Han-Ting Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Han-Ting Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Departments of Neuroscience, Behavioral Medicine & Psychiatry, and Physiology & Pharmacology, the Rockefeller Neuroscience Institute, West Virginia University Health Sciences Center, Morgantown, West Virginia 26506, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Han-Ting++Zhang">Han-Ting Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath7">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lee Josephson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lee Josephson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lee++Josephson">Lee Josephson</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath8">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lu Wang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lu Wang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States</div><div class="loa-info-affiliations-info">Center of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine and PET/CT-MRI Center, The First Affiliated Hospital of Jinan University, 613 West Huangpu Road, Tianhe District, Guangzhou 510630, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lu++Wang">Lu Wang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath9">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8049-1991" title="Orcid link">https://orcid.org/0000-0002-8049-1991</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Steven H. Liang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Steven H. Liang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Radiology, Division of Nuclear Medicine and Molecular Imaging Massachusetts General Hospital and Harvard Medical School, 55 Fruit Street, Boston, Massachusetts 02114, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#a5c9ccc4cbc28bd6d1c0d3c0cbe5c8c2cd8bcdc4d7d3c4d7c18bc0c1d0"><span class="__cf_email__" data-cfemail="066a6f67686128757263706368466b616e286e67747067746228636273">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Steven+H.++Liang">Steven H. Liang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath10">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1413-6315" title="Orcid link">https://orcid.org/0000-0003-1413-6315</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00115&amp;href=/doi/10.1021%2Facs.jmedchem.1c00115" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 7083–7109</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 27, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>21 January 2021</li><li><span class="item_label"><b>Published</b> online</span>27 May 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 June 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00115</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D7083%26pageCount%3D27%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJiyun%2BSun%252C%2BZhiwei%2BXiao%252C%2BAhmed%2BHaider%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D11%26contentID%3Dacs.jmedchem.1c00115%26title%3DAdvances%2Bin%2BCyclic%2BNucleotide%2BPhosphodiesterase-Targeted%2BPET%2BImaging%2Band%2BDrug%2BDiscovery%26numPages%3D27%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7109%26publicationDate%3DJune%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00115"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">701</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00115" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Jiyun&quot;,&quot;last_name&quot;:&quot;Sun&quot;},{&quot;first_name&quot;:&quot;Zhiwei&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Ahmed&quot;,&quot;last_name&quot;:&quot;Haider&quot;},{&quot;first_name&quot;:&quot;Catherine&quot;,&quot;last_name&quot;:&quot;Gebhard&quot;},{&quot;first_name&quot;:&quot;Hao&quot;,&quot;last_name&quot;:&quot;Xu&quot;},{&quot;first_name&quot;:&quot;Hai-Bin&quot;,&quot;last_name&quot;:&quot;Luo&quot;},{&quot;first_name&quot;:&quot;Han-Ting&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Lee&quot;,&quot;last_name&quot;:&quot;Josephson&quot;},{&quot;first_name&quot;:&quot;Lu&quot;,&quot;last_name&quot;:&quot;Wang&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;H. Liang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;27&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;7083-7109&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00115&quot;},&quot;abstract&quot;:&quot;Cyclic nucleotide phosphodiesterases (PDEs) control the intracellular concentrations of cAMP and cGMP in virtually all mammalian cells. Accordingly, the PDE family regulates a myriad of physiological functions, including cell proliferation, differentiation and apoptosis, gene expression, central nervous system function, and muscle contraction. Along this line, dysfunction of PDEs has been implicated in neurodegenerative disorders, coronary artery diseases, chronic obstructive pulmonary disease, and cancer development. To date, 11 PDE families have been identified; however, their distinct roles in the various pathologies are largely unexplored and subject to contemporary research efforts. Indeed, there is growing interest for the development of isoform-selective PDE inhibitors as potential therapeutic agents. Similarly, the evolving knowledge on the various PDE isoforms has channeled the identification of new PET probes, allowing isoform-selective imaging. This review highlights recent advances in PDE-targeted&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00115&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00115" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00115&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00115" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00115&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00115" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00115&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00115&amp;href=/doi/10.1021/acs.jmedchem.1c00115" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00115" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00115" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (11 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00115%26sid%3Dliteratum%253Aachs%26pmid%3D34042442%26genre%3Darticle%26aulast%3DSun%26date%3D2021%26atitle%3DAdvances%2Bin%2BCyclic%2BNucleotide%2BPhosphodiesterase-Targeted%2BPET%2BImaging%2Band%2BDrug%2BDiscovery%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D11%26spage%3D7083%26epage%3D7109%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=291663" title="Positron emission tomography">Positron emission tomography</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/11" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/jmcmar.2021.64.issue-11/20210610/jmcmar.2021.64.issue-11.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Cyclic nucleotide phosphodiesterases (PDEs) control the intracellular concentrations of cAMP and cGMP in virtually all mammalian cells. Accordingly, the PDE family regulates a myriad of physiological functions, including cell proliferation, differentiation and apoptosis, gene expression, central nervous system function, and muscle contraction. Along this line, dysfunction of PDEs has been implicated in neurodegenerative disorders, coronary artery diseases, chronic obstructive pulmonary disease, and cancer development. To date, 11 PDE families have been identified; however, their distinct roles in the various pathologies are largely unexplored and subject to contemporary research efforts. Indeed, there is growing interest for the development of isoform-selective PDE inhibitors as potential therapeutic agents. Similarly, the evolving knowledge on the various PDE isoforms has channeled the identification of new PET probes, allowing isoform-selective imaging. This review highlights recent advances in PDE-targeted PET tracer development, thereby focusing on efforts to assess disease-related PDE pathophysiology and to support isoform-selective drug discovery.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_21555" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_21555" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cyclic nucleotide phosphodiesterases (PDEs) constitute a superfamily of enzymes that catalyze the degradation of the second messengers, cyclic adenosine 3′,5′-monophosphate (cAMP) and cyclic guanosine 3′,5′-monophosphate (cGMP). Notably, cyclic nucleotide PDEs can be found in virtually all mammalian cells, where they modulate numerous downstream signaling processes by controlling the intracellular content of cyclic nucleotides and creating individual pockets of cyclic nucleotide signaling.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Indeed, PDEs mediate a variety of physiological processes, including ion channel function, muscle contraction, central nervous system (CNS) function, apoptosis, glycogenolysis, and gluconeogenesis. Dysfunction of PDEs, however, has been implicated in various neurological and cardiovascular diseases, chronic obstructive pulmonary disease (COPD), and cancer development.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> While ongoing research continues to tackle the plethora of unanswered questions regarding the roles of different PDE isoforms in related pathologies, there is a general consensus that the pharmacological inhibition of PDEs provides a promising therapeutic strategy for the treatment of various human diseases.<a onclick="showRef(event, 'ref1 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref4 ref5 ref6 ref7 ref8 ref9 ref10 ref11 ref12 ref13">(1,4−13)</a> Further, given the broad therapeutic implications, it is not surprising that PDEs have been deemed important targets for translational molecular imaging by positron emission tomography (PET).</div><div class="NLM_p">PET is a noninvasive imaging technique that allows visualization and quantification of biochemical processes <i>in vivo</i>. These processes include enzymatic and transporter activity, protein biosynthesis, as well as ligand binding to specific receptors or enzymes at the molecular and cellular levels. PET has not only been widely applied for disease diagnosis in oncology, neurology, and cardiology,<a onclick="showRef(event, 'ref14 ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref14 ref15 ref16">(14−16)</a> but has also been used to facilitate drug discovery.<a onclick="showRef(event, 'ref17 ref18'); return false;" href="javascript:void(0);" class="ref ref17 ref18">(17,18)</a> In preclinical and clinical drug development, PET provides critical information about target engagement and occupancy of a drug candidate at a given dose regimen. Further, PET can be used for the assessment of compound selectivity <i>in vivo</i>. Although research on PDEs has been carried out for decades, only a few PET radioligands, mainly focused on the subtypes of PDE2, PDE4, PDE5, PDE7, and PDE10, were developed for PDE-targeted PET imaging.<a onclick="showRef(event, 'ref19 ref20 ref21 ref22'); return false;" href="javascript:void(0);" class="ref ref19 ref20 ref21 ref22">(19−22)</a> Nevertheless, these probes have enabled real-time PDE quantification, thus significantly contributing to our contemporary understanding of PDE-related pathophysiology. Meanwhile, the development of radioligands for imaging PDEs has forged new paths for the evaluation of novel PDE inhibitors. To date, a number of PET radioligands, derived from clinically used PDE inhibitors, have been reported.</div><div class="NLM_p last">The growing interest in the development of isoform-selective PDE inhibitors as potential therapeutic agents has triggered a wave of enthusiasm and prompted calls for new PET probes that allow isoform-selective imaging. This review highlights recent advances in PDE-targeted PET tracer development, with particular focus on efforts to assess disease-related PDE pathophysiology and support drug discovery. With regard to PDE isoforms that have not yet been elucidated for PET imaging, we mainly discuss recent developments of respective isoform-selective therapeutics.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Overview of the Phosphodiesterase (PDE) Superfamily</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80013" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80013" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">To date, 11 PDE families have been identified based on the homology of their <i>C</i>-terminal catalytic domain (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Further, 21 isoforms comprising more than 100 splice variants were grouped according to their <i>N</i>-terminal regulatory domains. These PDEs are different in their 3D structure, kinetic properties, functions, and cellular expression.<a onclick="showRef(event, 'ref1 ref5 ref7 ref11'); return false;" href="javascript:void(0);" class="ref ref1 ref5 ref7 ref11">(1,5,7,11)</a> According to their substrate preference for either cAMP or cGMP, PDEs are subdivided into three groups: cAMP-specific PDEs 4, 7, and 8; cGMP-specific PDEs 5, 6, and 9; and dual-specific PDEs 1–3, 10, and 11, which hydrolyze both cAMP and cGMP. Because the concentration of cAMP or cGMP gives feedback on the activity of PDEs, some dual-specific PDEs are considered to be key players in the crosstalk between cAMP and cGMP. The <i>N-</i>terminal regulatory region of each PDE contains unique structural determinants, directing individual PDEs to different subcellular locations and signalosomes and further allowing them to specifically respond to different post-translational modifications, regulatory molecules, and signals.<a onclick="showRef(event, 'ref1 ref11 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref11 ref13">(1,11,13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Members of PDE superfamily.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Most cells harbor several PDE isoforms, though, in different concentrations, proportions, and subcellular locations. Although PDEs are widely expressed in the CNS and peripheral tissues, specific PDE isoform expression can vary according to cell type and localization, thereby allowing a remarkable functional diversity (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).<a onclick="showRef(event, 'ref1 ref13 ref23'); return false;" href="javascript:void(0);" class="ref ref1 ref13 ref23">(1,13,23)</a></div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0018.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Specific Hydrolysis of cAMP or cGMP by Different PDEs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Cyclic Nucleotide Phosphodiesterase Isozyme Families: Expression and Representative Physiological Functions</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PDE isoforms</th><th class="colsep0 rowsep0" align="center">Expression</th><th class="colsep0 rowsep0" align="center">Physiological functions</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE1(A, B, C)</td><td class="colsep0 rowsep0" align="left">High expression in the brain, heart, smooth muscles, and lungs.</td><td class="colsep0 rowsep0" align="left">PDE1A plays an important role in regulating the contraction of vascular smooth muscle cells and in sperm function, while PDE1B is involved in dopaminergic signaling, as well as the activation and survival of immune cells. The proliferation of vascular smooth muscle cells requires the participation of PDE1C, which has further been linked to neuronal signaling and sperm function.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE2(A)</td><td class="colsep0 rowsep0" align="left">High expression in the brain, heart (myocytes), liver, adrenal cortex, endothelium, and platelets.</td><td class="colsep0 rowsep0" align="left">PDE2A plays a key role in the crosstalk between cGMP and cAMP pathways. Further, it regulates cGMP concentration in neurons, aldosterone secretion from the adrenal gland, and cAMP- and PKA-mediated phosphorylation of Ca<sup>2+</sup> channels in the heart. PDE2A exerts a barrier function of endothelial cells under inflammatory conditions.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE3(A, B)</td><td class="colsep0 rowsep0" align="left">High expression in the heart, vascular smooth muscles, and platelets, as well as in the liver, adipose tissues, pancreatic β-cells, epithelium, and oocytes.</td><td class="colsep0 rowsep0" align="left">PDE3A regulates cardiac contractility, vascular smooth muscle contraction, platelet aggregation, oocyte maturation, and renin release, while PDE3B promotes insulin signaling and its antilipolytic effects, as well as the inhibitory effects of leptin and other signals on insulin secretion and renin release. Moreover, PDE3B regulates cell cycle/proliferation.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE4(A, B, C, D)</td><td class="colsep0 rowsep0" align="left">Expressed in the brain, heart, kidney, liver, lung, smooth muscle, endothelial cells, immunocytes, and Sertoli cells.</td><td class="colsep0 rowsep0" align="left">Brain function, monocyte and macrophage activation, neutrophil infiltration, vascular smooth muscle proliferation, fertility, vasodilation, and cardiac contractility require the participation of PDE4s.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE5(A)</td><td class="colsep0 rowsep0" align="left">Mainly expressed in the lungs, heart, and cerebellum, but can also be found in smooth and skeletal muscles, kidneys, and platelets.</td><td class="colsep0 rowsep0" align="left">The functions of PDE5A in vascular smooth muscle contraction have been well studied, especially in the male reproductive system and the lung. The regulation of nitric oxide (NO)-cGMP signaling pathways in the brain and platelets, however, are yet to be elucidated.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE6(A, B, C)</td><td class="colsep0 rowsep0" align="left">Highly expressed in the retina and pineal gland.</td><td class="colsep0 rowsep0" align="left">PDE6 plays a unique role of signal transduction in photoreceptors and regulates melatonin release from the pineal gland.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE7(A, B)</td><td class="colsep0 rowsep0" align="left">Predominantly found in the brain, heart, liver, skeletal muscles, kidneys, testes, and pancreas.</td><td class="colsep0 rowsep0" align="left">The function of PDE7 is studied in immune system- and CNS-related pathologies, as well as in some specific cancers, for example, chronic lymphocytic leukemia (CLL).</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE8(A, B)</td><td class="colsep0 rowsep0" align="left">Primarily expressed in the brain, liver, kidneys, colon, testes, ovary, spleen, and thyroid.</td><td class="colsep0 rowsep0" align="left">PDE8 plays a role in T-cell activation, sperm, or Leydig cell function.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE9(A)</td><td class="colsep0 rowsep0" align="left">Widely expressed in the brain, kidneys, spleen, prostate, and various gastrointestinal tissues.</td><td class="colsep0 rowsep0" align="left">PDE9A has been hypothesized to regulate NO-cGMP signaling in the brain; however, this hypothesis is yet to be corroborated.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE10(A)</td><td class="colsep0 rowsep0" align="left">Enriched in the brain and testes, followed by heart, muscles, and thyroid.</td><td class="colsep0 rowsep0" align="left">PDE10A inhibition can regulate the signaling mediated by dopamine D1 receptor (D1R) and dopamine D2 receptor (D2R). Therefore, the therapeutic potentials in neurological and psychiatric disorders, such as Huntington’s disease (HD), Parkinson’s disease (PD), and schizophrenia have drawn medicinal chemists’ attention.</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">PDE11(A)</td><td class="colsep0 rowsep0" align="left">Highly expressed in skeletal muscles, pituitary and salivary glands, liver, kidneys, testes, prostate, and thyroid.</td><td class="colsep0 rowsep0" align="left">Studies have indicated that PDE11A plays a role in sperm development and function.</td></tr></tbody></table></div></div><div class="NLM_p">In summary, these findings indicate that PDE isoforms have different functions to modulate distinct signaling pathways in the cell. This offers opportunities for selective targeting of specific PDE isoforms, while sparing others—a concept that has the potential to yield therapeutics with an optimal risk–benefit profile.<a onclick="showRef(event, 'ref1 ref5 ref12'); return false;" href="javascript:void(0);" class="ref ref1 ref5 ref12">(1,5,12)</a> Further, PDE isoform-selective targeting with PET probes will advance our knowledge on the distinct functions of these isoforms and may ultimately lead to the discovery of novel disease biomarkers.</div><div id="sec3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> cAMP-Specific PDEs</h3><div id="sec3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i7" class="anchor-spacer"></div><h4 class="article-section__title" id="_i7"> PDE4—Overview: Subtypes and Distribution</h4><div class="NLM_p">Phosphodiesterase-4 (PDE4) can specifically hydrolyze cAMP, an important secondary messenger for transducing external stimuli to intracellular chemical signals. PDE4 constitutes four subtypes (A, B, C, and D). The <i>N</i>-terminal region of every isoform is unique, containing the targeting domain (TD) and some upstream conserved regions (UCR1 and UCR2). The UCRs undergo phosphorylation by protein kinase A (PKA) and extracellular signal-regulated kinase (ERK). Of note, the highly conserved catalytic domain of all PDE4 isoforms is located at the <i>C</i>-terminal domain, which is linked to the <i>N</i>-terminal domain by the linker regions 1 and 2 (LR1 and LR2). As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, PDE4 isoforms can be categorized into long, short, supershort, and dead-short (not shown) enzymes—according to the presence and size of UCR1 and UCR2.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Diversity of domain organization of PDE4 isoforms. LR1/2, linker region 1/2; UCR1/2, upstream conserved region 1/2; PKA-P, protein kinase A-phosphorylation site; ERK-P, extracellular regulated protein kinases-phosphorylation site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec3_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i8" class="anchor-spacer"></div><h5 class="article-section__title" id="_i8"> Therapeutic Potential</h5><div class="NLM_p">PDE4 is widely expressed in the CNS and peripheral organs, where it plays important roles in a variety of pathophysiological processes, including inflammation, cancer, cardiovascular function, CNS function, and metabolic processes.<a onclick="showRef(event, 'ref1 ref24'); return false;" href="javascript:void(0);" class="ref ref1 ref24">(1,24)</a> Interestingly, some PDE4 isoforms, especially PDE4A, PDE4B, and PDE4D, play a major role in the hydrolysis of cAMP in most immune and inflammatory cells, including T cells, B cells, eosinophils, neutrophils, dendritic cells, monocytes, and macrophages. Accordingly, anti-inflammatory processes are mediated by PKA and/or exchange protein directly activated by cAMP (EPAC), following elevated cAMP levels through PDE4 inhibition. These molecular processes can result in activation, proliferation, and release of pro-inflammatory cytokines such as interleukin (IL)-1, IL-12, and IL-18, tumor necrosis factor alpha (TNF-α), and interferon gamma (IFNγ).<a onclick="showRef(event, 'ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref25 ref26">(25,26)</a> In an animal model of experimental autoimmune encephalomyelitis (EAE), enhanced intracellular cAMP levels, triggered by inhibition of PDE4, decreased cerebrovascular endothelial permeability and diminished transendothelial transport of inflammatory mediators. On one hand, inhibition of PDE4 can decrease T cell proliferation and reduce the secretion of pro-inflammatory cytokines (TNF-a and IL-17). On the other hand, it can stimulate the release of anti-inflammatory cytokine IL-10 in EAE mice.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">In the CNS, the regulation of intracellular cAMP levels by PDE4-mediated hydrolysis is a crucial mechanism to control downstream signaling. For instance, sufficient levels of cAMP are required for the activation of PKA and the subsequent phosphorylation of cAMP-response element binding protein (CREB), which contributes to a healthy memory function. In the corticostriatal network, signal transduction is mediated by cAMP/PKA signaling pathways. Accordingly, inhibition of PDE4 led to a cAMP/PKA/CREB-mediated enhancement of neuroplasticity.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> Given that PDE4 inhibition had proven effective for enhanced neuronal plasticity and anti-neuroinflammatory response in various animal models, including schizophrenia, Alzheimer’s disease (AD), multiple sclerosis (MS), and acute brain injury (ABI), recent studies have increasingly focused on exploiting PDE4 inhibition in the CNS.</div><div class="NLM_p">PDE4 activity is an important regulator of intracellular cAMP concentration, which, in turn, controls PKA-mediated phosphorylation of specific proteins, thereby regulating cardiac signaling by signalosomes in cardiomyocytes (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Notably, when cGMP levels are low in vascular endothelial cells (VECs), PDE4 activity plays a major role in activating PKA and EPAC.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Importantly, PDE4D and EPAC have been identified as key mediators in the regulation of the vascular permeability through pharmacological inhibition and siRNA-mediated knockdown.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> PDE4 is widely expressed and dominates the cAMP-hydrolysis in most human tumor cell lines. In these malignant cells, PDE4-cAMP-PKA/EPAC signaling pathways are involved in cell differentiation, proliferation, and apoptosis.<a onclick="showRef(event, 'ref10 ref29'); return false;" href="javascript:void(0);" class="ref ref10 ref29">(10,29)</a> In some animal models, PDE4 inhibitors such as roflumilast and exisulind have shown positive effects for the treatment of lung cancer, bladder cancer, chronic lymphatic leukemia, and colorectal cancer.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Regulatory functions of PDE4 inhibition in the heart, CNS, and immune system. GPCR, G protein-coupled receptor; Gs, stimulatory G protein; Gi, inhibitory G protein; sAc, soluble adenylyl cyclases; tAc, transmembrane adenylyl cyclases; ATP, adenosine triphosphate; cAMP, cyclic adenosine 3′,5′-monophosphate; 5′AMP, adenosine 5′-monophosphate; CNG, cyclic nucleotide-gated channel; PKA, protein kinase A; EPAC, exchange protein directly activated by cAMP; AKAPs, A-kinase anchor proteins; ABI, acute brain injury.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i9" class="anchor-spacer"></div><h5 class="article-section__title" id="_i9"> Drug Discovery</h5><div class="NLM_p">As previously mentioned, PDE4 inhibitors (shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) have shown positive therapeutic effects for animal models of various diseases. As of today, five drugs have been approved by the FDA. For instance, the PDE4-selective inhibitor roflumilast has been approved for the treatment of severe COPD and COPD exacerbations. Roflumilast attenuates COPD-related inflammation through multiple mechanisms, namely, the reduction of inflammatory mediators, the expression of cell surface markers and the inhibition of apoptosis. Data obtained from clinical trials suggest that roflumilast is most beneficial to patients with severe COPD and can reduce moderate to severe exacerbations.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> In addition, new clinical trials for several indications, including polycystic ovary syndrome, cognitive deficits in schizophrenia, cognition (dementia), insulin and blood sugar levels in prediabetic overweight and obese individuals, asthma, bronchiectasis, and lymphoma, are in progress. In 2014, oral apremilast, a PDE4 inhibitor, was approved by the FDA for the treatment of psoriasis. New clinical indications of apremilast for other inflammatory skin diseases, Behcet syndrome, and alcoholism are being explored.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Through a mechanism similar to that for apremilast, crisaborole ointment was approved for the treatment of mild to moderate atopic dermatitis in patients >2 years of age.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Drotaverine is a PDE4-selective inhibitor and structurally related to papaverine. Although approved for the treatment of functional bowel disorders and pain, caused by smooth muscle spasm in some countries, drotaverine was reported to elicit fainting, nausea, vomiting, seizures, and cardiac toxicity.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In contrast to drotaverine, ibudilast is a nonselective allosteric PDE inhibitor with an IC<sub>50</sub> ≤ 10 μM for human PDE 3, 4, 10, and 11. Anti-inflammatory activity of ibudilast in the peripheral immune system and in the CNS can play protective roles in the treatment of asthma, COPD, multiple sclerosis, chronic neuropathic pain, and opioid dependence. Thus, various forms of ibudilast have been approved as anti-inflammatory drugs for asthma and allergic conjunctivitis in Asian countries. Further, ibudilast is the medication of choice for the treatment of dizziness related to cerebral infarction.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative PDE4 inhibitors and <sup>11</sup>C/<sup>18</sup>F labeled PET radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Dual PDE 3 and 4 inhibitor RPL554 has shown anti-inflammatory effects by inhibiting PDE4 and is currently used for the treatment of respiratory diseases, such as COPD and asthma, despite exhibiting an IC<sub>50</sub> for PDE3 that is more than 3000 times that for PDE4.<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> PDE4 inhibitors have been shown to be effective against neurological disorders and psychiatric diseases in various preclinical studies; however, none is approved for the treatment of these conditions. In a preclinical study, the brain-penetrant PDE4-selective inhibitor, GSK356278, improved anxiety and enhanced cognition without inducing major side effects.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> Recently, the clinical phase I study (NCT01573819) of GSK356278, which is for the treatment of HD, depressive disorder, and anxiety disorders has been completed. In Phase II clinical trials, treatment with HT-0712 was evaluated for age-associated memory impairment (AAMI), because HT-0712 was found to enhance long-term memory formation and to reduce age-associated memory impairment in aged mice.<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></div><div class="NLM_p last">PDE4 inhibitors can induce serious side effects. Notably, distinct PDE4 isoforms have a highly conserved sequence and share a high degree of structural homology in the catalytic domains. Consequently, the development of isoform-selective PDE4 inhibitors is highly challenging. BPN14770 is a PDE4D-selective negative allosteric modulator with binding affinity values (IC<sub>50</sub>) of 7.8 nM and 7.4 nM for PDE4D7 and PDE4D3, respectively. BPN14770 was found to bind to a primate-specific <i>N</i>-terminal region, thereby inhibiting the PDE4-mediated degradation of cAMP. As such, BPN14770 blocked the amnesic effects of scopolamine, increased cAMP signaling in the brain, and increased brain-derived neurotrophic factor (BDNF) as well as markers of neuronal plasticity associated with memory.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> The enhancing effects on memory make BPN14770 a promising PDE4D-selective drug in clinical trials Phase II for the treatment of AD and fragile X syndrome.</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i10" class="anchor-spacer"></div><h5 class="article-section__title" id="_i10"> PET Ligands</h5><div class="NLM_p">Although studies of rolipram for the treatment of depression were terminated in the early 1990s due to the significant gastrointestinal side effects, rolipram is still used for research purposes and served as a lead molecule in drug discovery. Indeed, research on PET radioligands targeting the PDE superfamily (shown in <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>) started with [<sup>11</sup>C]rolipram. In 1997, Dasilva et al. first reported on <sup>11</sup>C labeled racemic rolipram and Ro 20–1724 as potential radioligands for imaging PDE4.<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(37)</a> In subsequent studies, [<sup>11</sup>C]Rolipram was found to exert higher selectivity for PDE4 than [<sup>11</sup>C]Ro 20–1724.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Notably, (<i>R</i>)-[<sup>11</sup>C]rolipram displayed enhanced brain uptake and selectivity toward PDE4 than racemic [<sup>11</sup>C]rolipram and (<i>S</i>)-[<sup>11</sup>C]rolipram. In addition, given that (<i>S</i>)-[<sup>11</sup>C]rolipram was rapidly metabolized <i>in vivo</i>, (<i>R</i>)-[<sup>11</sup>C]rolipram was considered to be more suitable than (<i>S</i>)-[<sup>11</sup>C]-rolipram for PET imaging.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(39)</a></div><div class="NLM_p">Evaluations using PET imaging in rats, pigs, monkeys, and humans revealed a heterogeneous and region-specific distribution of (<i>R</i>)-[<sup>11</sup>C]rolipram in the brain as well as the heart. PET studies in animal models of aging, obesity, diabetic cardiomyopathy, heart failure, adriamycin-induced cardiotoxicity, and myocardial infarction demonstrated that (<i>R</i>)-[<sup>11</sup>C]rolipram can be used to monitor PDE4 levels and impaired cAMP signaling.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43">(40−43)</a> For example, (<i>R</i>)-[<sup>11</sup>C]rolipram was used to image PDE4 after treatments with drugs affecting cAMP levels. These imaging studies revealed changes in PDE4 levels and provided insight into understanding disease states with altered concentrations of synaptic noradrenaline (NA), serotonin (5-HT), and histamine (HA).<a onclick="showRef(event, 'ref40 ref41'); return false;" href="javascript:void(0);" class="ref ref40 ref41">(40,41)</a> Additional research efforts provided a more comprehensive quantitative analysis of (<i>R</i>)-[<sup>11</sup>C]rolipram, accounting for data accuracy and reproducibility. As such, the level of radiotracer in the rat and canine heart was quantified using Logan analysis and models comprising one or two tissue-compartment models.<a onclick="showRef(event, 'ref44 ref45'); return false;" href="javascript:void(0);" class="ref ref44 ref45">(44,45)</a> In 2002, the first case of PET imaging using (<i>R</i>)-[<sup>11</sup>C]rolipram in the living human brain was reported.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> This initial study was followed by a series of clinical trials using (<i>R</i>)-[<sup>11</sup>C]rolipram both in healthy people (NCT01215552, NCT00250172) and in patients with CNS diseases, including HD (NCT01602900), MDD (NCT00369798), and McCune-Albright Syndrome (MAS, NCT02743377). (<i>R</i>)-[<sup>11</sup>C]rolipram PET showed an <i>in vivo</i> downregulation of brain PDE4 levels in MDD patients not receiving antidepressant therapy and supported the concept that a downregulation of the cAMP cascade, including adenylyl cyclases (ACs), cAMP-dependent PKA, CREB, and BDNF, is indeed involved in the pathology of MDD.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a> Due to the reversible binding of (<i>R</i>)-[<sup>11</sup>C]rolipram to PDE4, compartmental modeling was applicable to calculate <i>V</i><sub>T</sub>/<i>f</i><sub>P</sub> (total distribution volume/plasma free fraction) and to offset the effect of cerebral blood flow. Quantitative data of rolipram binding in certain brain regions displayed similar declines, ranging from 20% (frontal cortex and caudate) to 24% (cerebellum), with an average decrease of 22%. However, it was not possible to reliably assess disease severity by (<i>R</i>)-[<sup>11</sup>C]rolipram PET.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(46)</a></div><div class="NLM_p">Derivatization of rolipram led to the discovery of MNI-617, a PDE4 inhibitor with a 5-fold increased affinity for PDE4 (<i>K</i><sub>d</sub> = 0.26 nM), as compared to <i>R-</i>(−)<i>-</i>rolipram (<i>K</i><sub>d</sub> = 1.6 nM). The deutero-analogue <i>d</i><sub>2</sub>-[<sup>18</sup>F]MNI-617 was selected for <i>in vivo</i> evaluation, because the substitution of [<sup>18</sup>F]fluoromethyl by [<sup>18</sup>F]fluoromethyl-<i>d</i><sub>2</sub> was envisioned to increase metabolic stability and reduce enzyme-mediated defluorination, as previously shown for other probes.<a onclick="showRef(event, 'ref9 ref10'); return false;" href="javascript:void(0);" class="ref ref9 ref10">(9,10)</a> PET studies in rhesus monkeys revealed that the radioligand can penetrate the blood brain barrier (BBB), while exhibiting a distribution pattern that is consistent with previously reported PDE4 expression levels. Nonetheless, a rapid <i>in vivo</i> metabolism (<5% of intact parent radioligand in the plasma at 15 min post-injection) and significant accumulation of radioactivity in the skull, despite a deuterium-bearing fluoroethyl side chain, limited the application of <i>d</i><sub>2</sub>-[<sup>18</sup>F]MNI-617 for PDE4-targeted PET.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a></div><div class="NLM_p">Improving PET tracer selectivity among PDE4 subtypes is critical for successful tracer application. In 2017, Zhang et al. reported on the development of a PDE4B-preferring PET radioligand, codenamed [<sup>18</sup>F]PF-06445974. In the early stage of compound screening, <i>B</i><sub>max</sub> and brain biodistribution were used to define the required potency range and selectivity index. Following an initial SAR analysis and specificity assessment, promising ligands were used for PET studies. Under baseline conditions, PET studies in cynomolgus monkeys revealed that [<sup>18</sup>F]PF-06445974 reached a peak whole brain standard uptake values (SUVs) of ∼3 at 30 min post-injection. By quantitative PET measurements of tissue volume of distribution (<i>V</i><sub>T</sub>), a target occupancy of ∼92% was estimated after pretreatment with a structurally distinct PDE4B inhibitor (0.5 mg/kg, subcutaneous injection) 4 h prior to the tracer injection. In all, [<sup>18</sup>F]PF-06445974 serves as a promising lead scaffold for the further development of PDE4B-selective radioligands for PET imaging.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(48)</a></div><div class="NLM_p">PDE4D was found to be implicated in cognitive function and depression. Recently, four PET radioligands were labeled with <sup>11</sup>C for imaging PDE4D in the brain after a comprehensive compound screening, that accounted for inhibitory potency, selectivity, compound lipophilicity, and brain uptake. The most promising two probes, [<sup>11</sup>C]T1660 and [<sup>11</sup>C]T1650, showed high brain uptake (peak SUV of 3.52 and 3.28, respectively) and specific binding to PDE4D in the monkey CNS. Upon pretreatment with rolipram or BPN14770 (selective PDE4D inhibitor), highest specific binding of [<sup>11</sup>C]T1660 or [<sup>11</sup>C]T1650 was found in prefrontal cortex, temporal cortex, and hippocampus. Notably, [<sup>11</sup>C]T1650 was further advanced to a first-in-man PET study. Although high radioactivity uptake in the human brain was observed, brain <i>V</i><sub>T</sub> increased with scan duration, suggesting the accumulation of brain radiometabolites. Indeed, the high radiometabolite fraction detected in the plasma further supported the notion of accumulating brain radiometabolites, although a blocking effect was found in the hippocampus and amygdala. In conclusion, these findings imply that PDE4D-targeted PET in the nonhuman primate brain is feasible; however, radioligands with improved stability are required.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><div class="NLM_p last">Recently, <sup>11</sup>C-labeled sEH/PDE4 dual inhibitors have been synthesized for PET imaging of neuroinflammation. In particular, MPPA (<i>N</i>-(4-methoxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide) displayed good efficacy by <i>in vitro</i> assays with IC<sub>50</sub> values of 2.1 nM (hsEH) and 8.1 nM (PDE4); however, <i>in vivo</i> performance characteristics of [<sup>11</sup>C]MPPA are yet to be reported.<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(50)</a></div></div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> PDE7—Overview: Subtypes and Distribution</h4><div class="NLM_p">The mammalian cAMP PDE7 family is endowed with two subtypes, namely, PDE7A and PDE7B. While PDE7A consists of three splice variants, PDE7A1–3, in human, and two splice variants in rodents, a single PDE7B variant is known in humans and mice. In contrast, three PDE7B splice variants have been identified so far in rats.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> PDE7 isoenzymes have distinct distribution patterns among different species. As such, human and mouse PDE7B and PDE7A1, along with rat PDE7A2, are mainly located in the brain, while human and mouse PDE7A1 are predominantly expressed in immune cells. Generally speaking, PDE7 subtypes can be found in the mammalian heart, liver, skeletal muscles, kidneys, ovaries, testes, and pancreas.<a onclick="showRef(event, 'ref12 ref51 ref52'); return false;" href="javascript:void(0);" class="ref ref12 ref51 ref52">(12,51,52)</a> It is worth noting, however, that no regulatory domain has been identified in the <i>N</i>-terminal region of PDE7 to date.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></div><div id="sec3_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i12" class="anchor-spacer"></div><h5 class="article-section__title" id="_i12"> Therapeutic Potentials</h5><div class="NLM_p last">The therapeutic potential of targeting PDE7 encompasses immune-related, cardiovascular, reproductive, bone and muscle diseases, as well as CNS disorders and various cancer types. A growing body of evidence demonstrated that PDE7 is implicated in pro-inflammatory processes and plays a key role in T-cell activation/proliferation via regulation of cAMP.<a onclick="showRef(event, 'ref51 ref53'); return false;" href="javascript:void(0);" class="ref ref51 ref53">(51,53)</a> Attributed to their anti-inflammatory effect, PDE7 inhibitors may have the potential to outperform PDE4 inhibitors for the treatment of respiratory diseases in order to reduce typical side effects, such as nausea and vomiting. Similarly, PDE7 inhibition has recently emerged as a good therapeutic option for the treatment of different CNS disorders. As such, studies suggest that the inhibition of PDE7 may provide neuroprotection and be beneficial to treat impaired cognition, neuroinflammation, and depression. Therapeutic benefit from PDE7 inhibitors has been observed in animal models of neurological and inflammatory disorders, including Parkinson’s disease (PD), AD, stroke, MS, and LPS-induced autoimmune encephalomyelitis.<a onclick="showRef(event, 'ref54 ref55'); return false;" href="javascript:void(0);" class="ref ref54 ref55">(54,55)</a> Of note, PDE7 has further been suggested as a pharmacological target in oncology. As such, PDE7 has been linked to chronic lymphocytic leukemia (CLL), mantle cell lymphoma (MCL), and endometrial cancer (EC). Compared to the PDE7B expression in peripheral blood mononuclear cells (PBMCs) from healthy volunteers, PDE7B expression was found to be substantially increased (more than 20-fold) in both CLL and MCL patients’ PBMCs.<a onclick="showRef(event, 'ref52 ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref52 ref56 ref57">(52,56,57)</a> Furthermore, PDE7A was found to promote endometrial cancer cell migration and invasion by downregulation of the miR-1/133a cluster.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a></div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_4"><div id="ac_i13" class="anchor-spacer"></div><h5 class="article-section__title" id="_i13"> Drug Discovery</h5><div class="NLM_p">Due to the high degree of sequence homology (32% in the catalytic domain and 72% in the active site) between PDE7 and PDE4, most PDE7 inhibitors exert pharmacological activity on PDE4. Therefore, the development of PDE7 selective inhibitors is considered challenging. Nonetheless, there are some promising therapeutic agents, and this section will provide selected examples of PDE7-targeted drug development.</div><div class="NLM_p">BRL-50481 is a PDE7A1 selective inhibitor with an IC<sub>50</sub> of 0.26 μM and selectivity over PDE1B, PDE1C, PDE2, PDE3, PDE5, and PDE4A4 (IC<sub>50</sub> = 62 μM). Notably, BRL-50481 was first used as an <i>in vitro</i> tool in human pro-inflammatory cells. Notwithstanding the modest inhibitory effect on human monocytes, lung macrophages, and CD8<sup>+</sup> T-lymphocytes upon stand-alone BRL-50481 treatment, BRL-50481 significantly enhanced the effects of other cAMP-elevating drugs, especially when PDE7A1 was up-regulated.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> Similarly, a study with BRL-50481, TC3.6, S14, and VP1.15 indicated that the latter two enhanced oligodendrocyte precursor (OPC) survival and differentiation during brain development and in adulthood. Of note, PDE7 may act as a therapeutic remyelination agent for the treatment of MS.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> In a follow-up study, TC3.6 and VP1.15 have been demonstrated to possess potent neuroprotective and anti-inflammatory effects in other neurological disorders, including AD, PD, spinal cord injury, and MS.<a onclick="showRef(event, 'ref58 ref60'); return false;" href="javascript:void(0);" class="ref ref58 ref60">(58,60)</a> ASB16165, exhibiting an IC<sub>50</sub> value of 15 nM for human PDE7A, suppressed IL-12-induced IFN-γ production by T lymphoblasts and the induction of activated CD4<sup>+</sup>/CD8<sup>+</sup> T cells. These findings indicated that ASB16165 may be beneficial for the treatment of immunological disorders.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> In particular, ASB16165 was successfully used to treat TNF-α-mediated skin inflammation in a mouse model of TPA-induced dermatitis.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a></div><div class="NLM_p">In the past two decades, a series of heterocyclic small molecules, including benzo-thienothiadiazine dioxides,<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> pyrimidines,<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> thiadiazoles,<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> spiroquinazolinones,<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> sulfides,<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> thieno[3,2-<i>d</i>]pyrimidinones,<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> quinazolinones, and quinazolinethiones,<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> were studied as potent and selective PDE7 inhibitors. A summary of selected PDE7 inhibitors is depicted in <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selected PDE7-targeted therapeutic agents and PET radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_8" class="NLM_sec NLM_sec_level_4"><div id="ac_i14" class="anchor-spacer"></div><h5 class="article-section__title" id="_i14"> PET Ligands</h5><div class="NLM_p">To date, only a few clinical studies on PDE7 ligands have been reported, although several PDE7 selective inhibitors have been validated in animal models. Of note, the development of PDE7 selective PET radioligands is of paramount value to understand the role of PDE7 in various disease pathologies and guide drug discovery efforts. Compared to the diversity of therapeutic agents, radioligand development for PDE7 is lagging behind, with only a few reported examples. As such, [<sup>18</sup>F]MICA-003 (PDE7 IC<sub>50</sub> = 17.0 nM) and [<sup>11</sup>C]MICA-005 (PDE7 IC<sub>50</sub> = 1.7 nM), which are based on a spiroquinazolinone scaffold, were evaluated as PDE7 PET radioligands in the mammalian brain.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Both radioligands were able to penetrate the BBB rapidly and possessed good <i>in vivo</i> stability in the brain—with ∼84% of intact [<sup>11</sup>C]MICA-005 and ∼74% of intact [<sup>18</sup>F]MICA-003, respectively, at 15 min post-injection. Nevertheless, they displayed a homogeneous distribution across the brain, which is not in accordance with known target expression patterns. Further, a fast tracer washout from the brain was observed in PET imaging studies. Consequently, [<sup>18</sup>F]MICA-003 and [<sup>11</sup>C]MICA-005 were not suitable for PDE7 quantification in the brain.</div><div class="NLM_p">Recently, a triazolo-pyrazine derivative, code-named [<sup>11</sup>C]MTP38, was developed as PDE7-targeted PET radioligand. The synthesis of [<sup>11</sup>C]MTP38 was achieved from a bromo precursor using [<sup>11</sup>C]HCN.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Initial autoradiograms and PET scans of rat and rhesus monkey brains showed a higher tracer uptake in the striatum, as compared to the cerebellum. However, a relatively fast washout of [<sup>11</sup>C]MTP38 from the rat and monkey brains ultimately resulted in a moderate <i>in vivo</i> specificity in preclinical studies.<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> Nevertheless, [<sup>11</sup>C]MTP38 is the first PDE7 PET ligand tested in human subjects,<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> and further experiments are warranted to elucidate the suitability of [<sup>11</sup>C]MTP38 not only for subtype-selective PDE imaging, but also for studying target engagement in humans.</div><div class="NLM_p last">In light of the various PDE7-related pathologies, the development of PDE7 selective PET radioligands can help to better define underlying disease mechanisms, thereby providing crucial information for clinical drug discovery.</div></div></div><div id="sec3_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> PDE8—Overview: Subtypes, Distribution, and Characteristics</h4><div class="NLM_p">The cAMP PDE8 family is subdivided into PDE8A and PDE8B. While PDE8A is highly expressed in the testis and T-cells, PDE8B is mainly found in the brain and thyroid. PDE8 exhibits a higher affinity and lower <i>K</i><sub>m</sub> (≈ 0.04–0.15 μM) for cAMP, as compared to other PDE isoforms. Moreover, phosphorylation of PDE8 by PKA triggers its catalytic activity, rendering PDE8 a potential target to control intracellular cAMP levels.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div id="sec3_10" class="NLM_sec NLM_sec_level_4"><div id="ac_i16" class="anchor-spacer"></div><h5 class="article-section__title" id="_i16"> Therapeutic Potentials</h5><div class="NLM_p last">A growing body of evidence suggests that the assembly of PDE8 and Raf-1 may be a novel mechanism to target tumor cells, in which case the Ras/Raf/MEK/ERK pathway plays a critical role in malignant transformation.<a onclick="showRef(event, 'ref10 ref11'); return false;" href="javascript:void(0);" class="ref ref10 ref11">(10,11)</a> Further, the upregulation of both mRNA and protein expression of PDE8A on activated CD4(+) T cells suggests that PDE8-based therapeutics may potentially act as immunomodulators. Notably, studies in PDE8B knockout mice indicated that inhibition of PDE8B can improve cognitive and motor functions.<a onclick="showRef(event, 'ref73'); return false;" href="javascript:void(0);" class="ref ref73">(73)</a> Moreover, it has been reported that PDE8 plays a vital role in Ca<sup>2+</sup> transport in ventricular myocytes, thyroid dysfunction, sperm, and Leydig cell function, as well as T3 and T4 production.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div></div><div id="sec3_11" class="NLM_sec NLM_sec_level_4"><div id="ac_i17" class="anchor-spacer"></div><h5 class="article-section__title" id="_i17"> Drug Discovery</h5><div class="NLM_p">To date, most of the available PDE8 inhibitors are nonselective (e.g., dipyridamole and BC8–15). One of the few exceptions, PF-04957325, was developed by Pfizer and is a widely used PDE8-selective inhibitor with a nanomolar IC<sub>50</sub> value (0.7 nM for PDE8A, 0.3 nM for PDE8B, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). In a model of T-cell adhesion, the PF-04957325-induced suppression for T-cell adhesion to endothelial cells occurred during extravasation.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> These results imply that PDE8 inhibitors can be effective for the treatment of T-cell lymphomas. Currently, there is no example of PDE8 PET radioligands.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structure of PF-04957325, a PDE8-selective inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec3_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> cGMP-Specific PDEs</h3><div class="NLM_p">Several PDEs can degrade cGMP, which is synthesized from GTP by two guanylyl cyclases (GCs), namely, the soluble and particulate GCs. This degradation process serves to regulate the intracellular concentration of cGMP at specific subcellular compartments. Not only does cGMP activate cyclic nucleotide-gated channels (CNGs), but it also stimulates cGMP-dependent protein kinases (PKGs). Indeed, signaling via the cGMP pathway can promote phosphorylation of a large number of downstream targets. Three PDEs, specifically, PDE5, 6, and 9, were found to be merely allosterically modulated by cGMP.<a onclick="showRef(event, 'ref1 ref74'); return false;" href="javascript:void(0);" class="ref ref1 ref74">(1,74)</a> In comparison to PDE6 and PDE9, PDE5 has been relatively well studied in several pathologies, and as such, several PDE5-selective inhibitors and PET probes have been developed. In this section, the pharmacological effects of PDE5 inhibitors and the development of PET radioligands will be emphasized by examples in several disease models. Further, a brief introduction to PDE6- and PDE9-targeted drug development will be provided.</div><div id="sec3_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> PDE5—Structural Overview</h4><div class="NLM_p">The <i>N-</i>terminus of PDE5 is endowed with a phosphorylation site, two allosteric cGMP-binding sites (GAF domains), and at least parts of the dimerization domain. In contrast, the <i>C</i>-terminus bears the catalytic domain, encompassing two zinc-binding motifs and a catalytic cGMP-binding site.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div><div id="sec3_14" class="NLM_sec NLM_sec_level_4"><div id="ac_i20" class="anchor-spacer"></div><h5 class="article-section__title" id="_i20"> Therapeutic Potentials</h5><div class="NLM_p">PDE5 inhibitors, such as sildenafil and vardenafil, were first widely applied as treatments for erectile dysfunction (ED). With the assessment of their efficacy and safety as well as the understanding of the cGMP-mediated regulatory mechanisms, the application in nonreproductive diseases has triggered scientific interest. Accordingly, extensive and diverse preclinical and clinical trials have been performed in recent years, and concurrent PDE5 inhibitors have proven their efficacy for the treatment of pulmonary arterial hypertension (PAH). Indeed, two PDE5 inhibitors have been FDA approved for the treatment of PAH. Importantly, accumulating data indicates that PDE5 inhibitors may be useful to treat several diseases such as coronary artery disease, AD, PD, stroke, and solid tumors. A summary of the various implications of PDE5, stratified by disease area, is provided in <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>.</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Implications of mammalian PDE5 in various pathologies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The role of PDE5 is to degrade cGMP to 5′-GMP. PDE5 inhibition precludes the degradation of cGMP, thus resulting in an upregulation of intracellular cGMP, which enhances the NO/cGMP/PKG signaling pathway and its downstream signal transmission, causing a series of physiological and pathological effects. In the following section, we will introduce the molecular mechanisms by which PDE5 inhibitors contribute to smooth muscle relaxation, cardiovascular protection, and neuroprotection (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). Upon stimulation, endothelial cells release NO, which can diffuse into smooth muscle cells and activate sGCs. sGCs are required to catalyze the generation of cGMP from GTP. Notably, PDE5 inhibitors can block the hydrolysis of cGMP to increase the intracellular concentration of cGMP, which activates PKGs and regulates CNGs. The actions of myosin phosphatases, as well as the phosphorylation of inositol 1,4,5-trisphosphate (IP3) receptor and other substrates, ultimately result in smooth muscle relaxation.<a onclick="showRef(event, 'ref75 ref76'); return false;" href="javascript:void(0);" class="ref ref75 ref76">(75,76)</a></div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cyclic nucleotide signaling cascades leading to smooth muscle relaxation, cardioprotection, and neuroprotection. PDE5Is, PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Several studies on heart injury have concluded that PDE5 inhibitors can play a role in myocardial protection. Although there is ongoing controversy about the downstream mechanism of the NO/cGMP/PKG signaling pathway, it has been shown that the upregulation of cGMP by PDE5 inhibitors may enhance PKG activation, subsequently leading to mitochondrial <i>K</i><sub>ATP</sub> (MitoK<sub>ATP</sub>) channel opening. In mitochondria, opening the MitoK<sub>ATP</sub> channel is beneficial to partially compensate the membrane potential, and results in a normal H<sup>+</sup> electrochemical gradient for ATP synthesis. Further, the latter maintains a healthy Ca<sup>2+</sup> homeostasis, which is crucial to cell survival and exerts cardioprotection.<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a></div><div class="NLM_p last">Recently, applications of PDE5 inhibitors in neurological diseases have been growing fast, particularly in neuroinflammatory and neurodegenerative diseases, due to their protective effects on synaptic plasticity and memory function. The detailed mechanism of action of PDE5 inhibitors in the nervous system has been reviewed elsewhere.<a onclick="showRef(event, 'ref74 ref78'); return false;" href="javascript:void(0);" class="ref ref74 ref78">(74,78)</a> In general, the signaling pathways of NO/cGMP/PKG play an essential role in the treatment of several neurological diseases, such as AD, PD, neuropathic pain, and MS.</div></div><div id="sec3_15" class="NLM_sec NLM_sec_level_4"><div id="ac_i21" class="anchor-spacer"></div><h5 class="article-section__title" id="_i21"> Drug Discovery and PET Ligands</h5><div class="NLM_p">In 1998, sildenafil was the first PDE5 inhibitor to be approved by the FDA and EMA. Subsequently, a series of PDE5 inhibitors, including vardenafil, tadalafil, avanafil, udenafil, and mirodenafil, have been approved for the treatment of ED. In addition, some PDE5 inhibitors have been developed for new indications, including PAH and benign prostatic hyperplasia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> A summary of reported PDE5 inhibitor drugs and PET radioligands is depicted in <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative PDE5 inhibitors and PET radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The first <sup>11</sup>C-labeled PDE5 inhibitor, designated [<sup>11</sup>C]RAl-01, was synthesized by methylation of the phenolic precursor with [<sup>11</sup>C]CH<sub>3</sub>I. Whole-body PET imaging in pigs indicated a time-dependent uptake in the liver, as well as accumulation and elimination of radioactivity in the bile. Further, self-blocking studies, in which initial myocardial uptake of [<sup>11</sup>C]RAL-01 (mean SUV, 3.8 ± 0.8) was significantly reduced by an excess of nonradioactive RAL-01 (mean SUV = 2.6 ± 0.4), unveiled that <i>in vivo</i> binding of [<sup>11</sup>C]RAL-01 is reversible and consistent with the high PDE5 expression in the heart. Of note, however, a low tracer uptake was observed in the lungs, which was unexpected. Given (1) the homogeneous distribution in the brain and (2) that blocking experiments did not result in a statistically significant signal reduction, the use of [<sup>11</sup>C]RAL-01 for PDE5-targeted PET imaging was discontinued.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a></div><div class="NLM_p">Chekol et al. developed a series of <sup>11</sup>C and <sup>18</sup>F labeled PDE5A-selective inhibitors (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, <b>10</b>–<b>14</b> and <b>19</b>–<b>20</b>) based on structure–activity relationship studies with sildenafil, vardenafil derivates, and avanafil analogues.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> By <i>ex vivo</i> biodistribution studies of these radioligands in mice, the uptake of [<sup>11</sup>C]<b>10</b> ([<sup>11</sup>C]sildenafil) and [<sup>18</sup>F]<b>11</b> in the lung at 30 min p.i. (post injection) was highest among all organs (SUV<sub>max</sub> 8.0 ± 1.9 and 8.9 ± 0.8, respectively). After pretreatment with tadalafil (commercially available PDE5 inhibitor), a significantly reduced lung uptake of [<sup>11</sup>C]sildenafil (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>, <b>10</b>) (>86% reduction in %ID and SUV) was observed, indicating that [<sup>11</sup>C]<b>10</b> can specifically bind to PDE5 in the lungs. Nonetheless, other organs, especially the heart, showed no specific tracer binding. The limited uptake in the heart and reproductive system may be attributed to the low expression levels of PDE5 in these organs under physiological conditions. Further, it was shown that [<sup>11</sup>C]<b>10</b> crosses the BBB in rodents and nonhuman primates, however, with limited accumulation in the CNS parenchyma.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a> Of note, PET imaging with [<sup>11</sup>C]<b>10</b> revealed heterogeneous radiotracer distribution with high accumulation in the liver, kidneys, and bladder. In an early phase after tracer injection, images revealed that the radioactivity was accumulated in the brain. At later imaging time points (4–80 min), whole brain uptake was relatively low (%ID/cm<sup>3</sup> < 0.11). Accordingly, [<sup>11</sup>C]<b>10</b> was deemed unsuitable for the quantification of PDE5 expression or occupancy in the brain. Further, radiometabolic analysis using blood samples showed that [<sup>11</sup>C]<b>10</b> was rapidly washed out and metabolized, which is consistent with autoradiograms of <sup>14</sup>C-labeled sildenafil. <i>Ex vivo</i> biodistribution suggested that a fraction of the probe was bound to the blood vasculature and can be displaced with nonlabeled sildenafil. Indeed, displacement studies performed with PET further supported the latter hypothesis.</div><div class="NLM_p">Avanafil analogues <b>15</b>–<b>18</b> and pyrido[3,4-<i>b</i>]pyrazin-2(1<i>H</i>)-one derivatives <b>21</b>–<b>22</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>) were labeled with <sup>11</sup>C or <sup>18</sup>F to visualize PDE5 in the mammalian brain.<a onclick="showRef(event, 'ref82 ref83 ref84 ref85 ref86'); return false;" href="javascript:void(0);" class="ref ref82 ref83 ref84 ref85 ref86">(82−86)</a> Two quinoline-based derivatives, compounds <b>15</b> and <b>16</b>, with high inhibitory activities (IC<sub>50(PDE5)</sub> = 1.86 nM and IC<sub>50(PDE5A)</sub> = 5.92 nM) were labeled with <sup>18</sup>F via a one-step nucleophilic substitution reaction. <i>In vitro</i> autoradiograms of [<sup>18</sup>F]<b>15</b> and [<sup>18</sup>F]<b>16</b> on mouse tissue sections indicated a tracer binding in the heart and lung, which is in accordance with reported PDE5 expression patterns. The competitive binding studies did not show satisfactory specific PDE5 binding, potentially owing to off-target activity. Unfortunately, the high nonspecific binding was also detected by autoradiographic blocking studies of [<sup>18</sup>F]<b>15</b> and [<sup>18</sup>F]<b>16</b> on porcine brain slices.<a onclick="showRef(event, 'ref83 ref86'); return false;" href="javascript:void(0);" class="ref ref83 ref86">(83,86)</a> Given the reported estimations of <i>B</i><sub>max</sub> values (ca. 0.1 nM) in the mouse cerebrum, probes with subnanomolar binding affinity and improved <i>in vivo</i> stability are presumably necessary to achieve a binding potential suitable for neuroimaging.<a onclick="showRef(event, 'ref87'); return false;" href="javascript:void(0);" class="ref ref87">(87)</a></div><div class="NLM_p">In 2017, [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b>, with nanomolar binding affinities toward PDE5 (IC<sub>50</sub> 6.6 nM and 6.4 nM, respectively), were evaluated by <i>in vitro</i> autoradiography and dynamic PET studies in mice. Notably, <i>ex vivo</i> biodistribution studies in wild-type mice revealed an accumulation of [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b> in major organs including the kidneys, liver, lungs, and intestines at 2 min post-injection. Highest uptake value of [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b> was obtained in the lungs at all studied time points. Blocking experiments with tadalafil pretreatment indicated partial PDE5 binding of [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b> in the lungs (32% and 70% signal reductions, respectively, at 30 min p.i.). Evaluations of two tracers were further performed in transgenic mice, overexpressing cardiomyocyte-specific PDE5 (PDE5 TG). In biodistribution studies, highest PDE5-specific uptake was observed for [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b> in the myocardium of PDE5 TG mice at 30 min post-injection. Compared to the baseline scan, a significant reduction of myocardial tracer uptake of both radioligands (80% for [<sup>11</sup>C]<b>21</b> and 87% for [<sup>18</sup>F]<b>22</b>) was observed after tadalafil pretreatment of PDE5 TG mice. These blocking studies revealed that myocardial retention of [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b> in TG mice was PDE5-specific. Furthermore, PET imaging experiments showed specific and reversible binding of [<sup>18</sup>F]<b>22</b> to PDE5 in the myocardium of PDE5 TG mice, as confirmed by the efficient blockade effect with the structurally unrelated PDE5 inhibitor tadalafil in chasing and blocking experiments. Although high brain uptake of [<sup>11</sup>C]<b>21</b> and [<sup>18</sup>F]<b>22</b> was observed by dynamic microPET in rats, this uptake was found to be independent of PDE5, as self-blocking <i>in vivo</i> did not result in any significant reduction in brain uptake.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Finally, <sup>11</sup>C-labeled PDE5 PET tracers ([<sup>11</sup>C]<b>17</b> and [<sup>11</sup>C]<b>18</b>) have been developed for myocardial and neuroimaging; however, their preclinical evaluation has not yet been reported.<a onclick="showRef(event, 'ref84 ref88'); return false;" href="javascript:void(0);" class="ref ref84 ref88">(84,88)</a></div><div class="NLM_p last">In conclusion, PDE5-selective PET tracers that have been developed were particularly tailored toward imaging the cardiovascular system, the lungs, or the brain. Among the existing probes, some exhibit suitable performance characteristics, such as high specific uptake and retention, as well as a broad applicability across species. Nonetheless, myocardial- and lung-targeted probes were plagued by rapid <i>in vivo</i> metabolism. Further, although there is an increasing number of PET studies focusing on PDE5 in the brain, no radioligand with considerable <i>in vivo</i> specificity for PDE5 in the CNS has yet been reported. Possible hurdles include the blood-brain barrier and the relatively low PDE5 expression levels in the CNS. Thus, candidate molecules with high binding affinities, high metabolic stability, and the ability to enter the CNS are need for successful PDE5 PET imaging in the CNS.</div></div></div><div id="sec3_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> PDE6—Overview: Distribution and Function</h4><div class="NLM_p">Phosphodiesterase 6 (PDE6) is highly expressed in the retina, specifically in the internal membranes of retinal photoreceptors. Unlike other PDEs, it is a central effector enzyme in G protein-coupled visual transduction in vertebrate rod and cone photoreceptors.<a onclick="showRef(event, 'ref89 ref90 ref91 ref92'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91 ref92">(89−92)</a></div><div class="NLM_p">In the absence of light, the synthesis of cGMP is reduced by the attenuation of GC activating proteins (GCAPs) via high intracellular Ca<sup>2+</sup> (GCAP becomes loaded with Ca<sup>2+</sup> and can no longer activate GCs). Under these conditions, cGMP activity is suppressed, which increases the influx of Ca<sup>2+</sup> and Na<sup>+</sup> via CNGCs and maintains low cGMP levels. In the presence of light, however, photon (<i>h</i>ν) absorption induces rhodopsin conformational changes, which triggers the activation of the GTP-binding protein transducin, thereby releasing the inhibitory γ subunit from PDE6. Once PDE6 is active, it hydrolyzes cGMP and the decreasing cGMP levels lead to the closure of CNGCs. Since Ca<sup>2+</sup> is constantly extruded via Na<sup>+</sup>/Ca<sup>2+</sup>/K<sup>+</sup> exchanger (NCKX), a reduction of intracellular Ca<sup>2+</sup> levels can be observed, allowing Mg<sup>2+</sup> to replace Ca<sup>2+</sup> at the GCAP binding site, thereby reactivating GCAP and stimulating GC to synthesize new cGMP. This, in turn, leads to reopening of CNGCs and restores photoreceptor sensitivity during light adaptation (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref90 ref91 ref92 ref93 ref94'); return false;" href="javascript:void(0);" class="ref ref90 ref91 ref92 ref93 ref94">(90−94)</a> Consequently, both cGMP and Ca<sup>2+</sup> concentrations in the photoreceptor are closely linked by a feedback loop that would normally limit the levels of both second messengers to their physiological ranges.<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a></div><figure id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Role of PDE6 in rod outer segments. GTP, Guanosine triphosphate; GCs, guanylyl cyclases; GCAP, GC activating proteins; CNGC, cyclic nucleotide gated channel; 5′GMP, guanosine-5′-monophosphate; GTP, guanosine triphosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">cGMP/PKG-dependent cell death in photoreceptors was found in several experiments using mouse models of retinal degeneration (rd). Genetic loss-of-function mutations in PDE6 lead to the upregulation of cGMP. Both activation of CNGCs to elevate the Ca<sup>2+</sup> and activation of PKG via increasing cGMP are caused by photoreceptor cell death.<a onclick="showRef(event, 'ref96 ref97'); return false;" href="javascript:void(0);" class="ref ref96 ref97">(96,97)</a> Accordingly, PDE6 may be a potential biomarker for the diagnosis of retinopathy.</div><div class="NLM_p">It is noteworthy that PDE6 is also found to be expressed in breast cancer cell lines and breast cancer patient biopsies, at both mRNA and protein levels.<a onclick="showRef(event, 'ref98'); return false;" href="javascript:void(0);" class="ref ref98">(98)</a> However, further studies are needed to fully elucidate the role of PDE6 in breast cancer.</div><div class="NLM_p last">Due to the similarity in structure and biological activities, many PDE5 inhibitors also possess inhibitory activity to PDE6. For example, the most extensively studied PDE5 inhibitor, sildenafil, effectively inhibits the activity of rod PDE6 (<i>K</i><sub>i</sub> up to 30 nM). The notion that sildenafil can cause transient visual dysfunction has been underlined in clinical electroretinogram studies.<a onclick="showRef(event, 'ref89'); return false;" href="javascript:void(0);" class="ref ref89">(89)</a> Thus, undesired binding to PDE6 should be avoided in the development of other PDE inhibitors.</div></div><div id="sec3_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> PDE9</h4><div class="NLM_p">Among the cyclic nucleotide PDE superfamily, PDE9 specifically hydrolyzes cGMP with high efficiency. Structurally, all 21 splice variants are derived from a single PDE9A gene, and there are no GAF domains or other regulatory sequences in the <i>N</i>-terminal region. Human PDE9A has the highest expression levels in Purkinje neurons and the cerebellum, followed by the spleen, intestine, and other sublocations of the brain.<a onclick="showRef(event, 'ref1 ref13'); return false;" href="javascript:void(0);" class="ref ref1 ref13">(1,13)</a> The reported studies in animal models support the concept that PDE9 inhibitors could improve cognitive function by blocking PDE9 activity in the hippocampus and cortex. Therefore, PDE9 has emerged as a valuable therapeutic target to treat memory impairment in dementia.<a onclick="showRef(event, 'ref12 ref40 ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref12 ref40 ref41 ref42">(12,40−42)</a> Although both BI-409306 and PF-04447943 have been found to be safe and well-tolerated in the clinic, they failed to improve cognitive function in patients or healthy subjects. BI-409306 is currently being tested for the prevention of schizophrenia relapse as well as for the prevention of the first psychotic episode in schizophrenia patients.<a onclick="showRef(event, 'ref99'); return false;" href="javascript:void(0);" class="ref ref99">(99)</a></div><div class="NLM_p">Similar to PDE5, PDE9 was found to play a key role in the regulation of cGMP/PKG signaling pathways in the cardiovascular system. A wealth of studies support that PDE9 inhibitors can be a valid therapeutic target in heart failure, left ventricular hypertrophy, and sickle cell anemia.<a onclick="showRef(event, 'ref4 ref100 ref101'); return false;" href="javascript:void(0);" class="ref ref4 ref100 ref101">(4,100,101)</a> Furthermore, PDE9A expression levels in malignant breast tumors are higher than in control tissues.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a> BAY 73–6691 significantly inhibited cell proliferation and induced apoptosis of MCF-7 and MDA-MB468 breast cancer cells in a dose- and time-dependent manner.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">More PDE9 inhibitors with high binding affinity are being developed to combat neurodegenerative disorders, cardiovascular diseases, and various cancer types. A summary of representative inhibitors is provided in <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>.<a onclick="showRef(event, 'ref103 ref104'); return false;" href="javascript:void(0);" class="ref ref103 ref104">(103,104)</a></div><figure id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Representative PDE9-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i24">Dual-Specific PDEs</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_00434" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_00434" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> PDE1—Overview: Subtypes, Distribution, and Therapeutic Potentials</h3><div class="NLM_p">PDE1 possesses a dual-substrate activity and comprises three family subtypes (PDE1A, PDE1B, and PDE1C) with distinct distributions and various isoforms (<a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>). The ubiquitous expression of PDE1A in the brain is the lowest out of all three subtypes, while PDE1B shows the highest expression levels in the nucleus accumbens. With regard to the periphery, PDE1A is highly expressed in the kidney and thyroid gland, whereas PDE1C is predominantly expressed in the heart, urinary bladder, and lungs.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Among all PDEs, PDE1 is the only enzyme that is stimulated by Ca<sup>2+</sup>/calmodulin (CaM), thereby resulting in unique cross-talk between Ca<sup>2+</sup> and cyclic nucleotides.<a onclick="showRef(event, 'ref105'); return false;" href="javascript:void(0);" class="ref ref105">(105)</a> Owing to the specific distribution of PDE1 in the brain and its characteristic Ca<sup>2+</sup>/calmodulin-dependent activity, PDE1 inhibitors are generally deemed efficacious in improving the cognitive function in neurodegenerative diseases.</div><figure id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Selected PDE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> Drug Discovery</h4><div class="NLM_p last">The most established PDE1 selective inhibitor to date, vinpocetine (IC<sub>50(PDE1)</sub> = 30 μM), was found to cross the blood-brain barrier, resulting in a favorable outcome in patients suffering from disorders of cerebrovascular origin. Particularly in ischemic post-stroke patients, treatment with vinpocetine showed regional cerebral blood flow redistribution and enhancement of glucose brain supply.<a onclick="showRef(event, 'ref106'); return false;" href="javascript:void(0);" class="ref ref106">(106)</a> In preclinical mice studies, prolonged vinpocetine intake notably resulted in significant improvement of learning and memory.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> In clinical settings, vinpocetine was investigated in memory impairment (NCT00719953), cerebral infarction (NCT01400035), traumatic brain injury (NCT01515839), epilepsy (NCT02011971, suspended), and inflammation (NCT02878772). Further studies with vinpocetine indicated its antioxidant, anti-inflammatory, and anti-apoptotic effects,<a onclick="showRef(event, 'ref108'); return false;" href="javascript:void(0);" class="ref ref108">(108)</a> as well as cognitive dysfunction amelioration in AD patients.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> A highly potent and selective PDE1 inhibitor, ITI-214 (IC<sub>50(PDE1)</sub> = 0.058 nM, >1000-fold selectivity over other PDEs),<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a> enhanced acquisition, consolidation, and retrieval memory processes in rats.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> Results obtained from studies performed in heart failure disease models of rabbits and dogs suggested that ITI-214 is a potential novel therapeutic agent for patients with heart failure because it can inhibit the activity of PDE1, thereby enhancing cGMP signaling and mediating relaxation of vascular smooth muscles and prompting vasodilation. As such, ITI-214 is being currently assessed in a clinical trial of heart failure (NCT03387215, recruiting)—in addition to its evaluation in schizophrenia (NCT01900522, terminated) and PD (NCT03257046). Given these results, it is not surprising that two ITI-214 structurally related PDE1 inhibitors induced concentration-dependent relaxations and vasodilation in rats, namely, Lu AF58027 (IC<sub>50(PDE1)</sub> = 13 nM) and Lu AF41228 (IC<sub>50(PDE1)</sub> = 170 nM).<a onclick="showRef(event, 'ref112 ref113'); return false;" href="javascript:void(0);" class="ref ref112 ref113">(112,113)</a> Despite the continuous development of novel PDE1 inhibitors, such as the recently reported DNS-0056 (IC<sub>50(PDE1)</sub> = 26 nM)<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> and PF-04827736 (IC<sub>50(PDE1)</sub> = 9 nM),<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> no scientific work has been published describing the development of a PDE1 PET tracer. Nonetheless, there is a few examples toward PDE1 tracer development provided as part of a patent application and conference proceedings that show rapid brain uptake.<a onclick="showRef(event, 'ref116 ref117 ref118'); return false;" href="javascript:void(0);" class="ref ref116 ref117 ref118">(116−118)</a></div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> PDE2—Overview: Distribution and Therapeutic Potentials</h3><div class="NLM_p">Similar to PDE1, PED2 is a dual substrate-specific phosphodiesterase. However, unlike PED1, it is encoded by the single gene PDE2A with three splice variants (PDE2A1, PDE2A2, and PDE2A3) varying in their <i>N</i>-terminus. Their variability extends to their cellular localization and expression levels. For instance, PDE2A1 is soluble, while PDE2A2 and PDE2A3 are membrane-associated.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a> PDE2A mRNA is more abundant in human brain than peripheral tissues with the highest expression found to be in the caudate, nucleus accumbens, cortex, and hippocampus.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> These expression levels may justify the potential application of PDE2A inhibitors in memory and cognitive function enhancement.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> Each PDE2A variant contains GAF-A and GAF-B domains in their respective <i>N</i>-terminus. Binding of the cGMP to GAF-B positively stimulates the hydrolysis of cAMP and reduces aldosterone secretion, which in turn allows PDE2A to orchestrate a “cross-talk” between cAMP and cGMP signaling cascades.<a onclick="showRef(event, 'ref12 ref121'); return false;" href="javascript:void(0);" class="ref ref12 ref121">(12,121)</a></div><div id="sec4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> Drug Discovery</h4><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>, various PDE2A inhibitors have been developed and evaluated in preclinical and clinical settings.<a onclick="showRef(event, 'ref120 ref121'); return false;" href="javascript:void(0);" class="ref ref120 ref121">(120,121)</a> The very first known PDE2A selective inhibitor, adenine derivative EHNA (IC<sub>50(PDE2A)</sub> = 800 nM), was not suitable for clinical development owing to its limited potency. A follow-up candidate, BAY-60–7550 (IC<sub>50(PDE2A)</sub> = 4.7 ± 1 nM), enhanced long-term potentiation of synaptic transmission without altering basal synaptic transmission, and exhibited improved memory effects in rat studies. Further studies in rats revealed that the improvement occurred across different age groups via the enhancement of nitric oxide synthase (NOS) activity in the brain.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> Subsequent studies with BAY-60–7550 in rats confirmed the improvement of memory consolidation in both early and late phases.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> Further, treatment with BAY-60–7550 led to the reduction of stress-induced memory impairment by modulating the neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling pathway.<a onclick="showRef(event, 'ref124'); return false;" href="javascript:void(0);" class="ref ref124">(124)</a> Other PDE2A inhibitors such as ND-7001, PF-999 (also termed PF-05180999), and TAK-915 have been evaluated in clinical phase I trials.<a onclick="showRef(event, 'ref120 ref125'); return false;" href="javascript:void(0);" class="ref ref120 ref125">(120,125)</a> ND-7001 (IC<sub>50(PDE2A)</sub> = 1 nM)<a onclick="showRef(event, 'ref126 ref127'); return false;" href="javascript:void(0);" class="ref ref126 ref127">(126,127)</a> was found to be safe and well tolerated with no apparent withdrawal effects.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> PF-999 (IC<sub>50(PDE2A)</sub> = 1 nM) was not perceived as safe; its development was discontinued due to safety concerns (NCT01981499). Other trials were either withdrawn (NCT01981486) or the results have not been disclosed (NCT01429740 and NCT01530529). More recently, TAK-915 (IC<sub>50(PDE2A)</sub> = 0.61 nM)<a onclick="showRef(event, 'ref128'); return false;" href="javascript:void(0);" class="ref ref128">(128)</a> was used for the occupancy study of PDE2A in the brain (NCT02584569) after the evaluation of the safety and tolerability of TAK-915 in healthy volunteers (NCT02461160).</div><figure id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Selected PDE2 inhibitors and radiotracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> PET Ligands</h4><div class="NLM_p">In 2013, [<sup>18</sup>F]B-23 (IC<sub>50(hPDE2A)</sub> = 1.4 nM, IC<sub>50(rPDE10A)</sub> = 14 nM) was found to be a potent PDE2 PET tracer out of ∼200 compounds that were synthesized and evaluated by Janssen Pharmaceutica NV. As such, it was evaluated in biodistribution, radiometabolite analysis, and PET imaging studies.<a onclick="showRef(event, 'ref129'); return false;" href="javascript:void(0);" class="ref ref129">(129)</a> From the results of these experiments, [<sup>18</sup>F]B-23 showed the highest brain uptake and the slowest washout (2 min-to-30 min ratio = 7.1) in the striatum. Nonetheless, 92% and 82% of intact tracer was detected in the cerebrum and cerebellum, respectively, after 10 min post-injection in rats. The poor metabolic stability halted its further clinical development and utility. Concurrently, a highly selective PDE2 PET tracer, [<sup>18</sup>F]PF-05270430 (IC<sub>50(hPDE2A)</sub> = 0.53 nM), was reported by L. Zhang et al.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> It was developed based on the structure–activity relationship using PDE2 inhibitor <b>23</b> (IC<sub>50(PDE2A)</sub> = 2.3 nM, >500-fold over other PDEs) as a lead scaffold. PDE2 inhibitor <b>23</b> was identified based on PET probe design parameters for physicochemical properties, brain permeability, and nonspecific binding out of 77 radioligands. PET imaging in nonhuman primates showed a rapid and high uptake in the striatum, which could be specifically blocked by the structurally related PDE2A inhibitor PF-999.<a onclick="showRef(event, 'ref131'); return false;" href="javascript:void(0);" class="ref ref131">(131)</a> However, [<sup>18</sup>F]PF-05270430 displayed low binding potential values that were calculated with the cerebellum as a reference region.<a onclick="showRef(event, 'ref132'); return false;" href="javascript:void(0);" class="ref ref132">(132)</a></div><div class="NLM_p last">In 2015, Schröder et al. reported two <sup>18</sup>F-radiolabeled fluoroalkylated triazine derivatives, [<sup>18</sup>F]TA3 and [<sup>18</sup>F]TA4), as potential PET radioligands.<a onclick="showRef(event, 'ref133'); return false;" href="javascript:void(0);" class="ref ref133">(133)</a> Both [<sup>18</sup>F]TA3 (IC<sub>50(hPDE2A)</sub> = 11.4 nM, IC<sub>50(hPDE10A)</sub> = 318 nM) and [<sup>18</sup>F]TA4 (IC<sub>50(hPDE2A)</sub> = 7.3 nM, IC<sub>50(hPDE10A)</sub> = 913 nM) showed specific binding to regions in line with the known PDE2A distribution in rat brain in <i>in vitro</i> autoradiographic studies. Despite these results, the radiometabolites of the two radioligands were found to cross the blood-brain barrier when they were assessed in <i>ex vivo</i> mice metabolite studies, thus impeding their further development.<a onclick="showRef(event, 'ref134'); return false;" href="javascript:void(0);" class="ref ref134">(134)</a> Similarly, [<sup>18</sup>F]TA5 (IC<sub>50(hPDE2A)</sub> = 3 nM, IC<sub>50(hPDE10A)</sub> > 1000 nM), a potent PDE2A ligand belonging to the imidazopyridotriazine structural class, suffered from rapid degradation and the presence of radiomebolites in the mouse brain, thereby rendering [<sup>18</sup>F]TA5 unsuitable for PET imaging of PDE2A.<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> Contrary to these results, another PDE2A PET radioligand, [<sup>18</sup>F]BIT1 (IC<sub>50(PDE2A)</sub> = 3.3 nM, 16-fold over PDE10A), showed appropriate metabolic stability and moderate brain uptake in mice.<a onclick="showRef(event, 'ref136'); return false;" href="javascript:void(0);" class="ref ref136">(136)</a> The drawback of this tracer, however, became apparent in <i>in vitro</i> autoradiographic experiments with pig brain cryosections. Despite showing high tracer accumulation in regions known for their high PDE2A expression, [<sup>18</sup>F]BIT1 exhibited nonspecific binding in blocking studies with the structurally related PDE2A inhibitor TA1 and BIT1.<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a></div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> PDE3—Overview: Subtypes, Distribution, and Therapeutic Potentials</h3><div class="NLM_p">Comparable to the aforementioned PDE1 and PDE2, PDE3 hydrolyzes both cAMP and cGMP with a higher affinity for cGMP than for cAMP. It is transcribed from two genes (PDE3A, PDE3B) that encompass four variants (PDE3A1, PDE3A2, PDE3A3, and PDE3B).<a onclick="showRef(event, 'ref6 ref12'); return false;" href="javascript:void(0);" class="ref ref6 ref12">(6,12)</a> PDE3 is abundant in the cardiovascular system<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> where PDE3A exhibits the highest expression of all PDEs in the heart. PDE3B, on the other hand, shows the highest expression in the liver.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Owing to the diverse localization, these variants orchestrate various physiological responses via unique protein–protein interactions.<a onclick="showRef(event, 'ref138'); return false;" href="javascript:void(0);" class="ref ref138">(138)</a> Recently, PDE3 inhibition studies in mice showcased a critical role of PDE3 in basophil and mast cell degranulation, and suggested PDE3 inhibitors as potential therapeutic agents for allergic disease.<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a></div><div id="sec4_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Drug Discovery</h4><div class="NLM_p">As shown in <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>, a number of PDE3 inhibitors have already been approved by the FDA and other health authorities. For instance, cilostazol was FDA-approved in 1999 for intermittent claudication. Amrinone (FDA 1984), milrinone (FDA 1987), enoximone (France 1987), pimobendan (Japan 1994), and olprinone (Japan 1996) were approved for the treatment of congestive heart failure, while anagrelide was approved by the FDA in 1997 for the treatment of thrombocythemeia.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Today, numerous clinical trials have been concluded to evaluate the safety, tolerance, efficacy, and other pharmacological properties of these inhibitors. Cilostazol is the most investigated PDE3 inhibitor to date; 137 clinical trials have been registered so far on ClinicalTrial.gov, mainly in Asia (83). These trials explored the therapeutic potential of cilostazol against cerebral infarction, contraception, migraine, tinnitus, and other diseases. Cilostazol was initially considered efficient for the treatment of stroke.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> Given its improvement of cognitive function by elevating cerebral circulation and Aβ clearance,<a onclick="showRef(event, 'ref141'); return false;" href="javascript:void(0);" class="ref ref141">(141)</a> cilostazol showed great potency in suppression of cognitive decline in AD patients, though with no substantial effect on dementia.<a onclick="showRef(event, 'ref142'); return false;" href="javascript:void(0);" class="ref ref142">(142)</a> On the molecular level, the beneficial effects could be attributed to the prevention of oxidative damage in the hippocampus<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a> and the reduction of Aβ accumulation and tau phosphorylation through diminishing ApoE-mediated Ab aggregation.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a> Furthermore, a recent study encompassing 9148 participants showed a dose-dependent reduction of dementia emergence rates with cilostazol.<a onclick="showRef(event, 'ref145'); return false;" href="javascript:void(0);" class="ref ref145">(145)</a> The latest studies demonstrated the efficacy of cilostazol in alopecia,<a onclick="showRef(event, 'ref146'); return false;" href="javascript:void(0);" class="ref ref146">(146)</a> Down syndrome,<a onclick="showRef(event, 'ref147'); return false;" href="javascript:void(0);" class="ref ref147">(147)</a> and allergic diseases,<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> rendering cilostazol a multipurpose drug. Meanwhile, olprinone was proven to reduce liver ischemia-reperfusion injury by preventing oxidative stress and activating PKA.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> It was additionally evaluated as a possible therapy for acute respiratory distress syndrome (ARDS).<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a></div><figure id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Selected PDE3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> PDE10—Overview: Structure and Distribution</h3><div class="NLM_p">Phosphodiesterase-10 (PDE10) is a dual-substrate specific enzyme that can degrade the intracellular cAMP (<i>K</i><sub>m</sub> = 0.05 μM) and cGMP (<i>K</i><sub>m</sub> = 3 μM). Both substrates are key second messengers that regulate a number of cellular processes like long-term potentiation, synaptic plasticity, and neurotransmission. PDE10 was found to exhibit a high expression in the CNS (striatum, substantia nigra, and globus pallidus) and a limited distribution in peripheral tissues.<a onclick="showRef(event, 'ref150'); return false;" href="javascript:void(0);" class="ref ref150">(150)</a> Another peculiar characteristic is that PDE10 is the only family of mammalian PDEs that can be activated by cAMP via binding to the GAF domain of PDE10.<a onclick="showRef(event, 'ref151'); return false;" href="javascript:void(0);" class="ref ref151">(151)</a> Two known predominant human isoforms (cytosolic PDE10A1 and membrane-bound PDE10A2) share an almost-identical sequence with the exception of the <i>N</i>-terminal portion of PDE10A2 that bears a putative phosphorylation site by PKA.</div><div id="sec4_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> Therapeutic Potentials</h4><div class="NLM_p">The highest expression level of PDE10A in striatum compared to all other PDEs propose PDE10A inhibitors as a potential therapy for neurodegenerative and neuropsychiatric diseases, such as AD, HD, PD, and schizophrenia. The PKA/PKG-activated downstream proteins in the signaling cascade play significant roles in these diseases. For instance, CREB that is activated by PKA and BDNF modulate neuronal survival and plasticity. Furthermore, BDNF heavily influences striatal growth, and it has been found to exert a pathological increase in post-synaptic signaling in HD.<a onclick="showRef(event, 'ref152'); return false;" href="javascript:void(0);" class="ref ref152">(152)</a> Reports of <i>in vitro</i> studies using highly specific monoclonal antibodies showed that the phosphorylations of tau by PKA created an AD-like state, and led to the dysregulation of subcellular localization of the β catalytic subunit of PKA (PKA-Cβ), the βII regulatory subunit of PKA (PKA-RIIβ), and the 79 kDa A-kinase-anchoring protein (AKAP79), which are key players in neurofibrillary pathology in AD.<a onclick="showRef(event, 'ref153'); return false;" href="javascript:void(0);" class="ref ref153">(153)</a> EPACs were shown to influence the amyloid precursor protein (APP), a known key protein in AD.<a onclick="showRef(event, 'ref154'); return false;" href="javascript:void(0);" class="ref ref154">(154)</a> Recently, PDE10A was also found to be implicated in other diseases. Specifically, the <i>in vitro</i> decrease of nitrite production, induced by lipopolysaccharide (LPS), indicated the potential of allosteric PDE10A modulators as anti-inflammatory agents.<a onclick="showRef(event, 'ref155'); return false;" href="javascript:void(0);" class="ref ref155">(155)</a> Studies in PDE10A knockout mice validated the PDE10A regulatory role of caloric intake and energy expenditure.<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> PET imaging studies, on the other hand, demonstrated the expression of PDE10A in brown adipose tissues (BAT) in both mice and human. Uncoupling protein 1 (UCP-1) was found reduced in mice treated with the PDE10A inhibitor MP-10 (PF-02545920).<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> Finally, treatment with MP-10 inhibited the β-catenin signaling by activating cGMP/PKG signaling pathway. Consequently, the downstream transcription of cellular surviving factors was reduced, resulting in tumor cell growth suppression.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a></div><div class="NLM_p">PDE10A plays a substantial role in neurodegenerative disorders, obesity, inflammatory diseases, and cancer. Due to the high expression of PDE10A in the striatum (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>), clinical investigations were heavily focused on schizophrenia and HD. Contrary to the promising preclinical studies, the clinical outcomes were mostly disappointing.</div><figure id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Signaling pathways of PDE10 inhibitors for various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> Drug Discovery</h4><div class="NLM_p last">In the last two decades, the safe and tolerable inhibitor MP-10 has been the most investigated PDE10 inhibitor. Initial evaluations of MP-10 in schizophrenia were terminated early due to either alarming safety concerns (NCT00570063) or failing to meet the prespecified efficacy criteria (NCT01939548) or poor efficacy (NCT01175135).<a onclick="showRef(event, 'ref159'); return false;" href="javascript:void(0);" class="ref ref159">(159)</a> Clinical trials in the HD population did not fare any better; no significant differences could be detected between MP-10 and placebo (NCT01806896, NCT02197130). Early termination took place during a clinical phase II study assessment that was aiming at investigating the long-term safety, tolerability, and efficacy of MP-10 in HD patients as a result of discouraging findings obtained with study A8241021 (NCT02342548). Other PDE10A inhibitors followed suit when evaluated in schizophrenia and HD patients. For example, evaluation of AMG579 in healthy volunteers and patients was terminated due to business-related reasons (NCT01568203). Another example is TAK-063, which elicited higher incidence of akathisia, dystonia, and extrapyramidal syndromes than the placebo group in phase I (NCT01879722),<a onclick="showRef(event, 'ref160'); return false;" href="javascript:void(0);" class="ref ref160">(160)</a> whereas the phase II study of the same drug failed to reach the designated primary end point (NCT02477020).<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> Another PDE10A inhibitor, OMS643762, was tested in clinical phase II trials, more specifically in HD patients. This trial was, however, terminated by Omeros Corporation (NCT02074410), and evaluation of PBF-999 was similarly terminated due to an amendment in the proposed therapeutic indication (NCT02907294). Despite all the aforementioned results, the clinical interest in these drugs did not wane. There are multiple clinical trials that are still ongoing; MP-10 (NCT00463372), OMS643762 (NCT01952132), EVP-6308 (NCT02037074), RO5545965 (NCT02019329, NCT02824055) in schizophrenia patients, and PBF-999 (NCT02208934) in HD patients. Furthermore, the clinical interest in PDE10A inhibitors is branching toward other diseases, as in the case of the evaluation of PBF-999 in cancer (NCT03786484) and TAK-063 in preventing ketamine-induced brain activity changes (NCT01892189).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> PET Ligands</h4><div class="NLM_p">Based on the structure of specific PDE10A inhibitor MP-10 (PF-02545920, IC<sub>50 (PDE10A)</sub> = 0.18 nM), a number of <sup>11</sup>C- and <sup>18</sup>F-labeled analogues have been developed for the purpose of PET imaging of PDE10A (<a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig16" id="" class=" internalNav">16</a></a>). In 2011, Tu et al. reported that <i>in vivo</i> PET imaging studies with [<sup>11</sup>C]MP-10 displayed high selective binding in the striatum of both rat and rhesus monkey brains.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a> Later studies by Plisson et al. unveiled a rapid uptake and wash-out kinetics of [<sup>11</sup>C]MP-10 in porcine brains, underlining its potential clinical utility.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> PET imaging with [<sup>11</sup>C]MP-10 and <i>ex vivo</i> analysis proved that a prior treatment with an anti-psychotic medication (haloperidol, 2 mg/kg/d) in rodents did not alter PDE10A levels <i>in vivo</i>.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> However, due to the lipophilic nature of a radiolabeled metabolite that was able to cross the BBB, [<sup>11</sup>C]MP-10 showed reversible kinetics in baboon but irreversible kinetics in rhesus monkeys.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> To address the radioactive metabolite concern, Fan et al. developed TZ1964B (IC<sub>50 (PDE10A)</sub> = 0.40 ± 0.02 nM) by optimizing the labeling position.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> This strategy proved to be advantageous; [<sup>11</sup>C]TZ1964B showed high striatal uptake (1.8 SUV at 30 min p.i.), and no persistently increasing radioactivity in the brain was detected in <i>in vivo</i> PET studies, thereby indicating a superior radiometabolic stability of [<sup>11</sup>C]TZ1964B.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a> Further PET studies in rodents and nonhuman primates corroborated the earlier results obtained by Fan and co-workers.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a></div><figure id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0016.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Selected PDE10 inhibitors and radiotracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In the same year, Celen et al. reported the <sup>18</sup>F-labeled quinoline derivative [<sup>18</sup>F]JNJ-41510417 (IC<sub>50(PDE10A)</sub> = 0.5 nM) as a specific and reversible radiotracer for PDE10A with slow brain kinetics.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a> Later, a structurally related derivative, [<sup>18</sup>F]JNJ-42259152 (IC<sub>50(PDE10A)</sub> = 2 nM), was developed. It was characterized by a relatively faster brain kinetics and a higher specific to nonspecific binding ratio in rodents and nonhuman primates than [<sup>18</sup>F]JNJ-41510417.<a onclick="showRef(event, 'ref170 ref171'); return false;" href="javascript:void(0);" class="ref ref170 ref171">(170,171)</a> Following <i>in vivo</i> studies in a Huntington mouse model, early regional dysfunctions in PDE10A signaling was found in the caudate-putamen and lateral globus pallidus.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> Although significant reduction of putamen uptake in HD patients (63% decline compared with healthy controls) was observed, no evidence pertaining to a correlation between the loss of PDE10A and disease severity was found.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> In the presence of cAMP (10 μm), <i>in vitro</i> studies showed a higher binding affinity (<i>K</i><sub>d</sub> = 3.17 ± 0.91 nM) to PDE10A than without cAMP (<i>K</i><sub>d</sub> = 6.62 ± 0.7 nM), consistent with the particular role for cAMP to regulate the activity of PDE10A.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> In a PET imaging study with [<sup>18</sup>F]JNJ-41510417 in rats that were treated beforehand with <span class="smallcaps smallerCapital">d</span>-amphetamine and the D<sub>2</sub> antagonist SCH23390, prominent alterations in PDE10A binding were evident. These results suggest a potential interplay between DA neurotransmission and PDE10A expression.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> However, similar to [<sup>11</sup>C]MP-10, the radiometabolite obtained from the 2-[<sup>18</sup>F]fluoroethoxy group has confounded the brain imaging results and, as such, precluded the utility of this radioligand in future studies.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a></div><div class="NLM_p">Papaverine (IC<sub>50(PDE10A)</sub> = 36 nM) is a natural and potent PDE10A inhibitor that showed rapid brain clearance when it was labeled with carbon-11. Nonetheless, its structure served as the basis for further synthetic modifications such as PQ-10 (IC<sub>50(PDE10A)</sub> = 16 nM).<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> A radioanalogue of PQ-10, [<sup>18</sup>F]<b>24</b>, was developed by the Brust group where it showed better brain kinetics compared to [<sup>11</sup>C]papaverine, alongside an appropriate metabolic stability in mice. However, this radiotracer was plagued by the lack of specific binding properties, as shown by autoradiographic and <i>in vivo</i> blocking studies with MP-10.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> In 2014, the first report of [<sup>18</sup>F]MNI-654 (<i>K</i><sub>d</sub> = 0.029 nM) and [<sup>18</sup>F]MNI-659 (<i>K</i><sub>d</sub> = 0.097 nM) in humans from Oliver and co-workers demonstrated suitable stability (∼20% of intact parent remained at 120 min p.i. for both tracers) and high uptake in caudate, putamen, and globus pallidus (peak SUV of ∼0.7–1.0 for [<sup>18</sup>F]MNI-654 and ∼1.5–2.5 for [<sup>18</sup>F]MNI-659), which is in line with the known PDE10A distribution in the human brain.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> In view of the favorable kinetics, signal-to-background, and test–retest reliability, [<sup>18</sup>F]MNI-659 was selected by Russell et al. for imaging premanifest HD (pre-HD), manifest HD (m-HD) (stage 1 and 2), and healthy volunteers (HV).<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The striatal uptake of [<sup>18</sup>F]MNI-659 in the HD cohort was noticeably reduced (−48% than HV) and the authors observed a strong inverse correlation between the disease severity and PDE10A tracer uptake, inconsistent with prior studies using [<sup>18</sup>F]JNJ-42259152.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Later, a 15 month longitudinal study showed a sharp reduction in the basal ganglia BP<sub>ND</sub> (nondisplaceable binding potential, about 50% reduction compared to HV). Additionally, annualized rates of decline of [<sup>18</sup>F]MNI-659 uptake in caudate (16.6%), putamen (6.9%), and globus pallidus (5.8%) in all 8 HD participants, as compared to HV (1% in striatum), were observed, thus highlighting that [<sup>18</sup>F]MNI-659 is a sensitive and reliable imaging agent for PDE10A imaging.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> Similarly, an <i>in vivo</i> imaging trial in 40 healthy participants resulted in a 7.8% decline per decade of PDE10A availability in the striatum with regard to age and gender, and a decline to a lesser extent (4.3% per decade) of D<sub>2/3</sub> receptor availability in basal ganglia.<a onclick="showRef(event, 'ref181'); return false;" href="javascript:void(0);" class="ref ref181">(181)</a> Given the reduced uptake in striatum in those HD cohorts, <i>in vivo</i> imaging in heterozygous (HET) Q175 mice suggested an MRI-based spatial normalization rather than PET or CT template-based approach would be more favored in order to achieve a better accuracy of BP<sub>ND</sub> quantification.<a onclick="showRef(event, 'ref182'); return false;" href="javascript:void(0);" class="ref ref182">(182)</a> Furthermore, [<sup>18</sup>F]MNI-659 was the tracer of choice to measure PDE10A distribution in healthy post-mortem brains to acquire further information about its presence and density.<a onclick="showRef(event, 'ref183'); return false;" href="javascript:void(0);" class="ref ref183">(183)</a> Despite the potential utility of [<sup>18</sup>F]MNI-659 in preclinical and clinical evaluation of HD, the 2-[<sup>18</sup>F]fluoroethoxy group would be easily metabolized, thereby interfering with the brain PET imaging results. In 2019, [<sup>18</sup>F]<b>25</b> was developed by replacing the 2-[<sup>18</sup>F]fluoroethoxy group with a [<sup>18</sup>F]fluoromethoxy-<i>d</i><sub>2</sub> moiety. This small modification proved to be critical, leading to better radiometabolic profile and higher BP<sub>ND</sub> values than [<sup>18</sup>F]MNI-659, as well as placing it at the forefront for future clinical applications.<a onclick="showRef(event, 'ref184'); return false;" href="javascript:void(0);" class="ref ref184">(184)</a></div><div class="NLM_p">Notably, high-throughput screening (HTS) by Merck in 2015 resulted in the identification of [<sup>11</sup>C]MK-8913 (<i>K</i><sub>i</sub> = 0.15 nM), a structurally related ligand to [<sup>18</sup>F]MNI-659, out of a quinazolinone series. Blocking studies in rats and monkeys with the PDE10A inhibitor THPP-1 showed the specificity of [<sup>11</sup>C]MK-8913, and <i>in vivo</i> PET imaging in rats and rhesus monkeys both revealed high striatal uptakes and rapid brain washout. Unexpectedly, a series of <sup>11</sup>C labeled THPP-1 analogues showed poor brain uptake in <i>in vivo</i> rhesus monkey studies.<a onclick="showRef(event, 'ref185'); return false;" href="javascript:void(0);" class="ref ref185">(185)</a><i>In vitro</i> autoradiography with [<sup>3</sup>H]MK-8913 in human brain tissues similarly showed the highest accumulation in the striatum. Finally, the high selectivity (<i>K</i><sub>i</sub> > 1000 nM for all other PDEs), high <i>B</i><sub>max</sub>/<i>K</i><sub>d</sub> ratio, moderate lipophilicity (logD = 3.19), favorable radiometabolic profile, and exclusive brain presence of intact tracer suggested that [<sup>11</sup>C]MK-8913 was a promising PET tracer for further studies.<a onclick="showRef(event, 'ref186'); return false;" href="javascript:void(0);" class="ref ref186">(186)</a></div><div class="NLM_p">In all <i>in vivo</i> experiments comprising mice, rats, nonhuman primates, and healthy volunteers, [<sup>11</sup>C]Lu AE92686 (IC<sub>50(PDE10A)</sub> = 0.39 nM) exhibited selective uptake in the striatum with an excellent signal-to-noise ratio. Nonetheless, it suffered from poor metabolic stability in plasma; ∼15% of the intact tracer remained at 40 min p.i. in rats, while 27 ± 4% of the tracer remained at 30 min p.i. in cynomolgus monkeys.<a onclick="showRef(event, 'ref187'); return false;" href="javascript:void(0);" class="ref ref187">(187)</a> Further, studies in nonhuman primate brains demonstrated the specificity of [<sup>11</sup>C]Lu AE92686 in the striatum and the potential application for examining PDE10A in the globus pallidus and the substantia nigra.<a onclick="showRef(event, 'ref188'); return false;" href="javascript:void(0);" class="ref ref188">(188)</a> Following PET and MRI studies in schizophrenia patients treated with clozapine, olanzapine, or quetiapine and healthy controls, it was evident that there is a significant correlation between the striatal BP<sub>ND</sub> and cortical thickness in both patients and controls and that the striatal BP<sub>ND</sub> was significantly lower (<i>P</i> = 0.003)<a onclick="showRef(event, 'ref189'); return false;" href="javascript:void(0);" class="ref ref189">(189)</a> in patients. Since no correlation between PDE10A expression and cortical thickness was found within the patient group, further studies in early disease stages of patients with psychotic disorder would be necessary.</div><div class="NLM_p">Among seven structurally related candidates for PDE10A radioligands, [<sup>11</sup>C]T-773 (also known as [<sup>11</sup>C]KIT-6, IC<sub>50(PDE10A)</sub> = 0.77 nM) possessing the highest specific binding ratio and fastest washout in human brain was selected for further studies.<a onclick="showRef(event, 'ref190'); return false;" href="javascript:void(0);" class="ref ref190">(190)</a> T-773 was particularly selective for hPDE10A2 with >2500-fold selectivity over other PDEs. Further, in <i>in vitro</i> autoradiography studies with mice, rat, monkey, and human brain sections, [<sup>3</sup>H]T-773 and [<sup>11</sup>C]T-773 showed selective accumulation in the striatum of all the tested species.<a onclick="showRef(event, 'ref191'); return false;" href="javascript:void(0);" class="ref ref191">(191)</a> Moreover, lower standardized uptake values and significantly lower BP<sub>ND</sub> were found in both heterozygous and homozygous PDE10A knockout mice compared with wild-type controls by <i>in vivo</i> PET. These findings confirmed the selective binding of [<sup>11</sup>C]T-773 for PDE10A.<a onclick="showRef(event, 'ref192'); return false;" href="javascript:void(0);" class="ref ref192">(192)</a> Whole body PET imaging in rhesus monkeys (<i>n</i> = 2) showed that the average highest uptake was achieved in the stomach, kidneys, and liver, while excretion was partly via bile and subsequently the gastrointestinal tract besides the urinary tract.<a onclick="showRef(event, 'ref193'); return false;" href="javascript:void(0);" class="ref ref193">(193)</a> Moreover, [<sup>11</sup>C]T-773 was successfully employed to measure PDE10A occupancy by TAK-063 in the nonhuman primate striatum, although unexpected interactions were found between the uptake of [<sup>11</sup>C]T-773 and TAK-063 in the cerebellum.<a onclick="showRef(event, 'ref194'); return false;" href="javascript:void(0);" class="ref ref194">(194)</a> Subsequent PET imaging in humans corroborated the prior results of rapid brain penetration and high distribution in the striatum. The results also showed a clear decrease in the cerebellum, as previously observed in rhesus monkeys after the oral administration of TAK-063, suggesting an “off-target” interaction.<a onclick="showRef(event, 'ref195'); return false;" href="javascript:void(0);" class="ref ref195">(195)</a> In 2018, the <sup>18</sup>F-labeled analogues, [<sup>18</sup>F]FM-T-773-<i>d</i><sub>2</sub> and [<sup>18</sup>F]FE-T-773-<i>d</i><sub>4</sub>, were developed where they portrayed favorable kinetics and distribution in the nonhuman primate brains, thereby adding to the growing repertoire of available PDE10A PET probes for clinical applications.<a onclick="showRef(event, 'ref196'); return false;" href="javascript:void(0);" class="ref ref196">(196)</a></div><div class="NLM_p">[<sup>11</sup>C]AMG 7980 (IC<sub>50(PDE10A)</sub> = 1.9 nM) showed specific binding in the striatum and globus pallidus in nonhuman primates. The specific striatal uptake was lower than those of [<sup>11</sup>C]MP-10 and [<sup>18</sup>F]JNJ-42259152, and analytical HPLC results showed poor metabolic stability in the plasma (24% ± 15% of the parent compound remained at 70 min p.i.).<a onclick="showRef(event, 'ref197'); return false;" href="javascript:void(0);" class="ref ref197">(197)</a> In the following year, the keto-benzamidazole analogues, AMG 579 (IC<sub>50(PDE10A)</sub> = 0.18 nM) and [<sup>18</sup>F]AMG 580 (IC<sub>50(PDE10A)</sub> = 0.13 nM), were reported by Chen et al. to exhibit superior affinity and potency than [<sup>11</sup>C]AMG 7980. Furthermore, <i>in vitro</i> autoradiography with [<sup>3</sup>H]AMG 580 in brain slices of different species (rat, baboon, and human) all showed elevated signals in the respective striatal areas.<a onclick="showRef(event, 'ref198'); return false;" href="javascript:void(0);" class="ref ref198">(198)</a><i>In vivo</i> PET imaging mirrored these results and showed similarly a high accumulation in the striatum in rats, Rhesus monkeys, and baboons.<a onclick="showRef(event, 'ref199'); return false;" href="javascript:void(0);" class="ref ref199">(199)</a> However, due to its poor metabolic stability and binding potential compared to other available tracers, the development of this tracer came to a halt.</div><div class="NLM_p">In 2016, the Brust group reported a series of imidazo[1,5-<i>a</i>]quinoxalines PDE10A inhibitors, among which AQ28A showed a high potency (IC<sub>50(PDE10A)</sub> = 2.95 nM) with a remarkable selectivity (IC<sub>50</sub> > 1000 nM for all other PDEs).<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(200)</a> In mice, [<sup>18</sup>F]AQ28A showed moderate metabolic stability with 88% and 64% of the parent compound present in the brain and plasma, respectively, at 30 min p.i.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a> The region-specific accumulation (blocked with MP-10) in the striatum was determined to have a peak value of SUV = 2.7,<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a> while 130% and 30% higher SUVs in brown adipose tissue and striatum were demonstrated in obese mice in a PET/MR study, consistent with the notion of the PDE10A regulating the whole body energy balance.<a onclick="showRef(event, 'ref201'); return false;" href="javascript:void(0);" class="ref ref201">(201)</a><i>In vivo</i> PET imaging in normal weight mice with [<sup>18</sup>F]FDG showed a higher uptake of glucose by brown adipose tissue in response to the acute administration of MP-10 (30 mg/kg). Meanwhile, in studies in diet-induced obese mice, administration of MP-10 (10 mg/kg day) caused a weight loss (8.61 ± 0.37%) that could be attributed to increased energy expenditure and browning of visceral white adipose tissue. Moreover, the browning was also found in human white adipocytes treated with MP-10, highlighting the possibility for the application of PDE10A inhibitors in obese patients.<a onclick="showRef(event, 'ref202'); return false;" href="javascript:void(0);" class="ref ref202">(202)</a></div><div class="NLM_p last">Early in 2014, Plisson et al. reported on the pyrazolopyrimidine tracer, [<sup>11</sup>C]IMA107 (IC<sub>50(PDE10A)</sub> = 0.06 nM), delineating its good brain penetration, reversible kinetics, and first-class signal-to-noise ratio. The authors also investigated the ligand in pigs and baboons in a comparison with [<sup>11</sup>C]MP-10. Both [<sup>11</sup>C]IMA107 and [<sup>11</sup>C]MP-10 showed specific uptake in the putamen of the two species; however, they differed in their kinetics and metabolic profile. [<sup>11</sup>C]IMA107 exhibited slower brain kinetics and better metabolic stability (about 50% of intact at 90 min) than [<sup>11</sup>C]MP-10 (about 30% of intact tracer at 90 min) in baboons.<a onclick="showRef(event, 'ref203'); return false;" href="javascript:void(0);" class="ref ref203">(203)</a><i>In vivo</i> assessment of [<sup>11</sup>C]IMA107 demonstrated lower BP<sub>ND</sub> values in the caudate and putamen of PD patients with longer disease duration, higher unified PD rating scale part-III motor scores, and higher unified dyskinesia rating scale scores than healthy controls. This finding revealed the association between PDE10A expression loss, Parkinson’s duration, and severity of motor symptoms.<a onclick="showRef(event, 'ref204'); return false;" href="javascript:void(0);" class="ref ref204">(204)</a> Further, PET imaging with [<sup>11</sup>C]IMA107 and [<sup>11</sup>C]PE2I (radiotracer for imaging the dopamine transporter) unveiled a relationship between PDE10A and dopaminergic function; both PDE10A and DAT were decreased in the striatum of PD patients.<a onclick="showRef(event, 'ref205'); return false;" href="javascript:void(0);" class="ref ref205">(205)</a> Meanwhile, <i>in vivo</i> PET imaging with [<sup>11</sup>C]IMA107 and multimodal MRI showed an increase of PDE10A expression in motor thalamic nuclei and decrease in striatopallidal projecting striatum in an early HD model, unveiling an intriguing correlation between abnormal PDE10A expression and the probability of symptomatic onset.<a onclick="showRef(event, 'ref206'); return false;" href="javascript:void(0);" class="ref ref206">(206)</a> One year later, a significant drop of [<sup>11</sup>C]IMA107 signal in insular cortex and occipital fusiform gyrus was found in premanifest HD gene carriers in <i>in vivo</i> studies.<a onclick="showRef(event, 'ref207'); return false;" href="javascript:void(0);" class="ref ref207">(207)</a> Briefly, these studies outline the potential application of [<sup>11</sup>C]IMA107 for clinical diagnosis in early-phase neurodegenerative disorders. However, no significant correlation could be established between available PDE10A and the severity degree of schizophrenia<a onclick="showRef(event, 'ref208'); return false;" href="javascript:void(0);" class="ref ref208">(208)</a> or cocaine use disorder<a onclick="showRef(event, 'ref209'); return false;" href="javascript:void(0);" class="ref ref209">(209)</a> in PET studies with [<sup>11</sup>C]IMA107.</div></div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> PDE11</h3><div class="NLM_p">PDE11 is the last subfamily of PDEs that hydrolyzes both cAMP and cGMP with comparable affinities at physiological concentration, There is a single isoform, PDE11A, that comprises four variants (PDE11A1, PDE11A2, PDE11A3, and PDE11A4).<a onclick="showRef(event, 'ref210'); return false;" href="javascript:void(0);" class="ref ref210">(210)</a> Distinct from other variants, PDE11A4, phosphorylated by both PKA and PKG, retains two GAF domains in the <i>N</i>-terminal region.<a onclick="showRef(event, 'ref211'); return false;" href="javascript:void(0);" class="ref ref211">(211)</a> PDE11A is highly expressed in skeletal muscle, prostate, kidney, liver, pituitary and salivary glands, colon, and testicles.<a onclick="showRef(event, 'ref212'); return false;" href="javascript:void(0);" class="ref ref212">(212)</a> In PDE11A knockout studies, PDE11A expression was linked to an increase in spermatogenesis and fertilization potential, adrenocortical tumorigenesis, brain function regulation, social behavior,<a onclick="showRef(event, 'ref213'); return false;" href="javascript:void(0);" class="ref ref213">(213)</a> consolidation of recognition, and associative social memories.<a onclick="showRef(event, 'ref214'); return false;" href="javascript:void(0);" class="ref ref214">(214)</a> Conversely, PDE11A was associated with a decrease in lithium responsivity.<a onclick="showRef(event, 'ref215'); return false;" href="javascript:void(0);" class="ref ref215">(215)</a> Nevertheless, the development of PDE11A inhibitors is still in its infancy, as shown by the few compounds developed so far (<a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig17" id="" class=" internalNav">17</a></a>),<a onclick="showRef(event, 'ref216'); return false;" href="javascript:void(0);" class="ref ref216">(216)</a> and a potent and selective PDE11A has yet to be reported. Due to these limitations, it is exceedingly challenging to completely unravel the biological roles of PDE11A in the aforementioned disease conditions.</div><figure id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0017.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Selected PDE11 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i37">Conclusion and Prospects</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01437" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01437" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The PDE superfamily encompasses a remarkably diverse repertoire of enzymes that exhibit distinct subcellular localizations and signaling functions. While the complex PDE biology warrants further investigation, recent advances prompted the discovery of several new subtype-selective therapeutics and PET probes. Further, approved PDE inhibitors have been repurposed for novel indications. Prominent examples include PDE5 inhibitors for cardiovascular and metabolic diseases, PDE1- and PDE10-selective inhibitors for the treatment of schizophrenia, PDE4 inhibitors for diabetes, PDE7 inhibitors as anti-inflammatory drugs, and PDE3 inhibitors as inhibitors of vascular remodeling. Of note, structural insights from X-ray crystallography unveiled key differences in catalytic cores and protein–ligand interactions among the various PDE isoforms, thus channeling the design of novel structural scaffolds with high affinity and subtype-selectivity. Moreover, given the recent discovery of <i>N-</i>terminal allosteric domains, a novel concept for the design of PDE-targeted subtype-selective inhibitors involves the modulation of interactions between <i>N-</i>terminal regulatory domains and their <i>C-</i>terminal catalytic domains. Indeed, this concept has proven particularly successful in the case of PDE4 and similar approaches can be expected to facilitate the discovery of subtype-selective ligands for other PDE families.</div><div class="NLM_p last">Although innovative structural scaffolds, that were designed by computer-assisted and/or HTS-based medicinal chemistry, have served as lead compounds for the development of subtype-selective PET inhibitors, only a few PET radioligands—mainly exhibiting selectivity for PDE2, PDE4, PDE5, PDE7, or PDE10—have been developed so far. Indeed, selective PET radioligands are currently lacking for several PDE families, resulting in an unmet medical need. The availability of suitable PET radioligands for the various PDE families and subfamilies would enable real-time target quantification in living subjects, thus improving our contemporary understanding of PDE-related pathologies and target engagement of novel PDE inhibitors <i>in vivo</i>. Further, targeted translational molecular imaging harbors the potential to improve personalized clinical decision-making and guide novel targeted drug discovery with regard to optimal dose regimens, thereby laying the foundation for precision medicine.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00115" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43715" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43715" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven H. Liang</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Division of Nuclear Medicine
and Molecular Imaging Massachusetts General Hospital and Harvard Medical
School, 55 Fruit Street, Boston, Massachusetts 02114, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0003-1413-6315" title="Orcid link">https://orcid.org/0000-0003-1413-6315</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#a0ccc9c1cec78ed3d4c5d6c5cee0cdc7c88ec8c1d2d6c1d2c48ec5c4d5"><span class="__cf_email__" data-cfemail="82eeebe3ece5acf1f6e7f4e7ecc2efe5eaaceae3f0f4e3f0e6ace7e6f7">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiyun Sun</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Division of Nuclear Medicine
and Molecular Imaging Massachusetts General Hospital and Harvard Medical
School, 55 Fruit Street, Boston, Massachusetts 02114, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhiwei Xiao</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Division of Nuclear Medicine
and Molecular Imaging Massachusetts General Hospital and Harvard Medical
School, 55 Fruit Street, Boston, Massachusetts 02114, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahmed Haider</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Division of Nuclear Medicine
and Molecular Imaging Massachusetts General Hospital and Harvard Medical
School, 55 Fruit Street, Boston, Massachusetts 02114, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Catherine Gebhard</span> - <span class="hlFld-Affiliation affiliation">Department
of Nuclear Medicine, University Hospital
Zurich, Raemistrasse
100, Zurich 8006, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">Center
for Molecular Cardiology, University of
Zurich, Wagistrasse 12, Schlieren 8952, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hao Xu</span> - <span class="hlFld-Affiliation affiliation">Center
of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine
and PET/CT-MRI Center, The First Affiliated
Hospital of Jinan University, 613 West Huangpu Road, Tianhe District, Guangzhou 510630, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hai-Bin Luo</span> - <span class="hlFld-Affiliation affiliation">School
of Pharmaceutical Sciences, Sun Yat-Sen
University, Guangzhou 510006, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-2163-0509" title="Orcid link">https://orcid.org/0000-0002-2163-0509</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Han-Ting Zhang</span> - <span class="hlFld-Affiliation affiliation">Departments
of Neuroscience, Behavioral Medicine & Psychiatry, and Physiology
& Pharmacology, the Rockefeller Neuroscience Institute, West Virginia University Health Sciences Center, Morgantown, West Virginia 26506, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lee Josephson</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Division of Nuclear Medicine
and Molecular Imaging Massachusetts General Hospital and Harvard Medical
School, 55 Fruit Street, Boston, Massachusetts 02114, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lu Wang</span> - <span class="hlFld-Affiliation affiliation">Department
of Radiology, Division of Nuclear Medicine
and Molecular Imaging Massachusetts General Hospital and Harvard Medical
School, 55 Fruit Street, Boston, Massachusetts 02114, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Center
of Cyclotron and PET Radiopharmaceuticals, Department of Nuclear Medicine
and PET/CT-MRI Center, The First Affiliated
Hospital of Jinan University, 613 West Huangpu Road, Tianhe District, Guangzhou 510630, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="https://orcid.org/0000-0002-8049-1991" title="Orcid link">https://orcid.org/0000-0002-8049-1991</a></span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>J.S., Z.X., and A.H. contributed equally.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61218" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61218" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Jiyun Sun</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3314-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Jiyun Sun</b> obtained his B. Sc. degree in Material Chemistry with Professor Shuang-xi Liu in Nankai University (NKU) in 2012, followed by his Ph.D. in Applied Chemistry with Professor Kang Zhao in the School of Pharmaceutical Science and Technology (SPST), Tianjin University (TJU) in 2018. Then he started his postdoctoral research with Professor Hao Xu at the First Affiliated Hospital of Jinan University, and then with Prof. Steven H. Liang at the Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS). His research interests include radiochemistry and development of PET tracers for the central and peripheral nervous system.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Zhiwei Xiao</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3319-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Zhiwei Xiao</b> obtained his B.Sc. degree in Applied Chemistry in East China Normal University (ECNU) in 2013, followed by his Ph.D. in Organic Chemistry with Professor Qing-yun Chen in Shanghai Institute of Organic Chemistry (SIOC), Chinese Academy of Sciences (CAS) in 2019. After that, he joined Professor Hao Xu’s group at the First Affiliated Hospital of Jinan University and Professor Steven H. Liang’s group at Division of Nuclear Medicine and Molecular Imaging, Department of Radiology, Massachusetts General Hospital (MGH) and Harvard Medical School (HMS) for his postdoctoral. His research interests include novel methodology development of <sup>11</sup>C-/<sup>18</sup>F-labeling and development of PET tracers for neurodegenerative diseases.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Ahmed Haider</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3330-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Ahmed Haider</b> obtained his M.S. in Pharmaceutical Sciences at ETH Zurich, Switzerland, where he subsequently earned his Ph.D. in Radiochemistry and Molecular Imaging with Professor Simon M. Ametamey in 2018. In the same year, he moved to the Department of Nuclear Medicine at the University Hospital Zurich, working with Prof. Catherine Gebhard to advance cardiovascular gender medicine with particular focus on preclinical and clinical cardiovascular PET imaging. Recently, Dr. Haider joined Professor Steven H. Liang’s research group at the Division of Nuclear Medicine and Molecular Imaging at Harvard Medical School and Massachusetts General Hospital in Boston, U.S.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="22" class="article__inlineFigure"><h2 class="fig-label">Catherine Gebhard</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3335-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Catherine Gebhard</b> is a cardiologist who obtained her medical degree at the Eberhard Karls University of Tübingen, Germany, in 2004. After a postdoctoral fellowship in basic cardiovascular research at the University of Zurich, Switzerland, she completed her residency in internal medicine and cardiology in Switzerland. She joined the nuclear cardiology team at the Cyclotron Unit of Imperial College, London, UK, subsequently, the Department of Nuclear Medicine, University Hospital Zurich. From 2012 to 2015, she completed her training in interventional cardiology and Ph.D. studies in molecular imaging at the Montreal Heart Institute in Québec, Canada. Dr. Gebhard was appointed Assistant Professor at the University of Zurich in 2016 and is currently leading an interdisciplinary research team in the cardiovascular gender medicine at the University Hospital Zurich.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="23" class="article__inlineFigure"><h2 class="fig-label">Hao Xu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3340-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hao Xu</b> received his Ph.D. in Nuclear Medicine from Humboldt University of Berlin in 1996. Dr. Xu is currently the Director of the Nuclear Medicine Department and PET/CT-MRI Center at the First Affiliated Hospital of Jinan University (JNUH) and the Executive Vice Director of the Institute of Molecular and Functional Imaging at JNU. Dr. Xu’s research interests are clinical nuclear medicine and molecular imaging of cancer and neurological diseases.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="24" class="article__inlineFigure"><h2 class="fig-label">Hai-Bin Luo</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3345-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Hai-Bin Luo</b> works currently as a professor of medicinal chemistry in School of Pharmaceutical Science at Sun Yat-sen University. He received his bachelor degree and PhD degree from Xiamen University in 1999 and from Hong Kong Baptist University in 2005, respectively. In the end of 2006, he joined Sun Yat-sen University as an associate professor and was promoted to a full professor in 2011. His research currently encompasses the rational design and discovery of novel phosphodiesterase inhibitors for the treatment of several diseases, such as COVID-19, pulmonary fibrosis, and pulmonary hypertension.</p></figure></div><div class="bio" rid="ath7"><figure id="ath7" data-index="25" class="article__inlineFigure"><h2 class="fig-label">Han-Ting Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3350-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Han-Ting Zhang</b> is a tenured Professor of Neuroscience at the Rockefeller Neuroscience Institute, West Virginia University Health Sciences Center. He received his Bachelor/M.D. from Southern Medical University (formerly the First Military Medical University) in Guangzhou in 1987 and M.S./Ph.D. of Pharmacology from Beijing Institute of Pharmacology & Toxicology, China in 1992/1995. He was a postdoctoral fellow with Dr. James O’Donnell first at Louisiana State University Health Sciences Center in Shreveport, LA and then at University of Tennessee Health Science Center in Memphis, TN (1998-2002). Dr. Zhang’s research focuses include identification of CNS functional roles of cyclic nucleotide phosphodiesterases (PDEs), in particular, PDE4 in the brain, and intracellular signaling in the mediation of neurodegenerative and neuropsychiatric disorders, specifically Alzheimer’s disease, depression, anxiety, and alcoholism.</p></figure></div><div class="bio" rid="ath8"><figure id="ath8" data-index="26" class="article__inlineFigure"><h2 class="fig-label">Lee Josephson</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3355-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lee Josephson</b> obtained his B.S. in Chemistry from the University of Wisconsin and his Ph.D. in Chemical Biology at Stony Brook University (1975). He did a postdoctoral fellowship in the Department of Molecular and Cellular Biology at Harvard University. He was a cofounder of AMAG Pharmaceuticals (AMAG, AMEX Exchange) where he served as Chief Scientific Officer. He then joined the Department of Radiology at MGH, where he pioneered the use of magnetic nanoparticles and was a cofounder of T2 Biosystems (TTOO, NASDQ). His research interests include magnetic nanoparticles, imaging biomarkers for cell death and cell health, and peptide PEGylation. He is currently Associate Professor at HMS and a partner in MedChem Imaging LLC which supplies radiotracers to the pharmaceutical industry.</p></figure></div><div class="bio" rid="ath9"><figure id="ath9" data-index="27" class="article__inlineFigure"><h2 class="fig-label">Lu Wang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3360-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Lu Wang</b> received his B.S. in Pharmacy from the Ocean University of China in 2010, followed by his Ph.D. in Chemical Genomics from Peking University in 2016. Dr. Wang was a Senior Visiting Scholar at HMS/MGH (2014–2016) and has been a Visiting Research Fellow at NIRS (2017 to now). Dr. Wang is currently the Vice Director of the Center of Cyclotron and PET Radiopharmaceuticals (CCPR) in JNUH. Dr. Wang’s research interests include radiochemistry, PET tracer development, and clinical translational studies.</p></figure></div><div class="bio" rid="ath10"><figure id="ath10" data-index="28" class="article__inlineFigure"><h2 class="fig-label">Steven H. Liang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=BIO-d7e3365-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Steven H. Liang</b> obtained his B.S. at Tianjin University in 2003, followed by his Ph.D. in Chemistry with Professor Marco Ciufolini at the University of British Columbia in 2010. Then he started as a NSERC Fellow with Professor E. J. Corey at Harvard University. In 2012, Dr. Liang accepted a junior faculty position at HMS and MGH. Dr. Liang is currently the Director of Radiochemistry and Biomarker Development, Nuclear Medicine and Molecular Imaging at MGH, and Associate Professor of Radiology at HMS. Dr. Liang’s research interests include novel radiochemistry, imaging biomarker and radiotherapy development, and clinical translation.</p></figure></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05375" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05375" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank the Division of Nuclear Medicine and Molecular Imaging, Radiology, MGH, and Harvard Medical School, USA for general support. A.H. was supported by the Swiss National Science Foundation (SNSF).</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">AAMI</td><td class="NLM_def"><p class="first last">age-associated memory impairment</p></td></tr><tr><td class="NLM_term">ABI</td><td class="NLM_def"><p class="first last">acute brain injury</p></td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">APP</td><td class="NLM_def"><p class="first last">amyloid precursor protein</p></td></tr><tr><td class="NLM_term">ARDS</td><td class="NLM_def"><p class="first last">acute respiratory distress syndrome</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine triphosphate</p></td></tr><tr><td class="NLM_term">Bat</td><td class="NLM_def"><p class="first last">brown adipose tissue</p></td></tr><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">Bmax</td><td class="NLM_def"><p class="first last">maximum binding capacity</p></td></tr><tr><td class="NLM_term">BP<sub>ND</sub></td><td class="NLM_def"><p class="first last">nondisplaceable binding potential</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine 3′,5′-monophosphate</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine 3′,5′-monophosphate</p></td></tr><tr><td class="NLM_term">CLL</td><td class="NLM_def"><p class="first last">chronic lymphocytic leukemia</p></td></tr><tr><td class="NLM_term">CNGs</td><td class="NLM_def"><p class="first last">cyclic nucleotide-gated channels</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">COPD</td><td class="NLM_def"><p class="first last">chronic obstructive pulmonary disease</p></td></tr><tr><td class="NLM_term">CREB</td><td class="NLM_def"><p class="first last">cAMP-response element binding protein</p></td></tr><tr><td class="NLM_term">D1R</td><td class="NLM_def"><p class="first last">dopamine D1 receptor</p></td></tr><tr><td class="NLM_term">D2R</td><td class="NLM_def"><p class="first last">dopamine D2 receptor</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">EC</td><td class="NLM_def"><p class="first last">endometrial cancer</p></td></tr><tr><td class="NLM_term">ED</td><td class="NLM_def"><p class="first last">erectile dysfunction</p></td></tr><tr><td class="NLM_term">EPAC</td><td class="NLM_def"><p class="first last">exchange protein directly activated by cAMP</p></td></tr><tr><td class="NLM_term">ERK</td><td class="NLM_def"><p class="first last">extracellular signal-regulated kinase</p></td></tr><tr><td class="NLM_term"><i>f</i><sub>P</sub></td><td class="NLM_def"><p class="first last">plasma free fraction</p></td></tr><tr><td class="NLM_term">GCs</td><td class="NLM_def"><p class="first last">guanylyl cyclases</p></td></tr><tr><td class="NLM_term">GCAPs</td><td class="NLM_def"><p class="first last">GC activating proteins</p></td></tr><tr><td class="NLM_term">Gi</td><td class="NLM_def"><p class="first last">inhibitory G protein</p></td></tr><tr><td class="NLM_term">5′GMP</td><td class="NLM_def"><p class="first last">guanosine-5′-monophosphate</p></td></tr><tr><td class="NLM_term">Gs</td><td class="NLM_def"><p class="first last">stimulatory G protein</p></td></tr><tr><td class="NLM_term">GTP</td><td class="NLM_def"><p class="first last">guanosine triphosphate</p></td></tr><tr><td class="NLM_term">HA</td><td class="NLM_def"><p class="first last">histamine</p></td></tr><tr><td class="NLM_term">HD</td><td class="NLM_def"><p class="first last">Huntington’s disease</p></td></tr><tr><td class="NLM_term">5-HT</td><td class="NLM_def"><p class="first last">5-hydroxytryptamine</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening. HV, healthy volunteers</p></td></tr><tr><td class="NLM_term">%ID</td><td class="NLM_def"><p class="first last">injected dose of tissue</p></td></tr><tr><td class="NLM_term">IFNγ</td><td class="NLM_def"><p class="first last">interferon gamma</p></td></tr><tr><td class="NLM_term">IL-1</td><td class="NLM_def"><p class="first last">interleukin-1</p></td></tr><tr><td class="NLM_term">IP3R</td><td class="NLM_def"><p class="first last">inositol 1,4,5-trisphosphate receptor</p></td></tr><tr><td class="NLM_term">LPS</td><td class="NLM_def"><p class="first last">lipopolysaccharide</p></td></tr><tr><td class="NLM_term">LR1 and LR2</td><td class="NLM_def"><p class="first last">linker regions 1 and 2</p></td></tr><tr><td class="NLM_term">MAS</td><td class="NLM_def"><p class="first last">McCune-Albright Syndrome</p></td></tr><tr><td class="NLM_term">MCL</td><td class="NLM_def"><p class="first last">mantle cell lymphoma</p></td></tr><tr><td class="NLM_term">MDD</td><td class="NLM_def"><p class="first last">major depressive disorder</p></td></tr><tr><td class="NLM_term">MitoK<sub>ATP</sub></td><td class="NLM_def"><p class="first last">mitochondrial <i>K</i><sub>ATP</sub></p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">NA</td><td class="NLM_def"><p class="first last">synaptic noradrenaline</p></td></tr><tr><td class="NLM_term">NCKX</td><td class="NLM_def"><p class="first last">Na<sup>+</sup>/Ca<sup>2+</sup>/K<sup>+</sup> exchanger</p></td></tr><tr><td class="NLM_term">NO</td><td class="NLM_def"><p class="first last">nitric oxide</p></td></tr><tr><td class="NLM_term">NOS</td><td class="NLM_def"><p class="first last">nitric oxide synthase</p></td></tr><tr><td class="NLM_term">OPC</td><td class="NLM_def"><p class="first last">oligodendrocyte precursor</p></td></tr><tr><td class="NLM_term">PAH</td><td class="NLM_def"><p class="first last">pulmonary arterial hypertension</p></td></tr><tr><td class="NLM_term">PBMCs</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PDEs</td><td class="NLM_def"><p class="first last">cyclic nucleotide phosphodiesterases</p></td></tr><tr><td class="NLM_term">PET</td><td class="NLM_def"><p class="first last">positron emission tomography</p></td></tr><tr><td class="NLM_term">PKA</td><td class="NLM_def"><p class="first last">protein kinase A</p></td></tr><tr><td class="NLM_term">PKGs</td><td class="NLM_def"><p class="first last">cGMP-dependent protein kinases</p></td></tr><tr><td class="NLM_term">rd</td><td class="NLM_def"><p class="first last">retinal degeneration</p></td></tr><tr><td class="NLM_term">sAc</td><td class="NLM_def"><p class="first last">soluble adenylyl cyclases</p></td></tr><tr><td class="NLM_term">SUVs</td><td class="NLM_def"><p class="first last">standard uptake values</p></td></tr><tr><td class="NLM_term">tAc</td><td class="NLM_def"><p class="first last">transmembrane adenylyl cyclases</p></td></tr><tr><td class="NLM_term">TD</td><td class="NLM_def"><p class="first last">targeting domain</p></td></tr><tr><td class="NLM_term">TNF-α</td><td class="NLM_def"><p class="first last">tumor necrosis factor alpha</p></td></tr><tr><td class="NLM_term">UCP1</td><td class="NLM_def"><p class="first last">uncoupling protein 1</p></td></tr><tr><td class="NLM_term">UCR1 and UCR2</td><td class="NLM_def"><p class="first last">upstream conserved regions 1 and 2</p></td></tr><tr><td class="NLM_term">VECs</td><td class="NLM_def"><p class="first last">vascular endothelial cells</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>T</sub></td><td class="NLM_def"><p class="first last">total volume of distribution</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_61806" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_61806" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 216 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejeda, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1038/s41573-019-0033-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fs41573-019-0033-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31388135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=770-796&author=G.+S.+Baillieauthor=G.+S.+Tejedaauthor=M.+P.+Kelly&title=Therapeutic+targeting+of+3%E2%80%B2%2C5%E2%80%B2-cyclic+nucleotide+phosphodiesterases%3A+inhibition+and+beyond&doi=10.1038%2Fs41573-019-0033-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond</span></div><div class="casAuthors">Baillie, George S.; Tejeda, Gonzalo S.; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">770-796</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs), enzymes that degrade 3',5'-cyclic nucleotides, are being pursued as therapeutic targets for several diseases, including those affecting the nervous system, the cardiovascular system, fertility, immunity, cancer and metab.  Clin. development programs have focused exclusively on catalytic inhibition, which continues to be a strong focus of ongoing drug discovery efforts.  However, emerging evidence supports novel strategies to therapeutically target PDE function, including enhancing catalytic activity, normalizing altered compartmentalization and modulating post-translational modifications, as well as the potential use of PDEs as disease biomarkers.  Importantly, a more refined appreciation of the intramol. mechanisms regulating PDE function and trafficking is emerging, making these pioneering drug discovery efforts tractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_NtRRCDdas7Vg90H21EOLACvtfcHk0lgn3kTc1KhO9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF&md5=f8a348c9c9e534227d60e4f635d90b25</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41573-019-0033-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-019-0033-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26aulast%3DTejeda%26aufirst%3DG.%2BS.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DTherapeutic%2520targeting%2520of%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-cyclic%2520nucleotide%2520phosphodiesterases%253A%2520inhibition%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D770%26epage%3D796%26doi%3D10.1038%2Fs41573-019-0033-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span> <span> </span><span class="NLM_article-title">Inhibit a phosphodiesterase to treat heart failure?</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">2003</span>– <span class="NLM_lpage">2006</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.118.036325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1161%2FCIRCULATIONAHA.118.036325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30372138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB3cvksVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=2003-2006&author=J.+Leroyauthor=R.+Fischmeister&title=Inhibit+a+phosphodiesterase+to+treat+heart+failure%3F&doi=10.1161%2FCIRCULATIONAHA.118.036325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibit a Phosphodiesterase to Treat Heart Failure?</span></div><div class="casAuthors">Leroy Jerome; Fischmeister Rodolphe</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2003-2006</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ9M1qVxLqW-BOk4JA3soTqfW6udTcc2earNzigKddhyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvksVWisQ%253D%253D&md5=63cd12330d19e4bf9b1df1ea5d29af91</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.118.036325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.118.036325%26sid%3Dliteratum%253Aachs%26aulast%3DLeroy%26aufirst%3DJ.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3DInhibit%2520a%2520phosphodiesterase%2520to%2520treat%2520heart%2520failure%253F%26jtitle%3DCirculation%26date%3D2018%26volume%3D138%26spage%3D2003%26epage%3D2006%26doi%3D10.1161%2FCIRCULATIONAHA.118.036325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span> <span> </span><span class="NLM_article-title">A role for phosphodiesterase type-4 inhibitors in COPD?</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(01)05493-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0140-6736%2801%2905493-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11498207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BD3MvltFanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=256-257&author=D.+C.+Johnson&title=A+role+for+phosphodiesterase+type-4+inhibitors+in+COPD%3F&doi=10.1016%2FS0140-6736%2801%2905493-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A role for phosphodiesterase type-4 inhibitors in COPD?</span></div><div class="casAuthors">Johnson D C</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">9278</span>),
    <span class="NLM_cas:pages">256-7</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlTNSxBj3s9LxanA7vODO6fW6udTcc2earNzigKddhyrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvltFanug%253D%253D&md5=5c80c4594db751082ff6a7d3393dc628</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2801%2905493-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252801%252905493-9%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26atitle%3DA%2520role%2520for%2520phosphodiesterase%2520type-4%2520inhibitors%2520in%2520COPD%253F%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D256%26epage%3D257%26doi%3D10.1016%2FS0140-6736%2801%2905493-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holewinski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rainer, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranek, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostmann, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margulies, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Eyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>519</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1038/nature14332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnature14332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25799991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVSisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=2015&pages=472-476&author=D.+I.+Leeauthor=G.+Zhuauthor=T.+Sasakiauthor=G.+S.+Choauthor=N.+Hamdaniauthor=R.+Holewinskiauthor=S.+H.+Joauthor=T.+Dannerauthor=M.+Zhangauthor=P.+P.+Rainerauthor=D.+Bedjaauthor=J.+A.+Kirkauthor=M.+J.+Ranekauthor=W.+R.+Dostmannauthor=C.+Kwonauthor=K.+B.+Marguliesauthor=J.+E.+Van+Eykauthor=W.+J.+Paulusauthor=E.+Takimotoauthor=D.+A.+Kass&title=Phosphodiesterase+9A+controls+nitric-oxide-independent+cGMP+and+hypertrophic+heart+disease&doi=10.1038%2Fnature14332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease</span></div><div class="casAuthors">Lee, Dong I.; Zhu, Guangshuo; Sasaki, Takashi; Cho, Gun-Sik; Hamdani, Nazha; Holewinski, Ronald; Jo, Su-Hyun; Danner, Thomas; Zhang, Manling; Rainer, Peter P.; Bedja, Djahida; Kirk, Jonathan A.; Ranek, Mark J.; Dostmann, Wolfgang R.; Kwon, Chulan; Margulies, Kenneth B.; Van Eyk, Jennifer E.; Paulus, Walter J.; Takimoto, Eiki; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">519</span>
        (<span class="NLM_cas:issue">7544</span>),
    <span class="NLM_cas:pages">472-476</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclic guanosine monophosphate (cGMP) is a second messenger mol. that transduces nitric-oxide- and natriuretic-peptide-coupled signalling, stimulating phosphorylation changes by protein kinase G.  Enhancing cGMP synthesis or blocking its degrdn. by phosphodiesterase type 5A (PDE5A) protects against cardiovascular disease.  However, cGMP stimulation alone is limited by counter-adaptions including PDE upregulation.  Furthermore, although PDE5A regulates nitric-oxide-generated cGMP, nitric oxide signalling is often depressed by heart disease.  PDEs controlling natriuretic-peptide-coupled cGMP remain uncertain.  Here we show that cGMP-selective PDE9A (refs 7, 8) is expressed in the mammalian heart, including humans, and is upregulated by hypertrophy and cardiac failure.  PDE9A regulates natriuretic-peptide- rather than nitric-oxide-stimulated cGMP in heart myocytes and muscle, and its genetic or selective pharmacol. inhibition protects against pathol. responses to neurohormones, and sustained pressure-overload stress.  PDE9A inhibition reverses pre-established heart disease independent of nitric oxide synthase (NOS) activity, whereas PDE5A inhibition requires active NOS.  Transcription factor activation and phosphoproteome analyses of myocytes with each PDE selectively inhibited reveals substantial differential targeting, with phosphorylation changes from PDE5A inhibition being more sensitive to NOS activation.  Thus, unlike PDE5A, PDE9A can regulate cGMP signalling independent of the nitric oxide pathway, and its role in stress-induced heart disease suggests potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJLKvnCmv1obVg90H21EOLACvtfcHk0lj6LWVBV42xuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVSisLs%253D&md5=4019165bfaa00428341ce4c64908dc6e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature14332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14332%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BI.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DCho%26aufirst%3DG.%2BS.%26aulast%3DHamdani%26aufirst%3DN.%26aulast%3DHolewinski%26aufirst%3DR.%26aulast%3DJo%26aufirst%3DS.%2BH.%26aulast%3DDanner%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DRainer%26aufirst%3DP.%2BP.%26aulast%3DBedja%26aufirst%3DD.%26aulast%3DKirk%26aufirst%3DJ.%2BA.%26aulast%3DRanek%26aufirst%3DM.%2BJ.%26aulast%3DDostmann%26aufirst%3DW.%2BR.%26aulast%3DKwon%26aufirst%3DC.%26aulast%3DMargulies%26aufirst%3DK.%2BB.%26aulast%3DVan%2BEyk%26aufirst%3DJ.%2BE.%26aulast%3DPaulus%26aufirst%3DW.%2BJ.%26aulast%3DTakimoto%26aufirst%3DE.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DPhosphodiesterase%25209A%2520controls%2520nitric-oxide-independent%2520cGMP%2520and%2520hypertrophic%2520heart%2520disease%26jtitle%3DNature%26date%3D2015%26volume%3D519%26spage%3D472%26epage%3D476%26doi%3D10.1038%2Fnature14332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V. C.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting cyclic nucleotide phosphodiesterases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nrd4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnrd4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24687066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=290-314&author=D.+H.+Mauriceauthor=H.+Keauthor=F.+Ahmadauthor=Y.+Wangauthor=J.+Chungauthor=V.+C.+Manganiello&title=Advances+in+targeting+cyclic+nucleotide+phosphodiesterases&doi=10.1038%2Fnrd4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in targeting cyclic nucleotide phosphodiesterases</span></div><div class="casAuthors">Maurice, Donald H.; Ke, Hengming; Ahmad, Faiyaz; Wang, Yousheng; Chung, Jay; Manganiello, Vincent C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-314</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cyclic GMP, thereby regulating the intracellular concns. of these cyclic nucleotides, their signalling pathways and, consequently, myriad biol. responses in health and disease.  Currently, a small no. of PDE inhibitors are used clin. for treating the pathophysiol. dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.  However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMRfUs-zUmLVg90H21EOLACvtfcHk0lhjXN9lUZaHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D&md5=410c8d5bb5fbd7d2906e30dc1b5f2876</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4228%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DD.%2BH.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DManganiello%26aufirst%3DV.%2BC.%26atitle%3DAdvances%2520in%2520targeting%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D290%26epage%3D314%26doi%3D10.1038%2Fnrd4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattani-Cavalieri, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheshe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaev, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterases as therapeutic targets for respiratory diseases</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.pharmthera.2019.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30759374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFOluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2019&pages=225-242&author=H.+Zuoauthor=I.+Cattani-Cavalieriauthor=N.+Mushesheauthor=V.+O.+Nikolaevauthor=M.+Schmidt&title=Phosphodiesterases+as+therapeutic+targets+for+respiratory+diseases&doi=10.1016%2Fj.pharmthera.2019.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases as therapeutic targets for respiratory diseases</span></div><div class="casAuthors">Zuo, Haoxiao; Cattani-Cavalieri, Isabella; Musheshe, Nshunge; Nikolaev, Viacheslav O.; Schmidt, Martina</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">225-242</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, affect millions of people all over the world.  Cyclic adenosine monophosphate (cAMP) which is one of the most important second messengers, plays a vital role in relaxing airway smooth muscles and suppressing inflammation.  Given its vast role in regulating intracellular responses, cAMP provides an attractive pharmaceutical target in the treatment of chronic respiratory diseases.  Phosphodiesterases (PDEs) are enzymes that hydrolyze cyclic nucleotides and help control cyclic nucleotide signals in a compartmentalized manner.  Currently, the selective PDE4 inhibitor, roflumilast, is used as an add-on treatment for patients with severe COPD assocd. with bronchitis and a history of frequent exacerbations.  In addn., other novel PDE inhibitors are in different phases of clin. trials.  The current review provides an overview of the regulation of various PDEs and the potential application of selective PDE inhibitors in the treatment of COPD and asthma.  The possibility to combine various PDE inhibitors as a way to increase their therapeutic effectiveness is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkpdsY4rhBkrVg90H21EOLACvtfcHk0lhjXN9lUZaHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFOluro%253D&md5=a3b369d72b3fb0db1a04ba5bb03950f5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DH.%26aulast%3DCattani-Cavalieri%26aufirst%3DI.%26aulast%3DMusheshe%26aufirst%3DN.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DSchmidt%26aufirst%3DM.%26atitle%3DPhosphodiesterases%2520as%2520therapeutic%2520targets%2520for%2520respiratory%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D197%26spage%3D225%26epage%3D242%26doi%3D10.1016%2Fj.pharmthera.2019.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talarek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Listos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberto de Oliveira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tewari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arguelles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrzadi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseinzadeh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Onofrio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orhan, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momtaz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzaei, M. H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors say NO to Alzheimer’s disease</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">110822</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2019.110822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.fct.2019.110822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31536753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSrt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=110822&author=S.+M.+Nabaviauthor=S.+Talarekauthor=J.+Listosauthor=S.+F.+Nabaviauthor=K.+P.+Deviauthor=M.+Roberto+de+Oliveiraauthor=D.+Tewariauthor=S.+Arguellesauthor=S.+Mehrzadiauthor=A.+Hosseinzadehauthor=G.+D%E2%80%99Onofrioauthor=I.+E.+Orhanauthor=A.+Suredaauthor=S.+Xuauthor=S.+Momtazauthor=M.+H.+Farzaei&title=Phosphodiesterase+inhibitors+say+NO+to+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.fct.2019.110822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors say NO to Alzheimer's disease</span></div><div class="casAuthors">Nabavi, Seyed Mohammad; Talarek, Sylwia; Listos, Joanna; Nabavi, Seyed Fazel; Devi, Kasi Pandima; Roberto de Oliveira, Marcos; Tewari, Devesh; Arguelles, Sandro; Mehrzadi, Saeed; Hosseinzadeh, Azam; D'onofrio, Grazia; Orhan, Ilkay Erdogan; Sureda, Antoni; Xu, Suowen; Momtaz, Saeedeh; Farzaei, Mohammad Hosein</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110822</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs) consisted of 11 subtypes (PDE1 to PDE11) and over 40 isoforms that regulate levels of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP), the second messengers in cell functions.  PDE inhibitors (PDEIs) have been attractive therapeutic targets due to their involvement in diverse medical conditions, e.g. cardiovascular diseases, autoimmune diseases, Alzheimer's disease (AD), etc.  Among them; AD with a complex pathol. is a progressive neurodegenerative disorder which affect mostly senile people in the world and only symptomatic treatment particularly using cholinesterase inhibitors in clinic is available at the moment for AD.  Consequently, novel treatment strategies towards AD are still searched extensively.  Since PDEs are broadly expressed in the brain, PDEIs are considered to modulate neurodegenerative conditions through regulating cAMP and cGMP in the brain.  In this sense, several synthetic or natural mols. inhibiting various PDE subtypes such as rolipram and roflumilast (PDE4 inhibitors), vinpocetine (PDE1 inhibitor), cilostazol and milrinone (PDE3 inhibitors), sildenafil and tadalafil (PDE5 inhibitors), etc have been reported showing encouraging results for the treatment of AD.  In this review, PDE superfamily will be scrutinized from the view point of structural features, isoforms, functions and pharmacol. particularly attributed to PDEs as target for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot-owBa4CnKLVg90H21EOLACvtfcHk0lhjXN9lUZaHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSrt7vF&md5=babbb6149407a717ebd80b2d2c841021</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2019.110822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2019.110822%26sid%3Dliteratum%253Aachs%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26aulast%3DTalarek%26aufirst%3DS.%26aulast%3DListos%26aufirst%3DJ.%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DDevi%26aufirst%3DK.%2BP.%26aulast%3DRoberto%2Bde%2BOliveira%26aufirst%3DM.%26aulast%3DTewari%26aufirst%3DD.%26aulast%3DArguelles%26aufirst%3DS.%26aulast%3DMehrzadi%26aufirst%3DS.%26aulast%3DHosseinzadeh%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DOrhan%26aufirst%3DI.%2BE.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DMomtaz%26aufirst%3DS.%26aulast%3DFarzaei%26aufirst%3DM.%2BH.%26atitle%3DPhosphodiesterase%2520inhibitors%2520say%2520NO%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2019%26volume%3D134%26spage%3D110822%26doi%3D10.1016%2Fj.fct.2019.110822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasmeen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akram, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainsworth, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruuse, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2019.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.cellsig.2019.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31132399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyks7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2019&pages=108-119&author=S.+Yasmeenauthor=B.+H.+Akramauthor=A.+H.+Hainsworthauthor=C.+Kruuse&title=Cyclic+nucleotide+phosphodiesterases+%28PDEs%29+and+endothelial+function+in+ischaemic+stroke.+A+review&doi=10.1016%2Fj.cellsig.2019.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review</span></div><div class="casAuthors">Yasmeen, Saiqa; Akram, Bilal Hussain; Hainsworth, Atticus H.; Kruuse, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-119</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Endothelial dysfunction is a hallmark of cerebrovascular disease, including ischemic stroke.  Modulating endothelial signaling by cyclic nucleotides, cAMP and cGMP, is a potential therapeutic target in stroke.  Inhibitors of the cyclic nucleotide degrading phosphodiesterase (PDE) enzymes may restore cerebral endothelial function.  Current knowledge on PDE distribution and function in cerebral endothelial cells is sparse.  This review explores data on PDE distribution and effects of PDEi in cerebral endothelial cells and identifies which PDEs are potential treatment targets in stroke.  We performed a systematic search of electronic databases (Medline and Embase).  Our search terms were cerebral ischemia, cerebral endothelial cells, cyclic nucleotide, phosphodiesterase and phosphodiesterase inhibitors.  We found 23 publications which described effects of selective inhibitors of only three PDE families on endothelial function in ischemic stroke.  PDE3 inhibitors (PDE3i) (11 publications) and PDE4 inhibitors (PDE4i) (3 publications) showed anti-inflammatory, anti-apoptotic or pro-angiogenic effects.  PDE3i also reduced leukocyte infiltration and MMP-9 expression.  Both PDE3i and PDE4i increased expression of tight junction proteins and protected the blood-brain barrier.  PDE5 inhibitors (PDE5i) (6 publications) reduced inflammation and apoptosis.  In preclin. models, PDE5i enhanced cGMP/NO signaling assocd. with microvascular angiogenesis, increased cerebral blood flow and improved functional recovery.  Non-specific PDEi (3 publications) had mainly anti-inflammatory effects.  This review demonstrates that non-selective and selective PDEi of PDE3, PDE4 and PDE5 modulated endothelial function in cerebral ischemic stroke by regulating processes involved in vascular repair and neuroprotection and thus reduced cell death and inflammation.  Of note, they promoted angiogenesis, microcirculation and improved functional recovery; all are important in stroke prevention and recovery, and effects should be further evaluated in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGlsLgpMrtpLVg90H21EOLACvtfcHk0lg_2D7PSGMHyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyks7bN&md5=d7208b826005ce443afb323e7ae69411</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2019.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2019.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DYasmeen%26aufirst%3DS.%26aulast%3DAkram%26aufirst%3DB.%2BH.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26aulast%3DKruuse%26aufirst%3DC.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%2520%2528PDEs%2529%2520and%2520endothelial%2520function%2520in%2520ischaemic%2520stroke.%2520A%2520review%26jtitle%3DCell.%2520Signalling%26date%3D2019%26volume%3D61%26spage%3D108%26epage%3D119%26doi%3D10.1016%2Fj.cellsig.2019.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide signaling changes associated with normal aging and age related diseases of the brain</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2017.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.cellsig.2017.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29175000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCrsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2018&pages=281-291&author=M.+P.+Kelly&title=Cyclic+nucleotide+signaling+changes+associated+with+normal+aging+and+age+related+diseases+of+the+brain&doi=10.1016%2Fj.cellsig.2017.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain</span></div><div class="casAuthors">Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">281-291</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Deficits in brain function that are assocd. with aging and age-related diseases benefit very little from currently available therapies, suggesting a better understanding of the underlying mol. mechanisms is needed to develop improved drugs.  Here, we review the literature to test the hypothesis that a break down in cyclic nucleotide signaling at the level of synthesis, execution, and/or degrdn. may contribute to these deficits.  A no. of findings have been reported in both the human and animal model literature that point to brain region-specific changes in Galphas (a.k.a. Gαs or Gsα), adenylyl cyclase, 3',5'-adenosine monophosphate (cAMP) levels, protein kinase A (PKA), cAMP response element binding protein (CREB), exchange protein activated by cAMP (Epac), hyperpolarization-activated cyclic nucleotide-gated ion channels (HCNs), atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), sol. and particulate guanylyl cyclase, 3',5'-guanosine monophosphate (cGMP), protein kinase G (PKG) and phosphodiesterases (PDEs).  Among the most reproducible findings are 1) elevated circulating ANP and BNP levels being assocd. with cognitive dysfunction or dementia independent of cardiovascular effects, 2) reduced basal and/or NMDA-stimulated cGMP levels in brain with aging or Alzheimer's disease (AD), 3) reduced adenylyl cyclase activity in hippocampus and specific cortical regions with aging or AD, 4) reduced expression/activity of PKA in temporal cortex and hippocampus with AD, 5) reduced phosphorylation of CREB in hippocampus with aging or AD, 6) reduced expression/activity of the PDE4 family in brain with aging, 7) reduced expression of PDE10A in the striatum with Huntington's disease (HD) or Parkinson's disease, and 8) beneficial effects of select PDE inhibitors, particularly PDE10 inhibitors in HD models and PDE4 and PDE5 inhibitors in aging and AD models.  Although these findings generally point to a redn. in cyclic nucleotide signaling being assocd. with aging and age-related diseases, there are exceptions.  In particular, there is evidence for increased cAMP signaling specifically in aged prefrontal cortex, AD cerebral vessels, and PD hippocampus.  Thus, if cyclic nucleotide signaling is going to be targeted effectively for therapeutic gain, it will have to be manipulated in a brain region-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2H-lcTfawMrVg90H21EOLACvtfcHk0lg_2D7PSGMHyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCrsrbM&md5=b5ec812c24c12b4fcd1295ee6917bf11</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2017.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2017.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DCyclic%2520nucleotide%2520signaling%2520changes%2520associated%2520with%2520normal%2520aging%2520and%2520age%2520related%2520diseases%2520of%2520the%2520brain%26jtitle%3DCell.%2520Signalling%26date%3D2018%26volume%3D42%26spage%3D281%26epage%3D291%26doi%3D10.1016%2Fj.cellsig.2017.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of phosphodiesterase as cancer therapeutics</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejmech.2018.03.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29574203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=742-756&author=T.+Pengauthor=J.+Gongauthor=Y.+Jinauthor=Y.+Zhouauthor=R.+Tongauthor=X.+Weiauthor=L.+Baiauthor=J.+Shi&title=Inhibitors+of+phosphodiesterase+as+cancer+therapeutics&doi=10.1016%2Fj.ejmech.2018.03.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of phosphodiesterase as cancer therapeutics</span></div><div class="casAuthors">Peng, Ting; Gong, Jun; Jin, Yongzhe; Zhou, Yanping; Tong, Rongsheng; Wei, Xin; Bai, Lan; Shi, Jianyou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">742-756</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are a class of enzymes that hydrolyze cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) which is involved in many physiol. processes including visual transduction, cell proliferation and differentiation, cell-cycle regulation, gene expression, inflammation, apoptosis, and metabolic function.  PDEs are composed of 11 different families and each family contains different subtypes.  The distribution, expression, regulation mode and sensitivity to inhibitors of each subtype are different, and they are involved in cancer, inflammation, asthma, depression, erectile dysfunction and other pathol. processes of development.  A large no. of studies have shown that PDEs play an important role in the development of tumors by affecting the intracellular level of cAMP and/or cGMP and PDEs could become diagnostic markers or therapeutic targets.  This review will give a brief overview of the expression and regulation of PDE families in the process of tumorigenesis and their anti-tumor inhibitors, which may guide the design of novel therapeutic drugs targeting PDEs for anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrup-LedN_wNbVg90H21EOLACvtfcHk0lg_2D7PSGMHyA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOmsb4%253D&md5=444c1f6a9a183a97749241eb2f00d6b3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520phosphodiesterase%2520as%2520cancer%2520therapeutics%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D742%26epage%3D756%26doi%3D10.1016%2Fj.ejmech.2018.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets</span>. <i>Oral Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">e25</span>– <span class="NLM_lpage">e30</span>, <span class="refDoi"> DOI: 10.1111/odi.12275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fodi.12275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25056711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=e25-e30&author=F.+Ahmadauthor=T.+Murataauthor=K.+Shimizuauthor=E.+Degermanauthor=D.+Mauriceauthor=V.+Manganiello&title=Cyclic+nucleotide+phosphodiesterases%3A+important+signaling+modulators+and+therapeutic+targets&doi=10.1111%2Fodi.12275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fodi.12275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fodi.12275%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DDegerman%26aufirst%3DE.%26aulast%3DMaurice%26aufirst%3DD.%26aulast%3DManganiello%26aufirst%3DV.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%253A%2520important%2520signaling%2520modulators%2520and%2520therapeutic%2520targets%26jtitle%3DOral%2520Dis.%26date%3D2015%26volume%3D21%26spage%3De25%26epage%3De30%26doi%3D10.1111%2Fodi.12275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keravis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugnier, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01729.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fj.1476-5381.2011.01729.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22014080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1288-1305&author=T.+Keravisauthor=C.+Lugnier&title=Cyclic+nucleotide+phosphodiesterase+%28PDE%29+isozymes+as+targets+of+the+intracellular+signalling+network%3A+benefits+of+PDE+inhibitors+in+various+diseases+and+perspectives+for+future+therapeutic+developments&doi=10.1111%2Fj.1476-5381.2011.01729.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments</span></div><div class="casAuthors">Keravis, Therese; Lugnier, Claire</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1288-1305</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular messengers cAMP and cGMP in a compartmentalized manner represent an important enzyme class constituted by 11 gene-related families of isoenzymes (PDE1 to PDE11).  Downstream receptors, PDEs play a major role in controlling the signalosome at various levels of phosphorylations and protein/protein interactions.  Due to the multiplicity of isoenzymes, their various intracellular regulations and their different cellular and subcellular distributions, PDEs represent interesting targets in intracellular pathways.  Therefore, the investigation of PDE isoenzyme alterations related to various pathologies and the design of specific PDE inhibitors might lead to the development of new specific therapeutic strategies in numerous pathologies.  This manuscript (i) overviews the different PDEs including their endogenous regulations and their specific inhibitors; (ii) analyses the intracellular implications of PDEs in regulating signalling cascades in pathogenesis, exemplified by two diseases affecting cell cycle and proliferation; and (iii) discusses perspectives for future therapeutic developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvr2jfPTxnY7Vg90H21EOLACvtfcHk0liHVmixNe2cAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D&md5=dbf5913bc6c973d0640258c51b7c481d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01729.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01729.x%26sid%3Dliteratum%253Aachs%26aulast%3DKeravis%26aufirst%3DT.%26aulast%3DLugnier%26aufirst%3DC.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterase%2520%2528PDE%2529%2520isozymes%2520as%2520targets%2520of%2520the%2520intracellular%2520signalling%2520network%253A%2520benefits%2520of%2520PDE%2520inhibitors%2520in%2520various%2520diseases%2520and%2520perspectives%2520for%2520future%2520therapeutic%2520developments%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D1288%26epage%3D1305%26doi%3D10.1111%2Fj.1476-5381.2011.01729.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blount, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1152/physrev.00030.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1152%2Fphysrev.00030.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21527734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=651-690&author=S.+H.+Francisauthor=M.+A.+Blountauthor=J.+D.+Corbin&title=Mammalian+cyclic+nucleotide+phosphodiesterases%3A+molecular+mechanisms+and+physiological+functions&doi=10.1152%2Fphysrev.00030.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions</span></div><div class="casAuthors">Francis, Sharron H.; Blount, Mitsi A.; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-690</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11 families of enzymes.  PDEs break down cAMP and/or cGMP and are major determinants of cellular cN levels and, consequently, the actions of cN-signaling pathways.  PDEs exhibit a range of catalytic efficiencies for breakdown of cAMP and/or cGMP and are regulated by myriad processes including phosphorylation, cN binding to allosteric GAF domains, changes in expression levels, interaction with regulatory or anchoring proteins, and reversible translocation among subcellular compartments.  Selective PDE inhibitors are currently in clin. use for treatment of erectile dysfunction, pulmonary hypertension, intermittent claudication, and chronic pulmonary obstructive disease; many new inhibitors are being developed for treatment of these and other maladies.  Recently reported x-ray crystallog. structures have defined features that provide for specificity for cAMP or cGMP in PDE catalytic sites or their GAF domains, as well as mechanisms involved in catalysis, oligomerization, autoinhibition, and interactions with inhibitors.  In addn., major advances have been made in understanding the physiol. impact and the biochem. basis for selective localization and/or recruitment of specific PDE isoenzymes to particular subcellular compartments.  The many recent advances in understanding PDE structures, functions, and physiol. actions are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN99wWYsCXRbVg90H21EOLACvtfcHk0liHVmixNe2cAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D&md5=4aae757704a6243c9aa2648c32d5c759</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00030.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00030.2010%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DBlount%26aufirst%3DM.%2BA.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DMammalian%2520cyclic%2520nucleotide%2520phosphodiesterases%253A%2520molecular%2520mechanisms%2520and%2520physiological%2520functions%26jtitle%3DPhysiol.%2520Rev.%26date%3D2011%26volume%3D91%26spage%3D651%26epage%3D690%26doi%3D10.1152%2Fphysrev.00030.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallamini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwarthoed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borra, A.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography (PET) in oncology</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.3390/cancers6041821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fcancers6041821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25268160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2M7mtF2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1821-1889&author=A.+Gallaminiauthor=C.+Zwarthoedauthor=A.+Borra&title=Positron+emission+tomography+%28PET%29+in+oncology&doi=10.3390%2Fcancers6041821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Positron Emission Tomography (PET) in Oncology</span></div><div class="casAuthors">Gallamini Andrea; Zwarthoed Colette; Borra Anna</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1821-89</span>
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    </div><div class="casAbstract">Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment during or after treatment end and radiotherapy planning.  Moreover, the continuous technological progress of image generation and the introduction of sophisticated software to use PET scan as a biomarker paved the way to calculate new prognostic markers such as the metabolic tumor volume (MTV) and the total amount of tumor glycolysis (TLG).  FDG-PET/CT proved more sensitive than contrast-enhanced CT scan in staging of several type of lymphoma or in detecting widespread tumor dissemination in several solid cancers, such as breast, lung, colon, ovary and head and neck carcinoma.  As a consequence the stage of patients was upgraded, with a change of treatment in 10%-15% of them.  One of the most evident advantages of FDG-PET was its ability to detect, very early during treatment, significant changes in glucose metabolism or even complete shutoff of the neoplastic cell metabolism as a surrogate of tumor chemosensitivity assessment.  This could enable clinicians to detect much earlier the effectiveness of a given antineoplastic treatment, as compared to the traditional radiological detection of tumor shrinkage, which usually takes time and occurs much later.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPOtR_mX3I6Uh5eUSa2oe_fW6udTcc2ebAQx7CUy3r-rntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7mtF2mtQ%253D%253D&md5=6b04985394605f5fa9fd719f174541fe</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fcancers6041821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6041821%26sid%3Dliteratum%253Aachs%26aulast%3DGallamini%26aufirst%3DA.%26aulast%3DZwarthoed%26aufirst%3DC.%26aulast%3DBorra%26aufirst%3DA.%26atitle%3DPositron%2520emission%2520tomography%2520%2528PET%2529%2520in%2520oncology%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D1821%26epage%3D1889%26doi%3D10.3390%2Fcancers6041821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, D.</span></span> <span> </span><span class="NLM_article-title">Advantages in functional imaging of the brain</span>. <i>Front. Hum. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi"> DOI: 10.3389/fnhum.2015.00249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3389%2Ffnhum.2015.00249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25667571" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=9&author=W.+Mierauthor=D.+Mier&title=Advantages+in+functional+imaging+of+the+brain&doi=10.3389%2Ffnhum.2015.00249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffnhum.2015.00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnhum.2015.00249%26sid%3Dliteratum%253Aachs%26aulast%3DMier%26aufirst%3DW.%26aulast%3DMier%26aufirst%3DD.%26atitle%3DAdvantages%2520in%2520functional%2520imaging%2520of%2520the%2520brain%26jtitle%3DFront.%2520Hum.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D9%26doi%3D10.3389%2Ffnhum.2015.00249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jivraj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phinikaridou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botnar, R. M.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of myocardial infarction</span>. <i>Basic Res. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">397</span>, <span class="refDoi"> DOI: 10.1007/s00395-013-0397-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00395-013-0397-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24322905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVKnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2014&pages=397&author=N.+Jivrajauthor=A.+Phinikaridouauthor=A.+M.+Shahauthor=R.+M.+Botnar&title=Molecular+imaging+of+myocardial+infarction&doi=10.1007%2Fs00395-013-0397-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of myocardial infarction</span></div><div class="casAuthors">Jivraj, Naheed; Phinikaridou, Alkystis; Shah, Ajay M.; Botnar, Rene M.</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">397/1-397/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Myocardial infarction (MI), and subsequent heart failure, remains a major healthcare problem in the western and developing world and leads to substantial morbidity and mortality.  After MI, the ability of the myocardium to recover is closely assocd. with a complex immune response that often leads to adverse remodeling of the ventricle, and poor prognosis.  Currently used clin. imaging modalities allow the assessment of anatomy, perfusion, function, and viability but do not provide insights into specific biol. processes.  In contrast, novel non-invasive imaging methods, using targeted imaging agents, allow imaging of the mol. processes underlying the post-MI immune cell response, and sub- sequent remodeling.  Therefore, this may have significant diagnostic, prognostic, and therapeutic value, and may help to improve our understanding of post-infarct remodeling, in vivo.  Imaging modalities such as magnetic resonance imaging, single-photon emission computed tomog., and positron emission tomog. have been used in concert with radiolabeled and (super) paramagnetic probes to image each phase of the immune response.  These probes, which target apoptosis, necrosis, neutrophils, monocytes, enzymes, angiogenesis, extracellular matrix, and scar formation have been assessed and validated pre-clin.  Translating this work to the bedside in a cost-effective, clin. beneficial manner remains a significant challenge.  This article reviews these new imaging techniques as well as the corresponding pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJvMitKpXyt7Vg90H21EOLACvtfcHk0lgfizcwG-g7Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVKnu78%253D&md5=8d3cea80d4734ff4cf26cae3037756cf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00395-013-0397-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-013-0397-2%26sid%3Dliteratum%253Aachs%26aulast%3DJivraj%26aufirst%3DN.%26aulast%3DPhinikaridou%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%2BM.%26aulast%3DBotnar%26aufirst%3DR.%2BM.%26atitle%3DMolecular%2520imaging%2520of%2520myocardial%2520infarction%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2014%26volume%3D109%26spage%3D397%26doi%3D10.1007%2Fs00395-013-0397-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niphakis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Determining target engagement in living systems</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnchembio.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23508173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=200-205&author=G.+M.+Simonauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Determining+target+engagement+in+living+systems&doi=10.1038%2Fnchembio.1211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Determining target engagement in living systems</span></div><div class="casAuthors">Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. probes are crit. tools for elucidating the biol. functions of proteins and can lead to new medicines for treating disease.  The pharmacol. validation of protein function requires verification that chem. probes engage their intended targets in vivo.  Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that detg. this parameter should become std. practice for chem. probe and drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5eudh3YJSOLVg90H21EOLACvtfcHk0lgfizcwG-g7Tw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D&md5=48a97d0d8ff7a7de4f9de0e9c54a1c5c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1211%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDetermining%2520target%2520engagement%2520in%2520living%2520systems%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D200%26epage%3D205%26doi%3D10.1038%2Fnchembio.1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windhorst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercouillie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammertsma, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Guidelines to PET measurements of the target occupancy in the brain for drug development</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2255</span>– <span class="NLM_lpage">2262</span>, <span class="refDoi"> DOI: 10.1007/s00259-016-3476-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-016-3476-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27514528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOms7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=2255-2262&author=A.+Takanoauthor=A.+Varroneauthor=B.+Gulyasauthor=P.+Salvadoriauthor=A.+Geeauthor=A.+Windhorstauthor=J.+Vercouillieauthor=G.+Bormansauthor=A.+A.+Lammertsmaauthor=C.+Halldin&title=Guidelines+to+PET+measurements+of+the+target+occupancy+in+the+brain+for+drug+development&doi=10.1007%2Fs00259-016-3476-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines to PET measurements of the target occupancy in the brain for drug development</span></div><div class="casAuthors">Takano, Akihiro; Varrone, Andrea; Gulyas, Balazs; Salvadori, Piero; Gee, Antony; Windhorst, Albert; Vercouillie, Johnny; Bormans, Guy; Lammertsma, Adriaan A.; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2255-2262</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This guideline summarizes the current view of the European Assocn. of Nuclear Medicine Drug Development Committee.  The purpose of this guideline is to guarantee a high std. of PET studies that are aimed at measuring target occupancy in the brain within the framework of development programs of drugs that act within the central nervous system (CNS drugs).  This guideline is intended to present information specifically adapted to European practice.  The information provided should be applied within the context of local conditions and regulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrILKZLy_UrCbVg90H21EOLACvtfcHk0lgsmBMIxZ_RuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOms7zP&md5=5c992a4722c887a454817713acc69619</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00259-016-3476-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-016-3476-4%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DSalvadori%26aufirst%3DP.%26aulast%3DGee%26aufirst%3DA.%26aulast%3DWindhorst%26aufirst%3DA.%26aulast%3DVercouillie%26aufirst%3DJ.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DGuidelines%2520to%2520PET%2520measurements%2520of%2520the%2520target%2520occupancy%2520in%2520the%2520brain%2520for%2520drug%2520development%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D43%26spage%3D2255%26epage%3D2262%26doi%3D10.1007%2Fs00259-016-3476-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boscutti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span> <span> </span><span class="NLM_article-title">PET radioligands for imaging of the PDE10A in human: current status</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>691</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2018.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neulet.2018.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30099081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Sms7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=691&publication_year=2019&pages=11-17&author=G.+Boscuttiauthor=E.+A.+Rabinerauthor=C.+Plisson&title=PET+radioligands+for+imaging+of+the+PDE10A+in+human%3A+current+status&doi=10.1016%2Fj.neulet.2018.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PET Radioligands for imaging of the PDE10A in human: current status</span></div><div class="casAuthors">Boscutti, Giulia; Rabiner, Eugenii A.; Plisson, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">691</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The development of β+ emitter tracers labeled with carbon-11 or fluorine-18 having optimal characteristics of affinity and selectivity for the phosphodiesterase 10 A protein has received considerable attention, due to the major implication of this enzyme in neurol. and psychiatric disorders, such as Hungtington's disease, Parkinson's disease and schizophrenia.  The ability to quantify PDE10 A availability in the human brain in vivo will thus aid understanding its role in neurodegenerative and neuropsychiatric pathophysiol. as well as providing a valuable tool for drug development.  This manuscript reviews the different compd. series assessed to date as PET radioligand for the PDE10 A in human and their use to support the development programs of novel drugs or to evaluate PDE10 A alterations in pathologies as Huntington's, Parkinson's Diseases and Schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplICFntoPS8LVg90H21EOLACvtfcHk0lgsmBMIxZ_RuA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Sms7%252FO&md5=d8d2d82156b3fb546bf24a531803c53d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2018.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2018.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DBoscutti%26aufirst%3DG.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DPlisson%26aufirst%3DC.%26atitle%3DPET%2520radioligands%2520for%2520imaging%2520of%2520the%2520PDE10A%2520in%2520human%253A%2520current%2520status%26jtitle%3DNeurosci.%2520Lett.%26date%3D2019%26volume%3D691%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.neulet.2018.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Novel radioligands for cyclic nucleotide phosphodiesterase imaging with positron rmission tomography: An update on developments since 2012</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">650</span>, <span class="refDoi"> DOI: 10.3390/molecules21050650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules21050650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=650&author=S.+Schroderauthor=B.+Wenzelauthor=W.+Deuther-Conradauthor=M.+Scheunemannauthor=P.+Brust&title=Novel+radioligands+for+cyclic+nucleotide+phosphodiesterase+imaging+with+positron+rmission+tomography%3A+An+update+on+developments+since+2012&doi=10.3390%2Fmolecules21050650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21050650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21050650%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DNovel%2520radioligands%2520for%2520cyclic%2520nucleotide%2520phosphodiesterase%2520imaging%2520with%2520positron%2520rmission%2520tomography%253A%2520An%2520update%2520on%2520developments%2520since%25202012%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D650%26doi%3D10.3390%2Fmolecules21050650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ignacio
Andres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Recent advances in positron emission tomography (PET) radiotracers for imaging phosphodiesterases</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1224</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.2174/156802612800672853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2174%2F156802612800672853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22571785" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1224-1236&author=J.+Ignacio%0AAndresauthor=M.+De+Angelisauthor=J.+Alcazarauthor=S.+Celenauthor=G.+Bormans&title=Recent+advances+in+positron+emission+tomography+%28PET%29+radiotracers+for+imaging+phosphodiesterases&doi=10.2174%2F156802612800672853"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F156802612800672853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802612800672853%26sid%3Dliteratum%253Aachs%26aulast%3DIgnacio%2BAndres%26aufirst%3DJ.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520radiotracers%2520for%2520imaging%2520phosphodiesterases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1224%26epage%3D1236%26doi%3D10.2174%2F156802612800672853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">PET imaging of phosphodiesterases in brain</span>. <i>In PET and SPECT of Neurobiological Systems</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1007/978-3-030-53176-8_23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2F978-3-030-53176-8_23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=851-877&author=M.+Oomsauthor=G.+Bormans&title=PET+imaging+of+phosphodiesterases+in+brain&doi=10.1007%2F978-3-030-53176-8_23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-3-030-53176-8_23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-030-53176-8_23%26sid%3Dliteratum%253Aachs%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPET%2520imaging%2520of%2520phosphodiesterases%2520in%2520brain%26jtitle%3DIn%2520PET%2520and%2520SPECT%2520of%2520Neurobiological%2520Systems%26date%3D2021%26spage%3D851%26epage%3D877%26doi%3D10.1007%2F978-3-030-53176-8_23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakics, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span> <span> </span><span class="NLM_article-title">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuropharm.2010.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20493887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=367-374&author=V.+Lakicsauthor=E.+H.+Karranauthor=F.+G.+Boess&title=Quantitative+comparison+of+phosphodiesterase+mRNA+distribution+in+human+brain+and+peripheral+tissues&doi=10.1016%2Fj.neuropharm.2010.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span></div><div class="casAuthors">Lakics, Viktor; Karran, Eric H.; Boess, Frank G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic nucleotide-specific phosphodiesterases (PDEs) play a crit. role in signal transduction by regulating the level of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) in cells.  The gene expression pattern of a PDE provides important information regarding its role in physiol. and pathol. processes.  In this study, we have established the mRNA expression profile all PDE isoenzymes (PDE1A/B/C, 2A, 3A/B, 4A/B/C/D, 5A, 6A/B/C, 7A/B, 8A/B, 9A, 10A, 11A) in a human cDNA collection consisting of 10 brain regions (parietal, frontal, temporal cortex, hippocampus, striatum, thalamus, hypothalamus, substantia nigra, nucleus accumbens, cerebellum), spinal cord, dorsal root ganglia and 12 peripheral tissues (skeletal muscle, heart, thyroid, adrenal gland, pancreas, bladder, kidney, liver, lung, small intestine, spleen, and stomach).  Using quant. real-time polymerase chain reaction and parallel anal. of a carefully selected group of ref. genes, we have detd. the relative expression of each PDE isoenzyme across the 24 selected tissues, and also compared the expression of selected PDEs to each other within a given tissue type.  Several PDEs show strikingly selective expression (e.g. PDE10A and PDE1B mRNA levels in the caudate nucleus are 20-fold higher than in most other tissues; PDE1C and PDE3A are highly expressed in the heart and PDE8B is expressed very strongly in the thyroid gland).  This comprehensive approach provides a coherent and quant. view of the mRNA expression of the PDE gene family and enables an integration of data obtained with other non-quant. methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGz6OEkRjbLVg90H21EOLACvtfcHk0lhqk7YoYK6fNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ&md5=ee55772f572818eaa7194a1ae3f52f45</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DLakics%26aufirst%3DV.%26aulast%3DKarran%26aufirst%3DE.%2BH.%26aulast%3DBoess%26aufirst%3DF.%2BG.%26atitle%3DQuantitative%2520comparison%2520of%2520phosphodiesterase%2520mRNA%2520distribution%2520in%2520human%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D59%26spage%3D367%26epage%3D374%26doi%3D10.1016%2Fj.neuropharm.2010.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fertig, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. S.</span></span> <span> </span><span class="NLM_article-title">PDE4-mediated cAMP signalling</span>. <i>J. Cardiovasc. Dev. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">8</span>, <span class="refDoi"> DOI: 10.3390/jcdd5010008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fjcdd5010008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjslyrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=8&author=B.+A.+Fertigauthor=G.+S.+Baillie&title=PDE4-mediated+cAMP+signalling&doi=10.3390%2Fjcdd5010008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PDE4-mediated cAMP signalling</span></div><div class="casAuthors">Fertig, Bracy A.; Baillie, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Development and Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8/1-8/14</span>CODEN:
                <span class="NLM_cas:coden">JCDDB4</span>;
        ISSN:<span class="NLM_cas:issn">2308-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  CAMP is the archetypal and ubiquitous second messenger utilized for the fine control of many cardiovascular cell signalling systems.  The ability of cAMP to elicit cell surface receptor-specific responses relies on its compartmentalisation by cAMP hydrolyzing enzymes known as phosphodiesterases.  One family of these enzymes, PDE4, is particularly important in the cardiovascular system, where it has been extensively studied and shown to orchestrate complex, localised signalling that underpins many crucial functions of the heart.  In the cardiac myocyte, cAMP activates PKA, which phosphorylates a small subset of mostly sarcoplasmic substrate proteins that drive β-adrenergic enhancement of cardiac function.  The phosphorylation of these substrates, many of which are involved in cardiac excitation-contraction coupling, has been shown to be tightly regulated by highly localised pools of individual PDE4 isoforms.  The spatial and temporal regulation of cardiac signalling is made possible by the formation of macromol. "signalosomes", which often include a cAMP effector, such as PKA, its substrate, PDE4 and an anchoring protein such as an AKAP.  Studies described in the present review highlight the importance of this relationship for individual cardiac PKA substrates and we provide an overview of how this signalling paradigm is coordinated to promote efficient adrenergic enhancement of cardiac function.  The role of PDE4 also extends to the vascular endothelium, where it regulates vascular permeability and barrier function.  In this distinct location, PDE4 interacts with adherens junctions to regulate their stability.  These highly specific, non-redundant roles for PDE4 isoforms have far reaching therapeutic potential.  PDE inhibitors in the clinic have been plagued with problems due to the active site-directed nature of the compds. which concomitantly attenuate PDE activity in all highly localised "signalosomes".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1GQOAKh0NLVg90H21EOLACvtfcHk0lhqk7YoYK6fNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjslyrurs%253D&md5=55ab00b9daa0cd96454807732bd5f4bc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fjcdd5010008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcdd5010008%26sid%3Dliteratum%253Aachs%26aulast%3DFertig%26aufirst%3DB.%2BA.%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26atitle%3DPDE4-mediated%2520cAMP%2520signalling%26jtitle%3DJ.%2520Cardiovasc.%2520Dev.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3D8%26doi%3D10.3390%2Fjcdd5010008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 4 and its inhibitors in inflammatory diseases</span>. <i>Chang Gung Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.4103/2319-4170.106152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.4103%2F2319-4170.106152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22735051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC38jltVSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=197-210&author=S.+L.+Jinauthor=S.+L.+Dingauthor=S.+C.+Lin&title=Phosphodiesterase+4+and+its+inhibitors+in+inflammatory+diseases&doi=10.4103%2F2319-4170.106152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 4 and its inhibitors in inflammatory diseases</span></div><div class="casAuthors">Jin S-L Catherine; Ding Shiau-Li; Lin Shih-Chang</div><div class="citationInfo"><span class="NLM_cas:title">Chang Gung medical journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-210</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Type 4 cyclic nucleotide phosphodiesterases (PDE4) are a family of low km 3',5'-cyclic adenosine monophosphate (cAMP)-specific phosphodiesterases including at least 20 isozymes encoded by four genes (PDE4A, PDE4B, PDE4C, and PDE4D) in mammals.  Each PDE4 gene plays a special, nonredundant role in the control of cell function even though the four subfamilies share the highly conserved catalytic domain and upstream conserved region (UCR) 1 and UCR2 motifs of the regulatory domain.  By their wide tissue distribution as well as differential expression and regulation among various cell types, PDE4s are viewed as critical regulators of intracellular cAMP levels, cAMP signaling, and signal compartmentalization.  By increasing cAMP levels, PDE4 inhibitors show a broad spectrum of anti-inflammatory effects in almost all inflammatory cells.  Many PDE4 inhibitors have been evaluated in clinical trials for various inflammatory conditions.  Developed inhibitors, including the recently approved and marketed roflumilast, have considerable efficacy, but they also have adverse effects such as nausea and emesis which limit their dosing and subsequently their immunomodulatory activity.  Thus, the development of PDE4 inhibitors with improved therapeutic indexes has been a major focus of pharmaceutical research for the treatment of chronic inflammatory diseases.  Recent PDE4 gene knockout studies strongly suggest that PDE4 inhibitors with PDE4B selectivity may retain the anti-inflammatory effects while limiting side effects.  Development of PDE4 inhibitors with different delivery routes, such as topical application and inhalation, is also a promising approach for the treatment of pulmonary inflammatory conditions and dermatitis.  This review includes a brief overview of the domain structure and function of PDE4 isozymes, the role of PDE4s in inflammatory cell responses, and the potential therapeutic utility of PDE4 inhibitors in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTEpKl6OUluY3thwrmtH4OBfW6udTcc2eZXvQKZam6Mabntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jltVSntQ%253D%253D&md5=b6d609c93af09f56acb47c896bf4de32</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4103%2F2319-4170.106152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2319-4170.106152%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.%2BC.%26atitle%3DPhosphodiesterase%25204%2520and%2520its%2520inhibitors%2520in%2520inflammatory%2520diseases%26jtitle%3DChang%2520Gung%2520Med.%2520J.%26date%3D2012%26volume%3D35%26spage%3D197%26epage%3D210%26doi%3D10.4103%2F2319-4170.106152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguiar, R. C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2886</span>– <span class="NLM_lpage">2890</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-09-737676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1182%2Fblood-2016-09-737676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27756749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1ait7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=2886-2890&author=J.+D.+Cooneyauthor=R.+C.+Aguiar&title=Phosphodiesterase+4+inhibitors+have+wide-ranging+activity+in+B-cell+malignancies&doi=10.1182%2Fblood-2016-09-737676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies</span></div><div class="casAuthors">Cooney, Jeffrey D.; Aguiar, Ricardo C. T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2886-2890</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 (PDE4) inhibition restores the suppressive effects of 3',5'-cyclic adenosine monophosphate in lymphocytes.  In this concise review, we detail how PDE4 inhibition down-modulates the B-cell receptor (BCR)-related kinases spleen tyrosine kinase and phosphatidylinositol 3-kinase and inhibits vascular endothelial growth factor A secretion by tumor cells, inducing cancer cell apoptosis and blocking angiogenesis in the microenvironment.  We describe the successful clin. repurposing of PDE4 inhibitors in B-cell malignancies, and propose that given their anti-inflammatory/immunomodulatory activity, these agents will suppress BCR signals without the toxicity assocd. with other targeted biol. doublets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvT7KtkpSFOLVg90H21EOLACvtfcHk0ljznftPcWXGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1ait7k%253D&md5=fff5d8746f062bc1d9bd7214ad15ae6c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-09-737676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-09-737676%26sid%3Dliteratum%253Aachs%26aulast%3DCooney%26aufirst%3DJ.%2BD.%26aulast%3DAguiar%26aufirst%3DR.%2BC.%26atitle%3DPhosphodiesterase%25204%2520inhibitors%2520have%2520wide-ranging%2520activity%2520in%2520B-cell%2520malignancies%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D2886%26epage%3D2890%26doi%3D10.1182%2Fblood-2016-09-737676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase type 4 inhibition in CNS diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">985</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2019.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.tips.2019.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31704172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2htbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=971-985&author=A.+Bloklandauthor=P.+Heckmanauthor=T.+Vanmierloauthor=R.+Schreiberauthor=D.+Paesauthor=J.+Prickaerts&title=Phosphodiesterase+type+4+inhibition+in+CNS+diseases&doi=10.1016%2Fj.tips.2019.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase Type 4 Inhibition in CNS Diseases</span></div><div class="casAuthors">Blokland, Arjan; Heckman, Pim; Vanmierlo, Tim; Schreiber, Rudy; Paes, Dean; Prickaerts, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">971-985</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs) have been an interesting drug target for many diseases.  Although a vast no. of mainly preclin. studies demonstrates beneficial effects of PDE inhibitors for central nervous system (CNS) diseases, no drugs are currently available for CNS indications.  In this review, we discuss the rationale of PDE4 inhibitors for different CNS diseases, including memory impairments, striatal disorders, multiple sclerosis (MS), and acquired brain injury (ABI).  However, clin. development has been problematic due to mechanism-based adverse effects of these drugs in humans.  Our increased understanding of factors influencing the conformational state of the PDE4 enzyme and of how to influence the binding affinity of PDE4 subtype inhibitors, holds promise for the successful development of novel selective PDE4 inhibitors with higher efficacy and fewer adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBvx09wI08LVg90H21EOLACvtfcHk0ljznftPcWXGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2htbrL&md5=3c50827c42a97d8cb4913b69abd6179c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2019.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2019.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DHeckman%26aufirst%3DP.%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DPaes%26aufirst%3DD.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520type%25204%2520inhibition%2520in%2520CNS%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2019%26volume%3D40%26spage%3D971%26epage%3D985%26doi%3D10.1016%2Fj.tips.2019.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Titus, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calixte, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, C. M.</span></span> <span> </span><span class="NLM_article-title">A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury</span>. <i>Neurobiol. Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.nlm.2017.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nlm.2017.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29294383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvF2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2018&pages=38-49&author=D.+J.+Titusauthor=N.+M.+Wilsonauthor=O.+Alcazarauthor=D.+A.+Calixteauthor=W.+D.+Dietrichauthor=M.+E.+Gurneyauthor=C.+M.+Atkins&title=A+negative+allosteric+modulator+of+PDE4D+enhances+learning+after+traumatic+brain+injury&doi=10.1016%2Fj.nlm.2017.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury</span></div><div class="casAuthors">Titus, David J.; Wilson, Nicole M.; Alcazar, Oscar; Calixte, Dale A.; Dietrich, W. Dalton; Gurney, Mark E.; Atkins, Coleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Learning and Memory</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38-49</span>CODEN:
                <span class="NLM_cas:coden">NLMEFR</span>;
        ISSN:<span class="NLM_cas:issn">1074-7427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Traumatic brain injury (TBI) significantly decreases cAMP (cAMP) signaling which produces long-term synaptic plasticity deficits and chronic learning and memory impairments.  Phosphodiesterase 4 (PDE4) is a major family of cAMP hydrolyzing enzymes in the brain and of the four PDE4 subtypes, PDE4D in particular has been found to be involved in memory formation.  Although most PDE4 inhibitors target all PDE4 subtypes, PDE4D can be targeted with a selective, neg. allosteric modulator, D159687.  In this study, we hypothesized that treating animals with D159687 could reverse the cognitive deficits caused by TBI.  To test this hypothesis, adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury.  After 3 mo of recovery, animals were treated with D159687 (0.3 mg/kg, i.p.) at 30 min prior to cue and contextual fear conditioning, acquisition in the water maze or during a spatial working memory task.  Treatment with D159687 had no significant effect on these behavioral tasks in non-injured, sham animals, but did reverse the learning and memory deficits in chronic TBI animals.  Assessment of hippocampal slices at 3 mo post-TBI revealed that D159687 reversed both the depression in basal synaptic transmission in area CA1 as well as the late-phase of long-term potentiation.  These results demonstrate that a neg. allosteric modulator of PDE4D may be a potential therapeutic to improve chronic cognitive dysfunction following TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWcDR6Nl6uhrVg90H21EOLACvtfcHk0ljznftPcWXGig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvF2gug%253D%253D&md5=50d47684152b5ad9756eaf46a6adcfc9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.nlm.2017.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nlm.2017.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DTitus%26aufirst%3DD.%2BJ.%26aulast%3DWilson%26aufirst%3DN.%2BM.%26aulast%3DAlcazar%26aufirst%3DO.%26aulast%3DCalixte%26aufirst%3DD.%2BA.%26aulast%3DDietrich%26aufirst%3DW.%2BD.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DAtkins%26aufirst%3DC.%2BM.%26atitle%3DA%2520negative%2520allosteric%2520modulator%2520of%2520PDE4D%2520enhances%2520learning%2520after%2520traumatic%2520brain%2520injury%26jtitle%3DNeurobiol.%2520Learn.%2520Mem.%26date%3D2018%26volume%3D148%26spage%3D38%26epage%3D49%26doi%3D10.1016%2Fj.nlm.2017.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahlke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbrand, G.</span></span> <span> </span><span class="NLM_article-title">Cyclic 3′,5′-nucleotide phosphodiesterases: potential targets for anticancer therapy</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1021/tx000090l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx000090l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvF2kurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=944-948&author=D.+Markoauthor=G.+Pahlkeauthor=K.+H.+Merzauthor=G.+Eisenbrand&title=Cyclic+3%E2%80%B2%2C5%E2%80%B2-nucleotide+phosphodiesterases%3A+potential+targets+for+anticancer+therapy&doi=10.1021%2Ftx000090l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic 3',5'-Nucleotide Phosphodiesterases: Potential Targets for Anticancer Therapy</span></div><div class="casAuthors">Marko, Doris; Pahlke, Gudrun; Merz, Karl-Heinz; Eisenbrand, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">944-948</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 11 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCi1hocz577Vg90H21EOLACvtfcHk0liW1Pxg1-go5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvF2kurg%253D&md5=bdeb99e3e0e32f17e8767dc90402d3c5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Ftx000090l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx000090l%26sid%3Dliteratum%253Aachs%26aulast%3DMarko%26aufirst%3DD.%26aulast%3DPahlke%26aufirst%3DG.%26aulast%3DMerz%26aufirst%3DK.%2BH.%26aulast%3DEisenbrand%26aufirst%3DG.%26atitle%3DCyclic%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-nucleotide%2520phosphodiesterases%253A%2520potential%2520targets%2520for%2520anticancer%2520therapy%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2000%26volume%3D13%26spage%3D944%26epage%3D948%26doi%3D10.1021%2Ftx000090l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Press, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denholm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberthuer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatto, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuffnell, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fozard, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifilieff, A.</span></span> <span> </span><span class="NLM_article-title">Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7472</span>– <span class="NLM_lpage">7479</span>, <span class="refDoi"> DOI: 10.1021/jm300459a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300459a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOrurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7472-7479&author=N.+J.+Pressauthor=R.+J.+Taylorauthor=J.+D.+Fullertonauthor=P.+Tranterauthor=C.+McCarthyauthor=T.+H.+Kellerauthor=N.+Arnoldauthor=D.+Beerauthor=L.+Brownauthor=R.+Cheungauthor=J.+Christieauthor=A.+Denholmauthor=S.+Haberthuerauthor=J.+D.+Hattoauthor=M.+Keenanauthor=M.+K.+Mercerauthor=H.+Oakmanauthor=H.+Sahriauthor=A.+R.+Tuffnellauthor=M.+Tweedauthor=J.+W.+Tylerauthor=T.+Wagnerauthor=J.+R.+Fozardauthor=A.+Trifilieff&title=Solubility-driven+optimization+of+phosphodiesterase-4+inhibitors+leading+to+a+clinical+candidate&doi=10.1021%2Fjm300459a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Solubility-Driven Optimization of Phosphodiesterase-4 Inhibitors Leading to a Clinical Candidate</span></div><div class="casAuthors">Press, Neil J.; Taylor, Roger J.; Fullerton, Joseph D.; Tranter, Pamela; McCarthy, Clive; Keller, Thomas H.; Arnold, Nicola; Beer, David; Brown, Lyndon; Cheung, Robert; Christie, Julie; Denholm, Alastair; Haberthuer, Sandra; Hatto, Julia D. I.; Keenan, Mark; Mercer, Mark K.; Oakman, Helen; Sahri, Helene; Tuffnell, Andrew R.; Tweed, Morris; Tyler, John W.; Wagner, Trixie; Fozard, John R.; Trifilieff, Alexandre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7472-7479</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The soly.-driven optimization of a series of 1,7-naphthyridine phosphodiesterase-4 inhibitors is described.  Directed structural changes resulted in increased aq. soly., enabling superior pharmacokinetic properties with retention of PDE4 inhibition.  A range of potent and orally bioavailable compds. with good in vivo efficacy in animal models of inflammation and reduced emetic potential compared to previously described drugs were synthesized.  Compd. 2d (I) was taken forward as a clin. candidate for the treatment of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL0BzBNQVqnrVg90H21EOLACvtfcHk0liW1Pxg1-go5Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOrurnO&md5=deee9ca074de0b531a130d9a6ce530b2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300459a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300459a%26sid%3Dliteratum%253Aachs%26aulast%3DPress%26aufirst%3DN.%2BJ.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DFullerton%26aufirst%3DJ.%2BD.%26aulast%3DTranter%26aufirst%3DP.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DBeer%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DCheung%26aufirst%3DR.%26aulast%3DChristie%26aufirst%3DJ.%26aulast%3DDenholm%26aufirst%3DA.%26aulast%3DHaberthuer%26aufirst%3DS.%26aulast%3DHatto%26aufirst%3DJ.%2BD.%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DM.%2BK.%26aulast%3DOakman%26aufirst%3DH.%26aulast%3DSahri%26aufirst%3DH.%26aulast%3DTuffnell%26aufirst%3DA.%2BR.%26aulast%3DTweed%26aufirst%3DM.%26aulast%3DTyler%26aufirst%3DJ.%2BW.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26aulast%3DTrifilieff%26aufirst%3DA.%26atitle%3DSolubility-driven%2520optimization%2520of%2520phosphodiesterase-4%2520inhibitors%2520leading%2520to%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7472%26epage%3D7479%26doi%3D10.1021%2Fjm300459a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, S. M.</span></span> <span> </span><span class="NLM_article-title">Crisaborole ointment 2%: A review in mild to moderate atopic dermatitis</span>. <i>Am. J. Clin. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">843</span>, <span class="refDoi"> DOI: 10.1007/s40257-017-0327-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs40257-017-0327-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29076116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC1M7ltV2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-843&author=S.+M.+Hoy&title=Crisaborole+ointment+2%25%3A+A+review+in+mild+to+moderate+atopic+dermatitis&doi=10.1007%2Fs40257-017-0327-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis</span></div><div class="casAuthors">Hoy Sheridan M</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical dermatology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-843</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Crisaborole ointment 2% (Eucrisa®) is a novel, anti-inflammatory inhibitor of phosphodiesterase 4 (PDE4) that is available in the USA for the topical treatment of mild to moderate atopic dermatitis in patients aged ≥ 2 years.  In two short-term (28 days), identically designed, multicentre, phase III studies in this patient population, topical therapy with crisaborole ointment 2% reduced disease severity and pruritus severity compared with vehicle, with the effect established early and sustained over the course of treatment.  Improvements in the other signs of atopic dermatitis (erythema, exudation, excoriation, induration/papulation, and lichenification) were also seen.  Crisaborole ointment 2% was generally well tolerated in the short-term studies, with its favorable safety profile maintained over the longer term (up to 52 weeks) in a multicentre, extension study.  Most treatment-emergent adverse events (TEAEs) were of mild to moderate severity and considered unrelated to the study medication.  Moreover, the incidence of application-site pain following short- and longer-term topical therapy with crisaborole ointment 2% was low.  In conclusion, crisaborole ointment 2% is an effective and generally well tolerated new topical option for the management of mild to moderate atopic dermatitis in patients aged ≥ 2 years, with the potential to effectively treat this patient population over the longer term without the safety concerns associated with other current topical anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTv9G71HdF0KySm0e6ZOaemfW6udTcc2eYzgbaCG_Bbbbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7ltV2gtQ%253D%253D&md5=c9d41cfc31e81152a11df5400ee1c358</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs40257-017-0327-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40257-017-0327-4%26sid%3Dliteratum%253Aachs%26aulast%3DHoy%26aufirst%3DS.%2BM.%26atitle%3DCrisaborole%2520ointment%25202%2525%253A%2520A%2520review%2520in%2520mild%2520to%2520moderate%2520atopic%2520dermatitis%26jtitle%3DAm.%2520J.%2520Clin.%2520Dermatol.%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D843%26doi%3D10.1007%2Fs40257-017-0327-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rolan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span> <span> </span><span class="NLM_article-title">Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2897</span>– <span class="NLM_lpage">2904</span>, <span class="refDoi"> DOI: 10.1517/14656560903426189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1517%2F14656560903426189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19929708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVyjur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2897-2904&author=P.+Rolanauthor=M.+Hutchinsonauthor=K.+Johnson&title=Ibudilast%3A+a+review+of+its+pharmacology%2C+efficacy+and+safety+in+respiratory+and+neurological+disease&doi=10.1517%2F14656560903426189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease</span></div><div class="casAuthors">Rolan, P.; Hutchinson, Mr; Johnson, Kw</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2897-2904</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Ibudilast is a relatively nonselective phosphodiesterase inhibitor which has been marketed for almost 20 years in Japan for treating asthma.  More recently it has been found to have anti-inflammatory activity in both the peripheral immune system and in the CNS via glial cell attenuation.  This CNS-directed anti-inflammatory activity is of potential use in the treatment of multiple sclerosis, neuropathic pain, and in the improved efficacy and safety of opioids by decreasing opioid tolerance, withdrawal and reinforcement.  Its suitable pharmacokinetics and generally good tolerability make it a promising potential treatment for these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9-2fWYWu4bVg90H21EOLACvtfcHk0lj1Gy-IDzSV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVyjur%252FF&md5=321ef42e8f433e908780f8c19f7f1579</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F14656560903426189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903426189%26sid%3Dliteratum%253Aachs%26aulast%3DRolan%26aufirst%3DP.%26aulast%3DHutchinson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DK.%26atitle%3DIbudilast%253A%2520a%2520review%2520of%2520its%2520pharmacology%252C%2520efficacy%2520and%2520safety%2520in%2520respiratory%2520and%2520neurological%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D2897%26epage%3D2904%26doi%3D10.1517%2F14656560903426189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott-Banner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, C. P.</span></span> <span> </span><span class="NLM_article-title">Dual PDE3/4 and PDE4 inhibitors: novel treatments for COPD and other inflammatory airway diseases</span>. <i>Basic Clin. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1111/bcpt.12209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fbcpt.12209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24517491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=365-376&author=K.+H.+Abbott-Bannerauthor=C.+P.+Page&title=Dual+PDE3%2F4+and+PDE4+inhibitors%3A+novel+treatments+for+COPD+and+other+inflammatory+airway+diseases&doi=10.1111%2Fbcpt.12209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases</span></div><div class="casAuthors">Abbott-Banner, Katharine H.; Page, Clive P.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">365-376</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Selective phosphodiesterase (PDE) 4 and dual PDE3/4 inhibitors have attracted considerable interest as potential therapeutic agents for the treatment of respiratory diseases, largely by virtue of their anti-inflammatory (PDE4) and bifunctional bronchodilator/anti-inflammatory (PDE3/4) effects.  Many of these agents have, however, failed in early development for various reasons, including dose-limiting side effects when administered orally and lack of sufficient activity when inhaled.  Indeed, only one selective PDE4 inhibitor, the orally active roflumilast-n-oxide, has to date received marketing authorization.  The majority of the compds. that have failed were, however, orally administered and non-selective for either PDE3 (A,B) or PDE4 (A,B,C,D) subtypes.  Developing an inhaled dual PDE3/4 inhibitor that is rapidly cleared from the systemic circulation, potentially with subtype specificity, may represent one strategy to improve the therapeutic index and also exhibit enhanced efficacy vs. inhibition of either PDE3 or PDE4 alone, given the potential pos. interactions with regard to anti-inflammatory and bronchodilator effects that have been obsd. pre-clin. with dual inhibition of PDE3 and PDE4 compared with inhibition of either isoenzyme alone.  This MiniReview will summarize recent clin. data obtained with PDE inhibitors and the potential for these drugs to treat COPD and other inflammatory airways diseases such as asthma and cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj1ILnRPA11rVg90H21EOLACvtfcHk0lj1Gy-IDzSV8Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSitL4%253D&md5=d29edfe27d2514633d532bdd47d938d4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fbcpt.12209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcpt.12209%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott-Banner%26aufirst%3DK.%2BH.%26aulast%3DPage%26aufirst%3DC.%2BP.%26atitle%3DDual%2520PDE3%252F4%2520and%2520PDE4%2520inhibitors%253A%2520novel%2520treatments%2520for%2520COPD%2520and%2520other%2520inflammatory%2520airway%2520diseases%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D114%26spage%3D365%26epage%3D376%26doi%3D10.1111%2Fbcpt.12209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poffe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicentini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arban, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, P. B.</span></span> <span> </span><span class="NLM_article-title">GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.214155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fjpet.114.214155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24784567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGkurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=153-163&author=A.+R.+Rutterauthor=A.+Poffeauthor=P.+Cavalliniauthor=T.+G.+Davisauthor=J.+Schneckauthor=M.+Negriauthor=E.+Vicentiniauthor=D.+Montanariauthor=R.+Arbanauthor=F.+A.+Grayauthor=C.+H.+Daviesauthor=P.+B.+Wren&title=GSK356278%2C+a+potent%2C+selective%2C+brain-penetrant+phosphodiesterase+4+inhibitor+that+demonstrates+anxiolytic+and+cognition-enhancing+effects+without+inducing+side+effects+in+preclinical+species&doi=10.1124%2Fjpet.114.214155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species</span></div><div class="casAuthors">Rutter, A. Richard; Poffe, Alessandro; Cavallini, Palmina; Davis, T. Gregg; Schneck, Jessica; Negri, Michele; Vicentini, Elena; Montanari, Dino; Arban, Roberto; Gray, Frank A.; Davies, Ceri H.; Wren, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-163, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Small mol. phosphodiesterase (PDE) 4 inhibitors have long been known to show therapeutic benefit in various preclin. models of psychiatric and neurol. diseases because of their ability to elevate cAMP in various cell types of the central nervous system.  Despite the registration of the first PDE4 inhibitor, roflumilast, for the treatment of chronic obstructive pulmonary disease, the therapeutic potential of PDE4 inhibitors in neurol. diseases has never been fulfilled in the clinic due to severe dose-limiting side effects such as nausea and vomiting.  In this study, we describe the detailed pharmacol. characterization of GSK356278 [5-(5-((2,4-dimethylthiazol-5-yl)methyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine], a potent, selective, and brain-penetrant PDE4 inhibitor that shows a superior therapeutic index to both rolipram and roflumilast in various preclin. species and has potential for further development in the clinic for the treatment of psychiatric and neurol. diseases.  GSK356278 inhibited PDE4B enzyme activity with a pIC50 of 8.8 and bound to the high-affinity rolipram binding site with a pIC50 of 8.6.  In preclin. models, the therapeutic index as defined in a rodent lung inflammation model vs. rat pica feeding was >150 compared with 0.5 and 6.4 for rolipram and roflumilast, resp.  In a model of anxiety in common marmosets, the therapeutic index for GSK356278 was >10 vs. <1 for rolipram.  We also demonstrate that GSK356278 enhances performance in a model of executive function in cynomolgus macaques with no adverse effects, a therapeutic profile that supports further evaluation of GSK356278 in a clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo53EDHLd83CrVg90H21EOLACvtfcHk0li18dCPAsqmgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGkurbF&md5=82d72053beda7d67b1d1085470634bf1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.214155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.214155%26sid%3Dliteratum%253Aachs%26aulast%3DRutter%26aufirst%3DA.%2BR.%26aulast%3DPoffe%26aufirst%3DA.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DT.%2BG.%26aulast%3DSchneck%26aufirst%3DJ.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DVicentini%26aufirst%3DE.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DArban%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DF.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DWren%26aufirst%3DP.%2BB.%26atitle%3DGSK356278%252C%2520a%2520potent%252C%2520selective%252C%2520brain-penetrant%2520phosphodiesterase%25204%2520inhibitor%2520that%2520demonstrates%2520anxiolytic%2520and%2520cognition-enhancing%2520effects%2520without%2520inducing%2520side%2520effects%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D153%26epage%3D163%26doi%3D10.1124%2Fjpet.114.214155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span> <span> </span><span class="NLM_article-title">Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2299</span>– <span class="NLM_lpage">2309</span>, <span class="refDoi"> DOI: 10.1038/s41386-018-0178-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fs41386-018-0178-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30131563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=2299-2309&author=C.+Zhangauthor=Y.+Xuauthor=A.+Chowdharyauthor=D.+Foxauthor=M.+E.+Gurneyauthor=H.+T.+Zhangauthor=B.+D.+Auerbachauthor=R.+J.+Salviauthor=M.+Yangauthor=G.+Liauthor=J.+M.+O%E2%80%99Donnell&title=Memory+enhancing+effects+of+BPN14770%2C+an+allosteric+inhibitor+of+phosphodiesterase-4D%2C+in+wild-type+and+humanized+mice&doi=10.1038%2Fs41386-018-0178-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice</span></div><div class="casAuthors">Zhang, Chong; Xu, Ying; Chowdhary, Anirudh; Fox, 3rd, David; Gurney, Mark E.; Zhang, Han-Ting; Auerbach, Benjamin D.; Salvi, Richard J.; Yang, Mingxin; Li, Gaowen; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2299-2309</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Inhibitors of phosphodiesterase-4 (PDE4) have beneficial effects on memory in preclin. and clin. studies.  Development of these drugs has stalled due to dose-limiting side effects of nausea and emesis.  While use of subtype-selective inhibitors (i.e., for PDE4A, B, or D) could overcome this issue, conservation of the catalytic region, to which classical inhibitors bind, limits this approach.  The present study examd. the effects of BPN14770, an allosteric inhibitor of PDE4D, which binds to a primate-specific, N-terminal region.  In mice engineered to express PDE4D with this primate-specific sequence, BPN14770 was 100-fold more potent for improving memory than in wild-type mice; meanwhile, it exhibited low potency in a mouse surrogate model for emesis.  BPN14770 also antagonized the amnesic effects of scopolamine, increased cAMP signaling in brain, and increased BDNF and markers of neuronal plasticity assocd. with memory.  These data establish a relationship between PDE4D target engagement and effects on memory for BPN14770 and suggest clin. potential for PDE4D-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOsEgzBAlG_LVg90H21EOLACvtfcHk0li18dCPAsqmgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtLrI&md5=de5eee6e4aa249e64cd971b0c69e4fda</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41386-018-0178-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41386-018-0178-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChowdhary%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DAuerbach%26aufirst%3DB.%2BD.%26aulast%3DSalvi%26aufirst%3DR.%2BJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DMemory%2520enhancing%2520effects%2520of%2520BPN14770%252C%2520an%2520allosteric%2520inhibitor%2520of%2520phosphodiesterase-4D%252C%2520in%2520wild-type%2520and%2520humanized%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2018%26volume%3D43%26spage%3D2299%26epage%3D2309%26doi%3D10.1038%2Fs41386-018-0178-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindac, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groppi, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellekoop, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. F.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric onhibitors for the treatment of fragile X syndrome and other brain disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4884</span>– <span class="NLM_lpage">4901</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00193</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00193" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFSjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4884-4901&author=M.+E.+Gurneyauthor=R.+A.+Nugentauthor=X.+Moauthor=J.+A.+Sindacauthor=T.+J.+Hagenauthor=D.+Foxauthor=J.+M.+O%E2%80%99Donnellauthor=C.+Zhangauthor=Y.+Xuauthor=H.+T.+Zhangauthor=V.+E.+Groppiauthor=M.+Bailieauthor=R.+E.+Whiteauthor=D.+L.+Romeroauthor=A.+S.+Vellekoopauthor=J.+R.+Walkerauthor=M.+D.+Surmanauthor=L.+Zhuauthor=R.+F.+Campbell&title=Design+and+synthesis+of+selective+phosphodiesterase+4D+%28PDE4D%29+allosteric+onhibitors+for+the+treatment+of+fragile+X+syndrome+and+other+brain+disorders&doi=10.1021%2Facs.jmedchem.9b00193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders</span></div><div class="casAuthors">Gurney, Mark E.; Nugent, Richard A.; Mo, Xuesheng; Sindac, Janice A.; Hagen, Timothy J.; Fox, David; O'Donnell, James M.; Zhang, Chong; Xu, Ying; Zhang, Han-Ting; Groppi, Vincent E.; Bailie, Marc; White, Ronald E.; Romero, Donna L.; Vellekoop, A. Samuel; Walker, Joel R.; Surman, Matthew D.; Zhu, Lei; Campbell, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4884-4901</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel pyridine- and pyrimidine-based allosteric inhibitors are reported that achieve PDE4D subtype selectivity through recognition of a single amino acid difference on a key regulatory domain, known as UCR2, that opens and closes over the catalytic site for cAMP hydrolysis.  The design and optimization of lead compds. was based on iterative anal. of X-ray crystal structures combined with metabolite identification.  Selectivity for the activated, dimeric form of PDE4D provided potent memory enhancing effects in a mouse model of novel object recognition with improved tolerability and reduced vascular toxicity over earlier PDE4 inhibitors that lack subtype selectivity.  The lead compd., 28 (BPN14770), has entered midstage, human phase 2 clin. trials for the treatment of Fragile X Syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwRN4fRqnWNLVg90H21EOLACvtfcHk0li18dCPAsqmgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFSjtrc%253D&md5=fccb8282e360d7d9a3cde1a187fd2411</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00193%26sid%3Dliteratum%253Aachs%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DMo%26aufirst%3DX.%26aulast%3DSindac%26aufirst%3DJ.%2BA.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DBailie%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DR.%2BE.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26aulast%3DVellekoop%26aufirst%3DA.%2BS.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DSurman%26aufirst%3DM.%2BD.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%2BF.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selective%2520phosphodiesterase%25204D%2520%2528PDE4D%2529%2520allosteric%2520onhibitors%2520for%2520the%2520treatment%2520of%2520fragile%2520X%2520syndrome%2520and%2520other%2520brain%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4884%26epage%3D4901%26doi%3D10.1021%2Facs.jmedchem.9b00193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warsh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">Carbon-11 labeling of the selective inhibitors of phosphodiesterase- IV Ro-20–1724 and rolipram</span>. <i>J. Label. Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">678</span>– <span class="NLM_lpage">680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=678-680&author=J.+N.+DaSilvaauthor=C.+M.+Valenteauthor=A.+A.+Wilsonauthor=J.+J.+Warshauthor=S.+Houle&title=Carbon-11+labeling+of+the+selective+inhibitors+of+phosphodiesterase-+IV+Ro-20%E2%80%931724+and+rolipram"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DValente%26aufirst%3DC.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DWarsh%26aufirst%3DJ.%2BJ.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DCarbon-11%2520labeling%2520of%2520the%2520selective%2520inhibitors%2520of%2520phosphodiesterase-%2520IV%2520Ro-20%25E2%2580%25931724%2520and%2520rolipram%26jtitle%3DJ.%2520Label.%2520Compd.%2520Radiopharm.%26date%3D1997%26volume%3D40%26spage%3D678%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">Syntheses of the phosphodiesterase-4 inhibitors [<sup>11</sup>C]Ro 20–1724, <i>R</i>-, <i>R</i>/<i>S</i>- and <i>S</i>-[<sup>11</sup>C]rolipram</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1002/jlcr.465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFOru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=373-384&author=J.+N.+DaSilvaauthor=C.+M.+Lourencoauthor=A.+A.+Wilsonauthor=S.+Houle&title=Syntheses+of+the+phosphodiesterase-4+inhibitors+%5B11C%5DRo+20%E2%80%931724%2C+R-%2C+R%2FS-+and+S-%5B11C%5Drolipram&doi=10.1002%2Fjlcr.465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of the phosphodiesterase-4 inhibitors [11C]Ro 20-1724, R-, R/S- and S-[11C]rolipram</span></div><div class="casAuthors">DaSilva, Jean N.; Lourenco, Celia M.; Wilson, Alan A.; Houle, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-384</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The high affinity and selective cAMP-specific phosphodiesterase-4 inhibitors, Ro 20-1724 I (R = Me), (±)-, (R)-, and (S)-rolipram II (R = Me, R1 = ξ-H, α-, β-H, resp.), were labeled with 11C by O-[11C]methylation of their resp. phenolic precursors using [11C]methyl iodide.  The desmethyl precursor I (R = H) of Ro 20-1724 was prepd. by selective dealkylation with iodotrimethylsilane, whereas, dealkylation of racemic rolipram was not selective and yielded several products.  Enantiomeric sepn. of (R)- and (S)-desmethylrolipram II (R = H, R1 = α- and β-H, resp.) was carried out by chiral semi-preparative high performance liq. chromatog.  The final 11C-labeled products I (R = 11CH3) and II (R = 11CH3, R1 = ξ-H, α-, β-H) were prepd. in high radiochem. purity (>99%), yields (45-75%, decay-cor.) and specific activities (18.5-92.5 GBq/μmol), within 30 min from end-of-bombardment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEHpugWx2zDbVg90H21EOLACvtfcHk0lj-U7s0GaLWwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFOru7c%253D&md5=7367c01bd7286d124fb848b32ec610e1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.465%26sid%3Dliteratum%253Aachs%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DSyntheses%2520of%2520the%2520phosphodiesterase-4%2520inhibitors%2520%255B11C%255DRo%252020%25E2%2580%25931724%252C%2520R-%252C%2520R%252FS-%2520and%2520S-%255B11C%255Drolipram%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2001%26volume%3D44%26spage%3D373%26epage%3D384%26doi%3D10.1002%2Fjlcr.465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span> <span> </span><span class="NLM_article-title">Characterization of R-[<sup>11</sup>C]rolipram for PET imaging of phosphodiesterase-4: <i>in vivo</i> binding, metabolism, and dosimetry studies in rats</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/S0969-8051(01)00206-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0969-8051%2801%2900206-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11395307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVOiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=347-358&author=C.+M.+Lourencoauthor=S.+Houleauthor=A.+A.+Wilsonauthor=J.+N.+DaSilva&title=Characterization+of+R-%5B11C%5Drolipram+for+PET+imaging+of+phosphodiesterase-4%3A+in+vivo+binding%2C+metabolism%2C+and+dosimetry+studies+in+rats&doi=10.1016%2FS0969-8051%2801%2900206-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of R-[11C]rolipram for PET imaging of phosphodiesterase-4: in vivo binding, metabolism, and dosimetry studies in rats</span></div><div class="casAuthors">Lourenco, C. M.; Houle, S.; Wilson, A. A.; DaSilva, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-358</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The high-affinity phosphodiesterase-4 (PDE4) inhibitor R-rolipram and the less potent S-enantiomer, both labeled with 11C, were evaluated in vivo in rats.  Regional brain uptake of R-[11C]rolipram was higher than R/S-[11C]rolipram, whereas S-[11C]rolipram retention subsided rapidly to levels below blood.  Binding of R-[11C]rolipram was selective for PDE4 over PDE1, since treatment with PDE4 competitors Ro 20-1724, or R-, S- or R/S-rolipram, but not with the PDE1 inhibitor vinpocetine, significantly reduced radioactivity uptake to non-specific levels.  R-Rolipram (ED50 ≃ 0.04 mg/Kg) was approx. 13 fold more potent than S-rolipram at inhibiting R-[11C]rolipram binding in all brain regions.  Nevertheless, S-[11C]rolipram appears to be unsuitable for measuring the non-specific binding of R-[11C]rolipram.  Only unchanged R-[11C]rolipram was detected in rat brain homogenates.  Addnl., the estd. absorbed radiation dose extrapolated to humans was low.  These results support further investigation of R-[11C]rolipram in studying PDE4 in vivo by positron emission tomog. imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa3qyPcFHsp7Vg90H21EOLACvtfcHk0lj-U7s0GaLWwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVOiurg%253D&md5=a45d55dd30d579912d14a5e0ac7ffd0e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900206-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900206-2%26sid%3Dliteratum%253Aachs%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DCharacterization%2520of%2520R-%255B11C%255Drolipram%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-4%253A%2520in%2520vivo%2520binding%252C%2520metabolism%252C%2520and%2520dosimetry%2520studies%2520in%2520rats%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D347%26epage%3D358%26doi%3D10.1016%2FS0969-8051%2801%2900206-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsukada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakiuchi, T.</span></span> <span> </span><span class="NLM_article-title">Transient focal ischemia affects the cAMP second messenger system and coupled dopamine D1 and 5-HT1A receptors in the living monkey brain: a positron emission tomography study using microdialysis</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1097/01.WCB.0000126974.07553.86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1097%2F01.WCB.0000126974.07553.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15362720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=898-906&author=H.+Tsukadaauthor=D.+Fukumotoauthor=S.+Nishiyamaauthor=K.+Satoauthor=T.+Kakiuchi&title=Transient+focal+ischemia+affects+the+cAMP+second+messenger+system+and+coupled+dopamine+D1+and+5-HT1A+receptors+in+the+living+monkey+brain%3A+a+positron+emission+tomography+study+using+microdialysis&doi=10.1097%2F01.WCB.0000126974.07553.86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Transient Focal Ischemia Affects the cAMP Second Messenger System and Coupled Dopamine D1 and 5-HT1A Receptors in the Living Monkey Brain: A Positron Emission Tomography Study Using Microdialysis</span></div><div class="casAuthors">Tsukada, Hideo; Fukumoto, Dai; Nishiyama, Shingo; Sato, Kengo; Kakiuchi, Takeharu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">898-906</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Using positron emission tomog. (PET) and microdialysis, the present study showed that neuronal damages after transient focal ischemia was partly induced by hyperactivation of the cyclic adenosine 3',5'-monophosphate (cAMP) second messenger system through modulations of dopamine D1 and serotonin 5-HT1A receptors in the living brains of cynomolgus monkeys.  Occlusion of the right middle cerebral artery for 3 h suppressed CBF in the striatum, and reperfusion induced hyperperfusion in the neocortex and striatum of the occluded side.  Six hours after reperfusion, the activity of the cAMP second messenger system assayed with [11C]rolipram was significantly facilitated in the neocortex and striatum where CBF was lowered more than 40% of normal during occlusion ("ischemic" area).  Seven days later, impaired dopamine D1 and 5-HT1A receptor binding, measured with [11C]SCH23390 and [carbonyl-11C]WAY-100635, resp., was obsd. in the ischemic area.  Microdialysis anal. revealed that the striatal dopamine level provided a transient and marked increased during occlusion and after reperfusion, whereas the cortical serotonin level transiently increased only after reperfusion, and was at an undetectable level thereafter.  Administration of rolipram (0.1 and 1 mg/kg, i.v.) during occlusion facilitated redn. of dopamine D1 binding, whereas rolipram administration 6 h after reperfusion induced a further decrease in 5-HT1A receptor binding.  These results suggest that the activation of cAMP second messenger system modulated by dopamine D1 and 5-HT1A receptors could be involved in the neuronal degeneration after transient cerebral ischemic insult.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXrjx_38oJ4bVg90H21EOLACvtfcHk0lhELH3BjqASFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlSjtLg%253D&md5=bca2ff01c5258864782f557955ee2743</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1097%2F01.WCB.0000126974.07553.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.WCB.0000126974.07553.86%26sid%3Dliteratum%253Aachs%26aulast%3DTsukada%26aufirst%3DH.%26aulast%3DFukumoto%26aufirst%3DD.%26aulast%3DNishiyama%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKakiuchi%26aufirst%3DT.%26atitle%3DTransient%2520focal%2520ischemia%2520affects%2520the%2520cAMP%2520second%2520messenger%2520system%2520and%2520coupled%2520dopamine%2520D1%2520and%25205-HT1A%2520receptors%2520in%2520the%2520living%2520monkey%2520brain%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520using%2520microdialysis%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2004%26volume%3D24%26spage%3D898%26epage%3D906%26doi%3D10.1097%2F01.WCB.0000126974.07553.86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span> <span> </span><span class="NLM_article-title">Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2006.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.lfs.2006.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16499932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlKrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=356-364&author=C.+M.+Lourencoauthor=M.+Kenkauthor=R.+S.+Beanlandsauthor=J.+N.+DaSilva&title=Increasing+synaptic+noradrenaline%2C+serotonin+and+histamine+enhances+in+vivo+binding+of+phosphodiesterase-4+inhibitor+%28R%29-%5B11C%5Drolipram+in+rat+brain%2C+lung+and+heart&doi=10.1016%2Fj.lfs.2006.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart</span></div><div class="casAuthors">Lourenco, Celia M.; Kenk, Miran; Beanlands, Rob S.; DaSilva, Jean N.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-364</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) is one of the main enzymes that specifically terminate the action of cAMP, thereby contributing to intracellular signaling following stimulation of various G protein-coupled receptors.  PDE4 expression and activity are modulated by agents affecting cAMP levels.  The selective PDE4 inhibitor (R)-rolipram labeled with C-11 was tested in vivo in rats to analyze changes in PDE4 levels following drug treatments that increase synaptic noradrenaline (NA), serotonin (5HT), histamine (HA) and dopamine (DA) levels.  We hypothesized that increasing synaptic neurotransmitter levels and subsequent cAMP-mediated signaling would significantly enhance (R)-[11C]rolipram retention and specific binding to PDE4 in vivo.  Pretreatments were performed 3 h prior to tracer injection, and rats were sacrificed 45 min later.  Biodistribution studies revealed a dose-dependent increase in (R)-[11C]rolipram uptake following administration of the monoamine oxidase (MAO) inhibitor tranylcypromine, NA and 5HT reuptake inhibitors (desipramine [DMI], maprotiline; and fluoxetine, sertraline, resp.), and the HA H3 receptor antagonist (thioperamide), but not with DA transporter blockers GBR 12909, cocaine or DA D1 agonist SKF 81297.  Significant increases in rat brain and heart reflect changes in PDE4 specific binding (total - non-specific binding [coinjection with satg. dose of (R)-rolipram]).  These results demonstrate that acute treatments elevating synaptic NA, 5HT and HA, but not DA levels, significantly enhance (R)-[11C]rolipram binding.  Use of (R)-[11C]rolipram and positron emission tomog. as an index of PDE4 activity could provide insight into understanding disease states with altered NA, 5HT and HA concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfQN-TWuD2k7Vg90H21EOLACvtfcHk0lhELH3BjqASFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlKrsbg%253D&md5=a13ba5348390c7fea798c49ff0d1506f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2006.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2006.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DIncreasing%2520synaptic%2520noradrenaline%252C%2520serotonin%2520and%2520histamine%2520enhances%2520in%2520vivo%2520binding%2520of%2520phosphodiesterase-4%2520inhibitor%2520%2528R%2529-%255B11C%255Drolipram%2520in%2520rat%2520brain%252C%2520lung%2520and%2520heart%26jtitle%3DLife%2520Sci.%26date%3D2006%26volume%3D79%26spage%3D356%26epage%3D364%26doi%3D10.1016%2Fj.lfs.2006.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thackeray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deKemp, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span> <span> </span><span class="NLM_article-title">In vivo selective binding of (<i>R</i>)-[<sup>11</sup>C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=17210463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=71-77&author=M.+Kenkauthor=M.+Greeneauthor=J.+Thackerayauthor=R.+A.+deKempauthor=M.+Lortieauthor=S.+Thornauthor=R.+S.+Beanlandsauthor=J.+N.+DaSilva&title=In+vivo+selective+binding+of+%28R%29-%5B11C%5Drolipram+to+phosphodiesterase-4+provides+the+basis+for+studying+intracellular+cAMP+signaling+in+the+myocardium+and+other+peripheral+tissues&doi=10.1016%2Fj.nucmedbio.2006.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues</span></div><div class="casAuthors">Kenk, Miran; Greene, Michael; Thackeray, James; de Kemp, Robert A.; Lortie, Mireille; Thorn, Stephanie; Beanlands, Rob S.; Da Silva, Jean N.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) enzymes specifically break down the second messenger cAMP, thereby terminating the intracellular signaling cascade that plays an essential role in neurohormonal modulation of many physiol. systems.  PDE4 activity and expression are regulated by cAMP levels, suggesting that measurement of PDE4 provides an index of intracellular cAMP signaling.  Male Sprague-Dawley rats were administered (R)- or the less active enantiomer (S)-[11C]rolipram and sacrificed 30 min later with tracer retention measured in various tissues.  Co-injections with satg. doses of unlabeled (R)-rolipram, (S)-rolipram and Ro 20-1724, as well as subtype-selective PDE inhibitors vinpocetine, Bay 60-7550, cilostazol and zaprinast were used to establish binding selectivity for PDE4 over PDE1, PDE2, PDE3 and PDE5 subtypes, resp.  Autoradiog. was performed to substantiate results of biodistribution studies in the myocardium.  In vivo (R)-[11C]rolipram retention was dose-dependently reduced by co-injections of (R)-rolipram and (S)-rolipram (ED50 values of 0.03 mg/kg and 0.2 mg/kg, resp.).  Vinpocetine, Bay 60-7550, cilostazol and zaprinast had no effect on (R)-[11C]rolipram binding, while (R)-rolipram and Ro 20-1724 reduced the tracer uptake to nonspecific levels in PDE4-rich tissues.  In addn. to the brain, (R)-[11C]rolipram binds selectively to PDE4 across all cardiac regions, skeletal muscle, lungs and pancreas, but not in the adipose tissues.  In vivo findings were confirmed by in vitro autoradiog. studies, suggesting that (R)-[11C]rolipram can be applied to evaluate alterations in central and peripheral PDE4 levels and cAMP-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUv6Hif0382LVg90H21EOLACvtfcHk0lhELH3BjqASFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVaisQ%253D%253D&md5=4614225628d13a693e85f7b594c01d0c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DGreene%26aufirst%3DM.%26aulast%3DThackeray%26aufirst%3DJ.%26aulast%3DdeKemp%26aufirst%3DR.%2BA.%26aulast%3DLortie%26aufirst%3DM.%26aulast%3DThorn%26aufirst%3DS.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DIn%2520vivo%2520selective%2520binding%2520of%2520%2528R%2529-%255B11C%255Drolipram%2520to%2520phosphodiesterase-4%2520provides%2520the%2520basis%2520for%2520studying%2520intracellular%2520cAMP%2520signaling%2520in%2520the%2520myocardium%2520and%2520other%2520peripheral%2520tissues%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D71%26epage%3D77%26doi%3D10.1016%2Fj.nucmedbio.2006.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, W. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">Imaging cAMP-specific phosphodiesterase-4 in human brain with <i>R</i>-[<sup>11</sup>C]rolipram and positron emission tomography</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1680</span>– <span class="NLM_lpage">1683</span>, <span class="refDoi"> DOI: 10.1007/s00259-002-0950-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-002-0950-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=12458404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFGisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=1680-1683&author=J.+N.+DaSilvaauthor=C.+M.+Lourencoauthor=J.+H.+Meyerauthor=D.+Husseyauthor=W.+Z.+Potterauthor=S.+Houle&title=Imaging+cAMP-specific+phosphodiesterase-4+in+human+brain+with+R-%5B11C%5Drolipram+and+positron+emission+tomography&doi=10.1007%2Fs00259-002-0950-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography</span></div><div class="casAuthors">DaSilva, Jean N.; Lourenco, Celia M.; Meyer, Jeffrey H.; Hussey, Douglas; Potter, William Z.; Houle, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1680-1683</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Evidence of disruptions in cAMP-mediated signaling in several neuropsychiatric disorders has led to the development of R-[11C]rolipram for imaging phosphodiesterase-4 (PDE4) enzymes with positron emission tomog. (PET).  The high-affinity PDE4 inhibitor rolipram was previously reported to have an antidepressant effect in humans.  PDE4 is abundant in the brain, and it hydrolyzes cAMP produced following stimulation of various neurotransmitter systems.  PDE4 is regulated by intracellular cAMP levels.  This paper presents the first PET study of R-[11C]rolipram in living human brain.  Consistent with the wide distribution of PDE4, high radioactivity retention was obsd. in all regions representing the gray matter.  Rapid metab. was obsd., and kinetic anal. demonstrated that the data fit in a two-tissue compartment model.  R-[11C]Rolipram is thus suitable for imaging PDE4 and possibly cAMP signal transduction in the living human brain with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4f-ekS8OB1bVg90H21EOLACvtfcHk0ljGMmgACjV1jg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFGisbk%253D&md5=0bd3e6eebccd951ba9b35262b6a4e0c5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-0950-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-0950-y%26sid%3Dliteratum%253Aachs%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DHussey%26aufirst%3DD.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DImaging%2520cAMP-specific%2520phosphodiesterase-4%2520in%2520human%2520brain%2520with%2520R-%255B11C%255Drolipram%2520and%2520positron%2520emission%2520tomography%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2002%26volume%3D29%26spage%3D1680%26epage%3D1683%26doi%3D10.1007%2Fs00259-002-0950-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deKemp, R. A.</span></span> <span> </span><span class="NLM_article-title">PET of (<i>R</i>)-<sup>11</sup>C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.2967/jnumed.110.082701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.110.082701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21270457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC3M7kvVOrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=263-269&author=A.+J.+Thomasauthor=J.+N.+DaSilvaauthor=M.+Lortieauthor=J.+M.+Renaudauthor=M.+Kenkauthor=R.+S.+Beanlandsauthor=R.+A.+deKemp&title=PET+of+%28R%29-11C-rolipram+binding+to+phosphodiesterase-4+is+reproducible+and+sensitive+to+increased+norepinephrine+in+the+rat+heart&doi=10.2967%2Fjnumed.110.082701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart</span></div><div class="casAuthors">Thomas Adam J; DaSilva Jean N; Lortie Mireille; Renaud Jennifer M; Kenk Miran; Beanlands Rob S; deKemp Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Phosphodiesterase-4 (PDE4) plays a critical role in the regulation of β-adrenergic receptor-stimulated cyclic adenosine monophosphate cell signaling in the heart. (R)-rolipram, a PDE4-selective inhibitor, has been studied previously as a radiotracer for the quantification of PDE4 levels.  The aim of this study was to characterize (R)-(11)C-rolipram binding in the rat myocardium in vivo, using small-animal PET.  METHODS:  Male Sprague-Dawley rats (n = 30) were administered (R)-(11)C-rolipram and imaged for 60 min to evaluate tracer binding and reproducibility, quantified using Logan slope analysis of the distribution volume.  Dynamic (13)N-ammonia imaging was performed to quantify myocardial blood flow and assist in cardiac regional analysis.  Saturation studies evaluated the sensitivity of (R)-(11)C-rolipram to PDE4 blocking by unlabeled cold (R)-rolipram (0.0001-1.0 mg/kg), for estimation of the median effective dose (ED(50)) in the heart. (R)-(11)C-rolipram response to enhanced norepinephrine stimulation of the β-adrenergic receptor with desipramine (20 mg/kg, intravenous) was also studied.  Intrarat variability studies (n = 5) were conducted with test-retest imaging at 16 ± 7 d.  RESULTS:  A reduction of Logan slope was observed with increasing cold mass coadministered with the tracer, with an ED(50) of 0.0019 mg/kg (95% confidence interval, 0.0014-0.0052) estimated from the saturation studies.  This ED(50) predicted less than 10% enzyme occupancy at 0.0002 mg of cold (R)-rolipram per kilogram (mass/body weight).  Low-occupancy imaging at 0.00018 ± 0.00002 mg/kg produced a mean Logan slope of 5.5 ± 0.85 mL/cm(3).  Enzyme saturation of more than 90%, compared with low-occupancy conditions, occurred at more than 0.02 mg/kg, with a complete blocking dose (>1 mg of (R)-rolipram per kilogram) resulting in a Logan slope of 3.3 ± 0.1 mL/cm(3), representing a 40% reduction.  Compared with baseline, a Logan slope of 6.8 ± 0.7 mL/cm(3) in desipramine-challenged animals was observed, representing a 30% increase due to acute norepinephrine stimulation, despite a reduction in myocardial blood flow.  Intrarat and intraoperator variability was less than 5% between repeated measures.  CONCLUSION:  (R)-(11)C-rolipram shows the ability to monitor increases and decreases in PDE4 availability in the rat myocardium, with good reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT91rgD6KwIGe-MdeMhXAHkfW6udTcc2eZWUHx7bco0Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7kvVOrtA%253D%253D&md5=efba521380cb00ccaaacf9e24c952480</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.110.082701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.110.082701%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BJ.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DLortie%26aufirst%3DM.%26aulast%3DRenaud%26aufirst%3DJ.%2BM.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DdeKemp%26aufirst%3DR.%2BA.%26atitle%3DPET%2520of%2520%2528R%2529-11C-rolipram%2520binding%2520to%2520phosphodiesterase-4%2520is%2520reproducible%2520and%2520sensitive%2520to%2520increased%2520norepinephrine%2520in%2520the%2520rat%2520heart%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D263%26epage%3D269%26doi%3D10.2967%2Fjnumed.110.082701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deKemp, R. A.</span></span> <span> </span><span class="NLM_article-title">Analysis of (<i>R</i>)- and (<i>S</i>)-[<sup>11</sup>C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1007/s11307-011-0482-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs11307-011-0482-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21424298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1CjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=225-236&author=M.+Lortieauthor=J.+N.+DaSilvaauthor=M.+Kenkauthor=S.+Thornauthor=D.+Davisauthor=D.+Birnieauthor=R.+S.+Beanlandsauthor=R.+A.+deKemp&title=Analysis+of+%28R%29-+and+%28S%29-%5B11C%5Drolipram+kinetics+in+canine+myocardium+for+the+evaluation+of+phosphodiesterase-4+with+PET&doi=10.1007%2Fs11307-011-0482-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET</span></div><div class="casAuthors">Lortie Mireille; DaSilva Jean N; Kenk Miran; Thorn Stephanie; Davis Darryl; Birnie David; Beanlands Rob S B; deKemp Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  (R)-[(11)C]rolipram and (S)-[(11)C]rolipram have been proposed to investigate phosphodiesterase-4 and, indirectly, cAMP-mediated signaling with PET.  This study assessed binding of these tracers to phosphodiesterase-4 in canine myocardium.  PROCEDURES:  Seven dogs underwent (R)-[(11)C]rolipram and (S)-[(11)C]rolipram dynamic PET imaging at baseline and with co-injection of saturating doses of (R)-rolipram.  Dual-input compartment models were applied to estimate the volumes of distribution (V(T)).  RESULTS:  The model comprising one compartment for unmetabolized tracer and one compartment for labeled metabolites provided excellent fits to data acquired with (S)-[(11)C]rolipram at baseline and with both enantiomers during co-injection scans.  Use of two compartments for unmetabolized (R)-[(11)C]rolipram at baseline was warranted according to Akaike and Schwarz criteria.  V(T) estimates obtained with these models were robust (CV ≤ 8.2%) and reproducible (CV ≤ 15%).  CONCLUSION:  An important fraction (~65%) of the V (T) of (R)-[(11)C]rolipram at baseline reflects specific binding.  Thus, the latter may be a useful index of phosphodiesterase-4 levels in canine myocardium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAmjGZPcBQkq__Jf7-eMvJfW6udTcc2eZWUHx7bco0Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1CjsA%253D%253D&md5=c1885295c664ea99ba6c63019240a8b2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs11307-011-0482-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-011-0482-6%26sid%3Dliteratum%253Aachs%26aulast%3DLortie%26aufirst%3DM.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DThorn%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DBirnie%26aufirst%3DD.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DdeKemp%26aufirst%3DR.%2BA.%26atitle%3DAnalysis%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-%255B11C%255Drolipram%2520kinetics%2520in%2520canine%2520myocardium%2520for%2520the%2520evaluation%2520of%2520phosphodiesterase-4%2520with%2520PET%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26spage%3D225%26epage%3D236%26doi%3D10.1007%2Fs11307-011-0482-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickstein, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drevets, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.,  Jr</span></span> <span> </span><span class="NLM_article-title">Downregulation of brain phosphodiesterase type IV measured with <sup>11</sup>C-(<i>R</i>)-rolipram positron emission tomography in major depressive disorder</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2012.04.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.biopsych.2012.04.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22677471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=548-554&author=M.+Fujitaauthor=C.+S.+Hinesauthor=S.+S.+Zoghbiauthor=A.+G.+Mallingerauthor=L.+P.+Dicksteinauthor=J.+S.+Liowauthor=Y.+Zhangauthor=V.+W.+Pikeauthor=W.+C.+Drevetsauthor=R.+B.+Innisauthor=C.+A.+Zarate&title=Downregulation+of+brain+phosphodiesterase+type+IV+measured+with+11C-%28R%29-rolipram+positron+emission+tomography+in+major+depressive+disorder&doi=10.1016%2Fj.biopsych.2012.04.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of Brain Phosphodiesterase Type IV Measured with 11C-(R)-Rolipram Positron Emission Tomography in Major Depressive Disorder</span></div><div class="casAuthors">Fujita, Masahiro; Hines, Christina S.; Zoghbi, Sami S.; Mallinger, Alan G.; Dickstein, Leah P.; Liow, Jeih-San; Zhang, Yi; Pike, Victor W.; Drevets, Wayne C.; Innis, Robert B.; Zarate, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">548-554</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Phosphodiesterase type IV (PDE4), an important component of the cyclic adenosine monophosphate (cAMP) cascade, selectively metabolizes cAMP in the brain to the inactive monophosphate.  Basic studies suggest that PDE4 mediates the effects of several antidepressants.  This study sought to quantify the binding of 11C-(R)-rolipram, a PDE4 inhibitor, as an indirect measure of this enzyme's activity in the brain of individuals with major depressive disorder (MDD) compared with healthy control subjects.  Methods: 11C-(R)-Rolipram brain positron emission tomog. scans were performed in 28 unmedicated MDD subjects and 25 age- and gender-matched healthy control subjects.  Patients were moderately depressed and about one half were treatment-naive.  11C-(R)-Rolipram binding in the brain was measured using arterial 11C-(R)-rolipram levels to correct for the influence of cerebral blood flow.  Results: Major depressive disorder subjects showed a widespread, approx. 20% redn. in 11C-(R)-rolipram binding (p = .002), which was not caused by different vols. of gray matter.  Decreased rolipram binding of similar magnitudes was obsd. in most brain areas.  Rolipram binding did not correlate with the severity of depressive or anxiety symptoms.  Conclusions: This study is the first to demonstrate that brain levels of PDE4, a crit. enzyme that regulates cAMP, are decreased in unmedicated individuals with MDD in vivo.  These results are in line with human postmortem and rodent studies demonstrating downregulation of the cAMP cascade in MDD and support the hypothesis that agents such as PDE4 inhibitors, which increase activity within the cAMP cascade, may have antidepressant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcoV9dpiu1LrVg90H21EOLACvtfcHk0lhBTD1CnvUsiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWht7k%253D&md5=96434e8c72969801f3e2713c83b63d92</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.04.030%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DHines%26aufirst%3DC.%2BS.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMallinger%26aufirst%3DA.%2BG.%26aulast%3DDickstein%26aufirst%3DL.%2BP.%26aulast%3DLiow%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26atitle%3DDownregulation%2520of%2520brain%2520phosphodiesterase%2520type%2520IV%2520measured%2520with%252011C-%2528R%2529-rolipram%2520positron%2520emission%2520tomography%2520in%2520major%2520depressive%2520disorder%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D548%26epage%3D554%26doi%3D10.1016%2Fj.biopsych.2012.04.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinescu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span> <span> </span><span class="NLM_article-title">Identification and <i>in vivo</i> evaluation of a fluorine-18 rolipram analogue, [<sup>18</sup>F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.3389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27006107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=205-213&author=D.+Thomaeauthor=T.+J.+Morleyauthor=H.+S.+Leeauthor=O.+Barretauthor=C.+Constantinescuauthor=C.+Papinauthor=R.+M.+Baldwinauthor=G.+D.+Tamagnanauthor=D.+Alagille&title=Identification+and+in+vivo+evaluation+of+a+fluorine-18+rolipram+analogue%2C+%5B18F%5DMNI-617%2C+as+a+radioligand+for+PDE4+imaging+in+mammalian+brain&doi=10.1002%2Fjlcr.3389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and in vivo evaluation of a fluorine-18 rolipram analogue, [18F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain</span></div><div class="casAuthors">Thomae, David; Morley, Thomas J.; Lee, Hsiaoju S.; Barret, Olivier; Constantinescu, Cristian; Papin, Caroline; Baldwin, Ronald M.; Tamagnan, Gilles D.; Alagille, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">205-213</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 4 is the most prevalent PDE in the central nervous system (CNS) and catalyzes hydrolysis of intracellular cAMP, a secondary messenger.  By therapeutic inhibition of PDE4, intracellular cAMP levels can be stabilized, and the symptoms of psychiatric and neurodegenerative disorders including depression, memory loss and Parkinson's disease can be ameliorated.  Radiotracers targeting PDE4 can be used to study PDE4 d. and function, and evaluate new PDE4 therapeutics, in vivo in a non-invasive way, as has been shown using the carbon-11 labeled PDE4 inhibitor R-(-)-rolipram.  Herein we describe a small series of rolipram analogs that contain fluoro- or iodo-substituents that could be used as fluorine-18 PET or iodine-123 SPECT PDE4 radiotracers.  This series was evaluated with an in vitro binding assay and a 4-(fluoromethyl) deriv. of rolipram, MNI-617, was identified, with a five-fold increase in affinity for PDE4 (Kd = 0.26 nM) over R-(-)-rolipram (Kd = 1.6 nM).  A deutero-analog d2-[18F]MNI-617 was radiolabeled and produced in 23% yield with high (>5 Ci/μmol) specific activity and evaluated in non-human primate, where it rapidly entered the brain, with SUVs between 4 and 5, and with a distribution pattern consistent with that of PDE4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm-mbS1eH8hbVg90H21EOLACvtfcHk0lhBTD1CnvUsiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Cntbo%253D&md5=d35fb9713bc93376bb2c7d97967436aa</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3389%26sid%3Dliteratum%253Aachs%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DMorley%26aufirst%3DT.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DConstantinescu%26aufirst%3DC.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DAlagille%26aufirst%3DD.%26atitle%3DIdentification%2520and%2520in%2520vivo%2520evaluation%2520of%2520a%2520fluorine-18%2520rolipram%2520analogue%252C%2520%255B18F%255DMNI-617%252C%2520as%2520a%2520radioligand%2520for%2520PDE4%2520imaging%2520in%2520mammalian%2520brain%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2016%26volume%3D59%26spage%3D205%26epage%3D213%26doi%3D10.1002%2Fjlcr.3389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszpit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciabola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8538</span>– <span class="NLM_lpage">8551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8538-8551&author=L.+Zhangauthor=L.+Chenauthor=E.+M.+Beckauthor=T.+A.+Chappieauthor=R.+V.+Coelhoauthor=S.+D.+Doranauthor=K.+H.+Fanauthor=C.+J.+Helalauthor=J.+M.+Humphreyauthor=Z.+Hughesauthor=K.+Kuszpitauthor=E.+A.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+Leeauthor=R.+J.+Matherauthor=N.+C.+Patelauthor=M.+B.+Skaddanauthor=S.+Sciabolaauthor=P.+R.+Verhoestauthor=J.+M.+Youngauthor=K.+Zasadnyauthor=A.+Villalobos&title=The+discovery+of+a+novel+phosphodiesterase+%28PDE%29+4B-preferring+radioligand+for+positron+emission+tomography+%28PET%29+imaging&doi=10.1021%2Facs.jmedchem.7b01050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging</span></div><div class="casAuthors">Zhang, Lei; Chen, Laigao; Beck, Elizabeth M.; Chappie, Thomas A.; Coelho, Richard V.; Doran, Shawn D.; Fan, Kuo-Hsien; Humphrey, John M.; Hughes, Zoe; Kuszpit, Kyle; Lachapelle, Erik A.; Lazzaro, John T.; Mather, Robert J.; Patel, Nandini C.; Skaddan, Marc B.; Sciabola, Simone; Verhoest, Patrick R.; Young, Joseph M.; Zasadny, Kenneth; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8538-8551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort in identifying phosphodiesterase (PDE) 4B-preferring inhibitors for the treatment of central nervous system (CNS) disorders, we sought to identify a positron emission tomog. (PET) ligand to enable target occupancy measurement in vivo.  Through a systematic and cost-effective PET discovery process, involving expression level (Bmax) and biodistribution detn., a PET-specific structure-activity relationship (SAR) effort, and specific binding assessment using a LC-MS/MS "cold tracer" method, we have identified 8 (PF-06445974) as a promising PET lead.  Compd. 8 has exquisite potency at PDE4B, good selectivity over PDE4D, excellent brain permeability, and a high level of specific binding in the "cold tracer" study.  In subsequent non-human primate (NHP) PET imaging studies, [18F]8 showed rapid brain uptake and high target specificity, indicating that [18F]8 is a promising PDE4B-preferring radioligand for clin. PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAKXd3Cu5nRLVg90H21EOLACvtfcHk0lhBTD1CnvUsiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI&md5=cecad407201ce6c59ac5a3257e921d07</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DFan%26aufirst%3DK.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520phosphodiesterase%2520%2528PDE%2529%25204B-preferring%2520radioligand%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8538%26epage%3D8551%26doi%3D10.1021%2Facs.jmedchem.7b01050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladding, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manly, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amato, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindac, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span> <span> </span><span class="NLM_article-title">Discovery, radiolabeling, and evaluation of subtype-selective inhibitors for positron emission tomography imaging of brain phosphodiesterase-4D</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1323</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.0c00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.0c00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls12hurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1311-1323&author=Y.+Wakabayashiauthor=S.+Teluauthor=R.+M.+Dickauthor=M.+Fujitaauthor=M.+Oomsauthor=C.+L.+Morseauthor=J.+S.+Liowauthor=J.+S.+Hongauthor=R.+L.+Gladdingauthor=L.+S.+Manlyauthor=S.+S.+Zoghbiauthor=X.+Moauthor=E.+C.+D%E2%80%99Amatoauthor=J.+A.+Sindacauthor=R.+A.+Nugentauthor=B.+E.+Marronauthor=M.+E.+Gurneyauthor=R.+B.+Innisauthor=V.+W.+Pike&title=Discovery%2C+radiolabeling%2C+and+evaluation+of+subtype-selective+inhibitors+for+positron+emission+tomography+imaging+of+brain+phosphodiesterase-4D&doi=10.1021%2Facschemneuro.0c00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D</span></div><div class="casAuthors">Wakabayashi, Yuichi; Telu, Sanjay; Dick, Rachel M.; Fujita, Masahiro; Ooms, Maarten; Morse, Cheryl L.; Liow, Jeih-San; Hong, Jinsoo S.; Gladding, Robert L.; Manly, Lester S.; Zoghbi, Sami S.; Mo, Xuesheng; D'Amato, Emily C.; Sindac, Janice A.; Nugent, Richard A.; Marron, Brian E.; Gurney, Mark E.; Innis, Robert B.; Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1311-1323</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We aimed to develop radioligands for PET imaging of brain phosphodiesterase subtype 4D (PDE4D), a potential target for developing cognition enhancing or antidepressive drugs.  Exploration of several chem. series gave four leads with high PDE4D inhibitory potency and selectivity, optimal lipophilicity, and good brain uptake.  These leads featured alkoxypyridinyl cores.  They were successfully labeled with carbon-11 (t1/2 = 20.4 min) for evaluation with PET in monkey.  Whereas two of these radioligands did not provide PDE4D-specific signal in monkey brain, two others, [11C]T1660 and [11C]T1650, provided sizable specific signal, as judged by pharmacol. challenge using rolipram or a selective PDE4D inhibitor (BPN14770) and subsequent biomathematical anal.  Specific binding was highest in prefrontal cortex, temporal cortex, and hippocampus, regions that are important for cognitive function. [11C]T1650 was progressed to evaluation in humans with PET, but the output measure of brain enzyme d. (VT) increased with scan duration.  This instability over time suggests that radiometabolite(s) were accumulating in the brain.  BPN14770 blocked PDE4D uptake in human brain after a single dose, but the percentage occupancy was difficult to est. because of the unreliability of measuring VT.  Overall, these results show that imaging of PDE4D in primate brain is feasible but that further radioligand refinement is needed, most likely to avoid problematic radiometabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozp5xQe0DK5LVg90H21EOLACvtfcHk0lgX32NeiL97DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls12hurk%253D&md5=579a4aa455db9718cb25a79ad21830ec</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.0c00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.0c00077%26sid%3Dliteratum%253Aachs%26aulast%3DWakabayashi%26aufirst%3DY.%26aulast%3DTelu%26aufirst%3DS.%26aulast%3DDick%26aufirst%3DR.%2BM.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DMorse%26aufirst%3DC.%2BL.%26aulast%3DLiow%26aufirst%3DJ.%2BS.%26aulast%3DHong%26aufirst%3DJ.%2BS.%26aulast%3DGladding%26aufirst%3DR.%2BL.%26aulast%3DManly%26aufirst%3DL.%2BS.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMo%26aufirst%3DX.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DE.%2BC.%26aulast%3DSindac%26aufirst%3DJ.%2BA.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DDiscovery%252C%2520radiolabeling%252C%2520and%2520evaluation%2520of%2520subtype-selective%2520inhibitors%2520for%2520positron%2520emission%2520tomography%2520imaging%2520of%2520brain%2520phosphodiesterase-4D%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2020%26volume%3D11%26spage%3D1311%26epage%3D1323%26doi%3D10.1021%2Facschemneuro.0c00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1654</span>– <span class="NLM_lpage">1659</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2019.04.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31047754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXoslamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1654-1659&author=L.+Jiaauthor=C.+Miaoauthor=F.+Dongauthor=W.+Liauthor=M.+Wangauthor=Q.+H.+Zhengauthor=Z.+Xu&title=Facile+synthesis+of+carbon-11-labeled+sEH%2FPDE4+dual+inhibitors+as+new+potential+PET+agents+for+imaging+of+sEH%2FPDE4+enzymes+in+neuroinflammation&doi=10.1016%2Fj.bmcl.2019.04.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation</span></div><div class="casAuthors">Jia, Limeng; Miao, Caihong; Dong, Fugui; Li, Wei; Wang, Min; Zheng, Qi-Huang; Xu, Zhidong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1654-1659</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To develop PET tracers for imaging of neuroinflammation, new carbon-11-labeled sEH/PDE4 dual inhibitors have been synthesized.  The ref. std. N-(4-methoxy-2-(trifluoromethyl)benzyl)benzamide (1, I) and its corresponding desmethylated precursor N-(4-hydroxy-2-(trifluoromethyl)benzyl)benzamide (2, II) were synthesized from (4-methoxy-2-(trifluoromethyl)phenyl)methanamine and benzoic acid in one and two steps with 84% and 49% overall chem. yield, resp.  The std. N-(4-methoxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide (MPPA, 4, IV) and its precursor N-(4-hydroxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide (5, V) were synthesized from Me 4-piperidinecarboxylate, propionyl chloride and (4-methoxy-2-(trifluoromethyl)phenyl)methanamine in two and three steps with 62% and 34% overall chem. yield, resp.  The target tracers N-(4-[11C]methoxy-2-(trifluoromethyl)benzyl)benzamide ([11C]1) and N-(4-[11C]methoxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide ([11C]MPPA, [11C]4) were prepd. from their corresponding precursors 2 and 5 with [11C]CH3OTf through O-[11C]methylation and isolated by HPLC combined with SPE in 25-35% radiochem. yield, based on [11C]CO2 and decay cor. to end of bombardment (EOB).  The radiochem. purity was >99%, and the molar activity (AM) at EOB was 370-740 GBq/μmol with a total synthesis time of 35-40-min from EOB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6uy86SbK0rVg90H21EOLACvtfcHk0lgX32NeiL97DA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXoslamtrc%253D&md5=c678e1b395306d56525ec30b39cd9d61</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DFacile%2520synthesis%2520of%2520carbon-11-labeled%2520sEH%252FPDE4%2520dual%2520inhibitors%2520as%2520new%2520potential%2520PET%2520agents%2520for%2520imaging%2520of%2520sEH%252FPDE4%2520enzymes%2520in%2520neuroinflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1654%26epage%3D1659%26doi%3D10.1016%2Fj.bmcl.2019.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esselstyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, A.</span></span> <span> </span><span class="NLM_article-title">PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/S0898-6568(01)00250-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0898-6568%2801%2900250-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11812656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=277-284&author=R.+Leeauthor=S.+Woldaauthor=E.+Moonauthor=J.+Esselstynauthor=C.+Hertelauthor=A.+Lerner&title=PDE7A+is+expressed+in+human+B-lymphocytes+and+is+up-regulated+by+elevation+of+intracellular+cAMP&doi=10.1016%2FS0898-6568%2801%2900250-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP</span></div><div class="casAuthors">Lee, Richard; Wolda, Sharon; Moon, Eunyi; Esselstyn, James; Hertel, Carmen; Lerner, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-284</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">PDE7A is a recently described 3',5'-cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase (PDE) whose expression has been detected in T-cells.  As treatment with the methylxanthine theophylline, a nonspecific PDE inhibitor, induces apoptosis in leukemic cells from patients with the B-lineage malignancy chronic lymphocytic leukemia (CLL), we sought to det. if PDE7A was a target of theophylline therapy in such cells.  Western anal. revealed expression of PDE7A in normal human splenic B-cells, primary CLL cells, and in a CLL-derived cell line (WSU-CLL).  Among the six cAMP PDEs (PDE1B, PDE3B, PDE4A, PDE4B, PDE4D, and PDE7) examd. in WSU-CLL, only PDE7A levels were augmented by treatment with methylxanthines.  The activity of PDE7A isolated from the WSU-CLL cell line by immunopptn. was inhibited by theophylline and IBMX with IC50 values of 343.5 and 8.6 μM, resp.  WSU-CLL PDE7A was also up-regulated by a novel specific inhibitor (IC242), which inhibits PDE7A from WSU-CLL cells with an IC50 value of 0.84 μM.  IC242-mediated up-regulation of PDE7A was blocked by the protein kinase A (PKA) inhibitor H-89.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwCXAfqTzsZbVg90H21EOLACvtfcHk0lhrHaKWlFSdEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1GqtQ%253D%253D&md5=9e33d67359c04efd8144079ae20a2962</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0898-6568%2801%2900250-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0898-6568%252801%252900250-9%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%26aulast%3DWolda%26aufirst%3DS.%26aulast%3DMoon%26aufirst%3DE.%26aulast%3DEsselstyn%26aufirst%3DJ.%26aulast%3DHertel%26aufirst%3DC.%26aulast%3DLerner%26aufirst%3DA.%26atitle%3DPDE7A%2520is%2520expressed%2520in%2520human%2520B-lymphocytes%2520and%2520is%2520up-regulated%2520by%2520elevation%2520of%2520intracellular%2520cAMP%26jtitle%3DCell.%2520Signalling%26date%3D2002%26volume%3D14%26spage%3D277%26epage%3D284%26doi%3D10.1016%2FS0898-6568%2801%2900250-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenlon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassenti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipps, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, P. A.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">19532</span>– <span class="NLM_lpage">19537</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806152105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1073%2Fpnas.0806152105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19033455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFanurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=19532-19537&author=L.+Zhangauthor=F.+Murrayauthor=A.+Zahnoauthor=J.+R.+Kanterauthor=D.+Chouauthor=R.+Sudaauthor=M.+Fenlonauthor=L.+Rassentiauthor=H.+Cottamauthor=T.+J.+Kippsauthor=P.+A.+Insel&title=Cyclic+nucleotide+phosphodiesterase+profiling+reveals+increased+expression+of+phosphodiesterase+7B+in+chronic+lymphocytic+leukemia&doi=10.1073%2Fpnas.0806152105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia</span></div><div class="casAuthors">Zhang, Lingzhi; Murray, Fiona; Zahno, Anja; Kanter, Joan R.; Chou, Daisy; Suda, Ryan; Fenlon, Michael; Rassenti, Laura; Cottam, Howard; Kipps, Thomas J.; Insel, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19532-19537</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterase (PDE) isoforms can influence disease pathogenesis and be novel therapeutic targets.  Because lower cAMP levels may contribute to the decreased apoptosis that occurs in chronic lymphocytic leukemia (CLL), we assessed the expression levels of PDE isoforms in peripheral blood mononuclear cells (PBMC) of healthy adults and patients with CLL.  We found a unique PDE mRNA signature in CLL: higher levels than in normal PBMC of PDE7B (increased ≈23-fold) and lower levels of PDE3B, 4D, 5A, and 9A mRNA (each decreased ≈30-fold).  Increased PDE7B mRNA in CLL correlates with a 10-fold-higher expression of PDE7B protein and results in an increased contribution of PDE7 to total PDE activity.  Consistent with the higher level of PDE7B expression, inhibitors of PDE7 (BRL-50481, IR-202) and a dual PDE4/PDE7 inhibitor (IR-284) selectively increase apoptosis in CLL cells compared with normal PBMC or B cells.  Apoptosis of CLL cells promoted by inhibitors of PDE7 and PDE4/7 is attenuated by PKA inhibition, occurs via a mitochondrial-dependent process, and is assocd. with increased cAMP accumulation and down-regulation of the antiapoptotic protein survivin and of PDE7B.  The increase in PDE7B expression and PDE7 inhibitor-promoted apoptosis implicates PDE7B as a drug target in CLL.  Our findings identify a unique PDE signature in CLL and illustrate the utility of broad analyses of PDE isoform expression in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc95nYYJPRbbVg90H21EOLACvtfcHk0lhrHaKWlFSdEQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFanurbI&md5=0c75070a6eeefdc4eadb103cacc15562</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806152105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806152105%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMurray%26aufirst%3DF.%26aulast%3DZahno%26aufirst%3DA.%26aulast%3DKanter%26aufirst%3DJ.%2BR.%26aulast%3DChou%26aufirst%3DD.%26aulast%3DSuda%26aufirst%3DR.%26aulast%3DFenlon%26aufirst%3DM.%26aulast%3DRassenti%26aufirst%3DL.%26aulast%3DCottam%26aufirst%3DH.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DInsel%26aufirst%3DP.%2BA.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterase%2520profiling%2520reveals%2520increased%2520expression%2520of%2520phosphodiesterase%25207B%2520in%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D19532%26epage%3D19537%26doi%3D10.1073%2Fpnas.0806152105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Rodriguez, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenzana, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia de Sola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bribian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3449</span>– <span class="NLM_lpage">3462</span>, <span class="refDoi"> DOI: 10.1007/s00018-013-1340-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00018-013-1340-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23661015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=3449-3462&author=E.+M.+Medina-Rodriguezauthor=F.+J.+Arenzanaauthor=J.+Pastorauthor=M.+Redondoauthor=V.+Palomoauthor=R.+Garcia+de+Solaauthor=C.+Gilauthor=A.+Martinezauthor=A.+Bribianauthor=F.+de+Castro&title=Inhibition+of+endogenous+phosphodiesterase+7+promotes+oligodendrocyte+precursor+differentiation+and+survival&doi=10.1007%2Fs00018-013-1340-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival</span></div><div class="casAuthors">Medina-Rodriguez, E. M.; Arenzana, F. J.; Pastor, J.; Redondo, M.; Palomo, V.; Garcia de Sola, R.; Gil, C.; Martinez, A.; Bribian, A.; de Castro, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3449-3462</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">During the development of the central nervous system (CNS), oligodendrocyte precursors (OPCs) are generated in specific sites within the neural tube and then migrate to colonize the entire CNS, where they differentiate into myelin-forming oligodendrocytes.  Demyelinating diseases such as multiple sclerosis (MS) are characterized by the death of these cells.  The CNS reacts to demyelination and by promoting spontaneous remyelination, an effect mediated by endogenous OPCs, cells that represent approx. 5-7 % of the cells in the adult brain.  Numerous factors influence oligodendrogliogenesis and oligodendrocyte differentiation, including morphogens, growth factors, chemotropic mols., extracellular matrix proteins, and intracellular cAMP levels.  Here, we show that during development and in early adulthood, OPCs in the murine cerebral cortex contain phosphodiesterase-7 (PDE7) that metabolizes cAMP.  We investigated the effects of different PDE7 inhibitors (the well-known BRL-50481 and two new ones, TC3.6 and VP1.15) on OPC proliferation, survival, and differentiation.  While none of the PDE7 inhibitors analyzed altered OPC proliferation, TC3.6 and VP1.15 enhanced OPC survival and differentiation, processes in which ERK intracellular signaling played a key role.  PDE7 expression was also obsd. in OPCs isolated from adult human brains and the differentiation of these OPCs into more mature oligodendroglial phenotypes was accelerated by treatment with both new PDE7 inhibitors.  These findings reveal new roles for PDE7 in regulating OPC survival and differentiation during brain development and in adulthood, and they may further our understanding of myelination and facilitate the development of therapeutic remyelination strategies for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlaa101VvgBbVg90H21EOLACvtfcHk0liuwP9KjNTF0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb7M&md5=d0e7a29102b12cbee0ffabc516940626</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00018-013-1340-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-013-1340-2%26sid%3Dliteratum%253Aachs%26aulast%3DMedina-Rodriguez%26aufirst%3DE.%2BM.%26aulast%3DArenzana%26aufirst%3DF.%2BJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DGarcia%2Bde%2BSola%26aufirst%3DR.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBribian%26aufirst%3DA.%26aulast%3Dde%2BCastro%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520endogenous%2520phosphodiesterase%25207%2520promotes%2520oligodendrocyte%2520precursor%2520differentiation%2520and%2520survival%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2013%26volume%3D70%26spage%3D3449%26epage%3D3462%26doi%3D10.1007%2Fs00018-013-1340-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soteras, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Val, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul-Fernandez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Alvarez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengod, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3274</span>– <span class="NLM_lpage">3284</span>, <span class="refDoi"> DOI: 10.1021/jm201720d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201720d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Sqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3274-3284&author=M.+Redondoauthor=J.+Breaauthor=D.+I.+Perezauthor=I.+Soterasauthor=C.+Valauthor=C.+Perezauthor=J.+A.+Morales-Garciaauthor=S.+Alonso-Gilauthor=N.+Paul-Fernandezauthor=R.+Martin-Alvarezauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=A.+Perez-Castilloauthor=G.+Mengodauthor=N.+E.+Campilloauthor=A.+Martinezauthor=C.+Gil&title=Effect+of+phosphodiesterase+7+%28PDE7%29+inhibitors+in+experimental+autoimmune+encephalomyelitis+mice.+Discovery+of+a+new+chemically+diverse+family+of+compounds&doi=10.1021%2Fjm201720d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds</span></div><div class="casAuthors">Redondo, Miriam; Brea, Jose; Perez, Daniel I.; Soteras, Ignacio; Val, Cristina; Perez, Concepcion; Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Paul-Fernandez, Nuria; Martin-Alvarez, Rocio; Cadavid, Maria Isabel; Loza, Maria Isabel; Perez-Castillo, Ana; Mengod, Guadalupe; Campillo, Nuria E.; Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3274-3284</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 7 is involved in proinflammatory processes, being widely expressed both on lymphocytes and on certain brain regions.  Specific inhibitors of PDE7 have been recently reported as potential new drugs for the treatment of neurol. disorders because of their ability to increase intracellular levels of cAMP and thus to modulate the inflammatory process, as a neuroprotective well-established strategy.  Multiple sclerosis is an unmet disease in which pathologies on the immune system, T-cells, and specific neural cells are involved simultaneously.  Therefore, PDE7 inhibitors able to interfere with all these targets may represent an innovative therapy for this pathol.  Here, we report a new chem. diverse family of heterocyclic PDE7 inhibitors, discovered and optimized by using mol. modeling studies, able to increase cAMP levels in cells, decrease inflammatory activation on primary neural cultures, and also attenuate the clin. symptoms in the exptl. autoimmune encephalomyelitis (EAE) mouse model.  These results led us to propose the use of PDE7 inhibitors as innovative therapeutic agents for the treatment of multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhQkmBFI_vSbVg90H21EOLACvtfcHk0liuwP9KjNTF0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Sqsb8%253D&md5=83f3c2b660d47862bc6b0b34208cb5ef</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm201720d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201720d%26sid%3Dliteratum%253Aachs%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DSoteras%26aufirst%3DI.%26aulast%3DVal%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DPaul-Fernandez%26aufirst%3DN.%26aulast%3DMartin-Alvarez%26aufirst%3DR.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMengod%26aufirst%3DG.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DEffect%2520of%2520phosphodiesterase%25207%2520%2528PDE7%2529%2520inhibitors%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520mice.%2520Discovery%2520of%2520a%2520new%2520chemically%2520diverse%2520family%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3274%26epage%3D3284%26doi%3D10.1021%2Fjm201720d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echeverry-Alzate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz-SanCristobal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Moreno, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase7 inhibition activates adult neurogenesis in hippocampus and subventricular zone in vitro and in vivo</span>. <i>Stem Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1002/stem.2480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fstem.2480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27538853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=458-472&author=J.+A.+Morales-Garciaauthor=V.+Echeverry-Alzateauthor=S.+Alonso-Gilauthor=M.+Sanz-SanCristobalauthor=J.+A.+Lopez-Morenoauthor=C.+Gilauthor=A.+Martinezauthor=A.+Santosauthor=A.+Perez-Castillo&title=Phosphodiesterase7+inhibition+activates+adult+neurogenesis+in+hippocampus+and+subventricular+zone+in+vitro+and+in+vivo&doi=10.1002%2Fstem.2480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo</span></div><div class="casAuthors">Morales-Garcia, Jose A.; Echeverry-Alzate, Victor; Alonso-Gil, Sandra; Sanz-SanCristobal, Marina; Lopez-Moreno, Jose A.; Gil, Carmen; Martinez, Ana; Santos, Angel; Perez-Castillo, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells (Durham, NC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">458-472</span>CODEN:
                <span class="NLM_cas:coden">STCEEJ</span>;
        ISSN:<span class="NLM_cas:issn">1066-5099</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">The phosphodiesterase 7 (PDE7) enzyme is one of the enzymes responsible for controlling intracellular levels of cyclic adenosine 3',5'-monophosphate in the immune and central nervous system.  We have previously shown that inhibitors of this enzyme are potent neuroprotective and anti-inflammatory agents.  In addn., we also demonstrated that PDE7 inhibition induces endogenous neuroregenerative processes toward a dopaminergic phenotype.  Here, we show that PDE7 inhibition controls stem cell expansion in the subgranular zone of the dentate gyrus of the hippocampus (SGZ) and the subventricular zone (SVZ) in the adult rat brain.  Neurospheres cultures obtained from SGZ and SVZ of adult rats treated with PDE7 inhibitors presented an increased proliferation and neuronal differentiation compared to control cultures.  PDE7 inhibitors treatment of neurospheres cultures also resulted in an increase of the levels of phosphorylated cAMP response element binding protein, suggesting that their effects were indeed mediated through the activation of the cAMP/PKA signaling pathway.  In addn., adult rats orally treated with S14, a specific inhibitor of PDE7, presented elevated nos. of proliferating progenitor cells, and migrating precursors in the SGZ and the SVZ.  Moreover, long-term treatment with this PDE7 inhibitor shows a significant increase in newly generated neurons in the olfactory bulb and the hippocampus.  Also a better performance in memory tests was obsd. in S14 treated rats, suggesting a functional relevance for the S14-induced increase in SGZ neurogenesis.  Taken together, our results indicate for the first time that inhibition of PDE7 directly regulates proliferation, migration and differentiation of neural stem cells, improving spatial learning and memory tasks.  Stem Cells 2017;35:458-472.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDd7pfIZXKbrVg90H21EOLACvtfcHk0lgFZcN18AXPYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWhu7Y%253D&md5=504d27eac431bc5cef902129045558aa</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fstem.2480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.2480%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DEcheverry-Alzate%26aufirst%3DV.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DSanz-SanCristobal%26aufirst%3DM.%26aulast%3DLopez-Moreno%26aufirst%3DJ.%2BA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26atitle%3DPhosphodiesterase7%2520inhibition%2520activates%2520adult%2520neurogenesis%2520in%2520hippocampus%2520and%2520subventricular%2520zone%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DStem%2520Cells%26date%3D2017%26volume%3D35%26spage%3D458%26epage%3D472%26doi%3D10.1002%2Fstem.2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auriga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzelmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, P. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bcp.2009.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19737543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKntLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=321-329&author=H.+Dongauthor=C.+Zittauthor=C.+Aurigaauthor=A.+Hatzelmannauthor=P.+M.+Epstein&title=Inhibition+of+PDE3%2C+PDE4+and+PDE7+potentiates+glucocorticoid-induced+apoptosis+and+overcomes+glucocorticoid+resistance+in+CEM+T+leukemic+cells&doi=10.1016%2Fj.bcp.2009.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells</span></div><div class="casAuthors">Dong, Hongli; Zitt, Christof; Auriga, Cornelia; Hatzelmann, Armin; Epstein, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-329</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stimulation of the cAMP signaling pathway has been shown to induce apoptosis and augment the effects of glucocorticoids in inducing apoptosis in leukemic cells.  We recently reported that in primary B cell chronic lymphocytic leukemic (B-CLL) cells, apoptosis could be induced by stimulating the cAMP signaling pathway with a phosphodiesterase 4 (PDE4) inhibitor alone; while in contrast, in the CEM T leukemic cell line, PDE4 inhibitors alone were ineffective, and concurrent stimulation of adenylyl cyclase was required to see effects.  We report here that in the CEM and Jurkat T leukemic cell lines, the most abundantly expressed PDEs are PDE3B, PDE4A, PDE4D, PDE7A, and PDE8A.  Selective inhibition of PDE3, PDE4, or PDE7 alone produces little effect on cell viability, but inhibition of all three of these PDEs together dramatically enhances glucocorticoid-induced apoptosis in CEM cells, and overcomes glucocorticoid resistance in a glucocorticoid-resistant CEM cell line.  These studies indicate that for some leukemic cell types, a desired therapeutic effect may be achieved by inhibiting more than one form of PDE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaEL_2OkPoJrVg90H21EOLACvtfcHk0lgFZcN18AXPYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKntLbF&md5=7831a904a52d0e6e6dc9eedb374e4c1e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZitt%26aufirst%3DC.%26aulast%3DAuriga%26aufirst%3DC.%26aulast%3DHatzelmann%26aufirst%3DA.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26atitle%3DInhibition%2520of%2520PDE3%252C%2520PDE4%2520and%2520PDE7%2520potentiates%2520glucocorticoid-induced%2520apoptosis%2520and%2520overcomes%2520glucocorticoid%2520resistance%2520in%2520CEM%2520T%2520leukemic%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D321%26epage%3D329%26doi%3D10.1016%2Fj.bcp.2009.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span> <span> </span><span class="NLM_article-title">High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma</span>. <i>Leuk. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1016/j.leukres.2013.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.leukres.2013.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23453122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFyitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2013&pages=536-540&author=C.+Fangauthor=H.+J.+Dongauthor=Z.+J.+Zouauthor=L.+Fanauthor=L.+Wangauthor=R.+Zhangauthor=J.+Xuauthor=W.+Xuauthor=J.+Y.+Li&title=High+expression+of+cyclic+nucleotide+phosphodiesterase+7B+mRNA+predicts+poor+prognosis+in+mantle+cell+lymphoma&doi=10.1016%2Fj.leukres.2013.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma</span></div><div class="casAuthors">Fang, Cheng; Dong, Hua-Jie; Zou, Zhi-Jian; Fan, Lei; Wang, Li; Zhang, Run; Xu, Ji; Xu, Wei; Li, Jian-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">536-540</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In order to det. the relationship between expression of cyclic nucleotide phosphodiesterase isoform 7B (PDE7B) and mantle cell lymphoma (MCL) progression, PDE7B mRNA expression was measured by qRT-PCR in 21 untreated MCL patients with bone marrow involvement and 20 healthy donors.  The expression level of PDE7B was markedly higher in MCL patients compared with normal controls (P = 0.001), and the higher level of PDE7B expression was assocd. with unfavorable cytogenetic characteristics in MCL.  It was showed that higher expression of PDE7B might be a novel unfavorable prognostic indicator in MCL, which possess important clin. significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVGXk16jHy5rVg90H21EOLACvtfcHk0lgFZcN18AXPYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFyitbY%253D&md5=c7063ccb02403c4d5a208c1f794c1ffb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2013.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2013.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DH.%2BJ.%26aulast%3DZou%26aufirst%3DZ.%2BJ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26atitle%3DHigh%2520expression%2520of%2520cyclic%2520nucleotide%2520phosphodiesterase%25207B%2520mRNA%2520predicts%2520poor%2520prognosis%2520in%2520mantle%2520cell%2520lymphoma%26jtitle%3DLeuk.%2520Res.%26date%3D2013%26volume%3D37%26spage%3D536%26epage%3D540%26doi%3D10.1016%2Fj.leukres.2013.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiyomaru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuhashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enokida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shozu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span> <span> </span><span class="NLM_article-title">The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.3892/ijo.2015.2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3892%2Fijo.2015.2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25955017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvV2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=325-334&author=N.+Yamamotoauthor=R.+Nishikawaauthor=T.+Chiyomaruauthor=Y.+Gotoauthor=I.+Fukumotoauthor=H.+Usuiauthor=A.+Mitsuhashiauthor=H.+Enokidaauthor=M.+Nakagawaauthor=M.+Shozuauthor=N.+Seki&title=The+tumor-suppressive+microRNA-1%2F133a+cluster+targets+PDE7A+and+inhibits+cancer+cell+migration+and+invasion+in+endometrial+cancer&doi=10.3892%2Fijo.2015.2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer</span></div><div class="casAuthors">Yamamoto, Noriko; Nishikawa, Rika; Chiyomaru, Takeshi; Goto, Yusuke; Fukumoto, Ichiro; Usui, Hirokazu; Mitsuhashi, Akira; Enokida, Hideki; Nakagawa, Masayuki; Shozu, Makio; Seki, Naohiko</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">325-334</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">In developed countries, endometrial cancer (EC) is the most common malignancy among women.  Unopposed estrogen therapy, obesity, nulliparity, diabetes mellitus and arterial hypertension have been linked to an increased risk of EC.  However, the mol. mechanisms of EC oncogenesis and metastasis have not yet been fully elucidated.  Our recent studies of microRNA (miRNA) expression signatures revealed that the microRNA-1/133a (miR-1/133a) cluster is frequently downregulated in various types of human cancers.  However, the functional role of the miR-1/133a cluster in EC cells is still unknown.  Thus, the aim of this study was to investigate the functional significance of the miR-1/133a cluster and its regulated mol. targets, with an emphasis on the contributions of miR-1/133a to EC oncogenesis and metastasis.  We found that the expression levels of miR-1 and miR-133a were significantly reduced in EC tissues.  Moreover, restoration of mature miR-1 or miR-133a miRNAs significantly inhibited cancer cell migration and invasion, suggesting that these clustered miRNAs act as tumor suppressors.  Prediction of miRNA targets revealed that phosphodiesterase 7A (PDE7A) was a potential target gene regulated by both miR-1 and miR-133a.  PDE7A was confirmed to be overexpressed in EC clin. specimens and silencing of PDE7A significantly inhibited cancer cell migration and invasion.  Our data demonstrated that downregulation of the miR-1/133a cluster promoted cancer cell migration and invasion via overexpression of PDE7A in EC cells.  Elucidation of the mol. networks regulated by tumor-suppressive miRNAs will provide insights into the mol. mechanisms of EC oncogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzPHz5IDMu47Vg90H21EOLACvtfcHk0ljKsphTOpMqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvV2hug%253D%253D&md5=0a12f2e1727b7f81a54f59e7c16f60e0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3892%2Fijo.2015.2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2015.2986%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DNishikawa%26aufirst%3DR.%26aulast%3DChiyomaru%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DFukumoto%26aufirst%3DI.%26aulast%3DUsui%26aufirst%3DH.%26aulast%3DMitsuhashi%26aufirst%3DA.%26aulast%3DEnokida%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DShozu%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26atitle%3DThe%2520tumor-suppressive%2520microRNA-1%252F133a%2520cluster%2520targets%2520PDE7A%2520and%2520inhibits%2520cancer%2520cell%2520migration%2520and%2520invasion%2520in%2520endometrial%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2015%26volume%3D47%26spage%3D325%26epage%3D334%26doi%3D10.3892%2Fijo.2015.2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslinski, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnette, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giembycz, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of BRL 50481 [3-(<i>N</i>,<i>N</i>-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8<sup>+</sup> T-lymphocytes</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1689</span>, <span class="refDoi"> DOI: 10.1124/mol.104.002246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fmol.104.002246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15371556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1679-1689&author=S.+J.+Smithauthor=L.+B.+Cieslinskiauthor=R.+Newtonauthor=L.+E.+Donnellyauthor=P.+S.+Fenwickauthor=A.+G.+Nicholsonauthor=P.+J.+Barnesauthor=M.+S.+Barnetteauthor=M.+A.+Giembycz&title=Discovery+of+BRL+50481+%5B3-%28N%2CN-dimethylsulfonamido%29-4-methyl-nitrobenzene%5D%2C+a+selective+inhibitor+of+phosphodiesterase+7%3A+in+vitro+studies+in+human+monocytes%2C+lung+macrophages%2C+and+CD8%2B+T-lymphocytes&doi=10.1124%2Fmol.104.002246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: In vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes</span></div><div class="casAuthors">Smith, Susan J.; Cieslinski, Lenora B.; Newton, Robert; Donnelly, Louise E.; Fenwick, Peter S.; Nicholson, Andrew G.; Barnes, Peter J.; Barnette, Mary S.; Giembycz, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1679-1689</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The biochem. and pharmacol. characteristics in human proinflammatory cells of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a novel and selective inhibitor of phosphodiesterase (PDE) 7, are described.  BRL 50481 inhibited the activity of hrPDE7A1 expressed in baculovirus-infected Spodoptera frugiperda 9 cells in a competitive manner (Ki value of 180 nM) and was 416 and 1884 times less potent against PDE3 and 38 and 238 times less potent against PDE4 at a substrate concn. of 1 μM and 50 nM cAMP, resp.  Western blotting identified HSPDE7A1 but not HSPDE7A2 in three human cell types that are implicated in the pathogenesis of chronic obstructive lung disease, namely, CD8+ T-lymphocytes, monocytes, and lung macrophages.  BRL 50481 had no effect on the proliferation of CD8+ T-lymphocytes and only marginally (∼2-11%) reduced the generation of tumor necrosis factor (TNF)α from blood monocytes and lung macrophages.  However, in the presence of BRL 50481 the inhibitory effect of rolipram was enhanced on all three cell types.  The expression of HSPDE7A1 was increased in a time-dependent manner in monocytes that were "aged" in culture medium.  Under this condition, BRL 50481 now inhibited TNFα generation in a concn.-dependent manner.  In aged monocytes, rolipram, Org 9935 (a PDE3 inhibitor), and prostaglandin E2 inhibited TNFα generation in a concn.-dependent manner and interacted additively with BRL 50481.  BRL 50481 is the first fully documented PDE7 inhibitor that has acceptable selectivity for in vitro studies.  Furthermore, although BRL 50481 had only a modest inhibitory effect per se on the proinflammatory cells studied, it acted at least additively with other cAMP-elevating drugs, esp. when HSPDE7A1 was up-regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSYIDHaxfl97Vg90H21EOLACvtfcHk0ljKsphTOpMqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jE&md5=372d21ea04165ae5ae3a05d5bfd09d52</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.002246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.002246%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DCieslinski%26aufirst%3DL.%2BB.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DDonnelly%26aufirst%3DL.%2BE.%26aulast%3DFenwick%26aufirst%3DP.%2BS.%26aulast%3DNicholson%26aufirst%3DA.%2BG.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DBarnette%26aufirst%3DM.%2BS.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520BRL%252050481%2520%255B3-%2528N%252CN-dimethylsulfonamido%2529-4-methyl-nitrobenzene%255D%252C%2520a%2520selective%2520inhibitor%2520of%2520phosphodiesterase%25207%253A%2520in%2520vitro%2520studies%2520in%2520human%2520monocytes%252C%2520lung%2520macrophages%252C%2520and%2520CD8%252B%2520T-lymphocytes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1679%26epage%3D1689%26doi%3D10.1124%2Fmol.104.002246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhateja, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajpai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangana, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khairatkar-Joshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharat, L. A.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson’s disease model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6286</span>– <span class="NLM_lpage">6291</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2012.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22944118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12ltrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6286-6291&author=A.+Banerjeeauthor=S.+Patilauthor=M.+Y.+Pawarauthor=S.+Gullapalliauthor=P.+K.+Guptaauthor=M.+N.+Gandhiauthor=D.+K.+Bhatejaauthor=M.+Bajpaiauthor=R.+R.+Sanganaauthor=G.+S.+Gudiauthor=N.+Khairatkar-Joshiauthor=L.+A.+Gharat&title=Imidazopyridazinones+as+novel+PDE7+inhibitors%3A+SAR+and+in+vivo+studies+in+Parkinson%E2%80%99s+disease+model&doi=10.1016%2Fj.bmcl.2012.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model</span></div><div class="casAuthors">Banerjee, Abhisek; Patil, Sandip; Pawar, Mahesh Y.; Gullapalli, Srinivas; Gupta, Praveen K.; Gandhi, Maulik N.; Bhateja, Deepak K.; Bajpai, Malini; Sangana, Ramachandra Rao; Gudi, Girish S.; Khairatkar-Joshi, Neelima; Gharat, Laxmikant A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6286-6291</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationship studies of a series of compds. from imidazopyridazinone scaffold as PDE7 inhibitors are disclosed.  Potent analogs such as compds. I (31 nM), II (27 nM), and III (12 nM) were identified.  The PDE selectivity and pharmacokinetic profile of compds. I, II, and III are also disclosed.  The adequate CNS penetration of compd. I in mice allowed it to be tested in the MPTP induced PD model and haloperidol induced catalepsy model to probe the differential pharmacol. of PDE7 in the striatal pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f6iMTgY1mrVg90H21EOLACvtfcHk0ljKsphTOpMqAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12ltrbJ&md5=8991dc46813cf83ca1efb1941c82314c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DPawar%26aufirst%3DM.%2BY.%26aulast%3DGullapalli%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DP.%2BK.%26aulast%3DGandhi%26aufirst%3DM.%2BN.%26aulast%3DBhateja%26aufirst%3DD.%2BK.%26aulast%3DBajpai%26aufirst%3DM.%26aulast%3DSangana%26aufirst%3DR.%2BR.%26aulast%3DGudi%26aufirst%3DG.%2BS.%26aulast%3DKhairatkar-Joshi%26aufirst%3DN.%26aulast%3DGharat%26aufirst%3DL.%2BA.%26atitle%3DImidazopyridazinones%2520as%2520novel%2520PDE7%2520inhibitors%253A%2520SAR%2520and%2520in%2520vivo%2520studies%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6286%26epage%3D6291%26doi%3D10.1016%2Fj.bmcl.2012.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadoshima-Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murafuji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span> <span> </span><span class="NLM_article-title">ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-γ production by mouse activated T lymphocytes</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2009.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.imlet.2009.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19195485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=193-197&author=K.+Kadoshima-Yamaokaauthor=M.+Murakawaauthor=M.+Gotoauthor=Y.+Tanakaauthor=H.+Inoueauthor=H.+Murafujiauthor=A.+Nagahiraauthor=Y.+Hayashiauthor=K.+Nagahiraauthor=K.+Miuraauthor=T.+Nakatsukaauthor=K.+Chamotoauthor=Y.+Fukudaauthor=T.+Nishimura&title=ASB16165%2C+a+novel+inhibitor+for+phosphodiesterase+7A+%28PDE7A%29%2C+suppresses+IL-12-induced+IFN-%CE%B3+production+by+mouse+activated+T+lymphocytes&doi=10.1016%2Fj.imlet.2009.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-γ production by mouse activated T lymphocytes</span></div><div class="casAuthors">Kadoshima-Yamaoka, Kumiko; Murakawa, Masao; Goto, Megumi; Tanaka, Yoshitaka; Inoue, Hidekazu; Murafuji, Hidenobu; Nagahira, Asako; Hayashi, Yasuhiro; Nagahira, Kazuhiro; Miura, Kenju; Nakatsuka, Takashi; Chamoto, Kenji; Fukuda, Yoshiaki; Nishimura, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-197</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes.  In the present study, a possible involvement of PDE7A in function of preactivated T cells (i.e. T lymphoblasts) was investigated using ASB16165, an inhibitor for PDE7A.  ASB16165, which has an IC50 value of 15 nM for human PDE7A, suppressed IL-12-induced IFN-γ prodn. by T lymphoblasts which have been prepd. by stimulating mouse T cells with anti-CD3 antibody.  In the same expt., rolipram, a PDE4-specific inhibitor, showed similar effect, while calcineurin antagonist FK506 did not.  Forskolin (an adenylyl cyclase activator) and dibutyryl cAMP also inhibited the IL-12-induced IFN-γ synthesis.  Rp-8-Br-cAMPS, an inhibitor of protein kinase A (PKA), reduced the suppressive effect of ASB16165 on the IFN-γ prodn. by T lymphoblasts.  The rescue of IFN-γ prodn. by Rp-8-Br-cAMPS was also obsd. in the inhibition by rolipram and forskolin.  These findings suggest that PDE7A may regulate function of activated T cells in a cAMP/PKA-dependent manner, and that PDE4 might share the role.  The data in our study also indicate that PDE7 inhibitors such as ASB16165 will be beneficial for the patients with immunol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAte6iaG1VJ7Vg90H21EOLACvtfcHk0lhgC734WndmJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFOgur0%253D&md5=7b942e86a71bc68cd8eb2ef43bfccfcf</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2009.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2009.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DKadoshima-Yamaoka%26aufirst%3DK.%26aulast%3DMurakawa%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DMurafuji%26aufirst%3DH.%26aulast%3DNagahira%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DNagahira%26aufirst%3DK.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DNakatsuka%26aufirst%3DT.%26aulast%3DChamoto%26aufirst%3DK.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DASB16165%252C%2520a%2520novel%2520inhibitor%2520for%2520phosphodiesterase%25207A%2520%2528PDE7A%2529%252C%2520suppresses%2520IL-12-induced%2520IFN-%25CE%25B3%2520production%2520by%2520mouse%2520activated%2520T%2520lymphocytes%26jtitle%3DImmunol.%2520Lett.%26date%3D2009%26volume%3D122%26spage%3D193%26epage%3D197%26doi%3D10.1016%2Fj.imlet.2009.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadoshima-Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murafuji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span> <span> </span><span class="NLM_article-title">ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-α level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>613</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejphar.2009.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19379723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1yisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=613&publication_year=2009&pages=163-166&author=K.+Kadoshima-Yamaokaauthor=M.+Gotoauthor=M.+Murakawaauthor=R.+Yoshiokaauthor=Y.+Tanakaauthor=H.+Inoueauthor=H.+Murafujiauthor=S.+Kankiauthor=Y.+Hayashiauthor=K.+Nagahiraauthor=A.+Ogataauthor=T.+Nakatsukaauthor=Y.+Fukuda&title=ASB16165%2C+a+phosphodiesterase+7A+inhibitor%2C+reduces+cutaneous+TNF-%CE%B1+level+and+ameliorates+skin+edema+in+phorbol+ester+12-O-tetradecanoylphorbol-13-acetate-induced+skin+inflammation+model+in+mice&doi=10.1016%2Fj.ejphar.2009.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-α level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice</span></div><div class="casAuthors">Kadoshima-Yamaoka, Kumiko; Goto, Megumi; Murakawa, Masao; Yoshioka, Ryosuke; Tanaka, Yoshitaka; Inoue, Hidekazu; Murafuji, Hidenobu; Kanki, Satomi; Hayashi, Yasuhiro; Nagahira, Kazuhiro; Ogata, Atsuto; Nakatsuka, Takashi; Fukuda, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">613</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">163-166</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Possible role of phosphodiesterase 7A (PDE7A) in skin inflammation was examd. using ASB16165, a specific inhibitor for PDE7A.  Epicutaneous application of phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) to mouse ear resulted in induction of skin edema, and topical treatment with ASB16165 inhibited the induction of skin edema in a dose-dependent manner.  The TPA challenge also increased the level of TNF-α at the application site, and the ASB16165 treatment reduced the TNF-α level in the skin.  In addn., ASB16165 suppressed the prodn. of TNF-α by human keratinocytes stimulated in vitro with TPA and calcium ionophore.  Forskolin, an activator of adenylyl cyclase, as well as dibutyryl cAMP also showed inhibitory effect on the TNF-α prodn. in the cells, suggesting involvement of cAMP in TNF-α generation.  These results demonstrate that PDE7A might regulate TNF-α prodn. in keratinocytes in a cAMP-dependent fashion.  As immunostaining anal. revealed that PDE7A is expressed in the epidermis and TNF-α is known to contribute to the TPA-induced edema, it is possible that the inhibitory effect of ASB16165 on skin edema in mouse TPA-induced dermatitis model is mediated by suppression of TNF-α prodn.  This is the first report suggesting the assocn. of PDE7A with the function of keratinocytes.  ASB16165 will be useful as an agent for skin inflammation in which TNF-α plays a pathogenic role (e.g. psoriasis).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouSZNzXzWby7Vg90H21EOLACvtfcHk0lhgC734WndmJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1yisL8%253D&md5=2c33247cfb564c069c8106b94dbb7ab0</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DKadoshima-Yamaoka%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DMurakawa%26aufirst%3DM.%26aulast%3DYoshioka%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DMurafuji%26aufirst%3DH.%26aulast%3DKanki%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DNagahira%26aufirst%3DK.%26aulast%3DOgata%26aufirst%3DA.%26aulast%3DNakatsuka%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DY.%26atitle%3DASB16165%252C%2520a%2520phosphodiesterase%25207A%2520inhibitor%252C%2520reduces%2520cutaneous%2520TNF-%25CE%25B1%2520level%2520and%2520ameliorates%2520skin%2520edema%2520in%2520phorbol%2520ester%252012-O-tetradecanoylphorbol-13-acetate-induced%2520skin%2520inflammation%2520model%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D613%26spage%3D163%26epage%3D166%26doi%3D10.1016%2Fj.ejphar.2009.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segarra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miro, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casacuberta, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azorin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigdomenech, P.</span></span> <span> </span><span class="NLM_article-title">Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">689</span>, <span class="refDoi"> DOI: 10.1021/jm990382n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990382n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1Khsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=683-689&author=A.+Martinezauthor=A.+Castroauthor=C.+Gilauthor=M.+Miralpeixauthor=V.+Segarraauthor=T.+Domenechauthor=J.+Beletaauthor=J.+M.+Palaciosauthor=H.+Ryderauthor=X.+Miroauthor=C.+Bonetauthor=J.+M.+Casacubertaauthor=F.+Azorinauthor=B.+Pinaauthor=P.+Puigdomenech&title=Benzyl+derivatives+of+2%2C1%2C3-benzo-+and+benzothieno%5B3%2C2-a%5Dthiadiazine+2%2C2-dioxides%3A+first+phosphodiesterase+7+inhibitors&doi=10.1021%2Fjm990382n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyl Derivatives of 2,1,3-Benzo- and Benzothieno[3,2-a]thiadiazine 2,2-Dioxides: First Phosphodiesterase 7 Inhibitors</span></div><div class="casAuthors">Martinez, Ana; Castro, Ana; Gil, Carmen; Miralpeix, Montserrat; Segarra, Victor; Domenech, Teresa; Beleta, Jorge; Palacios, Jose M.; Ryder, Hamish; Miro, Xavier; Bonet, Carles; Casacuberta, Josep M.; Azorin, Ferran; Pina, Benjami; Puigdomenech, Pere</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-689</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a new family of benzyl derivs. of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides was achieved.  The biol. data revealed the first heterocyclic family of compds. with PDE 7 inhibitory properties, appearing to be a new objective for the treatment of T-cell-dependent disorders.  The IC50 values or percent inhibition values of the compds. against PDE 7 were calcd. by testing them against human recombinant PDE 7 expressed in S. cerevisiae.  In this expression system the only cyclic nucleotide hydrolyzing activity present in cell exts. corresponded to human PDE 7.  Isoenzyme selectivity PDE 7 vs. PDE 4 and PDE 3 was also measured.  Considering simultaneously inhibition of the three different isoenzymes, monobenzyl derivs. I (R = OMe) and II showed interesting PDE 7 potency (around 10 μM); although not statistically significant, a trend toward selectivity with respect to PDE 3 and PDE 4 was obtained.  Benzothiadiazine I (R = Ph), although less potent at PDE 7 (IC50 = 25 μM), also showed a trend of selectivity toward PDE 3 and PDE 4.  These compds. are considered the best leads for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7NtxEgDIInLVg90H21EOLACvtfcHk0lguHxXlwfvflQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1Khsg%253D%253D&md5=1f4198daccc462d90e2c3c1b8d53dade</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm990382n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990382n%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26aulast%3DRyder%26aufirst%3DH.%26aulast%3DMiro%26aufirst%3DX.%26aulast%3DBonet%26aufirst%3DC.%26aulast%3DCasacuberta%26aufirst%3DJ.%2BM.%26aulast%3DAzorin%26aufirst%3DF.%26aulast%3DPina%26aufirst%3DB.%26aulast%3DPuigdomenech%26aufirst%3DP.%26atitle%3DBenzyl%2520derivatives%2520of%25202%252C1%252C3-benzo-%2520and%2520benzothieno%255B3%252C2-a%255Dthiadiazine%25202%252C2-dioxides%253A%2520first%2520phosphodiesterase%25207%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D683%26epage%3D689%26doi%3D10.1021%2Fjm990382n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadler, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, W. J.</span></span> <span> </span><span class="NLM_article-title">Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1935</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2009.02.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19272774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1arsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1935-1938&author=J.+Guoauthor=A.+Watsonauthor=J.+Kempsonauthor=M.+Carlsenauthor=J.+Barbosaauthor=K.+Stebbinsauthor=D.+Leeauthor=J.+Doddauthor=S.+G.+Nadlerauthor=M.+McKinnonauthor=J.+Barrishauthor=W.+J.+Pitts&title=Identification+of+potent+pyrimidine+inhibitors+of+phosphodiesterase+7+%28PDE7%29+and+their+ability+to+inhibit+T+cell+proliferation&doi=10.1016%2Fj.bmcl.2009.02.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation</span></div><div class="casAuthors">Guo, Junqing; Watson, Andrew; Kempson, James; Carlsen, Marianne; Barbosa, Joseph; Stebbins, Karen; Lee, Deborah; Dodd, John; Nadler, Steven G.; McKinnon, Murray; Barrish, Joel; Pitts, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1935-1938</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of pyrimidine based inhibitors of PDE7 are discussed.  The synthesis, structure-activity relationships (SAR) and selectivity against several other PDE family members as well as activity in T cells are presented.  These compds. were found to have effects on T cell proliferation, however it is not clear whether the mechanism is related to PDE7 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOy2sf7uz1gbVg90H21EOLACvtfcHk0lguHxXlwfvflQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1arsrg%253D&md5=fb37ad52040df80c4fc76d8f0c605f25</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.060%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DKempson%26aufirst%3DJ.%26aulast%3DCarlsen%26aufirst%3DM.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DStebbins%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DNadler%26aufirst%3DS.%2BG.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26atitle%3DIdentification%2520of%2520potent%2520pyrimidine%2520inhibitors%2520of%2520phosphodiesterase%25207%2520%2528PDE7%2529%2520and%2520their%2520ability%2520to%2520inhibit%2520T%2520cell%2520proliferation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1935%26epage%3D1938%26doi%3D10.1016%2Fj.bmcl.2009.02.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vergne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proust, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mafroud, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigglesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellhaas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barvian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tertre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulard, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4613</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2004.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15324874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4607-4613&author=F.+Vergneauthor=P.+Bernardelliauthor=E.+Lorthioisauthor=N.+Phamauthor=E.+Proustauthor=C.+Oliveiraauthor=A.+K.+Mafroudauthor=F.+Royerauthor=R.+Wrigglesworthauthor=J.+Schellhaasauthor=M.+Barvianauthor=F.+Moreauauthor=M.+Idrissiauthor=A.+Tertreauthor=B.+Bertinauthor=M.+Coupeauthor=P.+Bernaauthor=P.+Soulard&title=Discovery+of+thiadiazoles+as+a+novel+structural+class+of+potent+and+selective+PDE7+inhibitors.+Part+1%3A+design%2C+synthesis+and+structure-activity+relationship+studies&doi=10.1016%2Fj.bmcl.2004.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies</span></div><div class="casAuthors">Vergne, Fabrice; Bernardelli, Patrick; Lorthiois, Edwige; Pham, Nga; Proust, Emmanuelle; Oliveira, Chrystelle; Mafroud, Abdel-Kader; Royer, Frederique; Wrigglesworth, Roger; Schellhaas, Jennifer; Barvian, Mark; Moreau, Francois; Idrissi, Moulay; Tertre, Anita; Bertin, Bernadette; Coupe, Magali; Berna, Patrick; Soulard, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4607-4613</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and SAR studies of a series of thiadiazoles, e.g., I, as inhibitors of PDE7 are discussed.  The best compds. from the series displayed low nanomolar inhibitory activity and are selective vs. PDE4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDIZv5eu8DVLVg90H21EOLACvtfcHk0ljES5qIjWPIRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbg%253D&md5=03e61c0f25cc278fa402d11c3c0e4d37</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DVergne%26aufirst%3DF.%26aulast%3DBernardelli%26aufirst%3DP.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DPham%26aufirst%3DN.%26aulast%3DProust%26aufirst%3DE.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DMafroud%26aufirst%3DA.%2BK.%26aulast%3DRoyer%26aufirst%3DF.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DSchellhaas%26aufirst%3DJ.%26aulast%3DBarvian%26aufirst%3DM.%26aulast%3DMoreau%26aufirst%3DF.%26aulast%3DIdrissi%26aufirst%3DM.%26aulast%3DTertre%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DB.%26aulast%3DCoupe%26aufirst%3DM.%26aulast%3DBerna%26aufirst%3DP.%26aulast%3DSoulard%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520thiadiazoles%2520as%2520a%2520novel%2520structural%2520class%2520of%2520potent%2520and%2520selective%2520PDE7%2520inhibitors.%2520Part%25201%253A%2520design%252C%2520synthesis%2520and%2520structure-activity%2520relationship%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4607%26epage%3D4613%26doi%3D10.1016%2Fj.bmcl.2004.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mafroud, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proust, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuze, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tertre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigglesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descours, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berna, P.</span></span> <span> </span><span class="NLM_article-title">Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4623</span>– <span class="NLM_lpage">4626</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2004.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15324876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4623-4626&author=E.+Lorthioisauthor=P.+Bernardelliauthor=F.+Vergneauthor=C.+Oliveiraauthor=A.+K.+Mafroudauthor=E.+Proustauthor=L.+Heuzeauthor=F.+Moreauauthor=M.+Idrissiauthor=A.+Tertreauthor=B.+Bertinauthor=M.+Coupeauthor=R.+Wrigglesworthauthor=A.+Descoursauthor=P.+Soulardauthor=P.+Berna&title=Spiroquinazolinones+as+novel%2C+potent%2C+and+selective+PDE7+inhibitors.+Part+1&doi=10.1016%2Fj.bmcl.2004.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1</span></div><div class="casAuthors">Lorthiois, Edwige; Bernardelli, Patrick; Vergne, Fabrice; Oliveira, Chrystelle; Mafroud, Abdel-Kader; Proust, Emmanuelle; Heuze, Lamia; Moreau, Francois; Idrissi, Moulay; Tertre, Anita; Bertin, Bernadette; Coupe, Magali; Wrigglesworth, Roger; Descours, Arnaud; Soulard, Patricia; Berna, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4623-4626</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and SAR studies of spiroquinazolinones as novel PDE7 inhibitors are discussed.  The best compds. from the series displayed nanomolar inhibitory affinity and were selective vs. other PDE isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF8ehETjuUaLVg90H21EOLACvtfcHk0ljES5qIjWPIRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbY%253D&md5=b9cfa3872dcb29f500c4754c8168e6c4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DBernardelli%26aufirst%3DP.%26aulast%3DVergne%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DMafroud%26aufirst%3DA.%2BK.%26aulast%3DProust%26aufirst%3DE.%26aulast%3DHeuze%26aufirst%3DL.%26aulast%3DMoreau%26aufirst%3DF.%26aulast%3DIdrissi%26aufirst%3DM.%26aulast%3DTertre%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DB.%26aulast%3DCoupe%26aufirst%3DM.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DDescours%26aufirst%3DA.%26aulast%3DSoulard%26aufirst%3DP.%26aulast%3DBerna%26aufirst%3DP.%26atitle%3DSpiroquinazolinones%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520PDE7%2520inhibitors.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4623%26epage%3D4626%26doi%3D10.1016%2Fj.bmcl.2004.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracia-Rubio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ros-Simo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valverde, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">Modulation of cAMP-specific PDE without emetogenic activity: new sulfide-like PDE7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8590</span>– <span class="NLM_lpage">8607</span>, <span class="refDoi"> DOI: 10.1021/jm501090m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501090m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8590-8607&author=A.+M.+Garciaauthor=J.+Breaauthor=J.+A.+Morales-Garciaauthor=D.+I.+Perezauthor=A.+Gonzalezauthor=S.+Alonso-Gilauthor=I.+Gracia-Rubioauthor=C.+Ros-Simoauthor=S.+Condeauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=A.+Perez-Castilloauthor=O.+Valverdeauthor=A.+Martinezauthor=C.+Gil&title=Modulation+of+cAMP-specific+PDE+without+emetogenic+activity%3A+new+sulfide-like+PDE7+inhibitors&doi=10.1021%2Fjm501090m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cAMP-Specific PDE without Emetogenic Activity: New Sulfide-Like PDE7 Inhibitors</span></div><div class="casAuthors">Garcia, Ana M.; Brea, Jose; Morales-Garcia, Jose A.; Perez, Daniel I.; Gonzalez, Alejandro; Alonso-Gil, Sandra; Gracia-Rubio, Irene; Ros-Simo, Clara; Conde, Santiago; Cadavid, Maria Isabel; Loza, Maria Isabel; Perez-Castillo, Ana; Valverde, Olga; Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8590-8607</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A forward chem. genetic approach was followed to discover new targets and lead compds. for Parkinson's disease (PD) treatment.  By anal. of the cell protection produced by some small mols., a di-Ph sulfide compd. was revealed to be a new phosphodiesterase 7 (PDE7) inhibitor and identified as a new hit.  This result allows us to confirm the utility of PDE7 inhibitors as a potential pharmacol. treatment of PD.  On the basis of these data, a diverse family of di-Ph sulfides has been developed and pharmacol. evaluated in the present work.  Moreover, to gain insight into the safety of PDE7 inhibitors for human chronic treatment, the authors evaluated the new compds. in a surrogate emesis model, showing nonemetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm1xLipgnyN7Vg90H21EOLACvtfcHk0liLNlIKQRKgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrjO&md5=4ab21e80ba3a2fa20177a3a91bfcdb95</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm501090m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501090m%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DA.%2BM.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DGracia-Rubio%26aufirst%3DI.%26aulast%3DRos-Simo%26aufirst%3DC.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DValverde%26aufirst%3DO.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DModulation%2520of%2520cAMP-specific%2520PDE%2520without%2520emetogenic%2520activity%253A%2520new%2520sulfide-like%2520PDE7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8590%26epage%3D8607%26doi%3D10.1021%2Fjm501090m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamei, N.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2014.11.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25529739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=649-653&author=Y.+Endoauthor=K.+Kawaiauthor=T.+Asanoauthor=S.+Amanoauthor=Y.+Asanumaauthor=K.+Sawadaauthor=K.+Oguraauthor=N.+Nagataauthor=N.+Ueoauthor=N.+Takahashiauthor=Y.+Sonodaauthor=N.+Kamei&title=Discovery+and+SAR+study+of+2-%284-pyridylamino%29thieno%5B3%2C2-d%5Dpyrimidin-4%283H%29-ones+as+soluble+and+highly+potent+PDE7+inhibitors&doi=10.1016%2Fj.bmcl.2014.11.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors</span></div><div class="casAuthors">Endo, Yusuke; Kawai, Kentaro; Asano, Takeshi; Amano, Seiji; Asanuma, Yoshihito; Sawada, Keisuke; Ogura, Keiji; Nagata, Naoya; Ueo, Noriko; Takahashi, Nobuaki; Sonoda, Yo; Kamei, Noriyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-653</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and SAR study of a new series of sol. and highly potent phosphodiesterase (PDE) 7 inhibitors are described herein.  The authors explored a new lead compd. with improved soly., which led to the discovery of a 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-one series.  The introduction of 3-piperidines at the 7-position resulted in the significant enhancement of PDE7 activity.  In particular, compd. I also showed strong PDE7 inhibitory activity; good selectivity against PDE3, 4, and 5; and good aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1wFrTvh9FIbVg90H21EOLACvtfcHk0liLNlIKQRKgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyksL3K&md5=ad8f5cce007ad0e86c8016d0845b13d0</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.090%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DAmano%26aufirst%3DS.%26aulast%3DAsanuma%26aufirst%3DY.%26aulast%3DSawada%26aufirst%3DK.%26aulast%3DOgura%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DUeo%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DSonoda%26aufirst%3DY.%26aulast%3DKamei%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520SAR%2520study%2520of%25202-%25284-pyridylamino%2529thieno%255B3%252C2-d%255Dpyrimidin-4%25283H%2529-ones%2520as%2520soluble%2520and%2520highly%2520potent%2520PDE7%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D649%26epage%3D653%26doi%3D10.1016%2Fj.bmcl.2014.11.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elfeky, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobahi, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gineinah, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>353</i></span>, <span class="NLM_elocation-id">1900211</span> <span class="refDoi"> DOI: 10.1002/ardp.201900211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fardp.201900211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFWitrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2020&author=S.+M.+Elfekyauthor=T.+R.+Sobahiauthor=M.+M.+Gineinahauthor=N.+S.+Ahmed&title=Synthesis%2C+biological+screening%2C+and+molecular+docking+of+quinazolinone+and+quinazolinethione+as+phosphodiesterase+7+inhibitors&doi=10.1002%2Fardp.201900211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors</span></div><div class="casAuthors">Elfeky, Sherin M.; Sobahi, Tariq R.; Gineinah, Magdy M.; Ahmed, Nesreen S.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1900211</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Substituted isatoic anhydrides were used as starting materials for the synthesis of compds. 5-16 through alkali hydrolysis, Schiff base reactions, and oxidn.  Compds. 18-23 were obtained by thionation of their oxo isosteres using Lawesson's reagent.  Cyclocondesation of anthranilic acid with thiourea afforded compds. 25-27, which were S-alkylated to afford compds. 28-30, which were thionated using Lawesson's reagent to afford 31-33.  The compds. were tested for their in vitro inhibitory activity against the phosphodiesterase 7A (PDE7A) enzyme compared with the selective PDE7 inhibitor BRL50481.  All the compds. showed the inhibitory activity on the enzyme at micromolar levels.  Compds. 9 and 25 showed the highest inhibitory activity on the enzyme: IC50 = 0.096 and 0.074μM, resp., comparable to BRL50481 (IC50 = 0.072μM).  The binding mode and binding affinity of the target compds. at the enzyme PDE7A-binding site were studied through mol. docking.  Compds. 9 and 25 showed good recognition at the enzyme-binding site and were capable of binding in an inhibitory mode similar to the ref. compd. BRL50481, forming the necessary interactions with the key amino acids.  Docking studies and enzyme assay were in agreement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorclFgoUSpQrVg90H21EOLACvtfcHk0liLNlIKQRKgbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFWitrjM&md5=25449bd4201f1792b67877280ed1dadd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fardp.201900211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201900211%26sid%3Dliteratum%253Aachs%26aulast%3DElfeky%26aufirst%3DS.%2BM.%26aulast%3DSobahi%26aufirst%3DT.%2BR.%26aulast%3DGineinah%26aufirst%3DM.%2BM.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26atitle%3DSynthesis%252C%2520biological%2520screening%252C%2520and%2520molecular%2520docking%2520of%2520quinazolinone%2520and%2520quinazolinethione%2520as%2520phosphodiesterase%25207%2520inhibitors%26jtitle%3DArch.%2520Pharm.%26date%3D2020%26volume%3D353%26doi%3D10.1002%2Fardp.201900211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servaes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyffels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedeurwaerdere, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobants, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staelens, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of two novel radioligands for PDE7 imaging in the brain</span>. <i>The 21st International Symposium on Radiopharmaceutical Sciences.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_fpage">S295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=S295&author=D.+Thomaeauthor=S.+Servaesauthor=N.+Vazquezauthor=L.+Wyffelsauthor=S.+Dedeurwaerdereauthor=P.+Van+der+Vekenauthor=J.+Joossensauthor=K.+Augustynsauthor=S.+Stroobantsauthor=S.+Staelens&title=Synthesis+and+preclinical+evaluation+of+two+novel+radioligands+for+PDE7+imaging+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DServaes%26aufirst%3DS.%26aulast%3DVazquez%26aufirst%3DN.%26aulast%3DWyffels%26aufirst%3DL.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DStroobants%26aufirst%3DS.%26aulast%3DStaelens%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520two%2520novel%2520radioligands%2520for%2520PDE7%2520imaging%2520in%2520the%2520brain%26jtitle%3DThe%252021st%2520International%2520Symposium%2520on%2520Radiopharmaceutical%2520Sciences.%26date%3D2005%26spage%3DS295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obokata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakuwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of [11C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1007/s00259-021-05269-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-021-05269-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32561969" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=1&author=N.+Obokataauthor=C.+Sekiauthor=T.+Hirataauthor=J.+Maedaauthor=H.+Ishiiauthor=Y.+Nagaiauthor=T.+Matsumuraauthor=M.+Takakuwaauthor=H.+Fukudaauthor=T.+Minamimotoauthor=K.+Kawamuraauthor=M.-R.+Zhangauthor=T.+Nakajimaauthor=T.+Saijoauthor=M.+Higuchi&title=Synthesis+and+preclinical+evaluation+of+%5B11C%5DMTP38+as+a+novel+PET+ligand+for+phosphodiesterase+7+in+the+brain&doi=10.1007%2Fs00259-021-05269-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs00259-021-05269-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-021-05269-4%26sid%3Dliteratum%253Aachs%26aulast%3DObokata%26aufirst%3DN.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DHirata%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DTakakuwa%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DMinamimoto%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DSaijo%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520%255B11C%255DMTP38%2520as%2520a%2520novel%2520PET%2520ligand%2520for%2520phosphodiesterase%25207%2520in%2520the%2520brain%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2021%26spage%3D1%26doi%3D10.1007%2Fs00259-021-05269-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takado, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichise, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span> <span> </span><span class="NLM_article-title">A first-in-human study of (11)C-MTP38, a novel PET ligand for phosphodiesterase 7</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1007/s00259-021-05235-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-021-05235-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32561969" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=1&author=M.+Kubotaauthor=C.+Sekiauthor=Y.+Kimuraauthor=K.+Takahataauthor=H.+Shimadaauthor=Y.+Takadoauthor=K.+Matsuokaauthor=K.+Tagaiauthor=Y.+Sanoauthor=Y.+Yamamotoauthor=M.+Okadaauthor=T.+Kikuchiauthor=M.+Ichiseauthor=K.+Kawamuraauthor=M.+R.+Zhangauthor=M.+Higuchi&title=A+first-in-human+study+of+%2811%29C-MTP38%2C+a+novel+PET+ligand+for+phosphodiesterase+7&doi=10.1007%2Fs00259-021-05235-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2Fs00259-021-05235-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-021-05235-0%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DTakahata%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DTakado%26aufirst%3DY.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DTagai%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DIchise%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DA%2520first-in-human%2520study%2520of%2520%252811%2529C-MTP38%252C%2520a%2520novel%2520PET%2520ligand%2520for%2520phosphodiesterase%25207%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2021%26spage%3D1%26doi%3D10.1007%2Fs00259-021-05235-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, P. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E. P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2018.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neubiorev.2018.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29454746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Wktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=233-254&author=P.+R.+A.+Heckmanauthor=A.+Bloklandauthor=E.+P.+P.+Bollenauthor=J.+Prickaerts&title=Phosphodiesterase+inhibition+and+modulation+of+corticostriatal+and+hippocampal+circuits%3A+Clinical+overview+and+translational+considerations&doi=10.1016%2Fj.neubiorev.2018.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations</span></div><div class="casAuthors">Heckman, P. R. A.; Blokland, A.; Bollen, E. P. P.; Prickaerts, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-254</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The corticostriatal and hippocampal circuits contribute to the neurobiol. underpinnings of several neuropsychiatric disorders, including Alzheimer's disease, Parkinson's disease and schizophrenia.  Based on biol. function, these circuits can be clustered into motor circuits, associative/cognitive circuits and limbic circuits.  Together, dysfunctions in these circuits produce the wide range of symptoms obsd. in related neuropsychiatric disorders.  Intracellular signaling in these circuits is largely mediated through the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway with an addnl. role for the cyclic guanosine monophosphate (cGMP)/ protein kinase G (PKG) pathway, both of which can be regulated by phosphodiesterase inhibitors (PDE inhibitors).  Through their effects on cAMP response element-binding protein (CREB) and Dopamine- and cAMP-Regulated PhosphoProtein MR 32kDa (DARPP-32), cyclic nucleotide pathways are involved in synaptic transmission, neuron excitability, neuroplasticity and neuroprotection.  In this clin. review, we provide an overview of the current clin. status, discuss the general mechanism of action of PDE inhibitors in relation to the corticostriatal and hippocampal circuits and consider several translational challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8E39qiE5ybVg90H21EOLACvtfcHk0lg1OiUfGGeUNQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Wktbw%253D&md5=22af530e8aaab77dd07baece8cb68bf6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2018.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DP.%2BR.%2BA.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DE.%2BP.%2BP.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520inhibition%2520and%2520modulation%2520of%2520corticostriatal%2520and%2520hippocampal%2520circuits%253A%2520Clinical%2520overview%2520and%2520translational%2520considerations%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D87%26spage%3D233%26epage%3D254%26doi%3D10.1016%2Fj.neubiorev.2018.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C. A.</span>; <span class="NLM_string-name">Nunes, A. K. S.</span>; <span class="NLM_string-name">Rapôso, C.</span></span> <span> </span><span class="NLM_article-title">The role of NO/cGMP signaling on neuroinflammation: A new therapeutic opportunity</span>. In  <i>Mechanisms of Neuroinflammation</i>, <span class="NLM_year">2017</span>, <span class="NLM_publisher-loc">United Kingdom</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.5772%2Fintechopen.68990" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+A.+Peixoto&author=A.+K.+S.+Nunes&author=C.+Rap%C3%B4so&title=Mechanisms+of+Neuroinflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.5772%2Fintechopen.68990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252Fintechopen.68990%26sid%3Dliteratum%253Aachs%26aulast%3DPeixoto%26aufirst%3DC.%2BA.%26atitle%3DThe%2520role%2520of%2520NO%252FcGMP%2520signaling%2520on%2520neuroinflammation%253A%2520A%2520new%2520therapeutic%2520opportunity%26btitle%3DMechanisms%2520of%2520Neuroinflammation%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, T. F.</span></span> <span> </span><span class="NLM_article-title">Expression, distribution and regulation of phosphodiesterase 5</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3439</span>– <span class="NLM_lpage">3457</span>, <span class="refDoi"> DOI: 10.2174/138161206778343064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2174%2F138161206778343064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=17017938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3439-3457&author=C.+S.+Linauthor=G.+Linauthor=Z.+C.+Xinauthor=T.+F.+Lue&title=Expression%2C+distribution+and+regulation+of+phosphodiesterase+5&doi=10.2174%2F138161206778343064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, distribution and regulation of phosphodiesterase 5</span></div><div class="casAuthors">Lin, Ching-Shwun; Lin, Guiting; Xin, Zhong-Cheng; Lue, Tom F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3439-3457</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 5 (PDE5) is 1 of 11 members of the mammalian phosphodiesterase family that hydrolyzes cGMP and cAMP.  Best known as the target of the impotence drug, sildenafil, PDE5 degrades cGMP in smooth muscle cells so as to maintain the contracted state of contractile organs such as the penis, blood vessels, uterus, and intestines.  In addn., it regulates numerous other physiol. processes such as neurogenesis and apoptosis.  Like all other PDEs, PDE5 is dimeric; each subunit is ∼100 kDa in size and has 2 allosteric cGMP-binding sites and a catalytic domain.  Protein kinase G (PKG)-mediated phosphorylation and allosteric cGMP binding up-regulate PDE5 activity, whereas PP1 phosphatase-mediated dephosphorylation down-regulates.  Sildenafil and other selective inhibitors inhibit PDE5 by binding to the catalytic site.  From 2 promoters a single PDE5A gene at human chromosome 4q26 encodes 3 alternatively spliced isoforms (PDE5A1-3) that differ in the N-terminus.  The PDE5A promoter is located upstream of the 3 isoform-specific 1st exons (in the order of A1-A3-A2) and consists of a 139-bp core, a 308-bp upstream enhancer, and a 156-bp downstream enhancer.  The weaker 182-bp PDE5A2 promoter is located between the A3- and A2-specific exons and contains an indispensable Sp1-binding sequence.  Both promoters are responsive to cGMP or cAMP stimulation, and several studies have demonstrated regulation of PDE5 expression possibly through these promoters.  Virtually all tissues and cell types express PDE5, with heart and cardiomyocytes being contentious.  PDE5A1 and PDE5A2 are ubiquitous, but PDE5A3 is specific to smooth muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp50kF64plnCbVg90H21EOLACvtfcHk0lggJTLp2dFbnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7%252FJ&md5=4e50e20562709050deb7cff9a38c73e5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2174%2F138161206778343064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778343064%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BS.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DZ.%2BC.%26aulast%3DLue%26aufirst%3DT.%2BF.%26atitle%3DExpression%252C%2520distribution%2520and%2520regulation%2520of%2520phosphodiesterase%25205%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3439%26epage%3D3457%26doi%3D10.2174%2F138161206778343064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giovannoni, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Piaz, V.</span></span> <span> </span><span class="NLM_article-title">PDE5 inhibitors and their applications</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2587</span>, <span class="refDoi"> DOI: 10.2174/092986710791859360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2174%2F092986710791859360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20491634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2564-2587&author=M.+P.+Giovannoniauthor=C.+Vergelliauthor=A.+Grazianoauthor=V.+Dal+Piaz&title=PDE5+inhibitors+and+their+applications&doi=10.2174%2F092986710791859360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">PDE5 inhibitors and their applications</span></div><div class="casAuthors">Giovannoni, M. P.; Vergelli, C.; Graziano, A.; Dal Piaz, V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2564-2587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  PDE5 belongs to a superfamily of enzymes that catalyzes the hydrolysis of cyclic nucleotides cAMP and cGMP to the corresponding 5-nucleoside monophosphate.  PDE5 takes part in many physiol. and pathol. functions, therefore selective PDE5 inhibitors are potentially useful for a variety of pathologies.  At the present, PDE5 inhibitors available on the market have been used for the treatment of erectile dysfunction but, at the same time, are in clin. trials investigating other pathologies such as pulmonary arterial hypertension, coronary vasospasm, benign prostatic hyperplasia etc.  This review analyzes the PDE5 inhibitors currently in clin. use, the drugs in clin. trials and the most representative chem. classes published in literature in this last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvcIgBfP9AWbVg90H21EOLACvtfcHk0lggJTLp2dFbnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nJ&md5=d80cc3a18546e004b08ad22245849ce3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.2174%2F092986710791859360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859360%26sid%3Dliteratum%253Aachs%26aulast%3DGiovannoni%26aufirst%3DM.%2BP.%26aulast%3DVergelli%26aufirst%3DC.%26aulast%3DGraziano%26aufirst%3DA.%26aulast%3DDal%2BPiaz%26aufirst%3DV.%26atitle%3DPDE5%2520inhibitors%2520and%2520their%2520applications%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2564%26epage%3D2587%26doi%3D10.2174%2F092986710791859360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marban, E.</span></span> <span> </span><span class="NLM_article-title">The role of mitochondrial K<sub>ATP</sub> channels in cardioprotection</span>. <i>Basic Res. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1007/s003950070047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs003950070047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11005583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFSkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2000&pages=285-289&author=T.+Satoauthor=E.+Marban&title=The+role+of+mitochondrial+KATP+channels+in+cardioprotection&doi=10.1007%2Fs003950070047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitochondrial KATP channels in cardioprotection</span></div><div class="casAuthors">Sato, Toshiaki; Marban, Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-289</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Dr. Dietrich Steinkopff Verlag GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review with 51 refs.  Topics discussed include the pharmacol. of mitochondrial KATP channels, the connection between cardioprotection and mitochondrial KATP channels, the link between signaling in ischemic preconditioning (IPC) and the mitochondrial KATP channel, and the mechanism of cardioprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuM0_I595rXrVg90H21EOLACvtfcHk0lggJTLp2dFbnQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFSkt7s%253D&md5=e8682716af73393f0fe9faaac6754238</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2Fs003950070047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs003950070047%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26aulast%3DMarban%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520mitochondrial%2520KATP%2520channels%2520in%2520cardioprotection%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2000%26volume%3D95%26spage%3D285%26epage%3D289%26doi%3D10.1007%2Fs003950070047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">940207</span>, <span class="refDoi"> DOI: 10.1155/2015/940207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1155%2F2015%2F940207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26770022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC28ngslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=940207&author=C.+A.+Peixotoauthor=A.+K.+Nunesauthor=A.+Garcia-Osta&title=Phosphodiesterase-5+inhibitors%3A+action+on+the+signaling+pathways+of+neuroinflammation%2C+neurodegeneration%2C+and+cognition&doi=10.1155%2F2015%2F940207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition</span></div><div class="casAuthors">Peixoto Christina Alves; Nunes Ana Karolina Santana; Garcia-Osta Ana</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2015</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">940207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphodiesterase type 5 inhibitors (PDE5-Is) have recently emerged as a potential therapeutic strategy for neuroinflammatory, neurodegenerative, and memory loss diseases.  Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effect by increasing expression of nitric oxide synthases and accumulation of cGMP and activating protein kinase G (PKG), the signaling pathway of which is thought to play an important role in the development of several neurodiseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS).  The aim of this paper was to review present knowledge of the signaling pathways that underlie the use of PDE5-Is in neuroinflammation, neurogenesis, learning, and memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyhEh7K_YIpSCEBeYuoi7AfW6udTcc2ebOdYX4pxLis7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28ngslCjtw%253D%253D&md5=7117c842c4d9c185516fefbb66f09185</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1155%2F2015%2F940207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F940207%26sid%3Dliteratum%253Aachs%26aulast%3DPeixoto%26aufirst%3DC.%2BA.%26aulast%3DNunes%26aufirst%3DA.%2BK.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DPhosphodiesterase-5%2520inhibitors%253A%2520action%2520on%2520the%2520signaling%2520pathways%2520of%2520neuroinflammation%252C%2520neurodegeneration%252C%2520and%2520cognition%26jtitle%3DMediators%2520Inflammation%26date%3D2015%26volume%3D2015%26spage%3D940207%26doi%3D10.1155%2F2015%2F940207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodahl, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, radiolabeling and in vivo evaluation of [<sup>11</sup>C]RAL-01, a potential phosphodiesterase 5 radioligand</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2006.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16843833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=593-597&author=S.+Jakobsenauthor=G.+M.+Kodahlauthor=A.+K.+Olsenauthor=P.+Cumming&title=Synthesis%2C+radiolabeling+and+in+vivo+evaluation+of+%5B11C%5DRAL-01%2C+a+potential+phosphodiesterase+5+radioligand&doi=10.1016%2Fj.nucmedbio.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand</span></div><div class="casAuthors">Jakobsen, Steen; Kodahl, Gitte Munkebo; Olsen, Aage Kristian; Cumming, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-597</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Very few tracers are available for imaging studies of second messenger systems.  We developed a radiosynthesis for the phosphodiesterase (PDE) 5 inhibitor [11C]RAL-01.  Whole body distribution studies using positron emission tomog. (PET) revealed a time-dependant passage through the liver and accumulation of radioactivity in the bile of the Landrace pig.  Displaceable binding was readily discerned in the myocardium, and traces of binding were seen in pulmonary tissue, consistent with the use of this class of drug in the treatment of pulmonary hypertension and heart failure.  [11C]RAL-01 readily entered the brain and obtained an equil. distribution vol. of 4-5 mL g-1.  Mean parametric images suggested the presence of a small displaceable binding component, but this binding was not significant in the present group of three pigs.  Thus, [11C]RAL-01 shows considerable promise for PET studies of biliary elimination and of PDE5 binding in the cardiovascular system.  However, analogs of higher affinity may be required for investigations of central nervous system binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPKVRbPHi74bVg90H21EOLACvtfcHk0lgQpMH_1LNIsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWrtrw%253D&md5=f5c53dad2b47d7c536e8b2809791fb2b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DKodahl%26aufirst%3DG.%2BM.%26aulast%3DOlsen%26aufirst%3DA.%2BK.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520radiolabeling%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255DRAL-01%252C%2520a%2520potential%2520phosphodiesterase%25205%2520radioligand%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D593%26epage%3D597%26doi%3D10.1016%2Fj.nucmedbio.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chekol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheysens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleynhens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokreisz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoof, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of PET radioligands for in vivo visualization of phosphodiesterase 5 (PDE5)</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2013.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2013.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24290227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKitrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=155-162&author=R.+Chekolauthor=O.+Gheysensauthor=J.+Cleynhensauthor=P.+Pokreiszauthor=G.+Vanhoofauthor=M.+Ahamedauthor=S.+Janssensauthor=A.+Verbruggenauthor=G.+Bormans&title=Evaluation+of+PET+radioligands+for+in+vivo+visualization+of+phosphodiesterase+5+%28PDE5%29&doi=10.1016%2Fj.nucmedbio.2013.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of PET radioligands for in vivo visualization of phosphodiesterase 5 (PDE5)</span></div><div class="casAuthors">Chekol, Rufael; Gheysens, Olivier; Cleynhens, Jan; Pokreisz, Peter; Vanhoof, Greet; Ahamed, Muneer; Janssens, Stefan; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-162</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) is considered to play an important role in various etiologies such as pulmonary arterial hypertension (PAH) and chronic heart failure.  This PDE5 modulation represents an important prognostic and/or therapeutic target; however, there is currently no method to non-invasively evaluate the PDE5 expression levels in vivo.  Radiolabeled tracers were prepd. by N-alkylation of the corresponding precursors with [11C]methyl trifluoromethanesulfonate ([11C]CH3OTf) or 2-[18 F]fluoroethyl trifluoromethanesulfonate ([18 F]FEtOTf).  Biodistribution of radiolabeled tracers was studied in NMRI mice and their specific binding to PDE5 was investigated by comparing their lung retention as the enzyme is abundantly expressed in this organ.The overall radiochem. yields ranged between 24% and 60% for labeled radiotracers with radiochem. purity of > 99%.  The highest retention in the lungs at 30 min post injection was obsd. for vardenafil derivs. [11C]-7 and [18 F]-11 and the retention of the ethoxyethyl pyrazolopyrimidine deriv. [11C]-37 was moderate.  The other investigated compds. [11C]-8, [11C]-14, [11C]-21 and [11C]-33 showed lower retention in lungs in agreement with their lower in-vitro affinity for PDE5.Among the different radiolabeled PDE5 inhibitors evaluated in this study, the vardenafil derivs. [11C]-7 and [18 F]-11 are found to be promising tracers for in vivo visualization of PDE5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkmHPuwoB1bVg90H21EOLACvtfcHk0lgQpMH_1LNIsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKitrjE&md5=1bffbf456898cd836b28e8d506e7f44c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2013.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2013.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DChekol%26aufirst%3DR.%26aulast%3DGheysens%26aufirst%3DO.%26aulast%3DCleynhens%26aufirst%3DJ.%26aulast%3DPokreisz%26aufirst%3DP.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DAhamed%26aufirst%3DM.%26aulast%3DJanssens%26aufirst%3DS.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520PET%2520radioligands%2520for%2520in%2520vivo%2520visualization%2520of%2520phosphodiesterase%25205%2520%2528PDE5%2529%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D155%26epage%3D162%26doi%3D10.1016%2Fj.nucmedbio.2013.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Vallejo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczupak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dopeso-Reyes, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanciego, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1111/jnc.13454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fjnc.13454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26641206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2016&pages=403-415&author=V.+Gomez-Vallejoauthor=A.+Ugarteauthor=C.+Garcia-Barrosoauthor=M.+Cuadrado-Tejedorauthor=B.+Szczupakauthor=I.+G.+Dopeso-Reyesauthor=J.+L.+Lanciegoauthor=A.+Garcia-Ostaauthor=J.+Llopauthor=J.+Oyarzabalauthor=R.+Franco&title=Pharmacokinetic+investigation+of+sildenafil+using+positron+emission+tomography+and+determination+of+its+effect+on+cerebrospinal+fluid+cGMP+levels&doi=10.1111%2Fjnc.13454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels</span></div><div class="casAuthors">Gomez-Vallejo, Vanessa; Ugarte, Ana; Garcia-Barroso, Carolina; Cuadrado-Tejedor, Mar; Szczupak, Boguslaw; Dopeso-Reyes, Iria G.; Lanciego, Jose L.; Garcia-Osta, Ana; Llop, Jordi; Oyarzabal, Julen; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-415</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Sildenafil (Viagra) is a selective inhibitor of phosphodiesterase type 5 (PDE5), which degrades cGMP to the linear nucleotide.  Sildenafil is acutely used in erectile dysfunction and chronically in pulmonary hypertension.  Evidence in the last decade shows that sildenafil may have potential as a therapeutic option for Alzheimer's disease or other neurodegenerative disorders.  The purpose of this work was to explore whether sildenafil crosses the blood-brain barrier.  Pharmacokinetic properties of sildenafil in rodents were investigated using 11C-radiolabeling followed by in vivo positron emission tomog. (PET) and ex vivo tissue dissection and gamma counting.  PET results in rats suggest penetration into the central nervous system.  Ex vivo data in perfused animals suggest that trapping of [11C]sildenafil within the cerebral vascular endothelium limits accumulation in the central nervous system parenchyma.  Peroral sildenafil administration to Macaca fascicularis and subsequent chem. anal. of plasma and cerebrospinal fluid (CSF) using liq. chromatog. coupled with tandem mass spectrometry showed that drug content in the CSF was high enough to achieve PDE5 inhibition, which was also demonstrated by the significant increases in CSF cGMP levels.  Central actions of sildenafil include both relaxation of the cerebral vasculature and inhibition of PDE5 in neurons and glia.  This central action of sildenafil may underlie its efficacy in neuroprotection models, and may justify the continued search for a PDE5 ligand suitable for PET imaging.  Sildenafil interacts with phosphodiesterase type 5 (PDE5) expressed in the endothelium and/or smooth muscle cells of brain vessels and also crosses the blood-brain barrier to interact with PDE5 expressed in brain cells.  At therapeutic doses, the concn. of sildenafil in the cerebrospinal fluid (CSF) is high enough to inhibit PDE5 in the neural cells (neurons and glia).  In turn, the concn. of cGMP likely increases in parenchymal cells and, as shown in the CSF.  Read the Editorial Highlight for this article on page 220.  Cover Image for this issue: doi: 10.1111/jnc.13302.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrNfPXruaaALVg90H21EOLACvtfcHk0liseFezHFy75g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVKitw%253D%253D&md5=6de24b35db0c575431eabc500fc87fbd</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13454%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Vallejo%26aufirst%3DV.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DSzczupak%26aufirst%3DB.%26aulast%3DDopeso-Reyes%26aufirst%3DI.%2BG.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DLlop%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPharmacokinetic%2520investigation%2520of%2520sildenafil%2520using%2520positron%2520emission%2520tomography%2520and%2520determination%2520of%2520its%2520effect%2520on%2520cerebrospinal%2520fluid%2520cGMP%2520levels%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D136%26spage%3D403%26epage%3D415%26doi%3D10.1111%2Fjnc.13454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chekol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheysens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleynhens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokreisz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoof, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Carbon-11 and fluorine-18 radiolabeled pyridopyrazinone derivatives for positron emission tomography (PET) imaging of phosphodiesterase-5 (PDE5)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01666</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01666" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWms7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=486-496&author=R.+Chekolauthor=O.+Gheysensauthor=M.+Ahamedauthor=J.+Cleynhensauthor=P.+Pokreiszauthor=G.+Vanhoofauthor=S.+Janssensauthor=A.+Verbruggenauthor=G.+Bormans&title=Carbon-11+and+fluorine-18+radiolabeled+pyridopyrazinone+derivatives+for+positron+emission+tomography+%28PET%29+imaging+of+phosphodiesterase-5+%28PDE5%29&doi=10.1021%2Facs.jmedchem.6b01666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-11 and Fluorine-18 Radiolabeled Pyridopyrazinone Derivatives for Positron Emission Tomography (PET) Imaging of Phosphodiesterase-5 (PDE5)</span></div><div class="casAuthors">Chekol, Rufael; Gheysens, Olivier; Ahamed, Muneer; Cleynhens, Jan; Pokreisz, Peter; Vanhoof, Greet; Janssens, Stefan; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) plays an important role in various pathologies including pulmonary arterial hypertension and cardiomyopathy.  PDE5 represents an important therapeutic and/or prognostic target, but noninvasive assessment of PDE5 expression is lacking.  The purpose of this study was to develop and evaluate pyridopyrazinone derivs. labeled with carbon-11 or fluorine-18 as PDE5-specific PET tracers.  In biodistribution studies, highest PDE5-specific retention was obsd. for [11C]-12 and [18F]-17 in the lungs of wild-type mice and in the myocardium of transgenic mice with cardiomyocyte-specific PDE5 overexpression at 30 min postinjection.  In vivo dynamic microPET images in rats revealed that both tracers crossed the blood-brain barrier but brain retention was not PDE5-specific.  Both [11C]-12 and [18F]-17 showed specific binding to PDE5 in myocardium of transgenic mice; however [18F]-17 showed significantly higher PDE5-specific inhibitable binding than [11C]-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqztFgTc-Z9TrVg90H21EOLACvtfcHk0liseFezHFy75g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWms7zO&md5=048a160400b14b316eaf1b4af802044c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01666%26sid%3Dliteratum%253Aachs%26aulast%3DChekol%26aufirst%3DR.%26aulast%3DGheysens%26aufirst%3DO.%26aulast%3DAhamed%26aufirst%3DM.%26aulast%3DCleynhens%26aufirst%3DJ.%26aulast%3DPokreisz%26aufirst%3DP.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DJanssens%26aufirst%3DS.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DCarbon-11%2520and%2520fluorine-18%2520radiolabeled%2520pyridopyrazinone%2520derivatives%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520phosphodiesterase-5%2520%2528PDE5%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D486%26epage%3D496%26doi%3D10.1021%2Facs.jmedchem.6b01666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chezal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial-Besset, A.</span></span> <span> </span><span class="NLM_article-title">Development of a new radiofluorinated quinoline analog for PET imaging of phosphodiesterase 5 (PDE5) in brain</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.3390/ph9020022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fph9020022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVKqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=22&author=J.+Liuauthor=B.+Wenzelauthor=S.+Dukic-Stefanovicauthor=R.+Teodoroauthor=F.+A.+Ludwigauthor=W.+Deuther-Conradauthor=S.+Schroderauthor=J.+M.+Chezalauthor=E.+Moreauauthor=P.+Brustauthor=A.+Maisonial-Besset&title=Development+of+a+new+radiofluorinated+quinoline+analog+for+PET+imaging+of+phosphodiesterase+5+%28PDE5%29+in+brain&doi=10.3390%2Fph9020022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new radiofluorinated quinoline analog for PET imaging of phosphodiesterase 5 (PDE5) in brain</span></div><div class="casAuthors">Liu, Jianrong; Wenzel, Barbara; Dukic-Stefanovic, Sladjana; Teodoro, Rodrigo; Ludwig, Friedrich-Alexander; Deuther-Conrad, Winnie; Schroeder, Susann; Chezal, Jean-Michel; Moreau, Emmanuel; Brust, Peter; Maisonial-Besset, Aurelie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">22/1-22/15</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are enzymes that play a major role in cell signalling by hydrolyzing the secondary messengers cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP) throughout the body and brain.  Altered cyclic nucleotide-mediated signalling has been assocd. with a wide array of disorders, including neurodegenerative disorders.  Recently, PDE5 has been shown to be involved in neurodegenerative disorders such as Alzheimer's disease, but its precise role has not been elucidated yet.  To visualize and quantify the expression of this enzyme in brain, we developed a radiotracer for specific PET imaging of PDE5.  A quinoline-based lead compd. has been structurally modified resulting in the fluoroethoxymethyl deriv. ICF24027 with high inhibitory activity towards PDE5 (IC50 = 1.86 nM).  Radiolabelling with fluorine-18 was performed by a one-step nucleophilic substitution reaction using a tosylate precursor (RCY(EOB) = 12.9% ± 1.8%; RCP > 99%; SA(EOS) = 70-126 GBq/μmol).  In vitro autoradiog. studies of [18F]ICF24027 on different mouse tissue as well as on porcine brain slices demonstrated a moderate specific binding to PDE5.  In vivo studies in mice revealed that [18F]ICF24027 was metabolized under formation of brain penetrable radiometabolites making the radiotracer unsuitable for PET imaging of PDE5 in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooSgVz7_FolrVg90H21EOLACvtfcHk0liseFezHFy75g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVKqur8%253D&md5=2f1068c745deb16ee1326eaf65f3beb0</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3390%2Fph9020022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9020022%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DLudwig%26aufirst%3DF.%2BA.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DChezal%26aufirst%3DJ.%2BM.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DMaisonial-Besset%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520a%2520new%2520radiofluorinated%2520quinoline%2520analog%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520in%2520brain%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D22%26doi%3D10.3390%2Fph9020022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer’s disease</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">108873</span>, <span class="refDoi"> DOI: 10.1016/j.apradiso.2019.108873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.apradiso.2019.108873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31470193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1GktL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2019&pages=108873&author=F.+Dongauthor=J.+Duauthor=C.+Miaoauthor=L.+Jiaauthor=W.+Liauthor=M.+Wangauthor=Q.+H.+Zhengauthor=Z.+Xu&title=Radiosynthesis+of+carbon-11+labeled+PDE5+inhibitors+as+new+potential+PET+radiotracers+for+imaging+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.apradiso.2019.108873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease</span></div><div class="casAuthors">Dong, Fugui; Du, Jie; Miao, Caihong; Jia, Limeng; Li, Wei; Wang, Min; Zheng, Qi-Huang; Xu, Zhidong</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108873</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To develop PET tracers for imaging of Alzheimer's disease, new carbon-11 labeled potent and selective PDE5 inhibitors have been synthesized.  The ref. stds. (5) and (12), and their corresponding desmethylated precursors (6) and (13) were synthesized from Me 2-amino-5-bromobenzoate and (4-methoxyphenyl)methanamine in multiple steps with 2%, 1%, 1% and 0.2% overall chem. yield, resp.  The radiotracers ([11C]5) and ([11C]12) were prepd. from their corresponding precursors 6 and 13 with [11C]CH3OTf through O-11C-methylation and isolated by HPLC combined with SPE in 40-50% radiochem. yield, based on [11C]CO2 and decay cor. to EOB.  The radiochem. purity was >99%, and the molar activity (Am) at EOB was in a range of 370-740 GBq/μmol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLcZ9vyLEuLVg90H21EOLACvtfcHk0ljC64s9ryKOsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1GktL7M&md5=c30f25f6570a5233a5343c4efb19c163</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2019.108873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2019.108873%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DF.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DRadiosynthesis%2520of%2520carbon-11%2520labeled%2520PDE5%2520inhibitors%2520as%2520new%2520potential%2520PET%2520radiotracers%2520for%2520imaging%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2019%26volume%3D154%26spage%3D108873%26doi%3D10.1016%2Fj.apradiso.2019.108873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial-Besset, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canitrot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baufond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chezal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejmech.2017.03.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28544981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlWmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=548-560&author=J.+Liuauthor=A.+Maisonial-Bessetauthor=B.+Wenzelauthor=D.+Canitrotauthor=A.+Baufondauthor=J.+M.+Chezalauthor=P.+Brustauthor=E.+Moreau&title=Synthesis+and+in+vitro+evaluation+of+new+fluorinated+quinoline+derivatives+with+high+affinity+for+PDE5%3A+Towards+the+development+of+new+PET+neuroimaging+probes&doi=10.1016%2Fj.ejmech.2017.03.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes</span></div><div class="casAuthors">Liu, Jianrong; Maisonial-Besset, Aurelie; Wenzel, Barbara; Canitrot, Damien; Baufond, Ariane; Chezal, Jean-Michel; Brust, Peter; Moreau, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">548-560</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new radiofluorinated quinoline derivs. I [R1 = Et, cyclopropyl; R2 = cyano, trifluoromethyl; R3 = fluoromethyl, hydroxy, 2-fluoroethoxy] for the visualization of PDE5 in brain using PET imaging was synthesized.  Based on currently known PDE5 inhibitors, a series of fluorinated compds. I bearing a quinoline core were synthesized via multi-steps reaction pathways.  Their affinity for PDE5 and selectivity over other PDE families were investigated.  According to the data collected from the in vitro screening, compd. I [R1 = ethyl/cyclopropyl, R2 = cyano, R3 = 2-fluoroethoxy] bearing a fluoroethoxy group at the C-3 position of the quinoline core appeared to be the most promising structures and was further radiolabeled with fluorine-18 for in vitro and in vivo evaluations as PET radiotracer for neuroimaging of PDE5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBnUYEYe1P7Vg90H21EOLACvtfcHk0ljC64s9ryKOsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlWmuro%253D&md5=75ada3588ebf3ce711bcdcd850df6ffd</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.091%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMaisonial-Besset%26aufirst%3DA.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DCanitrot%26aufirst%3DD.%26aulast%3DBaufond%26aufirst%3DA.%26aulast%3DChezal%26aufirst%3DJ.%2BM.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DMoreau%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520new%2520fluorinated%2520quinoline%2520derivatives%2520with%2520high%2520affinity%2520for%2520PDE5%253A%2520Towards%2520the%2520development%2520of%2520new%2520PET%2520neuroimaging%2520probes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D548%26epage%3D560%26doi%3D10.1016%2Fj.ejmech.2017.03.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chezal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial-Besset, A.</span></span> <span> </span><span class="NLM_article-title">Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.01.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bioorg.2019.01.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30753989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2019&pages=346-362&author=B.+Wenzelauthor=J.+Liuauthor=S.+Dukic-Stefanovicauthor=W.+Deuther-Conradauthor=R.+Teodoroauthor=F.+A.+Ludwigauthor=J.+M.+Chezalauthor=E.+Moreauauthor=P.+Brustauthor=A.+Maisonial-Besset&title=Targeting+cyclic+nucleotide+phosphodiesterase+5+%28PDE5%29+in+brain%3A+Toward+the+development+of+a+PET+radioligand+labeled+with+fluorine-18&doi=10.1016%2Fj.bioorg.2019.01.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18</span></div><div class="casAuthors">Wenzel, Barbara; Liu, Jianrong; Dukic-Stefanovic, Sladjana; Deuther-Conrad, Winnie; Teodoro, Rodrigo; Ludwig, Friedrich-Alexander; Chezal, Jean-Michel; Moreau, Emmanuel; Brust, Peter; Maisonial-Besset, Aurelie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">346-362</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the aim to develop a specific radioligand for imaging the cyclic nucleotide phosphodiesterase 5 (PDE5) in brain by positron emission tomog. (PET), seven new fluorinated inhibitors (3-9) were synthesized on the basis of a quinoline core.  The inhibitory activity for PDE5 together with a panel of other PDEs was detd. in vitro and two derivs. were selected for IC50 value detn.  The most promising compd. 7 (IC50 = 5.92 nM for PDE5A), contg. a 3-fluoroazetidine moiety, was further radiolabeled by aliph. nucleophilic substitution of two different leaving groups (nosylate and tosylate) using [18F]fluoride.  The use of the nosylate precursor and tetra-Bu ammonium [18F]fluoride ([18F]TBAF) in 3-methyl-3-pentanol combined with the addn. of a small amt. of water proved to be the best radiolabeling conditions achieving a RCY of 4.9 ± 1.5% in an automated procedure.  Preliminary biol. investigations in vitro and in vivo were performed to characterize this new PDE5 radioligand.  Metab. studies of [18F]7 in mice revealed a fast metabolic degrdn. with the formation of radiometabolites which have been detected in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-88BZ5aZD3rVg90H21EOLACvtfcHk0ljC64s9ryKOsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVansL4%253D&md5=4fd10c022a6303d6d782177d6b802b8d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DLudwig%26aufirst%3DF.%2BA.%26aulast%3DChezal%26aufirst%3DJ.%2BM.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DMaisonial-Besset%26aufirst%3DA.%26atitle%3DTargeting%2520cyclic%2520nucleotide%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520in%2520brain%253A%2520Toward%2520the%2520development%2520of%2520a%2520PET%2520radioligand%2520labeled%2520with%2520fluorine-18%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D86%26spage%3D346%26epage%3D362%26doi%3D10.1016%2Fj.bioorg.2019.01.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, P.</span></span> <span> </span><span class="NLM_article-title">A business of some heat: molecular imaging of phosphodiesterase 5</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1111/jnc.13453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fjnc.13453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26990291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2016&pages=220-221&author=P.+Cumming&title=A+business+of+some+heat%3A+molecular+imaging+of+phosphodiesterase+5&doi=10.1111%2Fjnc.13453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">A business of some heat: molecular imaging of phosphodiesterase 5</span></div><div class="casAuthors">Cumming, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-221</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcGW-tgajlyLVg90H21EOLACvtfcHk0lh7jrnMjfj_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVKitg%253D%253D&md5=0273552b82c661a77a79d652fb93ff1a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13453%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DA%2520business%2520of%2520some%2520heat%253A%2520molecular%2520imaging%2520of%2520phosphodiesterase%25205%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D136%26spage%3D220%26epage%3D221%26doi%3D10.1111%2Fjnc.13453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. H.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [<sup>11</sup>C]TPN171 as a new potential PET heart imaging agent</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">109190</span>, <span class="refDoi"> DOI: 10.1016/j.apradiso.2020.109190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.apradiso.2020.109190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32501230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXos1Slt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2020&pages=109190&author=Z.+Xuauthor=L.+Jiaauthor=W.+Liuauthor=W.+Liauthor=Y.+Songauthor=Q.+H.+Zheng&title=Radiosynthesis+of+a+carbon-11+labeled+PDE5+inhibitor+%5B11C%5DTPN171+as+a+new+potential+PET+heart+imaging+agent&doi=10.1016%2Fj.apradiso.2020.109190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [11C]TPN171 as a new potential PET heart imaging agent</span></div><div class="casAuthors">Xu, Zhidong; Jia, Limeng; Liu, Wenqing; Li, Wei; Song, Ying; Zheng, Qi-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109190</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To develop PET tracers for imaging of heart disease, a new carbon-11 labeled potent and selective PDE5 inhibitor [11C]TPN171 ([11C]9) has been synthesized.  The ref. std. TPN171 (9) and its corresponding precursor desmethyl-TPN171 (11) were synthesized from Me 3-oxovalerate and 2-hydroxybenzonitrile in 9 and 10 steps with 31% and 25% overall chem. yield, resp.  The radiotracer [11C]TPN171 was prepd. from desmethyl-TPN171 with [11C]CH3OTf through N-11C-methylation and isolated by HPLC purifn. followed by SPE formulation in 45-55% radiochem. yield, based on [11C]CO2 and decay cor. to EOB.  The radiochem. purity was >99%, and the molar activity (Am) at EOB was in a range of 370-740 GBq/μmol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxER-ICt_sd7Vg90H21EOLACvtfcHk0lh7jrnMjfj_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXos1Slt7k%253D&md5=cf4eb7007dbff64286684876edbfb047</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2020.109190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2020.109190%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26atitle%3DRadiosynthesis%2520of%2520a%2520carbon-11%2520labeled%2520PDE5%2520inhibitor%2520%255B11C%255DTPN171%2520as%2520a%2520new%2520potential%2520PET%2520heart%2520imaging%2520agent%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2020%26volume%3D162%26spage%3D109190%26doi%3D10.1016%2Fj.apradiso.2020.109190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cote, R. H.</span></span> <span> </span><span class="NLM_article-title">Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">S28</span>– <span class="NLM_lpage">S33</span>, <span class="refDoi"> DOI: 10.1038/sj.ijir.3901212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fsj.ijir.3901212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15224133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=S28-S33&author=R.+H.+Cote&title=Characteristics+of+photoreceptor+PDE+%28PDE6%29%3A+similarities+and+differences+to+PDE5&doi=10.1038%2Fsj.ijir.3901212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5</span></div><div class="casAuthors">Cote, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S28-S33</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 6 (PDE6) is highly concd. in the retina.  It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cGMP in rod and cone outer segments in response to light.  The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits.  Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding).  The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cAMP (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains.  Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrGvfie0U1bVg90H21EOLACvtfcHk0lh7jrnMjfj_7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D&md5=7700b18905668782047be0bbdd461726</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901212%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DCharacteristics%2520of%2520photoreceptor%2520PDE%2520%2528PDE6%2529%253A%2520similarities%2520and%2520differences%2520to%2520PDE5%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2004%26volume%3D16%26spage%3DS28%26epage%3DS33%26doi%3D10.1038%2Fsj.ijir.3901212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tolone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belhadj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rentsch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers</span>. <i>Genes</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">453</span>, <span class="refDoi"> DOI: 10.3390/genes10060453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fgenes10060453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ehsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=453&author=A.+Toloneauthor=S.+Belhadjauthor=A.+Rentschauthor=F.+Schwedeauthor=F.+Paquet-Durand&title=The+cGMP+pathway+and+inherited+photoreceptor+degeneration%3A+targets%2C+compounds%2C+and+biomarkers&doi=10.3390%2Fgenes10060453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers</span></div><div class="casAuthors">Tolone, Arianna; Belhadj, Soumaya; Rentsch, Andreas; Schwede, Frank; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Genes</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453</span>CODEN:
                <span class="NLM_cas:coden">GENEG9</span>;
        ISSN:<span class="NLM_cas:issn">2073-4425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Photoreceptor physiol. and pathophysiol. is intricately linked to guanosine-3',5'-cyclic monophosphate (cGMP)-signaling.  Here, we discuss the importance of cGMP-signaling for the pathogenesis of hereditary retinal degeneration.  Excessive accumulation of cGMP in photoreceptors is a common denominator in cell death caused by a variety of di erent gene mutations.  The cGMP-dependent cell death pathway may be targeted for the treatment of inherited photoreceptor degeneration, using specifically designed and formulated inhibitory cGMP analogs.  Moreover, cGMP-signaling and its down-stream targets may be exploited for the development of novel biomarkers that could facilitate monitoring of disease progression and reveal the response to treatment in future clin. trials.  We then briefly present the importance of appropriate formulations for delivery to the retina, both for drug and biomarker applications.  Finally, the review touches on important aspects of future clin. translation, highlighting the need for interdisciplinary cooperation of researchers from a diverse range of fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnfVBgGiBOBLVg90H21EOLACvtfcHk0lgnpCSADO5y8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ehsrfF&md5=e948169c60cb9150218e4adf8b231dc5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3390%2Fgenes10060453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fgenes10060453%26sid%3Dliteratum%253Aachs%26aulast%3DTolone%26aufirst%3DA.%26aulast%3DBelhadj%26aufirst%3DS.%26aulast%3DRentsch%26aufirst%3DA.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DThe%2520cGMP%2520pathway%2520and%2520inherited%2520photoreceptor%2520degeneration%253A%2520targets%252C%2520compounds%252C%2520and%2520biomarkers%26jtitle%3DGenes%26date%3D2019%26volume%3D10%26spage%3D453%26doi%3D10.3390%2Fgenes10060453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, R. H.</span></span> <span> </span><span class="NLM_article-title">The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">19486</span>– <span class="NLM_lpage">19497</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.011002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.RA119.011002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31690623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB3MjlsFCnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=19486-19497&author=M.+J.+Irwinauthor=R.+Guptaauthor=X.+Z.+Gaoauthor=K.+B.+Cahillauthor=F.+Chuauthor=R.+H.+Cote&title=The+molecular+architecture+of+photoreceptor+phosphodiesterase+6+%28PDE6%29+with+activated+G+protein+elucidates+the+mechanism+of+visual+excitation&doi=10.1074%2Fjbc.RA119.011002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation</span></div><div class="casAuthors">Irwin Michael J; Gupta Richa; Gao Xiong-Zhuo; Cahill Karyn B; Chu Feixia; Cote Rick H</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">19486-19497</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Photoreceptor phosphodiesterase 6 (PDE6) is the central effector of the visual excitation pathway in both rod and cone photoreceptors, and PDE6 mutations that alter PDE6 structure or regulation can result in several human retinal diseases.  The rod PDE6 holoenzyme consists of two catalytic subunits (Pαβ) whose activity is suppressed in the dark by binding of two inhibitory γ-subunits (Pγ).  Upon photoactivation of rhodopsin, the heterotrimeric G protein (transducin) is activated, resulting in binding of the activated transducin α-subunit (Gtα) to PDE6, displacement of Pγ from the PDE6 active site, and enzyme activation.  Although the biochemistry of this pathway is understood, a lack of detailed structural information about the PDE6 activation mechanism hampers efforts to develop therapeutic interventions for managing PDE6-associated retinal diseases.  To address this gap, here we used a cross-linking MS-based approach to create a model of the entire interaction surface of Pγ with the regulatory and catalytic domains of Pαβ in its nonactivated state.  Following reconstitution of PDE6 and activated Gtα with liposomes and identification of cross-links between Gtα and PDE6 subunits, we determined that the PDE6-Gtα protein complex consists of two Gtα-binding sites per holoenzyme.  Each Gtα interacts with the catalytic domains of both catalytic subunits and induces major changes in the interaction sites of the Pγ subunit with the catalytic subunits.  These results provide the first structural model for the activated state of the transducin-PDE6 complex during visual excitation, enhancing our understanding of the molecular etiology of inherited retinal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQod-4D8xoMrWx8TEN9K18QfW6udTcc2eY9rO-WpHvvLbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjlsFCnsg%253D%253D&md5=8944b65b4420523af61fbf49629bd8d3</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.011002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.011002%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DM.%2BJ.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DX.%2BZ.%26aulast%3DCahill%26aufirst%3DK.%2BB.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DThe%2520molecular%2520architecture%2520of%2520photoreceptor%2520phosphodiesterase%25206%2520%2528PDE6%2529%2520with%2520activated%2520G%2520protein%2520elucidates%2520the%2520mechanism%2520of%2520visual%2520excitation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D19486%26epage%3D19497%26doi%3D10.1074%2Fjbc.RA119.011002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chabre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deterre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuong, T. M.</span></span> <span> </span><span class="NLM_article-title">Visual signal transduction: the cycle of transducin shuttling between rhodopsin and cGMP phosphodiesterase</span>. <i>Cold Spring Harbor Symp. Quant. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1101/SQB.1988.053.01.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1101%2FSQB.1988.053.01.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=2855482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADyaK3cXls1OnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=313-324&author=M.+Chabreauthor=J.+Bigayauthor=F.+Bruckertauthor=F.+Bornancinauthor=P.+Deterreauthor=C.+Pfisterauthor=T.+M.+Vuong&title=Visual+signal+transduction%3A+the+cycle+of+transducin+shuttling+between+rhodopsin+and+cGMP+phosphodiesterase&doi=10.1101%2FSQB.1988.053.01.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Visual signal transduction:  the cycle of transducin shuttling between rhodopsin and cGMP phosphodiesterase</span></div><div class="casAuthors">Chabre, M.; Bigay, J.; Bruckert, F.; Bornancin, F.; Deterre, P.; Pfister, C.; Vuong, T. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Mol. Biol. Signal Transduction, Pt. 1</span>),
    <span class="NLM_cas:pages">313-24</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review, with ∼25 refs., on transducin as it shuttles between rhodopsin and phosphodiesterase.  Lateral diffusion of rhodopsin and GTP interaction with transducin as a model G-protein are included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpET59p2U20p7Vg90H21EOLACvtfcHk0lgnpCSADO5y8w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1OnsLs%253D&md5=48e6f02cf219e4b86475fc5c3be2219c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1101%2FSQB.1988.053.01.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252FSQB.1988.053.01.038%26sid%3Dliteratum%253Aachs%26aulast%3DChabre%26aufirst%3DM.%26aulast%3DBigay%26aufirst%3DJ.%26aulast%3DBruckert%26aufirst%3DF.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DDeterre%26aufirst%3DP.%26aulast%3DPfister%26aufirst%3DC.%26aulast%3DVuong%26aufirst%3DT.%2BM.%26atitle%3DVisual%2520signal%2520transduction%253A%2520the%2520cycle%2520of%2520transducin%2520shuttling%2520between%2520rhodopsin%2520and%2520cGMP%2520phosphodiesterase%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1988%26volume%3D53%26spage%3D313%26epage%3D324%26doi%3D10.1101%2FSQB.1988.053.01.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qureshi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schöneberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loerke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giesebrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn, C. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, M.</span></span> <span> </span><span class="NLM_article-title">Asymmetric properties of rod cGMP Phosphodiesterase 6 (PDE6): structural and functional analysis</span>. <i>BMC Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">A76</span>, <span class="refDoi"> DOI: 10.1186/2050-6511-16-S1-A76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1186%2F2050-6511-16-S1-A76" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=A76&author=B.+M.+Qureshiauthor=E.+Behrmannauthor=J.+Sch%C3%B6nebergauthor=J.+Loerkeauthor=J.+B%C3%BCrgerauthor=T.+Mielkeauthor=J.+Giesebrechtauthor=F.+No%C3%A9author=K.+P.+Hofmannauthor=C.+M.+T.+Spahnauthor=M.+Heck&title=Asymmetric+properties+of+rod+cGMP+Phosphodiesterase+6+%28PDE6%29%3A+structural+and+functional+analysis&doi=10.1186%2F2050-6511-16-S1-A76"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1186%2F2050-6511-16-S1-A76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2050-6511-16-S1-A76%26sid%3Dliteratum%253Aachs%26aulast%3DQureshi%26aufirst%3DB.%2BM.%26aulast%3DBehrmann%26aufirst%3DE.%26aulast%3DSch%25C3%25B6neberg%26aufirst%3DJ.%26aulast%3DLoerke%26aufirst%3DJ.%26aulast%3DB%25C3%25BCrger%26aufirst%3DJ.%26aulast%3DMielke%26aufirst%3DT.%26aulast%3DGiesebrecht%26aufirst%3DJ.%26aulast%3DNo%25C3%25A9%26aufirst%3DF.%26aulast%3DHofmann%26aufirst%3DK.%2BP.%26aulast%3DSpahn%26aufirst%3DC.%2BM.%2BT.%26aulast%3DHeck%26aufirst%3DM.%26atitle%3DAsymmetric%2520properties%2520of%2520rod%2520cGMP%2520Phosphodiesterase%25206%2520%2528PDE6%2529%253A%2520structural%2520and%2520functional%2520analysis%26jtitle%3DBMC%2520Pharmacol.%2520Toxicol.%26date%3D2015%26volume%3D16%26spage%3DA76%26doi%3D10.1186%2F2050-6511-16-S1-A76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, P. M.</span></span> <span> </span><span class="NLM_article-title">PDE and sGC hand in hand to see the light</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">17704</span>– <span class="NLM_lpage">17705</span>, <span class="refDoi"> DOI: 10.1073/pnas.1421161111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1073%2Fpnas.1421161111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25468979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=17704-17705&author=P.+M.+Vanhoutte&title=PDE+and+sGC+hand+in+hand+to+see+the+light&doi=10.1073%2Fpnas.1421161111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">PDE and sGC hand in hand to see the light</span></div><div class="casAuthors">Vanhoutte, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">17704-17705</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  The title research of Sikka, G. et al. (ibid, pages 17977-17982) is reviewed with commentary.  Sikka et al. suggest that melanopsin, a non-image-forming opsin (opsin4, Opn4), may play a physiol. role in the regulation of vascular tone by mediating photorelaxation.  This means that light of a defined wavelength known to stimulate opsin4 in other systems induces relaxation of the vascular smooth muscle cells of melanopsin-contg. blood vessels.  This response is clearly eNOS-, NO-,and endothelium-independent but, as pointed out by the authors, may involve other components of the blood vessel wall.  The authors show that the response to light is due to hyperpolarization of the vascular smooth muscle cells resulting from the activation of sol. guanylyl cyclase (sGC), but does not involve protein kinase G (PKG).  In addn., Sikka et al. very convincingly demonstrate that phosphodiesterase 6 (PDE6) is present in their prepns. and that inhibitors of that enzyme prevent the response.  This study not only provides an intriguing mol. explanation for a phenomenon (photorelaxation) that has puzzled vascular biologists for more than half a century but also forces us to rethink the fate of the products generated by sGC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryAQMybosXl7Vg90H21EOLACvtfcHk0ljN-WZdRU_BBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrtL%252FL&md5=8d6a6a1f9c2e8d679b826213b246e28c</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1421161111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1421161111%26sid%3Dliteratum%253Aachs%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26atitle%3DPDE%2520and%2520sGC%2520hand%2520in%2520hand%2520to%2520see%2520the%2520light%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D17704%26epage%3D17705%26doi%3D10.1073%2Fpnas.1421161111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olshevskaya, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermilov, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dizhoor, A. M.</span></span> <span> </span><span class="NLM_article-title">Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1023/A:1014248208584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1023%2FA%3A1014248208584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11952089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2002&pages=139-147&author=E.+V.+Olshevskayaauthor=A.+N.+Ermilovauthor=A.+M.+Dizhoor&title=Factors+that+affect+regulation+of+cGMP+synthesis+in+vertebrate+photoreceptors+and+their+genetic+link+to+human+retinal+degeneration&doi=10.1023%2FA%3A1014248208584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration</span></div><div class="casAuthors">Olshevskaya, Elena V.; Ermilov, Alexandre N.; Dizhoor, Alexander M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  CGMP is essential for the ability of rods and cones to respond to the light stimuli.  Light triggers hydrolysis of cGMP and stops the influx of sodium and calcium through the cGMP-gated ion channels.  The consequence of this event is 2-fold: first, the decrease in the inward sodium current plays the major role in an abrupt hyperpolarization of the cellular membrane: secondly, the decrease in the Ca2+ influx diminishes the free intracellular Ca2+ concn.  While the former constitutes the essence of the phototransduction pathway in rods and cones, the latter gives rise to a potent feedback mechanism that accelerates photoreceptor recovery and adaptation to background light.  One of the most important events by which Ca2+ feedback controls recovery and light adaptation is synthesis of cGMP by guanylyl cyclase.  Two isoenzymes of membrane photoreceptor guanylyl cyclase (retGC) have been identified in rods and cones that are regulated by Ca2+-binding proteins, GCAPs.  At low intracellular concns. of Ca2+ typical for light-adapted rods and cones GCAPs activate RetGC, but concns. above 500 nM typical for dark-adapted photoreceptors turn them into inhibitors of retGC.  A variety of mutations found in GCAP and retGC genes have been linked to several forms of human congenital retinal diseases, such as dominant cone degeneration, cone-rod dystrophy and Leber congenital amaurosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaviMSMnCoBLVg90H21EOLACvtfcHk0ljN-WZdRU_BBg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGhtrk%253D&md5=7cf234dccffddb3b6972105123a8c74e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1023%2FA%3A1014248208584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1014248208584%26sid%3Dliteratum%253Aachs%26aulast%3DOlshevskaya%26aufirst%3DE.%2BV.%26aulast%3DErmilov%26aufirst%3DA.%2BN.%26aulast%3DDizhoor%26aufirst%3DA.%2BM.%26atitle%3DFactors%2520that%2520affect%2520regulation%2520of%2520cGMP%2520synthesis%2520in%2520vertebrate%2520photoreceptors%2520and%2520their%2520genetic%2520link%2520to%2520human%2520retinal%2520degeneration%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2002%26volume%3D230%26spage%3D139%26epage%3D147%26doi%3D10.1023%2FA%3A1014248208584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalakis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zrenner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e112142</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0112142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1371%2Fjournal.pone.0112142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25392995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=B.+Arango-Gonzalezauthor=D.+Trifunovicauthor=A.+Sahabogluauthor=K.+Kranzauthor=S.+Michalakisauthor=P.+Farinelliauthor=S.+Kochauthor=F.+Kochauthor=S.+Cottetauthor=U.+Janssen-Bienholdauthor=K.+Dedekauthor=M.+Bielauthor=E.+Zrennerauthor=T.+Eulerauthor=P.+Ekstromauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Identification+of+a+common+non-apoptotic+cell+death+mechanism+in+hereditary+retinal+degeneration&doi=10.1371%2Fjournal.pone.0112142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span></div><div class="casAuthors">Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Kranz, Katharina; Michalakis, Stylianos; Farinelli, Pietro; Koch, Susanne; Koch, Fred; Cottet, Sandra; Janssen-Bienhold, Ulrike; Dedek, Karin; Biel, Martin; Zrenner, Eberhart; Euler, Thomas; Ekstroem, Per; Ueffing, Marius; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e112142/1-e112142/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration.  We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death.  We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance.  Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose.  Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEcYvkyewtrVg90H21EOLACvtfcHk0ljYs5___18dtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL&md5=53c0c17980aa77b6c8addc7cff796a1a</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0112142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0112142%26sid%3Dliteratum%253Aachs%26aulast%3DArango-Gonzalez%26aufirst%3DB.%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DKranz%26aufirst%3DK.%26aulast%3DMichalakis%26aufirst%3DS.%26aulast%3DFarinelli%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DKoch%26aufirst%3DF.%26aulast%3DCottet%26aufirst%3DS.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DDedek%26aufirst%3DK.%26aulast%3DBiel%26aufirst%3DM.%26aulast%3DZrenner%26aufirst%3DE.%26aulast%3DEuler%26aufirst%3DT.%26aulast%3DEkstrom%26aufirst%3DP.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520a%2520common%2520non-apoptotic%2520cell%2520death%2520mechanism%2520in%2520hereditary%2520retinal%2520degeneration%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0112142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Two pathways of rod photoreceptor cell death induced by elevated cGMP</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2299</span>– <span class="NLM_lpage">2306</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddx121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1093%2Fhmg%2Fddx121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28379353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFais7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=2299-2306&author=T.+Wangauthor=S.+H.+Tsangauthor=J.+Chen&title=Two+pathways+of+rod+photoreceptor+cell+death+induced+by+elevated+cGMP&doi=10.1093%2Fhmg%2Fddx121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Two pathways of rod photoreceptor cell death induced by elevated cGMP</span></div><div class="casAuthors">Wang, Tian; Tsang, Stephen H.; Chen, Jeannie</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2299-2306</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">1460-2083</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">CGMP is a second messenger in phototransduction, a G-protein signaling cascade that conveys photon absorption by rhodopsin to a change in current at the rod photoreceptor outer segment plasma membrane.  Basal cGMP level is strictly controlled by the opposing actions of phosphodiesterase (PDE6) and retinal guanylyl cyclases (GCs), and mutations in genes that disrupt cGMP homeostasis leads to retinal degeneration in humans through mechanisms that are incompletely understood.  The purpose of this study is to examine two distinct cellular targets of cGMP: the cGMP-gated (CNG) channels and protein kinase G (PRKG), and how each may contribute to rod cell death.  Using a mouse genetic approach, we found that abolishing expression of CNG channels prolongs rod survival caused by elevated cGMP in a PDE6 mutant mouse model.  This observation supports the use of channel blockers to delay rod death, which is expected to prolong useful vision through enhanced cone survival.  However, the absence of CNG channel alone also caused abnormal cGMP accumulation.  In a mouse model of CNG channel loss-of-function, abolishing PRKG1 expression had a long-lasting effect in promoting rod cell survival.  Our data strongly implicate two distinct cGMP-mediated cell death pathways, and suggest that therapeutic designs targeting both pathways will be more effective at slowing photoreceptor cell death caused by elevated cGMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRFY3AluI1i7Vg90H21EOLACvtfcHk0ljYs5___18dtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFais7o%253D&md5=0a2d794d212b6ecd7b8df6c324091b63</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddx121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddx121%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DTsang%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTwo%2520pathways%2520of%2520rod%2520photoreceptor%2520cell%2520death%2520induced%2520by%2520elevated%2520cGMP%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2017%26volume%3D26%26spage%3D2299%26epage%3D2306%26doi%3D10.1093%2Fhmg%2Fddx121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, P. M.</span></span> <span> </span><span class="NLM_article-title">Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells</span>. <i>SpringerPlus</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">680</span>, <span class="refDoi"> DOI: 10.1186/2193-1801-2-680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1186%2F2193-1801-2-680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24683528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Whsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=680&author=H.+Dongauthor=K.+P.+Claffeyauthor=S.+Brockeauthor=P.+M.+Epstein&title=Expression+of+phosphodiesterase+6+%28PDE6%29+in+human+breast+cancer+cells&doi=10.1186%2F2193-1801-2-680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells</span></div><div class="casAuthors">Dong, Hongli; Claffey, Kevin P.; Brocke, Stefan; Epstein, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">SpringerPlus</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">680/1-680/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">SPRIFB</span>;
        ISSN:<span class="NLM_cas:issn">2193-1801</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Considerable epidemiol. evidence demonstrates a pos. assocn. between artificial light at night (LAN) levels and incidence rates of breast cancer, suggesting that exposure to LAN is a risk factor for breast cancer.  There is a 30-50 % higher risk of breast cancer in the highest LAN exposed countries compared to the lowest LAN countries, and studies showing higher incidence of breast cancer among shift workers exposed to more LAN have led the International Agency for Research on Cancer to classify shift work as a probable human carcinogen.  Nevertheless, the means by which light can affect breast cancer is still unknown.  In this study we examd. established human breast cancer cell lines and patients' primary breast cancer tissues for expression of genetic components of phosphodiesterase 6 (PDE6), a cGMP-specific PDE involved in transduction of the light signal, and previously thought to be selectively expressed in photoreceptors.  By microarray anal. we find highly significant expression of mRNA for the PDE6B, PDE6C, and PDE6D genes in both the cell lines and patients' tissues, minimal expression of PDE6A and PDE6G and no expression of PDE6H.  Using antibody specific for PDE6β, we find expression of PDE6B protein in a wide range of patients' tissues by immunohistochem., and in MCF-7 breast cancer cells by immunofluorescence and Western blot anal.  Considerable expression of key circadian genes, PERIOD 2, CLOCK, TIMELESS, CRYPTOCHROME 1, and CRYPTOCHROME 2 was also seen in all breast cancer cell lines and all patients' breast cancer tissues.  These studies indicate that genes for PDE6 and control of circadian rhythm are expressed in human breast cancer cells and tissues and may play a role in transducing the effects of light on breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZdjd-brp86LVg90H21EOLACvtfcHk0ljYs5___18dtw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Whsr%252FJ&md5=74cec2df2c22739690381ccb3553c733</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2F2193-1801-2-680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2193-1801-2-680%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DH.%26aulast%3DClaffey%26aufirst%3DK.%2BP.%26aulast%3DBrocke%26aufirst%3DS.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26atitle%3DExpression%2520of%2520phosphodiesterase%25206%2520%2528PDE6%2529%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DSpringerPlus%26date%3D2013%26volume%3D2%26spage%3D680%26doi%3D10.1186%2F2193-1801-2-680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schanzle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner-Ciossek, C.</span></span> <span> </span><span class="NLM_article-title">The novel phosphodiesterase 9A inhibitor BI 409306 increases cyclic guanosine monophosphate levels in the brain, promotes synaptic plasticity, and enhances memory function in rodents</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.260059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fjpet.119.260059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31578258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1Wltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2019&pages=633-641&author=H.+Rosenbrockauthor=R.+Giovanniniauthor=G.+Schanzleauthor=E.+Korosauthor=F.+Rungeauthor=H.+Fuchsauthor=A.+Martiauthor=K.+G.+Reymannauthor=U.+H.+Schroderauthor=E.+Fedeleauthor=C.+Dorner-Ciossek&title=The+novel+phosphodiesterase+9A+inhibitor+BI+409306+increases+cyclic+guanosine+monophosphate+levels+in+the+brain%2C+promotes+synaptic+plasticity%2C+and+enhances+memory+function+in+rodents&doi=10.1124%2Fjpet.119.260059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The novel phosphodiesterase 9A inhibitor BI 409306 increases cyclic guanosine monophosphate levels in the brain, promotes synaptic plasticity, and enhances memory function in rodents</span></div><div class="casAuthors">Rosenbrock, Holger; Giovannini, Riccardo; Schaenzle, Gerhard; Koros, Eliza; Runge, Frank; Fuchs, Holger; Marti, Anelise; Reymann, Klaus G.; Schroeder, Ulrich H.; Fedele, Ernesto; Dorner-Ciossek, Cornelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">633-646</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-methyl-d-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) is an established cellular model underlying learning and memory, and involves intracellular signaling mediated by the second messenger cyclic guanosine monophosphate (cGMP).  As phosphodiesterase (PDE)9A selectively hydrolyzes cGMP in areas of the brain related to cognition, PDE9A inhibitors may improve cognitive function by enhancing NMDA receptor-dependent LTP.  This study aimed to pharmacol. characterize BI 409306, a novel PDE9A inhibitor, using in vitro assays and in vivo detn. of cGMP levels in the brain.  Further, the effects of BI 409306 on synaptic plasticity evaluated by LTP in ex vivo hippocampal slices and on cognitive performance in rodents were also investigated.  In vitro assays demonstrated that BI 409306 is a potent and selective inhibitor of human and rat PDE9A with mean concns. at half-maximal inhibition (IC50) of 65 and 168 nM.  BI 409306 increased cGMP levels in rat prefrontal cortex and cerebrospinal fluid and attenuated a redn. in mouse striatum cGMP induced by the NMDA-receptor antagonist MK-801.  In ex vivo rat brain slices, BI 409306 enhanced LTP induced by both weak and strong tetanic stimulation.  Treatment of mice with BI 409306 reversed MK-801-induced working memory deficits in a T-maze spontaneous-alternation task and improved long-term memory in an object recognition task.  These findings suggest that BI 409306 is a potent and selective inhibitor of PDE9A.  BI 409306 shows target engagement by increasing cGMP levels in brain, facilitates synaptic plasticity as demonstrated by enhancement of hippocampal LTP, and improves episodic and working memory function in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFFF-k-V2uQ7Vg90H21EOLACvtfcHk0lgIJEstjzmBag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1Wltrc%253D&md5=8df2e014d7252294520c064daf206709</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.260059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.260059%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DGiovannini%26aufirst%3DR.%26aulast%3DSchanzle%26aufirst%3DG.%26aulast%3DKoros%26aufirst%3DE.%26aulast%3DRunge%26aufirst%3DF.%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroder%26aufirst%3DU.%2BH.%26aulast%3DFedele%26aufirst%3DE.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26atitle%3DThe%2520novel%2520phosphodiesterase%25209A%2520inhibitor%2520BI%2520409306%2520increases%2520cyclic%2520guanosine%2520monophosphate%2520levels%2520in%2520the%2520brain%252C%2520promotes%2520synaptic%2520plasticity%252C%2520and%2520enhances%2520memory%2520function%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26volume%3D371%26spage%3D633%26epage%3D641%26doi%3D10.1124%2Fjpet.119.260059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moschetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunderlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feifel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boland, K.</span></span> <span> </span><span class="NLM_article-title">The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2018.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.euroneuro.2018.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29567399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=643-655&author=V.+Moschettiauthor=M.+Kimauthor=M.+Sandauthor=G.+Wunderlichauthor=G.+Andersenauthor=U.+Feifelauthor=I.+J.+Jangauthor=W.+Timmerauthor=H.+Rosenbrockauthor=K.+Boland&title=The+safety%2C+tolerability+and+pharmacokinetics+of+BI+409306%2C+a+novel+and+potent+PDE9+inhibitor%3A+Overview+of+three+Phase+I+randomised+trials+in+healthy+volunteers&doi=10.1016%2Fj.euroneuro.2018.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomized trials in healthy volunteers</span></div><div class="casAuthors">Moschetti, Viktoria; Kim, Maria; Sand, Michael; Wunderlich, Glen; Andersen, Grit; Feifel, Ulrich; Jang, In-Jin; Timmer, Wolfgang; Rosenbrock, Holger; Boland, Katja</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-655</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Safety, tolerability and pharmacokinetics of BI 409306, a potent and selective phosphodiesterase 9A inhibitor, were assessed in healthy subjects in three Phase I, within-dose group, double-blind trials.  Trial 1 randomized young and elderly subjects to receive BI 409306 25, 50, 100 mg, placebo once daily (OD) or BI 409306 50 mg twice daily (young) for 14 days.  Trial 2 randomized young poor metabolizers (PM) of cytochrome P 450 isoform 2C19 (CYP2C19) and elderly subjects to receive BI 409306 25, 50 mg or placebo OD for 14 days.  Trial 3 randomized Chinese and Japanese extensive metabolizers of CYP2C19 to receive single doses (SD) of BI 409306 25, 50, 100 mg or placebo and Chinese (PM) to SD of BI 409306 100 mg or placebo (Part 1).  Japanese PM received SD of BI 409306 100 mg or placebo (Day 1) followed by BI 409306 100 mg or placebo OD for 7 days after a 48-h washout period (Part 2).  Reported adverse events (AE) were mild-to-moderate intensity and increased with BI 409306 dose.  Eye disorders were most commonly reported (Trial 1: 40.0-41.7%, Trial 2: 29.2-37.5%, Trial 3: 18.2-66.7%) and increased with dose and systemic exposure.  PM reported more AEs than other treatment groups, corresponding to higher systemic exposure to BI 409306.  Systemic exposure to BI 409306 produced dose-dependent increases and was slightly greater in elderly vs. young subgroups (Trial 1).  Steady state was achieved by Day 2-3.  Overall, BI 409306 demonstrated good safety, tolerability and minor accumulation after multiple dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcPdm9PaZH7Vg90H21EOLACvtfcHk0lgIJEstjzmBag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgtL8%253D&md5=05bba157a7076beb48c216fbcff7deda</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2018.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2018.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMoschetti%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DSand%26aufirst%3DM.%26aulast%3DWunderlich%26aufirst%3DG.%26aulast%3DAndersen%26aufirst%3DG.%26aulast%3DFeifel%26aufirst%3DU.%26aulast%3DJang%26aufirst%3DI.%2BJ.%26aulast%3DTimmer%26aufirst%3DW.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DBoland%26aufirst%3DK.%26atitle%3DThe%2520safety%252C%2520tolerability%2520and%2520pharmacokinetics%2520of%2520BI%2520409306%252C%2520a%2520novel%2520and%2520potent%2520PDE9%2520inhibitor%253A%2520Overview%2520of%2520three%2520Phase%2520I%2520randomised%2520trials%2520in%2520healthy%2520volunteers%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2018%26volume%3D28%26spage%3D643%26epage%3D655%26doi%3D10.1016%2Fj.euroneuro.2018.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, L.</span></span> <span> </span><span class="NLM_article-title">cGMP modulation therapeutics for sickle cell disease</span>. <i>Exp. Biol. Med. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1177/1535370219827276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1177%2F1535370219827276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktlKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2019&pages=132-146&author=N.+Conranauthor=L.+Torres&title=cGMP+modulation+therapeutics+for+sickle+cell+disease&doi=10.1177%2F1535370219827276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP modulation therapeutics for sickle cell disease</span></div><div class="casAuthors">Conran, Nicola; Torres, Lidiane</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-146</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3699</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Sickle cell disease (SCD) is an inherited disease caused by the prodn. of abnormal Hb (Hb) S, whose deoxygenation-induced polymn. results in red blood cell (RBC) sickling and numerous pathophysiol. consequences.  SCD affects approx. 300,000 newborns worldwide each year and is assocd. with acute and chronic complications, including frequent painful vaso-occlusive episodes that often require hospitalization.  Chronic intravascular hemolysis in SCD significantly reduces vascular nitric oxide (NO) bioavailability, consequently decreasing intracellular signaling via cyclic guanosine monophosphate (cGMP), in turn diminishing vasodilation and contributing to the inflammatory mechanisms that trigger vaso-occlusive processes.  Oxidative stress may further reduce NO bioavailability in SCD and can oxidize the intracellular enzyme target of NO, sol. guanylate cyclase (sGC), rendering it inactive.  Increasing intracellular cGMP-dependent signaling constitutes an important pharmacol. therapeutic approach for SCD with a view to augmenting vasodilation, and reducing inflammatory mechanisms, as well as for increasing the prodn. of anti-polymg. fetal Hb in erythroid cells.  Pharmacol. agents under pre-clin. and clin. investigation for SCD include NO-based therapeutics to augment NO bioavailability, as well as heme-dependent sGC stimulators and heme-independent sGC activators that directly stimulate native and oxidized sGC, resp., therefore bypassing the need for vascular NO delivery.  Addnl., the phosphodiesterases (PDEs) that degrade intracellular cyclic nucleotides with specific cellular distributions are attractive drug targets for SCD; PDE9 is highly expressed in hematopoietic cells, making the use of PDE9 inhibitors, originally developed for use in neurol. diseases, a potential approach that could rapidly amplify intracellular cGMP concns. in a relatively tissue-specific manner.  Impact statement: Sickle cell disease (SCD) is one of the most common inherited diseases and is assocd. with a reduced life expectancy and acute and chronic complications, including frequent painful vaso-occlusive episodes that often require hospitalization.  At present, treatment of SCD is limited to hematopoietic stem cell transplant, transfusion, and limited options for pharmacotherapy, based principally on hydroxyurea therapy.  This review highlights the importance of intracellular cGMP-dependent signaling pathways in SCD pathophysiol.; modulation of these pathways with sol. guanylate cyclase (sGC) stimulators or phosphodiesterase (PDE) inhibitors could potentially provide vasorelaxation and anti-inflammatory effects, as well as elevate levels of anti-sickling fetal Hb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovV6MaRlwtwbVg90H21EOLACvtfcHk0lgIJEstjzmBag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktlKrsr8%253D&md5=39addb6bc5181a92e916849a60dbcbaf</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1177%2F1535370219827276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1535370219827276%26sid%3Dliteratum%253Aachs%26aulast%3DConran%26aufirst%3DN.%26aulast%3DTorres%26aufirst%3DL.%26atitle%3DcGMP%2520modulation%2520therapeutics%2520for%2520sickle%2520cell%2520disease%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2019%26volume%3D244%26spage%3D132%26epage%3D146%26doi%3D10.1177%2F1535370219827276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karami-Tehrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeinifard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atri, M.</span></span> <span> </span><span class="NLM_article-title">Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors</span>. <i>Arch. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.arcmed.2012.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.arcmed.2012.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22960860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGjur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2012&pages=470-475&author=F.+Karami-Tehraniauthor=M.+Moeinifardauthor=M.+Aghaeiauthor=M.+Atri&title=Evaluation+of+PDE5+and+PDE9+expression+in+benign+and+malignant+breast+tumors&doi=10.1016%2Fj.arcmed.2012.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of PDE5 and PDE9 Expression in Benign and Malignant Breast Tumors</span></div><div class="casAuthors">Karami-Tehrani, Fatemeh; Moeinifard, Marzieh; Aghaei, Mahmoud; Atri, Morteza</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">470-475</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterases 5 and 9 (PDE5, PDE9) are enzymes responsible for regulating second messenger signaling by hydrolyzing 3',5' cyclic guanosine monophosphate (cGMP).  PDE isoforms are deregulated in some types of human cancer.  The present study was carried out to evaluate the expression of phosphodiesterase isoenzymes, PDE5 and PDE9, in benign and malignant breast tumors.  The expression levels of PDE5 and PDE9 were assayed in malignant and benign breast tumors and corresponding normal breast tissues using quant. real-time RT-PCR.  Moreover, the correlation between PDE5, PDE9 relative expression and clinicopathol. characteristics were analyzed.  The relative expressions of PDE5 and PDE9 in malignant tumors were significantly higher than those of resp. normal breast tissues and benign tumors (5.5-fold, p <0.001 and 6-fold, p <0.001, resp.).  Furthermore, a significant pos. correlation was found between PDE5 and PDE9 overexpression and tumor grade, stage, and lymph node involvement.  However, a neg. correlation was obsd. with age.  Based on the present results, it is concluded that assessment of PDE5 and PDE9 expression may be useful in the differential diagnosis of benign and malignant breast disease and successful treatment of breast cancer.  To the best of our knowledge, this is the first study to show that PDE5 and PDE9 expression levels are higher in malignant breast tumors than those of normal and benign breast tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIGx8wlYEgibVg90H21EOLACvtfcHk0lhUoOGcPZMQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGjur7F&md5=b9c1346a0083c4edf25d887516939e34</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2012.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2012.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DKarami-Tehrani%26aufirst%3DF.%26aulast%3DMoeinifard%26aufirst%3DM.%26aulast%3DAghaei%26aufirst%3DM.%26aulast%3DAtri%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520PDE5%2520and%2520PDE9%2520expression%2520in%2520benign%2520and%2520malignant%2520breast%2520tumors%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2012%26volume%3D43%26spage%3D470%26epage%3D475%26doi%3D10.1016%2Fj.arcmed.2012.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fors, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall-Murphy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9055</span>– <span class="NLM_lpage">9068</span>, <span class="refDoi"> DOI: 10.1021/jm3009635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9055-9068&author=M.+M.+Claffeyauthor=C.+J.+Helalauthor=P.+R.+Verhoestauthor=Z.+Kangauthor=K.+S.+Forsauthor=S.+Jungauthor=J.+Zhongauthor=M.+W.+Bundesmannauthor=X.+Houauthor=S.+Luiauthor=R.+J.+Kleimanauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=F.+Mennitiauthor=C.+J.+Schmidtauthor=W.+E.+Hoffmanauthor=M.+Hajosauthor=L.+McDowellauthor=R.+E.+O%E2%80%99Connorauthor=M.+Macdougall-Murphyauthor=K.+R.+Fonsecaauthor=S.+L.+Beckerauthor=F.+R.+Nelsonauthor=S.+Liras&title=Application+of+structure-based+drug+design+and+parallel+chemistry+to+identify+selective%2C+brain+penetrant%2C+in+vivo+active+phosphodiesterase+9A+inhibitors&doi=10.1021%2Fjm3009635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span></div><div class="casAuthors">Claffey, Michelle M.; Helal, Christopher J.; Verhoest, Patrick R.; Kang, Zhijun; Bundesmann, Mark W.; Hou, Xinjun; Lui, Shenping; Kleiman, Robin J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Menniti, Frank; Schmidt, Christopher J.; Hoffman, William E.; Hajos, Mihaly; McDowell, Laura; O'Connor, Rebecca E.; MacDougall-Murphy, Mary; Fonseca, Kari R.; Becker, Stacey L.; Nelson, Frederick R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9055-9068</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9A inhibitors have shown activity in preclin. models of cognition with potential application as novel therapies for treating Alzheimer's disease.  Our clin. candidate, PF-04447943 (2), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochem. properties outside the range assocd. with traditional CNS drugs.  To address the potential risk of restricted CNS penetration with 2 in human clin. trials, we sought to identify a preclin. candidate with no asymmetry in rat brain penetration and that could advance into development.  Merging the medicinal chem. strategies of structure-based design with parallel chem., a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C.  Optimization afforded preclin. candidate 19 that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with the ability to increase cyclic guanosine monophosphosphate levels in rat CSF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphK4OmJAu-pbVg90H21EOLACvtfcHk0lhUoOGcPZMQkw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ&md5=5e3aea9b0bfd660973c1e5fd56b6d933</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm3009635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009635%26sid%3Dliteratum%253Aachs%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DFors%26aufirst%3DK.%2BS.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLui%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DMenniti%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DMacdougall-Murphy%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DApplication%2520of%2520structure-based%2520drug%2520design%2520and%2520parallel%2520chemistry%2520to%2520identify%2520selective%252C%2520brain%2520penetrant%252C%2520in%2520vivo%2520active%2520phosphodiesterase%25209A%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9055%26epage%3D9068%26doi%3D10.1021%2Fjm3009635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8558</span>, <span class="refDoi"> DOI: 10.1021/jm301189c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.+X.+Shaoauthor=P.+Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.+B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-based+discovery+of+highly+selective+phosphodiesterase-9A+inhibitors+and+implications+for+inhibitor+design&doi=10.1021%2Fjm301189c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0lhR_faosoYOjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.%2BX.%26aulast%3DWu%26aufirst%3DP.%2BY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-based%2520discovery%2520of%2520highly%2520selective%2520phosphodiesterase-9A%2520inhibitors%2520and%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558%26doi%3D10.1021%2Fjm301189c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikuttyamma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastav, A.</span></span> <span> </span><span class="NLM_article-title">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.3892/ijmm.18.1.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3892%2Fijmm.18.1.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16786160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=95-105&author=R.+K.+Sharmaauthor=S.+B.+Dasauthor=A.+Lakshmikuttyammaauthor=P.+Selvakumarauthor=A.+Shrivastav&title=Regulation+of+calmodulin-stimulated+cyclic+nucleotide+phosphodiesterase+%28PDE1%29%3A+review&doi=10.3892%2Fijmm.18.1.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review</span></div><div class="casAuthors">Sharma, Rajendra K.; Das, Shankar B.; Lakshmikuttyamma, Ashakumary; Selvakumar, Ponniah; Shrivastav, Anuraag</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">A review.  The response of living cells to change in cell environment depends on the action of second messenger mols.  The two second messenger mols. cAMP and Ca2+ regulate a large no. of eukaryotic cellular events.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems.  Some PDE1 isoenzymes have similar kinetic and immunol. properties but are differentially regulated by Ca2+ and calmodulin.  Accumulating evidence suggests that the activity of PDE1 is selectively regulated by cross-talk between Ca2+ and cAMP signaling pathways.  These isoenzymes are also further distinguished by various pharmacol. agents.  We have demonstrated a potentially novel regulation of PDE1 by calpain.  This study suggests that limited proteolysis by calpain could be an alternative mechanism for the activation of PDE1.  We have also shown PDE1 activity, expression and effect of calpain in the rat model in vitro of cardiac ischemia-reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZnr-AhNApDLVg90H21EOLACvtfcHk0lhR_faosoYOjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D&md5=671b71e77c39fcf4782b9d3e2bceebcd</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.3892%2Fijmm.18.1.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.18.1.95%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDas%26aufirst%3DS.%2BB.%26aulast%3DLakshmikuttyamma%26aufirst%3DA.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DShrivastav%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520calmodulin-stimulated%2520cyclic%2520nucleotide%2520phosphodiesterase%2520%2528PDE1%2529%253A%2520review%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2006%26volume%3D18%26spage%3D95%26epage%3D105%26doi%3D10.3892%2Fijmm.18.1.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bönöczk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyás, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam-Vizi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kárpáti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapás, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szántay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koncz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelles, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vas, A.</span></span> <span> </span><span class="NLM_article-title">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/S0361-9230(00)00354-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0361-9230%2800%2900354-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11113577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=245-254&author=P.+B%C3%B6n%C3%B6czkauthor=B.+Guly%C3%A1sauthor=V.+Adam-Viziauthor=A.+Nemesauthor=E.+K%C3%A1rp%C3%A1tiauthor=B.+Kissauthor=M.+Kap%C3%A1sauthor=C.+Sz%C3%A1ntayauthor=I.+Konczauthor=T.+Zellesauthor=A.+Vas&title=Role+of+sodium+channel+inhibition+in+neuroprotection%3A+effect+of+vinpocetine&doi=10.1016%2FS0361-9230%2800%2900354-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span></div><div class="casAuthors">Bonoczk, P.; Gulyas, B.; Adam-Vizi, V.; Nemes, A.; Karpati, E.; Kiss, B.; Kapas, M.; Szantay, C.; Koncz, I.; Zelles, T.; Vas, A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-254</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 111 refs.  Vinpocetine (Et apovincaminate) discovered during the late 1960s has successfully been used in the treatment of central nervous system disorders of cerebrovascular origin for decades.  The increase in the regional cerebral blood flow in response to vinpocetine administration is well established and strengthened by new diagnostical techniques (transcranial Doppler, near IR spectroscopy, positron emission tomog.).  The latest in vitro studies have revealed the effect of the compd. on Ca2+/calmodulin dependent cGMP-phosphodiesterase 1, voltage-operated Ca2+ channels, glutamate receptors and voltage dependent Na+-channels; the latest being esp. relevant to the neuroprotective action of vinpocetine.  The good brain penetration profile and heterogeneous brain distribution pattern (mainly in the thalamus, basal ganglia and visual cortex) of labeled vinpocetine were demonstrated by positron emission tomog. in primates and man.  Multicentric, randomized, placebo-controlled clin. studies proved the efficacy of orally administered vinpocetine in patients with org. psychosyndrome.  Recently positron emission tomog. studies have proved that vinpocetine is able to redistribute regional cerebral blood flow and enhance glucose supply of brain tissue in ischemic post-stroke patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFVCMjshLcbVg90H21EOLACvtfcHk0lhR_faosoYOjQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D&md5=656c03dd9e9cd41a7638c6eb8674c5e4</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2800%2900354-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252800%252900354-3%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6n%25C3%25B6czk%26aufirst%3DP.%26aulast%3DGuly%25C3%25A1s%26aufirst%3DB.%26aulast%3DAdam-Vizi%26aufirst%3DV.%26aulast%3DNemes%26aufirst%3DA.%26aulast%3DK%25C3%25A1rp%25C3%25A1ti%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DKap%25C3%25A1s%26aufirst%3DM.%26aulast%3DSz%25C3%25A1ntay%26aufirst%3DC.%26aulast%3DKoncz%26aufirst%3DI.%26aulast%3DZelles%26aufirst%3DT.%26aulast%3DVas%26aufirst%3DA.%26atitle%3DRole%2520of%2520sodium%2520channel%2520inhibition%2520in%2520neuroprotection%253A%2520effect%2520of%2520vinpocetine%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2000%26volume%3D53%26spage%3D245%26epage%3D254%26doi%3D10.1016%2FS0361-9230%2800%2900354-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K. L.</span></span> <span> </span><span class="NLM_article-title">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>620</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejphar.2009.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19699735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=620&publication_year=2009&pages=49-56&author=R.+Deshmukhauthor=V.+Sharmaauthor=S.+Mehanauthor=N.+Sharmaauthor=K.+L.+Bedi&title=Amelioration+of+intracerebroventricular+streptozotocin+induced+cognitive+dysfunction+and+oxidative+stress+by+vinpocetine+-+a+PDE1+inhibitor&doi=10.1016%2Fj.ejphar.2009.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span></div><div class="casAuthors">Deshmukh, Rahul; Sharma, Vivek; Mehan, Sidharth; Sharma, Nidhi; Bedi, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">620</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known to be beneficial in disorders assocd. with cognitive decline.  The present study was designed to investigate the effect of vinpocetine (PDE1 inhibitor) on intracerebroventricular (i.c.v.) streptozotocin induced exptl. sporadic dementia of Alzheimer's type.  Infusion of streptozotocin impaired learning and memory, increased oxidative-nitritive stress and induced cholinergic hypofunction in rats.  Chronic treatment with vinpocetine (5, 10 and 20 mg/kg i.p.) for 21 days following first i.c.v. streptozotocin infusion significantly improved learning and memory in Morris water maze and passive avoidance paradigms.  Further, vinpocetine significantly reduced the oxidative-nitritive stress, as evidenced by decrease in malondialdehyde (MDA) and nitrite levels, and restored the reduced glutathione (GSH) levels.  Significant increase in acetylcholinesterase activity and lactate dehydrogenase levels was obsd. in the present model indicating cholinergic hypofunction and increase in neuronal cell damage.  Chronic treatment with vinpocetine also reduced significantly the increase in acetylcholinesterase activity and lactate dehydrogenase levels indicating restorative capacity of vinpocetine with respect to cholinergic functions and preventing the neuronal damage.  The obsd. beneficial effects of vinpocetine on spatial memory may be due to its ability to favorably modulate cholinergic functions, prevent neuronal cell damage and possibly through its antioxidant mechanism also.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokMQmZ9Cf3ybVg90H21EOLACvtfcHk0liZL8THdTIjUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L&md5=59b849a1799de087fe52b8eb62605be5</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDeshmukh%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DMehan%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DBedi%26aufirst%3DK.%2BL.%26atitle%3DAmelioration%2520of%2520intracerebroventricular%2520streptozotocin%2520induced%2520cognitive%2520dysfunction%2520and%2520oxidative%2520stress%2520by%2520vinpocetine%2520-%2520a%2520PDE1%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D620%26spage%3D49%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2009.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Kuraishy, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gareeb, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naji, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mamorry, F.</span></span> <span> </span><span class="NLM_article-title">Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review</span>. <i>Brain Circ.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.4103/bc.bc_46_19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.4103%2Fbc.bc_46_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32166194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB383ivVGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=1-10&author=H.+M.+Al-Kuraishyauthor=A.+I.+Al-Gareebauthor=M.+T.+Najiauthor=F.+Al-Mamorry&title=Role+of+vinpocetine+in+ischemic+stroke+and+poststroke+outcomes%3A+A+critical+review&doi=10.4103%2Fbc.bc_46_19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review</span></div><div class="casAuthors">Al-Kuraishy Hayder M; Al-Gareeb Ali I; Naji Marwa Thaier; Al-Mamorry Farah</div><div class="citationInfo"><span class="NLM_cas:title">Brain circulation</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vinpocetine (VPN) is a synthetic ethyl-ester derivative of the alkaloid apovincamine from Vinca minor leaves.  VPN is a selective inhibitor of phosphodiesterase type 1 (PDE1) that has potential neurological effects through inhibition of voltage-gated sodium channel and reduction of neuronal calcium influx.  VPN has noteworthy antioxidant, anti-inflammatory, and anti-apoptotic effects with inhibitory effect on glial and astrocyte cells during and following ischemic stroke (IS).  VPN is effective as adjuvant therapy in the management of epilepsy; it reduces seizure frequency by 50% in a dose of 2 mg/kg/day.  VPN improves psychomotor performances through modulation of brain monoamine pathway mainly on dopamine and serotonin, which play an integral role in attenuation of depressive symptoms.  VPN recover cognitive functions and spatial memory through inhibition of hippocampal and cortical PDE1 with augmentation of cyclic adenosin monophosphate and cyclic guanosin monophosphate ratio, enhancement of cholinergic neurotransmission, and inhibition of neuronal inflammatory mediators.  Therefore, VPN is an effective agent in the management of IS and plays an integral role in the prevention and attenuation of poststroke epilepsy, depression, and cognitive deficit through direct cAMP/cGMP-dependent pathway or indirectly through anti-inflammatory and antioxidant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBCuQOoiVQZIxhnOQkIHOxfW6udTcc2eYhpE-kso9XD7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383ivVGiuw%253D%253D&md5=fcb519bbc1909ba04a5734cb0ce1277a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.4103%2Fbc.bc_46_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Fbc.bc_46_19%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Kuraishy%26aufirst%3DH.%2BM.%26aulast%3DAl-Gareeb%26aufirst%3DA.%2BI.%26aulast%3DNaji%26aufirst%3DM.%2BT.%26aulast%3DAl-Mamorry%26aufirst%3DF.%26atitle%3DRole%2520of%2520vinpocetine%2520in%2520ischemic%2520stroke%2520and%2520poststroke%2520outcomes%253A%2520A%2520critical%2520review%26jtitle%3DBrain%2520Circ.%26date%3D2020%26volume%3D6%26spage%3D1%26epage%3D10%26doi%3D10.4103%2Fbc.bc_46_19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shekarian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salehi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoufi, S.</span></span> <span> </span><span class="NLM_article-title">The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of Amyloid Beta (αβ) peptide</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">112512</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2020.112512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bbr.2020.112512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31991177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlCgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2020&pages=112512&author=M.+Shekarianauthor=A.+Komakiauthor=S.+Shahidiauthor=A.+Sarihiauthor=I.+Salehiauthor=S.+Raoufi&title=The+protective+and+therapeutic+effects+of+vinpocetine%2C+a+PDE1+inhibitor%2C+on+oxidative+stress+and+learning+and+memory+impairment+induced+by+an+intracerebroventricular+%28ICV%29+injection+of+Amyloid+Beta+%28%CE%B1%CE%B2%29+peptide&doi=10.1016%2Fj.bbr.2020.112512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide</span></div><div class="casAuthors">Shekarian, Meysam; Komaki, Alireza; Shahidi, Siamak; Sarihi, Abdolrahman; Salehi, Iraj; Raoufi, Safoura</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112512</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disease leading to cognitive and memory impairment.  This study aimed at investigating the therapeutic and preserving effects of vinpocetine on amyloid beta (Aβ)-induced rat model of AD.  Sixty male adult Wistar rats were randomly divided into 6 groups (n = 10 per group) as follows: 1; control, 2; sham, 3; Aβ, 4; pre-treatment (vinpocetine + Aβ): oral gavage administration of vinpocetine at 4 mg/kg for 30 days followed by intracerebroventricular (ICV) injection of Aβ, 5; treatment (Aβ + vinpocetine): Aβ ICV injection followed by vinpocetine administration for 30 days, 6; pre-treatment + treatment (vinpocetine + Aβ + vinpocetine): vinpocetine administration for 30 days before and 30 days after AD induction.  Following treatments, the animals' learning and memory were investigated using passive avoidance learning (PAL) task, Morris water maze (MWM), and novel object recognition (NOR) tests.  The results demonstrated that Aβ significantly enhanced escape latency and the distance traveled in the MWM, decreased step-through latency, and increased time spent in the dark compartment in PAL.  Vinpocetine ameliorated the Aβ-infused memory deficits in both MWM and PAL tests.  Administration of vinpocetine in the Aβ rats increased the discrimination index of the NOR test.  It also significantly diminished the nitric oxide and malondialdehyde levels and restored the reduced glutathione (GSH) levels.  Vinpocetine can improve memory and learning impairment following Aβ infusion due to its different properties, including antioxidant effects, which indicates that vinpocetine administration can lead to the amelioration of cognitive dysfunction in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogIHcin7IhRLVg90H21EOLACvtfcHk0lh9JA7YKwA3JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlCgsbo%253D&md5=3d398db734f39ac5c930850458cb0ea3</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2020.112512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2020.112512%26sid%3Dliteratum%253Aachs%26aulast%3DShekarian%26aufirst%3DM.%26aulast%3DKomaki%26aufirst%3DA.%26aulast%3DShahidi%26aufirst%3DS.%26aulast%3DSarihi%26aufirst%3DA.%26aulast%3DSalehi%26aufirst%3DI.%26aulast%3DRaoufi%26aufirst%3DS.%26atitle%3DThe%2520protective%2520and%2520therapeutic%2520effects%2520of%2520vinpocetine%252C%2520a%2520PDE1%2520inhibitor%252C%2520on%2520oxidative%2520stress%2520and%2520learning%2520and%2520memory%2520impairment%2520induced%2520by%2520an%2520intracerebroventricular%2520%2528ICV%2529%2520injection%2520of%2520Amyloid%2520Beta%2520%2528%25CE%25B1%25CE%25B2%2529%2520peptide%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2020%26volume%3D383%26spage%3D112512%26doi%3D10.1016%2Fj.bbr.2020.112512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+L.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+W.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0lh9JA7YKwA3JQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%2BW.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadenberg, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mates, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">3113</span>– <span class="NLM_lpage">3124</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4346-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00213-016-4346-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27342643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=3113-3124&author=G.+L.+Snyderauthor=J.+Prickaertsauthor=M.+L.+Wadenbergauthor=L.+Zhangauthor=H.+L.+Zhengauthor=W.+Yaoauthor=S.+Akkermanauthor=H.+W.+Zhuauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+Davisauthor=P.+Liauthor=S.+Matesauthor=L.+P.+Wennogle&title=Preclinical+profile+of+ITI-214%2C+an+inhibitor+of+phosphodiesterase+1%2C+for+enhancement+of+memory+performance+in+rats&doi=10.1007%2Fs00213-016-4346-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span></div><div class="casAuthors">Snyder, Gretchen L.; Prickaerts, Jos; Wadenberg, Marie-Louise; Zhang, Lei; Zheng, Hailin; Yao, Wei; Akkerman, Sven; Zhu, Hongwen; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert; Li, Peng; Mates, Sharon; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3113-3124</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Therapeutic agents for memory enhancement in psychiatric disorders, such as schizophrenia, are urgently needed.  Objective: The aim of this study is to characterize the preclin. profile of ITI-214, a potent inhibitor of phosphodiesterase 1 (PDE1).  Methods: ITI-214 was assayed for inhibition of PDE1 vs. other PDE enzyme families using recombinant human PDE enzymes and for off-target binding to 70 substrates (General SEP II diversity panel; Caliper Life Sciences).  Effects of ITI-214 (0.1-10 mg/kg, po) on memory performance were assayed in rats using the novel object recognition (NOR) paradigm, with drug given at specified time points prior to or following exposure to objects in an open field.  ITI-214 was evaluated for potential drug-drug interaction with risperidone in rats using conditioned avoidance response (CAR) and pharmacokinetic assessments.  Results: ITI-214 inhibited PDE1A (Ki = 33 pmol) with >1000-fold selectivity for the nearest other PDE family (PDE4D) and displayed minimal off-target binding interactions in a 70-substrate selectivity profile.  By using specific timing of oral ITI-214 administration, it was demonstrated in the NOR that ITI-214 is able to enhance acquisition, consolidation, and retrieval memory processes.  All memory effects were in the absence of effects on exploratory behavior.  ITI-214 did not disrupt the risperidone pharmacokinetic profile or effects in CAR.  Conclusions: ITI-214 improved the memory processes of acquisition, consolidation, and retrieval across a broad dose range (0.1-10 mg/kg, po) without disrupting the antipsychotic-like activity of a clin. antipsychotic medication, specifically risperidone.  Clin. development of ITI-214 is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7eUb8S0yISLVg90H21EOLACvtfcHk0lhpYwcmKlRIWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF&md5=90f1653bd30aaf1ffe5a543f0181e4c1</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4346-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4346-2%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DWadenberg%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%2BL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%2BW.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMates%26aufirst%3DS.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DPreclinical%2520profile%2520of%2520ITI-214%252C%2520an%2520inhibitor%2520of%2520phosphodiesterase%25201%252C%2520for%2520enhancement%2520of%2520memory%2520performance%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26spage%3D3113%26epage%3D3124%26doi%3D10.1007%2Fs00213-016-4346-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinilla, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedegaard, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, U.</span></span> <span> </span><span class="NLM_article-title">Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">2563</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1111/bph.13868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fbph.13868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28548283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=2563-2575&author=M.+Laursenauthor=L.+Beckauthor=J.+Kehlerauthor=C.+T.+Christoffersenauthor=C.+Bundgaardauthor=S.+Mogensenauthor=T.+J.+Mowauthor=E.+Pinillaauthor=J.+S.+Knudsenauthor=E.+R.+Hedegaardauthor=M.+Grunnetauthor=U.+Simonsen&title=Novel+selective+PDE+type+1+inhibitors+cause+vasodilatation+and+lower+blood+pressure+in+rats&doi=10.1111%2Fbph.13868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats</span></div><div class="casAuthors">Laursen, Morten; Beck, Lilliana; Kehler, Jan; Christoffersen, Claus Tornby; Bundgaard, Christoffer; Mogensen, Susie; Mow, Tomas Joachim; Pinilla, Estefano; Knudsen, Jakob Schoellhammer; Hedegaard, Elise Roge; Grunnet, Morten; Simonsen, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2563-2575</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The PDE enzymes (PDE1-11) hydrolyze and thus inactivate cyclic nucleotides and are important in the regulation of the cardiovascular system.  Here,we have investigated the effects on the cardiovascular system, of two novel selective PDE1 inhibitors, Lu AF41228 and Lu AF58027.  Exptl. Approach : We used rat mesenteric small arteries (internal diams. of 200-300 μm), RT-PCR and measured isometric wall tension.  Effects of Lu AF41228 and Lu AF58027 on heart rate and BP were assessed in both anesthetized and conscious male rats.  Key Results : Nanomolar concns. of Lu AF41228 and Lu AF58027 inhibited PDE1A, PDE1B and PDE1C enzyme activity, while micromolar concns. were required to observe inhibitory effects at other PDEs.  RT-PCR revealed expression of PDE1A, PDE1B and PDE1C in rat brain, heart and aorta, but only PDE1A and PDE1B in mesenteric arteries.  In rat isolated mesenteric arteries contracted with phenylephrine or U46619, Lu AF41228 and Lu AF58027 induced concn.-dependent relaxations which were markedly reduced by inhibitors of guanylate cyclase, ODQ, and adenylate cyclase, SQ22536, and in prepns. without endothelium.  In anesthetized rats, Lu AF41228 and Lu AF58027 dose-dependently lowered mean BP and increased heart rate.  In conscious rats with telemetric pressure transducers, repeated dosing with Lu AF41228 lowered mean arterial BP 10-15 mmHg and increased heart rate.  Conclusions and Implications : These novel PDE1 inhibitors induce vasodilation and lower BP, suggesting a potential use of these vasodilators in the treatment of hypertension and vasospasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW-SCH2nKBlrVg90H21EOLACvtfcHk0lhpYwcmKlRIWg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmu7%252FF&md5=6379f7126cbddb332c41e5713e02427d</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fbph.13868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13868%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DM.%26aulast%3DBeck%26aufirst%3DL.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DMogensen%26aufirst%3DS.%26aulast%3DMow%26aufirst%3DT.%2BJ.%26aulast%3DPinilla%26aufirst%3DE.%26aulast%3DKnudsen%26aufirst%3DJ.%2BS.%26aulast%3DHedegaard%26aufirst%3DE.%2BR.%26aulast%3DGrunnet%26aufirst%3DM.%26aulast%3DSimonsen%26aufirst%3DU.%26atitle%3DNovel%2520selective%2520PDE%2520type%25201%2520inhibitors%2520cause%2520vasodilatation%2520and%2520lower%2520blood%2520pressure%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D2563%26epage%3D2575%26doi%3D10.1111%2Fbph.13868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khammy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalsgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkersen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aalkjr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span> <span> </span><span class="NLM_article-title">PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">4186</span>– <span class="NLM_lpage">4198</span>, <span class="refDoi"> DOI: 10.1111/bph.14034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fbph.14034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28910498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Glt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=4186-4198&author=M.+M.+Khammyauthor=T.+Dalsgaardauthor=P.+H.+Larsenauthor=C.+T.+Christoffersenauthor=D.+Clausenauthor=L.+K.+Rasmussenauthor=L.+Folkersenauthor=M.+Grunnetauthor=J.+Kehlerauthor=C.+Aalkjrauthor=J.+Nielsen&title=PDE1A+inhibition+elicits+cGMP-dependent+relaxation+of+rat+mesenteric+arteries&doi=10.1111%2Fbph.14034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries</span></div><div class="casAuthors">Khammy, Makhala Michell; Dalsgaard, Thomas; Larsen, Peter Hjorringgaard; Christoffersen, Claus Tornby; Clausen, Dorte; Rasmussen, Lars Kyhn; Folkersen, Lasse; Grunnet, Morten; Kehler, Jan; Aalkjaer, Christian; Nielsen, Jacob</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4186-4198</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PDE1, a subfamily of cyclic nucleotide PDEs consisting of three isoforms, PDE1A, PDE1B and PDE1C, has been implicated in the regulation of vascular tone.  The PDE1 isoform(s) responsible for tone regulation is unknown.  This study used isoform-preferring PDE1 inhibitors, Lu AF58027, Lu AF64196, Lu AF66896 and Lu AF67897, to investigate the relative contribution of PDE1 isoforms to regulation of vascular tone.  Exptl. Approach : In rat mesenteric arteries, expression and localization of Pde1 isoforms were detd. by quant. PCR and in situ hybridization, and physiol. impact of PDE1 inhibition was evaluated by isometric tension recordings.  Key Results : In rat mesenteric arteries, Pde1a mRNA expression was higher than Pde1b and Pde1c.  In situ hybridization revealed localization of Pde1a to vascular smooth muscle cells (VSMCs) and only minor appearance of Pde1b and Pde1c.  The potency of the PDE1 inhibitors at eliciting relaxation showed excellent correlation with their potency at inhibiting PDE1A.  Thus, Lu AF58027 was the most potent at inhibiting PDE1A and was also the most potent at eliciting relaxation in mesenteric arteries.  Inhibition of NOS with L-NAME, sol. GC with ODQ or PKG with Rp-8-Br-PET-cGMP all attenuated the inhibitory effect of PDE1 on relaxation, whereas PKA inhibition with H89 had no effect.  Conclusions and Implications : Pde1a is the dominant PDE1 isoform present in VSMCs, and relaxation mediated by PDE1A inhibition is predominantly driven by enhanced cGMP signalling.  These results imply that isoform-selective PDE1 inhibitors are powerful investigative tools allowing examn. of physiol. and pathol. roles of PDE1 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA0cqyoTWmrbVg90H21EOLACvtfcHk0litaovX4LRNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Glt7jI&md5=3aa92761452be0e054b03ccb2a3724de</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fbph.14034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14034%26sid%3Dliteratum%253Aachs%26aulast%3DKhammy%26aufirst%3DM.%2BM.%26aulast%3DDalsgaard%26aufirst%3DT.%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DClausen%26aufirst%3DD.%26aulast%3DRasmussen%26aufirst%3DL.%2BK.%26aulast%3DFolkersen%26aufirst%3DL.%26aulast%3DGrunnet%26aufirst%3DM.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DAalkjr%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DJ.%26atitle%3DPDE1A%2520inhibition%2520elicits%2520cGMP-dependent%2520relaxation%2520of%2520rat%2520mesenteric%2520arteries%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D4186%26epage%3D4198%26doi%3D10.1111%2Fbph.14034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branstetter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrous, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barido, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerston, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedervall, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmelzer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabaei, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective phosphodiesterase 1 inhibitors with memory enhancing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3472</span>– <span class="NLM_lpage">3483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3472-3483&author=B.+Dyckauthor=B.+Branstetterauthor=T.+Gharbaouiauthor=A.+R.+Hudsonauthor=J.+G.+Breitenbucherauthor=L.+Gomezauthor=I.+Botrousauthor=T.+Marroneauthor=R.+Baridoauthor=C.+K.+Allerstonauthor=E.+P.+Cedervallauthor=R.+Xuauthor=V.+Sridharauthor=R.+Barkerauthor=K.+Aertgeertsauthor=K.+Schmelzerauthor=D.+Neulauthor=D.+Leeauthor=M.+E.+Massariauthor=C.+B.+Andersenauthor=K.+Sebringauthor=X.+B.+Zhouauthor=R.+Petroskiauthor=J.+Limberisauthor=M.+Augustinauthor=L.+E.+Chunauthor=T.+E.+Edwardsauthor=M.+Petersauthor=A.+Tabatabaei&title=Discovery+of+selective+phosphodiesterase+1+inhibitors+with+memory+enhancing+properties&doi=10.1021%2Facs.jmedchem.7b00302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties</span></div><div class="casAuthors">Dyck, Brian; Branstetter, Bryan; Gharbaoui, Tawfik; Hudson, Andrew R.; Breitenbucher, J. Guy; Gomez, Laurent; Botrous, Iriny; Marrone, Tami; Barido, Richard; Allerston, Charles K.; Cedervall, E. Peder; Xu, Rui; Sridhar, Vandana; Barker, Ryan; Aertgeerts, Kathleen; Schmelzer, Kara; Neul, David; Lee, Dong; Massari, Mark Eben; Andersen, Carsten B.; Sebring, Kristen; Zhou, Xianbo; Petroski, Robert; Limberis, James; Augustin, Martin; Chun, Lawrence E.; Edwards, Thomas E.; Peters, Marco; Tabatabaei, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3472-3483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent thienotriazolopyrimidinone-based PDE1 inhibitors was discovered.  X-ray crystal structures of example compds. from this series in complex with the catalytic domain of PDE1B and PDE10A were detd., allowing optimization of PDE1B potency and PDE selectivity.  Redn. of hERG affinity led to greater than a 3000-fold selectivity for PDE1B over hERG. 6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one was identified as an orally bioavailable and brain penetrating PDE1B enzyme inhibitor with potent memory-enhancing effects in a rat model of object recognition memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX2wxwLW-OPLVg90H21EOLACvtfcHk0litaovX4LRNeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D&md5=ff7c3c08432646621c8d2cc32693e75f</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00302%26sid%3Dliteratum%253Aachs%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DBranstetter%26aufirst%3DB.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DHudson%26aufirst%3DA.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMarrone%26aufirst%3DT.%26aulast%3DBarido%26aufirst%3DR.%26aulast%3DAllerston%26aufirst%3DC.%2BK.%26aulast%3DCedervall%26aufirst%3DE.%2BP.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DSridhar%26aufirst%3DV.%26aulast%3DBarker%26aufirst%3DR.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DSchmelzer%26aufirst%3DK.%26aulast%3DNeul%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DMassari%26aufirst%3DM.%2BE.%26aulast%3DAndersen%26aufirst%3DC.%2BB.%26aulast%3DSebring%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.%2BB.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DLimberis%26aufirst%3DJ.%26aulast%3DAugustin%26aufirst%3DM.%26aulast%3DChun%26aufirst%3DL.%2BE.%26aulast%3DEdwards%26aufirst%3DT.%2BE.%26aulast%3DPeters%26aufirst%3DM.%26aulast%3DTabatabaei%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520selective%2520phosphodiesterase%25201%2520inhibitors%2520with%2520memory%2520enhancing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3472%26epage%3D3483%26doi%3D10.1021%2Facs.jmedchem.7b00302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Movsesian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandeput, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective periphery-restricted quinazoline inhibitors of the cyclic nucleotide phosphodiesterase PDE1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4635</span>– <span class="NLM_lpage">4640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVCiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4635-4640&author=J.+M.+Humphreyauthor=M.+Movsesianauthor=C.+W.+Am+Endeauthor=S.+L.+Beckerauthor=T.+A.+Chappieauthor=S.+Jenkinsonauthor=J.+L.+Lirasauthor=S.+Lirasauthor=C.+Orozcoauthor=J.+Panditauthor=F.+F.+Vajdosauthor=F.+Vandeputauthor=E.+Yangauthor=F.+S.+Menniti&title=Discovery+of+potent+and+selective+periphery-restricted+quinazoline+inhibitors+of+the+cyclic+nucleotide+phosphodiesterase+PDE1&doi=10.1021%2Facs.jmedchem.8b00374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1</span></div><div class="casAuthors">Humphrey, John M.; Movsesian, Matthew; am Ende, Christopher W.; Becker, Stacey L.; Chappie, Thomas A.; Jenkinson, Stephen; Liras, Jennifer L.; Liras, Spiros; Orozco, Christine; Pandit, Jayvardhan; Vajdos, Felix F.; Vandeput, Fabrice; Yang, Eddie; Menniti, Frank S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4635-4640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We disclose the discovery and X-ray cocrystal data of potent, selective quinazoline inhibitors of PDE1.  Inhibitor (S)-3 readily attains free plasma concns. above PDE1 IC50 values and has restricted brain access.  The racemic compd. 3 inhibits >75% of PDE hydrolytic activity in sol. samples of human myocardium, consistent with heightened PDE1 activity in this tissue.  These compds. represent promising new tools to probe the value of PDE1 inhibition in the treatment of cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyfBNdGu_yn7Vg90H21EOLACvtfcHk0lgUvy6TijDqXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVCiu7k%253D&md5=733a5dbd18abb79d3522a6cce873df71</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00374%26sid%3Dliteratum%253Aachs%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DMovsesian%26aufirst%3DM.%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DOrozco%26aufirst%3DC.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DVandeput%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520periphery-restricted%2520quinazoline%2520inhibitors%2520of%2520the%2520cyclic%2520nucleotide%2520phosphodiesterase%2520PDE1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4635%26epage%3D4640%26doi%3D10.1021%2Facs.jmedchem.8b00374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Wennogle, L. P.</span>; <span class="NLM_string-name">Zhao, J.</span>; <span class="NLM_string-name">Zheng, H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-1-trageting tracers and methods</span>. WO <span class="NLM_patent">2011043816 A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+Li&author=L.+P.+Wennogle&author=J.+Zhao&author=H.+Zheng&title=Phosphodiesterase-1-trageting+tracers+and+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26atitle%3DPhosphodiesterase-1-trageting%2520tracers%2520and%2520methods%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kealey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aigbirhio, F. I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and radiolabelling of the first potential PET radiotracer for imaging PDE1</span>. <i>J. Labelled Comp Radiopharm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">S111</span>– <span class="NLM_lpage">S640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28502124" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=S111-S640&issue=1&author=S.+Kealeyauthor=F.+I.+Aigbirhio&title=Synthesis+and+radiolabelling+of+the+first+potential+PET+radiotracer+for+imaging+PDE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKealey%26aufirst%3DS.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DSynthesis%2520and%2520radiolabelling%2520of%2520the%2520first%2520potential%2520PET%2520radiotracer%2520for%2520imaging%2520PDE1%26jtitle%3DJ.%2520Labelled%2520Comp%2520Radiopharm%26date%3D2017%26volume%3D60%26issue%3D1%26spage%3DS111%26epage%3DS640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuzhuppilly
Ramakrishnan, N.</span>; <span class="NLM_string-name">Kealey, S.</span>; <span class="NLM_string-name">Zhou, X.</span>; <span class="NLM_string-name">Williamson, D.</span>; <span class="NLM_string-name">Aigbirhio, F.</span></span> <span> </span><span class="NLM_article-title">In vivo PET evaluation of a potential PDE1 radiotracer - [11C](±)-PF04822163</span>. In  <i>The XII International Symposium of Functional Neuroreceptor Mapping of the Living Brain</i>, <span class="NLM_publisher-loc">London, UK</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=N.+Kuzhuppilly%0ARamakrishnan&author=S.+Kealey&author=X.+Zhou&author=D.+Williamson&author=F.+Aigbirhio&title=In+vivo+PET+evaluation+of+a+potential+PDE1+radiotracer+-+%5B11C%5D%28%C2%B1%29-PF04822163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKuzhuppilly%2BRamakrishnan%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520PET%2520evaluation%2520of%2520a%2520potential%2520PDE1%2520radiotracer%2520-%2520%255B11C%255D%2528%25C2%25B1%2529-PF04822163%26jtitle%3DThe%2520XII%2520International%2520Symposium%2520of%2520Functional%2520Neuroreceptor%2520Mapping%2520of%2520the%2520Living%2520Brain%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoidl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koesling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, M.</span></span> <span> </span><span class="NLM_article-title">Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">25782</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.017194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.M109.017194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19632989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25782-90&author=C.+Russwurmauthor=G.+Zoidlauthor=D.+Koeslingauthor=M.+Russwurm&title=Dual+acylation+of+PDE2A+splice+variant+3%3A+targeting+to+synaptic+membranes&doi=10.1074%2Fjbc.M109.017194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Dual acylation of PDE2A splice variant 3: Targeting to synaptic membranes</span></div><div class="casAuthors">Russwurm, Corina; Zoidl, Georg; Koesling, Doris; Russwurm, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25782-25790</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cGMP-stimulated PDE2A hydrolyzes both cyclic nucleotides, cGMP and cAMP.  Three splice variants have been cloned from several species.  Whereas PDE2A1 is sol., PDE2A2 and PDE2A3 are membrane-bound enzymes of rat and bovine origin, resp.  To date it is unclear whether one species expresses all three variants.  The splice variants only differ in their N termini, which likely det. the subcellular localization.  However, the mechanism for membrane attachment remains unknown.  Here, we show that myristoylation underlies membrane targeting of PDE2A3.  The myristoylated enzyme was bound to plasma membranes, whereas mutation of the myristoyl recipient Gly2 prevented incorporation of [3H]myristate and turned PDE2A3 completely sol.  Addnl., Cys5 and to a minor extent Cys11 are required for targeting of PDE2A3.  Substitution of the putatively palmitoylated cysteines partially solubilized the enzyme and led to an accumulation in the endoplasmic reticulum/Golgi compartment, as shown by fluorescence microscopy in HEK 293 and PC12 cells.  In vivo, PDE2A is expressed in many tissues.  By using newly generated antibodies selectively detecting the splice variants PDE2A3 or PDE2A1, resp., we demonstrate on the protein level PDE2A3 expression in mouse brain where it is entirely membrane-assocd. and a widespread expression of sol. PDE2A1 in mouse tissues.  We show that PDE2A localizes to synaptosomal membranes and in primary cultures of hippocampal neurons partially overlaps with the presynaptic marker synaptophysin as demonstrated by immunofluorescence.  In sum, these results demonstrate dual acylation as mechanism targeting neuronal PDE2A3 to synapses thereby ensuring local control of cyclic nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGAPRP71KIt7Vg90H21EOLACvtfcHk0lgUvy6TijDqXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtr7I&md5=b5a55f15e1bc5b15d7b74867e8160be2</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.017194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.017194%26sid%3Dliteratum%253Aachs%26aulast%3DRusswurm%26aufirst%3DC.%26aulast%3DZoidl%26aufirst%3DG.%26aulast%3DKoesling%26aufirst%3DD.%26aulast%3DRusswurm%26aufirst%3DM.%26atitle%3DDual%2520acylation%2520of%2520PDE2A%2520splice%2520variant%25203%253A%2520targeting%2520to%2520synaptic%2520membranes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25782%26epage%3D90%26doi%3D10.1074%2Fjbc.M109.017194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span> <span> </span><span class="NLM_article-title">PDE2 inhibition: potential for the treatment of cognitive disorders</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6522</span>– <span class="NLM_lpage">6527</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2013.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24189054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6522-6527&author=L.+Gomezauthor=J.+G.+Breitenbucher&title=PDE2+inhibition%3A+potential+for+the+treatment+of+cognitive+disorders&doi=10.1016%2Fj.bmcl.2013.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">PDE2 inhibition: Potential for the treatment of cognitive disorders</span></div><div class="casAuthors">Gomez, Laurent; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6522-6527</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase inhibition has received much attention in the past 20 years for the potential treatment of CNS disorders.  A primary focus of this work is the enhancement of memory and/or cognitive functioning.  The role of PDEs in the augmentation of cyclic nucleotide signaling makes these enzymes attractive targets for enhancing the effects of neuronal communication.  This review focuses on recent findings with respect to the role of PDE2 inhibition in cognitive functioning.  Special attention is paid to recently disclosed, selective tool compds. and the use of these tool compds. to support the role of PDE2 inhibition in cognition.  Recently reported SAR and modeling work will be presented along with discussion of the entry of new PDE2 inhibitors into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUUFzh2-kTrVg90H21EOLACvtfcHk0lgcpBfG8sKjOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL&md5=04ca2bdc35dc0b436a228ba62934b91e</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DPDE2%2520inhibition%253A%2520potential%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6522%26epage%3D6527%26doi%3D10.1016%2Fj.bmcl.2013.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Am Ende, C. W.</span>; <span class="NLM_string-name">Kormos, B.</span>; <span class="NLM_string-name">Humphrey, J. M.</span></span> <span> </span><span class="NLM_article-title">The state of the art in selective PDE2A inhibitor design</span>. In  <i>Phosphodiesterases and Their Inhibitors</i>; <span class="NLM_year">2014</span>; Chapter 6, p  <span class="NLM_fpage">83</span>. <span class="refDoi"> DOI: 10.1002/9783527682348.ch06</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2F9783527682348.ch06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=83&author=C.+W.+Am+Ende&author=B.+Kormos&author=J.+M.+Humphrey&title=Phosphodiesterases+and+Their+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2F9783527682348.ch06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527682348.ch06%26sid%3Dliteratum%253Aachs%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26atitle%3DThe%2520state%2520of%2520the%2520art%2520in%2520selective%2520PDE2A%2520inhibitor%2520design%26btitle%3DPhosphodiesterases%2520and%2520Their%2520Inhibitors%26date%3D2014%26spage%3D83%26doi%3D10.1002%2F9783527682348.ch06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domek-Lopacinska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strosznajder, J. B.</span></span> <span> </span><span class="NLM_article-title">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1216</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2008.02.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.brainres.2008.02.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=18499090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1216&publication_year=2008&pages=68-77&author=K.+Domek-Lopacinskaauthor=J.+B.+Strosznajder&title=The+effect+of+selective+inhibition+of+cyclic+GMP+hydrolyzing+phosphodiesterases+2+and+5+on+learning+and+memory+processes+and+nitric+oxide+synthase+activity+in+brain+during+aging&doi=10.1016%2Fj.brainres.2008.02.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span></div><div class="casAuthors">Domek-Lopacinska, K.; Strosznajder, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our previous studies have shown that there is a lower cGMP concn. in the aged brain as well as an alteration in the activity of cGMP-hydrolyzing phosphodiesterases (PDEs) and nitric oxide synthase (NOS).  The aim of this study was to investigate the effect of specific inhibitors of selected PDEs on object recognition memory and locomotor activity during aging, and to correlate their action with NOS activity in the following brain regions: hippocampus, striatum, and cerebral cortex.  The study was carried out using 3, 12, and 24 mo-old rats.  Inhibitors of PDE2 and PDE5 (Bayer 60-7550 and zaprinast, resp.) were used.  Evaluation of memory and locomotor activity was carried out using an object recognition task and the open field test.  NOS activity was detd. using a radiochem. method after behavioral anal. in the cytosolic fraction from all brain areas investigated.  We have found that the inhibitor of PDE2, Bayer 60-7550, improves object recognition memory in all age groups investigated and increases basal constitutive NOS activity in the hippocampus and striatum.  Moreover, in 3 mo-old rats, addnl. inhibition of PDE5 by zaprinast improves object memory and elevates NOS activity in all brain regions studied.  Specific inhibition of nNOS eliminates the effect of Bayer 60-7550 on memory function and on NOS activity in 24 mo-old rats.  In summary, our results indicate that inhibition of PDE2 is able to improve cognition and memory function in 3, 12, and 24 mo-old rats through the enhancement of nNOS activity in the brain, whereas inhibition of PDE5 is effective only in 3 mo-old animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroSn1Uayy6qrVg90H21EOLACvtfcHk0lgcpBfG8sKjOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D&md5=bbc77008c158141527bb046db313f6bf</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.02.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.02.108%26sid%3Dliteratum%253Aachs%26aulast%3DDomek-Lopacinska%26aufirst%3DK.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520effect%2520of%2520selective%2520inhibition%2520of%2520cyclic%2520GMP%2520hydrolyzing%2520phosphodiesterases%25202%2520and%25205%2520on%2520learning%2520and%2520memory%2520processes%2520and%2520nitric%2520oxide%2520synthase%2520activity%2520in%2520brain%2520during%2520aging%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1216%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.brainres.2008.02.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Donkelaar, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrington, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J. H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1925</span>, <span class="refDoi"> DOI: 10.1038/npp.2009.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnpp.2009.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19262466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1914-1925&author=K.+Ruttenauthor=E.+L.+Van+Donkelaarauthor=L.+Ferringtonauthor=A.+Bloklandauthor=E.+Bollenauthor=H.+W.+Steinbuschauthor=P.+A.+Kellyauthor=J.+H.+Prickaerts&title=Phosphodiesterase+inhibitors+enhance+object+memory+independent+of+cerebral+blood+flow+and+glucose+utilization+in+rats&doi=10.1038%2Fnpp.2009.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span></div><div class="casAuthors">Rutten, Kris; Van Donkelaar, Eva L.; Ferrington, Linda; Blokland, Arjan; Bollen, Eva; Steinbusch, Harry W. M.; Kelly, Paul A. T.; Prickaerts, Jos H. H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-1925</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors prevent the breakdown of the second messengers, cAMP (cAMP) and cyclic GMP (cGMP), and are currently studied as possible targets for cognitive enhancement.  Earlier studies indicated beneficial effects of PDE inhibitors in object recognition.  In this study we tested the effects of three PDE inhibitors on spatial memory as assessed in a place and object recognition task.  Furthermore, as both cAMP and cGMP are known vasodilators, the effects of PDE inhibition on cognitive functions could be explained by enhancement of cerebrovascular function.  We examd. this possibility by measuring the effects of PDE5 and PDE4 inhibitor treatment on local cerebral blood flow and glucose utilization in rats using [14C]-iodoantipyrine and [14C]-2-deoxyglucose quant. autoradiog., resp.  In the spatial location task, PDE5 inhibition (cGMP) with vardenafil enhanced only early phase consolidation, PDE4 inhibition (cAMP) with rolipram enhanced only late phase consolidation, and PDE2 inhibition (cAMP and cGMP) with Bay 60-7550 enhanced both consolidation processes.  Furthermore, PDE5 inhibition had no cerebrovascular effects in hippocampal or rhinal areas.  PDE4 inhibition increased rhinal, but not hippocampal blood flow, whereas it decreased glucose utilization in both areas.  In general, PDE5 inhibition decreased the ratio between blood flow and glucose utilization, indicative of general oligemia; whereas PDE4 inhibition increased this ratio, indicative of general hyperemia.  Both oligemic and hyperemic conditions are detrimental for brain function and do not explain memory enhancement.  These results underscore the specific effects of cAMP and cGMP on memory consolidation (object and spatial memory) and provide evidence that the underlying mechanisms of PDE inhibition on cognition are independent of cerebrovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAElwT0GL1rVg90H21EOLACvtfcHk0lhuFCkOlDwGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D&md5=506d0fbcb1b4a7a0c25bf92ab08fc270</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.24%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DVan%2BDonkelaar%26aufirst%3DE.%2BL.%26aulast%3DFerrington%26aufirst%3DL.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3DKelly%26aufirst%3DP.%2BA.%26aulast%3DPrickaerts%26aufirst%3DJ.%2BH.%26atitle%3DPhosphodiesterase%2520inhibitors%2520enhance%2520object%2520memory%2520independent%2520of%2520cerebral%2520blood%2520flow%2520and%2520glucose%2520utilization%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1914%26epage%3D1925%26doi%3D10.1038%2Fnpp.2009.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klabnik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neurobiolaging.2014.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25442113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=955-970&author=Y.+Xuauthor=J.+Panauthor=J.+Sunauthor=L.+Dingauthor=L.+Ruanauthor=M.+Reedauthor=X.+Yuauthor=J.+Klabnikauthor=D.+Linauthor=J.+Liauthor=L.+Chenauthor=C.+Zhangauthor=H.+Zhangauthor=J.+M.+O%E2%80%99Donnell&title=Inhibition+of+phosphodiesterase+2+reverses+impaired+cognition+and+neuronal+remodeling+caused+by+chronic+stress&doi=10.1016%2Fj.neurobiolaging.2014.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span></div><div class="casAuthors">Xu, Ying; Pan, Jianchun; Sun, Jiao; Ding, Lianshu; Ruan, Lina; Reed, Miranda; Yu, Xuefeng; Klabni, Jonathan; Lin, Dan; Li, Jianxin; Chen, Ling; Zhang, Chong; Zhang, Hanting; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">955-970</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic stress and neuronal vulnerability have recently been recognized as factors contributing to cognitive disorders.  One way to modify neuronal vulnerability is through mediation of phosphodiesterase 2 (PDE2), an enzyme that exerts its action on cognitive processes via the control of intracellular second messengers, cGMP and, to a lesser extent, cAMP.  This study explored the effects of a PDE2 inhibitor, Bay 60-7550, on stress-induced learning and memory dysfunction in terms of its ramification on behavioral, morphol., and mol. changes.  Bay 60-7550 reversed stress-induced cognitive impairment in the Morris water maze, novel object recognition, and location tasks (object recognition test and/or object location test), effects prevented by treatment with 7-NI, a selective inhibitor of neuronal nitric oxide synthase; MK801, a glutamate receptor (NMDAR) inhibitor; myr-AIP, a CaMKII inhibitor; and KT5823, a protein kinase G inhibitor.  Bay 60-7550 also ameliorated stress-induced structural remodeling in the CA1 of the hippocampus, leading to increases in dendritic branching, length, and spine d.  However, the neuroplasticity initiated by Bay 60-7550 was not seen in the presence of 7-NI, MK801, myr-AIP, or KT5823.  PDE2 inhibition reduced stress-induced extracellular-regulated protein kinase activation and attenuated stress-induced decreases in transcription factors (e.g., Elk-1, TORC1, and CREB phosphorylation) and plasticity-related proteins (e.g., Egr-1 and brain-derived neurotrophic factor).  Pretreatment with inhibitors of NMDA, CaMKII, neuronal nitric oxide synthase, and protein kinase G (or protein kinase A) blocked the effects of Bay 60-7550 on cGMP or cAMP signaling.  These findings indicate that the effect of PDE2 inhibition on stress-induced memory impairment is potentially mediated via modulation of neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4VvV9CfvU7Vg90H21EOLACvtfcHk0lhuFCkOlDwGQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL&md5=bd201c08a67c20c036958d7ed02cd25f</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DRuan%26aufirst%3DL.%26aulast%3DReed%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DKlabnik%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520reverses%2520impaired%2520cognition%2520and%2520neuronal%2520remodeling%2520caused%2520by%2520chronic%2520stress%26jtitle%3DNeurobiol.%2520Aging%26date%3D2015%26volume%3D36%26spage%3D955%26epage%3D970%26doi%3D10.1016%2Fj.neurobiolaging.2014.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span> <span> </span><span class="NLM_article-title">Novel phosphodiesterase inhibitors for cognitive improvement in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5467</span>– <span class="NLM_lpage">5483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5467-5483&author=Y.+Wuauthor=Z.+Liauthor=Y.+Y.+Huangauthor=D.+Wuauthor=H.+B.+Luo&title=Novel+phosphodiesterase+inhibitors+for+cognitive+improvement+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b01370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease</span></div><div class="casAuthors">Wu, Yinuo; Li, Zhe; Huang, Yi-You; Wu, Deyan; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5467-5483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is one of the greatest public health challenges.  Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).  Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concn. of cAMP and/or cGMP.  Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclin. studies and over 15 of them have been subjected to clin. trials.  The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclin. studies and clin. trials.  The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom1l9eMNKCt7Vg90H21EOLACvtfcHk0ljScIx9XgCP9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D&md5=87cd22fa21c661f4cb5dc2155368bd7c</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DY.%2BY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26atitle%3DNovel%2520phosphodiesterase%2520inhibitors%2520for%2520cognitive%2520improvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5467%26epage%3D5483%26doi%3D10.1021%2Facs.jmedchem.7b01370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1002/syn.21840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26178667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=484-496&author=D.+Fernandez-Fernandezauthor=H.+Rosenbrockauthor=K.+S.+Kroker&title=Inhibition+of+PDE2A%2C+but+not+PDE9A%2C+modulates+presynaptic+short-term+plasticity+measured+by+paired-pulse+facilitation+in+the+CA1+region+of+the+hippocampus&doi=10.1002%2Fsyn.21840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span></div><div class="casAuthors">Fernandez-Fernandez, Diego; Rosenbrock, Holger; Kroker, Katja S.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease.  Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals.  However, the functional relevance of their putative different localization in the neuron is not understood.  Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A.  For this purpose, we used paired-pulse facilitation (PPF), a model of short-term synaptic plasticity related to presynaptic function.  First, we performed a series of expts. to validate the model in acute rat hippocampal slices using several ref. substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists.  Second, we analyzed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission.  Our results show that the interplay between the adenylyl cyclase activator forskolin, the sol. guanylyl cyclase activator BAY 41-8543 and the PDE2A inhibitor PF-999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition.  On the contrary, inhibition of PDE9A did not alter PPF under similar conditions.  In conclusion, these data provide new evidence supporting a role of PDE2A modulating short-term synaptic plasticity.  Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMx3KC2TNDKrVg90H21EOLACvtfcHk0ljScIx9XgCP9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI&md5=990c6e54c53f4d8a08ae91d2fbdcef83</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21840%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Fernandez%26aufirst%3DD.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKroker%26aufirst%3DK.%2BS.%26atitle%3DInhibition%2520of%2520PDE2A%252C%2520but%2520not%2520PDE9A%252C%2520modulates%2520presynaptic%2520short-term%2520plasticity%2520measured%2520by%2520paired-pulse%2520facilitation%2520in%2520the%2520CA1%2520region%2520of%2520the%2520hippocampus%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D484%26epage%3D496%26doi%3D10.1002%2Fsyn.21840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable, brain-penetrating, in vivo active phosphodiesterase 2A inhibitor lead series for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7658</span>– <span class="NLM_lpage">7676</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7658-7676&author=S.+Mikamiauthor=S.+Sasakiauthor=Y.+Asanoauthor=O.+Ujikawaauthor=S.+Fukumotoauthor=K.+Nakashimaauthor=H.+Okiauthor=N.+Kamiguchiauthor=H.+Imadaauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+an+orally+bioavailable%2C+brain-penetrating%2C+in+vivo+active+phosphodiesterase+2A+inhibitor+lead+series+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Sasaki, Shigekazu; Asano, Yasutomi; Ujikawa, Osamu; Fukumoto, Shoji; Nakashima, Kosuke; Oki, Hideyuki; Kamiguchi, Naomi; Imada, Haruka; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7658-7676</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors describe the discovery of a potent, selective, brain-penetrating, in vivo active phosphodiesterase (PDE) 2A inhibitor lead series.  To identify high-quality leads suitable for optimization and enable validation of the physiol. function of PDE2A in vivo, structural modifications of the high-throughput screening hit were performed.  The lead generation efforts revealed three key potency-enhancing functionalities with minimal increases in mol. wt. (MW) and no change in topol. polar surface area (TPSA).  Combining these structural elements led to the identification of 6-methyl-N-((1R)-1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (38a), a mol. with the desired balance of preclin. properties.  Further characterization by cocrystal structure anal. of (38a) bound to PDE2A uncovered a unique binding mode and provided insights into its obsd. potency and PDE selectivity.  Compd. (38a) significantly elevated 3',5'-cGMP levels in mouse brain following oral administration, thus validating this compd. as a useful pharmacol. tool and an attractive lead for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXk4ZjO3RKAbVg90H21EOLACvtfcHk0lgzRcd3ao38qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO&md5=361f9ce22899da731673ed86ade3f8aa</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00709%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%252C%2520brain-penetrating%252C%2520in%2520vivo%2520active%2520phosphodiesterase%25202A%2520inhibitor%2520lead%2520series%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7658%26epage%3D7676%26doi%3D10.1021%2Facs.jmedchem.7b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate N-((1<i>S</i>)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2, 3-dihydropyrido[2,3-<i>b</i>]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915): A highly potent, selective, and brain-penetrating phosphodiesterase 2A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7677</span>– <span class="NLM_lpage">7702</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7677-7702&author=S.+Mikamiauthor=S.+Nakamuraauthor=T.+Ashizawaauthor=I.+Nomuraauthor=M.+Kawasakiauthor=S.+Sasakiauthor=H.+Okiauthor=H.+Kokuboauthor=I.+D.+Hoffmanauthor=H.+Zouauthor=N.+Uchiyamaauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=H.+Imadaauthor=N.+Suzukiauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+clinical+candidate+N-%28%281S%29-1-%283-fluoro-4-%28trifluoromethoxy%29phenyl%29-2-methoxyethyl%29-7-methoxy-2-oxo-2%2C+3-dihydropyrido%5B2%2C3-b%5Dpyrazine-4%281H%29-carboxamide+%28TAK-915%29%3A+A+highly+potent%2C+selective%2C+and+brain-penetrating+phosphodiesterase+2A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Nakamura, Shinji; Ashizawa, Tomoko; Nomura, Izumi; Kawasaki, Masanori; Sasaki, Shigekazu; Oki, Hideyuki; Kokubo, Hironori; Hoffman, Isaac D.; Zou, Hua; Uchiyama, Noriko; Nakashima, Kosuke; Kamiguchi, Naomi; Imada, Haruka; Suzuki, Noriko; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7677-7702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 2A inhibitors have emerged as a novel mechanism with potential therapeutic option to ameliorate cognitive dysfunction in schizophrenia or Alzheimer's disease through upregulation of cyclic nucleotides in the brain, and thereby achieve potentiation of cyclic nucleotide signaling pathways.  This article details the expedited optimization of the authors' recently disclosed pyrazolo[1,5-a]pyrimidine lead compd. 4b, leading to the discovery of clin. candidate 36 (I) (TAK-915), which demonstrates an appropriate combination of potency, PDE selectivity, and favorable pharmacokinetic (PK) properties, including brain penetration.  Successful identification of 36 was realized through application of structure-based drug design (SBDD) to further improve potency and PDE selectivity, coupled with prospective design focused on physicochem. properties to deliver brain penetration.  Oral administration of 36 demonstrated significant elevation of 3',5'-cGMP levels in mouse brains, and improved cognitive performance in a novel object recognition task in rats.  Consequently, compd. 36 was advanced into human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCUw5grC_66rVg90H21EOLACvtfcHk0lgzRcd3ao38qQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I&md5=f87cb3ac86b6299fc90e336b88ea2a21</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00807%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DAshizawa%26aufirst%3DT.%26aulast%3DNomura%26aufirst%3DI.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%2520N-%2528%25281S%2529-1-%25283-fluoro-4-%2528trifluoromethoxy%2529phenyl%2529-2-methoxyethyl%2529-7-methoxy-2-oxo-2%252C%25203-dihydropyrido%255B2%252C3-b%255Dpyrazine-4%25281H%2529-carboxamide%2520%2528TAK-915%2529%253A%2520A%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrating%2520phosphodiesterase%25202A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7677%26epage%3D7702%26doi%3D10.1021%2Facs.jmedchem.7b00807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrös-Gil, J. I.</span>; <span class="NLM_string-name">Rombouts, F. J. R.</span>; <span class="NLM_string-name">Traban-Co-Suarez, A. A.</span>; <span class="NLM_string-name">Vanhoof, G. C. P.</span>; <span class="NLM_string-name">De Angelis, M.</span>; <span class="NLM_string-name">Buijnsters, P. J. J. A.</span>; <span class="NLM_string-name">Guillemont, J. E. G.</span>; <span class="NLM_string-name">Bormans, G. M. R.</span>; <span class="NLM_string-name">Celen, S. J. L.</span>; <span class="NLM_string-name">Vliegen, M.</span></span> <span> </span><span class="NLM_article-title">l-Aryl-4-methyl-[l,2,4]triazolo[4,3-a]quinoxaline derivatives</span>. WO <span class="NLM_patent">2013000924 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+I.+Andr%C3%B6s-Gil&author=F.+J.+R.+Rombouts&author=A.+A.+Traban-Co-Suarez&author=G.+C.+P.+Vanhoof&author=M.+De+Angelis&author=P.+J.+J.+A.+Buijnsters&author=J.+E.+G.+Guillemont&author=G.+M.+R.+Bormans&author=S.+J.+L.+Celen&author=M.+Vliegen&title=l-Aryl-4-methyl-%5Bl%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dquinoxaline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25B6s-Gil%26aufirst%3DJ.%2BI.%26atitle%3Dl-Aryl-4-methyl-%255Bl%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dquinoxaline%2520derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span> <span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4568</span>– <span class="NLM_lpage">4579</span>, <span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lhyNwfEbJHgGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabulsi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naganawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafzadeh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyden, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropchan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-PF-05270430, a novel PET radioligand for the phosphodiesterase 2A enzyme</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1453</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.171454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.115.171454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27199356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaktbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1448-1453&author=L.+Chenauthor=N.+Nabulsiauthor=M.+Naganawaauthor=K.+Zasadnyauthor=M.+B.+Skaddanauthor=L.+Zhangauthor=S.+Najafzadehauthor=S.+F.+Linauthor=C.+J.+Helalauthor=T.+L.+Boydenauthor=C.+Changauthor=J.+Ropchanauthor=R.+E.+Carsonauthor=A.+Villalobosauthor=Y.+Huang&title=Preclinical+evaluation+of+18F-PF-05270430%2C+a+novel+PET+radioligand+for+the+phosphodiesterase+2A+enzyme&doi=10.2967%2Fjnumed.115.171454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of 18F-PF-05270430, a novel PET radioligand for the phosphodiesterase 2A enzyme</span></div><div class="casAuthors">Chen, Laigao; Nabulsi, Nabeel; Naganawa, Mika; Zasadny, Kenneth; Skaddan, Marc B.; Zhang, Lei; Najafzadeh, Soheila; Lin, Shu-fei; Helal, Christopher J.; Boyden, Tracey L.; Chang, Cheng; Ropchan, Jim; Carson, Richard E.; Villalobos, Anabella; Huang, Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1448-1453</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">The enzyme phosphodiesterase 2A (PF-05270430) is a potential target for development of novel therapeutic agents for the treatment of cognitive impairments.  The goal of the present study was to evaluate the PDE2A ligand 18F-PF-05270430, 4-(3-fluoroazetidin-1-yl)-7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo[1,5-f][1,2,4]triazine, in nonhuman primates.  18F-PF-05270430 was radiolabeled by 2 methods via nucleophilic substitution of its tosylate precursor.  Tissue metabolite anal. in rodents and PET imaging in nonhuman primates under baseline and blocking conditions were performed to det. the pharmacokinetic and binding characteristics of the new radioligand.  Various kinetic modeling approaches were assessed to select the optimal method for anal. of imaging data.  18F-PF-05270430 was synthesized in greater than 98% radiochem. purity and high specific activity.  In the nonhuman primate brain, uptake of 18F-PF-05270430 was fast, with peak concn. (SUVs of 1.5-1.8 in rhesus monkeys) achieved within 7 min after injection.  The rank order of uptake was striatum > neocortical regions > cerebellum.  Regional time-activity curves were well fitted by the 2-tissuecompartment model and the multilinear anal.-1 (MA1) method to arrive at reliable ests. of regional distribution vol. (VT) and binding potential (BPND) with 120 min of scan data.  Regional VT values (MA1) ranged from 1.28 mL/cm3 in the cerebellum to 3.71 mL/cm3 in the putamen, with a BPND of 0.25 in the temporal cortex and 1.92 in the putamen.  Regional BPND values estd. by the simplified ref. tissue model (SRTM) were similar to those from MA1.  Test-retest variability in high-binding regions (striatum) was 4% ± 6% for MA1 VT, 13% ± 6% for MA1 BPND, and 13% ± 7% SRTM BPND, resp.  Pretreatment of animals with the PDE2A inhibitor PF-05180999 resulted in a dose-dependent redn. of 18F-PF-05270430 specific binding, with a half maximal effective concn. of 69.4 ng/mL in plasma PF-05180999 concn.  18F-PF-05270430 displayed fast and reversible kinetics in nonhuman primates, as well as specific binding blockable by a PDE2A inhibitor.  This is the first PET tracer with desirable imaging properties and demonstrated ability to image and quantify PDE2A in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonEqcoW7Fj7bVg90H21EOLACvtfcHk0lhyNwfEbJHgGQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaktbzL&md5=7ef3b7de193aec4ce0b11d86c9104e73</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.171454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.171454%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DNabulsi%26aufirst%3DN.%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNajafzadeh%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBoyden%26aufirst%3DT.%2BL.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DRopchan%26aufirst%3DJ.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-PF-05270430%252C%2520a%2520novel%2520PET%2520radioligand%2520for%2520the%2520phosphodiesterase%25202A%2520enzyme%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1448%26epage%3D1453%26doi%3D10.2967%2Fjnumed.115.171454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naganawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabulsi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropchan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarabar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartinis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span> <span> </span><span class="NLM_article-title">First-in-human assessment of the novel PDE2A PET radiotracer <sup>18</sup>F-PF-05270430</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1388</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.166850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.115.166850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27103022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaktLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1388-1395&author=M.+Naganawaauthor=R.+N.+Waterhouseauthor=N.+Nabulsiauthor=S.+F.+Linauthor=D.+Labareeauthor=J.+Ropchanauthor=S.+Tarabarauthor=N.+DeMartinisauthor=A.+Ogdenauthor=A.+Banerjeeauthor=Y.+Huangauthor=R.+E.+Carson&title=First-in-human+assessment+of+the+novel+PDE2A+PET+radiotracer+18F-PF-05270430&doi=10.2967%2Fjnumed.115.166850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430</span></div><div class="casAuthors">Naganawa, Mika; Waterhouse, Rikki N.; Nabulsi, Nabeel; Lin, Shu-Fei; Labaree, David; Ropchan, Jim; Tarabar, Sanela; De Martinis, Nicholas; Ogden, Adam; Banerjee, Anindita; Huang, Yiyun; Carson, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1388-1395</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">This was a first-in-human study of the novel phosphodiesterase-2A (PDE2A) PET ligand 18F-PF-05270430.  The primary goals were to det. the appropriate tracer kinetic model to quantify brain uptake and to examine the within-subject test-retest variability.  Methods: In advance of human studies, radiation dosimetry was detd. in nonhuman primates.  Six healthy male subjects participated in a test-retest protocol with dynamic scans and metabolite-cor. input functions.  Nine brain regions of interest were studied, including the striatum, white matter, neocortical regions, and cerebellum.  Multiple modeling methods were applied to calc. vol. of distribution (VT) and binding potentials relative to the nondisplaceable tracer in tissue (BPND), concn. of tracer in plasma (BPP), and free tracer in tissue (BPF).  The cerebellum was selected as a ref. region to calc. binding potentials.  Results: The dosimetry study provided an ED of less than 0.30 mSv/MBq, with the gallbladder as the crit. organ; the human target dose was 185 MBq.  There were no adverse events or clin. detectable pharmacol. effects reported.  Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum.  Regional time-activity curves were well fit by multilinear anal.-1, and a 70-min scan duration was sufficient to quantify VT and the binding potentials.  BPND, with mean values ranging from 0.3 to 0.8, showed the best intrasubject and intersubject variability and reliability.  Test-retest variability in the whole brain (excluding the cerebellum) of VT, BPND, and BPP were 8%, 16%, and 17%, resp.  Conclusion: 18F-PF-05270430 shows promise as a PDE2A PET ligand, albeit with low binding potential values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPWWBE9u0cFLVg90H21EOLACvtfcHk0lhVw68SPWh5VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaktLbL&md5=1cf1e3dc43a79238626d2e49418acb5c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.166850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.166850%26sid%3Dliteratum%253Aachs%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26aulast%3DNabulsi%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DRopchan%26aufirst%3DJ.%26aulast%3DTarabar%26aufirst%3DS.%26aulast%3DDeMartinis%26aufirst%3DN.%26aulast%3DOgden%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26atitle%3DFirst-in-human%2520assessment%2520of%2520the%2520novel%2520PDE2A%2520PET%2520radiotracer%252018F-PF-05270430%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1388%26epage%3D1395%26doi%3D10.2967%2Fjnumed.115.166850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, S.</span>; <span class="NLM_string-name">Wenzel, B.</span>; <span class="NLM_string-name">Deuther-Conrad, W.</span>; <span class="NLM_string-name">Teodoro, R.</span>; <span class="NLM_string-name">Egerland, U.</span>; <span class="NLM_string-name">Kranz, M.</span>; <span class="NLM_string-name">Fischer, S.</span>; <span class="NLM_string-name">Höfgen, N.</span>; <span class="NLM_string-name">Steinbach, J.</span>; <span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labelled triazine derivatives for PET imaging of phosphodiesterase 2A</span>. In  <i>21st International Symposium on Radiopharmaceutical Sciences · ISRS 2015 Columbia, USA</i>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Schr%C3%B6der&author=B.+Wenzel&author=W.+Deuther-Conrad&author=R.+Teodoro&author=U.+Egerland&author=M.+Kranz&author=S.+Fischer&author=N.+H%C3%B6fgen&author=J.+Steinbach&author=P.+Brust&title=Novel+18F-labelled+triazine+derivatives+for+PET+imaging+of+phosphodiesterase+2A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DS.%26atitle%3DNovel%252018F-labelled%2520triazine%2520derivatives%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase%25202A%26jtitle%3D21st%2520International%2520Symposium%2520on%2520Radiopharmaceutical%2520Sciences%2520%25C2%25B7%2520ISRS%25202015%2520Columbia%252C%2520USA%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, <sup>18</sup>F-radiolabelling and biological characterization of novel fluoroalkylated triazine derivatives for in vivo imaging of phosphodiesterase 2A in brain via positron emission tomography</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">9591</span>– <span class="NLM_lpage">9615</span>, <span class="refDoi"> DOI: 10.3390/molecules20069591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules20069591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26016549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2MfotVylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=9591-9615&author=S.+Schroderauthor=B.+Wenzelauthor=W.+Deuther-Conradauthor=R.+Teodoroauthor=U.+Egerlandauthor=M.+Kranzauthor=M.+Scheunemannauthor=N.+Hofgenauthor=J.+Steinbachauthor=P.+Brust&title=Synthesis%2C+18F-radiolabelling+and+biological+characterization+of+novel+fluoroalkylated+triazine+derivatives+for+in+vivo+imaging+of+phosphodiesterase+2A+in+brain+via+positron+emission+tomography&doi=10.3390%2Fmolecules20069591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography</span></div><div class="casAuthors">Schroder Susann; Wenzel Barbara; Deuther-Conrad Winnie; Teodoro Rodrigo; Kranz Mathias; Scheunemann Matthias; Steinbach Jorg; Brust Peter; Egerland Ute; Hofgen Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecules (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">9591-615</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphodiesterase 2A (PDE2A) is highly and specifically expressed in particular brain regions that are affected by neurological disorders and in certain tumors.  Development of a specific PDE2A radioligand would enable molecular imaging of the PDE2A protein via positron emission tomography (PET).  Herein we report on the syntheses of three novel fluoroalkylated triazine derivatives (TA2-4) and on the evaluation of their effect on the enzymatic activity of human PDE2A.  The most potent PDE2A inhibitors were 18F-radiolabelled ([18F]TA3 and [18F]TA4) and investigated regarding their potential as PET radioligands for imaging of PDE2A in mouse brain.  In vitro autoradiography on rat brain displayed region-specific distribution of [18F]TA3 and [18F]TA4, which is consistent with the expression pattern of PDE2A protein.  Metabolism studies of both [18F]TA3 and [18F]TA4 in mice showed a significant accumulation of two major radiometabolites of each radioligand in brain as investigated by micellar radio-chromatography.  Small-animal PET/MR studies in mice using [18F]TA3 revealed a constantly increasing uptake of activity in the non-target region cerebellum, which may be caused by the accumulation of brain penetrating radiometabolites.  Hence, [18F]TA3 and [18F]TA4 are exclusively suitable for in vitro investigation of PDE2A.  Nevertheless, further structural modification of these promising radioligands might result in metabolically stable derivatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYL82f4RkqVs25P7XSLhESfW6udTcc2eYcgegFiruCNLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfotVylsw%253D%253D&md5=ef2b8ab1e0551d41e098a35002a257e6</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20069591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20069591%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DHofgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DSynthesis%252C%252018F-radiolabelling%2520and%2520biological%2520characterization%2520of%2520novel%2520fluoroalkylated%2520triazine%2520derivatives%2520for%2520in%2520vivo%2520imaging%2520of%2520phosphodiesterase%25202A%2520in%2520brain%2520via%2520positron%2520emission%2520tomography%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D9591%26epage%3D9615%26doi%3D10.3390%2Fmolecules20069591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Investigation of an <sup>18</sup>F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">556</span>, <span class="refDoi"> DOI: 10.3390/molecules23030556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules23030556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=556&author=S.+Schroderauthor=B.+Wenzelauthor=W.+Deuther-Conradauthor=R.+Teodoroauthor=M.+Kranzauthor=M.+Scheunemannauthor=U.+Egerlandauthor=N.+Hofgenauthor=D.+Brielauthor=J.+Steinbachauthor=P.+Brust&title=Investigation+of+an+18F-labelled+Imidazopyridotriazine+for+Molecular+Imaging+of+Cyclic+Nucleotide+Phosphodiesterase+2A&doi=10.3390%2Fmolecules23030556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23030556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23030556%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DHofgen%26aufirst%3DN.%26aulast%3DBriel%26aufirst%3DD.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DInvestigation%2520of%2520an%252018F-labelled%2520Imidazopyridotriazine%2520for%2520Molecular%2520Imaging%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%25202A%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D556%26doi%3D10.3390%2Fmolecules23030556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritawidya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toussaint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine: A Potential radioligand for in vivo phosphodiesterase 2A (PDE2A) PET imaging</span>. <i>23rd International Symposium on Radiopharmaceutical Sciences, Beijing, China</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">S162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=S162&author=R.+Ritawidyaauthor=R.+Teodoroauthor=B.+Wenzelauthor=M.+Kranzauthor=M.+Toussaintauthor=S.+Dukic-Stefanovicauthor=W.+Deuther-Conradauthor=M.+Scheunemannauthor=P.+Brust&title=Synthesis+and+biological+investigation+of+a+novel+fluorine-18+labeled+benzoimidazotriazine%3A+A+Potential+radioligand+for+in+vivo+phosphodiesterase+2A+%28PDE2A%29+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRitawidya%26aufirst%3DR.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DToussaint%26aufirst%3DM.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520investigation%2520of%2520a%2520novel%2520fluorine-18%2520labeled%2520benzoimidazotriazine%253A%2520A%2520Potential%2520radioligand%2520for%2520in%2520vivo%2520phosphodiesterase%25202A%2520%2528PDE2A%2529%2520PET%2520imaging%26jtitle%3D23rd%2520International%2520Symposium%2520on%2520Radiopharmaceutical%2520Sciences%252C%2520Beijing%252C%2520China%26date%3D2016%26spage%3DS162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritawidya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toussaint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine-based radioligand for the imaging of phosphodiesterase 2A with positron emission tomography</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4149</span>, <span class="refDoi"> DOI: 10.3390/molecules24224149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules24224149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyrsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=4149&author=R.+Ritawidyaauthor=B.+Wenzelauthor=R.+Teodoroauthor=M.+Toussaintauthor=M.+Kranzauthor=W.+Deuther-Conradauthor=S.+Dukic-Stefanovicauthor=F.+A.+Ludwigauthor=M.+Scheunemannauthor=P.+Brust&title=Radiosynthesis+and+biological+investigation+of+a+novel+fluorine-18+labeled+benzoimidazotriazine-based+radioligand+for+the+imaging+of+phosphodiesterase+2A+with+positron+emission+tomography&doi=10.3390%2Fmolecules24224149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine-based radioligand for the imaging of phosphodiesterase 2A with positron emission tomography</span></div><div class="casAuthors">Ritawidya, Rien; Wenzel, Barbara; Teodoro, Rodrigo; Toussaint, Magali; Kranz, Mathias; Deuther-Conrad, Winnie; Dukic-Stefanovic, Sladjana; Ludwig, Friedrich-Alexander; Scheunemann, Matthias; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4149</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A specific radioligand for the imaging of cyclic nucleotide phosphodiesterase 2A (PDE2A) via positron emission tomog. (PET) would be helpful for research on the physiol. and disease-related changes in the expression of this enzyme in the brain.  In this report, the radiosynthesis of a novel PDE2A radioligand and the subsequent biol. evaluation were described.  Our prospective compd. 1-(2-chloro-5-methoxy phenyl)-8-(2-fluoropyridin-4-yl)-3-methylbenzo[e]imidazo[5,1-c][1,2,4]triazine, benzoimidazotriazine (BIT1) (IC50 PDE2A = 3.33 nM; 16-fold selectivity over PDE10A) was fluorine-18 labeled via arom. nucleophilic substitution of the corresponding nitro precursor using the K[18F]F-K2.2.2-carbonate complex system.  The new radioligand [18F]BIT1 was obtained with a high radiochem. yield (54 ± 2%, n = 3), a high radiochem. purity (≥99%), and high molar activities (155-175 GBq/μmol, n = 3).  In vitro autoradiog. on pig brain cryosections exhibited a heterogeneous spatial distribution of [18F]BIT1 corresponding to the known pattern of expression of PDE2A.  The investigation of in vivo metab. of [18F]BIT1 in a mouse revealed sufficient metabolic stability.  PET studies in mouse exhibited a moderate brain uptake of [18F]BIT1 with a max. standardized uptake value of ∼0.7 at 5 min p.i.  However, in vivo blocking studies revealed a non-target specific binding of [18F]BIT1.  Therefore, further structural modifications are needed to improve target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEakGihEqbT7Vg90H21EOLACvtfcHk0lh0yzYDSTwYog"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyrsLfM&md5=ae71f979c3026e1680feec4777810175</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24224149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24224149%26sid%3Dliteratum%253Aachs%26aulast%3DRitawidya%26aufirst%3DR.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DToussaint%26aufirst%3DM.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DLudwig%26aufirst%3DF.%2BA.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DRadiosynthesis%2520and%2520biological%2520investigation%2520of%2520a%2520novel%2520fluorine-18%2520labeled%2520benzoimidazotriazine-based%2520radioligand%2520for%2520the%2520imaging%2520of%2520phosphodiesterase%25202A%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D4149%26doi%3D10.3390%2Fmolecules24224149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Movsesian, M.</span></span> <span> </span><span class="NLM_article-title">Novel approaches to targeting PDE3 in cardiovascular disease</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.pharmthera.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27108947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2016&pages=74-81&author=M.+Movsesian&title=Novel+approaches+to+targeting+PDE3+in+cardiovascular+disease&doi=10.1016%2Fj.pharmthera.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches to targeting PDE3 in cardiovascular disease</span></div><div class="casAuthors">Movsesian, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-81</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibitors of PDE3, a family of dual-specificity cyclic nucleotide phosphodiesterases, are used clin. to increase cardiac contractility by raising intracellular cAMP content in cardiac myocytes and to reduce vascular resistance by increasing intracellular cGMP content in vascular smooth muscle myocytes.  When used in the treatment of patients with heart failure, PDE3 inhibitors are effective in the acute setting but increase sudden cardiac death with long-term administration, possibly reflecting pro-apoptotic and pro-hypertrophic consequences of increased cAMP-mediated signaling in cardiac myocytes.  CAMP-mediated signaling in cardiac myocytes is highly compartmentalized, and different phosphodiesterases, by controlling cAMP content in functionally discrete intracellular microcompartments, regulate different cAMP-mediated pathways.  Four variants/isoforms of PDE3 (PDE3A1, PDE3A2, PDE3A3, and PDE3B) are expressed in cardiac myocytes, and new exptl. results have demonstrated that these isoforms, which are differentially localized intracellularly through unique protein-protein interactions, control different physiol. responses.  While the catalytic regions of these isoforms may be too similar to allow the catalytic activity of each isoform to be selectively inhibited, targeting their unique protein-protein interactions may allow desired responses to be elicited without the adverse consequences that limit the usefulness of existing PDE3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpySUN0pntSI7Vg90H21EOLACvtfcHk0lh2v4a68sKRDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D&md5=6e933dbd53f91fb96ad1664b273d8d99</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMovsesian%26aufirst%3DM.%26atitle%3DNovel%2520approaches%2520to%2520targeting%2520PDE3%2520in%2520cardiovascular%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D163%26spage%3D74%26epage%3D81%26doi%3D10.1016%2Fj.pharmthera.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beute, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nastiti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogenboom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreurs, M. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hockman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KleinJan, A.</span></span> <span> </span><span class="NLM_article-title">PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">470</span>, <span class="refDoi"> DOI: 10.3389/fphar.2020.00470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3389%2Ffphar.2020.00470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32425769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKktrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=470&author=J.+Beuteauthor=K.+Ganeshauthor=H.+Nastitiauthor=R.+Hoogenboomauthor=V.+Bosauthor=J.+Folkertsauthor=M.+W.+J.+Schreursauthor=S.+Hockmanauthor=R.+W.+Hendriksauthor=A.+KleinJan&title=PDE3+inhibition+reduces+epithelial+mast+cell+numbers+in+allergic+airway+inflammation+and+attenuates+degranulation+of+basophils+and+mast+cells&doi=10.3389%2Ffphar.2020.00470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells</span></div><div class="casAuthors">Beute, Jan; Ganesh, Keerthana; Nastiti, Hedwika; Hoogenboom, Robin; Bos, Vivica; Folkerts, Jelle; Schreurs, Marco W. J.; Hockman, Steve; Hendriks, Rudi W.; Jan, Alex Klein</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">00470</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Epithelial mast cells are generally present in the airways of patients with allergic asthma that are inadequately controlled.  Airway mast cells (MCs) are critically involved in allergic airway inflammation and contribute directly to the main symptoms of allergic patients.  Phosphodiesterase 3 (PDE3) tailors signaling of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are crit. intracellular second messenger mols. in various signaling pathways.  This paper investigates the pathophysiol. role and disease-modifying effects of PDE3 in mouse bone marrowderived MCs (bmMCs), human LAD2- and HMC1 mast cell lines, human blood basophils, and peripheral blood-derived primary human MCs (HuMCs).  In a chronic house dust mite (HDM)-driven allergic airway inflammation mouse model, we obsd. that PDE3 deficiency or PDE3 inhibition (PDE3i) therapy reduced the nos. of epithelial MCs, when compared to control mice.  Mouse bone marrow-derived MCs (bmMCs) and the human HMC1 and LAD2 cell lines predominantly expressed PDE3B and PDE4A.  BmMCs from Pde3-/- mice showed reduced loss of the degranulation marker CD107b compared with wild-type BmMCs, when stimulated in an IgE (IgE)-dependent manner.  Following both IgE-mediated and substance P-mediated activation, PDE3i-pretreated basophils, LAD2 cells, and HuMCs, showed less degranulation than diluent controls, as measured by surface CD63 expression.  MCs lacking PDE3 or treated with the PDE3i enoximone exhibited a lower calcium flux upon stimulation with ionomycine.  In conclusion PDE3 plays a crit. role in basophil and mast cell degranulation and therefore its inhibition may be a treatment option in allergic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPS1Ku6tG3B7Vg90H21EOLACvtfcHk0lh2v4a68sKRDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKktrzO&md5=7770ec4eee777eeb975a27681a174e30</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2020.00470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2020.00470%26sid%3Dliteratum%253Aachs%26aulast%3DBeute%26aufirst%3DJ.%26aulast%3DGanesh%26aufirst%3DK.%26aulast%3DNastiti%26aufirst%3DH.%26aulast%3DHoogenboom%26aufirst%3DR.%26aulast%3DBos%26aufirst%3DV.%26aulast%3DFolkerts%26aufirst%3DJ.%26aulast%3DSchreurs%26aufirst%3DM.%2BW.%2BJ.%26aulast%3DHockman%26aufirst%3DS.%26aulast%3DHendriks%26aufirst%3DR.%2BW.%26aulast%3DKleinJan%26aufirst%3DA.%26atitle%3DPDE3%2520inhibition%2520reduces%2520epithelial%2520mast%2520cell%2520numbers%2520in%2520allergic%2520airway%2520inflammation%2520and%2520attenuates%2520degranulation%2520of%2520basophils%2520and%2520mast%2520cells%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D11%26spage%3D470%26doi%3D10.3389%2Ffphar.2020.00470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span>. <i>Am. J. Geriatr. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1097/JGP.0b013e31819431ea</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1097%2FJGP.0b013e31819431ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19307864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=353-354&author=H.+Araiauthor=T.+Takahashi&title=A+combination+therapy+of+donepezil+and+cilostazol+for+patients+with+moderate+Alzheimer+disease%3A+pilot+follow-up+study&doi=10.1097%2FJGP.0b013e31819431ea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span></div><div class="casAuthors">Arai Heii; Takahashi Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCx1PkgV5nGvEeosoOnpOLfW6udTcc2ebjM0qAiaKgELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D&md5=722b0e9a3896ed1fcc3161ff5ec31d93</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1097%2FJGP.0b013e31819431ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJGP.0b013e31819431ea%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26atitle%3DA%2520combination%2520therapy%2520of%2520donepezil%2520and%2520cilostazol%2520for%2520patients%2520with%2520moderate%2520Alzheimer%2520disease%253A%2520pilot%2520follow-up%2520study%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2009%26volume%3D17%26spage%3D353%26epage%3D354%26doi%3D10.1097%2FJGP.0b013e31819431ea" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, S.</span></span> <span> </span><span class="NLM_article-title">PDE3 inhibitors repurposed as treatments for age-related cognitive impairment</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4306</span>– <span class="NLM_lpage">4316</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-1374-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs12035-018-1374-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30311144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2qsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2019&pages=4306-4316&author=S.+Yanaiauthor=S.+Endo&title=PDE3+inhibitors+repurposed+as+treatments+for+age-related+cognitive+impairment&doi=10.1007%2Fs12035-018-1374-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment</span></div><div class="casAuthors">Yanai, Shuichi; Endo, Shogo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4306-4316</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  As the population of older individuals grows worldwide, researchers have increasingly focused their attention on identifying key mol. targets of age-related cognitive impairments, with the aim of developing possible therapeutic interventions.  Two such mols. are the intracellular cyclic nucleotides, cAMP and cGMP.  These second messengers mediate fundamental aspects of brain function relevant to memory, learning, and cognitive function.  In this review, we provide an overview of different PDE inhibitors, and then we focus on pharmacol. and physiol. effects of PDE3 inhibitors in the CNS and peripheral tissues.  Finally, we discuss findings from exptl. and preliminary clin. studies and the potential beneficial effects of the PDE3 inhibitor cilostazol on age-related cognitive impairments.  In the innovation pipeline of pharmaceutical development, the antiplatelet agent cilostazol has come into the spotlight as a novel treatment for mild cognitive impairment.  Overall, the repurposing of cilostazol may represent a potentially promising way to treat mild cognitive impairment, Alzheimer's disease, and vascular dementia.  In this review, we present a brief summary of cAMP signaling and different PDE inhibitors, followed by a discussion of the pharmacol. and physiol. role of PDE3 inhibitors.  In this context, we discuss the repurposing of a PDE3 inhibitor, cilostazol, as a potential treatment for age-related cognitive impairment based on recent research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndGKXeWmnBLVg90H21EOLACvtfcHk0lhcQkkF4zIxhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2qsLvM&md5=486846fb15c92bc158cadca2f74c4cca</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-1374-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-1374-4%26sid%3Dliteratum%253Aachs%26aulast%3DYanai%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DS.%26atitle%3DPDE3%2520inhibitors%2520repurposed%2520as%2520treatments%2520for%2520age-related%2520cognitive%2520impairment%26jtitle%3DMol.%2520Neurobiol.%26date%3D2019%26volume%3D56%26spage%3D4306%26epage%3D4316%26doi%3D10.1007%2Fs12035-018-1374-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span> <span> </span><span class="NLM_article-title">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span>. <i>Psychogeriatrics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1111/psyg.12021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fpsyg.12021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25707423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=164-169&author=A.+Taguchiauthor=Y.+Takataauthor=M.+Iharaauthor=Y.+Kasaharaauthor=M.+Tsujiauthor=M.+Nishinoauthor=D.+Sternauthor=M.+Okada&title=Cilostazol+improves+cognitive+function+in+patients+with+mild+cognitive+impairment%3A+a+retrospective+analysis&doi=10.1111%2Fpsyg.12021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span></div><div class="casAuthors">Taguchi Akihiko; Takata Yu; Ihara Masafumi; Kasahara Yukiko; Tsuji Masahiro; Nishino Madoka; Stern David; Okada Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Cerebral ischemia and accumulation of amyloid β (Aβ) are major risk factors for the development of dementia, including vascular dementia and Alzheimer's disease.  Cilostazol, an antiplatelet drug, has been shown to improve cerebral circulation and reduce accumulation of Aβ.  In this study, the long-term effect of cilostazol on cognitive function was investigated retrospectively.  METHODS:  Medical records at Sumotoitsuki Hospital were surveyed to find all patients treated with cilostazol and evaluated by the Mini-Mental State Examination (MMSE) during at least two visits separated by an interval of more than 6 months.  Patients receiving anti-dementia drugs were excluded.  Temporal changes in MMSE scores were compared between patients treated with cilostazol (n = 70) and those who ceased administration of this drug (n = 22).  The mean follow-up period was 691 days.  RESULTS:  Decrease in MMSE score was significantly ameliorated by administration of cilostazol.  Subgroup analysis revealed that cilostazol significantly improved MMSE score in patients with mild cognitive impairment, though no significant effect was observed in patients with normal cognitive function or dementia.  CONCLUSIONS:  Although there are limitations to such a retrospective study, these results significantly encourage undertaking a prospective cohort study to determine the effect of cilostazol on mild cognitive impairment where no treatments currently exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkwhSfdrbgnCXXDYhVZBdlfW6udTcc2ebUdObkqkcCWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D&md5=96c6a6e5803056c9a9c96d4f28376871</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1111%2Fpsyg.12021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpsyg.12021%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DTakata%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DCilostazol%2520improves%2520cognitive%2520function%2520in%2520patients%2520with%2520mild%2520cognitive%2520impairment%253A%2520a%2520retrospective%2520analysis%26jtitle%3DPsychogeriatrics%26date%3D2013%26volume%3D13%26spage%3D164%26epage%3D169%26doi%3D10.1111%2Fpsyg.12021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takiguchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol prevents amyloid β peptide<sub>25–35</sub>-induced memory impairment and oxidative stress in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1912</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fj.1476-5381.2010.01014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20825411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=1899-1912&author=M.+Hiramatsuauthor=O.+Takiguchiauthor=A.+Nishiyamaauthor=H.+Mori&title=Cilostazol+prevents+amyloid+%CE%B2+peptide25%E2%80%9335-induced+memory+impairment+and+oxidative+stress+in+mice&doi=10.1111%2Fj.1476-5381.2010.01014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice</span></div><div class="casAuthors">Hiramatsu, Masayuki; Takiguchi, Osanao; Nishiyama, Aki; Mori, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1899-1912</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cilostazol may be effective in dementia assocd. with a cerebral ischemia.  In this study, we examd. whether it exerts beneficial effects on learning and/or memory impairment induced by Aβ25-35 in mice, and compared its effects with those of aspirin.  Aβ25-35 (9 nmol) was administered to mice i.c.v.  Learning and memory behavior were evaluated by measuring spontaneous alternation in a Y-maze and a step-down type passive avoidance test, on the 5th and 8th days after injection resp.  Levels of lipid peroxidn. (malondialdehyde) and cytokines in the frontal cortex and hippocampus were measured 2, 3, 5 and 7 days after the Aβ25-35 injection.  The effects of repeated administration of cilostazol and aspirin (both at 30 and 100 mg/kg-1, p.o.) on any changes induced by Aβ25-35 were evaluated.  Repeated administration of cilostazol significantly attenuated the impairment of spontaneous alternation and the shortened step-down latency induced by Aβ25-35.  Aspirin did not show any beneficial effect.  A significant increase in the levels of malondialdehyde (MDA) and IL-1β (only measured in hippocampus) was obsd. 2, 3 and 5 days after the Aβ25-35 injection in the frontal cortex and hippocampus.  Repeated administration of cilostazol (100 mg/kg-1) completely prevented the increase in MDA levels but failed to antagonize the increase in the expression of IL-1β induced by Aβ25-35.  These results suggest that the protective effect of cilostazol on Aβ25-35-induced memory impairment may be related to oxidative stress in the frontal cortex and the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo29phkvEihHLVg90H21EOLACvtfcHk0lhcQkkF4zIxhA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK&md5=d3e02a6445fdea4e98b023cf78f4c2a0</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01014.x%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DM.%26aulast%3DTakiguchi%26aufirst%3DO.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DCilostazol%2520prevents%2520amyloid%2520%25CE%25B2%2520peptide25%25E2%2580%259335-induced%2520memory%2520impairment%2520and%2520oxidative%2520stress%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D1899%26epage%3D1912%26doi%3D10.1111%2Fj.1476-5381.2010.01014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leem, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. K.</span></span> <span> </span><span class="NLM_article-title">Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2011.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bbrc.2011.04.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21530492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVyrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2011&pages=602-608&author=S.+H.+Parkauthor=J.+H.+Kimauthor=S.+S.+Baeauthor=K.+W.+Hongauthor=D.+S.+Leeauthor=J.+Y.+Leemauthor=B.+T.+Choiauthor=H.+K.+Shin&title=Protective+effect+of+the+phosphodiesterase+III+inhibitor+cilostazol+on+amyloid+%CE%B2-induced+cognitive+deficits+associated+with+decreased+amyloid+%CE%B2+accumulation&doi=10.1016%2Fj.bbrc.2011.04.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation</span></div><div class="casAuthors">Park, Sun Haeng; Kim, Ji Hyun; Bae, Sun Sik; Hong, Ki Whan; Lee, Dong-Seok; Leem, Jae Yoon; Choi, Byung Tae; Shin, Hwa Kyoung</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">602-608</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), which is characterized by progressive cognitive impairment, is the most common neurodegenerative disease.  Here, the authors investigated the preventive effect of a phosphodiesterase III inhibitor, cilostazol against cognitive decline in AD mouse model.  In vitro studies using N2a cells stably expressing human amyloid precursor protein Swedish mutation (N2aSwe) showed that cilostazol decreased the amyloid β (Aβ) levels in the conditioned medium and cell lysates.  Cilostazol attenuated the expression of ApoE, which is responsible for Aβ aggregation, in N2aSwe.  Intracerebroventricular injection of Aβ25-35 in C57BL/6J mice resulted in increased immunoreactivity of Aβ and p-Tau, and microglia activation in the brain.  Oral administration of cilostazol for 2 wk before Aβ administration and once a day for 4 wk post-surgery almost completely prevented the Aβ-induced increases of Aβ and p-Tau immunoreactivity, as well as CD11b immunoreactivity.  However, post-treatment with cilostazol 4 wk after Aβ administration, when Aβ was already accumulated, did not prevent the Aβ-induced neuropathol. responses.  Furthermore, cilostazol did not affect the neprilysin and insulin degrading enzymes involved in the degrdn. of the Aβ peptide, but decreased ApoE levels in Aβ-injected brain.  In addn., cilostazol significantly improved spatial learning and memory in Aβ-injected mice.  The findings suggest that a phosphodiesterase III inhibitor, cilostazol significantly decreased Aβ accumulation and improved memory impairment induced by Aβ25-35.  The beneficial effects of cilostazol might be explained by the redn. of Aβ accumulation and tau phosphorylation, not through an increase in Aβ degrdn. but via a significant decrease in ApoE-mediated Aβ aggregation.  Cilostazol may be the basis of a novel strategy for the therapy of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIK7eM16DWzLVg90H21EOLACvtfcHk0lipLexZ8bmEpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVyrsLY%253D&md5=81e6fd05d6b4bff87ca77e926ec569e1</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2011.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2011.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DBae%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DLeem%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DB.%2BT.%26aulast%3DShin%26aufirst%3DH.%2BK.%26atitle%3DProtective%2520effect%2520of%2520the%2520phosphodiesterase%2520III%2520inhibitor%2520cilostazol%2520on%2520amyloid%2520%25CE%25B2-induced%2520cognitive%2520deficits%2520associated%2520with%2520decreased%2520amyloid%2520%25CE%25B2%2520accumulation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D408%26spage%3D602%26epage%3D608%26doi%3D10.1016%2Fj.bbrc.2011.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol use is associated with reduced risk of dementia: A nationwide cohort study</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1007/s13311-017-0512-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs13311-017-0512-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28194663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=784-791&author=S.+Y.+Taiauthor=C.+Y.+Chienauthor=Y.+H.+Changauthor=Y.+H.+Yang&title=Cilostazol+use+is+associated+with+reduced+risk+of+dementia%3A+A+nationwide+cohort+study&doi=10.1007%2Fs13311-017-0512-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study</span></div><div class="casAuthors">Tai, Shu-Yu; Chien, Chen-Yu; Chang, Yu-Han; Yang, Yuan-Han</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-791</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Whether antiplatelet agents have a preventive effect on cognitive function remains unknown.  We examd. the potential assocn. between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population.  Patients initiating cilostazol therapy between 1 Jan. 2004 and 31 Dec. 2009 without a prior history of dementia were identified from Taiwan's National Health Insurance database.  Participants were stratified by age, sex, comorbidities, and comedication.  The outcome of interest was all-cause dementia (ICD-9-CM codes 290.0, 290.4, 294.1, 331.0).  Cox regression models were used to est. the hazard ratio (HR) of dementia.  The cumulative cilostazol dosage was stratified by quartile of defined daily doses using no cilostazol use as a ref.  A total of 9148 participants 40 years of age or older and free of dementia at baseline were analyzed.  Patients using cilostazol (n = 2287) had a significantly decreased risk of incident dementia compared with patients not using the drug [n = 6861; adjusted HR (aHR) 0.75; 95% confidence interval (CI) 0.61-0.92].  Notably, cilostazol use was found to have a dose-dependent assocn. with reduced rate of dementia emergence (p for trend = 0.001).  Subgroup anal. identified a decline of dementia in cilostazol users with diagnosed ischemic heart disease (aHR 0.44, 95% CI 0.24-0.83) and cerebral vascular disease (aHR 0.34, 95% CI 0.21-0.54).  These observations suggest that cilostazol use may reduce the risk to develop dementia, and a high cumulative dose further decreases the risk of dementia.  These findings should be examd. further in randomized clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ZP4x682GkLVg90H21EOLACvtfcHk0lipLexZ8bmEpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D&md5=d5867d3221d14af26c08fe9d65fc8cca</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs13311-017-0512-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-017-0512-4%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DS.%2BY.%26aulast%3DChien%26aufirst%3DC.%2BY.%26aulast%3DChang%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DY.%2BH.%26atitle%3DCilostazol%2520use%2520is%2520associated%2520with%2520reduced%2520risk%2520of%2520dementia%253A%2520A%2520nationwide%2520cohort%2520study%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D784%26epage%3D791%26doi%3D10.1007%2Fs13311-017-0512-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, O.</span></span> <span> </span><span class="NLM_article-title">The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.jdermsci.2018.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.jdermsci.2018.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29678305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=60-68&author=H.+I.+Choiauthor=D.+Y.+Kimauthor=S.+J.+Choiauthor=C.+Y.+Shinauthor=S.+T.+Hwangauthor=K.+H.+Kimauthor=O.+Kwon&title=The+effect+of+cilostazol%2C+a+phosphodiesterase+3+%28PDE3%29+inhibitor%2C+on+human+hair+growth+with+the+dual+promoting+mechanisms&doi=10.1016%2Fj.jdermsci.2018.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms</span></div><div class="casAuthors">Choi, Hye-In; Kim, Dong Young; Choi, Soon-Jin; Shin, Chang-Yup; Hwang, Sungjoo Tommy; Kim, Kyu Han; Kwon, Ohsang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-68</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, increases the intracellular level of cyclic adenosine monophosphate to cause vasodilation.  Topical application of cilostazol is reported to improve local blood flow and enhance wound healing; however, its effect on human hair follicles is unknown.  The purpose of this study was to det. the effect of cilostazol on hair growth.  We investigated the expression of PDE3 in human dermal papilla cells (DPCs), outer root sheath cells (ORSCs), and hair follicles.  The effects of cilostazol on DPC and ORSC proliferation were evaluated using BrdU and WST-1 assays.  The expression of various growth factors in DPCs was investigated by growth factor antibody array.  Addnl., hair shaft elongation was measured using ex vivo hair follicle organ cultures, and anagen induction was evaluated in C57BL/6 mice.  Finally, the effects of cilostazol on vessel formation and activation of the mitogen-activated protein kinase pathway were evaluated.  We confirmed high mRNA and protein expression of PDE3 in human DPCs.  Cilostazol not only enhanced the proliferation of human DPCs but also regulated the secretion of several growth factors responsible for hair growth.  Furthermore, it promoted hair shaft elongation ex vivo, with increased proliferation of matrix keratinocytes.  Cilostazol also accelerated anagen induction by stimulating vessel formation and upregulating the levels of phosphorylated extracellular signal-regulated kinase, c-Jun N-terminal kinase, and P38 after its topical application in C57BL/6 mice.  Our results show that cilostazol promotes hair growth and may serve as a therapeutic agent for the treatment of alopecia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx2LPJgK2EXLVg90H21EOLACvtfcHk0lgJQUWj5qZeiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cns7w%253D&md5=4131befac73c13e5bb21277748b1adec</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2018.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2018.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BI.%26aulast%3DKim%26aufirst%3DD.%2BY.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DShin%26aufirst%3DC.%2BY.%26aulast%3DHwang%26aufirst%3DS.%2BT.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKwon%26aufirst%3DO.%26atitle%3DThe%2520effect%2520of%2520cilostazol%252C%2520a%2520phosphodiesterase%25203%2520%2528PDE3%2529%2520inhibitor%252C%2520on%2520human%2520hair%2520growth%2520with%2520the%2520dual%2520promoting%2520mechanisms%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2018%26volume%3D91%26spage%3D60%26epage%3D68%26doi%3D10.1016%2Fj.jdermsci.2018.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohshima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span> <span> </span><span class="NLM_article-title">Cilostazol, a phosphodiesterase 3 inhibitor, moderately attenuates behaviors depending on sex in the Ts65Dn mouse model of down syndrome</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">106</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2020.00106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3389%2Ffnagi.2020.00106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32372946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1OlsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=106&author=M.+Tsujiauthor=M.+Ohshimaauthor=Y.+Yamamotoauthor=S.+Saitoauthor=Y.+Hattoriauthor=E.+Tanakaauthor=A.+Taguchiauthor=M.+Iharaauthor=Y.+Ogawa&title=Cilostazol%2C+a+phosphodiesterase+3+inhibitor%2C+moderately+attenuates+behaviors+depending+on+sex+in+the+Ts65Dn+mouse+model+of+down+syndrome&doi=10.3389%2Ffnagi.2020.00106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol, a phosphodiesterase 3 inhibitor, moderately attenuates behaviors depending on sex in the Ts65Dn mouse model of down syndrome</span></div><div class="casAuthors">Tsuji, Masahiro; Ohshima, Makiko; Yamamoto, Yumi; Saito, Satoshi; Hattori, Yorito; Tanaka, Emi; Taguchi, Akihiko; Ihara, Masafumi; Ogawa, Yuko</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">106</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">People with Down syndrome, which is a trisomy of chromosome 21, exhibit intellectual disability from infancy and neuropathol. similar to Alzheimer's disease, such as amyloid plaques, from an early age.  Recently, we showed that cilostazol, a selective inhibitor of phosphodiesterase (PDE) 3, promotes the clearance of amyloid β and rescues cognitive deficits in a mouse model of Alzheimer's disease.  The objective of the present study was to examine whether cilostazol improves behaviors in the most widely used animal model of Down syndrome, i.e., Ts65Dn mice.  Mice were supplemented with cilostazol from the fetal period until young adulthood.  Supplementation significantly ameliorated novel-object recognition in Ts65Dn females and partially ameliorated sensorimotor function as detd. by the rotarod test in Ts65Dn females and hyperactive locomotion in Ts65Dn males.  Cilostazol supplementation significantly shortened swimming distance in Ts65Dn males in the Morris water maze test, suggesting that the drug improved cognitive function, although it did not shorten swimming duration, which was due to decreased swimming speed.  Thus, this study suggests that early supplementation with cilostazol partially rescues behavioral abnormalities seen in Down syndrome and indicates that the effects are sex-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdf15YFRuXbVg90H21EOLACvtfcHk0lgJQUWj5qZeiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1OlsrbO&md5=566847b002963d79600afbf6a1738266</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2020.00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2020.00106%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DOhshima%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DE.%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DY.%26atitle%3DCilostazol%252C%2520a%2520phosphodiesterase%25203%2520inhibitor%252C%2520moderately%2520attenuates%2520behaviors%2520depending%2520on%2520sex%2520in%2520the%2520Ts65Dn%2520mouse%2520model%2520of%2520down%2520syndrome%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2020%26volume%3D12%26spage%3D106%26doi%3D10.3389%2Ffnagi.2020.00106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bejaoui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaouali, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakly, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Abdennebi, H.</span></span> <span> </span><span class="NLM_article-title">Olprinone protects the liver from ischemia-reperfusion injury through oxidative stress prevention and protein kinase Akt activation</span>. <i>Can. J. Physiol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1139/cjpp-2017-0153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1139%2Fcjpp-2017-0153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28675791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2018&pages=227-231&author=M.+Bejaouiauthor=M.+A.+Zaoualiauthor=R.+Saklyauthor=H.+Ben+Abdennebi&title=Olprinone+protects+the+liver+from+ischemia-reperfusion+injury+through+oxidative+stress+prevention+and+protein+kinase+Akt+activation&doi=10.1139%2Fcjpp-2017-0153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Olprinone protects the liver from ischemia-reperfusion injury through oxidative stress prevention and protein kinase Akt activation</span></div><div class="casAuthors">Bejaoui, Mohamed; Zaouali, Mohamed Amine; Sakly, Rim; Ben Abdennebi, Hassen</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-231</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">Canadian Science Publishing</span>)
        </div><div class="casAbstract">Liver ischemia-reperfusion (IR) injury is inevitable in surgical procedures such as hepatic resection and liver transplantation.  It represents a leading cause of liver graft dysfunction and primary nonfunction after transplantation.  Phosphodiesterase (PDE) inhibitors are emerging as effective drugs able to reduce IR damage.  The aim of this study was to investigate the effect of selective PDE-3 inhibitor olprinone (Olp) against liver IR injury.  Male Wistar rats were subjected to 1 h of partial warm ischemia (70%) followed by 6 h of reperfusion.  Before ischemia, rats were treated with saline (IR group), Olp (Olp group), or Olp with Akt inhibitor LY294002 (Olp plus LY group).  After reperfusion, hepatic injury (transaminase activities), mitochondrial damage (glutamate dehydrogenase activity), oxidative stress (malondialdehyde and glutathione concns. and catalase and superoxide dismutase activities), and protein kinase Akt activation were evaluated.  Rat treatment with Olp reduced liver injury, prevented mitochondrial damage, decreased lipid peroxidn., and enhanced antioxidant enzymes.  Also, Olp induced a significant activation in protein kinase Akt.  Inhibition of Akt with LY294002 abolished all of the protective effects of Olp.  In conclusion, Olp treatment may be an effective strategy in reducing liver IR injury through oxidative stress prevention and Akt activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNo7zUdO9H87Vg90H21EOLACvtfcHk0lgJQUWj5qZeiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCgsQ%253D%253D&md5=036751057a795420e2b172c3d717c7c3</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1139%2Fcjpp-2017-0153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fcjpp-2017-0153%26sid%3Dliteratum%253Aachs%26aulast%3DBejaoui%26aufirst%3DM.%26aulast%3DZaouali%26aufirst%3DM.%2BA.%26aulast%3DSakly%26aufirst%3DR.%26aulast%3DBen%2BAbdennebi%26aufirst%3DH.%26atitle%3DOlprinone%2520protects%2520the%2520liver%2520from%2520ischemia-reperfusion%2520injury%2520through%2520oxidative%2520stress%2520prevention%2520and%2520protein%2520kinase%2520Akt%2520activation%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2018%26volume%3D96%26spage%3D227%26epage%3D231%26doi%3D10.1139%2Fcjpp-2017-0153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosutova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balentova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamkov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calkovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokra, D.</span></span> <span> </span><span class="NLM_article-title">Effects of PDE3 inhibitor olprinone on the respiratory parameters, inflammation, and apoptosis in an experimental model of acute respiratory distress syndrome</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3382</span>, <span class="refDoi"> DOI: 10.3390/ijms21093382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fijms21093382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVOjtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=3382&author=P.+Kosutovaauthor=P.+Mikolkaauthor=S.+Balentovaauthor=M.+Adamkovauthor=A.+Calkovskaauthor=D.+Mokra&title=Effects+of+PDE3+inhibitor+olprinone+on+the+respiratory+parameters%2C+inflammation%2C+and+apoptosis+in+an+experimental+model+of+acute+respiratory+distress+syndrome&doi=10.3390%2Fijms21093382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of PDE3 inhibitor olprinone on the respiratory parameters, inflammation, and apoptosis in an experimental model of acute respiratory distress syndrome</span></div><div class="casAuthors">Kosutova, Petra; Mikolka, Pavol; Balentova, Sona; Adamkov, Marian; Calkovska, Andrea; Mokra, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3382</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This study aimed to investigate whether a selective phosphodiesterase-3 (PDE3) inhibitor olprinone can pos. influence the inflammation, apoptosis, and respiratory parameters in animals with acute respiratory distress syndrome (ARDS) model induced by repetitive saline lung lavage.  Adult rabbits were divided into 3 groups: ARDS without therapy (ARDS), ARDS treated with olprinone i.v. (1 mg/kg; ARDS/PDE3), and healthy ventilated controls (Control), and were oxygen-ventilated for the following 4 h.  Dynamic lung-thorax compliance (Cdyn), mean airway pressure (MAP), arterial oxygen satn. (SaO2), alveolar-arterial gradient (AAG), ratio between partial pressure of oxygen in arterial blood to a fraction of inspired oxygen (PaO2/FiO2), oxygenation index (OI), and ventilation efficiency index (VEI) were evaluated every hour.  Post mortem, inflammatory and oxidative markers interleukin (IL)-6, IL-1β, a receptor for advanced glycation end products (RAGE), IL-10, total antioxidant capacity (TAC), 3-nitrotyrosine (3NT), and malondialdehyde (MDA) and apoptosis (apoptotic index and caspase-3) were assessed in the lung tissue.  Treatment with olprinone reduced the release of inflammatory mediators and markers of oxidative damage decreased apoptosis of epithelial cells and improved respiratory parameters.  The results indicate a future potential of PDE3 inhibitors also in the therapy of ARDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqug1lMVKPz_7Vg90H21EOLACvtfcHk0lhcmo7jZy9BfQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVOjtrvO&md5=0f504f7a8894cf7d8df59264c2220a26</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.3390%2Fijms21093382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21093382%26sid%3Dliteratum%253Aachs%26aulast%3DKosutova%26aufirst%3DP.%26aulast%3DMikolka%26aufirst%3DP.%26aulast%3DBalentova%26aufirst%3DS.%26aulast%3DAdamkov%26aufirst%3DM.%26aulast%3DCalkovska%26aufirst%3DA.%26aulast%3DMokra%26aufirst%3DD.%26atitle%3DEffects%2520of%2520PDE3%2520inhibitor%2520olprinone%2520on%2520the%2520respiratory%2520parameters%252C%2520inflammation%252C%2520and%2520apoptosis%2520in%2520an%2520experimental%2520model%2520of%2520acute%2520respiratory%2520distress%2520syndrome%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D3382%26doi%3D10.3390%2Fijms21093382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coskran, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamowicz, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strick, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, D. T.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1369/jhc.6A6930.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1369%2Fjhc.6A6930.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16864896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=1205-1213&author=T.+M.+Coskranauthor=D.+Mortonauthor=F.+S.+Mennitiauthor=W.+O.+Adamowiczauthor=R.+J.+Kleimanauthor=A.+M.+Ryanauthor=C.+A.+Strickauthor=C.+J.+Schmidtauthor=D.+T.+Stephenson&title=Immunohistochemical+localization+of+phosphodiesterase+10A+in+multiple+mammalian+species&doi=10.1369%2Fjhc.6A6930.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species</span></div><div class="casAuthors">Coskran, Timothy M.; Morton, Daniel; Menniti, Frank S.; Adamowicz, Wendy O.; Kleiman, Robin J.; Ryan, Anne M.; Strick, Christine A.; Schmidt, Christopher J.; Stephenson, Diane T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1205-1213</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">A monoclonal antibody directed against the N-terminal of rat phosphodiesterase 10A (PDE10A) was used to localize PDE10A in multiple central nervous system (CNS) and peripheral tissues from mouse, rat, dog, cynomolgus macaque, and human.  PDE10A immunoreactivity is strongly expressed in the CNS of these species with limited expression in peripheral tissues.  Within the brain, strong immunoreactivity is present in both neuronal cell bodies and neuropil of the striatum, in striatonigral and striatopallidal white matter tracks, and in the substantia nigra and globus pallidus.  Outside the brain, PDE10A immunoreactivity is less intense, and distribution is limited to few tissues such as the testis, epididymal sperm, and enteric ganglia.  These data demonstrate that PDE10A is an evolutionarily conserved phosphodiesterase highly expressed in the brain but with restricted distribution in the periphery in multiple mammalian species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfW0o5F66eLVg90H21EOLACvtfcHk0lgoOhicQXhpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqurrJ&md5=03df0a34bb9e43ad63b84b734e6c1974</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1369%2Fjhc.6A6930.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.6A6930.2006%26sid%3Dliteratum%253Aachs%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DAdamowicz%26aufirst%3DW.%2BO.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DRyan%26aufirst%3DA.%2BM.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26atitle%3DImmunohistochemical%2520localization%2520of%2520phosphodiesterase%252010A%2520in%2520multiple%2520mammalian%2520species%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2006%26volume%3D54%26spage%3D1205%26epage%3D1213%26doi%3D10.1369%2Fjhc.6A6930.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koesling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, M.</span></span> <span> </span><span class="NLM_article-title">Activation of PDE10 and PDE11 phosphodiesterases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">1210</span>– <span class="NLM_lpage">1219</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.263806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.M111.263806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22105073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC387is1Crtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=1210-1219&author=R.+Jagerauthor=C.+Russwurmauthor=F.+Schwedeauthor=H.+G.+Genieserauthor=D.+Koeslingauthor=M.+Russwurm&title=Activation+of+PDE10+and+PDE11+phosphodiesterases&doi=10.1074%2Fjbc.M111.263806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of PDE10 and PDE11 phosphodiesterases</span></div><div class="casAuthors">Jager Ronald; Russwurm Corina; Schwede Frank; Genieser Hans-Gottfried; Koesling Doris; Russwurm Michael</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1210-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The most recently identified cyclic nucleotide phosphodiesterases, PDE10 and PDE11, contain a tandem of so-called GAF domains in their N-terminal regulatory regions.  In PDE2 and PDE5, the GAF domains mediate cGMP stimulation; however, their function in PDE10 and PDE11 remains controversial.  Although the GAF domains of PDE10 mediate cAMP-induced stimulation of chimeric adenylyl cyclases, cAMP binding did not stimulate the PDE10 holoenzyme.  Comparable data about cGMP and the PDE11 GAF domains exist.  Here, we identified synthetic ligands for the GAF domains of PDE10 and PDE11 to reduce interference of the GAF ligand with the catalytic reaction of PDE.  With these ligands, GAF-mediated stimulation of the PDE10 and PDE11 holoenzymes is demonstrated for the first time.  Furthermore, PDE10 is shown to be activated by cAMP, which paradoxically results in potent competitive inhibition of cGMP turnover by cAMP.  PDE11, albeit susceptible to GAF-dependent stimulation, is not activated by the native cyclic nucleotides cAMP and cGMP.  In summary, PDE11 can be stimulated by GAF domain ligands, but its native ligand remains to be identified, and PDE10 is the only PDE activated by cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPLtDOMxj8oNTiMd2aNQVUfW6udTcc2eb8i9xa5i9LY7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387is1Crtw%253D%253D&md5=5557bf6173db79a35bd8ce0d7e937a37</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.263806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.263806%26sid%3Dliteratum%253Aachs%26aulast%3DJager%26aufirst%3DR.%26aulast%3DRusswurm%26aufirst%3DC.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DGenieser%26aufirst%3DH.%2BG.%26aulast%3DKoesling%26aufirst%3DD.%26aulast%3DRusswurm%26aufirst%3DM.%26atitle%3DActivation%2520of%2520PDE10%2520and%2520PDE11%2520phosphodiesterases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D1210%26epage%3D1219%26doi%3D10.1074%2Fjbc.M111.263806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuccato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciammola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigamonti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffredo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedlander, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmusk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, E.</span></span> <span> </span><span class="NLM_article-title">Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1126/science.1059581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1126%2Fscience.1059581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11408619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFGjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=493-498&author=C.+Zuccatoauthor=A.+Ciammolaauthor=D.+Rigamontiauthor=B.+R.+Leavittauthor=D.+Goffredoauthor=L.+Contiauthor=M.+E.+MacDonaldauthor=R.+M.+Friedlanderauthor=V.+Silaniauthor=M.+R.+Haydenauthor=T.+Timmuskauthor=S.+Sipioneauthor=E.+Cattaneo&title=Loss+of+huntingtin-mediated+BDNF+gene+transcription+in+Huntington%E2%80%99s+disease&doi=10.1126%2Fscience.1059581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Huntingtin-mediated BDNF gene transcription in Huntington's disease</span></div><div class="casAuthors">Zuccato, Chiara; Ciammola, Andrea; Rigamonti, Dorotea; Leavitt, Blair R.; Goffredo, Donato; Conti, Luciano; MacDonald, Marcy E.; Friedlander, Robert M.; Silani, Vincenzo; Hayden, Michael R.; Timmusk, Tonis; Sipione, Simonetta; Cattaneo, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5529</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Huntingtin is a 350-kDa protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder.  The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain.  However, loss of a beneficial activity of wild-type Huntingtin may also cause the death of striatal neurons.  Here we demonstrate that wild-type Huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain.  We show that this beneficial activity of Huntingtin is lost when the protein becomes mutated, resulting in decreased prodn. of cortical BDNF.  This leads to insufficient neurotrophic support for striatal neurons, which then die.  Restoring wild-type Huntingtin activity and increasing BDNF prodn. may be therapeutic approaches for treating HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM4Z_NQRioP7Vg90H21EOLACvtfcHk0lgoOhicQXhpYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFGjtr0%253D&md5=aeb2de58b5782f2f08a9683556608d81</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1126%2Fscience.1059581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1059581%26sid%3Dliteratum%253Aachs%26aulast%3DZuccato%26aufirst%3DC.%26aulast%3DCiammola%26aufirst%3DA.%26aulast%3DRigamonti%26aufirst%3DD.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DGoffredo%26aufirst%3DD.%26aulast%3DConti%26aufirst%3DL.%26aulast%3DMacDonald%26aufirst%3DM.%2BE.%26aulast%3DFriedlander%26aufirst%3DR.%2BM.%26aulast%3DSilani%26aufirst%3DV.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DTimmusk%26aufirst%3DT.%26aulast%3DSipione%26aufirst%3DS.%26aulast%3DCattaneo%26aufirst%3DE.%26atitle%3DLoss%2520of%2520huntingtin-mediated%2520BDNF%2520gene%2520transcription%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D493%26epage%3D498%26doi%3D10.1126%2Fscience.1059581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jicha, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kress, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span> <span> </span><span class="NLM_article-title">cAMP-dependent protein kinase phosphorylations on Tau in Alzheimer’s disease</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">7486</span>– <span class="NLM_lpage">7494</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.19-17-07486.1999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1523%2FJNEUROSCI.19-17-07486.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10460255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADyaK1MXlslWms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=7486-7494&author=G.+A.+Jichaauthor=C.+Weaverauthor=E.+Laneauthor=C.+Viannaauthor=Y.+Kressauthor=J.+Rockwoodauthor=P.+Davies&title=cAMP-dependent+protein+kinase+phosphorylations+on+Tau+in+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.19-17-07486.1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">cAMP-dependent protein kinase phosphorylations on Tau in Alzheimer's disease</span></div><div class="casAuthors">Jicha, Gregory A.; Weaver, Charles; Lane, Eric; Vianna, Cintia; Kress, Yvonne; Rockwood, Julia; Davies, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7486-7494</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">To elucidate the role cAMP-dependent protein kinase (PKA) phosphorylations on tau play in Alzheimer's disease, we have generated highly specific monoclonal antibodies, CP-3 and PG-5, which recognize the PKA-dependent phosphorylations of ser214 and ser409 in tau resp.  The present study demonstrates by immunohistochem. anal., CP-3 and PG-5 immunoreactivity with neurofibrillary pathol. in both early and advanced Alzheimer's disease, but not in normal brain tissue and demonstrates that cAMP-dependent protein kinase phosphorylations on tau precede or are coincident with the initial appearance of filamentous aggregates of tau.  Studies using heat-stable prepns. demonstrate that neither site appears to be phosphorylated to any appreciable extent in normal rodent or human brain.  Further anal. demonstrates that the β catalytic subunit of PKA (Cβ), the β II regulatory subunit of PKA (RIIβ), and the 79 kDa A-kinase-anchoring-protein (AKAP79), are tightly assocd. with the neurofibrillary pathol., positioning cAMP-dependent protein kinase to participate directly in the pathol. hyperphosphorylation of tau seen in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2-_aEtC_SIbVg90H21EOLACvtfcHk0li2_Q1yzIQUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslWms74%253D&md5=d75b62fd8a29a0e611fcfc9fa7b13a38</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-17-07486.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-17-07486.1999%26sid%3Dliteratum%253Aachs%26aulast%3DJicha%26aufirst%3DG.%2BA.%26aulast%3DWeaver%26aufirst%3DC.%26aulast%3DLane%26aufirst%3DE.%26aulast%3DVianna%26aufirst%3DC.%26aulast%3DKress%26aufirst%3DY.%26aulast%3DRockwood%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26atitle%3DcAMP-dependent%2520protein%2520kinase%2520phosphorylations%2520on%2520Tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D7486%26epage%3D7494%26doi%3D10.1523%2FJNEUROSCI.19-17-07486.1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McPhee, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, L. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kewney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darroch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooreman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, S. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer’s disease</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1332</span>, <span class="refDoi"> DOI: 10.1042/BST20051330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1042%2FBST0331330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16246111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1330-1332&author=I.+McPheeauthor=L.+C.+D.+Gibsonauthor=J.+Kewneyauthor=C.+Darrochauthor=P.+A.+Stevensauthor=D.+Spinksauthor=A.+Cooremanauthor=S.+J.+MacKenzie&title=Cyclic+nucleotide+signalling%3A+a+molecular+approach+to+drug+discovery+for+Alzheimer%E2%80%99s+disease&doi=10.1042%2FBST20051330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide signaling: a molecular approach to drug discovery for Alzheimer's disease</span></div><div class="casAuthors">McPhee, I.; Gibson, L. C. D.; Kewney, J.; Darroch, C.; Stevens, P. A.; Spinks, D.; Cooreman, A.; MacKenzie, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1330-1332</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The EPAC (exchange protein directly activated by cAMP) proteins are GEFs (guanine nucleotide-exchange factors) that activate Rap GTPases upon binding to cAMP.  The involvement of these proteins in a no. of diseases, neurodegenerative, inflammatory and metabolic, has started to show how they may prove to be important targets for therapeutic intervention.  We first became interested in EPAC when we discovered that the expression levels of both EPAC1 and EPAC2 were altered in those regions of the brain assocd. with Alzheimer's disease [McPhee, Breslin, Kewney, MacKenzie, Cooreman, Gibson and Hammond (2004) International Patent no. WO 2004/096199 A2].  It was known that compds. could be designed to be selective for EPAC over PKA (protein kinase A); however, these compds. were all based around the core structure of cAMP.  We decided to screen a small compd. library (10000 compds.) to investigate the possibility of developing a compd. series outside of the cAMP structure.  We subsequently developed a novel, high-throughput screen based on the displacement of [3H]cAMP from the EPAC cAMP-binding site and identified small mol. hits from the Scottish Biomedical Lead Generation Library.  These compds. selectively bind to the cAMP-binding sites of EPAC1 and EPAC2 and are structurally dissimilar to cAMP.  They have similar affinities for both EPAC1 and EPAC2 and have a high degree of specificity for EPAC over PKA.  We believe that these compds. provide a valuable starting point for a drug optimization program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouyPDxphsRO7Vg90H21EOLACvtfcHk0li2_Q1yzIQUcg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsL3O&md5=a7bd75bee9d72e8a91883bbd698c0f80</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1042%2FBST0331330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0331330%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DI.%26aulast%3DGibson%26aufirst%3DL.%2BC.%2BD.%26aulast%3DKewney%26aufirst%3DJ.%26aulast%3DDarroch%26aufirst%3DC.%26aulast%3DStevens%26aufirst%3DP.%2BA.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DCooreman%26aufirst%3DA.%26aulast%3DMacKenzie%26aufirst%3DS.%2BJ.%26atitle%3DCyclic%2520nucleotide%2520signalling%253A%2520a%2520molecular%2520approach%2520to%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2005%26volume%3D33%26spage%3D1330%26epage%3D1332%26doi%3D10.1042%2FBST20051330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">Targeting PDE10A GAF domain with small molecules: A way for allosteric modulation with anti-inflammatory effects</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1472</span>, <span class="refDoi"> DOI: 10.3390/molecules22091472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules22091472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWgsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1472&author=A.+M.+Garciaauthor=J.+Breaauthor=A.+Gonzalez-Garciaauthor=C.+Perezauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=A.+Martinezauthor=C.+Gil&title=Targeting+PDE10A+GAF+domain+with+small+molecules%3A+A+way+for+allosteric+modulation+with+anti-inflammatory+effects&doi=10.3390%2Fmolecules22091472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PDE10A GAF domain with small molecules: a way for allosteric modulation with anti-inflammatory effects</span></div><div class="casAuthors">Garcia, Ana M.; Brea, Jose; Gonzalez-Garcia, Alejandro; Perez, Concepcion; Cadavid, Maria Isabel; Loza, Maria Isabel; Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1472/1-1472/8</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) enzymes regulate the levels of cyclic nucleotides, cAMP, and/or cGMP, being attractive therapeutic targets.  In order to modulate PDE activity in a selective way, we focused our efforts on the search of allosteric modulators.  Based on the crystal structure of the PDE10A GAF-B domain, a virtual screening study allowed the discovery of new hits that were also tested exptl., showing inhibitory activities in the micromolar range.  Moreover, these new PDE10A inhibitors were able to decrease the nitrite prodn. in LPS-stimulated cells, thus demonstrating their potential as anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt-1hKgjMtnLVg90H21EOLACvtfcHk0lhm__4FTgj9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWgsrzJ&md5=1665309bf5f8a224ee692a7b3c40e4ea</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091472%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DA.%2BM.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DGonzalez-Garcia%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DTargeting%2520PDE10A%2520GAF%2520domain%2520with%2520small%2520molecules%253A%2520A%2520way%2520for%2520allosteric%2520modulation%2520with%2520anti-inflammatory%2520effects%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1472%26doi%3D10.3390%2Fmolecules22091472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nawrocki, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toolan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keohane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.2337/db13-0247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2337%2Fdb13-0247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24101672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=300-311&author=A.+R.+Nawrockiauthor=C.+G.+Rodriguezauthor=D.+M.+Toolanauthor=O.+Priceauthor=M.+Henryauthor=G.+Forrestauthor=D.+Szetoauthor=C.+A.+Keohaneauthor=Y.+Panauthor=K.+M.+Smithauthor=I.+T.+Raheemauthor=C.+D.+Coxauthor=J.+Hwaauthor=J.+J.+Rengerauthor=S.+M.+Smith&title=Genetic+deletion+and+pharmacological+inhibition+of+phosphodiesterase+10A+protects+mice+from+diet-induced+obesity+and+insulin+resistance&doi=10.2337%2Fdb13-0247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance</span></div><div class="casAuthors">Nawrocki, Andrea R.; Rodriguez, Carlos G.; Toolan, Dawn M.; Price, Olga; Henry, Melanie; Forrest, Gail; Szeto, Daphne; Keohane, Carol Ann; Pan, Yie; Smith, Karen M.; Raheem, Izzat T.; Cox, Christopher D.; Hwa, Joyce; Renger, John J.; Smith, Sean M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">300-311</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a novel therapeutic target for the treatment of schizophrenia.  Here we report a novel role of PDE10A in the regulation of caloric intake and energy homeostasis.  PDE10A-deficient mice are resistant to diet-induced obesity (DIO) and assocd. metabolic disturbances.  Inhibition of wt. gain is due to hypophagia after mice are fed a highly palatable diet rich in fats and sugar but not a std. diet.  PDE10A deficiency produces a decrease in caloric intake without affecting meal frequency, daytime vs. nighttime feeding behavior, or locomotor activity.  We tested THPP-6, a small mol. PDE10A inhibitor, in DIO mice.  THPP-6 treatment resulted in decreased food intake, body wt. loss, and reduced adiposity at doses that produced antipsychotic efficacy in behavioral models.  We show that PDE10A inhibition increased whole-body energy expenditure in DIO mice fed a Western-style diet, achieving wt. loss and reducing adiposity beyond the extent seen with food restriction alone.  Therefore, chronic THPP-6 treatment conferred improved insulin sensitivity and reversed hyperinsulinemia.  These data demonstrate that PDE10A inhibition represents a novel antipsychotic target that may have addnl. metabolic benefits over current medications for schizophrenia by suppressing food intake, alleviating wt. gain, and reducing the risk for the development of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpKRCUJQfObVg90H21EOLACvtfcHk0lhm__4FTgj9iQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsQ%253D%253D&md5=64c728352a9482af90ddbf86acc68a58</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.2337%2Fdb13-0247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb13-0247%26sid%3Dliteratum%253Aachs%26aulast%3DNawrocki%26aufirst%3DA.%2BR.%26aulast%3DRodriguez%26aufirst%3DC.%2BG.%26aulast%3DToolan%26aufirst%3DD.%2BM.%26aulast%3DPrice%26aufirst%3DO.%26aulast%3DHenry%26aufirst%3DM.%26aulast%3DForrest%26aufirst%3DG.%26aulast%3DSzeto%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DHwa%26aufirst%3DJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26atitle%3DGenetic%2520deletion%2520and%2520pharmacological%2520inhibition%2520of%2520phosphodiesterase%252010A%2520protects%2520mice%2520from%2520diet-induced%2520obesity%2520and%2520insulin%2520resistance%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D300%26epage%3D311%26doi%3D10.2337%2Fdb13-0247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hankir, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronisch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloting, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabri, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiker, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, W. K.</span></span> <span> </span><span class="NLM_article-title">A novel thermoregulatory role for PDE10A in mouse and human adipocytes</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.15252/emmm.201506085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.15252%2Femmm.201506085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27247380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xosl2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=796-812&author=M.+K.+Hankirauthor=M.+Kranzauthor=T.+Gnadauthor=J.+Weinerauthor=S.+Wagnerauthor=W.+Deuther-Conradauthor=F.+Bronischauthor=K.+Steinhoffauthor=J.+Luthardtauthor=N.+Klotingauthor=S.+Hesseauthor=J.+P.+Seibylauthor=O.+Sabriauthor=J.+T.+Heikerauthor=M.+Bluherauthor=A.+Pfeiferauthor=P.+Brustauthor=W.+K.+Fenske&title=A+novel+thermoregulatory+role+for+PDE10A+in+mouse+and+human+adipocytes&doi=10.15252%2Femmm.201506085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A novel thermoregulatory role for PDE10A in mouse and human adipocytes</span></div><div class="casAuthors">Hankir, Mohammed K.; Kranz, Mathias; Gnad, Thorsten; Weiner, Juliane; Wagner, Sally; Deuther-Conrad, Winnie; Bronisch, Felix; Steinhoff, Karen; Luthardt, Julia; Kloeting, Nora; Hesse, Swen; Seibyl, John P.; Sabri, Osama; Heiker, John T.; Blueher, Matthias; Pfeifer, Alexander; Brust, Peter; Fenske, Wiebke K.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">796-812</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase type 10A (PDE10A) is highly enriched in striatum and is under evaluation as a drug target for several psychiatric/neurodegenerative diseases.  Preclin. studies implicate PDE10A in the regulation of energy homeostasis, but the mechanisms remain unclear.  By utilizing small-animal PET/MRI and the novel radioligand [18F]-AQ28A, we found marked levels of PDE10A in interscapular brown adipose tissue (BAT) of mice.  Pharmacol. inactivation of PDE10A with the highly selective inhibitor MP-10 recruited BAT and potentiated thermogenesis in vivo.  In diet-induced obese mice, chronic administration of MP-10 caused wt. loss assocd. with increased energy expenditure, browning of white adipose tissue, and improved insulin sensitivity.  Anal. of human PET data further revealed marked levels of PDE10A in the supraclavicular region where brown/beige adipocytes are clustered in adults.  Finally, the inhibition of PDE10A with MP-10 stimulated thermogenic gene expression in human brown adipocytes and induced browning of human white adipocytes.  Collectively, our findings highlight a novel thermoregulatory role for PDE10A in mouse and human adipocytes and promote PDE10A inhibitors as promising candidates for the treatment of obesity and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqSV38fvPb7Vg90H21EOLACvtfcHk0licfwR9tHL4yQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xosl2nu7o%253D&md5=f24b4ab2ae0805bcaae4df511f0be275</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.15252%2Femmm.201506085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201506085%26sid%3Dliteratum%253Aachs%26aulast%3DHankir%26aufirst%3DM.%2BK.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DGnad%26aufirst%3DT.%26aulast%3DWeiner%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBronisch%26aufirst%3DF.%26aulast%3DSteinhoff%26aufirst%3DK.%26aulast%3DLuthardt%26aufirst%3DJ.%26aulast%3DKloting%26aufirst%3DN.%26aulast%3DHesse%26aufirst%3DS.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DSabri%26aufirst%3DO.%26aulast%3DHeiker%26aufirst%3DJ.%2BT.%26aulast%3DBluher%26aufirst%3DM.%26aulast%3DPfeifer%26aufirst%3DA.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DFenske%26aufirst%3DW.%2BK.%26atitle%3DA%2520novel%2520thermoregulatory%2520role%2520for%2520PDE10A%2520in%2520mouse%2520and%2520human%2520adipocytes%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D796%26epage%3D812%26doi%3D10.15252%2Femmm.201506085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Alcantara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canzoneri, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wierzbicki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span> <span> </span><span class="NLM_article-title">Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">27403</span>– <span class="NLM_lpage">27415</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.18632%2Foncotarget.4741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26299804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC287lsVSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=27403-27415&author=N.+Liauthor=X.+Chenauthor=B.+Zhuauthor=V.+Ramirez-Alcantaraauthor=J.+C.+Canzoneriauthor=K.+Leeauthor=S.+Siglerauthor=B.+Garyauthor=Y.+Liauthor=W.+Zhangauthor=M.+P.+Moyerauthor=E.+A.+Salterauthor=A.+Wierzbickiauthor=A.+B.+Keetonauthor=G.+A.+Piazza&title=Suppression+of+%CE%B2-catenin%2FTCF+transcriptional+activity+and+colon+tumor+cell+growth+by+dual+inhibition+of+PDE5+and+10&doi=10.18632%2Foncotarget.4741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10</span></div><div class="casAuthors">Li Nan; Chen Xi; Zhu Bing; Ramirez-Alcantara Veronica; Canzoneri Joshua C; Lee Kevin; Sigler Sara; Gary Bernard; Keeton Adam B; Piazza Gary A; Li Yonghe; Zhang Wei; Moyer Mary P; Salter E Alan; Wierzbicki Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">27403-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previous studies suggest the anti-inflammatory drug, sulindac inhibits tumorigenesis by a COX independent mechanism involving cGMP PDE inhibition.  Here we report that the cGMP PDE isozymes, PDE5 and 10, are elevated in colon tumor cells compared with normal colonocytes, and that inhibitors and siRNAs can selectively suppress colon tumor cell growth.  Combined treatment with inhibitors or dual knockdown suppresses tumor cell growth to a greater extent than inhibition from either isozyme alone.  A novel sulindac derivative, ADT-094 was designed to lack COX-1/-2 inhibitory activity but have improved potency to inhibit PDE5 and 10.  ADT-094 displayed >500 fold higher potency to inhibit colon tumor cell growth compared with sulindac by activating cGMP/PKG signaling to suppress proliferation and induce apoptosis.  Combined inhibition of PDE5 and 10 by treatment with ADT-094, PDE isozyme-selective inhibitors, or by siRNA knockdown also suppresses β-catenin, TCF transcriptional activity, and the levels of downstream targets, cyclin D1 and survivin.  These results suggest that dual inhibition of PDE5 and 10 represents novel strategy for developing potent and selective anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZOcrzvUtxVNenUz0lpNqnfW6udTcc2ebDVLm5Kw9oQrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287lsVSktQ%253D%253D&md5=b141f2a8df2d86294a60f81bf37d6e6e</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4741%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DRamirez-Alcantara%26aufirst%3DV.%26aulast%3DCanzoneri%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSigler%26aufirst%3DS.%26aulast%3DGary%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DSalter%26aufirst%3DE.%2BA.%26aulast%3DWierzbicki%26aufirst%3DA.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26atitle%3DSuppression%2520of%2520%25CE%25B2-catenin%252FTCF%2520transcriptional%2520activity%2520and%2520colon%2520tumor%2520cell%2520growth%2520by%2520dual%2520inhibition%2520of%2520PDE5%2520and%252010%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D27403%26epage%3D27415%26doi%3D10.18632%2Foncotarget.4741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeMartinis, N.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walling, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, A.</span></span> <span> </span><span class="NLM_article-title">A roof-of-concept study evaluating the phosphodiesterase 10A inhibitor PF-02545920 in the adjunctive treatment of suboptimally controlled symptoms of schizophrenia</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1097/JCP.0000000000001047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1097%2FJCP.0000000000001047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31205187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1Kqtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=318-328&author=N.+DeMartinisauthor=R.+N.+Lopezauthor=E.+H.+Pickeringauthor=C.+J.+Schmidtauthor=L.+Gertsikauthor=D.+P.+Wallingauthor=A.+Ogden&title=A+roof-of-concept+study+evaluating+the+phosphodiesterase+10A+inhibitor+PF-02545920+in+the+adjunctive+treatment+of+suboptimally+controlled+symptoms+of+schizophrenia&doi=10.1097%2FJCP.0000000000001047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia</span></div><div class="casAuthors">DeMartinis, Nicholas, III; Lopez, Rene N.; Pickering, Eve H.; Schmidt, Christopher J.; Gertsik, Lev; Walling, David P.; Ogden, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Effective treatments for managing suboptimal clin. responses to current therapy for schizophrenia remain a crit. unmet need.  Phosphodiesterase 10A (PDE10A) inhibition represents a mechanistically novel approach to the treatment of schizophrenia, with preclin. studies suggesting improvements in partially responsive symptoms could be achieved through adjunctive use of the PDE10A inhibitor PF-02545920.  Therefore, the adjunctive safety, tolerability, pharmacokinetics, and efficacy of multiple repeat doses of PF-02545920 were investigated in a phase 1b study and subsequent phase 2 study.  The phase 1b study randomized 37 adult patients with stable symptomatol. and stable antipsychotic regimens within 3 cohorts.  Study participants received ascending doses of PF-02545920 or placebo for 10 to 18 days.  The phase 2 study randomized 240 outpatients with stable symptomatol. but suboptimal response to current antipsychotic regimens 1:1:1 to PF-02545920 5 mg, PF-02545920 15 mg, or placebo every 12 h for 12 wk.  The primary efficacy end point of the phase 2 study was change in the Pos. and Neg. Syndrome Scale total score from baseline to week 12, with changes in other clin. assessments as secondary end points.  Treatment was well tolerated, and obsd. PF-02545920 exposures were within the range predicted to be adequate for demonstrating efficacy.  However, no significant differences in the prespecified efficacy end points between the 2 PF-02545920 treatment arms and placebo were obsd.  Current data and results of a prior monotherapy study in which PF-02545920 failed to differentiate from placebo refute the hypothesis that PDE10A inhibitors have use as antipsychotic agents for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQT0Fch8zyO7Vg90H21EOLACvtfcHk0lgnkYd1eoqBUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1Kqtr3K&md5=c0fcd49bf1bfb669f3d120285ff9b432</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1097%2FJCP.0000000000001047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0000000000001047%26sid%3Dliteratum%253Aachs%26aulast%3DDeMartinis%26aufirst%3DN.%26aulast%3DLopez%26aufirst%3DR.%2BN.%26aulast%3DPickering%26aufirst%3DE.%2BH.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DGertsik%26aufirst%3DL.%26aulast%3DWalling%26aufirst%3DD.%2BP.%26aulast%3DOgden%26aufirst%3DA.%26atitle%3DA%2520roof-of-concept%2520study%2520evaluating%2520the%2520phosphodiesterase%252010A%2520inhibitor%2520PF-02545920%2520in%2520the%2520adjunctive%2520treatment%2520of%2520suboptimally%2520controlled%2520symptoms%2520of%2520schizophrenia%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2019%26volume%3D39%26spage%3D318%26epage%3D328%26doi%3D10.1097%2FJCP.0000000000001047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affinito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roepcke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, T. A.</span></span> <span> </span><span class="NLM_article-title">A randomized multiple dose pharmacokinetic study of a novel PDE10A inhibitor TAK-063 in subjects with stable schizophrenia and Japanese subjects and modeling of exposure relationships to adverse events</span>. <i>Drugs R&amp;D</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1007/s40268-017-0214-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs40268-017-0214-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29103081" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=631-643&author=P.+Goldsmithauthor=J.+Affinitoauthor=M.+McCueauthor=M.+Tsaiauthor=S.+Roepckeauthor=J.+Xieauthor=L.+Gertsikauthor=T.+A.+Macek&title=A+randomized+multiple+dose+pharmacokinetic+study+of+a+novel+PDE10A+inhibitor+TAK-063+in+subjects+with+stable+schizophrenia+and+Japanese+subjects+and+modeling+of+exposure+relationships+to+adverse+events&doi=10.1007%2Fs40268-017-0214-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1007%2Fs40268-017-0214-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-017-0214-8%26sid%3Dliteratum%253Aachs%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DAffinito%26aufirst%3DJ.%26aulast%3DMcCue%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DM.%26aulast%3DRoepcke%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGertsik%26aufirst%3DL.%26aulast%3DMacek%26aufirst%3DT.%2BA.%26atitle%3DA%2520randomized%2520multiple%2520dose%2520pharmacokinetic%2520study%2520of%2520a%2520novel%2520PDE10A%2520inhibitor%2520TAK-063%2520in%2520subjects%2520with%2520stable%2520schizophrenia%2520and%2520Japanese%2520subjects%2520and%2520modeling%2520of%2520exposure%2520relationships%2520to%2520adverse%2520events%26jtitle%3DDrugs%2520R%2526amp%253BD%26date%3D2017%26volume%3D17%26spage%3D631%26epage%3D643%26doi%3D10.1007%2Fs40268-017-0214-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affinito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahableshwarkar, A. R.</span></span> <span> </span><span class="NLM_article-title">A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia</span>. <i>Schizophr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1016/j.schres.2018.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.schres.2018.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30190165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB3c3mtlWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2019&pages=289-294&author=T.+A.+Macekauthor=M.+McCueauthor=X.+Dongauthor=E.+Hansonauthor=P.+Goldsmithauthor=J.+Affinitoauthor=A.+R.+Mahableshwarkar&title=A+phase+2%2C+randomized%2C+placebo-controlled+study+of+the+efficacy+and+safety+of+TAK-063+in+subjects+with+an+acute+exacerbation+of+schizophrenia&doi=10.1016%2Fj.schres.2018.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia</span></div><div class="casAuthors">Macek Thomas A; Dong Xinxin; Hanson Elizabeth; Affinito John; Mahableshwarkar Atul R; McCue Maggie; Goldsmith Paul</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">289-294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  TAK-063 is a potent, selective inhibitor of phosphodiesterase 10A, an enzyme selectively expressed in medium spiny neurons of the striatum.  This randomized, parallel-group study evaluated the efficacy and safety of 20-mg daily TAK-063 versus placebo in subjects with acutely exacerbated symptoms of schizophrenia (NCT02477020).  METHODS:  Adults aged 18 to 65 with diagnosed schizophrenia and psychotic symptoms that exacerbated within 60 days before screening were included.  Subjects who discontinued psychotropic medications before screening were randomized 1:1 to 6 weeks of placebo (n = 81) or 20-mg TAK-063 (n = 83).  Weekly efficacy visits were conducted during the treatment period, and dose de-escalation was allowed (blinded) to 10-mg TAK-063 for intolerability.  RESULTS:  The primary endpoint, change from baseline in the Positive and Negative Syndrome Scale total score at week 6, was not achieved (least-squares mean difference vs placebo [standard error] = -5.46 [3.44]; p = 0.115).  Secondary endpoints were generally supportive of antipsychotic efficacy.  Consistent with previous phase 1 studies, TAK-063 was safe and well tolerated, and most adverse events were mild or moderate in severity and did not result in discontinuation.  No deaths occurred, and the incidence of akathisia and dystonia, categories of extrapyramidal syndromes, was more frequent in the TAK-063 group than placebo.  CONCLUSIONS:  Although the study did not meet the primary endpoint (effect size = 0.308), the effects of TAK-063 on the primary and secondary endpoints may be suggestive of antipsychotic activity.  Interpretation of these results is confounded by a relatively high placebo effect and a lack of dose-ranging or active reference.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvmehFgKXv78yail4HZd-ifW6udTcc2ebfdICl4jm8sbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3mtlWmtw%253D%253D&md5=5910ce3affa7412cc1b7b281fbe1bb61</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2018.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2018.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DMacek%26aufirst%3DT.%2BA.%26aulast%3DMcCue%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DHanson%26aufirst%3DE.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DAffinito%26aufirst%3DJ.%26aulast%3DMahableshwarkar%26aufirst%3DA.%2BR.%26atitle%3DA%2520phase%25202%252C%2520randomized%252C%2520placebo-controlled%2520study%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520TAK-063%2520in%2520subjects%2520with%2520an%2520acute%2520exacerbation%2520of%2520schizophrenia%26jtitle%3DSchizophr.%2520Res.%26date%3D2019%26volume%3D204%26spage%3D289%26epage%3D294%26doi%3D10.1016%2Fj.schres.2018.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padakanti, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoghi, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and in vivo evaluation of [<sup>11</sup>C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1673</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.01.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmc.2011.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21315609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFylt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1666-1673&author=Z.+Tuauthor=J.+Fanauthor=S.+Liauthor=L.+A.+Jonesauthor=J.+Cuiauthor=P.+K.+Padakantiauthor=J.+Xuauthor=D.+Zengauthor=K.+I.+Shoghiauthor=J.+S.+Perlmutterauthor=R.+H.+Mach&title=Radiosynthesis+and+in+vivo+evaluation+of+%5B11C%5DMP-10+as+a+PET+probe+for+imaging+PDE10A+in+rodent+and+non-human+primate+brain&doi=10.1016%2Fj.bmc.2011.01.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain</span></div><div class="casAuthors">Tu, Zhude; Fan, Jinda; Li, Shihong; Jones, Lynne A.; Cui, Jinquan; Padakanti, Prashanth K.; Xu, Jinbin; Zeng, Dexing; Shoghi, Kooresh I.; Perlmutter, Joel S.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1666-1673</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-((4-(1-[11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-quinoline (MP-10), a specific PDE10A inhibitor (IC50 = 0.18 nM with 100-fold selectivity over other PDEs), was radiosynthesized by alkylation of the desmethyl precursor with [11C]CH3I, ∼45% yield, >92% radiochem. purity, >370 GBq/μmol specific activity at end of bombardment (EOB).  Evaluation in Sprague-Dawley rats revealed that [11C]MP-10 had highest brain accumulation in the PDE10A enriched-striatum, the 30 min striatum: cerebellum ratio reached 6.55.  MicroPET studies of [11C]MP-10 in monkeys displayed selective uptake in striatum.  However, a radiolabeled metabolite capable of penetrating the blood-brain-barrier may limit the clin. utility of [11C]MP-10 as a PDE10A PET tracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreVaHkkAyq4rVg90H21EOLACvtfcHk0lgdFD97VUu0ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFylt7w%253D&md5=540b2a12c8c00307644df97a3d193d2a</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DPadakanti%26aufirst%3DP.%2BK.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DRadiosynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255DMP-10%2520as%2520a%2520PET%2520probe%2520for%2520imaging%2520PDE10A%2520in%2520rodent%2520and%2520non-human%2520primate%2520brain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1666%26epage%3D1673%26doi%3D10.1016%2Fj.bmc.2011.01.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinzimmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and in vivo evaluation of [<sup>11</sup>C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2011.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2011.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21843784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVajsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=875-884&author=C.+Plissonauthor=C.+Salinasauthor=D.+Weinzimmerauthor=D.+Labareeauthor=S.+F.+Linauthor=Y.+S.+Dingauthor=S.+Jakobsenauthor=P.+W.+Smithauthor=K.+Eijiauthor=R.+E.+Carsonauthor=R.+N.+Gunnauthor=E.+A.+Rabiner&title=Radiosynthesis+and+in+vivo+evaluation+of+%5B11C%5DMP-10+as+a+positron+emission+tomography+radioligand+for+phosphodiesterase+10A&doi=10.1016%2Fj.nucmedbio.2011.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and in vivo evaluation of [11C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A</span></div><div class="casAuthors">Plisson, Christophe; Salinas, Cristian; Weinzimmer, David; Labaree, David; Lin, Shu-Fei; Ding, Yu-Shin; Jakobsen, Steen; Smith, Paul W.; Eiji, Kawanishi; Carson, Richard E.; Gunn, Roger N.; Rabiner, Eugenii A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">875-884</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: The aim of this study was to evaluate a newly reported positron emission tomog. (PET) radioligand [11C]MP-10, a potent and selective inhibitor of the central phosphodiesterase 10A enzyme (PDE10A) in vivo, using PET.  Methods: A procedure was developed for labeling MP-10 with carbon-11. [11C]MP-10 was evaluated in vivo both in the pig and baboon brain.  Results: Alkylation of the corresponding desmethyl compd. with [11C]methyl iodide produced [11C]MP-10 with good radiochem. yield and specific activity.  PET studies in the pig showed that [11C]MP-10 rapidly entered the brain reaching peak tissue concn. at 1-2 min postadministration, followed by washout from the tissue.  Administration of a selective PDE10A inhibitor reduced the binding in all brain regions to the levels of the cerebellum, demonstrating the saturability and selectivity of [11C]MP-10 binding.  In the nonhuman primate, the brain tissue kinetics of [11C]MP-10 were slower, reaching peak tissue concns. at 30-60 min postadministration.  In both species, the obsd. rank order of regional brain signal was striatum>diencephalon>cortical regions=cerebellum, consistent with the known distribution and concn. of PDE10A. [11C]MP-10 brain kinetics were well described by a two-tissue compartment model, and ests. of total vol. of distribution (VT) were obtained.  Blocking studies with unlabeled MP-10 revealed the suitability of the cerebellum as a ref. tissue and enabled the estn. of regional binding potential (BP ND) as the outcome measure of specific binding.  Quantification of [11C]MP-10 binding using the simplified ref. tissue model with cerebellar input function produced BP ND ests. consistent with those obtained by the two-tissue compartment model.  Conclusion: We demonstrated that [11C]MP-10 possesses good characteristics for the in vivo quantification of the PDE10A in the brain by PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXXGU_U-Xg7rVg90H21EOLACvtfcHk0lgdFD97VUu0ng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVajsLrO&md5=9dbea840abf1f40243929038b6cf5c8c</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DWeinzimmer%26aufirst%3DD.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DDing%26aufirst%3DY.%2BS.%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DEiji%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26atitle%3DRadiosynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255DMP-10%2520as%2520a%2520positron%2520emission%2520tomography%2520radioligand%2520for%2520phosphodiesterase%252010A%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2011%26volume%3D38%26spage%3D875%26epage%3D884%26doi%3D10.1016%2Fj.nucmedbio.2011.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kealey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauridsen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensbol, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span> <span> </span><span class="NLM_article-title">Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [<sup>11</sup>C] MP-10 PET rodent imaging study with ex vivo confirmation</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e376</span> <span class="refDoi"> DOI: 10.1038/tp.2014.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Ftp.2014.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24690597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Khtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&author=S.+Natesanauthor=S.+Ashworthauthor=J.+Nielsenauthor=S.+P.+Tangauthor=C.+Salinasauthor=S.+Kealeyauthor=J.+B.+Lauridsenauthor=T.+B.+Stensbolauthor=R.+N.+Gunnauthor=E.+A.+Rabinerauthor=S.+Kapur&title=Effect+of+chronic+antipsychotic+treatment+on+striatal+phosphodiesterase+10A+levels%3A+a+%5B11C%5D+MP-10+PET+rodent+imaging+study+with+ex+vivo+confirmation&doi=10.1038%2Ftp.2014.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [11C]MP-10 PET rodent imaging study with ex vivo confirmation</span></div><div class="casAuthors">Natesan, S.; Ashworth, S.; Nielsen, J.; Tang, S.-P.; Salinas, C.; Kealey, S.; Lauridsen, J. B.; Stensboel, T. B.; Gunn, R. N.; Rabiner, E. A.; Kapur, S.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e376</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A no. of phosphodiesterase 10A (PDE10) inhibitors are about to undergo clin. evaluation for their efficacy in treating schizophrenia.  As phosphodiesterases are in the same signalling pathway as dopamine D2 receptors, it is possible that prior antipsychotic treatment could influence these enzyme systems in patients.  Chronic, in contrast to acute, antipsychotic treatment has been reported to increase brain PDE10A levels in rodents.  The aim of this study was to confirm these findings in a manner that can be translated to human imaging studies to understand its consequences.  Positron emission tomog. (PET) scanning was used to evaluate PDE10A enzyme availability, after chronic haloperidol administration, using a specific PDE10A ligand ([11C]MP-10).  The binding of [11C]MP-10 in the striatum and the cerebellum was measured in rodents and a simplified ref. tissue model (SRTM) with cerebellum as the ref. region was used to det. the binding potential (BPND).  In rats treated chronically with haloperidol (2 mg kg-1 per day), there was no significant difference in PDE10A levels compared with the vehicle-treated group (BPND±s.d.: 3.57±0.64 vs. 2.86±0.71).  Following PET scans, ex vivo anal. of striatal brain tissue for PDE10A mRNA (Pde10a) and PDE10A enzyme activity showed no significant difference.  Similarly, the PDE10A protein content detd. by western blot anal. was similar between the two groups, contrary to an earlier finding.  The results of the study indicate that prior exposure to antipsychotic medication in rodents does not alter PDE10A levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps1okMJG8N1LVg90H21EOLACvtfcHk0lhnvab5yAQ63A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Khtb4%253D&md5=6bd49e8ed4c45b06b2a441ec9622d189</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1038%2Ftp.2014.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2014.17%26sid%3Dliteratum%253Aachs%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DAshworth%26aufirst%3DS.%26aulast%3DNielsen%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DS.%2BP.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DKealey%26aufirst%3DS.%26aulast%3DLauridsen%26aufirst%3DJ.%2BB.%26aulast%3DStensbol%26aufirst%3DT.%2BB.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DEffect%2520of%2520chronic%2520antipsychotic%2520treatment%2520on%2520striatal%2520phosphodiesterase%252010A%2520levels%253A%2520a%2520%255B11C%255D%2520MP-10%2520PET%2520rodent%2520imaging%2520study%2520with%2520ex%2520vivo%2520confirmation%26jtitle%3DTransl.%2520Psychiatry%26date%3D2014%26volume%3D4%26doi%3D10.1038%2Ftp.2014.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallezot, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapinos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafzadeh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Further evaluation of [<sup>11</sup>C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1002/syn.21792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25450608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVKmurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=86-95&author=S.+F.+Linauthor=D.+Labareeauthor=M.+K.+Chenauthor=D.+Holdenauthor=J.+D.+Gallezotauthor=M.+Kapinosauthor=J.+K.+Tengauthor=S.+Najafzadehauthor=C.+Plissonauthor=E.+A.+Rabinerauthor=R.+N.+Gunnauthor=R.+E.+Carsonauthor=Y.+Huang&title=Further+evaluation+of+%5B11C%5DMP-10+as+a+radiotracer+for+phosphodiesterase+10A%3A+PET+imaging+study+in+rhesus+monkeys+and+brain+tissue+metabolite+analysis&doi=10.1002%2Fsyn.21792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis</span></div><div class="casAuthors">Lin, Shu-Fei; Labaree, David; Chen, Ming-Kai; Holden, Daniel; Gallezot, Jean-Dominique; Kapinos, Michael; Teng, Jo-Ku; Najafzadeh, Soheila; Plisson, Christophe; Rabiner, Eugenii A.; Gunn, Roger N.; Carson, Richard E.; Huang, Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-95</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">[11C]MP-10 is a potent and specific PET tracer previously shown to be suitable for imaging the phosphodiesterase 10A (PDE10A) in baboons with reversible kinetics and high specific binding.  However, another report indicated that [11C]MP-10 displayed seemingly irreversible kinetics in rhesus monkeys, potentially due to the presence of a radiolabeled metabolite capable of penetrating the blood-brain-barrier (BBB) into the brain.  This study was designed to address the discrepancies between the species by re-evaluating [11C]MP-10 in vivo in rhesus monkey with baseline scans to assess tissue uptake kinetics and self-blocking scans with unlabeled MP-10 to det. binding specificity.  Ex vivo studies with one rhesus monkey and 4 Sprague-Dawley rats were also performed to investigate the presence of radiolabeled metabolites in the brain.  Our results indicated that [11C]MP-10 displayed reversible uptake kinetics in rhesus monkeys, albeit slower than in baboons.  Administration of unlabeled MP-10 reduced the binding of [11C]MP-10 in a dose-dependent manner in all brain regions including the cerebellum.  Consequently, the cerebellum appeared not to be a suitable ref. tissue in rhesus monkeys.  Regional vol. of distribution (VT) was mostly reliably derived with the multilinear anal. (MA1) method.  In ex vivo studies in the monkey and rats only negligible amt. of radiometabolites was seen in the brain of either species.  In summary, results from the present study strongly support the suitability of [11C]MP-10 as a radiotracer for PET imaging and quantification of PDE10A in nonhuman primates.  Synapse, 2014. © 2014 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqsGsO2Aev7Vg90H21EOLACvtfcHk0lhnvab5yAQ63A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVKmurfN&md5=41cb1ab19cc0c097c65e84d7828a6f07</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21792%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DM.%2BK.%26aulast%3DHolden%26aufirst%3DD.%26aulast%3DGallezot%26aufirst%3DJ.%2BD.%26aulast%3DKapinos%26aufirst%3DM.%26aulast%3DTeng%26aufirst%3DJ.%2BK.%26aulast%3DNajafzadeh%26aufirst%3DS.%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DFurther%2520evaluation%2520of%2520%255B11C%255DMP-10%2520as%2520a%2520radiotracer%2520for%2520phosphodiesterase%252010A%253A%2520PET%2520imaging%2520study%2520in%2520rhesus%2520monkeys%2520and%2520brain%2520tissue%2520metabolite%2520analysis%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D86%26epage%3D95%26doi%3D10.1002%2Fsyn.21792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothfuss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> biological evaluation of pyrazole group-containing analogues for PDE10A</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1039/c2md20239e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1039%2Fc2md20239e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23585921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVChsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=443-449&author=J.+Liauthor=H.+Jinauthor=H.+Zhouauthor=J.+Rothfussauthor=Z.+Tu&title=Synthesis+and+in+vitro+biological+evaluation+of+pyrazole+group-containing+analogues+for+PDE10A&doi=10.1039%2Fc2md20239e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro biological evaluation of pyrazole group-containing analogues for PDE10A</span></div><div class="casAuthors">Li, Junfeng; Jin, Hongjun; Zhou, Haiying; Rothfuss, Justin; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">443-449</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Twenty eight new analogs were synthesized by optimizing the structure of MP-10 and their in vitro binding affinities towards PDE10 Å, PDE3A/B, and PDE4A/B were detd.  Among these new analogs are very potent towards PDE10 Å and have IC50 values of 0.40 ± 0.02, 0.28 ± 0.06, 1.82 ± 0.25, 0.24 ± 0.05, 0.36 ± 0.03 and 1.78 ± 0.03 nM, resp.; these six compds. displayed high selectivity for PDE10 Å vs. PDE3A/3B/4A/4B.  The promising compds. will be further validated in vivo to identify PDE10 Å imaging tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Q3Egx64AEbVg90H21EOLACvtfcHk0lhCANSPjavJcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVChsbk%253D&md5=f364b5c0215d910d60ac0d18a4dc4220</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1039%2Fc2md20239e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20239e%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DRothfuss%26aufirst%3DJ.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520biological%2520evaluation%2520of%2520pyrazole%2520group-containing%2520analogues%2520for%2520PDE10A%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D443%26epage%3D449%26doi%3D10.1039%2Fc2md20239e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padakanti, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span> <span> </span><span class="NLM_article-title">Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2648</span>– <span class="NLM_lpage">2654</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmc.2014.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24721831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlslSqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2648-2654&author=J.+Fanauthor=X.+Zhangauthor=J.+Liauthor=H.+Jinauthor=P.+K.+Padakantiauthor=L.+A.+Jonesauthor=H.+P.+Floresauthor=Y.+Suauthor=J.+S.+Perlmutterauthor=Z.+Tu&title=Radiosyntheses+and+in+vivo+evaluation+of+carbon-11+PET+tracers+for+PDE10A+in+the+brain+of+rodent+and+nonhuman+primate&doi=10.1016%2Fj.bmc.2014.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate</span></div><div class="casAuthors">Fan, Jinda; Zhang, Xiang; Li, Junfeng; Jin, Hongjun; Padakanti, Prashanth K.; Jones, Lynne A.; Flores, Hubert P.; Su, Yi; Perlmutter, Joel S.; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2648-2654</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The radiosyntheses and in vivo evaluation of four carbon-11 labeled quinoline group-contg. radioligands are reported here.  Radiolabeling of [11C]1-4 was achieved by alkylation of their corresponding desmethyl precursors with [11C]CH3I.  Preliminary biodistribution evaluation in Sprague-Dawley rats demonstrated that [11C]1 and [11C]2 had high striatal accumulation (at peak time) for [11C]1 and [11C]2 were 6.0-fold and 4.5-fold at 60 min, resp.  Following MP-10 pretreatment, striatal uptake in rats of [11C]1 and [11C]2 was reduced, suggesting that the tracers bind specifically to PDE10A.  MicroPET studies of [11C]1 and [11C]2 in nonhuman primates (NHP) also showed good tracer retention in the striatum with rapid clearance from non-target brain regions.  Striatal uptake (SUV) of [11C]1 reached 1.8 at 30 min with a 3.5-fold striatum:cerebellum ratio.  In addn., HPLC anal. of solvent exts. from NHP plasma samples suggested that [11C]1 had a very favorable metabolic stability.  Our preclin. investigations suggest that [11C]1 is a promising candidate for quantification of PDE10A in vivo using PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS2h3C-yQwb7Vg90H21EOLACvtfcHk0lhCANSPjavJcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlslSqu7s%253D&md5=4c6ee08f881da1c4ea349d3952acd48b</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DPadakanti%26aufirst%3DP.%2BK.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DFlores%26aufirst%3DH.%2BP.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DRadiosyntheses%2520and%2520in%2520vivo%2520evaluation%2520of%2520carbon-11%2520PET%2520tracers%2520for%2520PDE10A%2520in%2520the%2520brain%2520of%2520rodent%2520and%2520nonhuman%2520primate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2648%26epage%3D2654%26doi%3D10.1016%2Fj.bmc.2014.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2015.07.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2015.07.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26216275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yhtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2015&pages=253-262&author=H.+Liuauthor=H.+Jinauthor=X.+Yueauthor=X.+Zhangauthor=H.+Yangauthor=J.+Liauthor=H.+Floresauthor=Y.+Suauthor=J.+S.+Perlmutterauthor=Z.+Tu&title=Preclinical+evaluation+of+a+promising+C-11+labeled+PET+tracer+for+imaging+phosphodiesterase+10A+in+the+brain+of+living+subject&doi=10.1016%2Fj.neuroimage.2015.07.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject</span></div><div class="casAuthors">Liu, Hui; Jin, Hongjun; Yue, Xuyi; Zhang, Xiang; Yang, Hao; Li, Junfeng; Flores, Hubert; Su, Yi; Perlmutter, Joel S.; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">253-262</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) plays a key role in the regulation of brain striatal signaling.  A PET tracer for PDE10A may serve as a tool to evaluate PDE10A expression in vivo in central nervous system disorders with striatal pathol.  Here, we further characterized the binding properties of a previously reported radioligand we developed for PDE10A, [11C]TZ1964B, in rodents and nonhuman primates (NHPs).  The tritiated counterpart [3H]TZ1964B was used for in vitro binding characterizations in rat striatum homogenates and in vitro autoradiog. studies in rat brain slices.  The carbon-11 labeled [11C]TZ1964B was utilized in the ex vivo autoradiog. studies for the brain of rats and microPET imaging studies for the brain of NHPs.  MicroPET scans of [11C]TZ1964B in NHPs were conducted at baseline, as well as with using a selective PDE10A inhibitor MP-10 for either pretreatment or displacement.  The in vivo regional target occupancy (Occ) was obtained by pretreating with different doses of MP-10 (0.05-2.00 mg/kg).  Both in vitro binding assays and in vitro autoradiog. studies revealed a nanomolar binding affinity of [3H]TZ1964B to the rat striatum.  The striatal binding of [3H]TZ1964B and [11C]TZ1964B was either displaced or blocked by MP-10 in rats and NHPs.  Autoradiog. and microPET imaging confirmed that the specific binding of the radioligand was found in the striatum but not in the cerebellum.  Blocking studies also confirmed the suitability of the cerebellum as an appropriate ref. region.  The binding potentials (BPND) of [11C]TZ1964B in the NHP striatum that were calcd. using either the Logan ref. model (LoganREF, 3.96 ± 0.17) or the simplified ref. tissue model (SRTM, 4.64 ± 0.47), with the cerebellum as the ref. region, was high and had good reproducibility.  The occupancy studies indicated a MP-10 dose of 0.31 ± 0.09 mg/kg (LoganREF)/0.45 ± 0.17 mg/kg (SRTM) occupies 50% striatal PDE10A binding sites.  Studies in rats and NHPs demonstrated radiolabeled TZ1964B has a high binding affinity and good specificity for PDE10A, as well as favorable in vivo pharmacokinetic properties and binding profiles.  Our data suggests that [11C]TZ1964B is a promising radioligand for in vivo imaging PDE10A in the brain of living subject.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN3uo0CfJYU7Vg90H21EOLACvtfcHk0lhCANSPjavJcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yhtbvJ&md5=09bcfb0fa42e4deaadc22344fdbf8061</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2015.07.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2015.07.049%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DFlores%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DPreclinical%2520evaluation%2520of%2520a%2520promising%2520C-11%2520labeled%2520PET%2520tracer%2520for%2520imaging%2520phosphodiesterase%252010A%2520in%2520the%2520brain%2520of%2520living%2520subject%26jtitle%3DNeuroImage%26date%3D2015%26volume%3D121%26spage%3D253%26epage%3D262%26doi%3D10.1016%2Fj.neuroimage.2015.07.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitneni, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedeurwaerdere, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1591</span>, <span class="refDoi"> DOI: 10.2967/jnumed.110.077040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.110.077040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20847170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=S.+Dedeurwaerdereauthor=D.+Moecharsauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andresauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ41510417+as+a+radioligand+for+PET+imaging+of+phosphodiesterase-10A+in+the+brain&doi=10.2967%2Fjnumed.110.077040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET Imaging of phosphodiesterase-10A in the brain</span></div><div class="casAuthors">Celen, Sofie; Koole, Michel; De Angelis, Meri; Sannen, Ivan; Chitneni, Satish K.; Alcazar, Jesus; Dedeurwaerdere, Stefanie; Moechars, Dieder; Schmidt, Mark; Verbruggen, Alfons; Langlois, Xavier; Van Laere, Koen; Andres, Jose Ignacio; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1584-1591</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Phosphodiesterases are enzymes that inactivate the intracellular second messengers 3',5'-cyclic adenosine-monophosphate and/or cyclic guanosine-monophosphate.  Of all 11 known phosphodiesterase families, phosphodiesterase-10A (PDE10A) has the most restricted distribution, with high expression in the striatum.  PDE10A inhibitors are pursued as drugs for treatment of neuropsychiatric disorders.  We have synthesized and evaluated 18F-JNJ41510417 as a selective and high-affinity radioligand for in vivo brain imaging of PDE10A using PET.  Methods: The biodistribution of 18F-JNJ41510417 was evaluated in rats.  Rat plasma and perfused brain homogenates were analyzed by high-performance liq. chromatog. to quantify radiometabolites.  Dynamic small-animal PET was performed in rats and in wild-type and PDE10A knock-out mice and compared with ex vivo autoradiog.  Blocking and displacement expts. were performed using the nonradioactive analog and other selective PDE10A inhibitors.  Results: Tissue distribution studies showed predominant hepatobiliary excretion, sufficient brain uptake (0.56 ± 0.00 percentage injected dose at 2 min after tracer injection), and continuous accumulation of the tracer in the striatum over time; rapid washout of nonspecific binding from other brain regions was obsd.  Polar radiometabolites were detected in plasma and brain tissue.  Dynamic small-animal PET showed continuous tracer accumulation in the striatum, with rapid decline in the cortex and cerebellum.  Pretreatment and chase expts. with PDE10A inhibitors showed that the tracer binding to PDE10A was specific and reversible.  Imaging in PDE10A knock-out and wild-type mice further confirmed that binding in the striatum was specific for PDE10A.  Conclusion: Expts. in rats and PDE10A knock-out mice indicate that 18F-JNJ41510417 binds specifically and reversibly to PDE10A in the striatum, suggesting that this new fluorinated quinoline deriv. is a promising candidate for in vivo imaging of PDE10A using PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwofQ-1zM9rVg90H21EOLACvtfcHk0lgnjtqjLoSA-g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrnL&md5=4d40c29032952f223e1fc9df7e5f6b42</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.110.077040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.110.077040%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591%26doi%3D10.2967%2Fjnumed.110.077040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudyana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span> <span> </span><span class="NLM_article-title">Human biodistribution and dosimetry of <sup>18</sup>F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1007/s00259-012-2270-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-012-2270-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23160998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC3s7kt1OgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=254-261&author=K.+Van+Laereauthor=R.+U.+Ahmadauthor=H.+Hudyanaauthor=S.+Celenauthor=K.+Duboisauthor=M.+E.+Schmidtauthor=G.+Bormansauthor=M.+Koole&title=Human+biodistribution+and+dosimetry+of+18F-JNJ42259152%2C+a+radioligand+for+phosphodiesterase+10A+imaging&doi=10.1007%2Fs00259-012-2270-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging</span></div><div class="casAuthors">Van Laere Koen; Ahmad Rawaha U; Hudyana Hendra; Celen Sofie; Dubois Kristof; Schmidt Mark E; Bormans Guy; Koole Michel</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">254-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Phosphodiesterase 10A (PDE10A) is a cAMP/cGMP-hydrolysing enzyme with a central role in striatal signalling and implicated in neuropsychiatric disorders such as Huntington's disease, Parkinson's disease, schizophrenia and addiction.  We have developed a novel PDE10A PET ligand, (18)F-JNJ42259152, and describe here its human dynamic biodistribution, safety and dosimetry.  METHODS:  Six male subjects (age range 23-67 years) underwent ten dynamic whole-body PET/CT scans over 6 h after bolus injection of 175.5 ± 9.4 MBq (18)F-JNJ42259152.  Source organs were delineated on PET/CT and individual organ doses and effective dose were determined using the OLINDA software.  RESULTS:  F-JNJ42259152 was readily taken up by the brain and showed exclusive retention in the brain, especially in the striatum with good washout starting after 20 min.  The tracer was cleared through both the hepatobiliary and the urinary routes.  No defluorination was observed.  Organ absorbed doses were largest for the gallbladder (239 μSv/MBq) and upper large intestine (138 μSv/MBq).  The mean effective dose was 24.9 ± 4.1 μSv/MBq.  No adverse events were encountered.  CONCLUSION:  In humans, (18)F-JNJ42259152 has an appropriate distribution, brain kinetics and safety.  The estimated effective dose was within WHO class IIb with low interindividual variability.  Therefore, the tracer is suitable for further kinetic evaluation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSG3cQLgkqOMjl5L8hwNX0fW6udTcc2eZ0eDXjLu9Hfrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7kt1OgsA%253D%253D&md5=168d719b36355388d5f8f99931b730db</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2270-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2270-1%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAhmad%26aufirst%3DR.%2BU.%26aulast%3DHudyana%26aufirst%3DH.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DDubois%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DKoole%26aufirst%3DM.%26atitle%3DHuman%2520biodistribution%2520and%2520dosimetry%2520of%252018F-JNJ42259152%252C%2520a%2520radioligand%2520for%2520phosphodiesterase%252010A%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26spage%3D254%26epage%3D261%26doi%3D10.1007%2Fs00259-012-2270-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of [<sup>18</sup>F]JNJ42259152 as a PET tracer for PDE10A</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2013.04.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2013.04.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23664955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=13-22&author=S.+Celenauthor=M.+Kooleauthor=M.+Oomsauthor=M.+De+Angelisauthor=I.+Sannenauthor=J.+Cornelisauthor=J.+Alcazarauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andresauthor=G.+Bormans&title=Preclinical+evaluation+of+%5B18F%5DJNJ42259152+as+a+PET+tracer+for+PDE10A&doi=10.1016%2Fj.neuroimage.2013.04.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of [18F]JNJ42259152 as a PET tracer for PDE10A</span></div><div class="casAuthors">Celen, S.; Koole, M.; Ooms, M.; De Angelis, M.; Sannen, I.; Cornelis, J.; Alcazar, J.; Schmidt, M.; Verbruggen, A.; Langlois, X.; Van Laere, K.; Andres, J. I.; Bormans, G.</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-22</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase-10A (PDE10A) is implicated in several neuropsychiatric disorders involving basal ganglia neurotransmission, such as schizophrenia, obsessive-compulsive disorder and Huntington's disease.  To confirm target engagement and exposure-occupancy relationships of clin. candidates for treatment, and to further explore the in vivo biol. of PDE10A, non-invasive imaging using a specific PET ligand is warranted.  Recently we have reported the in vivo evaluation of [18F]JNJ41510417 which showed specific binding to PDE10A in rat striatum, but with relatively slow kinetics.  A chem. related deriv. JNJ42259152 was found to have a similar in vivo occupancy, but lower lipophilicity and lower PDE10A in vitro inhibitory activity compared to JNJ41510417. 18F-labeled JNJ42259152 was therefore evaluated as a potential PDE10A PET radiotracer.  Baseline PET in rats and monkey showed specific retention in the PDE10A-rich striatum, and fast wash-out, with a good contrast to non-specific binding, in other brain regions.  Pretreatment and chase expts. in rats with the selective PDE10A inhibitor MP-10 showed that tracer binding was specific and reversible.  Absence of specific binding in PDE10A knock-out (KO) mice further confirmed PDE10A specificity.  In vivo radiometabolite anal. using high performance liq. chromatog. (HPLC) showed presence of polar radiometabolites in rat plasma and brain.  In vivo imaging in rat and monkey further showed faster brain kinetics, and higher striatum-to-cerebellum ratios for [18F]JNJ42259152 compared to [18F]JNJ41510417.  The arterial input function cor. for radiometabolites was detd. in rats and basic kinetic modeling was established.  For a 60-min acquisition time interval, striatal binding potential of the intact tracer referenced to the cerebellum showed good correlation with corresponding binding potential values of a Simplified Ref. Tissue Model and referenced Logan Plot, the latter using a population averaged ref. tissue-to-plasma clearance rate and offering the possibility to generate representative parametric binding potential images.  In conclusion we can state that in vivo imaging in PDE10A KO mice, rats and monkey demonstrates that [18F]JNJ42259152 provides a PDE10A-specific signal in the striatum with good pharmacokinetic properties.  Although presence of a polar radiometabolite in rat brain yielded a systematic but reproducible underestimation of the striatal BPND, a Logan ref. tissue model approach using 60 min acquisition data is appropriate for quantification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZPDGMkDaCELVg90H21EOLACvtfcHk0lgdVWqpmEDLiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrsbvN&md5=9e7b715690c4cacd7cc96cbbf235a41c</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2013.04.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2013.04.123%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DCornelis%26aufirst%3DJ.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%2520%255B18F%255DJNJ42259152%2520as%2520a%2520PET%2520tracer%2520for%2520PDE10A%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D82%26spage%3D13%26epage%3D22%26doi%3D10.1016%2Fj.neuroimage.2013.04.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rietjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangarajan, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vunckx, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdeolivas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmelreich, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casteels, C.</span></span> <span> </span><span class="NLM_article-title">Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2858</span>– <span class="NLM_lpage">2869</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neurobiolaging.2014.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25018107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCgu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=2858-2869&author=M.+Oomsauthor=R.+Rietjensauthor=J.+R.+Rangarajanauthor=K.+Vunckxauthor=S.+Valdeolivasauthor=F.+Maesauthor=U.+Himmelreichauthor=J.+Fernandez-Ruizauthor=G.+Bormansauthor=K.+Van+Laereauthor=C.+Casteels&title=Early+decrease+of+type+1+cannabinoid+receptor+binding+and+phosphodiesterase+10A+activity+in+vivo+in+R6%2F2+Huntington+mice&doi=10.1016%2Fj.neurobiolaging.2014.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice</span></div><div class="casAuthors">Ooms, Maarten; Rietjens, Roma; Rangarajan, Janaki Raman; Vunckx, Kathleen; Valdeolivas, Sara; Maes, Frederik; Himmelreich, Uwe; Fernandez-Ruiz, Javier; Bormans, Guy; Van Laere, Koen; Casteels, Cindy</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2858-2869</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several lines of evidence imply early alterations in endocannabinoid and phosphodiesterase 10A (PDE10A) signaling in Huntington disease (HD).  Using [18F]MK-9470 and [18F]JNJ42259152 small-animal positron emission tomog. (PET), we investigated for the first time cerebral changes in type 1 cannabinoid (CB1) receptor binding and PDE10A levels in vivo in presymptomatic, early symptomatic, and late symptomatic HD (R6/2) mice, in relation to glucose metab. ([18F]FDG PET), brain morphol. (magnetic resonance imaging) and motor function.  Ten R6/2 and 16 wild-type (WT) mice were investigated at 3 different time points between the age of 4 and 13 wk.  Parametric CB1 receptor and PDE10A images were anatomically standardized to Paxinos space and analyzed voxelwise.  Volumetric microMRI imaging was performed to assess HD pathol.  In R6/2 mice, CB1 receptor binding was decreased in comparison with WT in a cluster comprising the bilateral caudate-putamen, globus pallidus, and thalamic nucleus at week 5 (-8.1% ± 2.6%, p = 1.7 × 10-5).  Longitudinal follow-up showed further progressive decline compared with controls in a cluster comprising the bilateral hippocampus, caudate-putamen, globus pallidus, superior colliculus, thalamic nucleus, and cerebellum (late vs. presymptomatic age: -13.7% ± 3.1% for R6/2 and +1.5% ± 4.0% for WT, p = 1.9 × 10-5).  In R6/2 mice, PDE10A binding potential also decreased over time to reach significance at early and late symptomatic HD (late vs. presymptomatic age: -79.1% ± 1.9% for R6/2 and +2.1% ± 2.7% for WT, p = 1.5 × 10-4).  The obsd. changes in CB1 receptor and PDE10A binding were correlated to anomalies exhibited by R6/2 animals in motor function, whereas no correlation was found with magnetic resonance imaging-based striatal vol.  Our findings point to early regional dysfunctions in endocannabinoid and PDE10A signaling, involving the caudate-putamen and lateral globus pallidus, which may play a role in the progression of the disease in R6/2 animals.  PET quantification of in vivo CB1 and/or PDE10A binding may thus be useful early biomarkers for HD.  Our results also provide evidence of subtle motor deficits at earlier stages than previously described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5XNTctrfkLbVg90H21EOLACvtfcHk0lgdVWqpmEDLiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCgu7zK&md5=c00883141f277d6a576e7d89537fb276</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DRietjens%26aufirst%3DR.%26aulast%3DRangarajan%26aufirst%3DJ.%2BR.%26aulast%3DVunckx%26aufirst%3DK.%26aulast%3DValdeolivas%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DF.%26aulast%3DHimmelreich%26aufirst%3DU.%26aulast%3DFernandez-Ruiz%26aufirst%3DJ.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DCasteels%26aufirst%3DC.%26atitle%3DEarly%2520decrease%2520of%2520type%25201%2520cannabinoid%2520receptor%2520binding%2520and%2520phosphodiesterase%252010A%2520activity%2520in%2520vivo%2520in%2520R6%252F2%2520Huntington%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D2858%26epage%3D2869%26doi%3D10.1016%2Fj.neurobiolaging.2014.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeois, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postnov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, W.</span></span> <span> </span><span class="NLM_article-title">PET imaging shows loss of striatal PDE10A in patients with Huntington disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000000037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1212%2FWNL.0000000000000037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24353339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns12qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=279-281&author=R.+Ahmadauthor=S.+Bourgeoisauthor=A.+Postnovauthor=M.+E.+Schmidtauthor=G.+Bormansauthor=K.+Van+Laereauthor=W.+Vandenberghe&title=PET+imaging+shows+loss+of+striatal+PDE10A+in+patients+with+Huntington+disease&doi=10.1212%2FWNL.0000000000000037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">PET imaging shows loss of striatal PDE10A in patients with Huntington disease</span></div><div class="casAuthors">Ahmad Rawaha; Bourgeois Sophie; Postnov Andrey; Schmidt Mark E; Bormans Guy; Van Laere Koen; Vandenberghe Wim</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) belongs to a family of enzymes that hydrolyze cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate.(1) PDE10A is highly enriched in striatal medium spiny neurons (MSNs), where it regulates intracellular signaling.(1) PDE10A has been proposed as a therapeutic target for Huntington disease (HD), a disorder that preferentially affects MSNs, based on the observation that pharmacologic inhibition of PDE10A in transgenic HD mice significantly improved behavioral and neuropathologic abnormalities.(2) However, earlier work had shown that striatal PDE10A levels in HD mice already decline to minimal levels before onset of motor symptoms,(3) possibly because mutant huntingtin represses PDE10A transcription.  Also, postmortem analysis of striatum of 3 patients with HD revealed strong reduction of PDE10A levels.(3) Depletion of PDE10A in HD striatum would at first sight seem hard to reconcile with a beneficial effect of PDE10A inhibitors in HD.  However, a recent study reported a dramatic increase, rather than decrease, of PDE10A protein in MSNs of HD mice.(4) In light of these conflicting results and the strong interest in development of PDE10A inhibitors for clinical use in HD, it is important to determine whether PDE10A levels are affected in the striatum of patients with HD in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTseEUOb2KKAQaK-_ZudimnfW6udTcc2eZNMy-8ngx7xLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns12qsQ%253D%253D&md5=dde2b872d2e565c5e675b51506326f26</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000000037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000000037%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DBourgeois%26aufirst%3DS.%26aulast%3DPostnov%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DVandenberghe%26aufirst%3DW.%26atitle%3DPET%2520imaging%2520shows%2520loss%2520of%2520striatal%2520PDE10A%2520in%2520patients%2520with%2520Huntington%2520disease%26jtitle%3DNeurology%26date%3D2014%26volume%3D82%26spage%3D279%26epage%3D281%26doi%3D10.1212%2FWNL.0000000000000037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attili, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">[<sup>18</sup>F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1111/jnc.13855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fjnc.13855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27664396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslyktrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2016&pages=897-906&author=M.+Oomsauthor=B.+Attiliauthor=S.+Celenauthor=M.+Kooleauthor=A.+Verbruggenauthor=K.+Van+Laereauthor=G.+Bormans&title=%5B18F%5DJNJ42259152+binding+to+phosphodiesterase+10A%2C+a+key+regulator+of+medium+spiny+neuron+excitability%2C+is+altered+in+the+presence+of+cyclic+AMP&doi=10.1111%2Fjnc.13855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP</span></div><div class="casAuthors">Ooms, Maarten; Attili, Bala; Celen, Sofie; Koole, Michel; Verbruggen, Alfons; Van Laere, Koen; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">897-906</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a key regulator of medium spiny neuron excitability.  Therefore, it plays an important role in the regulation of motor, reward, and cognitive processes.  Despite the interest in PDE10A as a drug and positron emission tomog. (PET) imaging target, little is known about the regulation of PDE10A enzymic activity.  This study aimed to further investigate the role of cAMP in the regulation of PDE10A activity and PDE10A PET imaging.  Using [18F]JNJ42259152 as radioligand, we investigated alterations in PDE10A binding secondary to changes in cAMP levels.  An in vitro striatum homogenate binding assay was developed to det. KD and Bmax of [18F]JNJ42259152.  Homogenate binding was assessed after addn. of increasing concns. of exogenous cAMP (1, 10, and 100 μM).  Rats were treated using JNJ49137530 and rolipram to induce in vivo alterations of cAMP.  The effect of the induced cAMP alterations on PDE10A binding was assessed by comparing [18F]JNJ42259152 microPET studies after treatment to microPET studies acquired at baseline conditions prior to treatment.  In vitro binding affinity of [18F]JNJ42259152 was higher in the presence of cAMP compared to baseline conditions (KD = 3.17 ± 0.91 nM with 10 μM cAMP vs. KD = 6.62 ± 0.7 nM at baseline).  Inhibition of PDE4 using rolipram significantly increased [18F]JNJ42259152 binding (BPND = 2.61 ± 0.50 vs. 1.91 ± 0.36 at baseline).  Administration of the PDE2 inhibitor JNJ49137530 significantly increased PDE10A binding potential (BPND = 2.74 ± 0.22 vs. 2.05 ± 0.16 at baseline).  Our data indicate an important role for cAMP in the regulation of PDE10A activity.  Addnl., our data show a profound interaction between several PDEs in striatum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCws11u-3H-LVg90H21EOLACvtfcHk0lhv9Eb1eAy_Kg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslyktrvM&md5=6e4b6e91a7e91403d1a2e892ea54cb0d</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13855%26sid%3Dliteratum%253Aachs%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DAttili%26aufirst%3DB.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3D%255B18F%255DJNJ42259152%2520binding%2520to%2520phosphodiesterase%252010A%252C%2520a%2520key%2520regulator%2520of%2520medium%2520spiny%2520neuron%2520excitability%252C%2520is%2520altered%2520in%2520the%2520presence%2520of%2520cyclic%2520AMP%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D139%26spage%3D897%26epage%3D906%26doi%3D10.1111%2Fjnc.13855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudyana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span> <span> </span><span class="NLM_article-title">Quantification of <sup>18</sup>F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.2967/jnumed.112.118679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.112.118679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23843566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaqu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1285-1293&author=K.+Van%0ALaereauthor=R.+U.+Ahmadauthor=H.+Hudyanaauthor=K.+Duboisauthor=M.+E.+Schmidtauthor=S.+Celenauthor=G.+Bormansauthor=M.+Koole&title=Quantification+of+18F-JNJ-42259152%2C+a+novel+phosphodiesterase+10A+PET+tracer%3A+kinetic+modeling+and+test-retest+study+in+human+brain&doi=10.2967%2Fjnumed.112.118679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain</span></div><div class="casAuthors">Van Laere, Koen; Ahmad, Rawaha U.; Hudyana, Hendra; Dubois, Kristof; Schmidt, Mark E.; Celen, Sofie; Bormans, Guy; Koole, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1285-1293</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) plays a central role in striatal signaling and is implicated in several neuropsychiatric disorders, such as movement disorders and schizophrenia.  We performed initial brain kinetic modeling of the novel PDE10A tracer 18F-JNJ-42259152 (2-[[4-[1-(2-18F-fluoroethyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-3,5-dimethyl-pyridine) and studied test-retest reproducibility in healthy volunteers.  Methods: Twelve healthy volunteers (5 men, 7 women; age range, 42-77 y) were scanned dynamically up to 135 min after bolus injection of 172.5 ± 10.3 MBq of 18F-JNJ42259152.  Four volunteers (2 men, 2 women) underwent retest scanning, with a mean interscan interval of 37 d.  Input functions and tracer parent fractions were detd. using arterial sampling and high-performance liq. chromatog. anal.  Vols. of interest for the putamen, caudate nucleus, ventral striaturn, substantia nigra, thalamus, frontal cortex, and cerebellum were delineated using individual volumetric T1 MR imaging scans.  One-tissue (1T) and 2-tissue (2T) models were evaluated to calc. total distribution vol. (VT).  Simplified models were also tested to calc. binding potential (BPND), including the simplified ref. tissue model (SRTM) and multilinear ref. tissue model, using the frontal cortex as the optimal ref. tissue.  The stability of VT and BPND was assessed down to a 60-min scan time.  Results: The av. intact tracer half-life in blood was 90 min.  The 2T model VT values for the putamen, caudate nucleus, ventral striatum, substantia nigra, thalamus, frontal cortex, and cerebellum were 1.54 ± 0.37, 0.90 ± 0.24, 0.64 ± 0.18, 0.42 ± 0.09, 0.35 ± 0.09, 0.30 ± 0.07, and 0.36 ± 0.12, resp.  The 1T model provided significantly lower VT values, which were well correlated to the 2T VT.  SRTM BPND values referenced to the frontal cortex were 3.45 ± 0.43, 1.78 ± 0.35, 1.10 ± 0.31, and 0.44 ± 0.09 for the resp. target regions putamen, caudate nucleus, ventral striatum, and substantia nigra, with similar values for the multilinear ref. tissue model.  Good correlations were found for the target regions putamen, caudate nucleus, ventral striatum, and substantia nigra between the 2T-compartment model BPND and the SRTM BPND (r = 0.57, 0.82, 0.70, and 0.64, resp.).  SRTM BPND using a 90- and 60-min acquisition interval showed low bias.  Test-retest variability was 5%-19% for 2T VT and 5%-12% for BPND SRTM.  Conclusion: Kinetic modeling of 18F-JNJ-42259152 shows that PDE10A activity can be reliably quantified and simplified using a ref. tissue model with the frontal cortex as ref. and a 60-min acquisition period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNPcD7IchsJrVg90H21EOLACvtfcHk0lgrrM0lJgcQRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaqu7jL&md5=309f0829c367346e1180a63bb771c2fe</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.118679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.118679%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAhmad%26aufirst%3DR.%2BU.%26aulast%3DHudyana%26aufirst%3DH.%26aulast%3DDubois%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DKoole%26aufirst%3DM.%26atitle%3DQuantification%2520of%252018F-JNJ-42259152%252C%2520a%2520novel%2520phosphodiesterase%252010A%2520PET%2520tracer%253A%2520kinetic%2520modeling%2520and%2520test-retest%2520study%2520in%2520human%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1285%26epage%3D1293%26doi%3D10.2967%2Fjnumed.112.118679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbar Asskar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briel, D.</span></span> <span> </span><span class="NLM_article-title">Fluorine-containing 6,7-dialkoxybiaryl-based inhibitors for phosphodiesterase 10 A: synthesis and in vitro evaluation of inhibitory potency, selectivity, and metabolism</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1476</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fcmdc.201300522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24729456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVCgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1476-1487&author=G.+Schwanauthor=G.+Barbar+Asskarauthor=N.+Hofgenauthor=L.+Kubicovaauthor=U.+Funkeauthor=U.+Egerlandauthor=M.+Zahnauthor=K.+Nieberauthor=M.+Scheunemannauthor=N.+Straterauthor=P.+Brustauthor=D.+Briel&title=Fluorine-containing+6%2C7-dialkoxybiaryl-based+inhibitors+for+phosphodiesterase+10+A%3A+synthesis+and+in+vitro+evaluation+of+inhibitory+potency%2C+selectivity%2C+and+metabolism&doi=10.1002%2Fcmdc.201300522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-containing 6,7-dialkoxybiaryl-based inhibitors for phosphodiesterase 10 A: Synthesis and in vitro evaluation of inhibitory potency, selectivity, and metabolism</span></div><div class="casAuthors">Schwan, Gregor; Barbar Asskar, Ghadir; Hoefgen, Norbert; Kubicova, Lenka; Funke, Uta; Egerland, Ute; Zahn, Michael; Nieber, Karen; Scheunemann, Matthias; Straeter, Norbert; Brust, Peter; Briel, Detlef</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1476-1487</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Various derivs. of the potent phosphodiesterase 10 A (PDE10A) inhibitor PQ-10 I (R = H, R1 = R2 = Me) were synthesized to det. relationships between their mol. structure and binding properties.  Their roles as potential positron emission tomog. (PET) ligands were evaluated, as well as their inhibitory potency toward PDE10A and other PDEs, and their metabolic stability was detd. in vitro.  Halo-alkyl substituents at position 2 of the quinazoline moiety and/or halo-alkyloxy substituents at positions 6 or 7 affect not only the compds.' affinity, but also their selectivity toward PDE10A.  As a result of substituting the MeO group for a monofluoroethoxy or difluoroethoxy group at position 6 of the quinazoline ring, the selectivity for PDE10A over PDE3A increased.  The same result was obtained by 6,7-difluoride substitution on the quinoxaline moiety.  Finally, fluoro compds., such as I [R = H, R1 = FCH2, R2 = Me; R = H, R1 = Me, R2 = FCH2, F(CH2)2, F2CHCH2; R = F, R1 = R2 = Me], showed the highest inhibitory potential (IC50 = 11-65 nM for PDE10A).  Further, fluoroethoxy substitution at position 7 of the quinazoline ring improved metabolic stability over that of the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcfLu8wKjlkbVg90H21EOLACvtfcHk0lgrrM0lJgcQRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVCgt7Y%253D&md5=827806bd4dd9fc593f0a9a22da2a87c1</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300522%26sid%3Dliteratum%253Aachs%26aulast%3DSchwan%26aufirst%3DG.%26aulast%3DBarbar%2BAsskar%26aufirst%3DG.%26aulast%3DHofgen%26aufirst%3DN.%26aulast%3DKubicova%26aufirst%3DL.%26aulast%3DFunke%26aufirst%3DU.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DZahn%26aufirst%3DM.%26aulast%3DNieber%26aufirst%3DK.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DStrater%26aufirst%3DN.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DBriel%26aufirst%3DD.%26atitle%3DFluorine-containing%25206%252C7-dialkoxybiaryl-based%2520inhibitors%2520for%2520phosphodiesterase%252010%2520A%253A%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520inhibitory%2520potency%252C%2520selectivity%252C%2520and%2520metabolism%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1476%26epage%3D1487%26doi%3D10.1002%2Fcmdc.201300522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Funke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and radiotracer properties of a 7-(2-[<sup>18</sup>F]fluoroethoxy)-6-methoxypyrrolidinylquinazoline for imaging of phosphodiesterase 10A with PET</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.3390/ph5020169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fph5020169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24288087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVKgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=169-188&author=U.+Funkeauthor=W.+Deuther-Conradauthor=G.+Schwanauthor=A.+Maisonialauthor=M.+Scheunemannauthor=S.+Fischerauthor=A.+Hillerauthor=D.+Brielauthor=P.+Brust&title=Radiosynthesis+and+radiotracer+properties+of+a+7-%282-%5B18F%5Dfluoroethoxy%29-6-methoxypyrrolidinylquinazoline+for+imaging+of+phosphodiesterase+10A+with+PET&doi=10.3390%2Fph5020169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and radiotracer properties of a 7-(2-[18F]fluoroethoxy)-6-methoxypyrrolidinylquinazoline for imaging of phosphodiesterase 10A with PET</span></div><div class="casAuthors">Funke, Uta; Deuther-Conrad, Winnie; Schwan, Gregor; Maisonial, Aurelie; Scheunemann, Matthias; Fischer, Steffen; Hiller, Achim; Briel, Detlef; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-188</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a key enzyme of intracellular signal transduction which is involved in the regulation of neurotransmission.  The mol. imaging of PDE10A by PET is expected to allow a better understanding of physiol. and pathol. processes related to PDE10A expression and function in the brain.  The aim of this study was to develop a new 18F-labeled PDE10A ligand based on a 6,7-dimethoxy-4-pyrrolidinylquinazoline and to evaluate its properties in biodistribution studies.  Nucleophilic substitution of the 7-tosyloxy-analog led to the 7-[18F]fluoroethoxy-deriv. [18F]IV with radiochem. yields of 25% ± 9% (n = 9), high radiochem. purity of ≥99% and specific activities of 110-1,100 GBq/μmol.  [18F]IV showed moderate PDE10A affinity (KD,PDE10A = 14 nM) and high metabolic stability in the brain of female CD-1 mice, wherein the radioligand entered rapidly with a peak uptake of 2.3% ID/g in striatum at 5 min p.i.  However, ex vivo autoradiog. and in vivo blocking studies revealed no target specific accumulation and demonstrated [18F]IV to be inapplicable for imaging PDE10A with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo54WU6U6mjrVg90H21EOLACvtfcHk0lgrrM0lJgcQRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVKgtL4%253D&md5=ad3e963593f565c58e036b9965322c2b</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.3390%2Fph5020169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph5020169%26sid%3Dliteratum%253Aachs%26aulast%3DFunke%26aufirst%3DU.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DSchwan%26aufirst%3DG.%26aulast%3DMaisonial%26aufirst%3DA.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DHiller%26aufirst%3DA.%26aulast%3DBriel%26aufirst%3DD.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DRadiosynthesis%2520and%2520radiotracer%2520properties%2520of%2520a%25207-%25282-%255B18F%255Dfluoroethoxy%2529-6-methoxypyrrolidinylquinazoline%2520for%2520imaging%2520of%2520phosphodiesterase%252010A%2520with%2520PET%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D169%26epage%3D188%26doi%3D10.3390%2Fph5020169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G.</span></span> <span> </span><span class="NLM_article-title">In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: <sup>18</sup>F-MNI-659 and <sup>18</sup>F-MNI-654</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1297</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.2967/jnumed.113.122895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.113.122895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24898025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GnurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1297-1304&author=O.+Barretauthor=D.+Thomaeauthor=A.+Tavaresauthor=D.+Alagilleauthor=C.+Papinauthor=R.+Waterhouseauthor=T.+McCarthyauthor=D.+Jenningsauthor=K.+Marekauthor=D.+Russellauthor=J.+Seibylauthor=G.+Tamagnan&title=In+vivo+assessment+and+dosimetry+of+2+novel+PDE10A+PET+radiotracers+in+humans%3A+18F-MNI-659+and+18F-MNI-654&doi=10.2967%2Fjnumed.113.122895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654</span></div><div class="casAuthors">Barret, Olivier; Thomae, David; Tavares, Adriana; Alagille, David; Papin, Caroline; Waterhouse, Rikki; McCarthy, Timothy; Jennings, Danna; Marek, Ken; Russell, David; Seibyl, John; Tamagnan, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1297-1304</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 10A is an enzyme involved in the regulation of cyclic adenosine monophosphate and cyclic guanosine monophosphate and is highly expressed in medium-sized spiny neurons of the striatum, making it an attractive target for novel therapies for a variety of neurol. and psychiatric disorders that involve striatal function.  Potential ligands for PET imaging of PDE10A have been reported.  Here, we report the first-in-human characterization of 2 new PDE10A radioligands, 2-(2-(3-(1-(2-fluoroethyl)-1H-indazol-6-yl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione (18F-MNI-654) and 2-(2-(3-(4-(2-fluoroethoxy)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione (18F-MNI-659), with the goal of selecting the best one for use in future studies interrogating pathophysiol. changes in neuropsychiatric disorders and aiding pharmaceutical development targeting PDE10A.  Methods: Eleven healthy volunteers participated in this study (18F-MNI-654 test-retest, 2 men; 18F-MNI-659 test-retest, 4 men and 1 woman; 18F-MNI-659 dosimetry, 2 men and 2 women).  Brain PET images were acquired over 5.5 h for 18F-MNI-654 and over 3.5 h for 18F-MNI-659, and pharmacokinetic modeling with plasma- and ref.-region (cerebellar cortex)-based methods was performed.  Whole-body PET images were acquired over 6 h for 18F-MNI-659 and radiation dosimetry estd. with OLINDA.  Results: Both radiotracers were similarly metabolized, with about 20% of intact parent remaining at 120 min after injection.  PET time-activity data demonstrated that 18F-MNI-654 kinetics were much slower than 18F-MNI-659 kinetics.  For 18F-MNI-659, there was good agreement between the Logan and simplified ref. tissue models for nondisplaceable binding potential (BPND), supporting non-invasive quantification, with test-retest variability less than 10% and intraclass correlation greater than 0.9.  The 18F-MNI-659 ED was estd. at 0.024 mSv/MBq.  Conclusion: PET imaging in the human brain with 2 novel PDE10A 18F tracers is being reported.  Noninvasive quantification of 18F-MNI-659 with the simplified ref. tissue model using the cerebellum as a ref. is possible.  In addn., 18F-MNI-659 kinetics are fast enough for a good est. of BPND with 90 min of data, with values around 3.0 in the basal ganglia.  Finally, 18F-MNI-659 dosimetry is favorable and consistent with values reported for other PET radiotracers currently used in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWk3vV3AyzbVg90H21EOLACvtfcHk0lifJBAiUQCyuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GnurjJ&md5=cd718c4e9137e4003c7179032342378b</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.122895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.122895%26sid%3Dliteratum%253Aachs%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DTavares%26aufirst%3DA.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DWaterhouse%26aufirst%3DR.%26aulast%3DMcCarthy%26aufirst%3DT.%26aulast%3DJennings%26aufirst%3DD.%26aulast%3DMarek%26aufirst%3DK.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DSeibyl%26aufirst%3DJ.%26aulast%3DTamagnan%26aufirst%3DG.%26atitle%3DIn%2520vivo%2520assessment%2520and%2520dosimetry%2520of%25202%2520novel%2520PDE10A%2520PET%2520radiotracers%2520in%2520humans%253A%252018F-MNI-659%2520and%252018F-MNI-654%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1297%26epage%3D1304%26doi%3D10.2967%2Fjnumed.113.122895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K. L.</span></span> <span> </span><span class="NLM_article-title">The phosphodiesterase 10 positron emission tomography tracer, [<sup>18</sup>F]MNI-659, as a novel biomarker for early Huntington disease</span>. <i>JAMA Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1520</span>– <span class="NLM_lpage">1528</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2014.1954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1001%2Fjamaneurol.2014.1954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25322077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2M3htV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=1520-1528&author=D.+S.+Russellauthor=O.+Barretauthor=D.+L.+Jenningsauthor=J.+H.+Friedmanauthor=G.+D.+Tamagnanauthor=D.+Thomaeauthor=D.+Alagilleauthor=T.+J.+Morleyauthor=C.+Papinauthor=S.+Papapetropoulosauthor=R.+N.+Waterhouseauthor=J.+P.+Seibylauthor=K.+L.+Marek&title=The+phosphodiesterase+10+positron+emission+tomography+tracer%2C+%5B18F%5DMNI-659%2C+as+a+novel+biomarker+for+early+Huntington+disease&doi=10.1001%2Fjamaneurol.2014.1954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease</span></div><div class="casAuthors">Russell David S; Barret Olivier; Jennings Danna L; Tamagnan Gilles D; Alagille David; Morley Thomas J; Papin Caroline; Seibyl John P; Marek Kenneth L; Friedman Joseph H; Thomae David; Papapetropoulos Spyridon; Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1520-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">IMPORTANCE:  In Huntington disease (HD) striatal neuron loss precedes and predicts motor signs or symptoms.  Current imaging biomarkers lack adequate sensitivity for assessing the early stages of HD.  Developing an imaging biomarker for HD spanning the time of onset of motor signs remains a major unmet research need.  Intracellular proteins whose expression is altered by the mutant huntingtin protein may be superior markers for early HD stages.  OBJECTIVE:  To evaluate whether [18F]MNI-659 (2-(2-(3-(4-(2-[18F]fluoroethoxy)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione), a novel phosphodiesterase 10 positron emission tomography (PET) ligand, is a sensitive marker for striatal changes in early HD.  DESIGN, SETTING, AND PARTICIPANTS:  A cohort of individuals with HD, including premanifest (pre-HD) or manifest with motor signs (mHD), underwent clinical assessments, genetic determination, [18F]MNI-659 PET imaging, and brain magnetic resonance imaging.  Age-matched healthy volunteers (HVs) also received clinical assessments and PET and magnetic resonance imaging.  MAIN OUTCOMES AND MEASURES:  Binding potentials (BPnds) were estimated for brain regions of interest, specifically within the basal ganglia, and compared between participants with HD and the HVs and correlated with markers of HD severity and atrophy of basal ganglia nuclei.  RESULTS:  Eleven participants with HD (8 mHD and 3 pre-HD) and 9 HVs participated.  Ten of 11 HD participants had known huntingtin CAG repeat length, allowing determination of a burden of pathology (BOP) score.  One individual with HD declined CAG determination.  All participants with mHD had relatively early-stage disease (4 with stage 1 and 4 with stage 2) and a Unified Huntington's Disease Rating Scale (UHDRS) total Motor subscale score of less than 50.  The HD cohort had significantly lower striatal [18F]MNI-659 uptake than did the HV cohort (mean, -48.4%; P < .001).  The HD cohort as a whole had a reduction in the basal ganglia BPnd to approximately 50% of the level in the HVs (mean, -47.6%; P < .001).  The 3 pre-HD participants had intermediate basal ganglia BPnds.  Striatal [18F]MNI-659 uptake correlated strongly with the severity of disease measured by the clinical scale (UHDRS Motor subscale; R = 0.903; P < .001), the molecular marker (BOP; R = 0.908; P < .001), and regional atrophy (R = 0.667; P < .05).  CONCLUSIONS AND RELEVANCE:  As a promising striatal imaging biomarker, [18F]MNI-659 is potentially capable of assessing the extent of disease in early mHD.  Furthermore, [18F]MNI-659 may identify early changes in medium spiny neurons and serve as a marker to predict conversion to mHD.  Additional studies with larger, stratified cohorts of patients with HD and prospective studies of individuals with pre-HD are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRsGzrUWLbaY3yKPtYViAGfW6udTcc2eZQdUYU-19W_bntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3htV2luw%253D%253D&md5=c312a59c902ca482c7ac6f9f699a8d05</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2014.1954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2014.1954%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DD.%2BS.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DJennings%26aufirst%3DD.%2BL.%26aulast%3DFriedman%26aufirst%3DJ.%2BH.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DMorley%26aufirst%3DT.%2BJ.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DMarek%26aufirst%3DK.%2BL.%26atitle%3DThe%2520phosphodiesterase%252010%2520positron%2520emission%2520tomography%2520tracer%252C%2520%255B18F%255DMNI-659%252C%2520as%2520a%2520novel%2520biomarker%2520for%2520early%2520Huntington%2520disease%26jtitle%3DJAMA%2520Neurol.%26date%3D2014%26volume%3D71%26spage%3D1520%26epage%3D1528%26doi%3D10.1001%2Fjamaneurol.2014.1954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K. L.</span></span> <span> </span><span class="NLM_article-title">Change in PDE10 across early Huntington disease assessed by [<sup>18</sup>F]MNI-659 and PET imaging</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000002391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1212%2FWNL.0000000000002391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26802091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ygtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2016&pages=748-754&author=D.+S.+Russellauthor=D.+L.+Jenningsauthor=O.+Barretauthor=G.+D.+Tamagnanauthor=V.+M.+Carrollauthor=F.+Cailleauthor=D.+Alagilleauthor=T.+J.+Morleyauthor=C.+Papinauthor=J.+P.+Seibylauthor=K.+L.+Marek&title=Change+in+PDE10+across+early+Huntington+disease+assessed+by+%5B18F%5DMNI-659+and+PET+imaging&doi=10.1212%2FWNL.0000000000002391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging</span></div><div class="casAuthors">Russell, David S.; Jennings, Danna L.; Barret, Olivier; Tamagnan, Gilles D.; Carroll, Vincent M.; Caille, Fabien; Alagille, David; Morley, Thomas J.; Papin, Caroline; Seibyl, John P.; Marek, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">748-754</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To evaluate whether striatal [F]MNI-659 PET imaging of phosphodiesterase 10A (PDE10) serves as a sensitive and reliable biomarker of striatal neurodegeneration in a longitudinal cohort of participants with early Huntington disease (HD).  Methods: A cohort of participants with HD, including both participants premanifest or manifest with motor signs, underwent clin. assessments, genetic detn., and 2 [F]MNI-659 PET imaging sessions approx. 1 yr apart.  Eleven healthy control (HC) participants underwent clin. assessments and [F]MNI-659 PET imaging once.  Striatal binding potentials (BPnd) were estd. for brain regions of interest, specifically within the basal ganglia, and compared between baseline and follow-up imaging.  Clin. measures of HD severity were assessed at each visit.  Results: Eight participants with HD (6 manifest; 2 premanifest) participated.  Of those with manifest HD, all had relatively early stage disease (stage 1, n = 2; stage 2, n = 4) and a Unified Huntingtons Disease Rating Scale total motor score <45.  As expected, the HD cohort as a whole had a redn. in the basal ganglia BPnd to approx. 50% of that seen in HC.  Conclusion: Longitudinal data in this small cohort of participants with early HD support [F]MNI-659 PET imaging of PDE10 as a useful biomarker to track HD disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-gGe_KOgy7Vg90H21EOLACvtfcHk0liCBe_aIgyKfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ygtLc%253D&md5=715e32e75ae1fd223007380a92e6791c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000002391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000002391%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DD.%2BS.%26aulast%3DJennings%26aufirst%3DD.%2BL.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DCarroll%26aufirst%3DV.%2BM.%26aulast%3DCaille%26aufirst%3DF.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DMorley%26aufirst%3DT.%2BJ.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DMarek%26aufirst%3DK.%2BL.%26atitle%3DChange%2520in%2520PDE10%2520across%2520early%2520Huntington%2520disease%2520assessed%2520by%2520%255B18F%255DMNI-659%2520and%2520PET%2520imaging%26jtitle%3DNeurology%26date%3D2016%26volume%3D86%26spage%3D748%26epage%3D754%26doi%3D10.1212%2FWNL.0000000000002391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref181"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref181'); return false;" data-citation="" class="refNumLink">181</a></strong><div class="NLM_citation" id="cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrzljak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Tawil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzer-Attas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronzova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landwehrmeyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampaio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span> <span> </span><span class="NLM_article-title">Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with <sup>18</sup>F-MNI-659 and <sup>11</sup>C-raclopride with correction for partial volume effect</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2017.02.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2017.02.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28254508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Ogsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2017&pages=330-339&author=P.+Fazioauthor=M.+Schainauthor=L.+Mrzljakauthor=N.+Aminiauthor=S.+Nagauthor=N.+Al-Tawilauthor=C.+J.+Fitzer-Attasauthor=J.+Bronzovaauthor=B.+Landwehrmeyerauthor=C.+Sampaioauthor=C.+Halldinauthor=A.+Varrone&title=Patterns+of+age+related+changes+for+phosphodiesterase+type-10A+in+comparison+with+dopamine+D2%2F3+receptors+and+sub-cortical+volumes+in+the+human+basal+ganglia%3A+A+PET+study+with+18F-MNI-659+and+11C-raclopride+with+correction+for+partial+volume+effect&doi=10.1016%2Fj.neuroimage.2017.02.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18F-MNI-659 and 11C-raclopride with correction for partial volume effect</span></div><div class="casAuthors">Fazio, Patrik; Schain, Martin; Mrzljak, Ladislav; Amini, Nahid; Nag, Sangram; Al-Tawil, Nabil; Fitzer-Attas, Cheryl J.; Bronzova, Juliana; Landwehrmeyer, Bernhard; Sampaio, Cristina; Halldin, Christer; Varrone, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">330-339</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A enzyme (PDE10A) is an important striatal target that has been shown to be affected in patients with neurodegenerative disorders, particularly Huntington's disease (HD).  PDE10A is expressed on striatal neurons in basal ganglia where other known mol. targets are enriched such as dopamine D2/3 receptors (D2/3 R).  The aim of this study was to examine the availability of PDE10A enzyme in relation with age and gender and to compare those changes with those related to D2/3 R and vols. in different regions of the basal ganglia.  As a secondary objective we examd. the relative distribution of D2/3 R and PDE10A enzyme in the striatum and globus pallidus.  Forty control subjects (20F/20M; age: 44±11y, age range 27-69) from an ongoing positron emission tomog. (PET) study in HD gene expansion carriers were included.  Subjects were examd. with PET using the high-resoln. research tomograph (HRRT) and with 3T magnetic resonance imaging (MRI).  The PDE10A radioligand 18F-MNI-659 and D2/3 R radioligand 11C-raclopride were used.  The outcome measure was the binding potential (BPND) estd. with the two-tissue compartment model (18F-MNI-659) and the simplified ref. tissue model (11C-raclopride) using the cerebellum as ref. region.  The PET data were cor. for partial vol. effects.  In the striatum, PDE10A availability showed a significant age-related decline that was larger compared to the age-related decline of D2/3 R availability and to the age-related decline of vols. measured with MRI.  In the globus pallidus, a less pronounced decline of PDE10A availability was obsd., whereas D2/3 R availability and vols. seemed to be rather stable with aging.  The distribution of the PDE10A enzyme was different from the distribution of D2/3 R, with higher availability in the globus pallidus.  These results indicate that aging is assocd. with a considerable physiol. redn. of the availability of PDE10A enzyme in the striatum.  Moreover as result of the anal., in the striatum for both the mol. targets, we obsd. a gender effect with higher BPND the female group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Y4kPL-SiJbVg90H21EOLACvtfcHk0liCBe_aIgyKfw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Ogsbg%253D&md5=7222e155c4af49f0c622d7dbf1247d12</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2017.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2017.02.047%26sid%3Dliteratum%253Aachs%26aulast%3DFazio%26aufirst%3DP.%26aulast%3DSchain%26aufirst%3DM.%26aulast%3DMrzljak%26aufirst%3DL.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DNag%26aufirst%3DS.%26aulast%3DAl-Tawil%26aufirst%3DN.%26aulast%3DFitzer-Attas%26aufirst%3DC.%2BJ.%26aulast%3DBronzova%26aufirst%3DJ.%26aulast%3DLandwehrmeyer%26aufirst%3DB.%26aulast%3DSampaio%26aufirst%3DC.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DVarrone%26aufirst%3DA.%26atitle%3DPatterns%2520of%2520age%2520related%2520changes%2520for%2520phosphodiesterase%2520type-10A%2520in%2520comparison%2520with%2520dopamine%2520D2%252F3%2520receptors%2520and%2520sub-cortical%2520volumes%2520in%2520the%2520human%2520basal%2520ganglia%253A%2520A%2520PET%2520study%2520with%252018F-MNI-659%2520and%252011C-raclopride%2520with%2520correction%2520for%2520partial%2520volume%2520effect%26jtitle%3DNeuroImage%26date%3D2017%26volume%3D152%26spage%3D330%26epage%3D339%26doi%3D10.1016%2Fj.neuroimage.2017.02.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref182"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref182'); return false;" data-citation="" class="refNumLink">182</a></strong><div class="NLM_citation" id="cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertoglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaeghe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Linden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobants, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wityak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrzljak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staelens, S.</span></span> <span> </span><span class="NLM_article-title">MR-based spatial normalization improves [<sup>18</sup>F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0206613</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0206613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1371%2Fjournal.pone.0206613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30365550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtF2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+Bertoglioauthor=J.+Verhaegheauthor=L.+Kostenauthor=D.+Thomaeauthor=A.+Van+der+Lindenauthor=S.+Stroobantsauthor=J.+Wityakauthor=C.+Dominguezauthor=L.+Mrzljakauthor=S.+Staelens&title=MR-based+spatial+normalization+improves+%5B18F%5DMNI-659+PET+regional+quantification+and+detectability+of+disease+effect+in+the+Q175+mouse+model+of+Huntington%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0206613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">MR-based spatial normalization improves {18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease</span></div><div class="casAuthors">Bertoglio, Daniele; Verhaeghe, Jeroen; Kosten, Lauren; Thomae, David; Vander Linden, Annemie; Stroobants, Sigrid; Wityak, John; Dominguez, Celia; Mrzljak, Ladislav; Staelens, Steven</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0206613/1-e0206613/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We performed [18F] MNI-659 PET imaging in six months old heterozygous (HET) Q175 mice and wild-type (WT) littermates, followed by X-ray computed tomog. (CT) scan.  In the same week, individual T2-weighted MRI were acquired.  Spatial normalization and regional quantification of the PET/CT images was performed on MRI, [18F]MNI-659 PET, or CT template and compared to binding potential (BPND) using vols. manually delineated on the individual MR images.  Striatal vol. was significantly reduced in HET mice (-7.7%, p<0.0001) compared to WT littermates. [18F]MNI-659 BPND in striatum of HET animals was significantly reduced (p<0.0001) when compared to WT littermates using all three templates.  However, BPND values were significantly higher for HET mice using the PET template compared to the MRI and CT ones (p<0.0001), with an overestimation at lower activities.  On the other hand, the CT template spatial normalization introduced larger variability reducing the effect size.  The PET and CT template-based approaches resulted in a lower accuracy in BPND quantification with consequent decrease in the detectability of disease effect.  This study demonstrates that for [18F]MNI-659 brain PET imaging in mice the use of an MRI-based spatial normalization is recommended to achieve accurate quantification and fully exploit the detectability of disease effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoogwCVMIQnvrVg90H21EOLACvtfcHk0lhB5Dmuabugbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtF2isb4%253D&md5=d2aef11115ccf6bc483217626e5f3526</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0206613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0206613%26sid%3Dliteratum%253Aachs%26aulast%3DBertoglio%26aufirst%3DD.%26aulast%3DVerhaeghe%26aufirst%3DJ.%26aulast%3DKosten%26aufirst%3DL.%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DVan%2Bder%2BLinden%26aufirst%3DA.%26aulast%3DStroobants%26aufirst%3DS.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DMrzljak%26aufirst%3DL.%26aulast%3DStaelens%26aufirst%3DS.%26atitle%3DMR-based%2520spatial%2520normalization%2520improves%2520%255B18F%255DMNI-659%2520PET%2520regional%2520quantification%2520and%2520detectability%2520of%2520disease%2520effect%2520in%2520the%2520Q175%2520mouse%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0206613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref183"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref183'); return false;" data-citation="" class="refNumLink">183</a></strong><div class="NLM_citation" id="cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svedberg, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsios, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Sanjuan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleska, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrzljak, L.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [<sup>18</sup>F]MNI-659</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1711</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2019.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.brainres.2019.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30664847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1711&publication_year=2019&pages=140-145&author=M.+M.+Svedbergauthor=K.+Varnasauthor=A.+Varroneauthor=N.+Mitsiosauthor=J.+Mulderauthor=B.+Gulyasauthor=V.+Beaumontauthor=I.+Munoz-Sanjuanauthor=M.+M.+Zaleskaauthor=C.+J.+Schmidtauthor=C.+Halldinauthor=L.+Mrzljak&title=In+vitro+phosphodiesterase+10A+%28PDE10A%29+binding+in+whole+hemisphere+human+brain+using+the+PET+radioligand+%5B18F%5DMNI-659&doi=10.1016%2Fj.brainres.2019.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659</span></div><div class="casAuthors">Svedberg, Marie M.; Varnaes, Katarina; Varrone, Andrea; Mitsios, Nicholas; Mulder, Jan; Gulyas, Balazs; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Zaleska, Margaret M.; Schmidt, Christopher J.; Halldin, Christer; Mrzljak, Ladislav</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1711</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140-145</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Highly specific and sensitive biomarkers for pathologies related to dysfunctions in the basal ganglia circuit are of great value to assess therapeutic efficacy not only clin. to establish an early diagnosis, but also in terms of monitoring the efficacy of therapeutic interventions and decelerated neurodegeneration.  The phosphodiesterase 10A (PDE10A) enzyme plays a central role in striatal signaling and is implicated in several neuropsychiatric disorders involving striatal pathol., such as Huntingtons disease (HD) and schizophrenia.  Inhibition of PDE10A activates the neurons in the striatum and consequently leads to alteration of behavioral aspects modulated by the striatal circuit. [18F]MNI-659, (2-(2-(3-(4-(2-[18F]fluoroethoxy)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione), is a newly developed PET radioligand that shows a high binding to PDE10A in the human brain in vivo.  In the present study, we examd. the in vitro binding of [18F]MNI-659 in human postmortem brain to gain a better understanding of the presence, d., disease-related alterations and therapy related to changes in PDE10A expression.  The results show high specific binding of [18F]MNI-659 in the caudate nucleus, putamen and the hippocampal formation.  Low specific [18F]MNI-659 binding was detected in nucleus accumbens in comparison to the caudate nucleus and putamen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp45cuqYe-tiLVg90H21EOLACvtfcHk0lhB5Dmuabugbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCrtL4%253D&md5=8ec5f7836d96ac3a3611e11a2968706d</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2019.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2019.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DSvedberg%26aufirst%3DM.%2BM.%26aulast%3DVarnas%26aufirst%3DK.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DMitsios%26aufirst%3DN.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DV.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DMrzljak%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520binding%2520in%2520whole%2520hemisphere%2520human%2520brain%2520using%2520the%2520PET%2520radioligand%2520%255B18F%255DMNI-659%26jtitle%3DBrain%2520Res.%26date%3D2019%26volume%3D1711%26spage%3D140%26epage%3D145%26doi%3D10.1016%2Fj.brainres.2019.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref184"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref184'); return false;" data-citation="" class="refNumLink">184</a></strong><div class="NLM_citation" id="cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakizaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nengaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. R.</span></span> <span> </span><span class="NLM_article-title">Development of 2-(2-(3-(4-([<sup>18</sup>F]fluoromethoxy-<i>d</i>2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoli ne-1,3-dione for positron-emission-tomography imaging of phosphodiesterase 10A in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01366</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01366" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVens7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=688-698&author=W.+Moriauthor=T.+Yamasakiauthor=M.+Fujinagaauthor=M.+Ogawaauthor=Y.+Zhangauthor=A.+Hatoriauthor=L.+Xieauthor=K.+Kumataauthor=H.+Wakizakaauthor=Y.+Kuriharaauthor=T.+Ohkuboauthor=N.+Nengakiauthor=M.+R.+Zhang&title=Development+of+2-%282-%283-%284-%28%5B18F%5Dfluoromethoxy-d2%29phenyl%29-7-methyl-4-oxo-3%2C4-dihydroquinazolin-2-yl%29ethyl%29-4-isopropoxyisoindoli+ne-1%2C3-dione+for+positron-emission-tomography+imaging+of+phosphodiesterase+10A+in+the+brain&doi=10.1021%2Facs.jmedchem.8b01366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 2-(2-(3-(4-([18F]Fluoromethoxy-d2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione for Positron-Emission-Tomography Imaging of Phosphodiesterase 10A in the Brain</span></div><div class="casAuthors">Mori, Wakana; Yamasaki, Tomoteru; Fujinaga, Masayuki; Ogawa, Masanao; Zhang, Yiding; Hatori, Akiko; Xie, Lin; Kumata, Katsushi; Wakizaka, Hidekatsu; Kurihara, Yusuke; Ohkubo, Takayuki; Nengaki, Nobuki; Zhang, Ming-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">688-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a newly identified therapeutic target for central-nervous-system disorders.  2-(2-(3-(4-([18F]Fluoroethoxy)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione ([18F]MNI-659, [18F]5) is a useful positron-emission-tomog. (PET) ligand for imaging of PDE10A in the human brain.  However, the radiolabeled metabolite of [18F]5 can accumulate in the brain.  In this study, using [18F]5 as a lead compd., we designed four new 18F-labeled ligands ([18F]6-9) to find one more suitable than [18F]5.  Of these, 2-(2-(3-(4-([18F]fluoromethoxy-d2)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione ([18F]9) exhibited high in vitro binding affinity (Ki = 2.9 nM) to PDE10A and suitable lipophilicity (log D = 2.2).  In PET studies, the binding potential (BPND) of [18F]9 (5.8) to PDE10A in the striatum of rat brains was significantly higher than that of [18F]5 (4.6).  Furthermore, metabolite anal. showed much lower levels of contamination with radiolabeled metabolites in the brains of rats given [18F]9 than in those given [18F]5.  In conclusion, [18F]9 is a useful PET ligand for PDE10A imaging in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNZBmRsqYtq7Vg90H21EOLACvtfcHk0ljD8t_8_AICAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVens7vF&md5=f33639771fb1846d33104a564d9f9aab</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01366%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DW.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DWakizaka%26aufirst%3DH.%26aulast%3DKurihara%26aufirst%3DY.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DNengaki%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26atitle%3DDevelopment%2520of%25202-%25282-%25283-%25284-%2528%255B18F%255Dfluoromethoxy-d2%2529phenyl%2529-7-methyl-4-oxo-3%252C4-dihydroquinazolin-2-yl%2529ethyl%2529-4-isopropoxyisoindoli%2520ne-1%252C3-dione%2520for%2520positron-emission-tomography%2520imaging%2520of%2520phosphodiesterase%252010A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D688%26epage%3D698%26doi%3D10.1021%2Facs.jmedchem.8b01366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref185"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref185'); return false;" data-citation="" class="refNumLink">185</a></strong><div class="NLM_citation" id="cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetler, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evelhoch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGaughey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purcell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of [<sup>11</sup>C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4893</span>– <span class="NLM_lpage">4898</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2015.05.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26077491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsF2itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4893-4898&author=C.+D.+Coxauthor=E.+D.+Hostetlerauthor=B.+A.+Floresauthor=J.+L.+Evelhochauthor=H.+Fanauthor=L.+Gantertauthor=M.+Holahanauthor=W.+Engauthor=A.+Joshiauthor=G.+McGaugheyauthor=X.+Mengauthor=M.+Purcellauthor=I.+T.+Raheemauthor=K.+Riffelauthor=Y.+Yanauthor=J.+J.+Rengerauthor=S.+M.+Smithauthor=P.+J.+Coleman&title=Discovery+of+%5B11C%5DMK-8193+as+a+PET+tracer+to+measure+target+engagement+of+phosphodiesterase+10A+%28PDE10A%29+inhibitors&doi=10.1016%2Fj.bmcl.2015.05.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of [11C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors</span></div><div class="casAuthors">Cox, Christopher D.; Hostetler, Eric D.; Flores, Broc A.; Evelhoch, Jeffrey L.; Fan, Hong; Gantert, Liza; Holahan, Marie; Eng, Waisi; Joshi, Aniket; McGaughey, Georgia; Meng, Xiangjun; Purcell, Mona; Raheem, Izzat T.; Riffel, Kerry; Yan, Youwei; Renger, John J.; Smith, Sean M.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4893-4898</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) inhibition has recently been identified as a potential mechanism to treat multiple symptoms that manifest in schizophrenia.  In order to facilitate preclin. development and support key proof-of-concept clin. trials of novel PDE10A inhibitors, it is crit. to discover positron emission tomog. (PET) tracers that enable plasma concn./PDE10A occupancy relationships to be established across species with structurally diverse PDE10A inhibitors.  In this Letter, we describe how a high-throughput screening hit was optimized to provide [11C]MK-8193 (8j), a PET tracer that supports the detn. of plasma concn./PDE10A occupancy relationships for structurally diverse series of PDE10A inhibitors in both rat and rhesus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVYY9goOOHw7Vg90H21EOLACvtfcHk0ljD8t_8_AICAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsF2itb8%253D&md5=73dc73294c0c6ace954a0ba7d1827cfc</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.080%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DFlores%26aufirst%3DB.%2BA.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520%255B11C%255DMK-8193%2520as%2520a%2520PET%2520tracer%2520to%2520measure%2520target%2520engagement%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4893%26epage%3D4898%26doi%3D10.1016%2Fj.bmcl.2015.05.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref186"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref186'); return false;" data-citation="" class="refNumLink">186</a></strong><div class="NLM_citation" id="cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hostetler, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purcell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buist, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evelhoch, J. L.</span></span> <span> </span><span class="NLM_article-title">Preclinical characterization of the phosphodiesterase 10A PET tracer [<sup>11</sup>C]MK-8193</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1007/s11307-015-0910-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs11307-015-0910-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26596571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCqu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=579-587&author=E.+D.+Hostetlerauthor=H.+Fanauthor=A.+D.+Joshiauthor=Z.+Zengauthor=W.+Engauthor=L.+Gantertauthor=M.+Holahanauthor=X.+Mengauthor=P.+Millerauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=K.+Riffelauthor=C.+Salinasauthor=M.+Williamsauthor=B.+Maauthor=N.+Buistauthor=S.+M.+Smithauthor=P.+J.+Colemanauthor=C.+D.+Coxauthor=B.+A.+Floresauthor=I.+T.+Raheemauthor=J.+J.+Cookauthor=J.+L.+Evelhoch&title=Preclinical+characterization+of+the+phosphodiesterase+10A+PET+tracer+%5B11C%5DMK-8193&doi=10.1007%2Fs11307-015-0910-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [11C]MK-8193</span></div><div class="casAuthors">Hostetler, Eric D.; Fan, Hong; Joshi, Aniket D.; Zeng, Zhizhen; Eng, Waisi; Gantert, Liza; Holahan, Marie; Meng, Xianjun; Miller, Patricia; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Salinas, Cristian; Williams, Mangay; Ma, Bennett; Buist, Nicole; Smith, Sean M.; Coleman, Paul J.; Cox, Christopher D.; Flores, Brock A.; Raheem, Izzat T.; Cook, Jacquelynn J.; Evelhoch, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">579-587</span>CODEN:
                <span class="NLM_cas:coden">MIBOCZ</span>;
        ISSN:<span class="NLM_cas:issn">1860-2002</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: A positron emission tomog. (PET) tracer for the enzyme phosphodiesterase 10A (PDE10A) is desirable to guide the discovery and development of PDE10A inhibitors as potential therapeutics.  The preclin. characterization of the PDE10A PET tracer [11C]MK-8193 is described.  Procedures: In vitro binding studies with [3H]MK-8193 were conducted in rat, monkey, and human brain tissue.  PET studies with [11C]MK-8193 were conducted in rats and rhesus monkeys at baseline and following administration of a PDE10A inhibitor.  Results: [3H]MK-8193 is a high-affinity, selective PDE10A radioligand in rat, monkey, and human brain tissue.  In vivo, [11C]MK-8193 displays rapid kinetics, low test-retest variability, and a large specific signal that is displaced by a structurally diverse PDE10A inhibitor, enabling the detn. of pharmacokinetic/enzyme occupancy relationships.  Conclusions: [11C]MK-8193 is a useful PET tracer for the preclin. characterization of PDE10A therapeutic candidates in rat and monkey.  Further evaluation of [11C]MK-8193 in humans is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwvkeZtq8g8bVg90H21EOLACvtfcHk0lgTU82MHm3Ntw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCqu7%252FM&md5=280beea4b1e031e3cf2a218ed9837903</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1007%2Fs11307-015-0910-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-015-0910-0%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DBuist%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DFlores%26aufirst%3DB.%2BA.%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520phosphodiesterase%252010A%2520PET%2520tracer%2520%255B11C%255DMK-8193%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2016%26volume%3D18%26spage%3D579%26epage%3D587%26doi%3D10.1007%2Fs11307-015-0910-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref187"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref187'); return false;" data-citation="" class="refNumLink">187</a></strong><div class="NLM_citation" id="cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilburn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibblin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubberink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennum, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiniger-Brach, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreilgaard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of <sup>11</sup>C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1513</span>– <span class="NLM_lpage">1518</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.140178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.114.140178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24994928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSrur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1513-1518&author=J.+Kehlerauthor=J.+P.+Kilburnauthor=S.+Estradaauthor=S.+R.+Christensenauthor=A.+Wallauthor=A.+Thibblinauthor=M.+Lubberinkauthor=C.+Bundgaardauthor=L.+T.+Brennumauthor=B.+Steiniger-Brachauthor=C.+T.+Christoffersenauthor=S.+Timmermannauthor=M.+Kreilgaardauthor=G.+Antoniauthor=B.+Bang-Andersenauthor=J.+Nielsen&title=Discovery+and+development+of+11C-Lu+AE92686+as+a+radioligand+for+PET+imaging+of+phosphodiesterase10A+in+the+brain&doi=10.2967%2Fjnumed.114.140178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain</span></div><div class="casAuthors">Kehler, Jan; Kilburn, John Paul; Estrada, Sergio; Christensen, Soren Rahn; Wall, Anders; Thibblin, Alf; Lubberink, Mark; Bundgaard, Christoffer; Brennum, Lise Tourup; Steiniger-Brach, Bjorn; Christoffersen, Claus Tomby; Timmermann, Stine; Kreilgaard, Mads; Antoni, Gunnar; Bang-Andersen, Benny; Nielsen, Jacob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1513-1518</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) plays a key role in the regulation of brain striatal signaling, and several pharmaceutical companies currently investigate PDE10A inhibitors in clin. trials for various central nervous system diseases.  A PDE10A PET ligand may provide evidence that a clin. drug candidate reaches and binds to the target.  Here we describe the successful discovery and initial validation of the novel radiolabeled PDE10A ligand 5,8-dimethyl-2-[2-((1-11C-methyl)-4-phenyl-1H-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyridine (11C-Lu AE92686) and its tritiated analog 3H-Lu AE92686.  Methods: Initial in vitro expts. suggested Lu AE92686 as a promising radioligand, and the corresponding tritiated and 11C-labeled compds. were synthesized.  3H-Lu AE92686 was evaluated as a ligand for in vivo occupancy studies in mice and rats, and 11C-Lu AE92686 was evaluated as a PET tracer candidate in cynomolgus monkeys and in humans.  Results: 11C-Lu AE92686 displayed high specificity and selectivity for PDE10A-expressing regions in the brain of cynomolgus monkeys and humans.  Similar results were found in rodents using 3H-Lu AE92686.  The binding of 11C-Lu AE92686 and 3H-Lu AE92686 to striatum was completely and dose-dependently blocked by the structurally different PDE10A inhibitor 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (MP-10) in rodents and in monkeys.  In all species, specific binding of the radioligand was seen in the striatum but not in the cerebellum, supporting the use of the cerebellum as a ref. region.  The binding potentials (BPND) of 11C-Lu AE92686 in the striatum of both cynomolgus monkeys and humans were evaluated by the simplified ref. tissue model with the cerebellum as the ref. tissue, and BPND was found to be high and reproducible-i.e., BPNDs were 6.5 ± 0.3 (n = 3) and 7.5 ± 1.0 (n = 12) in monkeys and humans, resp.  Conclusion: Rodent, monkey, and human tests of labeled Lu AE92686 suggest that 11C-Lu AE92686 has great potential as a human PET tracer for the PDE10A enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojaLsSdAC7rbVg90H21EOLACvtfcHk0lgTU82MHm3Ntw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSrur3F&md5=a7a0842a56e497ae188e149a3488e620</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.140178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.140178%26sid%3Dliteratum%253Aachs%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DKilburn%26aufirst%3DJ.%2BP.%26aulast%3DEstrada%26aufirst%3DS.%26aulast%3DChristensen%26aufirst%3DS.%2BR.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DThibblin%26aufirst%3DA.%26aulast%3DLubberink%26aufirst%3DM.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DSteiniger-Brach%26aufirst%3DB.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DTimmermann%26aufirst%3DS.%26aulast%3DKreilgaard%26aufirst%3DM.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520development%2520of%252011C-Lu%2520AE92686%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1513%26epage%3D1518%26doi%3D10.2967%2Fjnumed.114.140178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref188"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref188'); return false;" data-citation="" class="refNumLink">188</a></strong><div class="NLM_citation" id="cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnema, S. J.</span></span> <span> </span><span class="NLM_article-title">Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1007/s00259-016-3544-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-016-3544-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27817159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=308-320&author=K.+C.+Yangauthor=V.+Stepanovauthor=N.+Aminiauthor=S.+Martinssonauthor=A.+Takanoauthor=J.+Nielsenauthor=C.+Bundgaardauthor=B.+Bang-Andersenauthor=S.+Grimwoodauthor=C.+Halldinauthor=L.+Fardeauthor=S.+J.+Finnema&title=Characterization+of+%5B11C%5DLu+AE92686+as+a+PET+radioligand+for+phosphodiesterase+10A+in+the+nonhuman+primate+brain&doi=10.1007%2Fs00259-016-3544-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain</span></div><div class="casAuthors">Yang, Kai-Chun; Stepanov, Vladimir; Amini, Nahid; Martinsson, Stefan; Takano, Akihiro; Nielsen, Jacob; Bundgaard, Christoffer; Bang-Andersen, Benny; Grimwood, Sarah; Halldin, Christer; Farde, Lars; Finnema, Sjoerd J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">308-320</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: [11C]Lu AE92686 is a positron emission tomog. (PET) radioligand that has recently been validated for examg. phosphodiesterase 10A (PDE10A) in the human striatum.  [11C]Lu AE92686 has high affinity for PDE10A (IC50 = 0.39 nM) and may also be suitable for examn. of the substantia nigra, a region with low d. of PDE10A.  Here, we report characterization of regional [11C]Lu AE92686 binding to PDE10A in the nonhuman primate (NHP) brain.  Methods: A total of 11 PET measurements, seven baseline and four following pretreatment with unlabeled Lu AE92686 or the structurally unrelated PDE10A inhibitor MP-10, were performed in five NHPs using a high resoln. research tomograph (HRRT).  [11C]Lu AE92686 binding was quantified using a radiometabolite-cor. arterial input function and compartmental and graphical modeling approaches.  Results: Regional time-activity curves were best described with the two-tissue compartment model (2TCM).  However, the distribution vol. (VT) values for all regions were obtained by the Logan plot anal., as reliable cerebellar VT values could not be derived by the 2TCM.  For cerebellum, a proposed ref. region, VT values increased by ∼30 % with increasing PET measurement duration from 63 to 123 min, while VT values in target regions remained stable.  Both pretreatment drugs significantly decreased [11C]Lu AE92686 binding in target regions, while no significant effect on cerebellum was obsd.  Binding potential (BPND) values, derived with the simplified ref. tissue model (SRTM), were 13-17 in putamen and 3-5 in substantia nigra and correlated well to values from the Logan plot anal.  Conclusions: The method proposed for quantification of [11C]Lu AE92686 binding in applied studies in NHP is based on 63 min PET data and SRTM with cerebellum as a ref. region.  The study supports that [11C]Lu AE92686 can be used for PET examns. of PDE10A binding also in substantia nigra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-yWXVCDhoZ7Vg90H21EOLACvtfcHk0lhH_9eJOUoong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiu7bI&md5=40a7c1aa947dec97ba54e6cd44787321</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1007%2Fs00259-016-3544-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-016-3544-9%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%2BC.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMartinsson%26aufirst%3DS.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DJ.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DFinnema%26aufirst%3DS.%2BJ.%26atitle%3DCharacterization%2520of%2520%255B11C%255DLu%2520AE92686%2520as%2520a%2520PET%2520radioligand%2520for%2520phosphodiesterase%252010A%2520in%2520the%2520nonhuman%2520primate%2520brain%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2017%26volume%3D44%26spage%3D308%26epage%3D320%26doi%3D10.1007%2Fs00259-016-3544-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref189"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref189'); return false;" data-citation="" class="refNumLink">189</a></strong><div class="NLM_citation" id="cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubberink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekselius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, G.</span></span> <span> </span><span class="NLM_article-title">Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1050</span> <span class="refDoi"> DOI: 10.1038/tp.2017.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Ftp.2017.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28267149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVSnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=R.+Bodenauthor=J.+Perssonauthor=A.+Wallauthor=M.+Lubberinkauthor=L.+Ekseliusauthor=E.+M.+Larssonauthor=G.+Antoni&title=Striatal+phosphodiesterase+10A+and+medial+prefrontal+cortical+thickness+in+patients+with+schizophrenia%3A+a+PET+and+MRI+study&doi=10.1038%2Ftp.2017.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study</span></div><div class="casAuthors">Boden, R.; Persson, J.; Wall, A.; Lubberink, M.; Ekselius, L.; Larsson, E.-M.; Antoni, G.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1050</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The enzyme phosphodiesterase 10A (PDE10A) is abundant in striatal medium spiny neurons and has been implicated in the pathophysiol. of schizophrenia in animal models and is investigated as a possible new pharmacol. treatment target.  A redn. of prefrontal cortical thickness is common in schizophrenia, but how this relates to PDE10A expression is unknown.  Our study aim was to compare, we believe for the first time, the striatal non-displaceable binding potential (BPND) of the new validated PDE10A ligand [11C]Lu AE92686 between patients with schizophrenia and healthy controls.  Furthermore, we aimed to assess the correlation of PDE10A BPND to cortical thickness.  Sixteen healthy male controls and 10 male patients with schizophrenia treated with clozapine, olanzapine or quetiapine were investigated with positron emission tomog. (PET) and magnetic resonance imaging (MRI).  Striatal binding potential (BPND) of [11C]Lu AE92686 was acquired through dynamic PET scans and cortical thickness by structural MRI.  Clin. assessments of symptoms and cognitive function were performed and the antipsychotic dosage was recorded.  Patients with schizophrenia had a significantly lower BPND of [11C]Lu AE92686 in striatum (P=0.003) than healthy controls.  The striatal BPND significantly correlated to cortical thickness in the medial prefrontal cortex and superior frontal gyrus across patients with schizophrenia and healthy controls.  No significant correlation was obsd. between the BPND for [11C]Lu AE92686 in striatum and age, schizophrenia symptoms, antipsychotic dosage, coffee consumption, smoking, duration of illness or cognitive function in the patients.  In conclusion, PDE10A may be important for functioning in the striato-cortical interaction and in the pathophysiol. of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql31MnbvlqVLVg90H21EOLACvtfcHk0lhH_9eJOUoong"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVSnsLY%253D&md5=c9443218293f591374f85ae5b6d2e076</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Ftp.2017.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2017.11%26sid%3Dliteratum%253Aachs%26aulast%3DBoden%26aufirst%3DR.%26aulast%3DPersson%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DLubberink%26aufirst%3DM.%26aulast%3DEkselius%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DE.%2BM.%26aulast%3DAntoni%26aufirst%3DG.%26atitle%3DStriatal%2520phosphodiesterase%252010A%2520and%2520medial%2520prefrontal%2520cortical%2520thickness%2520in%2520patients%2520with%2520schizophrenia%253A%2520a%2520PET%2520and%2520MRI%2520study%26jtitle%3DTransl.%2520Psychiatry%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Ftp.2017.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref190"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref190'); return false;" data-citation="" class="refNumLink">190</a></strong><div class="NLM_citation" id="cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Development of a series of novel carbon-11 labeled PDE10A inhibitors</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.3284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25891816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslegsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=202-208&author=V.+Stepanovauthor=S.+Miuraauthor=A.+Takanoauthor=N.+Aminiauthor=R.+Nakaoauthor=T.+Hasuiauthor=K.+Nakashimaauthor=T.+Taniguchiauthor=H.+Kimuraauthor=T.+Kuroitaauthor=C.+Halldin&title=Development+of+a+series+of+novel+carbon-11+labeled+PDE10A+inhibitors&doi=10.1002%2Fjlcr.3284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a series of novel carbon-11 labeled PDE10A inhibitors</span></div><div class="casAuthors">Stepanov, Vladimir; Miura, Shotaro; Takano, Akihiro; Amini, Nahid; Nakao, Ryuji; Hasui, Tomoaki; Nakashima, Kosuke; Taniguchi, Takahiko; Kimura, Haruhide; Kuroita, Takanobu; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A series of structurally related phosphodiesterase 10A (PDE10A) inhibitors with carbon-11 were synthesized and evaluated as potential positron emission tomog. (PET) radioligands for PDE10A using nonhuman primates.  The series consisted of seven compds. based on the 3-(1H-pyrazol-5-yl)pyridazin-4(1H)-one backbone.  These compds. were selected from the initial larger library based on a no. of parameters such as affinity, selectivity for hPDE10A in in-vitro tests, lipophilicity, and on the results of multidrug resistance protein 1 (MDR1)-LLCPK1 and the parallel artificial membrane permeability assays.  Seven radioligands were radiolabeled with carbon-11 employing O-methylation on the hydroxyl moiety using [11C]methyl triflate.  In-vivo examn. of each radioligand was performed using PET in rhesus monkeys; anal. of radiometabolites in plasma also was conducted using HPLC.  All seven radioligands were labeled with high (>90%) incorporation of [11C]methyl triflate into their appropriate precursors and with high specific radioactivity.  Carbon-11 labeled compds. I (X = CH, N) showed high accumulation in the striatum, consistent with the known anatomical distribution of PDE10A in brain, accompanied by fast washout and high specific binding ratio.  In particular compd. I (X = CH), was a promising PET tool for further examn. of PDE10A in human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp30BLNX0Ry7Vg90H21EOLACvtfcHk0ljbtIA7QjSkDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslegsbk%253D&md5=5a942473c561aa3cd691c3aa716bca1d</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3284%26sid%3Dliteratum%253Aachs%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DKuroita%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520series%2520of%2520novel%2520carbon-11%2520labeled%2520PDE10A%2520inhibitors%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2015%26volume%3D58%26spage%3D202%26epage%3D208%26doi%3D10.1002%2Fjlcr.3284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref191"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref191'); return false;" data-citation="" class="refNumLink">191</a></strong><div class="NLM_citation" id="cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2014.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25451212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVamsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=146-154&author=A.+Haradaauthor=K.+Suzukiauthor=S.+Miuraauthor=T.+Hasuiauthor=N.+Kamiguchiauthor=T.+Ishiiauthor=T.+Taniguchiauthor=T.+Kuroitaauthor=A.+Takanoauthor=V.+Stepanovauthor=C.+Halldinauthor=H.+Kimura&title=Characterization+of+the+binding+properties+of+T-773+as+a+PET+radioligand+for+phosphodiesterase+10A&doi=10.1016%2Fj.nucmedbio.2014.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A</span></div><div class="casAuthors">Harada, Akina; Suzuki, Kazunori; Miura, Shotaro; Hasui, Tomoaki; Kamiguchi, Naomi; Ishii, Tsuyoshi; Taniguchi, Takahiko; Kuroita, Takanobu; Takano, Akihiro; Stepanov, Vladimir; Halldin, Christer; Kimura, Haruhide</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a dual-substrate PDE that hydrolyzes both cAMP and cGMP and is selectively expressed in striatal medium spiny neurons.  Recent studies have suggested that PDE10A inhibition is a novel approach for the treatment of disorders such as schizophrenia and Huntington's disease.  A positron emission tomog. (PET) occupancy study can provide useful information for the development of PDE10A inhibitors.  We discovered T-773 as a candidate PET radioligand for PDE10A and investigated its properties by in vitro autoradiog. and a PET study in a monkey.  Profiling of T-773 as a PET radioligand for PDE10A was conducted by in vitro enzyme inhibitory assay, in vitro autoradiog., and PET study in a monkey.  T-773 showed a high binding affinity and selectivity for human recombinant PDE10A2 in vitro; the IC50 value in an enzyme inhibitory assay was 0.77 nmol/L, and selectivity over other PDEs was more than 2500-fold.  In autoradiog. studies using mouse, rat, monkey, or human brain sections, radiolabeled T-773 selectively accumulated in the striatum.  This selective accumulation was not obsd. in the brain sections of Pde10a-KO mice.  The binding of [3H]T-773 to PDE10A in rat brain sections was competitively inhibited by MP-10, a selective PDE10A inhibitor.  In rat brain sections, [3H]T-773 bound to a single high affinity site of PDE10A with Kd values of 12.2 ± 2.2 and 4.7 ± 1.2 nmol/L in the caudate-putamen and nucleus accumbens, resp.  In a monkey PET study, [11C]T-773 showed good brain penetration and striatum-selective accumulation.  These results suggest that [11C]T-773 is a potential PET radioligand for PDE10A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokE5ArBExezrVg90H21EOLACvtfcHk0ljbtIA7QjSkDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVamsLjI&md5=464e0aa5d1610036958a9507dc42f58f</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DKuroita%26aufirst%3DT.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520properties%2520of%2520T-773%2520as%2520a%2520PET%2520radioligand%2520for%2520phosphodiesterase%252010A%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2015%26volume%3D42%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.nucmedbio.2014.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref192"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref192'); return false;" data-citation="" class="refNumLink">192</a></strong><div class="NLM_citation" id="cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggkvist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of PDE10A knockout mice with a novel PET radiotracer: [<sup>11</sup>C]T-773</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1007/s11307-015-0822-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs11307-015-0822-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25622810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SmurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=445-449&author=M.+Tothauthor=J.+Haggkvistauthor=V.+Stepanovauthor=A.+Takanoauthor=R.+Nakaoauthor=N.+Aminiauthor=S.+Miuraauthor=H.+Kimuraauthor=T.+Taniguchiauthor=B.+Gulyasauthor=C.+Halldin&title=Molecular+imaging+of+PDE10A+knockout+mice+with+a+novel+PET+radiotracer%3A+%5B11C%5DT-773&doi=10.1007%2Fs11307-015-0822-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [11C]T-773</span></div><div class="casAuthors">Toth, Miklos; Haeggkvist, Jenny; Stepanov, Vladimir; Takano, Akihiro; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Kimura, Haruhide; Taniguchi, Takahiko; Gulyas, Balazs; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">445-449</span>CODEN:
                <span class="NLM_cas:coden">MIBOCZ</span>;
        ISSN:<span class="NLM_cas:issn">1860-2002</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: [11C]T-773 is a new radioligand for positron emission tomog. (PET) targeting the phosphodiesterase 10A enzyme (PDE10A).  PDE10A is highly expressed in the striatum by medium spiny neurons, and it has been demonstrated to be involved in the regulation of striatal signaling through the redn. of medium spiny neuronal sensitivity towards glutamatergic excitation.  PDE10A is assocd. with Parkinson's disease and different neuropsychiatric disorders such as Huntington's disease, obsessive-compulsive disorders (OCD) and schizophrenia.  Studies have indicated that the inhibition of PDE10A may represent a novel therapeutic approach to the treatment of the aforementioned diseases characterized by the reduced activity of medium spiny neurons.  An appropriate PET radioligand for PDE10A would help to facilitate drug development and drug evaluation.  Procedures: We have evaluated the [11C]T-773 ligand in PDE10A knockout mice (heterozygous [HET] and homozygous [HOM]) as well as in normal control animals (WILD) with PET.  Results: The regional percent standardized uptake values (%SUV; mean ± SD) in the striatum were 48.2 ± 1.0 (HOM), 63.6 ± 5.3 (HET) and 85.1 ± 6.3 (WILD).  Between each animal group the striatal %SUV values were significantly different (p < 0.0001).  The striatal BPND values (mean ± SD) were 0.0 ± 0.0 (HOM), 0.14 ± 0.07 (HET) and 0.56 ± 0.15 (WILD).  The BPND values were significantly lower in homozygous and heterozygous animals compared to wild type (p < 0.0001).  Conclusions: The novel PDE10A radioligand [11C]T-773 shows increased signals with higher levels of PDE10A and acceptable binding in the striatum in control animals compared to knockout mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBr8ymNqXzHbVg90H21EOLACvtfcHk0ljbtIA7QjSkDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SmurfJ&md5=587cc1056274405af54320865e01acd8</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1007%2Fs11307-015-0822-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-015-0822-z%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DM.%26aulast%3DHaggkvist%26aufirst%3DJ.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DMolecular%2520imaging%2520of%2520PDE10A%2520knockout%2520mice%2520with%2520a%2520novel%2520PET%2520radiotracer%253A%2520%255B11C%255DT-773%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2015%26volume%3D17%26spage%3D445%26epage%3D449%26doi%3D10.1007%2Fs11307-015-0822-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref193"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref193'); return false;" data-citation="" class="refNumLink">193</a></strong><div class="NLM_citation" id="cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a novel PDE10A PET radioligand, [<sup>11</sup>C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1002/syn.21821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25892433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1Okuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=345-355&author=A.+Takanoauthor=V.+Stepanovauthor=B.+Gulyasauthor=R.+Nakaoauthor=N.+Aminiauthor=S.+Miuraauthor=H.+Kimuraauthor=T.+Taniguchiauthor=C.+Halldin&title=Evaluation+of+a+novel+PDE10A+PET+radioligand%2C+%5B11C%5DT-773%2C+in+nonhuman+primates%3A+brain+and+whole+body+PET+and+brain+autoradiography&doi=10.1002%2Fsyn.21821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a novel PDE10A PET radioligand, [11C]T-773, in nonhuman primates: Brain and whole body PET and brain autoradiography</span></div><div class="casAuthors">Takano, Akihiro; Stepanov, Vladimir; Gulyas, Balazs; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Kimura, Haruhide; Taniguchi, Takahiko; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">345-355</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is considered to be a key target for the treatment of several neuropsychiatric diseases.  The characteristics of [11C]T-773, a novel positron emission tomog. (PET) radioligand with high binding affinity and selectivity for PDE10A, were evaluated in autoradiog. and in nonhuman primate (NHP) PET.  Brain PET measurements were performed under baseline conditions and after administration of a selective PDE10A inhibitor, MP-10.  Total distribution vol. (VT) and binding potential (BPND) were calcd. using various kinetic models.  Whole body PET measurements were performed to calc. the ED of [11C]T-773.  Autoradiog. studies in postmortem human and monkey brain sections showed high accumulation of [11C]T-773 in the striatum and substantia nigra which was blocked by MP-10.  Brain PET showed high accumulation of [11C]T-773 in the striatum, and the data could be fitted using a two tissue compartment model.  BPND was approx. 1.8 in the putamen when the cerebellum was used as the ref. region.  Approx. 70% of PDE10A binding was occupied by 1.8 mg/kg of MP-10.  Whole body PET showed high accumulation of [11C]T-773 in the liver, kidney, heart, and brain in the initial phase.  The radioligand was partly excreted via bile and the gastrointestinal tract, and partly excreted through the urinary tract.  The calcd. ED was 0.007 mSv/MBq.  In conclusion, [11C]T-773 was demonstrated to be a promising PET radioligand for PDE10A with favorable brain kinetics.  Dosimetry results support multiple PET measurements per person in human studies.  Further research is required with [11C]T-773 in order to test the radioligand's potential clin. applications.  Synapse, 2015. © 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAv34x2bx9bVg90H21EOLACvtfcHk0lgjjl0iKpORkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1Okuro%253D&md5=62b32f8095221719757b3e91498c6964</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21821%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520a%2520novel%2520PDE10A%2520PET%2520radioligand%252C%2520%255B11C%255DT-773%252C%2520in%2520nonhuman%2520primates%253A%2520brain%2520and%2520whole%2520body%2520PET%2520and%2520brain%2520autoradiography%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D345%26epage%3D355%26doi%3D10.1002%2Fsyn.21821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref194"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref194'); return false;" data-citation="" class="refNumLink">194</a></strong><div class="NLM_citation" id="cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [<sup>11</sup>C]T-773 in nonhuman primates</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1002/syn.21896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26878349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2016&pages=253-263&author=A.+Takanoauthor=V.+Stepanovauthor=R.+Nakaoauthor=N.+Aminiauthor=B.+Gulyasauthor=H.+Kimuraauthor=C.+Halldin&title=Brain+PET+measurement+of+PDE10A+occupancy+by+TAK-063%2C+a+new+PDE10A+inhibitor%2C+using+%5B11C%5DT-773+in+nonhuman+primates&doi=10.1002%2Fsyn.21896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11C]T-773 in nonhuman primates</span></div><div class="casAuthors">Takano, Akihiro; Stepanov, Vladimir; Nakao, Ryuji; Amini, Nahid; Gulyas, Balazs; Kimura, Haruhide; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">253-263</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Because phosphodiesterase 10A (PDE10A) degrades both cyclic adenosine monophosphate and cyclic guanosine monophosphate and is distributed mainly in the striatum, PDE10A inhibitors have been considered to potentially be useful therapeutic agents for psychiatric and neurodegenerative diseases such as schizophrenia and Huntington's disease.  We measured striatal PDE10A occupancy by TAK-063, a newly developed compd. with high affinity and selectivity for PDE10A, using PET with [11C]T-773 in nonhuman primates.  Two 123-min dynamic PET measurements were performed on three female rhesus monkeys, once at baseline and again after i.v. administration of different doses of TAK-063 (0.2-1.6 mg/kg).  Total distribution vol. (VT) was calcd. with a two-tissue compartment model using metabolite-cor. plasma input.  Although the in vitro autoradiog. did not show high specific binding to [11C]T-773 in the cerebellum, VT in the cerebellum decreased after TAK-063 treatment.  The specific binding to PDE10A (VS) was calcd. as the difference of the VT between the target regions and the cerebellum.  PDE10A occupancy was calcd. as the percent change of VS.  The av. PDE10A occupancy of the caudate nucleus and putamen was 35.2% at 0.2 mg/kg and 83.2% at 1.6 mg/kg.  In conclusion, this nonhuman primate PET study demonstrated that [11C]T-773 is useful to est. the PDE10A occupancy by TAK-063 in the striatum although there is in vivo interaction of the uptake between [11C]T-773 and TAK-063 in the cerebellum.  These results warrant further clin. occupancy study for TAK-063.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKSzvhpfgFv7Vg90H21EOLACvtfcHk0lgjjl0iKpORkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKrurw%253D&md5=00c3ecbf2f6525fe871285d5da79adee</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21896%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DBrain%2520PET%2520measurement%2520of%2520PDE10A%2520occupancy%2520by%2520TAK-063%252C%2520a%2520new%2520PDE10A%2520inhibitor%252C%2520using%2520%255B11C%255DT-773%2520in%2520nonhuman%2520primates%26jtitle%3DSynapse%26date%3D2016%26volume%3D70%26spage%3D253%26epage%3D263%26doi%3D10.1002%2Fsyn.21896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref195"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref195'); return false;" data-citation="" class="refNumLink">195</a></strong><div class="NLM_citation" id="cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenkrona, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, T. A.</span></span> <span> </span><span class="NLM_article-title">A human [<sup>11</sup>C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2016.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2016.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27423256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ans7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2016&pages=10-17&author=A.+Takanoauthor=P.+Stenkronaauthor=V.+Stepanovauthor=N.+Aminiauthor=S.+Martinssonauthor=M.+Tsaiauthor=P.+Goldsmithauthor=J.+Xieauthor=J.+Wuauthor=T.+Uzauthor=C.+Halldinauthor=T.+A.+Macek&title=A+human+%5B11C%5DT-773+PET+study+of+PDE10A+binding+after+oral+administration+of+TAK-063%2C+a+PDE10A+inhibitor&doi=10.1016%2Fj.neuroimage.2016.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">A human [11C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor</span></div><div class="casAuthors">Takano, Akihiro; Stenkrona, Per; Stepanov, Vladimir; Amini, Nahid; Martinsson, Stefan; Tsai, Max; Goldsmith, Paul; Xie, Jinhui; Wu, Jingtao; Uz, Tolga; Halldin, Christer; Macek, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-17</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is selectively expressed in the striatal regions in the brain and may play a role in modulating dopaminergic and glutamatergic second messenger pathways.  PDE10A inhibitors are expected to be useful in treating neuropsychiatric disorders such as schizophrenia and Huntington's disease.  In this study, the brain kinetics of [11C]T-773 in the human brain and test-retest reproducibility of the outcome measures were evaluated.  Subsequently, the occupancy of a novel PDE10A inhibitor, TAK-063, was measured using [11C]T-773.  Dynamic PET measurements were conducted three times for 12 healthy male subjects after i.v. bolus injection of [11C]T-773: two baseline PETs and one postdose PET (3 h) after oral administration of TAK-063 for four subjects, and one baseline PET and two postdose PET (3 h and 23 h) for eight subjects.  Kinetic model anal. was performed with arterial input functions.  PDE10A occupancy was calcd. as the percent change of the binding specific to PDE10A (Vs) total distribution vol. (VT), which was calcd. as the VT of the putamen minus the VT of the cerebellum.  Regional brain uptake was highest in the putamen.  Time-activity curves of the brain regions were described with two tissue-compartment (2TC) models.  The mean VT was 5.5 ± 0.7 in the putamen and 2.3 ± 0.5 in the cerebellum in the baseline PET.  Abs. VT variability between the two baseline scans was less than 7%.  Reproducibility of VT was excellent.  PDE10A occupancy in the putamen ranged from 2.8% to 72.1% at 3 h after a single administration of 3 to 1000 mg of TAK-063, and increased in a dose- and plasma concn.-dependent manner.  At 23 h postdose, PDE10A occupancy in the putamen was 0 to 42.8% following administration of 3 to 100 mg of TAK-063.  In conclusion, [11C]T-773 showed good characteristics as a PET radioligand for PDE10A in the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphxQR4iFCU27Vg90H21EOLACvtfcHk0lgjjl0iKpORkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ans7jM&md5=0022ca662d19f77cdef95352248f91e6</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2016.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2016.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStenkrona%26aufirst%3DP.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMartinsson%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DM.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DMacek%26aufirst%3DT.%2BA.%26atitle%3DA%2520human%2520%255B11C%255DT-773%2520PET%2520study%2520of%2520PDE10A%2520binding%2520after%2520oral%2520administration%2520of%2520TAK-063%252C%2520a%2520PDE10A%2520inhibitor%26jtitle%3DNeuroImage%26date%3D2016%26volume%3D141%26spage%3D10%26epage%3D17%26doi%3D10.1016%2Fj.neuroimage.2016.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref196"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref196'); return false;" data-citation="" class="refNumLink">196</a></strong><div class="NLM_citation" id="cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Development of two fluorine-18 labeled PET radioligands targeting PDE10A and <i>in vivo</i> PET evaluation in nonhuman primates</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2017.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2017.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29223715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCis7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=12-19&author=V.+Stepanovauthor=A.+Takanoauthor=R.+Nakaoauthor=N.+Aminiauthor=S.+Miuraauthor=T.+Hasuiauthor=H.+Kimuraauthor=T.+Taniguchiauthor=C.+Halldin&title=Development+of+two+fluorine-18+labeled+PET+radioligands+targeting+PDE10A+and+in+vivo+PET+evaluation+in+nonhuman+primates&doi=10.1016%2Fj.nucmedbio.2017.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates</span></div><div class="casAuthors">Stepanov, Vladimir; Takano, Akihiro; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Hasui, Tomoaki; Kimura, Haruhide; Taniguchi, Takahiko; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-19</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a member of the PDE enzyme family that degrades cyclic adenosine and guanosine monophosphates (cAMP and cGMP).  Based on the successful development of [11C]T-773 as PDE10A positron emission tomog. (PET) radioligand, in this study our aim was to develop and evaluate fluorine-18 analogs of [11C]T-773.[18F]FM-T-773-d2 and [18F]FE-T-773-d4 were synthesized from the same precursor used for 11C-labeling of T-773 in a two-step approach via 18F-fluoromethylation and 18F-fluoroethylation, resp., using corresponding deuterated synthons.  A total of 12 PET measurements were performed in seven non-human primates.  First, baseline PET measurements were performed using High Resoln. Research Tomograph system with both [18F]FM-T-773-d2 and [18F]FE-T-773-d4; the uptake in whole brain and sep. brain regions, as well as the specific binding and tissue ratio between putamen and cerebellum, was examd.  Second, baseline and pretreatment PET measurements using MP-10 as the blocker were performed for [18F]FM-T-773-d2 including arterial blood sampling with radiometabolite anal. in four NHPs.  Both [18F]FM-T-773-d2 and [18F]FE-T-773-d4 were successfully radiolabeled with an av. molar activity of 293 ±114 GBq/μmol (n = 8) for [18F]FM-T-773-d2 and 209 ± 26 GBq/μmol (n = 4) for [18F]FE-T-773-d4, and a radiochem. yield of 10% (EOB, n = 12, range 3%-16%).  Both radioligands displayed high brain uptake (∼ 5.5% of injected radioactivity for [18F]FM-T-773-d2 and ∼ 3.5% for [18F]FE-T-773-d4 at the peak) and a fast washout.  Specific binding reached max. within 30 min for [18F]FM-T-773-d2 and after approx. 45 min for [18F]FE-T-773-d4. [18F]FM-T-773-d2 data fitted well with kinetic compartment models.  BPND values obtained indirectly through compartment models were correlated well with those obtained by SRTM.  BPND calcd. with SRTM was 1.0-1.7 in the putamen.  The occupancy with 1.8 mg/kg of MP-10 was approx. 60%.[18F]FM-T-773-d2 and [18F]FE-T-773-d4 were developed as fluorine-18 PET radioligands for PDE10A, with the [18F]FM-T-773-d2 being the more promising PET radioligand warranting further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHBb1tHdjrGrVg90H21EOLACvtfcHk0liN0XVXf20EXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCis7jP&md5=8aa86e0a00c15ff2af65d29113ff2b67</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2017.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520two%2520fluorine-18%2520labeled%2520PET%2520radioligands%2520targeting%2520PDE10A%2520and%2520in%2520vivo%2520PET%2520evaluation%2520in%2520nonhuman%2520primates%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2018%26volume%3D57%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.nucmedbio.2017.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref197"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref197'); return false;" data-citation="" class="refNumLink">197</a></strong><div class="NLM_citation" id="cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumfelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easwaramoorthy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castrillon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Dargham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slifstein, M.</span></span> <span> </span><span class="NLM_article-title">Initial characterization of a PDE10A selective positron emission tomography tracer [<sup>11</sup>C]AMG 7980 in non-human primates</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2014.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24607437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslKlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=343-349&author=D.+R.+Hwangauthor=E.+Huauthor=S.+Rumfeltauthor=B.+Easwaramoorthyauthor=J.+Castrillonauthor=C.+Davisauthor=J.+R.+Allenauthor=H.+Chenauthor=J.+Treanorauthor=A.+Abi-Darghamauthor=M.+Slifstein&title=Initial+characterization+of+a+PDE10A+selective+positron+emission+tomography+tracer+%5B11C%5DAMG+7980+in+non-human+primates&doi=10.1016%2Fj.nucmedbio.2014.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates</span></div><div class="casAuthors">Hwang, Dah-Ren; Hu, Essa; Rumfelt, Shannon; Easwaramoorthy, Balu; Castrillon, John; Davis, Carl; Allen, Jennifer R.; Chen, Hang; Treanor, James; Abi-Dargham, Anissa; Slifstein, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is an intracellular enzyme responsible for the breakdown of cyclic nucleotides which are important secondary messengers in the central nervous system.  Inhibition of PDE10A has been identified as a potential therapeutic target for treatment of various neuropsychiatric disorders.  To assist the drug development program, we have identified a selective PDE10A PET tracer, [11C]AMG 7980, for imaging PDE10A distribution using positron emission tomog.  [11C]AMG 7980 was prepd. in a one-pot, two-step reaction.  Dynamic PET scans were performed in non-human primates following a bolus or bolus plus const. infusion tracer injection paradigm.  Regions-of-interest were defined on individuals' MRIs and transferred to the co-registered PET images.  Data were analyzed using Logan graphical anal. with metabolite-cor. input function, the simplified ref. tissue model (SRTM) method and occupancy plots.  A benchmark PDE10A inhibitor was used to demonstrate PDE10A-specific binding.  [11C]AMG 7980 was prepd. with a mean specific activity of 99 ± 74 GBq/μmol (n = 10) and a synthesis time of 45 min.  Specific binding of the tracer was localized to the striatum and globus pallidus (GP) and low in other brain regions.  Thalamus was used as the ref. tissue to derive binding potentials (BPND).  The BPND for caudate, putamen, and GP were 0.23, 0.65, 0.51, resp. by the graphical method, and 0.42, 0.76, and 0.75 from the SRTM method.  A dose dependent decrease of BPND was obsd. with the pre-treatment of a PDE10A inhibitor.  A bolus plus infusion injection paradigm yielded similar results.  [11C]AMG 7980 has been successfully used for imaging PDE10A in non-human primate brain.  Despite the fast brain kinetics it can be used to measure target occupancy of PDE10A inhibitors in non-human primates and potentially applicable to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl8JWDNIZ407Vg90H21EOLACvtfcHk0liN0XVXf20EXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslKlu7g%253D&md5=f07bf68932610a520e1238a3098ff598</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DD.%2BR.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DEaswaramoorthy%26aufirst%3DB.%26aulast%3DCastrillon%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26aulast%3DSlifstein%26aufirst%3DM.%26atitle%3DInitial%2520characterization%2520of%2520a%2520PDE10A%2520selective%2520positron%2520emission%2520tomography%2520tracer%2520%255B11C%255DAMG%25207980%2520in%2520non-human%2520primates%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D343%26epage%3D349%26doi%3D10.1016%2Fj.nucmedbio.2014.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref198"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref198'); return false;" data-citation="" class="refNumLink">198</a></strong><div class="NLM_citation" id="cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester-Zeiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biorn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill Della Puppa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazules, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talreja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumfelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, O. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span> <span> </span><span class="NLM_article-title">AMG 580: a novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.220517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fjpet.114.220517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25502803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFSqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=327-337&author=H.+Chenauthor=D.+Lester-Zeinerauthor=J.+Shiauthor=S.+Millerauthor=C.+Glausauthor=E.+Huauthor=N.+Chenauthor=J.+Ableauthor=C.+Biornauthor=J.+Wongauthor=J.+Maauthor=K.+Michelsenauthor=G.+Hill+Della+Puppaauthor=T.+Kazulesauthor=H.+H.+Douauthor=S.+Talrejaauthor=X.+Zhaoauthor=A.+Chenauthor=S.+Rumfeltauthor=R.+K.+Kunzauthor=H.+Yeauthor=O.+R.+Thielauthor=T.+Williamsonauthor=C.+Davisauthor=A.+Porterauthor=D.+Immkeauthor=J.+R.+Allenauthor=J.+Treanor&title=AMG+580%3A+a+novel+small+molecule+phosphodiesterase+10A+%28PDE10A%29+positron+emission+tomography+tracer&doi=10.1124%2Fjpet.114.220517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">AMG 580: A novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer</span></div><div class="casAuthors">Chen, Hang; Lester-Zeiner, Dianna; Shi, Jianxia; Miller, Silke; Glaus, Charlie; Hu, Essa; Chen, Ning; Able, Jessica; Biorn, Christopher; Wong, Jamie; Ma, Ji; Michelsen, Klaus; Della Puppa, Geraldine Hill; Kazules, Tim; Dou, Hui Hannah; Talreja, Santosh; Zhao, Xiaoning; Chen, Ada; Rumfelt, Shannon; Kunz, Roxanne K.; Ye, Hu; Thiel, Oliver R.; Williamson, Toni; Davis, Carl; Porter, Amy; Immke, David; Allen, Jennifer R.; Treanor, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-337/1-327-337/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) inhibitors have therapeutic potential for the treatment of psychiatric and neurol. disorders, such as schizophrenia and Huntington's disease.  One of the key requirements for successful central nervous system drug development is to demonstrate target coverage of therapeutic candidates in brain for lead optimization in the drug discovery phase and for assisting dose selection in clin. development.  Therefore, we identified AMG 580 [1-(4-(3-(4-(1H-benzo[d] imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)-2- fluoropropan-1-one], a novel, selective small-mol. antagonist with subnanomolar affinity for rat, primate, and human PDE10A.  We showed that AMG580 is suitable as a tracer for lead optimization to det. target coverage by novel PDE10A inhibitors using triple-stage quadrupole liq. chromatog.-tandem mass spectrometry technol.  [3H]AMG 580 bound with high affinity in a specific and saturable manner to both striatal homogenates and brain slices from rats, baboons, and human in vitro.  Moreover, [18F]AMG 580 demonstrated prominent uptake by positron emission tomog. in rats, suggesting that radiolabeled AMG 580 may be suitable for further development as a noninvasive radiotracer for target coverage measurements in clin. studies.  These results indicate that AMG 580 is a potential imaging biomarker for mapping PDE10A distribution and ensuring target coverage by therapeutic PDE10A inhibitors in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozcuESxX7s_LVg90H21EOLACvtfcHk0liN0XVXf20EXA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFSqtr0%253D&md5=60f3c102f60fb4c4822b9d9d3a997b52</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.220517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.220517%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DGlaus%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBiorn%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DHill%2BDella%2BPuppa%26aufirst%3DG.%26aulast%3DKazules%26aufirst%3DT.%26aulast%3DDou%26aufirst%3DH.%2BH.%26aulast%3DTalreja%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DThiel%26aufirst%3DO.%2BR.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DImmke%26aufirst%3DD.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DTreanor%26aufirst%3DJ.%26atitle%3DAMG%2520580%253A%2520a%2520novel%2520small%2520molecule%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520positron%2520emission%2520tomography%2520tracer%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26spage%3D327%26epage%3D337%26doi%3D10.1124%2Fjpet.114.220517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref199"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref199'); return false;" data-citation="" class="refNumLink">199</a></strong><div class="NLM_citation" id="cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester-Zeiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of phosphodiesterase 10A (PDE10A) PET tracer AMG 580 to support clinical studies</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1ektL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=719-723&author=E.+Huauthor=N.+Chenauthor=R.+K.+Kunzauthor=D.+R.+Hwangauthor=K.+Michelsenauthor=C.+Davisauthor=J.+Maauthor=J.+Shiauthor=D.+Lester-Zeinerauthor=R.+Hungateauthor=J.+Treanorauthor=H.+Chenauthor=J.+R.+Allen&title=Discovery+of+phosphodiesterase+10A+%28PDE10A%29+PET+tracer+AMG+580+to+support+clinical+studies&doi=10.1021%2Facsmedchemlett.6b00185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies</span></div><div class="casAuthors">Hu, Essa; Chen, Ning; Kunz, Roxanne K.; Hwang, Dah-Ren; Michelsen, Klaus; Davis, Carl; Ma, Ji; Shi, Jianxia; Lester-Zeiner, Dianna; Hungate, Randall; Treanor, James; Chen, Hang; Allen, Jennifer R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">719-723</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of PDE10A PET tracer AMG 580 developed to support proof of concept studies with PDE10A inhibitors in the clinic.  To find a tracer with higher binding potential (BPND) in NHP than our previously reported tracer 1, we implemented a surface plasmon resonance assay to measure the binding off-rate to identify candidates with slower washout rate in vivo.  Five candidates (2-6) from two structurally distinct scaffolds were identified that possessed both the in vitro characteristics that would favor central penetration and the structural features necessary for PET isotope radiolabeling.  Two cinnolines (2, 3) and one keto-benzimidazole (5) exhibited PDE10A target specificity and brain uptake comparable to or better than 1 in the in vivo LC-MS/MS kinetics distribution study in SD rats.  In NHP PET imaging study, [18F]-5 produced a significantly improved BPND of 3.1 and was nominated as PDE10A PET tracer clin. candidate for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzWYWmHhOKz7Vg90H21EOLACvtfcHk0ljjG-q3iSj66A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1ektL8%253D&md5=342e1880548119b29ed28707d997aff4</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00185%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DHwang%26aufirst%3DD.%2BR.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520PET%2520tracer%2520AMG%2520580%2520to%2520support%2520clinical%2520studies%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D719%26epage%3D723%26doi%3D10.1021%2Facsmedchemlett.6b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">200</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipper, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoefgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and <i>in vitro</i> evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejmech.2015.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26562545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=97-108&author=S.+Wagnerauthor=M.+Scheunemannauthor=K.+Dipperauthor=U.+Egerlandauthor=N.+Hoefgenauthor=J.+Steinbachauthor=P.+Brust&title=Development+of+highly+potent+phosphodiesterase+10A+%28PDE10A%29+inhibitors%3A+Synthesis+and+in+vitro+evaluation+of+1%2C8-dipyridinyl-+and+1-pyridinyl-substituted+imidazo%5B1%2C5-a%5Dquinoxalines&doi=10.1016%2Fj.ejmech.2015.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines</span></div><div class="casAuthors">Wagner, Sally; Scheunemann, Matthias; Dipper, Karolin; Egerland, Ute; Hoefgen, Norbert; Steinbach, Joerg; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97-108</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein we report the synthesis of fluorinated inhibitors of phosphodiesterase 10A (PDE10A), which can be used potentially as a lead structure for the development of a 18F-labeled PDE10A imaging agent for positron emission tomog.  The use of o-fluoropyridines as residues could potentially enable the introduction of 18F through nucleophilic substitution for radiolabeling purposes.  2-Fluoropyridines are introduced by a Suzuki coupling at different positions of the mol.  The ref. compds., 1,8-dipyridinylimidazo[1,5-a]quinoxalines and 1-pyridinylimidazo[1,5-a]quinoxalines, show inhibitory potencies at best in the subnanomolar range and selectivity factors greater than 38 against other PDE's.  1,8-Dipyridinylimidazo[1,5-a]quinoxalines are more potent inhibitors than 1-pyridinylimidazo[1,5-a]quinoxalines.  Using 2-fluoro-3-pyridinyl as the residue provided the most potent inhibitors I (IC50 = 0.12 nM), II (IC50 = 0.048 nM), and III (IC50 = 0.037 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok5Llcb5Me3LVg90H21EOLACvtfcHk0ljjG-q3iSj66A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rL&md5=2f176dd7450db00bb2b9df696e2cef41</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DDipper%26aufirst%3DK.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DHoefgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520highly%2520potent%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitors%253A%2520Synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%25201%252C8-dipyridinyl-%2520and%25201-pyridinyl-substituted%2520imidazo%255B1%252C5-a%255Dquinoxalines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D107%26spage%3D97%26epage%3D108%26doi%3D10.1016%2Fj.ejmech.2015.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref201"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref201'); return false;" data-citation="" class="refNumLink">201</a></strong><div class="NLM_citation" id="cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hankir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.K. F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the new radioligand [<sup>18</sup>F]AQ-28A by small animal PET/MR demonstrates increase of PDE10A expression in striatum and brown adipose tissue (BAT) of obese mice</span>. <i>J. Label. Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">S52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=S52&author=S.+Wagnerauthor=M.+Kranzauthor=M.+Hankirauthor=W.+Deuther-Conradauthor=M.+Scheunemannauthor=R.+Teodoroauthor=B.+Wenzelauthor=S.+Fischerauthor=U.K.+F.+W.+Egerlandauthor=S.+Hesseauthor=N.+H%C3%B6fgenauthor=J.+Steinbachauthor=P.+Brust&title=Evaluation+of+the+new+radioligand+%5B18F%5DAQ-28A+by+small+animal+PET%2FMR+demonstrates+increase+of+PDE10A+expression+in+striatum+and+brown+adipose+tissue+%28BAT%29+of+obese+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DHankir%26aufirst%3DM.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DEgerland%26aufirst%3DU.K.%2BF.%2BW.%26aulast%3DHesse%26aufirst%3DS.%26aulast%3DH%25C3%25B6fgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520the%2520new%2520radioligand%2520%255B18F%255DAQ-28A%2520by%2520small%2520animal%2520PET%252FMR%2520demonstrates%2520increase%2520of%2520PDE10A%2520expression%2520in%2520striatum%2520and%2520brown%2520adipose%2520tissue%2520%2528BAT%2529%2520of%2520obese%2520mice%26jtitle%3DJ.%2520Label.%2520Compd.%2520Radiopharm.%26date%3D2015%26volume%3D58%26spage%3DS52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref202"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref202'); return false;" data-citation="" class="refNumLink">202</a></strong><div class="NLM_citation" id="cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoefgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and biological evaluation of the new PDE10A radioligand [<sup>18</sup>F]AQ28A</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.3471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27896836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=36-48&author=S.+Wagnerauthor=R.+Teodoroauthor=W.+Deuther-Conradauthor=M.+Kranzauthor=M.+Scheunemannauthor=S.+Fischerauthor=B.+Wenzelauthor=U.+Egerlandauthor=N.+Hoefgenauthor=J.+Steinbachauthor=P.+Brust&title=Radiosynthesis+and+biological+evaluation+of+the+new+PDE10A+radioligand+%5B18F%5DAQ28A&doi=10.1002%2Fjlcr.3471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and biological evaluation of the new PDE10A radioligand [18F]AQ28A</span></div><div class="casAuthors">Wagner, Sally; Teodoro, Rodrigo; Deuther-Conrad, Winnie; Kranz, Mathias; Scheunemann, Matthias; Fischer, Steffen; Wenzel, Barbara; Egerland, Ute; Hoefgen, Norbert; Steinbach, Joerg; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">In this study we developed, radiolabeled, and evaluated a new PDE10A radioligand, 8-bromo-1-(6-[18F]fluoropyridin-3-yl)-3,4-dimethylimidazo[1,5-a]quinoxaline ([18F]AQ28A).  Radiolabeling of[18F]AQ28A was done by both nucleophilic bromo-to-fluoro or nitro-to-fluoro exchange using K[18F]F-K2.2.2-carbonate complex with different yields.  Using the superior nitro precursor, we developed an automated synthesis on a Tracerlab FX F-N module and obtained [18F]AQ28A with high radiochem. yields (33 ± 6%) and specific activities (96-145 GBq.μmol-1) for further evaluation.  Initially, we investigated the binding of [18F]AQ28A to the brain of different species by autoradiog. and obsd. the highest d. of binding sites in striatum, the brain region with the highest PDE10A expression.  Subsequent dynamic PET studies in mice revealed a region-specific accumulation of [18F]AQ28A in this region, which could be blocked by preinjection of the selective PDE10A ligand MP-10.  In conclusion, the data suggested [18F]AQ28A was a suitable candidate for imaging of PDE10A in rodent brain by PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO4MFa_yebTbVg90H21EOLACvtfcHk0lj3YVtJy3xWTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7rM&md5=0cc6ea11a660eac6e5fff7df7eea5795</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3471%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DHoefgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DRadiosynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520new%2520PDE10A%2520radioligand%2520%255B18F%255DAQ28A%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2017%26volume%3D60%26spage%3D36%26epage%3D48%26doi%3D10.1002%2Fjlcr.3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref203"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref203'); return false;" data-citation="" class="refNumLink">203</a></strong><div class="NLM_citation" id="cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinzimmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabulsi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 10A PET radioligand development program: from pig to human</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.2967/jnumed.113.131409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.113.131409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24614221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=595-601&author=C.+Plissonauthor=D.+Weinzimmerauthor=S.+Jakobsenauthor=S.+Natesanauthor=C.+Salinasauthor=S.+F.+Linauthor=D.+Labareeauthor=M.+Q.+Zhengauthor=N.+Nabulsiauthor=T.+R.+Marquesauthor=S.+Kapurauthor=E.+Kawanishiauthor=T.+Saijoauthor=R.+N.+Gunnauthor=R.+E.+Carsonauthor=E.+A.+Rabiner&title=Phosphodiesterase+10A+PET+radioligand+development+program%3A+from+pig+to+human&doi=10.2967%2Fjnumed.113.131409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 10A PET radioligand development program: from pig to human</span></div><div class="casAuthors">Plisson, Christophe; Weinzimmer, David; Jakobsen, Steen; Natesan, Sridhar; Salinas, Cristian; Lin, Shu-Fei; Labaree, David; Zheng, Ming-Qiang; Nabulsi, Nabeel; Marques, Tiago Reis; Kapur, Shitij; Kawanishi, Eiji; Saijo, Takeaki; Gunn, Roger N.; Carson, Richard E.; Rabiner, Eugenii A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-601</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Four novel phosphodiesterase 10A (PDE10A) PET tracers have been synthesized, characterized in preclin. studies, and compared with the previously reported 11C-MP-10.  Methods: On the basis of in vitro data, IMA102, IMA104, IMA107, and IMA106 were identified as potential PDE10A radioligand candidates and labeled with either 11C via N-methylation or with 18F through an SN2 reaction, in the case of IMA102.  These candidates were compared with 11C-MP-10 in pilot in vivo studies in the pig brain.  On the basis of these data, 11C-IMA106 and 11C-IMA107 were taken into further evaluation and comparison with 11C-MP-10 in the primate brain.  Finally, the most promising radioligand candidate was progressed into human evaluation.  Results: All 5 tracers were produced with good radiochem. yield and specific activity.  All candidates readily entered the brain and demonstrated a heterogeneous distribution consistent with the known expression of PDE10A.  Baseline PET studies in the pig and baboon showed that 11C-IMA107 and 11C-MP-10 displayed the most favorable tissue kinetics and imaging properties.  The administration of selective PDE10A inhibitors reduced the binding of 11C-IMA107 and 11C-MP-10 in the PDE10A-rich brain regions, in a dose-dependent manner.  In the nonhuman primate brain, the tissue kinetics of 11C-IMA107 and 11C-MP-10 were well described by a 2-tissue-compartment model, allowing robust ests. of the regional total vol. of distribution.  Blockade with unlabeled MP-10 confirmed the suitability of the cerebellum as a ref. tissue and enabled the estn. of regional binding potential as the outcome measure of specific binding.  Conclusion: 11C-IMA107 was identified as the ligand with the highest binding potential while still possessing reversible kinetics.  The first human administration of 11C-IMA107 has demonstrated the expected regional distribution and suitably fast kinetics, indicating that 11C-IMA107 will be a useful tool for the investigation of PDE10A status in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm-Fd40QJWDLVg90H21EOLACvtfcHk0lj3YVtJy3xWTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOhtro%253D&md5=a0e5db2b744a2f49aac00507258f21b3</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.131409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.131409%26sid%3Dliteratum%253Aachs%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DWeinzimmer%26aufirst%3DD.%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DM.%2BQ.%26aulast%3DNabulsi%26aufirst%3DN.%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DKawanishi%26aufirst%3DE.%26aulast%3DSaijo%26aufirst%3DT.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26atitle%3DPhosphodiesterase%252010A%2520PET%2520radioligand%2520development%2520program%253A%2520from%2520pig%2520to%2520human%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D595%26epage%3D601%26doi%3D10.2967%2Fjnumed.113.131409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref204"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref204'); return false;" data-citation="" class="refNumLink">204</a></strong><div class="NLM_citation" id="cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis Marques, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhlert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tziortzi, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span> <span> </span><span class="NLM_article-title">Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">3016</span>– <span class="NLM_lpage">3029</span>, <span class="refDoi"> DOI: 10.1093/brain/awv214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1093%2Fbrain%2Fawv214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26198591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Flt1KqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=3016-3029&author=F.+Niccoliniauthor=S.+Haiderauthor=T.+Reis+Marquesauthor=N.+Muhlertauthor=A.+C.+Tziortziauthor=G.+E.+Searleauthor=S.+Natesanauthor=P.+Picciniauthor=S.+Kapurauthor=E.+A.+Rabinerauthor=R.+N.+Gunnauthor=S.+J.+Tabriziauthor=M.+Politis&title=Altered+PDE10A+expression+detectable+early+before+symptomatic+onset+in+Huntington%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawv214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease</span></div><div class="casAuthors">Niccolini Flavia; Politis Marios; Haider Salman; Tabrizi Sarah J; Reis Marques Tiago; Natesan Sridhar; Kapur Shitij; Muhlert Nils; Tziortzi Andri C; Searle Graham E; Piccini Paola; Rabiner Eugenii A; Gunn Roger N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 10</span>),
    <span class="NLM_cas:pages">3016-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There is an urgent need for early biomarkers and novel disease-modifying therapies in Huntington's disease.  Huntington's disease pathology involves the toxic effect of mutant huntingtin primarily in striatal medium spiny neurons, which highly express phosphodiesterase 10A (PDE10A).  PDE10A hydrolyses cAMP/cGMP signalling cascades, thus having a key role in the regulation of striatal output, and in promoting neuronal survival.  PDE10A could be a key therapeutic target in Huntington's disease.  Here, we used combined positron emission tomography (PET) and multimodal magnetic resonance imaging to assess PDE10A expression in vivo in a unique cohort of 12 early premanifest Huntington's disease gene carriers with a mean estimated 90% probability of 25 years before the predicted onset of clinical symptoms.  We show bidirectional changes in PDE10A expression in premanifest Huntington's disease gene carriers, which are associated with the probability of symptomatic onset.  PDE10A expression in early premanifest Huntington's disease was decreased in striatum and pallidum and increased in motor thalamic nuclei, compared to a group of matched healthy controls.  Connectivity-based analysis revealed prominent PDE10A decreases confined in the sensorimotor-striatum and in striatonigral and striatopallidal projecting segments.  The ratio between higher PDE10A expression in motor thalamic nuclei and lower PDE10A expression in striatopallidal projecting striatum was the strongest correlate with higher probability of symptomatic conversion in early premanifest Huntington's disease gene carriers.  Our findings demonstrate in vivo, a novel and earliest pathophysiological mechanism underlying Huntington's disease with direct implications for the development of new pharmacological treatments, which can promote neuronal survival and improve outcome in Huntington's disease gene carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQt45D4d8YjXeWhZTslLrfffW6udTcc2eZAtHeMSEx8gLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Flt1KqtA%253D%253D&md5=35244382e3e08926abebd5ce93bb061b</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawv214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawv214%26sid%3Dliteratum%253Aachs%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DReis%2BMarques%26aufirst%3DT.%26aulast%3DMuhlert%26aufirst%3DN.%26aulast%3DTziortzi%26aufirst%3DA.%2BC.%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DTabrizi%26aufirst%3DS.%2BJ.%26aulast%3DPolitis%26aufirst%3DM.%26atitle%3DAltered%2520PDE10A%2520expression%2520detectable%2520early%2520before%2520symptomatic%2520onset%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D3016%26epage%3D3029%26doi%3D10.1093%2Fbrain%2Fawv214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref205"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref205'); return false;" data-citation="" class="refNumLink">205</a></strong><div class="NLM_citation" id="cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousaf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltynie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson’s disease</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1505</span>– <span class="NLM_lpage">1515</span>, <span class="refDoi"> DOI: 10.1002/mds.27733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fmds.27733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31158314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFynsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=1505-1515&author=G.+Paganoauthor=F.+Niccoliniauthor=H.+Wilsonauthor=T.+Yousafauthor=N.+L.+Khanauthor=D.+Martinoauthor=C.+Plissonauthor=R.+N.+Gunnauthor=E.+A.+Rabinerauthor=P.+Picciniauthor=T.+Foltynieauthor=M.+Politis&title=Comparison+of+phosphodiesterase+10A+and+dopamine+transporter+levels+as+markers+of+disease+burden+in+early+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.27733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinsons disease</span></div><div class="casAuthors">Pagano, Gennaro; Niccolini, Flavia; Wilson, Heather; Yousaf, Tayyabah; Khan, Naheed L.; Martino, Davide; Plisson, Christophe; Gunn, Roger N.; Rabiner, Eugenii A.; Piccini, Paola; Foltynie, Thomas; Politis, Marios</div><div class="citationInfo"><span class="NLM_cas:title">Movement Disorders</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1505-1515</span>CODEN:
                <span class="NLM_cas:coden">MOVDEA</span>;
        ISSN:<span class="NLM_cas:issn">0885-3185</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To assess phosphodiesterase 10A levels in early PD and compare with loss of dopamine transporter as markers of disease burden.  Seventy-eight subjects were included in this study (17 early de novo, 15 early L-dopa-treated, 24 moderate-advanced L-dopa-treated patients with PD, and 22 healthy controls).  Early de novo PD patients showed loss of [11C]IMA107 and of [11C]PE2I binding in caudate and putamen (P < 0.001); early L-dopa-treated PD patients showed addnl. loss of [11C]IMA107 in the caudate (P < 0.001; annual decline 3.6%) and putamen (P < 0.001; annual decline 2.8%), but loss of [11C]PE2I only in the putamen (P < 0.001; annual decline 6.8%).  Lower [11C]IMA107 correlated with lower [11C]PE2I in the caudate and putamen.  Longer disease duration correlated with lower [11C]IMA107 in the caudate and putamen and with lower [11C]PE2I only in the putamen.  Higher burden of motor symptoms correlated with lower [11C]IMA107 in the caudate and putamen and with lower [11C]PE2I only in the putamen.  Our findings demonstrate loss of phosphodiesterase 10A levels very early in the course of PD and is assocd. with the gradual and progressive increase of motor symptoms.  Phosphodiesterase 10A imaging shows similar potential with dopamine transporter imaging to follow disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfPliKYC0FRrVg90H21EOLACvtfcHk0ljsWkPrS9Tqpg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFynsbzL&md5=b3f0d3717324e9d9b0a667742a744c97</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1002%2Fmds.27733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.27733%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DG.%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DH.%26aulast%3DYousaf%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DN.%2BL.%26aulast%3DMartino%26aufirst%3DD.%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DFoltynie%26aufirst%3DT.%26aulast%3DPolitis%26aufirst%3DM.%26atitle%3DComparison%2520of%2520phosphodiesterase%252010A%2520and%2520dopamine%2520transporter%2520levels%2520as%2520markers%2520of%2520disease%2520burden%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2019%26volume%3D34%26spage%3D1505%26epage%3D1515%26doi%3D10.1002%2Fmds.27733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref206"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref206'); return false;" data-citation="" class="refNumLink">206</a></strong><div class="NLM_citation" id="cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 10A in schizophrenia: A PET study using [<sup>11</sup>C]IMA107</span>. <i>Am. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1176/appi.ajp.2015.15040518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1176%2Fappi.ajp.2015.15040518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26892941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC28jit1GltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=714-721&author=T.+R.+Marquesauthor=S.+Natesanauthor=F.+Niccoliniauthor=M.+Politisauthor=R.+N.+Gunnauthor=G.+E.+Searleauthor=O.+Howesauthor=E.+A.+Rabinerauthor=S.+Kapur&title=Phosphodiesterase+10A+in+schizophrenia%3A+A+PET+study+using+%5B11C%5DIMA107&doi=10.1176%2Fappi.ajp.2015.15040518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107</span></div><div class="casAuthors">Marques Tiago Reis; Natesan Sridhar; Niccolini Flavia; Politis Marios; Gunn Roger N; Searle Graham E; Howes Oliver; Rabiner Eugenii A; Kapur Shitij</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">714-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Phosphodiesterase 10A (PDE10A) is an enzyme present in striatal medium spiny neurons that degrades the intracellular second messengers triggered by dopamine signaling.  The pharmaceutical industry has considerable interest in PDE10A inhibitors because they have been shown to have an antipsychotic-like effect in animal models.  However, the status of PDE10A in schizophrenia is unknown.  Using a newly developed and validated radioligand, [(11)C]IMA107, the authors report the first in vivo assessment of PDE10A brain expression in patients with schizophrenia.  METHOD:  The authors compared PDE10A availability in the brains of 12 patients with chronic schizophrenia and 12 matched healthy comparison subjects using [(11)C]IMA107 positron emission tomography (PET).  Regional estimates of the binding potential (BPND) of [(11)C]IMA107 were generated from dynamic PET scans using the simplified reference tissue model with the cerebellum as the reference tissue for nonspecific binding.  RESULTS:  There was no significant difference in [(11)C]IMA107 BPND between schizophrenia patients and comparison subjects in any of the brain regions studied (thalamus, caudate, putamen, nucleus accumbens, globus pallidus, and substantia nigra).  There was also no significant correlation between [(11)C]IMA107 BPND and the severity of psychotic symptoms or antipsychotic dosage.  CONCLUSIONS:  Patients with schizophrenia have normal availability of PDE10A in brain regions thought to be involved in the pathophysiology of this disorder.  The findings do not support the proposal of an altered PDE10A availability in schizophrenia.  The implication of this finding for future drug development is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5qxqBomUfwWhHGZei4OW9fW6udTcc2eZAtHeMSEx8gLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jit1GltA%253D%253D&md5=98c324f9f9df3fb3521fb5a1e96b7af0</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2015.15040518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2015.15040518%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DPolitis%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DHowes%26aufirst%3DO.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DPhosphodiesterase%252010A%2520in%2520schizophrenia%253A%2520A%2520PET%2520study%2520using%2520%255B11C%255DIMA107%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2016%26volume%3D173%26spage%3D714%26epage%3D721%26doi%3D10.1176%2Fappi.ajp.2015.15040518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref207"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref207'); return false;" data-citation="" class="refNumLink">207</a></strong><div class="NLM_citation" id="cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span> <span> </span><span class="NLM_article-title">Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers</span>. <i>J. Neurol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/j.jns.2016.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.jns.2016.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27538642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Slt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2016&pages=243-248&author=H.+Wilsonauthor=F.+Niccoliniauthor=S.+Haiderauthor=T.+R.+Marquesauthor=G.+Paganoauthor=C.+Coelloauthor=S.+Natesanauthor=S.+Kapurauthor=E.+A.+Rabinerauthor=R.+N.+Gunnauthor=S.+J.+Tabriziauthor=M.+Politis&title=Loss+of+extra-striatal+phosphodiesterase+10A+expression+in+early+premanifest+Huntington%E2%80%99s+disease+gene+carriers&doi=10.1016%2Fj.jns.2016.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers</span></div><div class="casAuthors">Wilson, Heather; Niccolini, Flavia; Haider, Salman; Marques, Tiago Reis; Pagano, Gennaro; Coello, Christopher; Natesan, Sridhar; Kapur, Shitij; Rabiner, Eugenii A.; Gunn, Roger N.; Tabrizi, Sarah J.; Politis, Marios</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">243-248</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a monogenic neurodegenerative disorder with an underlying pathol. involving the toxic effect of mutant huntingtin protein primarily in striatal and cortical neurons.  Phosphodiesterase 10A (PDE10A) regulates intracellular signalling cascades, thus having a key role in promoting neuronal survival.  Using positron emission tomog. (PET) with [11C]IMA107, we investigated the in vivo extra-striatal expression of PDE10A in 12 early premanifest HD gene carriers.  Image processing and kinetic modeling was performed using MIAKAT.  Parametric images of [11C]IMA107 non-displaceable binding potential (BPND) were generated from the dynamic [11C]IMA107 scans using the simplified ref. tissue model with the cerebellum as the ref. tissue for nonspecific binding.  We set a threshold criterion for meaningful quantification of [11C]IMA107 BPND at 0.30 in healthy control data; regions meeting this criterion were designated as regions of interest (ROIs).  MRI-based volumetric anal. showed no atrophy in ROIs.  We found significant differences in mean ROIs [11C]IMA107 BPND between HD gene carriers and healthy controls.  HD gene carriers had significant loss of PDE10A within the insular cortex and occipital fusiform gyrus compared to healthy controls.  Insula and occipital fusiform gyrus are important brain areas for the regulation of cognitive and limbic function that is impaired in HD.  Our findings suggest that dysregulation of PDE10A-mediated intracellular signalling could be an early phenomenon in the course of HD with relevance also for extra-striatal brain areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzyDHr5CCa7Vg90H21EOLACvtfcHk0lgipbfOH78y0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Slt7zI&md5=fc19f1fe2787af794e526f1cade12e6f</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2016.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2016.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DH.%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DPagano%26aufirst%3DG.%26aulast%3DCoello%26aufirst%3DC.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DTabrizi%26aufirst%3DS.%2BJ.%26aulast%3DPolitis%26aufirst%3DM.%26atitle%3DLoss%2520of%2520extra-striatal%2520phosphodiesterase%252010A%2520expression%2520in%2520early%2520premanifest%2520Huntington%25E2%2580%2599s%2520disease%2520gene%2520carriers%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2016%26volume%3D368%26spage%3D243%26epage%3D248%26doi%3D10.1016%2Fj.jns.2016.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref208"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref208'); return false;" data-citation="" class="refNumLink">208</a></strong><div class="NLM_citation" id="cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukoff Rizzo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinttala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulke, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markham, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charych, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pysden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankinen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallioinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sormunen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinne, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alakurtti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huilaja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurskainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasanen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anttila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahiminiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uusimaa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, N. J.</span></span> <span> </span><span class="NLM_article-title">Biallelic mutations in PDE10A lead to loss of striatal PDE10A and a hyperkinetic movement disorder with onset in infancy</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ajhg.2016.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ajhg.2016.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27058446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFKht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2016&pages=735-43&author=C.+P.+Diggleauthor=S.+J.+Sukoff+Rizzoauthor=M.+Popiolekauthor=R.+Hinttalaauthor=J.+P.+Schulkeauthor=M.+A.+Kurianauthor=I.+M.+Carrauthor=A.+F.+Markhamauthor=D.+T.+Bonthronauthor=C.+Watsonauthor=S.+M.+Sharifauthor=V.+Reinhartauthor=L.+C.+Jamesauthor=M.+A.+Vanase-Frawleyauthor=E.+Charychauthor=M.+Allenauthor=J.+Harmsauthor=C.+J.+Schmidtauthor=J.+Ngauthor=K.+Pysdenauthor=C.+Strickauthor=P.+Vieiraauthor=K.+Mankinenauthor=H.+Kokkonenauthor=M.+Kallioinenauthor=R.+Sormunenauthor=J.+O.+Rinneauthor=J.+Johanssonauthor=K.+Alakurttiauthor=L.+Huilajaauthor=T.+Hurskainenauthor=K.+Tasanenauthor=E.+Anttilaauthor=T.+R.+Marquesauthor=O.+Howesauthor=M.+Politisauthor=S.+Fahiminiyaauthor=K.+Q.+Nguyenauthor=J.+Majewskiauthor=J.+Uusimaaauthor=E.+Sheridanauthor=N.+J.+Brandon&title=Biallelic+mutations+in+PDE10A+lead+to+loss+of+striatal+PDE10A+and+a+hyperkinetic+movement+disorder+with+onset+in+infancy&doi=10.1016%2Fj.ajhg.2016.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy</span></div><div class="casAuthors">Diggle, Christine P.; Sukoff-Rizzo, Stacey J.; Popiolek, Michael; Hinttala, Reetta; Schulke, Jan-Philip; Kurian, Manju A.; Carr, Ian M.; Markham, Alexander F.; Bonthron, David T.; Watson, Christopher; Sharif, Saghira Malik; Reinhart, Veronica; James, Larry C.; Vanase-Frawley, Michelle A.; Charych, Erik; Allen, Melanie; Harms, John; Schmidt, Christopher J.; Ng, Joanne; Pysden, Karen; Strick, Christine; Vieira, Paivi; Mankinen, Katariina; Kokkonen, Hannaleena; Kallioinen, Matti; Sormunen, Raija; Rinne, Juha O.; Johansson, Jarkko; Alakurtti, Kati; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa; Anttila, Eija; Marques, Tiago Reis; Howes, Oliver; Politis, Marius; Fahiminiya, Somayyeh; Nguyen, Khanh Q.; Majewski, Jacek; Uusimaa, Johanna; Sheridan, Eamonn; Brandon, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">735-743</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deficits in the basal ganglia pathways modulating cortical motor activity underlie both Parkinson disease (PD) and Huntington disease (HD).  Phosphodiesterase 10A (PDE10A) is enriched in the striatum, and animal data suggest that it is a key regulator of this circuitry.  Here, we report on germline PDE10A mutations in eight individuals from two families affected by a hyperkinetic movement disorder due to homozygous mutations c.320A>G (p.Tyr107Cys) and c.346G>C (p.Ala116Pro).  Both mutations lead to a redn. in PDE10A levels in recombinant cellular systems, and critically, positron-emission-tomog. (PET) studies with a specific PDE10A ligand confirmed that the p.Tyr107Cys variant also reduced striatal PDE10A levels in one of the affected individuals.  A knock-in mouse model carrying the homologous p.Tyr97Cys variant had decreased striatal PDE10A and also displayed motor abnormalities.  Striatal prepns. from this animal had an impaired capacity to degrade cyclic adenosine monophosphate (cAMP) and a blunted pharmacol. response to PDE10A inhibitors.  These observations highlight the crit. role of PDE10A in motor control across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_vISP0guOL7Vg90H21EOLACvtfcHk0lgipbfOH78y0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFKht78%253D&md5=79585b919e71c6c401bfe469435d65ca</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2016.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2016.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DHinttala%26aufirst%3DR.%26aulast%3DSchulke%26aufirst%3DJ.%2BP.%26aulast%3DKurian%26aufirst%3DM.%2BA.%26aulast%3DCarr%26aufirst%3DI.%2BM.%26aulast%3DMarkham%26aufirst%3DA.%2BF.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DSharif%26aufirst%3DS.%2BM.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DJames%26aufirst%3DL.%2BC.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DCharych%26aufirst%3DE.%26aulast%3DAllen%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DPysden%26aufirst%3DK.%26aulast%3DStrick%26aufirst%3DC.%26aulast%3DVieira%26aufirst%3DP.%26aulast%3DMankinen%26aufirst%3DK.%26aulast%3DKokkonen%26aufirst%3DH.%26aulast%3DKallioinen%26aufirst%3DM.%26aulast%3DSormunen%26aufirst%3DR.%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DAlakurtti%26aufirst%3DK.%26aulast%3DHuilaja%26aufirst%3DL.%26aulast%3DHurskainen%26aufirst%3DT.%26aulast%3DTasanen%26aufirst%3DK.%26aulast%3DAnttila%26aufirst%3DE.%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DHowes%26aufirst%3DO.%26aulast%3DPolitis%26aufirst%3DM.%26aulast%3DFahiminiya%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DK.%2BQ.%26aulast%3DMajewski%26aufirst%3DJ.%26aulast%3DUusimaa%26aufirst%3DJ.%26aulast%3DSheridan%26aufirst%3DE.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26atitle%3DBiallelic%2520mutations%2520in%2520PDE10A%2520lead%2520to%2520loss%2520of%2520striatal%2520PDE10A%2520and%2520a%2520hyperkinetic%2520movement%2520disorder%2520with%2520onset%2520in%2520infancy%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2016%26volume%3D98%26spage%3D735%26epage%3D43%26doi%3D10.1016%2Fj.ajhg.2016.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref209"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref209'); return false;" data-citation="" class="refNumLink">209</a></strong><div class="NLM_citation" id="cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tollefson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopresti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott Mason, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narendran, R.</span></span> <span> </span><span class="NLM_article-title">Imaging phosphodiesterase-10a availability in cocaine use disorder with [<sup>11</sup>C]IMA107 and PET</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>73</i></span>, <span class="NLM_elocation-id">e22070</span> <span class="refDoi"> DOI: 10.1002/syn.22070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.22070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30240027" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2019&author=S.+Tollefsonauthor=J.+Gertlerauthor=M.+L.+Himesauthor=J.+Parisauthor=S.+Kendroauthor=B.+Loprestiauthor=N.+Scott+Masonauthor=R.+Narendran&title=Imaging+phosphodiesterase-10a+availability+in+cocaine+use+disorder+with+%5B11C%5DIMA107+and+PET&doi=10.1002%2Fsyn.22070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1002%2Fsyn.22070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.22070%26sid%3Dliteratum%253Aachs%26aulast%3DTollefson%26aufirst%3DS.%26aulast%3DGertler%26aufirst%3DJ.%26aulast%3DHimes%26aufirst%3DM.%2BL.%26aulast%3DParis%26aufirst%3DJ.%26aulast%3DKendro%26aufirst%3DS.%26aulast%3DLopresti%26aufirst%3DB.%26aulast%3DScott%2BMason%26aufirst%3DN.%26aulast%3DNarendran%26aufirst%3DR.%26atitle%3DImaging%2520phosphodiesterase-10a%2520availability%2520in%2520cocaine%2520use%2520disorder%2520with%2520%255B11C%255DIMA107%2520and%2520PET%26jtitle%3DSynapse%26date%3D2019%26volume%3D73%26doi%3D10.1002%2Fsyn.22070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref210"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref210'); return false;" data-citation="" class="refNumLink">210</a></strong><div class="NLM_citation" id="cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makhlouf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kshirsagar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederberger, C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 11: a brief review of structure, expression and function</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1038/sj.ijir.3901441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fsj.ijir.3901441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16395323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFChsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=501-509&author=A.+Makhloufauthor=A.+Kshirsagarauthor=C.+Niederberger&title=Phosphodiesterase+11%3A+a+brief+review+of+structure%2C+expression+and+function&doi=10.1038%2Fsj.ijir.3901441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 11: a brief review of structure, expression and function</span></div><div class="casAuthors">Makhlouf, A.; Kshirsagar, A.; Niederberger, C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 11 (PDE11) is the latest isoform of the phosphodiesterase family to be identified.  Interest in PDE11 has increased recently because tadalafil, an oral phosphodiesterase 5 inhibitor, cross-reacts with PDE11.  The function of PDE11 remains largely unknown, but growing evidence points to a possible role in male reprodn.  Here, the published literature on PDE11 structure, function, and expression is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQHo7j_8684LVg90H21EOLACvtfcHk0lgkvY7hVUCCGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFChsrvO&md5=b33fb2263603bc5efae8472a6bdfecf8</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901441%26sid%3Dliteratum%253Aachs%26aulast%3DMakhlouf%26aufirst%3DA.%26aulast%3DKshirsagar%26aufirst%3DA.%26aulast%3DNiederberger%26aufirst%3DC.%26atitle%3DPhosphodiesterase%252011%253A%2520a%2520brief%2520review%2520of%2520structure%252C%2520expression%2520and%2520function%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2006%26volume%3D18%26spage%3D501%26epage%3D509%26doi%3D10.1038%2Fsj.ijir.3901441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref211"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref211'); return false;" data-citation="" class="refNumLink">211</a></strong><div class="NLM_citation" id="cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujishige, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michibata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span> <span> </span><span class="NLM_article-title">Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">31469</span>– <span class="NLM_lpage">31479</span>, <span class="refDoi"> DOI: 10.1074/jbc.M003041200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.M003041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10906126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlCitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=31469-31479&author=K.+Yuasaauthor=J.+Koteraauthor=K.+Fujishigeauthor=H.+Michibataauthor=T.+Sasakiauthor=K.+Omori&title=Isolation+and+characterization+of+two+novel+phosphodiesterase+PDE11A+variants+showing+unique+structure+and+tissue-specific+expression&doi=10.1074%2Fjbc.M003041200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression</span></div><div class="casAuthors">Yuasa, Keizo; Kotera, Jun; Fujishige, Kotomi; Michibata, Hideo; Sasaki, Takashi; Omori, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">31469-31479</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CDNAs encoding a novel phosphodiesterase, phosphodiesterase 11A (PDE11A), were isolated by a combination of reverse transcriptase-polymerase chain reaction using degenerate oligonucleotide primers and rapid amplification of cDNA ends.  Their catalytic domain was identical to that of PDE11A1 (490 amino acids) reported during the course of this study.  However, the cDNAs we isolated had N termini distinct from PDE11A1, indicating two novel N-terminal variants of PDE11A.  PDE11A3 cDNA encoded a 684-amino acid protein including one complete and one incomplete GAF domain in the N-terminal region.  PDE11A4 was composed of 934 amino acids including two complete GAF domains and shared 630 C-terminal amino acids with PDE11A3 but had a distinct N terminus contg. the putative phosphorylation sites for cAMP- and cGMP-dependent protein kinases.  PDE11A3 transcripts were specifically expressed in testis, whereas PDE11A4 transcripts were particularly abundant in prostate.  Recombinant PDE11A4 expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 3.0 and 1.4 μM, resp., and the Vmax value with cAMP was almost twice that with cGMP.  Although PDE11A3 showed the same Km values as PDE11A4, the relative Vmax values of PDE11A3 were approx. one-sixth of those of PDE11A4.  PDE11A4, but not PDE11A3, was phosphorylated by both cAMP- and cGMP-dependent protein kinases in vitro.  Thus, the PDE11A gene undergoes tissue-specific alternative splicing that generates structurally and functionally distinct gene products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP-mE2wlBKDLVg90H21EOLACvtfcHk0lgkvY7hVUCCGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlCitLo%253D&md5=45ada9686385e445f515327b4c1e3777</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003041200%26sid%3Dliteratum%253Aachs%26aulast%3DYuasa%26aufirst%3DK.%26aulast%3DKotera%26aufirst%3DJ.%26aulast%3DFujishige%26aufirst%3DK.%26aulast%3DMichibata%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOmori%26aufirst%3DK.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520two%2520novel%2520phosphodiesterase%2520PDE11A%2520variants%2520showing%2520unique%2520structure%2520and%2520tissue-specific%2520expression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D31469%26epage%3D31479%26doi%3D10.1074%2Fjbc.M003041200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref212"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref212'); return false;" data-citation="" class="refNumLink">212</a></strong><div class="NLM_citation" id="cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fawcett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxendale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrouther, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrow, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, S. C.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3702</span>– <span class="NLM_lpage">3707</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.7.3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1073%2Fpnas.97.7.3702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10725373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlajsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3702-3707&author=L.+Fawcettauthor=R.+Baxendaleauthor=P.+Staceyauthor=C.+McGroutherauthor=I.+Harrowauthor=S.+Soderlingauthor=J.+Hetmanauthor=J.+A.+Beavoauthor=S.+C.+Phillips&title=Molecular+cloning+and+characterization+of+a+distinct+human+phosphodiesterase+gene+family%3A+PDE11A&doi=10.1073%2Fpnas.97.7.3702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A</span></div><div class="casAuthors">Fawcett, Lindsay; Baxendale, Rhona; Stacey, Peter; McGrouther, Collette; Harrow, Ian; Soderling, Scott; Hetman, Joanna; Beavo, Joseph A.; Phillips, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3702-3707</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The cloning, expression, and characterization of human PDE11A1, a member of a distinct cyclic nucleotide phosphodiesterase (PDE) family, is reported.  PDE11A exhibits ≤50% amino acid identity with the catalytic domains of all other PDEs, being most similar to PDE5, and has distinct biochem. properties.  The human PDE11A1 cDNA isolated contains a complete open reading frame encoding a 490-amino acid enzyme with a predicted mol. mass of 55,786 Da.  At the N-terminus PDE11A1 has a single GAF domain homologous to that found in other signaling mols., including PDE2, PDE5, PDE6, and PDE10, which constitutes a potential allosteric binding site for cGMP or another small ligand.  Tissue distribution studies indicate that PDE11A mRNA occurs at highest levels in skeletal muscle, prostate, kidney, liver, pituitary, and salivary glands and testis.  PDE11A is expressed as at least three major transcripts of ≈10.5, ≈8.5, and ≈6.0 kb, thus suggesting the existence of multiple subtypes.  This possibility is further supported by the detection of three distinct proteins of ≈78, ≈65, and ≈56 kDa by Western blotting of human tissues for PDE11A isoforms.  Recombinant human PDE11A1 hydrolyzes both cGMP and cAMP with Km values of 0.52 μM and 1.04 μM, resp., and similar Vmax values.  Therefore, PDE11A represents a dual-substrate PDE that may regulate both cGMP and cAMP under physiol. conditions.  PDE11A is sensitive to the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) as well as zaprinast and dipyridamole, inhibitors that are generally considered relatively specific for the cGMP-selective PDEs, with IC50 values of 49.8 μM, 12.0 μM, and 0.37 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_VJWznJpR_bVg90H21EOLACvtfcHk0lgkvY7hVUCCGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlajsr4%253D&md5=3c163b17327e91096fd2bcd7c7772918</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.7.3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.7.3702%26sid%3Dliteratum%253Aachs%26aulast%3DFawcett%26aufirst%3DL.%26aulast%3DBaxendale%26aufirst%3DR.%26aulast%3DStacey%26aufirst%3DP.%26aulast%3DMcGrouther%26aufirst%3DC.%26aulast%3DHarrow%26aufirst%3DI.%26aulast%3DSoderling%26aufirst%3DS.%26aulast%3DHetman%26aufirst%3DJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DPhillips%26aufirst%3DS.%2BC.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520distinct%2520human%2520phosphodiesterase%2520gene%2520family%253A%2520PDE11A%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D3702%26epage%3D3707%26doi%3D10.1073%2Fpnas.97.7.3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref213"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref213'); return false;" data-citation="" class="refNumLink">213</a></strong><div class="NLM_citation" id="cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shtutman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2016.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroscience.2016.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27544407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWmsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2016&pages=151-169&author=S.+Hegdeauthor=H.+Jiauthor=D.+Oliverauthor=N.+S.+Patelauthor=N.+Pouporeauthor=M.+Shtutmanauthor=M.+P.+Kelly&title=PDE11A+regulates+social+behaviors+and+is+a+key+mechanism+by+which+social+experience+sculpts+the+brain&doi=10.1016%2Fj.neuroscience.2016.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain</span></div><div class="casAuthors">Hegde, Shweta; Ji, Hao; Oliver, David; Patel, Neema S.; Poupore, Nicolas; Shtutman, Michael; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-169</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the fact that appropriate social behaviors are vital to thriving in one's environment, little is understood of the mol. mechanisms controlling social behaviors or how social experience sculpts these signaling pathways.  Here, we det. if Phosphodiesterase 11A (PDE11A), an enzyme that is enriched in the ventral hippocampal formation (VHIPP) and that breaks down cAMP and cGMP, regulates social behaviors.  PDE11 wild-type (WT), heterozygous (HT), and knockout (KO) mice were tested in various social approach assays and gene expression differences were measured by RNA sequencing.  The effect of social isolation on PDE11A4 compartmentalization and subsequent social interactions and social memory was also assessed.  Deletion of PDE11A triggered age- and sex-dependent deficits in social approach in specific social contexts but not others.  Mice appear to detect altered social behaviors of PDE11A KO mice, because C57BL/6J mice prefer to spend time with a sex-matched PDE11A WT vs. its KO littermate; whereas, a PDE11A KO prefers to spend time with a novel PDE11A KO vs. its WT littermate.  Not only is PDE11A required for intact social interactions, we found that 1 mo of social isolation vs. group housing decreased PDE11A4 protein expression specifically within the membrane fraction of VHIPP.  This isolation-induced decrease in PDE11A4 expression appears functional because social isolation impairs subsequent social approach behavior and social memory in a PDE11A genotype-dependent manner.  Pathway analyses following RNA sequencing suggests PDE11A is a key regulator of the oxytocin pathway and membrane signaling, consistent with its pivotal role in regulating social behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgvzxUXhd9CLVg90H21EOLACvtfcHk0ljqtnYNP2oJCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWmsL7I&md5=009789c35e20016c597bdc4dd2156ce4</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2016.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2016.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DOliver%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DN.%2BS.%26aulast%3DPoupore%26aufirst%3DN.%26aulast%3DShtutman%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DPDE11A%2520regulates%2520social%2520behaviors%2520and%2520is%2520a%2520key%2520mechanism%2520by%2520which%2520social%2520experience%2520sculpts%2520the%2520brain%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D335%26spage%3D151%26epage%3D169%26doi%3D10.1016%2Fj.neuroscience.2016.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref214"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref214'); return false;" data-citation="" class="refNumLink">214</a></strong><div class="NLM_citation" id="cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilarzyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Loss of function of phosphodiesterase 11A4 shows that recent and remote long-term memories can be uncoupled</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2307</span>– <span class="NLM_lpage">2321</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2019.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.cub.2019.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31303492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=2307-2321&author=K.+Pilarzykauthor=J.+Klettauthor=E.+A.+Penaauthor=L.+Porcherauthor=A.+J.+Smithauthor=M.+P.+Kelly&title=Loss+of+function+of+phosphodiesterase+11A4+shows+that+recent+and+remote+long-term+memories+can+be+uncoupled&doi=10.1016%2Fj.cub.2019.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Function of Phosphodiesterase 11A4 Shows that Recent and Remote Long-Term Memories Can Be Uncoupled</span></div><div class="casAuthors">Pilarzyk, Katy; Klett, Jennifer; Pena, Edsel A.; Porcher, Latarsha; Smith, Abigail J.; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2307-2321.e5</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Systems consolidation is a process by which memories initially require the hippocampus for recent long-term memory (LTM) but then become increasingly independent of the hippocampus and more dependent on the cortex for remote LTM.  Here, we study the role of phosphodiesterase 11A4 (PDE11A4) in systems consolidation.  PDE11A4, which degrades cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), is preferentially expressed in neurons of CA1, the subiculum, and the adjacently connected amygdalohippocampal region.  In male and female mice, deletion of PDE11A enhances remote LTM for social odor recognition and social transmission of food preference (STFP) despite eliminating or silencing recent LTM for those same social events.  Measurement of a surrogate marker of neuronal activation (i.e., Arc mRNA) suggests the recent LTM deficits obsd. in Pde11 knockout mice correspond with decreased activation of ventral CA1 relative to wild-type littermates.  In contrast, the enhanced remote LTM obsd. in Pde11a knockout mice corresponds with increased activation and altered functional connectivity of anterior cingulate cortex, frontal assocn. cortex, parasubiculum, and the superficial layer of medial entorhinal cortex.  The apparent increased neural activation obsd. in prefrontal cortex of Pde11a knockout mice during remote LTM retrieval may be related to an upregulation of the N-methyl-D-aspartate receptor subunits NR1 and NR2A.  Viral restoration of PDE11A4 to vCA1 alone is sufficient to rescue both the LTM phenotypes and upregulation of NR1 exhibited by Pde11a knockout mice.  Together, our findings suggest remote LTM can be decoupled from recent LTM, which may have relevance for cognitive deficits assocd. with aging, temporal lobe epilepsy, or transient global amnesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWjPjh6XZaGrVg90H21EOLACvtfcHk0ljqtnYNP2oJCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7jL&md5=83996a6341e03b3419cc4af7ccc016e1</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2019.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2019.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DPilarzyk%26aufirst%3DK.%26aulast%3DKlett%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DE.%2BA.%26aulast%3DPorcher%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DLoss%2520of%2520function%2520of%2520phosphodiesterase%252011A4%2520shows%2520that%2520recent%2520and%2520remote%2520long-term%2520memories%2520can%2520be%2520uncoupled%26jtitle%3DCurr.%2520Biol.%26date%3D2019%26volume%3D29%26spage%3D2307%26epage%3D2321%26doi%3D10.1016%2Fj.cub.2019.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref215"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref215'); return false;" data-citation="" class="refNumLink">215</a></strong><div class="NLM_citation" id="cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostino, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capell, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilarzyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuczkewycz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">PDE11A negatively regulates lithium responsivity</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1038/mp.2016.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fmp.2016.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27646265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFenu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1714-1724&author=G.+Pathakauthor=M.+J.+Agostinoauthor=K.+Bisharaauthor=W.+R.+Capellauthor=J.+L.+Fisherauthor=S.+Hegdeauthor=B.+A.+Ibrahimauthor=K.+Pilarzykauthor=C.+Sabinauthor=T.+Tuczkewyczauthor=S.+Wilsonauthor=M.+P.+Kelly&title=PDE11A+negatively+regulates+lithium+responsivity&doi=10.1038%2Fmp.2016.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">PDE11A negatively regulates lithium responsivity</span></div><div class="casAuthors">Pathak, G.; Agostino, M. J.; Bishara, K.; Capell, W. R.; Fisher, J. L.; Hegde, S.; Ibrahim, B. A.; Pilarzyk, K.; Sabin, C.; Tuczkewycz, T.; Wilson, S.; Kelly, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1714-1724</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Lithium responsivity in patients with bipolar disorder has been genetically assocd. with Phosphodiesterase 11A (PDE11A), and lithium decreases PDE11A mRNA in induced pluripotent stem cell-derived hippocampal neurons originating from lithium-responsive patients.  PDE11 is an enzyme uniquely enriched in the hippocampus that breaks down cAMP and cyclic GMP.  Here we detd. whether decreasing PDE11A expression is sufficient to increase lithium responsivity in mice.  In dorsal hippocampus and ventral hippocampus (VHIPP), lithium-responsive C57BL/6J and 129S6/SvEvTac mice show decreased PDE11A4 protein expression relative to lithium-unresponsive BALB/cJ mice.  In VHIPP, C57BL/6J mice also show differences in PDE11A4 compartmentalization relative to BALB/cJ mice.  In contrast, neither PDE2A nor PDE10A expression differ among the strains.  The compartment-specific differences in PDE11A4 protein expression are explained by a coding single-nucleotide polymorphism (SNP) at amino acid 499, which falls within the GAF-B homodimerization domain.  Relative to the BALB/cJ 499T, the C57BL/6J 499A decreases PDE11A4 homodimerization, which removes PDE11A4 from the membrane.  Consistent with the observation that lower PDE11A4 expression correlates with better lithium responsiveness, we found that Pde11a knockout mice (KO) given 0.4% lithium chow for 3+ weeks exhibit greater lithium responsivity relative to wild-type (WT) littermates in tail suspension, an antidepressant-predictive assay, and amphetamine hyperlocomotion, an anti-manic predictive assay.  Reduced PDE11A4 expression may represent a lithium-sensitive pathophysiol., because both C57BL/6J and Pde11a KO mice show increased expression of the pro-inflammatory cytokine interleukin-6 (IL-6) relative to BALB/cJ and PDE11A WT mice, resp.  Our finding that PDE11A4 neg. regulates lithium responsivity in mice suggests that the PDE11A SNPs identified in patients may be functionally relevant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBXAGJmh3H97Vg90H21EOLACvtfcHk0ljqtnYNP2oJCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFenu7bM&md5=2641fddb991559003159ef79b0284c27</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1038%2Fmp.2016.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2016.155%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DG.%26aulast%3DAgostino%26aufirst%3DM.%2BJ.%26aulast%3DBishara%26aufirst%3DK.%26aulast%3DCapell%26aufirst%3DW.%2BR.%26aulast%3DFisher%26aufirst%3DJ.%2BL.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DB.%2BA.%26aulast%3DPilarzyk%26aufirst%3DK.%26aulast%3DSabin%26aufirst%3DC.%26aulast%3DTuczkewycz%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DPDE11A%2520negatively%2520regulates%2520lithium%2520responsivity%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D1714%26epage%3D1724%26doi%3D10.1038%2Fmp.2016.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref216"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref216'); return false;" data-citation="" class="refNumLink">216</a></strong><div class="NLM_citation" id="cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ceyhan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birsoy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, C. S.</span></span> <span> </span><span class="NLM_article-title">Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.chembiol.2011.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22284362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ggt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=155-163&author=O.+Ceyhanauthor=K.+Birsoyauthor=C.+S.+Hoffman&title=Identification+of+biologically+active+PDE11-selective+inhibitors+using+a+yeast-based+high-throughput+screen&doi=10.1016%2Fj.chembiol.2011.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Biologically Active PDE11-Selective Inhibitors Using a Yeast-Based High-Throughput Screen</span></div><div class="casAuthors">Ceyhan, Ozge; Birsoy, Kivanc; Hoffman, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The biol. roles of cyclic nucleotide phosphodiesterase 11 (PDE11) enzymes are poorly understood, in part due to the lack of selective inhibitors.  To address the need for such compds., we completed an ∼200,000 compd. high-throughput screen (HTS) for PDE11 inhibitors using a yeast-based growth assay, and identified 4 potent and selective PDE11 inhibitors.  One compd., along with two structural analogs, elevates cAMP and cortisol levels in human adrenocortical cells, consistent with gene assocn. studies that link PDE11 activity to adrenal function.  As such, these compds. can immediately serve as chem. tools to study PDE11 function in cell culture, and as leads to develop therapeutics for the treatment of adrenal insufficiencies.  Our results further validate this yeast-based HTS platform for the discovery of potent, selective, and biol. active PDE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosoLwWtx7yMbVg90H21EOLACvtfcHk0lhOmffBO5BxOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ggt7w%253D&md5=6aa6eb3c95290e8991a83a0cfe989789</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DCeyhan%26aufirst%3DO.%26aulast%3DBirsoy%26aufirst%3DK.%26aulast%3DHoffman%26aufirst%3DC.%2BS.%26atitle%3DIdentification%2520of%2520biologically%2520active%2520PDE11-selective%2520inhibitors%2520using%2520a%2520yeast-based%2520high-throughput%2520screen%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D155%26epage%3D163%26doi%3D10.1016%2Fj.chembiol.2011.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180'],'ref181':['cit181'],'ref182':['cit182'],'ref183':['cit183'],'ref184':['cit184'],'ref185':['cit185'],'ref186':['cit186'],'ref187':['cit187'],'ref188':['cit188'],'ref189':['cit189'],'ref190':['cit190'],'ref191':['cit191'],'ref192':['cit192'],'ref193':['cit193'],'ref194':['cit194'],'ref195':['cit195'],'ref196':['cit196'],'ref197':['cit197'],'ref198':['cit198'],'ref199':['cit199'],'ref200':['cit200'],'ref201':['cit201'],'ref202':['cit202'],'ref203':['cit203'],'ref204':['cit204'],'ref205':['cit205'],'ref206':['cit206'],'ref207':['cit207'],'ref208':['cit208'],'ref209':['cit209'],'ref210':['cit210'],'ref211':['cit211'],'ref212':['cit212'],'ref213':['cit213'],'ref214':['cit214'],'ref215':['cit215'],'ref216':['cit216']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Members of PDE superfamily.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0018.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Specific Hydrolysis of cAMP or cGMP by Different PDEs</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Diversity of domain organization of PDE4 isoforms. LR1/2, linker region 1/2; UCR1/2, upstream conserved region 1/2; PKA-P, protein kinase A-phosphorylation site; ERK-P, extracellular regulated protein kinases-phosphorylation site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Regulatory functions of PDE4 inhibition in the heart, CNS, and immune system. GPCR, G protein-coupled receptor; Gs, stimulatory G protein; Gi, inhibitory G protein; sAc, soluble adenylyl cyclases; tAc, transmembrane adenylyl cyclases; ATP, adenosine triphosphate; cAMP, cyclic adenosine 3′,5′-monophosphate; 5′AMP, adenosine 5′-monophosphate; CNG, cyclic nucleotide-gated channel; PKA, protein kinase A; EPAC, exchange protein directly activated by cAMP; AKAPs, A-kinase anchor proteins; ABI, acute brain injury.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Representative PDE4 inhibitors and <sup>11</sup>C/<sup>18</sup>F labeled PET radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Selected PDE7-targeted therapeutic agents and PET radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Chemical structure of PF-04957325, a PDE8-selective inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Implications of mammalian PDE5 in various pathologies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Cyclic nucleotide signaling cascades leading to smooth muscle relaxation, cardioprotection, and neuroprotection. PDE5Is, PDE5 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Representative PDE5 inhibitors and PET radioligands.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Role of PDE6 in rod outer segments. GTP, Guanosine triphosphate; GCs, guanylyl cyclases; GCAP, GC activating proteins; CNGC, cyclic nucleotide gated channel; 5′GMP, guanosine-5′-monophosphate; GTP, guanosine triphosphate.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Representative PDE9-selective inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. Selected PDE1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. Selected PDE2 inhibitors and radiotracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. Selected PDE3 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. Signaling pathways of PDE10 inhibitors for various diseases.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig16" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Figure 16</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0016.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 16. Selected PDE10 inhibitors and radiotracers.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig16"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig17" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 17</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/medium/jm1c00115_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0017.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 17. Selected PDE11 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-11/acs.jmedchem.1c00115/20210602/images/large/jm1c00115_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00115&amp;id=fig17"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i51">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78416" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78416" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 216 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tejeda, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Therapeutic targeting of 3′,5′-cyclic nucleotide phosphodiesterases: inhibition and beyond</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">770</span>– <span class="NLM_lpage">796</span>, <span class="refDoi"> DOI: 10.1038/s41573-019-0033-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fs41573-019-0033-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31388135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2019&pages=770-796&author=G.+S.+Baillieauthor=G.+S.+Tejedaauthor=M.+P.+Kelly&title=Therapeutic+targeting+of+3%E2%80%B2%2C5%E2%80%B2-cyclic+nucleotide+phosphodiesterases%3A+inhibition+and+beyond&doi=10.1038%2Fs41573-019-0033-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of 3',5'-cyclic nucleotide phosphodiesterases: inhibition and beyond</span></div><div class="casAuthors">Baillie, George S.; Tejeda, Gonzalo S.; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">770-796</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs), enzymes that degrade 3',5'-cyclic nucleotides, are being pursued as therapeutic targets for several diseases, including those affecting the nervous system, the cardiovascular system, fertility, immunity, cancer and metab.  Clin. development programs have focused exclusively on catalytic inhibition, which continues to be a strong focus of ongoing drug discovery efforts.  However, emerging evidence supports novel strategies to therapeutically target PDE function, including enhancing catalytic activity, normalizing altered compartmentalization and modulating post-translational modifications, as well as the potential use of PDEs as disease biomarkers.  Importantly, a more refined appreciation of the intramol. mechanisms regulating PDE function and trafficking is emerging, making these pioneering drug discovery efforts tractable.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_NtRRCDdas7Vg90H21EOLACvtfcHk0lj6nSsHe86Q7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhsFamtLfF&md5=f8a348c9c9e534227d60e4f635d90b25</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fs41573-019-0033-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41573-019-0033-4%26sid%3Dliteratum%253Aachs%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26aulast%3DTejeda%26aufirst%3DG.%2BS.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DTherapeutic%2520targeting%2520of%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-cyclic%2520nucleotide%2520phosphodiesterases%253A%2520inhibition%2520and%2520beyond%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2019%26volume%3D18%26spage%3D770%26epage%3D796%26doi%3D10.1038%2Fs41573-019-0033-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischmeister, R.</span></span> <span> </span><span class="NLM_article-title">Inhibit a phosphodiesterase to treat heart failure?</span>. <i>Circulation</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">2003</span>– <span class="NLM_lpage">2006</span>, <span class="refDoi"> DOI: 10.1161/CIRCULATIONAHA.118.036325</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1161%2FCIRCULATIONAHA.118.036325" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30372138" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB3cvksVWisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2018&pages=2003-2006&author=J.+Leroyauthor=R.+Fischmeister&title=Inhibit+a+phosphodiesterase+to+treat+heart+failure%3F&doi=10.1161%2FCIRCULATIONAHA.118.036325"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibit a Phosphodiesterase to Treat Heart Failure?</span></div><div class="casAuthors">Leroy Jerome; Fischmeister Rodolphe</div><div class="citationInfo"><span class="NLM_cas:title">Circulation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">2003-2006</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ9M1qVxLqW-BOk4JA3soTqfW6udTcc2eY2xHgtIWtOlLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cvksVWisQ%253D%253D&md5=63cd12330d19e4bf9b1df1ea5d29af91</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1161%2FCIRCULATIONAHA.118.036325&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FCIRCULATIONAHA.118.036325%26sid%3Dliteratum%253Aachs%26aulast%3DLeroy%26aufirst%3DJ.%26aulast%3DFischmeister%26aufirst%3DR.%26atitle%3DInhibit%2520a%2520phosphodiesterase%2520to%2520treat%2520heart%2520failure%253F%26jtitle%3DCirculation%26date%3D2018%26volume%3D138%26spage%3D2003%26epage%3D2006%26doi%3D10.1161%2FCIRCULATIONAHA.118.036325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, D. C.</span></span> <span> </span><span class="NLM_article-title">A role for phosphodiesterase type-4 inhibitors in COPD?</span>. <i>Lancet</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>358</i></span>,  <span class="NLM_fpage">256</span>– <span class="NLM_lpage">257</span>, <span class="refDoi"> DOI: 10.1016/S0140-6736(01)05493-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0140-6736%2801%2905493-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11498207" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BD3MvltFanug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=256-257&author=D.+C.+Johnson&title=A+role+for+phosphodiesterase+type-4+inhibitors+in+COPD%3F&doi=10.1016%2FS0140-6736%2801%2905493-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">A role for phosphodiesterase type-4 inhibitors in COPD?</span></div><div class="casAuthors">Johnson D C</div><div class="citationInfo"><span class="NLM_cas:title">Lancet (London, England)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">358</span>
        (<span class="NLM_cas:issue">9278</span>),
    <span class="NLM_cas:pages">256-7</span>
        ISSN:<span class="NLM_cas:issn">0140-6736</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTlTNSxBj3s9LxanA7vODO6fW6udTcc2eYxJQOC-hzhHrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD3MvltFanug%253D%253D&md5=5c80c4594db751082ff6a7d3393dc628</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0140-6736%2801%2905493-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0140-6736%252801%252905493-9%26sid%3Dliteratum%253Aachs%26aulast%3DJohnson%26aufirst%3DD.%2BC.%26atitle%3DA%2520role%2520for%2520phosphodiesterase%2520type-4%2520inhibitors%2520in%2520COPD%253F%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D256%26epage%3D257%26doi%3D10.1016%2FS0140-6736%2801%2905493-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cho, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamdani, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holewinski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jo, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Danner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rainer, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedja, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kirk, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranek, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dostmann, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Margulies, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Eyk, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulus, W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takimoto, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kass, D. A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>519</i></span>,  <span class="NLM_fpage">472</span>– <span class="NLM_lpage">476</span>, <span class="refDoi"> DOI: 10.1038/nature14332</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnature14332" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25799991" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXltVSisLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=519&publication_year=2015&pages=472-476&author=D.+I.+Leeauthor=G.+Zhuauthor=T.+Sasakiauthor=G.+S.+Choauthor=N.+Hamdaniauthor=R.+Holewinskiauthor=S.+H.+Joauthor=T.+Dannerauthor=M.+Zhangauthor=P.+P.+Rainerauthor=D.+Bedjaauthor=J.+A.+Kirkauthor=M.+J.+Ranekauthor=W.+R.+Dostmannauthor=C.+Kwonauthor=K.+B.+Marguliesauthor=J.+E.+Van+Eykauthor=W.+J.+Paulusauthor=E.+Takimotoauthor=D.+A.+Kass&title=Phosphodiesterase+9A+controls+nitric-oxide-independent+cGMP+and+hypertrophic+heart+disease&doi=10.1038%2Fnature14332"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease</span></div><div class="casAuthors">Lee, Dong I.; Zhu, Guangshuo; Sasaki, Takashi; Cho, Gun-Sik; Hamdani, Nazha; Holewinski, Ronald; Jo, Su-Hyun; Danner, Thomas; Zhang, Manling; Rainer, Peter P.; Bedja, Djahida; Kirk, Jonathan A.; Ranek, Mark J.; Dostmann, Wolfgang R.; Kwon, Chulan; Margulies, Kenneth B.; Van Eyk, Jennifer E.; Paulus, Walter J.; Takimoto, Eiki; Kass, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">519</span>
        (<span class="NLM_cas:issue">7544</span>),
    <span class="NLM_cas:pages">472-476</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Cyclic guanosine monophosphate (cGMP) is a second messenger mol. that transduces nitric-oxide- and natriuretic-peptide-coupled signalling, stimulating phosphorylation changes by protein kinase G.  Enhancing cGMP synthesis or blocking its degrdn. by phosphodiesterase type 5A (PDE5A) protects against cardiovascular disease.  However, cGMP stimulation alone is limited by counter-adaptions including PDE upregulation.  Furthermore, although PDE5A regulates nitric-oxide-generated cGMP, nitric oxide signalling is often depressed by heart disease.  PDEs controlling natriuretic-peptide-coupled cGMP remain uncertain.  Here we show that cGMP-selective PDE9A (refs 7, 8) is expressed in the mammalian heart, including humans, and is upregulated by hypertrophy and cardiac failure.  PDE9A regulates natriuretic-peptide- rather than nitric-oxide-stimulated cGMP in heart myocytes and muscle, and its genetic or selective pharmacol. inhibition protects against pathol. responses to neurohormones, and sustained pressure-overload stress.  PDE9A inhibition reverses pre-established heart disease independent of nitric oxide synthase (NOS) activity, whereas PDE5A inhibition requires active NOS.  Transcription factor activation and phosphoproteome analyses of myocytes with each PDE selectively inhibited reveals substantial differential targeting, with phosphorylation changes from PDE5A inhibition being more sensitive to NOS activation.  Thus, unlike PDE5A, PDE9A can regulate cGMP signalling independent of the nitric oxide pathway, and its role in stress-induced heart disease suggests potential as a therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoJLKvnCmv1obVg90H21EOLACvtfcHk0liE0dvH-_qFHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXltVSisLs%253D&md5=4019165bfaa00428341ce4c64908dc6e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1038%2Fnature14332&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature14332%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DD.%2BI.%26aulast%3DZhu%26aufirst%3DG.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DCho%26aufirst%3DG.%2BS.%26aulast%3DHamdani%26aufirst%3DN.%26aulast%3DHolewinski%26aufirst%3DR.%26aulast%3DJo%26aufirst%3DS.%2BH.%26aulast%3DDanner%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DRainer%26aufirst%3DP.%2BP.%26aulast%3DBedja%26aufirst%3DD.%26aulast%3DKirk%26aufirst%3DJ.%2BA.%26aulast%3DRanek%26aufirst%3DM.%2BJ.%26aulast%3DDostmann%26aufirst%3DW.%2BR.%26aulast%3DKwon%26aufirst%3DC.%26aulast%3DMargulies%26aufirst%3DK.%2BB.%26aulast%3DVan%2BEyk%26aufirst%3DJ.%2BE.%26aulast%3DPaulus%26aufirst%3DW.%2BJ.%26aulast%3DTakimoto%26aufirst%3DE.%26aulast%3DKass%26aufirst%3DD.%2BA.%26atitle%3DPhosphodiesterase%25209A%2520controls%2520nitric-oxide-independent%2520cGMP%2520and%2520hypertrophic%2520heart%2520disease%26jtitle%3DNature%26date%3D2015%26volume%3D519%26spage%3D472%26epage%3D476%26doi%3D10.1038%2Fnature14332" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chung, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V. C.</span></span> <span> </span><span class="NLM_article-title">Advances in targeting cyclic nucleotide phosphodiesterases</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">290</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1038/nrd4228</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnrd4228" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24687066" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=290-314&author=D.+H.+Mauriceauthor=H.+Keauthor=F.+Ahmadauthor=Y.+Wangauthor=J.+Chungauthor=V.+C.+Manganiello&title=Advances+in+targeting+cyclic+nucleotide+phosphodiesterases&doi=10.1038%2Fnrd4228"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Advances in targeting cyclic nucleotide phosphodiesterases</span></div><div class="casAuthors">Maurice, Donald H.; Ke, Hengming; Ahmad, Faiyaz; Wang, Yousheng; Chung, Jay; Manganiello, Vincent C.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">290-314</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) catalyze the hydrolysis of cAMP and cyclic GMP, thereby regulating the intracellular concns. of these cyclic nucleotides, their signalling pathways and, consequently, myriad biol. responses in health and disease.  Currently, a small no. of PDE inhibitors are used clin. for treating the pathophysiol. dysregulation of cyclic nucleotide signalling in several disorders, including erectile dysfunction, pulmonary hypertension, acute refractory cardiac failure, intermittent claudication and chronic obstructive pulmonary disease.  However, pharmaceutical interest in PDEs has been reignited by the increasing understanding of the roles of individual PDEs in regulating the subcellular compartmentalization of specific cyclic nucleotide signalling pathways, by the structure-based design of novel specific inhibitors and by the development of more sophisticated strategies to target individual PDE variants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrwMRfUs-zUmLVg90H21EOLACvtfcHk0liE0dvH-_qFHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXltFOiu7s%253D&md5=410c8d5bb5fbd7d2906e30dc1b5f2876</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1038%2Fnrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4228%26sid%3Dliteratum%253Aachs%26aulast%3DMaurice%26aufirst%3DD.%2BH.%26aulast%3DKe%26aufirst%3DH.%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DChung%26aufirst%3DJ.%26aulast%3DManganiello%26aufirst%3DV.%2BC.%26atitle%3DAdvances%2520in%2520targeting%2520cyclic%2520nucleotide%2520phosphodiesterases%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D290%26epage%3D314%26doi%3D10.1038%2Fnrd4228" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattani-Cavalieri, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Musheshe, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolaev, V. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterases as therapeutic targets for respiratory diseases</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>197</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">242</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2019.02.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.pharmthera.2019.02.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30759374" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtFOluro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=197&publication_year=2019&pages=225-242&author=H.+Zuoauthor=I.+Cattani-Cavalieriauthor=N.+Mushesheauthor=V.+O.+Nikolaevauthor=M.+Schmidt&title=Phosphodiesterases+as+therapeutic+targets+for+respiratory+diseases&doi=10.1016%2Fj.pharmthera.2019.02.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterases as therapeutic targets for respiratory diseases</span></div><div class="casAuthors">Zuo, Haoxiao; Cattani-Cavalieri, Isabella; Musheshe, Nshunge; Nikolaev, Viacheslav O.; Schmidt, Martina</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">197</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">225-242</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic respiratory diseases, such as chronic obstructive pulmonary disease (COPD) and asthma, affect millions of people all over the world.  Cyclic adenosine monophosphate (cAMP) which is one of the most important second messengers, plays a vital role in relaxing airway smooth muscles and suppressing inflammation.  Given its vast role in regulating intracellular responses, cAMP provides an attractive pharmaceutical target in the treatment of chronic respiratory diseases.  Phosphodiesterases (PDEs) are enzymes that hydrolyze cyclic nucleotides and help control cyclic nucleotide signals in a compartmentalized manner.  Currently, the selective PDE4 inhibitor, roflumilast, is used as an add-on treatment for patients with severe COPD assocd. with bronchitis and a history of frequent exacerbations.  In addn., other novel PDE inhibitors are in different phases of clin. trials.  The current review provides an overview of the regulation of various PDEs and the potential application of selective PDE inhibitors in the treatment of COPD and asthma.  The possibility to combine various PDE inhibitors as a way to increase their therapeutic effectiveness is also emphasized.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkpdsY4rhBkrVg90H21EOLACvtfcHk0lhJsKgVvUGgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtFOluro%253D&md5=a3b369d72b3fb0db1a04ba5bb03950f5</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2019.02.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2019.02.002%26sid%3Dliteratum%253Aachs%26aulast%3DZuo%26aufirst%3DH.%26aulast%3DCattani-Cavalieri%26aufirst%3DI.%26aulast%3DMusheshe%26aufirst%3DN.%26aulast%3DNikolaev%26aufirst%3DV.%2BO.%26aulast%3DSchmidt%26aufirst%3DM.%26atitle%3DPhosphodiesterases%2520as%2520therapeutic%2520targets%2520for%2520respiratory%2520diseases%26jtitle%3DPharmacol.%2520Ther.%26date%3D2019%26volume%3D197%26spage%3D225%26epage%3D242%26doi%3D10.1016%2Fj.pharmthera.2019.02.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talarek, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Listos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabavi, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devi, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberto de Oliveira, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tewari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arguelles, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehrzadi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hosseinzadeh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Onofrio, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orhan, I. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sureda, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Momtaz, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farzaei, M. H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors say NO to Alzheimer’s disease</span>. <i>Food Chem. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>134</i></span>,  <span class="NLM_fpage">110822</span>, <span class="refDoi"> DOI: 10.1016/j.fct.2019.110822</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.fct.2019.110822" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31536753" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvVSrt7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=134&publication_year=2019&pages=110822&author=S.+M.+Nabaviauthor=S.+Talarekauthor=J.+Listosauthor=S.+F.+Nabaviauthor=K.+P.+Deviauthor=M.+Roberto+de+Oliveiraauthor=D.+Tewariauthor=S.+Arguellesauthor=S.+Mehrzadiauthor=A.+Hosseinzadehauthor=G.+D%E2%80%99Onofrioauthor=I.+E.+Orhanauthor=A.+Suredaauthor=S.+Xuauthor=S.+Momtazauthor=M.+H.+Farzaei&title=Phosphodiesterase+inhibitors+say+NO+to+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.fct.2019.110822"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors say NO to Alzheimer's disease</span></div><div class="casAuthors">Nabavi, Seyed Mohammad; Talarek, Sylwia; Listos, Joanna; Nabavi, Seyed Fazel; Devi, Kasi Pandima; Roberto de Oliveira, Marcos; Tewari, Devesh; Arguelles, Sandro; Mehrzadi, Saeed; Hosseinzadeh, Azam; D'onofrio, Grazia; Orhan, Ilkay Erdogan; Sureda, Antoni; Xu, Suowen; Momtaz, Saeedeh; Farzaei, Mohammad Hosein</div><div class="citationInfo"><span class="NLM_cas:title">Food and Chemical Toxicology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">134</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">110822</span>CODEN:
                <span class="NLM_cas:coden">FCTOD7</span>;
        ISSN:<span class="NLM_cas:issn">0278-6915</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs) consisted of 11 subtypes (PDE1 to PDE11) and over 40 isoforms that regulate levels of cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP), the second messengers in cell functions.  PDE inhibitors (PDEIs) have been attractive therapeutic targets due to their involvement in diverse medical conditions, e.g. cardiovascular diseases, autoimmune diseases, Alzheimer's disease (AD), etc.  Among them; AD with a complex pathol. is a progressive neurodegenerative disorder which affect mostly senile people in the world and only symptomatic treatment particularly using cholinesterase inhibitors in clinic is available at the moment for AD.  Consequently, novel treatment strategies towards AD are still searched extensively.  Since PDEs are broadly expressed in the brain, PDEIs are considered to modulate neurodegenerative conditions through regulating cAMP and cGMP in the brain.  In this sense, several synthetic or natural mols. inhibiting various PDE subtypes such as rolipram and roflumilast (PDE4 inhibitors), vinpocetine (PDE1 inhibitor), cilostazol and milrinone (PDE3 inhibitors), sildenafil and tadalafil (PDE5 inhibitors), etc have been reported showing encouraging results for the treatment of AD.  In this review, PDE superfamily will be scrutinized from the view point of structural features, isoforms, functions and pharmacol. particularly attributed to PDEs as target for AD therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot-owBa4CnKLVg90H21EOLACvtfcHk0lhJsKgVvUGgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvVSrt7vF&md5=babbb6149407a717ebd80b2d2c841021</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.fct.2019.110822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.fct.2019.110822%26sid%3Dliteratum%253Aachs%26aulast%3DNabavi%26aufirst%3DS.%2BM.%26aulast%3DTalarek%26aufirst%3DS.%26aulast%3DListos%26aufirst%3DJ.%26aulast%3DNabavi%26aufirst%3DS.%2BF.%26aulast%3DDevi%26aufirst%3DK.%2BP.%26aulast%3DRoberto%2Bde%2BOliveira%26aufirst%3DM.%26aulast%3DTewari%26aufirst%3DD.%26aulast%3DArguelles%26aufirst%3DS.%26aulast%3DMehrzadi%26aufirst%3DS.%26aulast%3DHosseinzadeh%26aufirst%3DA.%26aulast%3DD%25E2%2580%2599Onofrio%26aufirst%3DG.%26aulast%3DOrhan%26aufirst%3DI.%2BE.%26aulast%3DSureda%26aufirst%3DA.%26aulast%3DXu%26aufirst%3DS.%26aulast%3DMomtaz%26aufirst%3DS.%26aulast%3DFarzaei%26aufirst%3DM.%2BH.%26atitle%3DPhosphodiesterase%2520inhibitors%2520say%2520NO%2520to%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DFood%2520Chem.%2520Toxicol.%26date%3D2019%26volume%3D134%26spage%3D110822%26doi%3D10.1016%2Fj.fct.2019.110822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yasmeen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akram, B. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hainsworth, A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kruuse, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">108</span>– <span class="NLM_lpage">119</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2019.05.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.cellsig.2019.05.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31132399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtFyks7bN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2019&pages=108-119&author=S.+Yasmeenauthor=B.+H.+Akramauthor=A.+H.+Hainsworthauthor=C.+Kruuse&title=Cyclic+nucleotide+phosphodiesterases+%28PDEs%29+and+endothelial+function+in+ischaemic+stroke.+A+review&doi=10.1016%2Fj.cellsig.2019.05.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterases (PDEs) and endothelial function in ischaemic stroke. A review</span></div><div class="casAuthors">Yasmeen, Saiqa; Akram, Bilal Hussain; Hainsworth, Atticus H.; Kruuse, Christina</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108-119</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Endothelial dysfunction is a hallmark of cerebrovascular disease, including ischemic stroke.  Modulating endothelial signaling by cyclic nucleotides, cAMP and cGMP, is a potential therapeutic target in stroke.  Inhibitors of the cyclic nucleotide degrading phosphodiesterase (PDE) enzymes may restore cerebral endothelial function.  Current knowledge on PDE distribution and function in cerebral endothelial cells is sparse.  This review explores data on PDE distribution and effects of PDEi in cerebral endothelial cells and identifies which PDEs are potential treatment targets in stroke.  We performed a systematic search of electronic databases (Medline and Embase).  Our search terms were cerebral ischemia, cerebral endothelial cells, cyclic nucleotide, phosphodiesterase and phosphodiesterase inhibitors.  We found 23 publications which described effects of selective inhibitors of only three PDE families on endothelial function in ischemic stroke.  PDE3 inhibitors (PDE3i) (11 publications) and PDE4 inhibitors (PDE4i) (3 publications) showed anti-inflammatory, anti-apoptotic or pro-angiogenic effects.  PDE3i also reduced leukocyte infiltration and MMP-9 expression.  Both PDE3i and PDE4i increased expression of tight junction proteins and protected the blood-brain barrier.  PDE5 inhibitors (PDE5i) (6 publications) reduced inflammation and apoptosis.  In preclin. models, PDE5i enhanced cGMP/NO signaling assocd. with microvascular angiogenesis, increased cerebral blood flow and improved functional recovery.  Non-specific PDEi (3 publications) had mainly anti-inflammatory effects.  This review demonstrates that non-selective and selective PDEi of PDE3, PDE4 and PDE5 modulated endothelial function in cerebral ischemic stroke by regulating processes involved in vascular repair and neuroprotection and thus reduced cell death and inflammation.  Of note, they promoted angiogenesis, microcirculation and improved functional recovery; all are important in stroke prevention and recovery, and effects should be further evaluated in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpGlsLgpMrtpLVg90H21EOLACvtfcHk0lhJsKgVvUGgkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtFyks7bN&md5=d7208b826005ce443afb323e7ae69411</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2019.05.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2019.05.011%26sid%3Dliteratum%253Aachs%26aulast%3DYasmeen%26aufirst%3DS.%26aulast%3DAkram%26aufirst%3DB.%2BH.%26aulast%3DHainsworth%26aufirst%3DA.%2BH.%26aulast%3DKruuse%26aufirst%3DC.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%2520%2528PDEs%2529%2520and%2520endothelial%2520function%2520in%2520ischaemic%2520stroke.%2520A%2520review%26jtitle%3DCell.%2520Signalling%26date%3D2019%26volume%3D61%26spage%3D108%26epage%3D119%26doi%3D10.1016%2Fj.cellsig.2019.05.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide signaling changes associated with normal aging and age related diseases of the brain</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">291</span>, <span class="refDoi"> DOI: 10.1016/j.cellsig.2017.11.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.cellsig.2017.11.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29175000" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCrsrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2018&pages=281-291&author=M.+P.+Kelly&title=Cyclic+nucleotide+signaling+changes+associated+with+normal+aging+and+age+related+diseases+of+the+brain&doi=10.1016%2Fj.cellsig.2017.11.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide signaling changes associated with normal aging and age-related diseases of the brain</span></div><div class="casAuthors">Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">281-291</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Deficits in brain function that are assocd. with aging and age-related diseases benefit very little from currently available therapies, suggesting a better understanding of the underlying mol. mechanisms is needed to develop improved drugs.  Here, we review the literature to test the hypothesis that a break down in cyclic nucleotide signaling at the level of synthesis, execution, and/or degrdn. may contribute to these deficits.  A no. of findings have been reported in both the human and animal model literature that point to brain region-specific changes in Galphas (a.k.a. Gαs or Gsα), adenylyl cyclase, 3',5'-adenosine monophosphate (cAMP) levels, protein kinase A (PKA), cAMP response element binding protein (CREB), exchange protein activated by cAMP (Epac), hyperpolarization-activated cyclic nucleotide-gated ion channels (HCNs), atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), sol. and particulate guanylyl cyclase, 3',5'-guanosine monophosphate (cGMP), protein kinase G (PKG) and phosphodiesterases (PDEs).  Among the most reproducible findings are 1) elevated circulating ANP and BNP levels being assocd. with cognitive dysfunction or dementia independent of cardiovascular effects, 2) reduced basal and/or NMDA-stimulated cGMP levels in brain with aging or Alzheimer's disease (AD), 3) reduced adenylyl cyclase activity in hippocampus and specific cortical regions with aging or AD, 4) reduced expression/activity of PKA in temporal cortex and hippocampus with AD, 5) reduced phosphorylation of CREB in hippocampus with aging or AD, 6) reduced expression/activity of the PDE4 family in brain with aging, 7) reduced expression of PDE10A in the striatum with Huntington's disease (HD) or Parkinson's disease, and 8) beneficial effects of select PDE inhibitors, particularly PDE10 inhibitors in HD models and PDE4 and PDE5 inhibitors in aging and AD models.  Although these findings generally point to a redn. in cyclic nucleotide signaling being assocd. with aging and age-related diseases, there are exceptions.  In particular, there is evidence for increased cAMP signaling specifically in aged prefrontal cortex, AD cerebral vessels, and PD hippocampus.  Thus, if cyclic nucleotide signaling is going to be targeted effectively for therapeutic gain, it will have to be manipulated in a brain region-specific manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2H-lcTfawMrVg90H21EOLACvtfcHk0lhVmLLWqTPKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCrsrbM&md5=b5ec812c24c12b4fcd1295ee6917bf11</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.cellsig.2017.11.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cellsig.2017.11.004%26sid%3Dliteratum%253Aachs%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DCyclic%2520nucleotide%2520signaling%2520changes%2520associated%2520with%2520normal%2520aging%2520and%2520age%2520related%2520diseases%2520of%2520the%2520brain%26jtitle%3DCell.%2520Signalling%26date%3D2018%26volume%3D42%26spage%3D281%26epage%3D291%26doi%3D10.1016%2Fj.cellsig.2017.11.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peng, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tong, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of phosphodiesterase as cancer therapeutics</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>150</i></span>,  <span class="NLM_fpage">742</span>– <span class="NLM_lpage">756</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2018.03.046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejmech.2018.03.046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29574203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXlvVOmsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=150&publication_year=2018&pages=742-756&author=T.+Pengauthor=J.+Gongauthor=Y.+Jinauthor=Y.+Zhouauthor=R.+Tongauthor=X.+Weiauthor=L.+Baiauthor=J.+Shi&title=Inhibitors+of+phosphodiesterase+as+cancer+therapeutics&doi=10.1016%2Fj.ejmech.2018.03.046"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitors of phosphodiesterase as cancer therapeutics</span></div><div class="casAuthors">Peng, Ting; Gong, Jun; Jin, Yongzhe; Zhou, Yanping; Tong, Rongsheng; Wei, Xin; Bai, Lan; Shi, Jianyou</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">150</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">742-756</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are a class of enzymes that hydrolyze cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) which is involved in many physiol. processes including visual transduction, cell proliferation and differentiation, cell-cycle regulation, gene expression, inflammation, apoptosis, and metabolic function.  PDEs are composed of 11 different families and each family contains different subtypes.  The distribution, expression, regulation mode and sensitivity to inhibitors of each subtype are different, and they are involved in cancer, inflammation, asthma, depression, erectile dysfunction and other pathol. processes of development.  A large no. of studies have shown that PDEs play an important role in the development of tumors by affecting the intracellular level of cAMP and/or cGMP and PDEs could become diagnostic markers or therapeutic targets.  This review will give a brief overview of the expression and regulation of PDE families in the process of tumorigenesis and their anti-tumor inhibitors, which may guide the design of novel therapeutic drugs targeting PDEs for anticancer agent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrup-LedN_wNbVg90H21EOLACvtfcHk0lhVmLLWqTPKIQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXlvVOmsb4%253D&md5=444c1f6a9a183a97749241eb2f00d6b3</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2018.03.046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2018.03.046%26sid%3Dliteratum%253Aachs%26aulast%3DPeng%26aufirst%3DT.%26aulast%3DGong%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DTong%26aufirst%3DR.%26aulast%3DWei%26aufirst%3DX.%26aulast%3DBai%26aufirst%3DL.%26aulast%3DShi%26aufirst%3DJ.%26atitle%3DInhibitors%2520of%2520phosphodiesterase%2520as%2520cancer%2520therapeutics%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D150%26spage%3D742%26epage%3D756%26doi%3D10.1016%2Fj.ejmech.2018.03.046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degerman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maurice, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manganiello, V.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterases: important signaling modulators and therapeutic targets</span>. <i>Oral Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">e25</span>– <span class="NLM_lpage">e30</span>, <span class="refDoi"> DOI: 10.1111/odi.12275</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fodi.12275" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25056711" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2015&pages=e25-e30&author=F.+Ahmadauthor=T.+Murataauthor=K.+Shimizuauthor=E.+Degermanauthor=D.+Mauriceauthor=V.+Manganiello&title=Cyclic+nucleotide+phosphodiesterases%3A+important+signaling+modulators+and+therapeutic+targets&doi=10.1111%2Fodi.12275"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1111%2Fodi.12275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fodi.12275%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DF.%26aulast%3DMurata%26aufirst%3DT.%26aulast%3DShimizu%26aufirst%3DK.%26aulast%3DDegerman%26aufirst%3DE.%26aulast%3DMaurice%26aufirst%3DD.%26aulast%3DManganiello%26aufirst%3DV.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterases%253A%2520important%2520signaling%2520modulators%2520and%2520therapeutic%2520targets%26jtitle%3DOral%2520Dis.%26date%3D2015%26volume%3D21%26spage%3De25%26epage%3De30%26doi%3D10.1111%2Fodi.12275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Keravis, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lugnier, C.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>165</i></span>,  <span class="NLM_fpage">1288</span>– <span class="NLM_lpage">1305</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2011.01729.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fj.1476-5381.2011.01729.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22014080" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=165&publication_year=2012&pages=1288-1305&author=T.+Keravisauthor=C.+Lugnier&title=Cyclic+nucleotide+phosphodiesterase+%28PDE%29+isozymes+as+targets+of+the+intracellular+signalling+network%3A+benefits+of+PDE+inhibitors+in+various+diseases+and+perspectives+for+future+therapeutic+developments&doi=10.1111%2Fj.1476-5381.2011.01729.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterase (PDE) isozymes as targets of the intracellular signalling network: benefits of PDE inhibitors in various diseases and perspectives for future therapeutic developments</span></div><div class="casAuthors">Keravis, Therese; Lugnier, Claire</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">165</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1288-1305</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Cyclic nucleotide phosphodiesterases (PDEs) that specifically inactivate the intracellular messengers cAMP and cGMP in a compartmentalized manner represent an important enzyme class constituted by 11 gene-related families of isoenzymes (PDE1 to PDE11).  Downstream receptors, PDEs play a major role in controlling the signalosome at various levels of phosphorylations and protein/protein interactions.  Due to the multiplicity of isoenzymes, their various intracellular regulations and their different cellular and subcellular distributions, PDEs represent interesting targets in intracellular pathways.  Therefore, the investigation of PDE isoenzyme alterations related to various pathologies and the design of specific PDE inhibitors might lead to the development of new specific therapeutic strategies in numerous pathologies.  This manuscript (i) overviews the different PDEs including their endogenous regulations and their specific inhibitors; (ii) analyses the intracellular implications of PDEs in regulating signalling cascades in pathogenesis, exemplified by two diseases affecting cell cycle and proliferation; and (iii) discusses perspectives for future therapeutic developments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvr2jfPTxnY7Vg90H21EOLACvtfcHk0ljKY5DUg00k0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xis1Ohtb8%253D&md5=dbf5913bc6c973d0640258c51b7c481d</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2011.01729.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2011.01729.x%26sid%3Dliteratum%253Aachs%26aulast%3DKeravis%26aufirst%3DT.%26aulast%3DLugnier%26aufirst%3DC.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterase%2520%2528PDE%2529%2520isozymes%2520as%2520targets%2520of%2520the%2520intracellular%2520signalling%2520network%253A%2520benefits%2520of%2520PDE%2520inhibitors%2520in%2520various%2520diseases%2520and%2520perspectives%2520for%2520future%2520therapeutic%2520developments%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2012%26volume%3D165%26spage%3D1288%26epage%3D1305%26doi%3D10.1111%2Fj.1476-5381.2011.01729.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Francis, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blount, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corbin, J. D.</span></span> <span> </span><span class="NLM_article-title">Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions</span>. <i>Physiol. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">690</span>, <span class="refDoi"> DOI: 10.1152/physrev.00030.2010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1152%2Fphysrev.00030.2010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21527734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2011&pages=651-690&author=S.+H.+Francisauthor=M.+A.+Blountauthor=J.+D.+Corbin&title=Mammalian+cyclic+nucleotide+phosphodiesterases%3A+molecular+mechanisms+and+physiological+functions&doi=10.1152%2Fphysrev.00030.2010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Mammalian cyclic nucleotide phosphodiesterases: molecular mechanisms and physiological functions</span></div><div class="casAuthors">Francis, Sharron H.; Blount, Mitsi A.; Corbin, Jackie D.</div><div class="citationInfo"><span class="NLM_cas:title">Physiological Reviews</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">651-690</span>CODEN:
                <span class="NLM_cas:coden">PHREA7</span>;
        ISSN:<span class="NLM_cas:issn">0031-9333</span>.
    
            (<span class="NLM_cas:orgname">American Physiological Society</span>)
        </div><div class="casAbstract">A review.  The superfamily of cyclic nucleotide (cN) phosphodiesterases (PDEs) is comprised of 11 families of enzymes.  PDEs break down cAMP and/or cGMP and are major determinants of cellular cN levels and, consequently, the actions of cN-signaling pathways.  PDEs exhibit a range of catalytic efficiencies for breakdown of cAMP and/or cGMP and are regulated by myriad processes including phosphorylation, cN binding to allosteric GAF domains, changes in expression levels, interaction with regulatory or anchoring proteins, and reversible translocation among subcellular compartments.  Selective PDE inhibitors are currently in clin. use for treatment of erectile dysfunction, pulmonary hypertension, intermittent claudication, and chronic pulmonary obstructive disease; many new inhibitors are being developed for treatment of these and other maladies.  Recently reported x-ray crystallog. structures have defined features that provide for specificity for cAMP or cGMP in PDE catalytic sites or their GAF domains, as well as mechanisms involved in catalysis, oligomerization, autoinhibition, and interactions with inhibitors.  In addn., major advances have been made in understanding the physiol. impact and the biochem. basis for selective localization and/or recruitment of specific PDE isoenzymes to particular subcellular compartments.  The many recent advances in understanding PDE structures, functions, and physiol. actions are discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrN99wWYsCXRbVg90H21EOLACvtfcHk0ljKY5DUg00k0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXns1Cms7o%253D&md5=4aae757704a6243c9aa2648c32d5c759</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1152%2Fphysrev.00030.2010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fphysrev.00030.2010%26sid%3Dliteratum%253Aachs%26aulast%3DFrancis%26aufirst%3DS.%2BH.%26aulast%3DBlount%26aufirst%3DM.%2BA.%26aulast%3DCorbin%26aufirst%3DJ.%2BD.%26atitle%3DMammalian%2520cyclic%2520nucleotide%2520phosphodiesterases%253A%2520molecular%2520mechanisms%2520and%2520physiological%2520functions%26jtitle%3DPhysiol.%2520Rev.%26date%3D2011%26volume%3D91%26spage%3D651%26epage%3D690%26doi%3D10.1152%2Fphysrev.00030.2010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gallamini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zwarthoed, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borra, A.</span></span> <span> </span><span class="NLM_article-title">Positron emission tomography (PET) in oncology</span>. <i>Cancers</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1821</span>– <span class="NLM_lpage">1889</span>, <span class="refDoi"> DOI: 10.3390/cancers6041821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fcancers6041821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25268160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2M7mtF2mtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2014&pages=1821-1889&author=A.+Gallaminiauthor=C.+Zwarthoedauthor=A.+Borra&title=Positron+emission+tomography+%28PET%29+in+oncology&doi=10.3390%2Fcancers6041821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Positron Emission Tomography (PET) in Oncology</span></div><div class="casAuthors">Gallamini Andrea; Zwarthoed Colette; Borra Anna</div><div class="citationInfo"><span class="NLM_cas:title">Cancers</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1821-89</span>
        ISSN:<span class="NLM_cas:issn">2072-6694</span>.
    </div><div class="casAbstract">Since its introduction in the early nineties as a promising functional imaging technique in the management of neoplastic disorders, FDG-PET, and subsequently FDG-PET/CT, has become a cornerstone in several oncologic procedures such as tumor staging and restaging, treatment efficacy assessment during or after treatment end and radiotherapy planning.  Moreover, the continuous technological progress of image generation and the introduction of sophisticated software to use PET scan as a biomarker paved the way to calculate new prognostic markers such as the metabolic tumor volume (MTV) and the total amount of tumor glycolysis (TLG).  FDG-PET/CT proved more sensitive than contrast-enhanced CT scan in staging of several type of lymphoma or in detecting widespread tumor dissemination in several solid cancers, such as breast, lung, colon, ovary and head and neck carcinoma.  As a consequence the stage of patients was upgraded, with a change of treatment in 10%-15% of them.  One of the most evident advantages of FDG-PET was its ability to detect, very early during treatment, significant changes in glucose metabolism or even complete shutoff of the neoplastic cell metabolism as a surrogate of tumor chemosensitivity assessment.  This could enable clinicians to detect much earlier the effectiveness of a given antineoplastic treatment, as compared to the traditional radiological detection of tumor shrinkage, which usually takes time and occurs much later.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQPOtR_mX3I6Uh5eUSa2oe_fW6udTcc2eYyonTqIWfFhLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M7mtF2mtQ%253D%253D&md5=6b04985394605f5fa9fd719f174541fe</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.3390%2Fcancers6041821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fcancers6041821%26sid%3Dliteratum%253Aachs%26aulast%3DGallamini%26aufirst%3DA.%26aulast%3DZwarthoed%26aufirst%3DC.%26aulast%3DBorra%26aufirst%3DA.%26atitle%3DPositron%2520emission%2520tomography%2520%2528PET%2529%2520in%2520oncology%26jtitle%3DCancers%26date%3D2014%26volume%3D6%26spage%3D1821%26epage%3D1889%26doi%3D10.3390%2Fcancers6041821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mier, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mier, D.</span></span> <span> </span><span class="NLM_article-title">Advantages in functional imaging of the brain</span>. <i>Front. Hum. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">9</span>, <span class="refDoi"> DOI: 10.3389/fnhum.2015.00249</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3389%2Ffnhum.2015.00249" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25667571" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2015&pages=9&author=W.+Mierauthor=D.+Mier&title=Advantages+in+functional+imaging+of+the+brain&doi=10.3389%2Ffnhum.2015.00249"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.3389%2Ffnhum.2015.00249&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnhum.2015.00249%26sid%3Dliteratum%253Aachs%26aulast%3DMier%26aufirst%3DW.%26aulast%3DMier%26aufirst%3DD.%26atitle%3DAdvantages%2520in%2520functional%2520imaging%2520of%2520the%2520brain%26jtitle%3DFront.%2520Hum.%2520Neurosci.%26date%3D2015%26volume%3D9%26spage%3D9%26doi%3D10.3389%2Ffnhum.2015.00249" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jivraj, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phinikaridou, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botnar, R. M.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of myocardial infarction</span>. <i>Basic Res. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>109</i></span>,  <span class="NLM_fpage">397</span>, <span class="refDoi"> DOI: 10.1007/s00395-013-0397-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00395-013-0397-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24322905" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXptVKnu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2014&pages=397&author=N.+Jivrajauthor=A.+Phinikaridouauthor=A.+M.+Shahauthor=R.+M.+Botnar&title=Molecular+imaging+of+myocardial+infarction&doi=10.1007%2Fs00395-013-0397-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular imaging of myocardial infarction</span></div><div class="casAuthors">Jivraj, Naheed; Phinikaridou, Alkystis; Shah, Ajay M.; Botnar, Rene M.</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">397/1-397/16, 16 pp.</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Myocardial infarction (MI), and subsequent heart failure, remains a major healthcare problem in the western and developing world and leads to substantial morbidity and mortality.  After MI, the ability of the myocardium to recover is closely assocd. with a complex immune response that often leads to adverse remodeling of the ventricle, and poor prognosis.  Currently used clin. imaging modalities allow the assessment of anatomy, perfusion, function, and viability but do not provide insights into specific biol. processes.  In contrast, novel non-invasive imaging methods, using targeted imaging agents, allow imaging of the mol. processes underlying the post-MI immune cell response, and sub- sequent remodeling.  Therefore, this may have significant diagnostic, prognostic, and therapeutic value, and may help to improve our understanding of post-infarct remodeling, in vivo.  Imaging modalities such as magnetic resonance imaging, single-photon emission computed tomog., and positron emission tomog. have been used in concert with radiolabeled and (super) paramagnetic probes to image each phase of the immune response.  These probes, which target apoptosis, necrosis, neutrophils, monocytes, enzymes, angiogenesis, extracellular matrix, and scar formation have been assessed and validated pre-clin.  Translating this work to the bedside in a cost-effective, clin. beneficial manner remains a significant challenge.  This article reviews these new imaging techniques as well as the corresponding pathophysiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJvMitKpXyt7Vg90H21EOLACvtfcHk0liOLucAiSn08w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXptVKnu78%253D&md5=8d3cea80d4734ff4cf26cae3037756cf</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1007%2Fs00395-013-0397-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00395-013-0397-2%26sid%3Dliteratum%253Aachs%26aulast%3DJivraj%26aufirst%3DN.%26aulast%3DPhinikaridou%26aufirst%3DA.%26aulast%3DShah%26aufirst%3DA.%2BM.%26aulast%3DBotnar%26aufirst%3DR.%2BM.%26atitle%3DMolecular%2520imaging%2520of%2520myocardial%2520infarction%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2014%26volume%3D109%26spage%3D397%26doi%3D10.1007%2Fs00395-013-0397-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Simon, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niphakis, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cravatt, B. F.</span></span> <span> </span><span class="NLM_article-title">Determining target engagement in living systems</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1038/nchembio.1211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnchembio.1211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23508173" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2013&pages=200-205&author=G.+M.+Simonauthor=M.+J.+Niphakisauthor=B.+F.+Cravatt&title=Determining+target+engagement+in+living+systems&doi=10.1038%2Fnchembio.1211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Determining target engagement in living systems</span></div><div class="casAuthors">Simon, Gabriel M.; Niphakis, Micah J.; Cravatt, Benjamin F.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Chem. probes are crit. tools for elucidating the biol. functions of proteins and can lead to new medicines for treating disease.  The pharmacol. validation of protein function requires verification that chem. probes engage their intended targets in vivo.  Here we discuss technologies, both established and emergent, for measuring target engagement in living systems and propose that detg. this parameter should become std. practice for chem. probe and drug discovery programs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5eudh3YJSOLVg90H21EOLACvtfcHk0liOLucAiSn08w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktFWku7g%253D&md5=48a97d0d8ff7a7de4f9de0e9c54a1c5c</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.1211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.1211%26sid%3Dliteratum%253Aachs%26aulast%3DSimon%26aufirst%3DG.%2BM.%26aulast%3DNiphakis%26aufirst%3DM.%2BJ.%26aulast%3DCravatt%26aufirst%3DB.%2BF.%26atitle%3DDetermining%2520target%2520engagement%2520in%2520living%2520systems%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2013%26volume%3D9%26spage%3D200%26epage%3D205%26doi%3D10.1038%2Fnchembio.1211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvadori, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windhorst, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vercouillie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lammertsma, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Guidelines to PET measurements of the target occupancy in the brain for drug development</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2255</span>– <span class="NLM_lpage">2262</span>, <span class="refDoi"> DOI: 10.1007/s00259-016-3476-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-016-3476-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27514528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtlOms7zP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2016&pages=2255-2262&author=A.+Takanoauthor=A.+Varroneauthor=B.+Gulyasauthor=P.+Salvadoriauthor=A.+Geeauthor=A.+Windhorstauthor=J.+Vercouillieauthor=G.+Bormansauthor=A.+A.+Lammertsmaauthor=C.+Halldin&title=Guidelines+to+PET+measurements+of+the+target+occupancy+in+the+brain+for+drug+development&doi=10.1007%2Fs00259-016-3476-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Guidelines to PET measurements of the target occupancy in the brain for drug development</span></div><div class="casAuthors">Takano, Akihiro; Varrone, Andrea; Gulyas, Balazs; Salvadori, Piero; Gee, Antony; Windhorst, Albert; Vercouillie, Johnny; Bormans, Guy; Lammertsma, Adriaan A.; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2255-2262</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">This guideline summarizes the current view of the European Assocn. of Nuclear Medicine Drug Development Committee.  The purpose of this guideline is to guarantee a high std. of PET studies that are aimed at measuring target occupancy in the brain within the framework of development programs of drugs that act within the central nervous system (CNS drugs).  This guideline is intended to present information specifically adapted to European practice.  The information provided should be applied within the context of local conditions and regulations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrILKZLy_UrCbVg90H21EOLACvtfcHk0liOLucAiSn08w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtlOms7zP&md5=5c992a4722c887a454817713acc69619</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1007%2Fs00259-016-3476-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-016-3476-4%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DSalvadori%26aufirst%3DP.%26aulast%3DGee%26aufirst%3DA.%26aulast%3DWindhorst%26aufirst%3DA.%26aulast%3DVercouillie%26aufirst%3DJ.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DLammertsma%26aufirst%3DA.%2BA.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DGuidelines%2520to%2520PET%2520measurements%2520of%2520the%2520target%2520occupancy%2520in%2520the%2520brain%2520for%2520drug%2520development%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2016%26volume%3D43%26spage%3D2255%26epage%3D2262%26doi%3D10.1007%2Fs00259-016-3476-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boscutti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span> <span> </span><span class="NLM_article-title">PET radioligands for imaging of the PDE10A in human: current status</span>. <i>Neurosci. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>691</i></span>,  <span class="NLM_fpage">11</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.neulet.2018.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neulet.2018.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30099081" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Sms7%252FO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=691&publication_year=2019&pages=11-17&author=G.+Boscuttiauthor=E.+A.+Rabinerauthor=C.+Plisson&title=PET+radioligands+for+imaging+of+the+PDE10A+in+human%3A+current+status&doi=10.1016%2Fj.neulet.2018.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">PET Radioligands for imaging of the PDE10A in human: current status</span></div><div class="casAuthors">Boscutti, Giulia; Rabiner, Eugenii A.; Plisson, Christophe</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">691</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11-17</span>CODEN:
                <span class="NLM_cas:coden">NELED5</span>;
        ISSN:<span class="NLM_cas:issn">0304-3940</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">The development of β+ emitter tracers labeled with carbon-11 or fluorine-18 having optimal characteristics of affinity and selectivity for the phosphodiesterase 10 A protein has received considerable attention, due to the major implication of this enzyme in neurol. and psychiatric disorders, such as Hungtington's disease, Parkinson's disease and schizophrenia.  The ability to quantify PDE10 A availability in the human brain in vivo will thus aid understanding its role in neurodegenerative and neuropsychiatric pathophysiol. as well as providing a valuable tool for drug development.  This manuscript reviews the different compd. series assessed to date as PET radioligand for the PDE10 A in human and their use to support the development programs of novel drugs or to evaluate PDE10 A alterations in pathologies as Huntington's, Parkinson's Diseases and Schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplICFntoPS8LVg90H21EOLACvtfcHk0lhijXwxchz80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Sms7%252FO&md5=d8d2d82156b3fb546bf24a531803c53d</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.neulet.2018.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neulet.2018.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DBoscutti%26aufirst%3DG.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DPlisson%26aufirst%3DC.%26atitle%3DPET%2520radioligands%2520for%2520imaging%2520of%2520the%2520PDE10A%2520in%2520human%253A%2520current%2520status%26jtitle%3DNeurosci.%2520Lett.%26date%3D2019%26volume%3D691%26spage%3D11%26epage%3D17%26doi%3D10.1016%2Fj.neulet.2018.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Novel radioligands for cyclic nucleotide phosphodiesterase imaging with positron rmission tomography: An update on developments since 2012</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">650</span>, <span class="refDoi"> DOI: 10.3390/molecules21050650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules21050650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2016&pages=650&author=S.+Schroderauthor=B.+Wenzelauthor=W.+Deuther-Conradauthor=M.+Scheunemannauthor=P.+Brust&title=Novel+radioligands+for+cyclic+nucleotide+phosphodiesterase+imaging+with+positron+rmission+tomography%3A+An+update+on+developments+since+2012&doi=10.3390%2Fmolecules21050650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.3390%2Fmolecules21050650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules21050650%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DNovel%2520radioligands%2520for%2520cyclic%2520nucleotide%2520phosphodiesterase%2520imaging%2520with%2520positron%2520rmission%2520tomography%253A%2520An%2520update%2520on%2520developments%2520since%25202012%26jtitle%3DMolecules%26date%3D2016%26volume%3D21%26spage%3D650%26doi%3D10.3390%2Fmolecules21050650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ignacio
Andres, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Recent advances in positron emission tomography (PET) radiotracers for imaging phosphodiesterases</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1224</span>– <span class="NLM_lpage">1236</span>, <span class="refDoi"> DOI: 10.2174/156802612800672853</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2174%2F156802612800672853" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22571785" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2012&pages=1224-1236&author=J.+Ignacio%0AAndresauthor=M.+De+Angelisauthor=J.+Alcazarauthor=S.+Celenauthor=G.+Bormans&title=Recent+advances+in+positron+emission+tomography+%28PET%29+radiotracers+for+imaging+phosphodiesterases&doi=10.2174%2F156802612800672853"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.2174%2F156802612800672853&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802612800672853%26sid%3Dliteratum%253Aachs%26aulast%3DIgnacio%2BAndres%26aufirst%3DJ.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DRecent%2520advances%2520in%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520radiotracers%2520for%2520imaging%2520phosphodiesterases%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2012%26volume%3D12%26spage%3D1224%26epage%3D1236%26doi%3D10.2174%2F156802612800672853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">PET imaging of phosphodiesterases in brain</span>. <i>In PET and SPECT of Neurobiological Systems</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">851</span>– <span class="NLM_lpage">877</span>, <span class="refDoi"> DOI: 10.1007/978-3-030-53176-8_23</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2F978-3-030-53176-8_23" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=851-877&author=M.+Oomsauthor=G.+Bormans&title=PET+imaging+of+phosphodiesterases+in+brain&doi=10.1007%2F978-3-030-53176-8_23"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2F978-3-030-53176-8_23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-3-030-53176-8_23%26sid%3Dliteratum%253Aachs%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPET%2520imaging%2520of%2520phosphodiesterases%2520in%2520brain%26jtitle%3DIn%2520PET%2520and%2520SPECT%2520of%2520Neurobiological%2520Systems%26date%3D2021%26spage%3D851%26epage%3D877%26doi%3D10.1007%2F978-3-030-53176-8_23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lakics, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karran, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boess, F. G.</span></span> <span> </span><span class="NLM_article-title">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span>. <i>Neuropharmacology</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">367</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.neuropharm.2010.05.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuropharm.2010.05.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20493887" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2010&pages=367-374&author=V.+Lakicsauthor=E.+H.+Karranauthor=F.+G.+Boess&title=Quantitative+comparison+of+phosphodiesterase+mRNA+distribution+in+human+brain+and+peripheral+tissues&doi=10.1016%2Fj.neuropharm.2010.05.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Quantitative comparison of phosphodiesterase mRNA distribution in human brain and peripheral tissues</span></div><div class="casAuthors">Lakics, Viktor; Karran, Eric H.; Boess, Frank G.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">367-374</span>CODEN:
                <span class="NLM_cas:coden">NEPHBW</span>;
        ISSN:<span class="NLM_cas:issn">0028-3908</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Cyclic nucleotide-specific phosphodiesterases (PDEs) play a crit. role in signal transduction by regulating the level of adenosine 3',5'-cyclic monophosphate (cAMP) and guanosine 3',5'-cyclic monophosphate (cGMP) in cells.  The gene expression pattern of a PDE provides important information regarding its role in physiol. and pathol. processes.  In this study, we have established the mRNA expression profile all PDE isoenzymes (PDE1A/B/C, 2A, 3A/B, 4A/B/C/D, 5A, 6A/B/C, 7A/B, 8A/B, 9A, 10A, 11A) in a human cDNA collection consisting of 10 brain regions (parietal, frontal, temporal cortex, hippocampus, striatum, thalamus, hypothalamus, substantia nigra, nucleus accumbens, cerebellum), spinal cord, dorsal root ganglia and 12 peripheral tissues (skeletal muscle, heart, thyroid, adrenal gland, pancreas, bladder, kidney, liver, lung, small intestine, spleen, and stomach).  Using quant. real-time polymerase chain reaction and parallel anal. of a carefully selected group of ref. genes, we have detd. the relative expression of each PDE isoenzyme across the 24 selected tissues, and also compared the expression of selected PDEs to each other within a given tissue type.  Several PDEs show strikingly selective expression (e.g. PDE10A and PDE1B mRNA levels in the caudate nucleus are 20-fold higher than in most other tissues; PDE1C and PDE3A are highly expressed in the heart and PDE8B is expressed very strongly in the thyroid gland).  This comprehensive approach provides a coherent and quant. view of the mRNA expression of the PDE gene family and enables an integration of data obtained with other non-quant. methods.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGz6OEkRjbLVg90H21EOLACvtfcHk0lhijXwxchz80g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht1SqsLbJ&md5=ee55772f572818eaa7194a1ae3f52f45</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.neuropharm.2010.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuropharm.2010.05.004%26sid%3Dliteratum%253Aachs%26aulast%3DLakics%26aufirst%3DV.%26aulast%3DKarran%26aufirst%3DE.%2BH.%26aulast%3DBoess%26aufirst%3DF.%2BG.%26atitle%3DQuantitative%2520comparison%2520of%2520phosphodiesterase%2520mRNA%2520distribution%2520in%2520human%2520brain%2520and%2520peripheral%2520tissues%26jtitle%3DNeuropharmacology%26date%3D2010%26volume%3D59%26spage%3D367%26epage%3D374%26doi%3D10.1016%2Fj.neuropharm.2010.05.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fertig, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baillie, G. S.</span></span> <span> </span><span class="NLM_article-title">PDE4-mediated cAMP signalling</span>. <i>J. Cardiovasc. Dev. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">8</span>, <span class="refDoi"> DOI: 10.3390/jcdd5010008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fjcdd5010008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjslyrurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2018&pages=8&author=B.+A.+Fertigauthor=G.+S.+Baillie&title=PDE4-mediated+cAMP+signalling&doi=10.3390%2Fjcdd5010008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">PDE4-mediated cAMP signalling</span></div><div class="casAuthors">Fertig, Bracy A.; Baillie, George S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cardiovascular Development and Disease</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8/1-8/14</span>CODEN:
                <span class="NLM_cas:coden">JCDDB4</span>;
        ISSN:<span class="NLM_cas:issn">2308-3425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  CAMP is the archetypal and ubiquitous second messenger utilized for the fine control of many cardiovascular cell signalling systems.  The ability of cAMP to elicit cell surface receptor-specific responses relies on its compartmentalisation by cAMP hydrolyzing enzymes known as phosphodiesterases.  One family of these enzymes, PDE4, is particularly important in the cardiovascular system, where it has been extensively studied and shown to orchestrate complex, localised signalling that underpins many crucial functions of the heart.  In the cardiac myocyte, cAMP activates PKA, which phosphorylates a small subset of mostly sarcoplasmic substrate proteins that drive β-adrenergic enhancement of cardiac function.  The phosphorylation of these substrates, many of which are involved in cardiac excitation-contraction coupling, has been shown to be tightly regulated by highly localised pools of individual PDE4 isoforms.  The spatial and temporal regulation of cardiac signalling is made possible by the formation of macromol. "signalosomes", which often include a cAMP effector, such as PKA, its substrate, PDE4 and an anchoring protein such as an AKAP.  Studies described in the present review highlight the importance of this relationship for individual cardiac PKA substrates and we provide an overview of how this signalling paradigm is coordinated to promote efficient adrenergic enhancement of cardiac function.  The role of PDE4 also extends to the vascular endothelium, where it regulates vascular permeability and barrier function.  In this distinct location, PDE4 interacts with adherens junctions to regulate their stability.  These highly specific, non-redundant roles for PDE4 isoforms have far reaching therapeutic potential.  PDE inhibitors in the clinic have been plagued with problems due to the active site-directed nature of the compds. which concomitantly attenuate PDE activity in all highly localised "signalosomes".</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqG1GQOAKh0NLVg90H21EOLACvtfcHk0liroMyfs0CO_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjslyrurs%253D&md5=55ab00b9daa0cd96454807732bd5f4bc</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.3390%2Fjcdd5010008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fjcdd5010008%26sid%3Dliteratum%253Aachs%26aulast%3DFertig%26aufirst%3DB.%2BA.%26aulast%3DBaillie%26aufirst%3DG.%2BS.%26atitle%3DPDE4-mediated%2520cAMP%2520signalling%26jtitle%3DJ.%2520Cardiovasc.%2520Dev.%2520Dis.%26date%3D2018%26volume%3D5%26spage%3D8%26doi%3D10.3390%2Fjcdd5010008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jin, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 4 and its inhibitors in inflammatory diseases</span>. <i>Chang Gung Med. J.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">197</span>– <span class="NLM_lpage">210</span>, <span class="refDoi"> DOI: 10.4103/2319-4170.106152</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.4103%2F2319-4170.106152" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22735051" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC38jltVSntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2012&pages=197-210&author=S.+L.+Jinauthor=S.+L.+Dingauthor=S.+C.+Lin&title=Phosphodiesterase+4+and+its+inhibitors+in+inflammatory+diseases&doi=10.4103%2F2319-4170.106152"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 4 and its inhibitors in inflammatory diseases</span></div><div class="casAuthors">Jin S-L Catherine; Ding Shiau-Li; Lin Shih-Chang</div><div class="citationInfo"><span class="NLM_cas:title">Chang Gung medical journal</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">197-210</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Type 4 cyclic nucleotide phosphodiesterases (PDE4) are a family of low km 3',5'-cyclic adenosine monophosphate (cAMP)-specific phosphodiesterases including at least 20 isozymes encoded by four genes (PDE4A, PDE4B, PDE4C, and PDE4D) in mammals.  Each PDE4 gene plays a special, nonredundant role in the control of cell function even though the four subfamilies share the highly conserved catalytic domain and upstream conserved region (UCR) 1 and UCR2 motifs of the regulatory domain.  By their wide tissue distribution as well as differential expression and regulation among various cell types, PDE4s are viewed as critical regulators of intracellular cAMP levels, cAMP signaling, and signal compartmentalization.  By increasing cAMP levels, PDE4 inhibitors show a broad spectrum of anti-inflammatory effects in almost all inflammatory cells.  Many PDE4 inhibitors have been evaluated in clinical trials for various inflammatory conditions.  Developed inhibitors, including the recently approved and marketed roflumilast, have considerable efficacy, but they also have adverse effects such as nausea and emesis which limit their dosing and subsequently their immunomodulatory activity.  Thus, the development of PDE4 inhibitors with improved therapeutic indexes has been a major focus of pharmaceutical research for the treatment of chronic inflammatory diseases.  Recent PDE4 gene knockout studies strongly suggest that PDE4 inhibitors with PDE4B selectivity may retain the anti-inflammatory effects while limiting side effects.  Development of PDE4 inhibitors with different delivery routes, such as topical application and inhalation, is also a promising approach for the treatment of pulmonary inflammatory conditions and dermatitis.  This review includes a brief overview of the domain structure and function of PDE4 isozymes, the role of PDE4s in inflammatory cell responses, and the potential therapeutic utility of PDE4 inhibitors in inflammatory diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTEpKl6OUluY3thwrmtH4OBfW6udTcc2eYf5iHY9spcJrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38jltVSntQ%253D%253D&md5=b6d609c93af09f56acb47c896bf4de32</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.4103%2F2319-4170.106152&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252F2319-4170.106152%26sid%3Dliteratum%253Aachs%26aulast%3DJin%26aufirst%3DS.%2BL.%26aulast%3DDing%26aufirst%3DS.%2BL.%26aulast%3DLin%26aufirst%3DS.%2BC.%26atitle%3DPhosphodiesterase%25204%2520and%2520its%2520inhibitors%2520in%2520inflammatory%2520diseases%26jtitle%3DChang%2520Gung%2520Med.%2520J.%26date%3D2012%26volume%3D35%26spage%3D197%26epage%3D210%26doi%3D10.4103%2F2319-4170.106152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cooney, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aguiar, R. C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies</span>. <i>Blood</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">2886</span>– <span class="NLM_lpage">2890</span>, <span class="refDoi"> DOI: 10.1182/blood-2016-09-737676</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1182%2Fblood-2016-09-737676" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27756749" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1ait7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2016&pages=2886-2890&author=J.+D.+Cooneyauthor=R.+C.+Aguiar&title=Phosphodiesterase+4+inhibitors+have+wide-ranging+activity+in+B-cell+malignancies&doi=10.1182%2Fblood-2016-09-737676"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 4 inhibitors have wide-ranging activity in B-cell malignancies</span></div><div class="casAuthors">Cooney, Jeffrey D.; Aguiar, Ricardo C. T.</div><div class="citationInfo"><span class="NLM_cas:title">Blood</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">2886-2890</span>CODEN:
                <span class="NLM_cas:coden">BLOOAW</span>;
        ISSN:<span class="NLM_cas:issn">1528-0020</span>.
    
            (<span class="NLM_cas:orgname">American Society of Hematology</span>)
        </div><div class="casAbstract">Phosphodiesterase 4 (PDE4) inhibition restores the suppressive effects of 3',5'-cyclic adenosine monophosphate in lymphocytes.  In this concise review, we detail how PDE4 inhibition down-modulates the B-cell receptor (BCR)-related kinases spleen tyrosine kinase and phosphatidylinositol 3-kinase and inhibits vascular endothelial growth factor A secretion by tumor cells, inducing cancer cell apoptosis and blocking angiogenesis in the microenvironment.  We describe the successful clin. repurposing of PDE4 inhibitors in B-cell malignancies, and propose that given their anti-inflammatory/immunomodulatory activity, these agents will suppress BCR signals without the toxicity assocd. with other targeted biol. doublets.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrvT7KtkpSFOLVg90H21EOLACvtfcHk0liroMyfs0CO_Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1ait7k%253D&md5=fff5d8746f062bc1d9bd7214ad15ae6c</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1182%2Fblood-2016-09-737676&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1182%252Fblood-2016-09-737676%26sid%3Dliteratum%253Aachs%26aulast%3DCooney%26aufirst%3DJ.%2BD.%26aulast%3DAguiar%26aufirst%3DR.%2BC.%26atitle%3DPhosphodiesterase%25204%2520inhibitors%2520have%2520wide-ranging%2520activity%2520in%2520B-cell%2520malignancies%26jtitle%3DBlood%26date%3D2016%26volume%3D128%26spage%3D2886%26epage%3D2890%26doi%3D10.1182%2Fblood-2016-09-737676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanmierlo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paes, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase type 4 inhibition in CNS diseases</span>. <i>Trends Pharmacol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">971</span>– <span class="NLM_lpage">985</span>, <span class="refDoi"> DOI: 10.1016/j.tips.2019.10.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.tips.2019.10.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31704172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2htbrL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2019&pages=971-985&author=A.+Bloklandauthor=P.+Heckmanauthor=T.+Vanmierloauthor=R.+Schreiberauthor=D.+Paesauthor=J.+Prickaerts&title=Phosphodiesterase+type+4+inhibition+in+CNS+diseases&doi=10.1016%2Fj.tips.2019.10.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase Type 4 Inhibition in CNS Diseases</span></div><div class="casAuthors">Blokland, Arjan; Heckman, Pim; Vanmierlo, Tim; Schreiber, Rudy; Paes, Dean; Prickaerts, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Pharmacological Sciences</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">971-985</span>CODEN:
                <span class="NLM_cas:coden">TPHSDY</span>;
        ISSN:<span class="NLM_cas:issn">0165-6147</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterases (PDEs) have been an interesting drug target for many diseases.  Although a vast no. of mainly preclin. studies demonstrates beneficial effects of PDE inhibitors for central nervous system (CNS) diseases, no drugs are currently available for CNS indications.  In this review, we discuss the rationale of PDE4 inhibitors for different CNS diseases, including memory impairments, striatal disorders, multiple sclerosis (MS), and acquired brain injury (ABI).  However, clin. development has been problematic due to mechanism-based adverse effects of these drugs in humans.  Our increased understanding of factors influencing the conformational state of the PDE4 enzyme and of how to influence the binding affinity of PDE4 subtype inhibitors, holds promise for the successful development of novel selective PDE4 inhibitors with higher efficacy and fewer adverse effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSBvx09wI08LVg90H21EOLACvtfcHk0lgmBxM7L4smhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2htbrL&md5=3c50827c42a97d8cb4913b69abd6179c</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1016%2Fj.tips.2019.10.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tips.2019.10.006%26sid%3Dliteratum%253Aachs%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DHeckman%26aufirst%3DP.%26aulast%3DVanmierlo%26aufirst%3DT.%26aulast%3DSchreiber%26aufirst%3DR.%26aulast%3DPaes%26aufirst%3DD.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520type%25204%2520inhibition%2520in%2520CNS%2520diseases%26jtitle%3DTrends%2520Pharmacol.%2520Sci.%26date%3D2019%26volume%3D40%26spage%3D971%26epage%3D985%26doi%3D10.1016%2Fj.tips.2019.10.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Titus, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calixte, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dietrich, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atkins, C. M.</span></span> <span> </span><span class="NLM_article-title">A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury</span>. <i>Neurobiol. Learn. Mem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>148</i></span>,  <span class="NLM_fpage">38</span>– <span class="NLM_lpage">49</span>, <span class="refDoi"> DOI: 10.1016/j.nlm.2017.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nlm.2017.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29294383" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXkvF2gug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=148&publication_year=2018&pages=38-49&author=D.+J.+Titusauthor=N.+M.+Wilsonauthor=O.+Alcazarauthor=D.+A.+Calixteauthor=W.+D.+Dietrichauthor=M.+E.+Gurneyauthor=C.+M.+Atkins&title=A+negative+allosteric+modulator+of+PDE4D+enhances+learning+after+traumatic+brain+injury&doi=10.1016%2Fj.nlm.2017.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">A negative allosteric modulator of PDE4D enhances learning after traumatic brain injury</span></div><div class="casAuthors">Titus, David J.; Wilson, Nicole M.; Alcazar, Oscar; Calixte, Dale A.; Dietrich, W. Dalton; Gurney, Mark E.; Atkins, Coleen M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Learning and Memory</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">148</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">38-49</span>CODEN:
                <span class="NLM_cas:coden">NLMEFR</span>;
        ISSN:<span class="NLM_cas:issn">1074-7427</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Traumatic brain injury (TBI) significantly decreases cAMP (cAMP) signaling which produces long-term synaptic plasticity deficits and chronic learning and memory impairments.  Phosphodiesterase 4 (PDE4) is a major family of cAMP hydrolyzing enzymes in the brain and of the four PDE4 subtypes, PDE4D in particular has been found to be involved in memory formation.  Although most PDE4 inhibitors target all PDE4 subtypes, PDE4D can be targeted with a selective, neg. allosteric modulator, D159687.  In this study, we hypothesized that treating animals with D159687 could reverse the cognitive deficits caused by TBI.  To test this hypothesis, adult male Sprague Dawley rats received sham surgery or moderate parasagittal fluid-percussion brain injury.  After 3 mo of recovery, animals were treated with D159687 (0.3 mg/kg, i.p.) at 30 min prior to cue and contextual fear conditioning, acquisition in the water maze or during a spatial working memory task.  Treatment with D159687 had no significant effect on these behavioral tasks in non-injured, sham animals, but did reverse the learning and memory deficits in chronic TBI animals.  Assessment of hippocampal slices at 3 mo post-TBI revealed that D159687 reversed both the depression in basal synaptic transmission in area CA1 as well as the late-phase of long-term potentiation.  These results demonstrate that a neg. allosteric modulator of PDE4D may be a potential therapeutic to improve chronic cognitive dysfunction following TBI.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWcDR6Nl6uhrVg90H21EOLACvtfcHk0lgmBxM7L4smhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXkvF2gug%253D%253D&md5=50d47684152b5ad9756eaf46a6adcfc9</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1016%2Fj.nlm.2017.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nlm.2017.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DTitus%26aufirst%3DD.%2BJ.%26aulast%3DWilson%26aufirst%3DN.%2BM.%26aulast%3DAlcazar%26aufirst%3DO.%26aulast%3DCalixte%26aufirst%3DD.%2BA.%26aulast%3DDietrich%26aufirst%3DW.%2BD.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DAtkins%26aufirst%3DC.%2BM.%26atitle%3DA%2520negative%2520allosteric%2520modulator%2520of%2520PDE4D%2520enhances%2520learning%2520after%2520traumatic%2520brain%2520injury%26jtitle%3DNeurobiol.%2520Learn.%2520Mem.%26date%3D2018%26volume%3D148%26spage%3D38%26epage%3D49%26doi%3D10.1016%2Fj.nlm.2017.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marko, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pahlke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merz, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eisenbrand, G.</span></span> <span> </span><span class="NLM_article-title">Cyclic 3′,5′-nucleotide phosphodiesterases: potential targets for anticancer therapy</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">944</span>– <span class="NLM_lpage">948</span>, <span class="refDoi"> DOI: 10.1021/tx000090l</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx000090l" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmvF2kurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2000&pages=944-948&author=D.+Markoauthor=G.+Pahlkeauthor=K.+H.+Merzauthor=G.+Eisenbrand&title=Cyclic+3%E2%80%B2%2C5%E2%80%B2-nucleotide+phosphodiesterases%3A+potential+targets+for+anticancer+therapy&doi=10.1021%2Ftx000090l"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic 3',5'-Nucleotide Phosphodiesterases: Potential Targets for Anticancer Therapy</span></div><div class="casAuthors">Marko, Doris; Pahlke, Gudrun; Merz, Karl-Heinz; Eisenbrand, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Research in Toxicology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">944-948</span>CODEN:
                <span class="NLM_cas:coden">CRTOEC</span>;
        ISSN:<span class="NLM_cas:issn">0893-228X</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review with 11 refs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooCi1hocz577Vg90H21EOLACvtfcHk0lgmBxM7L4smhw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmvF2kurg%253D&md5=bdeb99e3e0e32f17e8767dc90402d3c5</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Ftx000090l&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx000090l%26sid%3Dliteratum%253Aachs%26aulast%3DMarko%26aufirst%3DD.%26aulast%3DPahlke%26aufirst%3DG.%26aulast%3DMerz%26aufirst%3DK.%2BH.%26aulast%3DEisenbrand%26aufirst%3DG.%26atitle%3DCyclic%25203%25E2%2580%25B2%252C5%25E2%2580%25B2-nucleotide%2520phosphodiesterases%253A%2520potential%2520targets%2520for%2520anticancer%2520therapy%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2000%26volume%3D13%26spage%3D944%26epage%3D948%26doi%3D10.1021%2Ftx000090l" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Press, N. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fullerton, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tranter, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keller, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arnold, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denholm, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haberthuer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatto, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keenan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mercer, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oakman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahri, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuffnell, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tweed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyler, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fozard, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifilieff, A.</span></span> <span> </span><span class="NLM_article-title">Solubility-driven optimization of phosphodiesterase-4 inhibitors leading to a clinical candidate</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">7472</span>– <span class="NLM_lpage">7479</span>, <span class="refDoi"> DOI: 10.1021/jm300459a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300459a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtFOrurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=7472-7479&author=N.+J.+Pressauthor=R.+J.+Taylorauthor=J.+D.+Fullertonauthor=P.+Tranterauthor=C.+McCarthyauthor=T.+H.+Kellerauthor=N.+Arnoldauthor=D.+Beerauthor=L.+Brownauthor=R.+Cheungauthor=J.+Christieauthor=A.+Denholmauthor=S.+Haberthuerauthor=J.+D.+Hattoauthor=M.+Keenanauthor=M.+K.+Mercerauthor=H.+Oakmanauthor=H.+Sahriauthor=A.+R.+Tuffnellauthor=M.+Tweedauthor=J.+W.+Tylerauthor=T.+Wagnerauthor=J.+R.+Fozardauthor=A.+Trifilieff&title=Solubility-driven+optimization+of+phosphodiesterase-4+inhibitors+leading+to+a+clinical+candidate&doi=10.1021%2Fjm300459a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Solubility-Driven Optimization of Phosphodiesterase-4 Inhibitors Leading to a Clinical Candidate</span></div><div class="casAuthors">Press, Neil J.; Taylor, Roger J.; Fullerton, Joseph D.; Tranter, Pamela; McCarthy, Clive; Keller, Thomas H.; Arnold, Nicola; Beer, David; Brown, Lyndon; Cheung, Robert; Christie, Julie; Denholm, Alastair; Haberthuer, Sandra; Hatto, Julia D. I.; Keenan, Mark; Mercer, Mark K.; Oakman, Helen; Sahri, Helene; Tuffnell, Andrew R.; Tweed, Morris; Tyler, John W.; Wagner, Trixie; Fozard, John R.; Trifilieff, Alexandre</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7472-7479</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The soly.-driven optimization of a series of 1,7-naphthyridine phosphodiesterase-4 inhibitors is described.  Directed structural changes resulted in increased aq. soly., enabling superior pharmacokinetic properties with retention of PDE4 inhibition.  A range of potent and orally bioavailable compds. with good in vivo efficacy in animal models of inflammation and reduced emetic potential compared to previously described drugs were synthesized.  Compd. 2d (I) was taken forward as a clin. candidate for the treatment of COPD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqL0BzBNQVqnrVg90H21EOLACvtfcHk0lii21e00MZQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtFOrurnO&md5=deee9ca074de0b531a130d9a6ce530b2</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Fjm300459a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300459a%26sid%3Dliteratum%253Aachs%26aulast%3DPress%26aufirst%3DN.%2BJ.%26aulast%3DTaylor%26aufirst%3DR.%2BJ.%26aulast%3DFullerton%26aufirst%3DJ.%2BD.%26aulast%3DTranter%26aufirst%3DP.%26aulast%3DMcCarthy%26aufirst%3DC.%26aulast%3DKeller%26aufirst%3DT.%2BH.%26aulast%3DArnold%26aufirst%3DN.%26aulast%3DBeer%26aufirst%3DD.%26aulast%3DBrown%26aufirst%3DL.%26aulast%3DCheung%26aufirst%3DR.%26aulast%3DChristie%26aufirst%3DJ.%26aulast%3DDenholm%26aufirst%3DA.%26aulast%3DHaberthuer%26aufirst%3DS.%26aulast%3DHatto%26aufirst%3DJ.%2BD.%26aulast%3DKeenan%26aufirst%3DM.%26aulast%3DMercer%26aufirst%3DM.%2BK.%26aulast%3DOakman%26aufirst%3DH.%26aulast%3DSahri%26aufirst%3DH.%26aulast%3DTuffnell%26aufirst%3DA.%2BR.%26aulast%3DTweed%26aufirst%3DM.%26aulast%3DTyler%26aufirst%3DJ.%2BW.%26aulast%3DWagner%26aufirst%3DT.%26aulast%3DFozard%26aufirst%3DJ.%2BR.%26aulast%3DTrifilieff%26aufirst%3DA.%26atitle%3DSolubility-driven%2520optimization%2520of%2520phosphodiesterase-4%2520inhibitors%2520leading%2520to%2520a%2520clinical%2520candidate%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D7472%26epage%3D7479%26doi%3D10.1021%2Fjm300459a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hoy, S. M.</span></span> <span> </span><span class="NLM_article-title">Crisaborole ointment 2%: A review in mild to moderate atopic dermatitis</span>. <i>Am. J. Clin. Dermatol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">837</span>– <span class="NLM_lpage">843</span>, <span class="refDoi"> DOI: 10.1007/s40257-017-0327-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs40257-017-0327-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29076116" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC1M7ltV2gtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2017&pages=837-843&author=S.+M.+Hoy&title=Crisaborole+ointment+2%25%3A+A+review+in+mild+to+moderate+atopic+dermatitis&doi=10.1007%2Fs40257-017-0327-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Crisaborole Ointment 2%: A Review in Mild to Moderate Atopic Dermatitis</span></div><div class="casAuthors">Hoy Sheridan M</div><div class="citationInfo"><span class="NLM_cas:title">American journal of clinical dermatology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">837-843</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Crisaborole ointment 2% (Eucrisa®) is a novel, anti-inflammatory inhibitor of phosphodiesterase 4 (PDE4) that is available in the USA for the topical treatment of mild to moderate atopic dermatitis in patients aged ≥ 2 years.  In two short-term (28 days), identically designed, multicentre, phase III studies in this patient population, topical therapy with crisaborole ointment 2% reduced disease severity and pruritus severity compared with vehicle, with the effect established early and sustained over the course of treatment.  Improvements in the other signs of atopic dermatitis (erythema, exudation, excoriation, induration/papulation, and lichenification) were also seen.  Crisaborole ointment 2% was generally well tolerated in the short-term studies, with its favorable safety profile maintained over the longer term (up to 52 weeks) in a multicentre, extension study.  Most treatment-emergent adverse events (TEAEs) were of mild to moderate severity and considered unrelated to the study medication.  Moreover, the incidence of application-site pain following short- and longer-term topical therapy with crisaborole ointment 2% was low.  In conclusion, crisaborole ointment 2% is an effective and generally well tolerated new topical option for the management of mild to moderate atopic dermatitis in patients aged ≥ 2 years, with the potential to effectively treat this patient population over the longer term without the safety concerns associated with other current topical anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTv9G71HdF0KySm0e6ZOaemfW6udTcc2ebftRORNOQwsrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M7ltV2gtQ%253D%253D&md5=c9d41cfc31e81152a11df5400ee1c358</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1007%2Fs40257-017-0327-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40257-017-0327-4%26sid%3Dliteratum%253Aachs%26aulast%3DHoy%26aufirst%3DS.%2BM.%26atitle%3DCrisaborole%2520ointment%25202%2525%253A%2520A%2520review%2520in%2520mild%2520to%2520moderate%2520atopic%2520dermatitis%26jtitle%3DAm.%2520J.%2520Clin.%2520Dermatol.%26date%3D2017%26volume%3D18%26spage%3D837%26epage%3D843%26doi%3D10.1007%2Fs40257-017-0327-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rolan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutchinson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, K.</span></span> <span> </span><span class="NLM_article-title">Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease</span>. <i>Expert Opin. Pharmacother.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2897</span>– <span class="NLM_lpage">2904</span>, <span class="refDoi"> DOI: 10.1517/14656560903426189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1517%2F14656560903426189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19929708" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVyjur%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=2897-2904&author=P.+Rolanauthor=M.+Hutchinsonauthor=K.+Johnson&title=Ibudilast%3A+a+review+of+its+pharmacology%2C+efficacy+and+safety+in+respiratory+and+neurological+disease&doi=10.1517%2F14656560903426189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease</span></div><div class="casAuthors">Rolan, P.; Hutchinson, Mr; Johnson, Kw</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Pharmacotherapy</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">2897-2904</span>CODEN:
                <span class="NLM_cas:coden">EOPHF7</span>;
        ISSN:<span class="NLM_cas:issn">1465-6566</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Ibudilast is a relatively nonselective phosphodiesterase inhibitor which has been marketed for almost 20 years in Japan for treating asthma.  More recently it has been found to have anti-inflammatory activity in both the peripheral immune system and in the CNS via glial cell attenuation.  This CNS-directed anti-inflammatory activity is of potential use in the treatment of multiple sclerosis, neuropathic pain, and in the improved efficacy and safety of opioids by decreasing opioid tolerance, withdrawal and reinforcement.  Its suitable pharmacokinetics and generally good tolerability make it a promising potential treatment for these conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql9-2fWYWu4bVg90H21EOLACvtfcHk0lii21e00MZQmw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVyjur%252FF&md5=321ef42e8f433e908780f8c19f7f1579</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1517%2F14656560903426189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14656560903426189%26sid%3Dliteratum%253Aachs%26aulast%3DRolan%26aufirst%3DP.%26aulast%3DHutchinson%26aufirst%3DM.%26aulast%3DJohnson%26aufirst%3DK.%26atitle%3DIbudilast%253A%2520a%2520review%2520of%2520its%2520pharmacology%252C%2520efficacy%2520and%2520safety%2520in%2520respiratory%2520and%2520neurological%2520disease%26jtitle%3DExpert%2520Opin.%2520Pharmacother.%26date%3D2009%26volume%3D10%26spage%3D2897%26epage%3D2904%26doi%3D10.1517%2F14656560903426189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Abbott-Banner, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, C. P.</span></span> <span> </span><span class="NLM_article-title">Dual PDE3/4 and PDE4 inhibitors: novel treatments for COPD and other inflammatory airway diseases</span>. <i>Basic Clin. Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>114</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">376</span>, <span class="refDoi"> DOI: 10.1111/bcpt.12209</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fbcpt.12209" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24517491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVSitL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=114&publication_year=2014&pages=365-376&author=K.+H.+Abbott-Bannerauthor=C.+P.+Page&title=Dual+PDE3%2F4+and+PDE4+inhibitors%3A+novel+treatments+for+COPD+and+other+inflammatory+airway+diseases&doi=10.1111%2Fbcpt.12209"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Dual PDE3/4 and PDE4 Inhibitors: Novel Treatments For COPD and Other Inflammatory Airway Diseases</span></div><div class="casAuthors">Abbott-Banner, Katharine H.; Page, Clive P.</div><div class="citationInfo"><span class="NLM_cas:title">Basic & Clinical Pharmacology & Toxicology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">114</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">365-376</span>CODEN:
                <span class="NLM_cas:coden">BCPTBO</span>;
        ISSN:<span class="NLM_cas:issn">1742-7835</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">A review.  Selective phosphodiesterase (PDE) 4 and dual PDE3/4 inhibitors have attracted considerable interest as potential therapeutic agents for the treatment of respiratory diseases, largely by virtue of their anti-inflammatory (PDE4) and bifunctional bronchodilator/anti-inflammatory (PDE3/4) effects.  Many of these agents have, however, failed in early development for various reasons, including dose-limiting side effects when administered orally and lack of sufficient activity when inhaled.  Indeed, only one selective PDE4 inhibitor, the orally active roflumilast-n-oxide, has to date received marketing authorization.  The majority of the compds. that have failed were, however, orally administered and non-selective for either PDE3 (A,B) or PDE4 (A,B,C,D) subtypes.  Developing an inhaled dual PDE3/4 inhibitor that is rapidly cleared from the systemic circulation, potentially with subtype specificity, may represent one strategy to improve the therapeutic index and also exhibit enhanced efficacy vs. inhibition of either PDE3 or PDE4 alone, given the potential pos. interactions with regard to anti-inflammatory and bronchodilator effects that have been obsd. pre-clin. with dual inhibition of PDE3 and PDE4 compared with inhibition of either isoenzyme alone.  This MiniReview will summarize recent clin. data obtained with PDE inhibitors and the potential for these drugs to treat COPD and other inflammatory airways diseases such as asthma and cystic fibrosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpj1ILnRPA11rVg90H21EOLACvtfcHk0lgXpUysZee7HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVSitL4%253D&md5=d29edfe27d2514633d532bdd47d938d4</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1111%2Fbcpt.12209&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbcpt.12209%26sid%3Dliteratum%253Aachs%26aulast%3DAbbott-Banner%26aufirst%3DK.%2BH.%26aulast%3DPage%26aufirst%3DC.%2BP.%26atitle%3DDual%2520PDE3%252F4%2520and%2520PDE4%2520inhibitors%253A%2520novel%2520treatments%2520for%2520COPD%2520and%2520other%2520inflammatory%2520airway%2520diseases%26jtitle%3DBasic%2520Clin.%2520Pharmacol.%2520Toxicol.%26date%3D2014%26volume%3D114%26spage%3D365%26epage%3D376%26doi%3D10.1111%2Fbcpt.12209" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutter, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poffe, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cavallini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneck, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Negri, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vicentini, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Montanari, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arban, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gray, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wren, P. B.</span></span> <span> </span><span class="NLM_article-title">GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>350</i></span>,  <span class="NLM_fpage">153</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.214155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fjpet.114.214155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24784567" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVGkurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=350&publication_year=2014&pages=153-163&author=A.+R.+Rutterauthor=A.+Poffeauthor=P.+Cavalliniauthor=T.+G.+Davisauthor=J.+Schneckauthor=M.+Negriauthor=E.+Vicentiniauthor=D.+Montanariauthor=R.+Arbanauthor=F.+A.+Grayauthor=C.+H.+Daviesauthor=P.+B.+Wren&title=GSK356278%2C+a+potent%2C+selective%2C+brain-penetrant+phosphodiesterase+4+inhibitor+that+demonstrates+anxiolytic+and+cognition-enhancing+effects+without+inducing+side+effects+in+preclinical+species&doi=10.1124%2Fjpet.114.214155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">GSK356278, a potent, selective, brain-penetrant phosphodiesterase 4 inhibitor that demonstrates anxiolytic and cognition-enhancing effects without inducing side effects in preclinical species</span></div><div class="casAuthors">Rutter, A. Richard; Poffe, Alessandro; Cavallini, Palmina; Davis, T. Gregg; Schneck, Jessica; Negri, Michele; Vicentini, Elena; Montanari, Dino; Arban, Roberto; Gray, Frank A.; Davies, Ceri H.; Wren, Paul B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">350</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">153-163, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Small mol. phosphodiesterase (PDE) 4 inhibitors have long been known to show therapeutic benefit in various preclin. models of psychiatric and neurol. diseases because of their ability to elevate cAMP in various cell types of the central nervous system.  Despite the registration of the first PDE4 inhibitor, roflumilast, for the treatment of chronic obstructive pulmonary disease, the therapeutic potential of PDE4 inhibitors in neurol. diseases has never been fulfilled in the clinic due to severe dose-limiting side effects such as nausea and vomiting.  In this study, we describe the detailed pharmacol. characterization of GSK356278 [5-(5-((2,4-dimethylthiazol-5-yl)methyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-N-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-b]pyridin-4-amine], a potent, selective, and brain-penetrant PDE4 inhibitor that shows a superior therapeutic index to both rolipram and roflumilast in various preclin. species and has potential for further development in the clinic for the treatment of psychiatric and neurol. diseases.  GSK356278 inhibited PDE4B enzyme activity with a pIC50 of 8.8 and bound to the high-affinity rolipram binding site with a pIC50 of 8.6.  In preclin. models, the therapeutic index as defined in a rodent lung inflammation model vs. rat pica feeding was >150 compared with 0.5 and 6.4 for rolipram and roflumilast, resp.  In a model of anxiety in common marmosets, the therapeutic index for GSK356278 was >10 vs. <1 for rolipram.  We also demonstrate that GSK356278 enhances performance in a model of executive function in cynomolgus macaques with no adverse effects, a therapeutic profile that supports further evaluation of GSK356278 in a clin. setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo53EDHLd83CrVg90H21EOLACvtfcHk0lgXpUysZee7HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVGkurbF&md5=82d72053beda7d67b1d1085470634bf1</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.214155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.214155%26sid%3Dliteratum%253Aachs%26aulast%3DRutter%26aufirst%3DA.%2BR.%26aulast%3DPoffe%26aufirst%3DA.%26aulast%3DCavallini%26aufirst%3DP.%26aulast%3DDavis%26aufirst%3DT.%2BG.%26aulast%3DSchneck%26aufirst%3DJ.%26aulast%3DNegri%26aufirst%3DM.%26aulast%3DVicentini%26aufirst%3DE.%26aulast%3DMontanari%26aufirst%3DD.%26aulast%3DArban%26aufirst%3DR.%26aulast%3DGray%26aufirst%3DF.%2BA.%26aulast%3DDavies%26aufirst%3DC.%2BH.%26aulast%3DWren%26aufirst%3DP.%2BB.%26atitle%3DGSK356278%252C%2520a%2520potent%252C%2520selective%252C%2520brain-penetrant%2520phosphodiesterase%25204%2520inhibitor%2520that%2520demonstrates%2520anxiolytic%2520and%2520cognition-enhancing%2520effects%2520without%2520inducing%2520side%2520effects%2520in%2520preclinical%2520species%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2014%26volume%3D350%26spage%3D153%26epage%3D163%26doi%3D10.1124%2Fjpet.114.214155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chowdhary, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auerbach, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salvi, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span> <span> </span><span class="NLM_article-title">Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">2299</span>– <span class="NLM_lpage">2309</span>, <span class="refDoi"> DOI: 10.1038/s41386-018-0178-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fs41386-018-0178-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30131563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtLrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2018&pages=2299-2309&author=C.+Zhangauthor=Y.+Xuauthor=A.+Chowdharyauthor=D.+Foxauthor=M.+E.+Gurneyauthor=H.+T.+Zhangauthor=B.+D.+Auerbachauthor=R.+J.+Salviauthor=M.+Yangauthor=G.+Liauthor=J.+M.+O%E2%80%99Donnell&title=Memory+enhancing+effects+of+BPN14770%2C+an+allosteric+inhibitor+of+phosphodiesterase-4D%2C+in+wild-type+and+humanized+mice&doi=10.1038%2Fs41386-018-0178-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Memory enhancing effects of BPN14770, an allosteric inhibitor of phosphodiesterase-4D, in wild-type and humanized mice</span></div><div class="casAuthors">Zhang, Chong; Xu, Ying; Chowdhary, Anirudh; Fox, 3rd, David; Gurney, Mark E.; Zhang, Han-Ting; Auerbach, Benjamin D.; Salvi, Richard J.; Yang, Mingxin; Li, Gaowen; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2299-2309</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Inhibitors of phosphodiesterase-4 (PDE4) have beneficial effects on memory in preclin. and clin. studies.  Development of these drugs has stalled due to dose-limiting side effects of nausea and emesis.  While use of subtype-selective inhibitors (i.e., for PDE4A, B, or D) could overcome this issue, conservation of the catalytic region, to which classical inhibitors bind, limits this approach.  The present study examd. the effects of BPN14770, an allosteric inhibitor of PDE4D, which binds to a primate-specific, N-terminal region.  In mice engineered to express PDE4D with this primate-specific sequence, BPN14770 was 100-fold more potent for improving memory than in wild-type mice; meanwhile, it exhibited low potency in a mouse surrogate model for emesis.  BPN14770 also antagonized the amnesic effects of scopolamine, increased cAMP signaling in brain, and increased BDNF and markers of neuronal plasticity assocd. with memory.  These data establish a relationship between PDE4D target engagement and effects on memory for BPN14770 and suggest clin. potential for PDE4D-selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOsEgzBAlG_LVg90H21EOLACvtfcHk0lgXpUysZee7HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFKqtLrI&md5=de5eee6e4aa249e64cd971b0c69e4fda</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1038%2Fs41386-018-0178-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41386-018-0178-6%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DChowdhary%26aufirst%3DA.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DAuerbach%26aufirst%3DB.%2BD.%26aulast%3DSalvi%26aufirst%3DR.%2BJ.%26aulast%3DYang%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DMemory%2520enhancing%2520effects%2520of%2520BPN14770%252C%2520an%2520allosteric%2520inhibitor%2520of%2520phosphodiesterase-4D%252C%2520in%2520wild-type%2520and%2520humanized%2520mice%26jtitle%3DNeuropsychopharmacology%26date%3D2018%26volume%3D43%26spage%3D2299%26epage%3D2309%26doi%3D10.1038%2Fs41386-018-0178-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindac, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hagen, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fox, D.,  III</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Groppi, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bailie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Romero, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vellekoop, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Surman, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, R. F.</span></span> <span> </span><span class="NLM_article-title">Design and synthesis of selective phosphodiesterase 4D (PDE4D) allosteric onhibitors for the treatment of fragile X syndrome and other brain disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">4884</span>– <span class="NLM_lpage">4901</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00193</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00193" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXnvFSjtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=4884-4901&author=M.+E.+Gurneyauthor=R.+A.+Nugentauthor=X.+Moauthor=J.+A.+Sindacauthor=T.+J.+Hagenauthor=D.+Foxauthor=J.+M.+O%E2%80%99Donnellauthor=C.+Zhangauthor=Y.+Xuauthor=H.+T.+Zhangauthor=V.+E.+Groppiauthor=M.+Bailieauthor=R.+E.+Whiteauthor=D.+L.+Romeroauthor=A.+S.+Vellekoopauthor=J.+R.+Walkerauthor=M.+D.+Surmanauthor=L.+Zhuauthor=R.+F.+Campbell&title=Design+and+synthesis+of+selective+phosphodiesterase+4D+%28PDE4D%29+allosteric+onhibitors+for+the+treatment+of+fragile+X+syndrome+and+other+brain+disorders&doi=10.1021%2Facs.jmedchem.9b00193"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Synthesis of Selective Phosphodiesterase 4D (PDE4D) Allosteric Inhibitors for the Treatment of Fragile X Syndrome and Other Brain Disorders</span></div><div class="casAuthors">Gurney, Mark E.; Nugent, Richard A.; Mo, Xuesheng; Sindac, Janice A.; Hagen, Timothy J.; Fox, David; O'Donnell, James M.; Zhang, Chong; Xu, Ying; Zhang, Han-Ting; Groppi, Vincent E.; Bailie, Marc; White, Ronald E.; Romero, Donna L.; Vellekoop, A. Samuel; Walker, Joel R.; Surman, Matthew D.; Zhu, Lei; Campbell, Robert F.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4884-4901</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Novel pyridine- and pyrimidine-based allosteric inhibitors are reported that achieve PDE4D subtype selectivity through recognition of a single amino acid difference on a key regulatory domain, known as UCR2, that opens and closes over the catalytic site for cAMP hydrolysis.  The design and optimization of lead compds. was based on iterative anal. of X-ray crystal structures combined with metabolite identification.  Selectivity for the activated, dimeric form of PDE4D provided potent memory enhancing effects in a mouse model of novel object recognition with improved tolerability and reduced vascular toxicity over earlier PDE4 inhibitors that lack subtype selectivity.  The lead compd., 28 (BPN14770), has entered midstage, human phase 2 clin. trials for the treatment of Fragile X Syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwRN4fRqnWNLVg90H21EOLACvtfcHk0lhhrbcvnDt8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXnvFSjtrc%253D&md5=fccb8282e360d7d9a3cde1a187fd2411</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00193%26sid%3Dliteratum%253Aachs%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DMo%26aufirst%3DX.%26aulast%3DSindac%26aufirst%3DJ.%2BA.%26aulast%3DHagen%26aufirst%3DT.%2BJ.%26aulast%3DFox%26aufirst%3DD.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DXu%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%2BT.%26aulast%3DGroppi%26aufirst%3DV.%2BE.%26aulast%3DBailie%26aufirst%3DM.%26aulast%3DWhite%26aufirst%3DR.%2BE.%26aulast%3DRomero%26aufirst%3DD.%2BL.%26aulast%3DVellekoop%26aufirst%3DA.%2BS.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DSurman%26aufirst%3DM.%2BD.%26aulast%3DZhu%26aufirst%3DL.%26aulast%3DCampbell%26aufirst%3DR.%2BF.%26atitle%3DDesign%2520and%2520synthesis%2520of%2520selective%2520phosphodiesterase%25204D%2520%2528PDE4D%2529%2520allosteric%2520onhibitors%2520for%2520the%2520treatment%2520of%2520fragile%2520X%2520syndrome%2520and%2520other%2520brain%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D4884%26epage%3D4901%26doi%3D10.1021%2Facs.jmedchem.9b00193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valente, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Warsh, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">Carbon-11 labeling of the selective inhibitors of phosphodiesterase- IV Ro-20–1724 and rolipram</span>. <i>J. Label. Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">678</span>– <span class="NLM_lpage">680</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1997&pages=678-680&author=J.+N.+DaSilvaauthor=C.+M.+Valenteauthor=A.+A.+Wilsonauthor=J.+J.+Warshauthor=S.+Houle&title=Carbon-11+labeling+of+the+selective+inhibitors+of+phosphodiesterase-+IV+Ro-20%E2%80%931724+and+rolipram"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DValente%26aufirst%3DC.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DWarsh%26aufirst%3DJ.%2BJ.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DCarbon-11%2520labeling%2520of%2520the%2520selective%2520inhibitors%2520of%2520phosphodiesterase-%2520IV%2520Ro-20%25E2%2580%25931724%2520and%2520rolipram%26jtitle%3DJ.%2520Label.%2520Compd.%2520Radiopharm.%26date%3D1997%26volume%3D40%26spage%3D678%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">Syntheses of the phosphodiesterase-4 inhibitors [<sup>11</sup>C]Ro 20–1724, <i>R</i>-, <i>R</i>/<i>S</i>- and <i>S</i>-[<sup>11</sup>C]rolipram</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">373</span>– <span class="NLM_lpage">384</span>, <span class="refDoi"> DOI: 10.1002/jlcr.465</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.465" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3MXivFOru7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2001&pages=373-384&author=J.+N.+DaSilvaauthor=C.+M.+Lourencoauthor=A.+A.+Wilsonauthor=S.+Houle&title=Syntheses+of+the+phosphodiesterase-4+inhibitors+%5B11C%5DRo+20%E2%80%931724%2C+R-%2C+R%2FS-+and+S-%5B11C%5Drolipram&doi=10.1002%2Fjlcr.465"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of the phosphodiesterase-4 inhibitors [11C]Ro 20-1724, R-, R/S- and S-[11C]rolipram</span></div><div class="casAuthors">DaSilva, Jean N.; Lourenco, Celia M.; Wilson, Alan A.; Houle, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds & Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">373-384</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">The high affinity and selective cAMP-specific phosphodiesterase-4 inhibitors, Ro 20-1724 I (R = Me), (±)-, (R)-, and (S)-rolipram II (R = Me, R1 = ξ-H, α-, β-H, resp.), were labeled with 11C by O-[11C]methylation of their resp. phenolic precursors using [11C]methyl iodide.  The desmethyl precursor I (R = H) of Ro 20-1724 was prepd. by selective dealkylation with iodotrimethylsilane, whereas, dealkylation of racemic rolipram was not selective and yielded several products.  Enantiomeric sepn. of (R)- and (S)-desmethylrolipram II (R = H, R1 = α- and β-H, resp.) was carried out by chiral semi-preparative high performance liq. chromatog.  The final 11C-labeled products I (R = 11CH3) and II (R = 11CH3, R1 = ξ-H, α-, β-H) were prepd. in high radiochem. purity (>99%), yields (45-75%, decay-cor.) and specific activities (18.5-92.5 GBq/μmol), within 30 min from end-of-bombardment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoEHpugWx2zDbVg90H21EOLACvtfcHk0lhhrbcvnDt8sw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXivFOru7c%253D&md5=7367c01bd7286d124fb848b32ec610e1</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.465&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.465%26sid%3Dliteratum%253Aachs%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DSyntheses%2520of%2520the%2520phosphodiesterase-4%2520inhibitors%2520%255B11C%255DRo%252020%25E2%2580%25931724%252C%2520R-%252C%2520R%252FS-%2520and%2520S-%255B11C%255Drolipram%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2001%26volume%3D44%26spage%3D373%26epage%3D384%26doi%3D10.1002%2Fjlcr.465" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span> <span> </span><span class="NLM_article-title">Characterization of R-[<sup>11</sup>C]rolipram for PET imaging of phosphodiesterase-4: <i>in vivo</i> binding, metabolism, and dosimetry studies in rats</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">347</span>– <span class="NLM_lpage">358</span>, <span class="refDoi"> DOI: 10.1016/S0969-8051(01)00206-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0969-8051%2801%2900206-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11395307" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3MXktVOiurg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2001&pages=347-358&author=C.+M.+Lourencoauthor=S.+Houleauthor=A.+A.+Wilsonauthor=J.+N.+DaSilva&title=Characterization+of+R-%5B11C%5Drolipram+for+PET+imaging+of+phosphodiesterase-4%3A+in+vivo+binding%2C+metabolism%2C+and+dosimetry+studies+in+rats&doi=10.1016%2FS0969-8051%2801%2900206-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of R-[11C]rolipram for PET imaging of phosphodiesterase-4: in vivo binding, metabolism, and dosimetry studies in rats</span></div><div class="casAuthors">Lourenco, C. M.; Houle, S.; Wilson, A. A.; DaSilva, J. N.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">347-358</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The high-affinity phosphodiesterase-4 (PDE4) inhibitor R-rolipram and the less potent S-enantiomer, both labeled with 11C, were evaluated in vivo in rats.  Regional brain uptake of R-[11C]rolipram was higher than R/S-[11C]rolipram, whereas S-[11C]rolipram retention subsided rapidly to levels below blood.  Binding of R-[11C]rolipram was selective for PDE4 over PDE1, since treatment with PDE4 competitors Ro 20-1724, or R-, S- or R/S-rolipram, but not with the PDE1 inhibitor vinpocetine, significantly reduced radioactivity uptake to non-specific levels.  R-Rolipram (ED50 ≃ 0.04 mg/Kg) was approx. 13 fold more potent than S-rolipram at inhibiting R-[11C]rolipram binding in all brain regions.  Nevertheless, S-[11C]rolipram appears to be unsuitable for measuring the non-specific binding of R-[11C]rolipram.  Only unchanged R-[11C]rolipram was detected in rat brain homogenates.  Addnl., the estd. absorbed radiation dose extrapolated to humans was low.  These results support further investigation of R-[11C]rolipram in studying PDE4 in vivo by positron emission tomog. imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoa3qyPcFHsp7Vg90H21EOLACvtfcHk0ljDOeOX_PB20A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXktVOiurg%253D&md5=a45d55dd30d579912d14a5e0ac7ffd0e</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1016%2FS0969-8051%2801%2900206-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-8051%252801%252900206-2%26sid%3Dliteratum%253Aachs%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DHoule%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DA.%2BA.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DCharacterization%2520of%2520R-%255B11C%255Drolipram%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-4%253A%2520in%2520vivo%2520binding%252C%2520metabolism%252C%2520and%2520dosimetry%2520studies%2520in%2520rats%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2001%26volume%3D28%26spage%3D347%26epage%3D358%26doi%3D10.1016%2FS0969-8051%2801%2900206-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsukada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kakiuchi, T.</span></span> <span> </span><span class="NLM_article-title">Transient focal ischemia affects the cAMP second messenger system and coupled dopamine D1 and 5-HT1A receptors in the living monkey brain: a positron emission tomography study using microdialysis</span>. <i>J. Cereb. Blood Flow Metab.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">898</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1097/01.WCB.0000126974.07553.86</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1097%2F01.WCB.0000126974.07553.86" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15362720" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtlSjtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2004&pages=898-906&author=H.+Tsukadaauthor=D.+Fukumotoauthor=S.+Nishiyamaauthor=K.+Satoauthor=T.+Kakiuchi&title=Transient+focal+ischemia+affects+the+cAMP+second+messenger+system+and+coupled+dopamine+D1+and+5-HT1A+receptors+in+the+living+monkey+brain%3A+a+positron+emission+tomography+study+using+microdialysis&doi=10.1097%2F01.WCB.0000126974.07553.86"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Transient Focal Ischemia Affects the cAMP Second Messenger System and Coupled Dopamine D1 and 5-HT1A Receptors in the Living Monkey Brain: A Positron Emission Tomography Study Using Microdialysis</span></div><div class="casAuthors">Tsukada, Hideo; Fukumoto, Dai; Nishiyama, Shingo; Sato, Kengo; Kakiuchi, Takeharu</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Cerebral Blood Flow & Metabolism</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">898-906</span>CODEN:
                <span class="NLM_cas:coden">JCBMDN</span>;
        ISSN:<span class="NLM_cas:issn">0271-678X</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Using positron emission tomog. (PET) and microdialysis, the present study showed that neuronal damages after transient focal ischemia was partly induced by hyperactivation of the cyclic adenosine 3',5'-monophosphate (cAMP) second messenger system through modulations of dopamine D1 and serotonin 5-HT1A receptors in the living brains of cynomolgus monkeys.  Occlusion of the right middle cerebral artery for 3 h suppressed CBF in the striatum, and reperfusion induced hyperperfusion in the neocortex and striatum of the occluded side.  Six hours after reperfusion, the activity of the cAMP second messenger system assayed with [11C]rolipram was significantly facilitated in the neocortex and striatum where CBF was lowered more than 40% of normal during occlusion ("ischemic" area).  Seven days later, impaired dopamine D1 and 5-HT1A receptor binding, measured with [11C]SCH23390 and [carbonyl-11C]WAY-100635, resp., was obsd. in the ischemic area.  Microdialysis anal. revealed that the striatal dopamine level provided a transient and marked increased during occlusion and after reperfusion, whereas the cortical serotonin level transiently increased only after reperfusion, and was at an undetectable level thereafter.  Administration of rolipram (0.1 and 1 mg/kg, i.v.) during occlusion facilitated redn. of dopamine D1 binding, whereas rolipram administration 6 h after reperfusion induced a further decrease in 5-HT1A receptor binding.  These results suggest that the activation of cAMP second messenger system modulated by dopamine D1 and 5-HT1A receptors could be involved in the neuronal degeneration after transient cerebral ischemic insult.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXrjx_38oJ4bVg90H21EOLACvtfcHk0ljDOeOX_PB20A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtlSjtLg%253D&md5=bca2ff01c5258864782f557955ee2743</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1097%2F01.WCB.0000126974.07553.86&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252F01.WCB.0000126974.07553.86%26sid%3Dliteratum%253Aachs%26aulast%3DTsukada%26aufirst%3DH.%26aulast%3DFukumoto%26aufirst%3DD.%26aulast%3DNishiyama%26aufirst%3DS.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DKakiuchi%26aufirst%3DT.%26atitle%3DTransient%2520focal%2520ischemia%2520affects%2520the%2520cAMP%2520second%2520messenger%2520system%2520and%2520coupled%2520dopamine%2520D1%2520and%25205-HT1A%2520receptors%2520in%2520the%2520living%2520monkey%2520brain%253A%2520a%2520positron%2520emission%2520tomography%2520study%2520using%2520microdialysis%26jtitle%3DJ.%2520Cereb.%2520Blood%2520Flow%2520Metab.%26date%3D2004%26volume%3D24%26spage%3D898%26epage%3D906%26doi%3D10.1097%2F01.WCB.0000126974.07553.86" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span> <span> </span><span class="NLM_article-title">Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart</span>. <i>Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">356</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/j.lfs.2006.01.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.lfs.2006.01.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16499932" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XltlKrsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2006&pages=356-364&author=C.+M.+Lourencoauthor=M.+Kenkauthor=R.+S.+Beanlandsauthor=J.+N.+DaSilva&title=Increasing+synaptic+noradrenaline%2C+serotonin+and+histamine+enhances+in+vivo+binding+of+phosphodiesterase-4+inhibitor+%28R%29-%5B11C%5Drolipram+in+rat+brain%2C+lung+and+heart&doi=10.1016%2Fj.lfs.2006.01.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Increasing synaptic noradrenaline, serotonin and histamine enhances in vivo binding of phosphodiesterase-4 inhibitor (R)-[11C]rolipram in rat brain, lung and heart</span></div><div class="casAuthors">Lourenco, Celia M.; Kenk, Miran; Beanlands, Rob S.; DaSilva, Jean N.</div><div class="citationInfo"><span class="NLM_cas:title">Life Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">356-364</span>CODEN:
                <span class="NLM_cas:coden">LIFSAK</span>;
        ISSN:<span class="NLM_cas:issn">0024-3205</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) is one of the main enzymes that specifically terminate the action of cAMP, thereby contributing to intracellular signaling following stimulation of various G protein-coupled receptors.  PDE4 expression and activity are modulated by agents affecting cAMP levels.  The selective PDE4 inhibitor (R)-rolipram labeled with C-11 was tested in vivo in rats to analyze changes in PDE4 levels following drug treatments that increase synaptic noradrenaline (NA), serotonin (5HT), histamine (HA) and dopamine (DA) levels.  We hypothesized that increasing synaptic neurotransmitter levels and subsequent cAMP-mediated signaling would significantly enhance (R)-[11C]rolipram retention and specific binding to PDE4 in vivo.  Pretreatments were performed 3 h prior to tracer injection, and rats were sacrificed 45 min later.  Biodistribution studies revealed a dose-dependent increase in (R)-[11C]rolipram uptake following administration of the monoamine oxidase (MAO) inhibitor tranylcypromine, NA and 5HT reuptake inhibitors (desipramine [DMI], maprotiline; and fluoxetine, sertraline, resp.), and the HA H3 receptor antagonist (thioperamide), but not with DA transporter blockers GBR 12909, cocaine or DA D1 agonist SKF 81297.  Significant increases in rat brain and heart reflect changes in PDE4 specific binding (total - non-specific binding [coinjection with satg. dose of (R)-rolipram]).  These results demonstrate that acute treatments elevating synaptic NA, 5HT and HA, but not DA levels, significantly enhance (R)-[11C]rolipram binding.  Use of (R)-[11C]rolipram and positron emission tomog. as an index of PDE4 activity could provide insight into understanding disease states with altered NA, 5HT and HA concns.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqfQN-TWuD2k7Vg90H21EOLACvtfcHk0ljDOeOX_PB20A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltlKrsbg%253D&md5=a13ba5348390c7fea798c49ff0d1506f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1016%2Fj.lfs.2006.01.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.lfs.2006.01.010%26sid%3Dliteratum%253Aachs%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DIncreasing%2520synaptic%2520noradrenaline%252C%2520serotonin%2520and%2520histamine%2520enhances%2520in%2520vivo%2520binding%2520of%2520phosphodiesterase-4%2520inhibitor%2520%2528R%2529-%255B11C%255Drolipram%2520in%2520rat%2520brain%252C%2520lung%2520and%2520heart%26jtitle%3DLife%2520Sci.%26date%3D2006%26volume%3D79%26spage%3D356%26epage%3D364%26doi%3D10.1016%2Fj.lfs.2006.01.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greene, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thackeray, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deKemp, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span> <span> </span><span class="NLM_article-title">In vivo selective binding of (<i>R</i>)-[<sup>11</sup>C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.10.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2006.10.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=17210463" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisVaisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2007&pages=71-77&author=M.+Kenkauthor=M.+Greeneauthor=J.+Thackerayauthor=R.+A.+deKempauthor=M.+Lortieauthor=S.+Thornauthor=R.+S.+Beanlandsauthor=J.+N.+DaSilva&title=In+vivo+selective+binding+of+%28R%29-%5B11C%5Drolipram+to+phosphodiesterase-4+provides+the+basis+for+studying+intracellular+cAMP+signaling+in+the+myocardium+and+other+peripheral+tissues&doi=10.1016%2Fj.nucmedbio.2006.10.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo selective binding of (R)-[11C]rolipram to phosphodiesterase-4 provides the basis for studying intracellular cAMP signaling in the myocardium and other peripheral tissues</span></div><div class="casAuthors">Kenk, Miran; Greene, Michael; Thackeray, James; de Kemp, Robert A.; Lortie, Mireille; Thorn, Stephanie; Beanlands, Rob S.; Da Silva, Jean N.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-77</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase-4 (PDE4) enzymes specifically break down the second messenger cAMP, thereby terminating the intracellular signaling cascade that plays an essential role in neurohormonal modulation of many physiol. systems.  PDE4 activity and expression are regulated by cAMP levels, suggesting that measurement of PDE4 provides an index of intracellular cAMP signaling.  Male Sprague-Dawley rats were administered (R)- or the less active enantiomer (S)-[11C]rolipram and sacrificed 30 min later with tracer retention measured in various tissues.  Co-injections with satg. doses of unlabeled (R)-rolipram, (S)-rolipram and Ro 20-1724, as well as subtype-selective PDE inhibitors vinpocetine, Bay 60-7550, cilostazol and zaprinast were used to establish binding selectivity for PDE4 over PDE1, PDE2, PDE3 and PDE5 subtypes, resp.  Autoradiog. was performed to substantiate results of biodistribution studies in the myocardium.  In vivo (R)-[11C]rolipram retention was dose-dependently reduced by co-injections of (R)-rolipram and (S)-rolipram (ED50 values of 0.03 mg/kg and 0.2 mg/kg, resp.).  Vinpocetine, Bay 60-7550, cilostazol and zaprinast had no effect on (R)-[11C]rolipram binding, while (R)-rolipram and Ro 20-1724 reduced the tracer uptake to nonspecific levels in PDE4-rich tissues.  In addn. to the brain, (R)-[11C]rolipram binds selectively to PDE4 across all cardiac regions, skeletal muscle, lungs and pancreas, but not in the adipose tissues.  In vivo findings were confirmed by in vitro autoradiog. studies, suggesting that (R)-[11C]rolipram can be applied to evaluate alterations in central and peripheral PDE4 levels and cAMP-mediated signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUv6Hif0382LVg90H21EOLACvtfcHk0ljlEGgBSl7pjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisVaisQ%253D%253D&md5=4614225628d13a693e85f7b594c01d0c</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.10.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.10.002%26sid%3Dliteratum%253Aachs%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DGreene%26aufirst%3DM.%26aulast%3DThackeray%26aufirst%3DJ.%26aulast%3DdeKemp%26aufirst%3DR.%2BA.%26aulast%3DLortie%26aufirst%3DM.%26aulast%3DThorn%26aufirst%3DS.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26atitle%3DIn%2520vivo%2520selective%2520binding%2520of%2520%2528R%2529-%255B11C%255Drolipram%2520to%2520phosphodiesterase-4%2520provides%2520the%2520basis%2520for%2520studying%2520intracellular%2520cAMP%2520signaling%2520in%2520the%2520myocardium%2520and%2520other%2520peripheral%2520tissues%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2007%26volume%3D34%26spage%3D71%26epage%3D77%26doi%3D10.1016%2Fj.nucmedbio.2006.10.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lourenco, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meyer, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hussey, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Potter, W. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houle, S.</span></span> <span> </span><span class="NLM_article-title">Imaging cAMP-specific phosphodiesterase-4 in human brain with <i>R</i>-[<sup>11</sup>C]rolipram and positron emission tomography</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1680</span>– <span class="NLM_lpage">1683</span>, <span class="refDoi"> DOI: 10.1007/s00259-002-0950-y</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-002-0950-y" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=12458404" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD38XptFGisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2002&pages=1680-1683&author=J.+N.+DaSilvaauthor=C.+M.+Lourencoauthor=J.+H.+Meyerauthor=D.+Husseyauthor=W.+Z.+Potterauthor=S.+Houle&title=Imaging+cAMP-specific+phosphodiesterase-4+in+human+brain+with+R-%5B11C%5Drolipram+and+positron+emission+tomography&doi=10.1007%2Fs00259-002-0950-y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Imaging cAMP-specific phosphodiesterase-4 in human brain with R-[11C]rolipram and positron emission tomography</span></div><div class="casAuthors">DaSilva, Jean N.; Lourenco, Celia M.; Meyer, Jeffrey H.; Hussey, Douglas; Potter, William Z.; Houle, Sylvain</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1680-1683</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer-Verlag</span>)
        </div><div class="casAbstract">Evidence of disruptions in cAMP-mediated signaling in several neuropsychiatric disorders has led to the development of R-[11C]rolipram for imaging phosphodiesterase-4 (PDE4) enzymes with positron emission tomog. (PET).  The high-affinity PDE4 inhibitor rolipram was previously reported to have an antidepressant effect in humans.  PDE4 is abundant in the brain, and it hydrolyzes cAMP produced following stimulation of various neurotransmitter systems.  PDE4 is regulated by intracellular cAMP levels.  This paper presents the first PET study of R-[11C]rolipram in living human brain.  Consistent with the wide distribution of PDE4, high radioactivity retention was obsd. in all regions representing the gray matter.  Rapid metab. was obsd., and kinetic anal. demonstrated that the data fit in a two-tissue compartment model.  R-[11C]Rolipram is thus suitable for imaging PDE4 and possibly cAMP signal transduction in the living human brain with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq4f-ekS8OB1bVg90H21EOLACvtfcHk0ljlEGgBSl7pjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XptFGisbk%253D&md5=0bd3e6eebccd951ba9b35262b6a4e0c5</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1007%2Fs00259-002-0950-y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-002-0950-y%26sid%3Dliteratum%253Aachs%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DLourenco%26aufirst%3DC.%2BM.%26aulast%3DMeyer%26aufirst%3DJ.%2BH.%26aulast%3DHussey%26aufirst%3DD.%26aulast%3DPotter%26aufirst%3DW.%2BZ.%26aulast%3DHoule%26aufirst%3DS.%26atitle%3DImaging%2520cAMP-specific%2520phosphodiesterase-4%2520in%2520human%2520brain%2520with%2520R-%255B11C%255Drolipram%2520and%2520positron%2520emission%2520tomography%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2002%26volume%3D29%26spage%3D1680%26epage%3D1683%26doi%3D10.1007%2Fs00259-002-0950-y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renaud, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deKemp, R. A.</span></span> <span> </span><span class="NLM_article-title">PET of (<i>R</i>)-<sup>11</sup>C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">269</span>, <span class="refDoi"> DOI: 10.2967/jnumed.110.082701</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.110.082701" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21270457" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC3M7kvVOrtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2011&pages=263-269&author=A.+J.+Thomasauthor=J.+N.+DaSilvaauthor=M.+Lortieauthor=J.+M.+Renaudauthor=M.+Kenkauthor=R.+S.+Beanlandsauthor=R.+A.+deKemp&title=PET+of+%28R%29-11C-rolipram+binding+to+phosphodiesterase-4+is+reproducible+and+sensitive+to+increased+norepinephrine+in+the+rat+heart&doi=10.2967%2Fjnumed.110.082701"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">PET of (R)-11C-rolipram binding to phosphodiesterase-4 is reproducible and sensitive to increased norepinephrine in the rat heart</span></div><div class="casAuthors">Thomas Adam J; DaSilva Jean N; Lortie Mireille; Renaud Jennifer M; Kenk Miran; Beanlands Rob S; deKemp Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Journal of nuclear medicine : official publication, Society of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">263-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">UNLABELLED:  Phosphodiesterase-4 (PDE4) plays a critical role in the regulation of β-adrenergic receptor-stimulated cyclic adenosine monophosphate cell signaling in the heart. (R)-rolipram, a PDE4-selective inhibitor, has been studied previously as a radiotracer for the quantification of PDE4 levels.  The aim of this study was to characterize (R)-(11)C-rolipram binding in the rat myocardium in vivo, using small-animal PET.  METHODS:  Male Sprague-Dawley rats (n = 30) were administered (R)-(11)C-rolipram and imaged for 60 min to evaluate tracer binding and reproducibility, quantified using Logan slope analysis of the distribution volume.  Dynamic (13)N-ammonia imaging was performed to quantify myocardial blood flow and assist in cardiac regional analysis.  Saturation studies evaluated the sensitivity of (R)-(11)C-rolipram to PDE4 blocking by unlabeled cold (R)-rolipram (0.0001-1.0 mg/kg), for estimation of the median effective dose (ED(50)) in the heart. (R)-(11)C-rolipram response to enhanced norepinephrine stimulation of the β-adrenergic receptor with desipramine (20 mg/kg, intravenous) was also studied.  Intrarat variability studies (n = 5) were conducted with test-retest imaging at 16 ± 7 d.  RESULTS:  A reduction of Logan slope was observed with increasing cold mass coadministered with the tracer, with an ED(50) of 0.0019 mg/kg (95% confidence interval, 0.0014-0.0052) estimated from the saturation studies.  This ED(50) predicted less than 10% enzyme occupancy at 0.0002 mg of cold (R)-rolipram per kilogram (mass/body weight).  Low-occupancy imaging at 0.00018 ± 0.00002 mg/kg produced a mean Logan slope of 5.5 ± 0.85 mL/cm(3).  Enzyme saturation of more than 90%, compared with low-occupancy conditions, occurred at more than 0.02 mg/kg, with a complete blocking dose (>1 mg of (R)-rolipram per kilogram) resulting in a Logan slope of 3.3 ± 0.1 mL/cm(3), representing a 40% reduction.  Compared with baseline, a Logan slope of 6.8 ± 0.7 mL/cm(3) in desipramine-challenged animals was observed, representing a 30% increase due to acute norepinephrine stimulation, despite a reduction in myocardial blood flow.  Intrarat and intraoperator variability was less than 5% between repeated measures.  CONCLUSION:  (R)-(11)C-rolipram shows the ability to monitor increases and decreases in PDE4 availability in the rat myocardium, with good reproducibility.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT91rgD6KwIGe-MdeMhXAHkfW6udTcc2eawCM-_Cu_DGbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3M7kvVOrtA%253D%253D&md5=efba521380cb00ccaaacf9e24c952480</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.110.082701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.110.082701%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DA.%2BJ.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DLortie%26aufirst%3DM.%26aulast%3DRenaud%26aufirst%3DJ.%2BM.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DdeKemp%26aufirst%3DR.%2BA.%26atitle%3DPET%2520of%2520%2528R%2529-11C-rolipram%2520binding%2520to%2520phosphodiesterase-4%2520is%2520reproducible%2520and%2520sensitive%2520to%2520increased%2520norepinephrine%2520in%2520the%2520rat%2520heart%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2011%26volume%3D52%26spage%3D263%26epage%3D269%26doi%3D10.2967%2Fjnumed.110.082701" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lortie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DaSilva, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kenk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thorn, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birnie, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beanlands, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">deKemp, R. A.</span></span> <span> </span><span class="NLM_article-title">Analysis of (<i>R</i>)- and (<i>S</i>)-[<sup>11</sup>C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">225</span>– <span class="NLM_lpage">236</span>, <span class="refDoi"> DOI: 10.1007/s11307-011-0482-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs11307-011-0482-6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21424298" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC383pt1CjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2012&pages=225-236&author=M.+Lortieauthor=J.+N.+DaSilvaauthor=M.+Kenkauthor=S.+Thornauthor=D.+Davisauthor=D.+Birnieauthor=R.+S.+Beanlandsauthor=R.+A.+deKemp&title=Analysis+of+%28R%29-+and+%28S%29-%5B11C%5Drolipram+kinetics+in+canine+myocardium+for+the+evaluation+of+phosphodiesterase-4+with+PET&doi=10.1007%2Fs11307-011-0482-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Analysis of (R)- and (S)-[(11)C]rolipram kinetics in canine myocardium for the evaluation of phosphodiesterase-4 with PET</span></div><div class="casAuthors">Lortie Mireille; DaSilva Jean N; Kenk Miran; Thorn Stephanie; Davis Darryl; Birnie David; Beanlands Rob S B; deKemp Robert A</div><div class="citationInfo"><span class="NLM_cas:title">Molecular imaging and biology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">225-36</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  (R)-[(11)C]rolipram and (S)-[(11)C]rolipram have been proposed to investigate phosphodiesterase-4 and, indirectly, cAMP-mediated signaling with PET.  This study assessed binding of these tracers to phosphodiesterase-4 in canine myocardium.  PROCEDURES:  Seven dogs underwent (R)-[(11)C]rolipram and (S)-[(11)C]rolipram dynamic PET imaging at baseline and with co-injection of saturating doses of (R)-rolipram.  Dual-input compartment models were applied to estimate the volumes of distribution (V(T)).  RESULTS:  The model comprising one compartment for unmetabolized tracer and one compartment for labeled metabolites provided excellent fits to data acquired with (S)-[(11)C]rolipram at baseline and with both enantiomers during co-injection scans.  Use of two compartments for unmetabolized (R)-[(11)C]rolipram at baseline was warranted according to Akaike and Schwarz criteria.  V(T) estimates obtained with these models were robust (CV ≤ 8.2%) and reproducible (CV ≤ 15%).  CONCLUSION:  An important fraction (~65%) of the V (T) of (R)-[(11)C]rolipram at baseline reflects specific binding.  Thus, the latter may be a useful index of phosphodiesterase-4 levels in canine myocardium.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSAmjGZPcBQkq__Jf7-eMvJfW6udTcc2eaHc2bzt_8zLLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC383pt1CjsA%253D%253D&md5=c1885295c664ea99ba6c63019240a8b2</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1007%2Fs11307-011-0482-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-011-0482-6%26sid%3Dliteratum%253Aachs%26aulast%3DLortie%26aufirst%3DM.%26aulast%3DDaSilva%26aufirst%3DJ.%2BN.%26aulast%3DKenk%26aufirst%3DM.%26aulast%3DThorn%26aufirst%3DS.%26aulast%3DDavis%26aufirst%3DD.%26aulast%3DBirnie%26aufirst%3DD.%26aulast%3DBeanlands%26aufirst%3DR.%2BS.%26aulast%3DdeKemp%26aufirst%3DR.%2BA.%26atitle%3DAnalysis%2520of%2520%2528R%2529-%2520and%2520%2528S%2529-%255B11C%255Drolipram%2520kinetics%2520in%2520canine%2520myocardium%2520for%2520the%2520evaluation%2520of%2520phosphodiesterase-4%2520with%2520PET%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2012%26volume%3D14%26spage%3D225%26epage%3D236%26doi%3D10.1007%2Fs11307-011-0482-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hines, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mallinger, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickstein, L. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drevets, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zarate, C. A.,  Jr</span></span> <span> </span><span class="NLM_article-title">Downregulation of brain phosphodiesterase type IV measured with <sup>11</sup>C-(<i>R</i>)-rolipram positron emission tomography in major depressive disorder</span>. <i>Biol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">554</span>, <span class="refDoi"> DOI: 10.1016/j.biopsych.2012.04.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.biopsych.2012.04.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22677471" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XosFWht7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=548-554&author=M.+Fujitaauthor=C.+S.+Hinesauthor=S.+S.+Zoghbiauthor=A.+G.+Mallingerauthor=L.+P.+Dicksteinauthor=J.+S.+Liowauthor=Y.+Zhangauthor=V.+W.+Pikeauthor=W.+C.+Drevetsauthor=R.+B.+Innisauthor=C.+A.+Zarate&title=Downregulation+of+brain+phosphodiesterase+type+IV+measured+with+11C-%28R%29-rolipram+positron+emission+tomography+in+major+depressive+disorder&doi=10.1016%2Fj.biopsych.2012.04.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of Brain Phosphodiesterase Type IV Measured with 11C-(R)-Rolipram Positron Emission Tomography in Major Depressive Disorder</span></div><div class="casAuthors">Fujita, Masahiro; Hines, Christina S.; Zoghbi, Sami S.; Mallinger, Alan G.; Dickstein, Leah P.; Liow, Jeih-San; Zhang, Yi; Pike, Victor W.; Drevets, Wayne C.; Innis, Robert B.; Zarate, Carlos A.</div><div class="citationInfo"><span class="NLM_cas:title">Biological Psychiatry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">548-554</span>CODEN:
                <span class="NLM_cas:coden">BIPCBF</span>;
        ISSN:<span class="NLM_cas:issn">0006-3223</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Background: Phosphodiesterase type IV (PDE4), an important component of the cyclic adenosine monophosphate (cAMP) cascade, selectively metabolizes cAMP in the brain to the inactive monophosphate.  Basic studies suggest that PDE4 mediates the effects of several antidepressants.  This study sought to quantify the binding of 11C-(R)-rolipram, a PDE4 inhibitor, as an indirect measure of this enzyme's activity in the brain of individuals with major depressive disorder (MDD) compared with healthy control subjects.  Methods: 11C-(R)-Rolipram brain positron emission tomog. scans were performed in 28 unmedicated MDD subjects and 25 age- and gender-matched healthy control subjects.  Patients were moderately depressed and about one half were treatment-naive.  11C-(R)-Rolipram binding in the brain was measured using arterial 11C-(R)-rolipram levels to correct for the influence of cerebral blood flow.  Results: Major depressive disorder subjects showed a widespread, approx. 20% redn. in 11C-(R)-rolipram binding (p = .002), which was not caused by different vols. of gray matter.  Decreased rolipram binding of similar magnitudes was obsd. in most brain areas.  Rolipram binding did not correlate with the severity of depressive or anxiety symptoms.  Conclusions: This study is the first to demonstrate that brain levels of PDE4, a crit. enzyme that regulates cAMP, are decreased in unmedicated individuals with MDD in vivo.  These results are in line with human postmortem and rodent studies demonstrating downregulation of the cAMP cascade in MDD and support the hypothesis that agents such as PDE4 inhibitors, which increase activity within the cAMP cascade, may have antidepressant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcoV9dpiu1LrVg90H21EOLACvtfcHk0lgnNImoMXygGA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XosFWht7k%253D&md5=96434e8c72969801f3e2713c83b63d92</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1016%2Fj.biopsych.2012.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.biopsych.2012.04.030%26sid%3Dliteratum%253Aachs%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DHines%26aufirst%3DC.%2BS.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMallinger%26aufirst%3DA.%2BG.%26aulast%3DDickstein%26aufirst%3DL.%2BP.%26aulast%3DLiow%26aufirst%3DJ.%2BS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DPike%26aufirst%3DV.%2BW.%26aulast%3DDrevets%26aufirst%3DW.%2BC.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DZarate%26aufirst%3DC.%2BA.%26atitle%3DDownregulation%2520of%2520brain%2520phosphodiesterase%2520type%2520IV%2520measured%2520with%252011C-%2528R%2529-rolipram%2520positron%2520emission%2520tomography%2520in%2520major%2520depressive%2520disorder%26jtitle%3DBiol.%2520Psychiatry%26date%3D2012%26volume%3D72%26spage%3D548%26epage%3D554%26doi%3D10.1016%2Fj.biopsych.2012.04.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Constantinescu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baldwin, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span> <span> </span><span class="NLM_article-title">Identification and <i>in vivo</i> evaluation of a fluorine-18 rolipram analogue, [<sup>18</sup>F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">205</span>– <span class="NLM_lpage">213</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3389</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.3389" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27006107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xks1Cntbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=205-213&author=D.+Thomaeauthor=T.+J.+Morleyauthor=H.+S.+Leeauthor=O.+Barretauthor=C.+Constantinescuauthor=C.+Papinauthor=R.+M.+Baldwinauthor=G.+D.+Tamagnanauthor=D.+Alagille&title=Identification+and+in+vivo+evaluation+of+a+fluorine-18+rolipram+analogue%2C+%5B18F%5DMNI-617%2C+as+a+radioligand+for+PDE4+imaging+in+mammalian+brain&doi=10.1002%2Fjlcr.3389"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Identification and in vivo evaluation of a fluorine-18 rolipram analogue, [18F]MNI-617, as a radioligand for PDE4 imaging in mammalian brain</span></div><div class="casAuthors">Thomae, David; Morley, Thomas J.; Lee, Hsiaoju S.; Barret, Olivier; Constantinescu, Cristian; Papin, Caroline; Baldwin, Ronald M.; Tamagnan, Gilles D.; Alagille, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">205-213</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 4 is the most prevalent PDE in the central nervous system (CNS) and catalyzes hydrolysis of intracellular cAMP, a secondary messenger.  By therapeutic inhibition of PDE4, intracellular cAMP levels can be stabilized, and the symptoms of psychiatric and neurodegenerative disorders including depression, memory loss and Parkinson's disease can be ameliorated.  Radiotracers targeting PDE4 can be used to study PDE4 d. and function, and evaluate new PDE4 therapeutics, in vivo in a non-invasive way, as has been shown using the carbon-11 labeled PDE4 inhibitor R-(-)-rolipram.  Herein we describe a small series of rolipram analogs that contain fluoro- or iodo-substituents that could be used as fluorine-18 PET or iodine-123 SPECT PDE4 radiotracers.  This series was evaluated with an in vitro binding assay and a 4-(fluoromethyl) deriv. of rolipram, MNI-617, was identified, with a five-fold increase in affinity for PDE4 (Kd = 0.26 nM) over R-(-)-rolipram (Kd = 1.6 nM).  A deutero-analog d2-[18F]MNI-617 was radiolabeled and produced in 23% yield with high (>5 Ci/μmol) specific activity and evaluated in non-human primate, where it rapidly entered the brain, with SUVs between 4 and 5, and with a distribution pattern consistent with that of PDE4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrm-mbS1eH8hbVg90H21EOLACvtfcHk0lhg8y8WH46bnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xks1Cntbo%253D&md5=d35fb9713bc93376bb2c7d97967436aa</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3389&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3389%26sid%3Dliteratum%253Aachs%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DMorley%26aufirst%3DT.%2BJ.%26aulast%3DLee%26aufirst%3DH.%2BS.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DConstantinescu%26aufirst%3DC.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DBaldwin%26aufirst%3DR.%2BM.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DAlagille%26aufirst%3DD.%26atitle%3DIdentification%2520and%2520in%2520vivo%2520evaluation%2520of%2520a%2520fluorine-18%2520rolipram%2520analogue%252C%2520%255B18F%255DMNI-617%252C%2520as%2520a%2520radioligand%2520for%2520PDE4%2520imaging%2520in%2520mammalian%2520brain%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2016%26volume%3D59%26spage%3D205%26epage%3D213%26doi%3D10.1002%2Fjlcr.3389" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coelho, R. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doran, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hughes, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuszpit, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lachapelle, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lazzaro, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mather, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sciabola, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Young, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span> <span> </span><span class="NLM_article-title">The discovery of a novel phosphodiesterase (PDE) 4B-preferring radioligand for positron emission tomography (PET) imaging</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">8538</span>– <span class="NLM_lpage">8551</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01050</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01050" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=8538-8551&author=L.+Zhangauthor=L.+Chenauthor=E.+M.+Beckauthor=T.+A.+Chappieauthor=R.+V.+Coelhoauthor=S.+D.+Doranauthor=K.+H.+Fanauthor=C.+J.+Helalauthor=J.+M.+Humphreyauthor=Z.+Hughesauthor=K.+Kuszpitauthor=E.+A.+Lachapelleauthor=J.+T.+Lazzaroauthor=C.+Leeauthor=R.+J.+Matherauthor=N.+C.+Patelauthor=M.+B.+Skaddanauthor=S.+Sciabolaauthor=P.+R.+Verhoestauthor=J.+M.+Youngauthor=K.+Zasadnyauthor=A.+Villalobos&title=The+discovery+of+a+novel+phosphodiesterase+%28PDE%29+4B-preferring+radioligand+for+positron+emission+tomography+%28PET%29+imaging&doi=10.1021%2Facs.jmedchem.7b01050"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging</span></div><div class="casAuthors">Zhang, Lei; Chen, Laigao; Beck, Elizabeth M.; Chappie, Thomas A.; Coelho, Richard V.; Doran, Shawn D.; Fan, Kuo-Hsien; Humphrey, John M.; Hughes, Zoe; Kuszpit, Kyle; Lachapelle, Erik A.; Lazzaro, John T.; Mather, Robert J.; Patel, Nandini C.; Skaddan, Marc B.; Sciabola, Simone; Verhoest, Patrick R.; Young, Joseph M.; Zasadny, Kenneth; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8538-8551</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort in identifying phosphodiesterase (PDE) 4B-preferring inhibitors for the treatment of central nervous system (CNS) disorders, we sought to identify a positron emission tomog. (PET) ligand to enable target occupancy measurement in vivo.  Through a systematic and cost-effective PET discovery process, involving expression level (Bmax) and biodistribution detn., a PET-specific structure-activity relationship (SAR) effort, and specific binding assessment using a LC-MS/MS "cold tracer" method, we have identified 8 (PF-06445974) as a promising PET lead.  Compd. 8 has exquisite potency at PDE4B, good selectivity over PDE4D, excellent brain permeability, and a high level of specific binding in the "cold tracer" study.  In subsequent non-human primate (NHP) PET imaging studies, [18F]8 showed rapid brain uptake and high target specificity, indicating that [18F]8 is a promising PDE4B-preferring radioligand for clin. PET imaging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpAKXd3Cu5nRLVg90H21EOLACvtfcHk0lhg8y8WH46bnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsFOmu7fI&md5=cecad407201ce6c59ac5a3257e921d07</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01050%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DCoelho%26aufirst%3DR.%2BV.%26aulast%3DDoran%26aufirst%3DS.%2BD.%26aulast%3DFan%26aufirst%3DK.%2BH.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DHughes%26aufirst%3DZ.%26aulast%3DKuszpit%26aufirst%3DK.%26aulast%3DLachapelle%26aufirst%3DE.%2BA.%26aulast%3DLazzaro%26aufirst%3DJ.%2BT.%26aulast%3DLee%26aufirst%3DC.%26aulast%3DMather%26aufirst%3DR.%2BJ.%26aulast%3DPatel%26aufirst%3DN.%2BC.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DSciabola%26aufirst%3DS.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DYoung%26aufirst%3DJ.%2BM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DThe%2520discovery%2520of%2520a%2520novel%2520phosphodiesterase%2520%2528PDE%2529%25204B-preferring%2520radioligand%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D8538%26epage%3D8551%26doi%3D10.1021%2Facs.jmedchem.7b01050" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakabayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Telu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dick, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujita, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morse, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liow, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gladding, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manly, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoghbi, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">D’Amato, E. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sindac, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nugent, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marron, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gurney, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Innis, R. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pike, V. W.</span></span> <span> </span><span class="NLM_article-title">Discovery, radiolabeling, and evaluation of subtype-selective inhibitors for positron emission tomography imaging of brain phosphodiesterase-4D</span>. <i>ACS Chem. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">1311</span>– <span class="NLM_lpage">1323</span>, <span class="refDoi"> DOI: 10.1021/acschemneuro.0c00077</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschemneuro.0c00077" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXls12hurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=1311-1323&author=Y.+Wakabayashiauthor=S.+Teluauthor=R.+M.+Dickauthor=M.+Fujitaauthor=M.+Oomsauthor=C.+L.+Morseauthor=J.+S.+Liowauthor=J.+S.+Hongauthor=R.+L.+Gladdingauthor=L.+S.+Manlyauthor=S.+S.+Zoghbiauthor=X.+Moauthor=E.+C.+D%E2%80%99Amatoauthor=J.+A.+Sindacauthor=R.+A.+Nugentauthor=B.+E.+Marronauthor=M.+E.+Gurneyauthor=R.+B.+Innisauthor=V.+W.+Pike&title=Discovery%2C+radiolabeling%2C+and+evaluation+of+subtype-selective+inhibitors+for+positron+emission+tomography+imaging+of+brain+phosphodiesterase-4D&doi=10.1021%2Facschemneuro.0c00077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery, Radiolabeling, and Evaluation of Subtype-Selective Inhibitors for Positron Emission Tomography Imaging of Brain Phosphodiesterase-4D</span></div><div class="casAuthors">Wakabayashi, Yuichi; Telu, Sanjay; Dick, Rachel M.; Fujita, Masahiro; Ooms, Maarten; Morse, Cheryl L.; Liow, Jeih-San; Hong, Jinsoo S.; Gladding, Robert L.; Manly, Lester S.; Zoghbi, Sami S.; Mo, Xuesheng; D'Amato, Emily C.; Sindac, Janice A.; Nugent, Richard A.; Marron, Brian E.; Gurney, Mark E.; Innis, Robert B.; Pike, Victor W.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1311-1323</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We aimed to develop radioligands for PET imaging of brain phosphodiesterase subtype 4D (PDE4D), a potential target for developing cognition enhancing or antidepressive drugs.  Exploration of several chem. series gave four leads with high PDE4D inhibitory potency and selectivity, optimal lipophilicity, and good brain uptake.  These leads featured alkoxypyridinyl cores.  They were successfully labeled with carbon-11 (t1/2 = 20.4 min) for evaluation with PET in monkey.  Whereas two of these radioligands did not provide PDE4D-specific signal in monkey brain, two others, [11C]T1660 and [11C]T1650, provided sizable specific signal, as judged by pharmacol. challenge using rolipram or a selective PDE4D inhibitor (BPN14770) and subsequent biomathematical anal.  Specific binding was highest in prefrontal cortex, temporal cortex, and hippocampus, regions that are important for cognitive function. [11C]T1650 was progressed to evaluation in humans with PET, but the output measure of brain enzyme d. (VT) increased with scan duration.  This instability over time suggests that radiometabolite(s) were accumulating in the brain.  BPN14770 blocked PDE4D uptake in human brain after a single dose, but the percentage occupancy was difficult to est. because of the unreliability of measuring VT.  Overall, these results show that imaging of PDE4D in primate brain is feasible but that further radioligand refinement is needed, most likely to avoid problematic radiometabolites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozp5xQe0DK5LVg90H21EOLACvtfcHk0lhg8y8WH46bnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXls12hurk%253D&md5=579a4aa455db9718cb25a79ad21830ec</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1021%2Facschemneuro.0c00077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschemneuro.0c00077%26sid%3Dliteratum%253Aachs%26aulast%3DWakabayashi%26aufirst%3DY.%26aulast%3DTelu%26aufirst%3DS.%26aulast%3DDick%26aufirst%3DR.%2BM.%26aulast%3DFujita%26aufirst%3DM.%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DMorse%26aufirst%3DC.%2BL.%26aulast%3DLiow%26aufirst%3DJ.%2BS.%26aulast%3DHong%26aufirst%3DJ.%2BS.%26aulast%3DGladding%26aufirst%3DR.%2BL.%26aulast%3DManly%26aufirst%3DL.%2BS.%26aulast%3DZoghbi%26aufirst%3DS.%2BS.%26aulast%3DMo%26aufirst%3DX.%26aulast%3DD%25E2%2580%2599Amato%26aufirst%3DE.%2BC.%26aulast%3DSindac%26aufirst%3DJ.%2BA.%26aulast%3DNugent%26aufirst%3DR.%2BA.%26aulast%3DMarron%26aufirst%3DB.%2BE.%26aulast%3DGurney%26aufirst%3DM.%2BE.%26aulast%3DInnis%26aufirst%3DR.%2BB.%26aulast%3DPike%26aufirst%3DV.%2BW.%26atitle%3DDiscovery%252C%2520radiolabeling%252C%2520and%2520evaluation%2520of%2520subtype-selective%2520inhibitors%2520for%2520positron%2520emission%2520tomography%2520imaging%2520of%2520brain%2520phosphodiesterase-4D%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2020%26volume%3D11%26spage%3D1311%26epage%3D1323%26doi%3D10.1021%2Facschemneuro.0c00077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">1654</span>– <span class="NLM_lpage">1659</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2019.04.036</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2019.04.036" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31047754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXoslamtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=1654-1659&author=L.+Jiaauthor=C.+Miaoauthor=F.+Dongauthor=W.+Liauthor=M.+Wangauthor=Q.+H.+Zhengauthor=Z.+Xu&title=Facile+synthesis+of+carbon-11-labeled+sEH%2FPDE4+dual+inhibitors+as+new+potential+PET+agents+for+imaging+of+sEH%2FPDE4+enzymes+in+neuroinflammation&doi=10.1016%2Fj.bmcl.2019.04.036"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Facile synthesis of carbon-11-labeled sEH/PDE4 dual inhibitors as new potential PET agents for imaging of sEH/PDE4 enzymes in neuroinflammation</span></div><div class="casAuthors">Jia, Limeng; Miao, Caihong; Dong, Fugui; Li, Wei; Wang, Min; Zheng, Qi-Huang; Xu, Zhidong</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">1654-1659</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To develop PET tracers for imaging of neuroinflammation, new carbon-11-labeled sEH/PDE4 dual inhibitors have been synthesized.  The ref. std. N-(4-methoxy-2-(trifluoromethyl)benzyl)benzamide (1, I) and its corresponding desmethylated precursor N-(4-hydroxy-2-(trifluoromethyl)benzyl)benzamide (2, II) were synthesized from (4-methoxy-2-(trifluoromethyl)phenyl)methanamine and benzoic acid in one and two steps with 84% and 49% overall chem. yield, resp.  The std. N-(4-methoxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide (MPPA, 4, IV) and its precursor N-(4-hydroxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide (5, V) were synthesized from Me 4-piperidinecarboxylate, propionyl chloride and (4-methoxy-2-(trifluoromethyl)phenyl)methanamine in two and three steps with 62% and 34% overall chem. yield, resp.  The target tracers N-(4-[11C]methoxy-2-(trifluoromethyl)benzyl)benzamide ([11C]1) and N-(4-[11C]methoxy-2-(trifluoromethyl)benzyl)-1-propionylpiperidine-4-carboxamide ([11C]MPPA, [11C]4) were prepd. from their corresponding precursors 2 and 5 with [11C]CH3OTf through O-[11C]methylation and isolated by HPLC combined with SPE in 25-35% radiochem. yield, based on [11C]CO2 and decay cor. to end of bombardment (EOB).  The radiochem. purity was >99%, and the molar activity (AM) at EOB was 370-740 GBq/μmol with a total synthesis time of 35-40-min from EOB.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrd6uy86SbK0rVg90H21EOLACvtfcHk0lgrkbrtY6Lh-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXoslamtrc%253D&md5=c678e1b395306d56525ec30b39cd9d61</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2019.04.036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2019.04.036%26sid%3Dliteratum%253Aachs%26aulast%3DJia%26aufirst%3DL.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DFacile%2520synthesis%2520of%2520carbon-11-labeled%2520sEH%252FPDE4%2520dual%2520inhibitors%2520as%2520new%2520potential%2520PET%2520agents%2520for%2520imaging%2520of%2520sEH%252FPDE4%2520enzymes%2520in%2520neuroinflammation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D29%26spage%3D1654%26epage%3D1659%26doi%3D10.1016%2Fj.bmcl.2019.04.036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lee, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolda, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moon, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Esselstyn, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hertel, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lerner, A.</span></span> <span> </span><span class="NLM_article-title">PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP</span>. <i>Cell. Signalling</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">277</span>– <span class="NLM_lpage">284</span>, <span class="refDoi"> DOI: 10.1016/S0898-6568(01)00250-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0898-6568%2801%2900250-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11812656" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD38Xms1GqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2002&pages=277-284&author=R.+Leeauthor=S.+Woldaauthor=E.+Moonauthor=J.+Esselstynauthor=C.+Hertelauthor=A.+Lerner&title=PDE7A+is+expressed+in+human+B-lymphocytes+and+is+up-regulated+by+elevation+of+intracellular+cAMP&doi=10.1016%2FS0898-6568%2801%2900250-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">PDE7A is expressed in human B-lymphocytes and is up-regulated by elevation of intracellular cAMP</span></div><div class="casAuthors">Lee, Richard; Wolda, Sharon; Moon, Eunyi; Esselstyn, James; Hertel, Carmen; Lerner, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Cellular Signalling</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">277-284</span>CODEN:
                <span class="NLM_cas:coden">CESIEY</span>;
        ISSN:<span class="NLM_cas:issn">0898-6568</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">PDE7A is a recently described 3',5'-cyclic adenosine monophosphate (cAMP)-specific phosphodiesterase (PDE) whose expression has been detected in T-cells.  As treatment with the methylxanthine theophylline, a nonspecific PDE inhibitor, induces apoptosis in leukemic cells from patients with the B-lineage malignancy chronic lymphocytic leukemia (CLL), we sought to det. if PDE7A was a target of theophylline therapy in such cells.  Western anal. revealed expression of PDE7A in normal human splenic B-cells, primary CLL cells, and in a CLL-derived cell line (WSU-CLL).  Among the six cAMP PDEs (PDE1B, PDE3B, PDE4A, PDE4B, PDE4D, and PDE7) examd. in WSU-CLL, only PDE7A levels were augmented by treatment with methylxanthines.  The activity of PDE7A isolated from the WSU-CLL cell line by immunopptn. was inhibited by theophylline and IBMX with IC50 values of 343.5 and 8.6 μM, resp.  WSU-CLL PDE7A was also up-regulated by a novel specific inhibitor (IC242), which inhibits PDE7A from WSU-CLL cells with an IC50 value of 0.84 μM.  IC242-mediated up-regulation of PDE7A was blocked by the protein kinase A (PKA) inhibitor H-89.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwCXAfqTzsZbVg90H21EOLACvtfcHk0lgrkbrtY6Lh-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xms1GqtQ%253D%253D&md5=9e33d67359c04efd8144079ae20a2962</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1016%2FS0898-6568%2801%2900250-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0898-6568%252801%252900250-9%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DR.%26aulast%3DWolda%26aufirst%3DS.%26aulast%3DMoon%26aufirst%3DE.%26aulast%3DEsselstyn%26aufirst%3DJ.%26aulast%3DHertel%26aufirst%3DC.%26aulast%3DLerner%26aufirst%3DA.%26atitle%3DPDE7A%2520is%2520expressed%2520in%2520human%2520B-lymphocytes%2520and%2520is%2520up-regulated%2520by%2520elevation%2520of%2520intracellular%2520cAMP%26jtitle%3DCell.%2520Signalling%26date%3D2002%26volume%3D14%26spage%3D277%26epage%3D284%26doi%3D10.1016%2FS0898-6568%2801%2900250-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murray, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahno, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chou, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suda, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenlon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rassenti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottam, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kipps, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Insel, P. A.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">19532</span>– <span class="NLM_lpage">19537</span>, <span class="refDoi"> DOI: 10.1073/pnas.0806152105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1073%2Fpnas.0806152105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19033455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhsFanurbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2008&pages=19532-19537&author=L.+Zhangauthor=F.+Murrayauthor=A.+Zahnoauthor=J.+R.+Kanterauthor=D.+Chouauthor=R.+Sudaauthor=M.+Fenlonauthor=L.+Rassentiauthor=H.+Cottamauthor=T.+J.+Kippsauthor=P.+A.+Insel&title=Cyclic+nucleotide+phosphodiesterase+profiling+reveals+increased+expression+of+phosphodiesterase+7B+in+chronic+lymphocytic+leukemia&doi=10.1073%2Fpnas.0806152105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide phosphodiesterase profiling reveals increased expression of phosphodiesterase 7B in chronic lymphocytic leukemia</span></div><div class="casAuthors">Zhang, Lingzhi; Murray, Fiona; Zahno, Anja; Kanter, Joan R.; Chou, Daisy; Suda, Ryan; Fenlon, Michael; Rassenti, Laura; Cottam, Howard; Kipps, Thomas J.; Insel, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">19532-19537</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Cyclic nucleotide phosphodiesterase (PDE) isoforms can influence disease pathogenesis and be novel therapeutic targets.  Because lower cAMP levels may contribute to the decreased apoptosis that occurs in chronic lymphocytic leukemia (CLL), we assessed the expression levels of PDE isoforms in peripheral blood mononuclear cells (PBMC) of healthy adults and patients with CLL.  We found a unique PDE mRNA signature in CLL: higher levels than in normal PBMC of PDE7B (increased ≈23-fold) and lower levels of PDE3B, 4D, 5A, and 9A mRNA (each decreased ≈30-fold).  Increased PDE7B mRNA in CLL correlates with a 10-fold-higher expression of PDE7B protein and results in an increased contribution of PDE7 to total PDE activity.  Consistent with the higher level of PDE7B expression, inhibitors of PDE7 (BRL-50481, IR-202) and a dual PDE4/PDE7 inhibitor (IR-284) selectively increase apoptosis in CLL cells compared with normal PBMC or B cells.  Apoptosis of CLL cells promoted by inhibitors of PDE7 and PDE4/7 is attenuated by PKA inhibition, occurs via a mitochondrial-dependent process, and is assocd. with increased cAMP accumulation and down-regulation of the antiapoptotic protein survivin and of PDE7B.  The increase in PDE7B expression and PDE7 inhibitor-promoted apoptosis implicates PDE7B as a drug target in CLL.  Our findings identify a unique PDE signature in CLL and illustrate the utility of broad analyses of PDE isoform expression in human disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoc95nYYJPRbbVg90H21EOLACvtfcHk0lgrkbrtY6Lh-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhsFanurbI&md5=0c75070a6eeefdc4eadb103cacc15562</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0806152105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0806152105%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DMurray%26aufirst%3DF.%26aulast%3DZahno%26aufirst%3DA.%26aulast%3DKanter%26aufirst%3DJ.%2BR.%26aulast%3DChou%26aufirst%3DD.%26aulast%3DSuda%26aufirst%3DR.%26aulast%3DFenlon%26aufirst%3DM.%26aulast%3DRassenti%26aufirst%3DL.%26aulast%3DCottam%26aufirst%3DH.%26aulast%3DKipps%26aufirst%3DT.%2BJ.%26aulast%3DInsel%26aufirst%3DP.%2BA.%26atitle%3DCyclic%2520nucleotide%2520phosphodiesterase%2520profiling%2520reveals%2520increased%2520expression%2520of%2520phosphodiesterase%25207B%2520in%2520chronic%2520lymphocytic%2520leukemia%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2008%26volume%3D105%26spage%3D19532%26epage%3D19537%26doi%3D10.1073%2Fpnas.0806152105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Medina-Rodriguez, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arenzana, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pastor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palomo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia de Sola, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bribian, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Castro, F.</span></span> <span> </span><span class="NLM_article-title">Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival</span>. <i>Cell. Mol. Life Sci.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3449</span>– <span class="NLM_lpage">3462</span>, <span class="refDoi"> DOI: 10.1007/s00018-013-1340-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00018-013-1340-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23661015" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2013&pages=3449-3462&author=E.+M.+Medina-Rodriguezauthor=F.+J.+Arenzanaauthor=J.+Pastorauthor=M.+Redondoauthor=V.+Palomoauthor=R.+Garcia+de+Solaauthor=C.+Gilauthor=A.+Martinezauthor=A.+Bribianauthor=F.+de+Castro&title=Inhibition+of+endogenous+phosphodiesterase+7+promotes+oligodendrocyte+precursor+differentiation+and+survival&doi=10.1007%2Fs00018-013-1340-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of endogenous phosphodiesterase 7 promotes oligodendrocyte precursor differentiation and survival</span></div><div class="casAuthors">Medina-Rodriguez, E. M.; Arenzana, F. J.; Pastor, J.; Redondo, M.; Palomo, V.; Garcia de Sola, R.; Gil, C.; Martinez, A.; Bribian, A.; de Castro, F.</div><div class="citationInfo"><span class="NLM_cas:title">Cellular and Molecular Life Sciences</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3449-3462</span>CODEN:
                <span class="NLM_cas:coden">CMLSFI</span>;
        ISSN:<span class="NLM_cas:issn">1420-682X</span>.
    
            (<span class="NLM_cas:orgname">Birkhaeuser Basel</span>)
        </div><div class="casAbstract">During the development of the central nervous system (CNS), oligodendrocyte precursors (OPCs) are generated in specific sites within the neural tube and then migrate to colonize the entire CNS, where they differentiate into myelin-forming oligodendrocytes.  Demyelinating diseases such as multiple sclerosis (MS) are characterized by the death of these cells.  The CNS reacts to demyelination and by promoting spontaneous remyelination, an effect mediated by endogenous OPCs, cells that represent approx. 5-7 % of the cells in the adult brain.  Numerous factors influence oligodendrogliogenesis and oligodendrocyte differentiation, including morphogens, growth factors, chemotropic mols., extracellular matrix proteins, and intracellular cAMP levels.  Here, we show that during development and in early adulthood, OPCs in the murine cerebral cortex contain phosphodiesterase-7 (PDE7) that metabolizes cAMP.  We investigated the effects of different PDE7 inhibitors (the well-known BRL-50481 and two new ones, TC3.6 and VP1.15) on OPC proliferation, survival, and differentiation.  While none of the PDE7 inhibitors analyzed altered OPC proliferation, TC3.6 and VP1.15 enhanced OPC survival and differentiation, processes in which ERK intracellular signaling played a key role.  PDE7 expression was also obsd. in OPCs isolated from adult human brains and the differentiation of these OPCs into more mature oligodendroglial phenotypes was accelerated by treatment with both new PDE7 inhibitors.  These findings reveal new roles for PDE7 in regulating OPC survival and differentiation during brain development and in adulthood, and they may further our understanding of myelination and facilitate the development of therapeutic remyelination strategies for the treatment of MS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlaa101VvgBbVg90H21EOLACvtfcHk0lgxwNqhXuT0GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlCntb7M&md5=d0e7a29102b12cbee0ffabc516940626</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1007%2Fs00018-013-1340-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00018-013-1340-2%26sid%3Dliteratum%253Aachs%26aulast%3DMedina-Rodriguez%26aufirst%3DE.%2BM.%26aulast%3DArenzana%26aufirst%3DF.%2BJ.%26aulast%3DPastor%26aufirst%3DJ.%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DPalomo%26aufirst%3DV.%26aulast%3DGarcia%2Bde%2BSola%26aufirst%3DR.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DBribian%26aufirst%3DA.%26aulast%3Dde%2BCastro%26aufirst%3DF.%26atitle%3DInhibition%2520of%2520endogenous%2520phosphodiesterase%25207%2520promotes%2520oligodendrocyte%2520precursor%2520differentiation%2520and%2520survival%26jtitle%3DCell.%2520Mol.%2520Life%2520Sci.%26date%3D2013%26volume%3D70%26spage%3D3449%26epage%3D3462%26doi%3D10.1007%2Fs00018-013-1340-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Redondo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soteras, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Val, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paul-Fernandez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin-Alvarez, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mengod, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campillo, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">Effect of phosphodiesterase 7 (PDE7) inhibitors in experimental autoimmune encephalomyelitis mice. Discovery of a new chemically diverse family of compounds</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3274</span>– <span class="NLM_lpage">3284</span>, <span class="refDoi"> DOI: 10.1021/jm201720d</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm201720d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xjt1Sqsb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3274-3284&author=M.+Redondoauthor=J.+Breaauthor=D.+I.+Perezauthor=I.+Soterasauthor=C.+Valauthor=C.+Perezauthor=J.+A.+Morales-Garciaauthor=S.+Alonso-Gilauthor=N.+Paul-Fernandezauthor=R.+Martin-Alvarezauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=A.+Perez-Castilloauthor=G.+Mengodauthor=N.+E.+Campilloauthor=A.+Martinezauthor=C.+Gil&title=Effect+of+phosphodiesterase+7+%28PDE7%29+inhibitors+in+experimental+autoimmune+encephalomyelitis+mice.+Discovery+of+a+new+chemically+diverse+family+of+compounds&doi=10.1021%2Fjm201720d"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds</span></div><div class="casAuthors">Redondo, Miriam; Brea, Jose; Perez, Daniel I.; Soteras, Ignacio; Val, Cristina; Perez, Concepcion; Morales-Garcia, Jose A.; Alonso-Gil, Sandra; Paul-Fernandez, Nuria; Martin-Alvarez, Rocio; Cadavid, Maria Isabel; Loza, Maria Isabel; Perez-Castillo, Ana; Mengod, Guadalupe; Campillo, Nuria E.; Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3274-3284</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 7 is involved in proinflammatory processes, being widely expressed both on lymphocytes and on certain brain regions.  Specific inhibitors of PDE7 have been recently reported as potential new drugs for the treatment of neurol. disorders because of their ability to increase intracellular levels of cAMP and thus to modulate the inflammatory process, as a neuroprotective well-established strategy.  Multiple sclerosis is an unmet disease in which pathologies on the immune system, T-cells, and specific neural cells are involved simultaneously.  Therefore, PDE7 inhibitors able to interfere with all these targets may represent an innovative therapy for this pathol.  Here, we report a new chem. diverse family of heterocyclic PDE7 inhibitors, discovered and optimized by using mol. modeling studies, able to increase cAMP levels in cells, decrease inflammatory activation on primary neural cultures, and also attenuate the clin. symptoms in the exptl. autoimmune encephalomyelitis (EAE) mouse model.  These results led us to propose the use of PDE7 inhibitors as innovative therapeutic agents for the treatment of multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhQkmBFI_vSbVg90H21EOLACvtfcHk0lgxwNqhXuT0GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xjt1Sqsb8%253D&md5=83f3c2b660d47862bc6b0b34208cb5ef</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1021%2Fjm201720d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201720d%26sid%3Dliteratum%253Aachs%26aulast%3DRedondo%26aufirst%3DM.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DSoteras%26aufirst%3DI.%26aulast%3DVal%26aufirst%3DC.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DPaul-Fernandez%26aufirst%3DN.%26aulast%3DMartin-Alvarez%26aufirst%3DR.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DMengod%26aufirst%3DG.%26aulast%3DCampillo%26aufirst%3DN.%2BE.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DEffect%2520of%2520phosphodiesterase%25207%2520%2528PDE7%2529%2520inhibitors%2520in%2520experimental%2520autoimmune%2520encephalomyelitis%2520mice.%2520Discovery%2520of%2520a%2520new%2520chemically%2520diverse%2520family%2520of%2520compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3274%26epage%3D3284%26doi%3D10.1021%2Fjm201720d" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Echeverry-Alzate, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz-SanCristobal, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez-Moreno, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase7 inhibition activates adult neurogenesis in hippocampus and subventricular zone in vitro and in vivo</span>. <i>Stem Cells</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">458</span>– <span class="NLM_lpage">472</span>, <span class="refDoi"> DOI: 10.1002/stem.2480</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fstem.2480" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27538853" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWhu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=458-472&author=J.+A.+Morales-Garciaauthor=V.+Echeverry-Alzateauthor=S.+Alonso-Gilauthor=M.+Sanz-SanCristobalauthor=J.+A.+Lopez-Morenoauthor=C.+Gilauthor=A.+Martinezauthor=A.+Santosauthor=A.+Perez-Castillo&title=Phosphodiesterase7+inhibition+activates+adult+neurogenesis+in+hippocampus+and+subventricular+zone+in+vitro+and+in+vivo&doi=10.1002%2Fstem.2480"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 7 Inhibition Activates Adult Neurogenesis in Hippocampus and Subventricular Zone In Vitro and In Vivo</span></div><div class="casAuthors">Morales-Garcia, Jose A.; Echeverry-Alzate, Victor; Alonso-Gil, Sandra; Sanz-SanCristobal, Marina; Lopez-Moreno, Jose A.; Gil, Carmen; Martinez, Ana; Santos, Angel; Perez-Castillo, Ana</div><div class="citationInfo"><span class="NLM_cas:title">Stem Cells (Durham, NC, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">458-472</span>CODEN:
                <span class="NLM_cas:coden">STCEEJ</span>;
        ISSN:<span class="NLM_cas:issn">1066-5099</span>.
    
            (<span class="NLM_cas:orgname">AlphaMed Press</span>)
        </div><div class="casAbstract">The phosphodiesterase 7 (PDE7) enzyme is one of the enzymes responsible for controlling intracellular levels of cyclic adenosine 3',5'-monophosphate in the immune and central nervous system.  We have previously shown that inhibitors of this enzyme are potent neuroprotective and anti-inflammatory agents.  In addn., we also demonstrated that PDE7 inhibition induces endogenous neuroregenerative processes toward a dopaminergic phenotype.  Here, we show that PDE7 inhibition controls stem cell expansion in the subgranular zone of the dentate gyrus of the hippocampus (SGZ) and the subventricular zone (SVZ) in the adult rat brain.  Neurospheres cultures obtained from SGZ and SVZ of adult rats treated with PDE7 inhibitors presented an increased proliferation and neuronal differentiation compared to control cultures.  PDE7 inhibitors treatment of neurospheres cultures also resulted in an increase of the levels of phosphorylated cAMP response element binding protein, suggesting that their effects were indeed mediated through the activation of the cAMP/PKA signaling pathway.  In addn., adult rats orally treated with S14, a specific inhibitor of PDE7, presented elevated nos. of proliferating progenitor cells, and migrating precursors in the SGZ and the SVZ.  Moreover, long-term treatment with this PDE7 inhibitor shows a significant increase in newly generated neurons in the olfactory bulb and the hippocampus.  Also a better performance in memory tests was obsd. in S14 treated rats, suggesting a functional relevance for the S14-induced increase in SGZ neurogenesis.  Taken together, our results indicate for the first time that inhibition of PDE7 directly regulates proliferation, migration and differentiation of neural stem cells, improving spatial learning and memory tasks.  Stem Cells 2017;35:458-472.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpDd7pfIZXKbrVg90H21EOLACvtfcHk0lgNCSgFwHbnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWhu7Y%253D&md5=504d27eac431bc5cef902129045558aa</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1002%2Fstem.2480&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fstem.2480%26sid%3Dliteratum%253Aachs%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DEcheverry-Alzate%26aufirst%3DV.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DSanz-SanCristobal%26aufirst%3DM.%26aulast%3DLopez-Moreno%26aufirst%3DJ.%2BA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DSantos%26aufirst%3DA.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26atitle%3DPhosphodiesterase7%2520inhibition%2520activates%2520adult%2520neurogenesis%2520in%2520hippocampus%2520and%2520subventricular%2520zone%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DStem%2520Cells%26date%3D2017%26volume%3D35%26spage%3D458%26epage%3D472%26doi%3D10.1002%2Fstem.2480" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitt, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Auriga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatzelmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, P. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>79</i></span>,  <span class="NLM_fpage">321</span>– <span class="NLM_lpage">329</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2009.09.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bcp.2009.09.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19737543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsVKntLbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=79&publication_year=2010&pages=321-329&author=H.+Dongauthor=C.+Zittauthor=C.+Aurigaauthor=A.+Hatzelmannauthor=P.+M.+Epstein&title=Inhibition+of+PDE3%2C+PDE4+and+PDE7+potentiates+glucocorticoid-induced+apoptosis+and+overcomes+glucocorticoid+resistance+in+CEM+T+leukemic+cells&doi=10.1016%2Fj.bcp.2009.09.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE3, PDE4 and PDE7 potentiates glucocorticoid-induced apoptosis and overcomes glucocorticoid resistance in CEM T leukemic cells</span></div><div class="casAuthors">Dong, Hongli; Zitt, Christof; Auriga, Cornelia; Hatzelmann, Armin; Epstein, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">79</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">321-329</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Stimulation of the cAMP signaling pathway has been shown to induce apoptosis and augment the effects of glucocorticoids in inducing apoptosis in leukemic cells.  We recently reported that in primary B cell chronic lymphocytic leukemic (B-CLL) cells, apoptosis could be induced by stimulating the cAMP signaling pathway with a phosphodiesterase 4 (PDE4) inhibitor alone; while in contrast, in the CEM T leukemic cell line, PDE4 inhibitors alone were ineffective, and concurrent stimulation of adenylyl cyclase was required to see effects.  We report here that in the CEM and Jurkat T leukemic cell lines, the most abundantly expressed PDEs are PDE3B, PDE4A, PDE4D, PDE7A, and PDE8A.  Selective inhibition of PDE3, PDE4, or PDE7 alone produces little effect on cell viability, but inhibition of all three of these PDEs together dramatically enhances glucocorticoid-induced apoptosis in CEM cells, and overcomes glucocorticoid resistance in a glucocorticoid-resistant CEM cell line.  These studies indicate that for some leukemic cell types, a desired therapeutic effect may be achieved by inhibiting more than one form of PDE.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaEL_2OkPoJrVg90H21EOLACvtfcHk0lgNCSgFwHbnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsVKntLbF&md5=7831a904a52d0e6e6dc9eedb374e4c1e</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2009.09.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2009.09.001%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DH.%26aulast%3DZitt%26aufirst%3DC.%26aulast%3DAuriga%26aufirst%3DC.%26aulast%3DHatzelmann%26aufirst%3DA.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26atitle%3DInhibition%2520of%2520PDE3%252C%2520PDE4%2520and%2520PDE7%2520potentiates%2520glucocorticoid-induced%2520apoptosis%2520and%2520overcomes%2520glucocorticoid%2520resistance%2520in%2520CEM%2520T%2520leukemic%2520cells%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2010%26volume%3D79%26spage%3D321%26epage%3D329%26doi%3D10.1016%2Fj.bcp.2009.09.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, Z. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J. Y.</span></span> <span> </span><span class="NLM_article-title">High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma</span>. <i>Leuk. Res.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">536</span>– <span class="NLM_lpage">540</span>, <span class="refDoi"> DOI: 10.1016/j.leukres.2013.02.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.leukres.2013.02.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23453122" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFyitbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2013&pages=536-540&author=C.+Fangauthor=H.+J.+Dongauthor=Z.+J.+Zouauthor=L.+Fanauthor=L.+Wangauthor=R.+Zhangauthor=J.+Xuauthor=W.+Xuauthor=J.+Y.+Li&title=High+expression+of+cyclic+nucleotide+phosphodiesterase+7B+mRNA+predicts+poor+prognosis+in+mantle+cell+lymphoma&doi=10.1016%2Fj.leukres.2013.02.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit57R"><div class="casContent"><span class="casTitleNuber">57</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of cyclic nucleotide phosphodiesterase 7B mRNA predicts poor prognosis in mantle cell lymphoma</span></div><div class="casAuthors">Fang, Cheng; Dong, Hua-Jie; Zou, Zhi-Jian; Fan, Lei; Wang, Li; Zhang, Run; Xu, Ji; Xu, Wei; Li, Jian-Yong</div><div class="citationInfo"><span class="NLM_cas:title">Leukemia Research</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">536-540</span>CODEN:
                <span class="NLM_cas:coden">LEREDD</span>;
        ISSN:<span class="NLM_cas:issn">0145-2126</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">In order to det. the relationship between expression of cyclic nucleotide phosphodiesterase isoform 7B (PDE7B) and mantle cell lymphoma (MCL) progression, PDE7B mRNA expression was measured by qRT-PCR in 21 untreated MCL patients with bone marrow involvement and 20 healthy donors.  The expression level of PDE7B was markedly higher in MCL patients compared with normal controls (P = 0.001), and the higher level of PDE7B expression was assocd. with unfavorable cytogenetic characteristics in MCL.  It was showed that higher expression of PDE7B might be a novel unfavorable prognostic indicator in MCL, which possess important clin. significance.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVGXk16jHy5rVg90H21EOLACvtfcHk0lgNCSgFwHbnUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFyitbY%253D&md5=c7063ccb02403c4d5a208c1f794c1ffb</span></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2Fj.leukres.2013.02.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.leukres.2013.02.006%26sid%3Dliteratum%253Aachs%26aulast%3DFang%26aufirst%3DC.%26aulast%3DDong%26aufirst%3DH.%2BJ.%26aulast%3DZou%26aufirst%3DZ.%2BJ.%26aulast%3DFan%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DJ.%2BY.%26atitle%3DHigh%2520expression%2520of%2520cyclic%2520nucleotide%2520phosphodiesterase%25207B%2520mRNA%2520predicts%2520poor%2520prognosis%2520in%2520mantle%2520cell%2520lymphoma%26jtitle%3DLeuk.%2520Res.%26date%3D2013%26volume%3D37%26spage%3D536%26epage%3D540%26doi%3D10.1016%2Fj.leukres.2013.02.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishikawa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiyomaru, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Usui, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsuhashi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Enokida, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakagawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shozu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, N.</span></span> <span> </span><span class="NLM_article-title">The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer</span>. <i>Int. J. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">325</span>– <span class="NLM_lpage">334</span>, <span class="refDoi"> DOI: 10.3892/ijo.2015.2986</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3892%2Fijo.2015.2986" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25955017" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvV2hug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2015&pages=325-334&author=N.+Yamamotoauthor=R.+Nishikawaauthor=T.+Chiyomaruauthor=Y.+Gotoauthor=I.+Fukumotoauthor=H.+Usuiauthor=A.+Mitsuhashiauthor=H.+Enokidaauthor=M.+Nakagawaauthor=M.+Shozuauthor=N.+Seki&title=The+tumor-suppressive+microRNA-1%2F133a+cluster+targets+PDE7A+and+inhibits+cancer+cell+migration+and+invasion+in+endometrial+cancer&doi=10.3892%2Fijo.2015.2986"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">The tumor-suppressive microRNA-1/133a cluster targets PDE7A and inhibits cancer cell migration and invasion in endometrial cancer</span></div><div class="casAuthors">Yamamoto, Noriko; Nishikawa, Rika; Chiyomaru, Takeshi; Goto, Yusuke; Fukumoto, Ichiro; Usui, Hirokazu; Mitsuhashi, Akira; Enokida, Hideki; Nakagawa, Masayuki; Shozu, Makio; Seki, Naohiko</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Oncology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">325-334</span>CODEN:
                <span class="NLM_cas:coden">IJONES</span>;
        ISSN:<span class="NLM_cas:issn">1791-2423</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">In developed countries, endometrial cancer (EC) is the most common malignancy among women.  Unopposed estrogen therapy, obesity, nulliparity, diabetes mellitus and arterial hypertension have been linked to an increased risk of EC.  However, the mol. mechanisms of EC oncogenesis and metastasis have not yet been fully elucidated.  Our recent studies of microRNA (miRNA) expression signatures revealed that the microRNA-1/133a (miR-1/133a) cluster is frequently downregulated in various types of human cancers.  However, the functional role of the miR-1/133a cluster in EC cells is still unknown.  Thus, the aim of this study was to investigate the functional significance of the miR-1/133a cluster and its regulated mol. targets, with an emphasis on the contributions of miR-1/133a to EC oncogenesis and metastasis.  We found that the expression levels of miR-1 and miR-133a were significantly reduced in EC tissues.  Moreover, restoration of mature miR-1 or miR-133a miRNAs significantly inhibited cancer cell migration and invasion, suggesting that these clustered miRNAs act as tumor suppressors.  Prediction of miRNA targets revealed that phosphodiesterase 7A (PDE7A) was a potential target gene regulated by both miR-1 and miR-133a.  PDE7A was confirmed to be overexpressed in EC clin. specimens and silencing of PDE7A significantly inhibited cancer cell migration and invasion.  Our data demonstrated that downregulation of the miR-1/133a cluster promoted cancer cell migration and invasion via overexpression of PDE7A in EC cells.  Elucidation of the mol. networks regulated by tumor-suppressive miRNAs will provide insights into the mol. mechanisms of EC oncogenesis and metastasis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqzPHz5IDMu47Vg90H21EOLACvtfcHk0ljeWdEmMin_Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvV2hug%253D%253D&md5=0a12f2e1727b7f81a54f59e7c16f60e0</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.3892%2Fijo.2015.2986&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijo.2015.2986%26sid%3Dliteratum%253Aachs%26aulast%3DYamamoto%26aufirst%3DN.%26aulast%3DNishikawa%26aufirst%3DR.%26aulast%3DChiyomaru%26aufirst%3DT.%26aulast%3DGoto%26aufirst%3DY.%26aulast%3DFukumoto%26aufirst%3DI.%26aulast%3DUsui%26aufirst%3DH.%26aulast%3DMitsuhashi%26aufirst%3DA.%26aulast%3DEnokida%26aufirst%3DH.%26aulast%3DNakagawa%26aufirst%3DM.%26aulast%3DShozu%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DN.%26atitle%3DThe%2520tumor-suppressive%2520microRNA-1%252F133a%2520cluster%2520targets%2520PDE7A%2520and%2520inhibits%2520cancer%2520cell%2520migration%2520and%2520invasion%2520in%2520endometrial%2520cancer%26jtitle%3DInt.%2520J.%2520Oncol.%26date%3D2015%26volume%3D47%26spage%3D325%26epage%3D334%26doi%3D10.3892%2Fijo.2015.2986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cieslinski, L. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newton, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donnelly, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenwick, P. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholson, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnette, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giembycz, M. A.</span></span> <span> </span><span class="NLM_article-title">Discovery of BRL 50481 [3-(<i>N</i>,<i>N</i>-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8<sup>+</sup> T-lymphocytes</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">1679</span>– <span class="NLM_lpage">1689</span>, <span class="refDoi"> DOI: 10.1124/mol.104.002246</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fmol.104.002246" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15371556" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2004&pages=1679-1689&author=S.+J.+Smithauthor=L.+B.+Cieslinskiauthor=R.+Newtonauthor=L.+E.+Donnellyauthor=P.+S.+Fenwickauthor=A.+G.+Nicholsonauthor=P.+J.+Barnesauthor=M.+S.+Barnetteauthor=M.+A.+Giembycz&title=Discovery+of+BRL+50481+%5B3-%28N%2CN-dimethylsulfonamido%29-4-methyl-nitrobenzene%5D%2C+a+selective+inhibitor+of+phosphodiesterase+7%3A+in+vitro+studies+in+human+monocytes%2C+lung+macrophages%2C+and+CD8%2B+T-lymphocytes&doi=10.1124%2Fmol.104.002246"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit59R"><div class="casContent"><span class="casTitleNuber">59</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: In vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes</span></div><div class="casAuthors">Smith, Susan J.; Cieslinski, Lenora B.; Newton, Robert; Donnelly, Louise E.; Fenwick, Peter S.; Nicholson, Andrew G.; Barnes, Peter J.; Barnette, Mary S.; Giembycz, Mark A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1679-1689</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">0026-895X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The biochem. and pharmacol. characteristics in human proinflammatory cells of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a novel and selective inhibitor of phosphodiesterase (PDE) 7, are described.  BRL 50481 inhibited the activity of hrPDE7A1 expressed in baculovirus-infected Spodoptera frugiperda 9 cells in a competitive manner (Ki value of 180 nM) and was 416 and 1884 times less potent against PDE3 and 38 and 238 times less potent against PDE4 at a substrate concn. of 1 μM and 50 nM cAMP, resp.  Western blotting identified HSPDE7A1 but not HSPDE7A2 in three human cell types that are implicated in the pathogenesis of chronic obstructive lung disease, namely, CD8+ T-lymphocytes, monocytes, and lung macrophages.  BRL 50481 had no effect on the proliferation of CD8+ T-lymphocytes and only marginally (∼2-11%) reduced the generation of tumor necrosis factor (TNF)α from blood monocytes and lung macrophages.  However, in the presence of BRL 50481 the inhibitory effect of rolipram was enhanced on all three cell types.  The expression of HSPDE7A1 was increased in a time-dependent manner in monocytes that were "aged" in culture medium.  Under this condition, BRL 50481 now inhibited TNFα generation in a concn.-dependent manner.  In aged monocytes, rolipram, Org 9935 (a PDE3 inhibitor), and prostaglandin E2 inhibited TNFα generation in a concn.-dependent manner and interacted additively with BRL 50481.  BRL 50481 is the first fully documented PDE7 inhibitor that has acceptable selectivity for in vitro studies.  Furthermore, although BRL 50481 had only a modest inhibitory effect per se on the proinflammatory cells studied, it acted at least additively with other cAMP-elevating drugs, esp. when HSPDE7A1 was up-regulated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqSYIDHaxfl97Vg90H21EOLACvtfcHk0ljeWdEmMin_Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVOit7jE&md5=372d21ea04165ae5ae3a05d5bfd09d52</span></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1124%2Fmol.104.002246&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.104.002246%26sid%3Dliteratum%253Aachs%26aulast%3DSmith%26aufirst%3DS.%2BJ.%26aulast%3DCieslinski%26aufirst%3DL.%2BB.%26aulast%3DNewton%26aufirst%3DR.%26aulast%3DDonnelly%26aufirst%3DL.%2BE.%26aulast%3DFenwick%26aufirst%3DP.%2BS.%26aulast%3DNicholson%26aufirst%3DA.%2BG.%26aulast%3DBarnes%26aufirst%3DP.%2BJ.%26aulast%3DBarnette%26aufirst%3DM.%2BS.%26aulast%3DGiembycz%26aufirst%3DM.%2BA.%26atitle%3DDiscovery%2520of%2520BRL%252050481%2520%255B3-%2528N%252CN-dimethylsulfonamido%2529-4-methyl-nitrobenzene%255D%252C%2520a%2520selective%2520inhibitor%2520of%2520phosphodiesterase%25207%253A%2520in%2520vitro%2520studies%2520in%2520human%2520monocytes%252C%2520lung%2520macrophages%252C%2520and%2520CD8%252B%2520T-lymphocytes%26jtitle%3DMol.%2520Pharmacol.%26date%3D2004%26volume%3D66%26spage%3D1679%26epage%3D1689%26doi%3D10.1124%2Fmol.104.002246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pawar, M. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gullapalli, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gandhi, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhateja, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bajpai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sangana, R. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gudi, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khairatkar-Joshi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharat, L. A.</span></span> <span> </span><span class="NLM_article-title">Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson’s disease model</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">6286</span>– <span class="NLM_lpage">6291</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2012.07.077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2012.07.077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22944118" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12ltrbJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=6286-6291&author=A.+Banerjeeauthor=S.+Patilauthor=M.+Y.+Pawarauthor=S.+Gullapalliauthor=P.+K.+Guptaauthor=M.+N.+Gandhiauthor=D.+K.+Bhatejaauthor=M.+Bajpaiauthor=R.+R.+Sanganaauthor=G.+S.+Gudiauthor=N.+Khairatkar-Joshiauthor=L.+A.+Gharat&title=Imidazopyridazinones+as+novel+PDE7+inhibitors%3A+SAR+and+in+vivo+studies+in+Parkinson%E2%80%99s+disease+model&doi=10.1016%2Fj.bmcl.2012.07.077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazopyridazinones as novel PDE7 inhibitors: SAR and in vivo studies in Parkinson's disease model</span></div><div class="casAuthors">Banerjee, Abhisek; Patil, Sandip; Pawar, Mahesh Y.; Gullapalli, Srinivas; Gupta, Praveen K.; Gandhi, Maulik N.; Bhateja, Deepak K.; Bajpai, Malini; Sangana, Ramachandra Rao; Gudi, Girish S.; Khairatkar-Joshi, Neelima; Gharat, Laxmikant A.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">6286-6291</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and structure-activity relationship studies of a series of compds. from imidazopyridazinone scaffold as PDE7 inhibitors are disclosed.  Potent analogs such as compds. I (31 nM), II (27 nM), and III (12 nM) were identified.  The PDE selectivity and pharmacokinetic profile of compds. I, II, and III are also disclosed.  The adequate CNS penetration of compd. I in mice allowed it to be tested in the MPTP induced PD model and haloperidol induced catalepsy model to probe the differential pharmacol. of PDE7 in the striatal pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr3f6iMTgY1mrVg90H21EOLACvtfcHk0ljeWdEmMin_Lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12ltrbJ&md5=8991dc46813cf83ca1efb1941c82314c</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2012.07.077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2012.07.077%26sid%3Dliteratum%253Aachs%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DPatil%26aufirst%3DS.%26aulast%3DPawar%26aufirst%3DM.%2BY.%26aulast%3DGullapalli%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DP.%2BK.%26aulast%3DGandhi%26aufirst%3DM.%2BN.%26aulast%3DBhateja%26aufirst%3DD.%2BK.%26aulast%3DBajpai%26aufirst%3DM.%26aulast%3DSangana%26aufirst%3DR.%2BR.%26aulast%3DGudi%26aufirst%3DG.%2BS.%26aulast%3DKhairatkar-Joshi%26aufirst%3DN.%26aulast%3DGharat%26aufirst%3DL.%2BA.%26atitle%3DImidazopyridazinones%2520as%2520novel%2520PDE7%2520inhibitors%253A%2520SAR%2520and%2520in%2520vivo%2520studies%2520in%2520Parkinson%25E2%2580%2599s%2520disease%2520model%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D6286%26epage%3D6291%26doi%3D10.1016%2Fj.bmcl.2012.07.077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadoshima-Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murafuji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahira, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamoto, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimura, T.</span></span> <span> </span><span class="NLM_article-title">ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-γ production by mouse activated T lymphocytes</span>. <i>Immunol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">193</span>– <span class="NLM_lpage">197</span>, <span class="refDoi"> DOI: 10.1016/j.imlet.2009.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.imlet.2009.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19195485" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjtFOgur0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2009&pages=193-197&author=K.+Kadoshima-Yamaokaauthor=M.+Murakawaauthor=M.+Gotoauthor=Y.+Tanakaauthor=H.+Inoueauthor=H.+Murafujiauthor=A.+Nagahiraauthor=Y.+Hayashiauthor=K.+Nagahiraauthor=K.+Miuraauthor=T.+Nakatsukaauthor=K.+Chamotoauthor=Y.+Fukudaauthor=T.+Nishimura&title=ASB16165%2C+a+novel+inhibitor+for+phosphodiesterase+7A+%28PDE7A%29%2C+suppresses+IL-12-induced+IFN-%CE%B3+production+by+mouse+activated+T+lymphocytes&doi=10.1016%2Fj.imlet.2009.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">ASB16165, a novel inhibitor for phosphodiesterase 7A (PDE7A), suppresses IL-12-induced IFN-γ production by mouse activated T lymphocytes</span></div><div class="casAuthors">Kadoshima-Yamaoka, Kumiko; Murakawa, Masao; Goto, Megumi; Tanaka, Yoshitaka; Inoue, Hidekazu; Murafuji, Hidenobu; Nagahira, Asako; Hayashi, Yasuhiro; Nagahira, Kazuhiro; Miura, Kenju; Nakatsuka, Takashi; Chamoto, Kenji; Fukuda, Yoshiaki; Nishimura, Takashi</div><div class="citationInfo"><span class="NLM_cas:title">Immunology Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">193-197</span>CODEN:
                <span class="NLM_cas:coden">IMLED6</span>;
        ISSN:<span class="NLM_cas:issn">0165-2478</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase 7A (PDE7A) has been suggested to be involved in activation of T lymphocytes.  In the present study, a possible involvement of PDE7A in function of preactivated T cells (i.e. T lymphoblasts) was investigated using ASB16165, an inhibitor for PDE7A.  ASB16165, which has an IC50 value of 15 nM for human PDE7A, suppressed IL-12-induced IFN-γ prodn. by T lymphoblasts which have been prepd. by stimulating mouse T cells with anti-CD3 antibody.  In the same expt., rolipram, a PDE4-specific inhibitor, showed similar effect, while calcineurin antagonist FK506 did not.  Forskolin (an adenylyl cyclase activator) and dibutyryl cAMP also inhibited the IL-12-induced IFN-γ synthesis.  Rp-8-Br-cAMPS, an inhibitor of protein kinase A (PKA), reduced the suppressive effect of ASB16165 on the IFN-γ prodn. by T lymphoblasts.  The rescue of IFN-γ prodn. by Rp-8-Br-cAMPS was also obsd. in the inhibition by rolipram and forskolin.  These findings suggest that PDE7A may regulate function of activated T cells in a cAMP/PKA-dependent manner, and that PDE4 might share the role.  The data in our study also indicate that PDE7 inhibitors such as ASB16165 will be beneficial for the patients with immunol. disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoAte6iaG1VJ7Vg90H21EOLACvtfcHk0liEGwZ-CNsU6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjtFOgur0%253D&md5=7b942e86a71bc68cd8eb2ef43bfccfcf</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.1016%2Fj.imlet.2009.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.imlet.2009.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DKadoshima-Yamaoka%26aufirst%3DK.%26aulast%3DMurakawa%26aufirst%3DM.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DMurafuji%26aufirst%3DH.%26aulast%3DNagahira%26aufirst%3DA.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DNagahira%26aufirst%3DK.%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DNakatsuka%26aufirst%3DT.%26aulast%3DChamoto%26aufirst%3DK.%26aulast%3DFukuda%26aufirst%3DY.%26aulast%3DNishimura%26aufirst%3DT.%26atitle%3DASB16165%252C%2520a%2520novel%2520inhibitor%2520for%2520phosphodiesterase%25207A%2520%2528PDE7A%2529%252C%2520suppresses%2520IL-12-induced%2520IFN-%25CE%25B3%2520production%2520by%2520mouse%2520activated%2520T%2520lymphocytes%26jtitle%3DImmunol.%2520Lett.%26date%3D2009%26volume%3D122%26spage%3D193%26epage%3D197%26doi%3D10.1016%2Fj.imlet.2009.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kadoshima-Yamaoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goto, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoshioka, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inoue, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murafuji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kanki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagahira, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakatsuka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, Y.</span></span> <span> </span><span class="NLM_article-title">ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-α level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>613</i></span>,  <span class="NLM_fpage">163</span>– <span class="NLM_lpage">166</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejphar.2009.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19379723" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXms1yisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=613&publication_year=2009&pages=163-166&author=K.+Kadoshima-Yamaokaauthor=M.+Gotoauthor=M.+Murakawaauthor=R.+Yoshiokaauthor=Y.+Tanakaauthor=H.+Inoueauthor=H.+Murafujiauthor=S.+Kankiauthor=Y.+Hayashiauthor=K.+Nagahiraauthor=A.+Ogataauthor=T.+Nakatsukaauthor=Y.+Fukuda&title=ASB16165%2C+a+phosphodiesterase+7A+inhibitor%2C+reduces+cutaneous+TNF-%CE%B1+level+and+ameliorates+skin+edema+in+phorbol+ester+12-O-tetradecanoylphorbol-13-acetate-induced+skin+inflammation+model+in+mice&doi=10.1016%2Fj.ejphar.2009.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">ASB16165, a phosphodiesterase 7A inhibitor, reduces cutaneous TNF-α level and ameliorates skin edema in phorbol ester 12-O-tetradecanoylphorbol-13-acetate-induced skin inflammation model in mice</span></div><div class="casAuthors">Kadoshima-Yamaoka, Kumiko; Goto, Megumi; Murakawa, Masao; Yoshioka, Ryosuke; Tanaka, Yoshitaka; Inoue, Hidekazu; Murafuji, Hidenobu; Kanki, Satomi; Hayashi, Yasuhiro; Nagahira, Kazuhiro; Ogata, Atsuto; Nakatsuka, Takashi; Fukuda, Yoshiaki</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">613</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">163-166</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Possible role of phosphodiesterase 7A (PDE7A) in skin inflammation was examd. using ASB16165, a specific inhibitor for PDE7A.  Epicutaneous application of phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA) to mouse ear resulted in induction of skin edema, and topical treatment with ASB16165 inhibited the induction of skin edema in a dose-dependent manner.  The TPA challenge also increased the level of TNF-α at the application site, and the ASB16165 treatment reduced the TNF-α level in the skin.  In addn., ASB16165 suppressed the prodn. of TNF-α by human keratinocytes stimulated in vitro with TPA and calcium ionophore.  Forskolin, an activator of adenylyl cyclase, as well as dibutyryl cAMP also showed inhibitory effect on the TNF-α prodn. in the cells, suggesting involvement of cAMP in TNF-α generation.  These results demonstrate that PDE7A might regulate TNF-α prodn. in keratinocytes in a cAMP-dependent fashion.  As immunostaining anal. revealed that PDE7A is expressed in the epidermis and TNF-α is known to contribute to the TPA-induced edema, it is possible that the inhibitory effect of ASB16165 on skin edema in mouse TPA-induced dermatitis model is mediated by suppression of TNF-α prodn.  This is the first report suggesting the assocn. of PDE7A with the function of keratinocytes.  ASB16165 will be useful as an agent for skin inflammation in which TNF-α plays a pathogenic role (e.g. psoriasis).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouSZNzXzWby7Vg90H21EOLACvtfcHk0liEGwZ-CNsU6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXms1yisL8%253D&md5=2c33247cfb564c069c8106b94dbb7ab0</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DKadoshima-Yamaoka%26aufirst%3DK.%26aulast%3DGoto%26aufirst%3DM.%26aulast%3DMurakawa%26aufirst%3DM.%26aulast%3DYoshioka%26aufirst%3DR.%26aulast%3DTanaka%26aufirst%3DY.%26aulast%3DInoue%26aufirst%3DH.%26aulast%3DMurafuji%26aufirst%3DH.%26aulast%3DKanki%26aufirst%3DS.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DNagahira%26aufirst%3DK.%26aulast%3DOgata%26aufirst%3DA.%26aulast%3DNakatsuka%26aufirst%3DT.%26aulast%3DFukuda%26aufirst%3DY.%26atitle%3DASB16165%252C%2520a%2520phosphodiesterase%25207A%2520inhibitor%252C%2520reduces%2520cutaneous%2520TNF-%25CE%25B1%2520level%2520and%2520ameliorates%2520skin%2520edema%2520in%2520phorbol%2520ester%252012-O-tetradecanoylphorbol-13-acetate-induced%2520skin%2520inflammation%2520model%2520in%2520mice%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D613%26spage%3D163%26epage%3D166%26doi%3D10.1016%2Fj.ejphar.2009.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castro, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miralpeix, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Segarra, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Domenech, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beleta, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palacios, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryder, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miro, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonet, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casacuberta, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Azorin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pina, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puigdomenech, P.</span></span> <span> </span><span class="NLM_article-title">Benzyl derivatives of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides: first phosphodiesterase 7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">683</span>– <span class="NLM_lpage">689</span>, <span class="refDoi"> DOI: 10.1021/jm990382n</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm990382n" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXns1Khsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=683-689&author=A.+Martinezauthor=A.+Castroauthor=C.+Gilauthor=M.+Miralpeixauthor=V.+Segarraauthor=T.+Domenechauthor=J.+Beletaauthor=J.+M.+Palaciosauthor=H.+Ryderauthor=X.+Miroauthor=C.+Bonetauthor=J.+M.+Casacubertaauthor=F.+Azorinauthor=B.+Pinaauthor=P.+Puigdomenech&title=Benzyl+derivatives+of+2%2C1%2C3-benzo-+and+benzothieno%5B3%2C2-a%5Dthiadiazine+2%2C2-dioxides%3A+first+phosphodiesterase+7+inhibitors&doi=10.1021%2Fjm990382n"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Benzyl Derivatives of 2,1,3-Benzo- and Benzothieno[3,2-a]thiadiazine 2,2-Dioxides: First Phosphodiesterase 7 Inhibitors</span></div><div class="casAuthors">Martinez, Ana; Castro, Ana; Gil, Carmen; Miralpeix, Montserrat; Segarra, Victor; Domenech, Teresa; Beleta, Jorge; Palacios, Jose M.; Ryder, Hamish; Miro, Xavier; Bonet, Carles; Casacuberta, Josep M.; Azorin, Ferran; Pina, Benjami; Puigdomenech, Pere</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">683-689</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The synthesis of a new family of benzyl derivs. of 2,1,3-benzo- and benzothieno[3,2-a]thiadiazine 2,2-dioxides was achieved.  The biol. data revealed the first heterocyclic family of compds. with PDE 7 inhibitory properties, appearing to be a new objective for the treatment of T-cell-dependent disorders.  The IC50 values or percent inhibition values of the compds. against PDE 7 were calcd. by testing them against human recombinant PDE 7 expressed in S. cerevisiae.  In this expression system the only cyclic nucleotide hydrolyzing activity present in cell exts. corresponded to human PDE 7.  Isoenzyme selectivity PDE 7 vs. PDE 4 and PDE 3 was also measured.  Considering simultaneously inhibition of the three different isoenzymes, monobenzyl derivs. I (R = OMe) and II showed interesting PDE 7 potency (around 10 μM); although not statistically significant, a trend toward selectivity with respect to PDE 3 and PDE 4 was obtained.  Benzothiadiazine I (R = Ph), although less potent at PDE 7 (IC50 = 25 μM), also showed a trend of selectivity toward PDE 3 and PDE 4.  These compds. are considered the best leads for further optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7NtxEgDIInLVg90H21EOLACvtfcHk0liEGwZ-CNsU6w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXns1Khsg%253D%253D&md5=1f4198daccc462d90e2c3c1b8d53dade</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.1021%2Fjm990382n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm990382n%26sid%3Dliteratum%253Aachs%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DCastro%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26aulast%3DMiralpeix%26aufirst%3DM.%26aulast%3DSegarra%26aufirst%3DV.%26aulast%3DDomenech%26aufirst%3DT.%26aulast%3DBeleta%26aufirst%3DJ.%26aulast%3DPalacios%26aufirst%3DJ.%2BM.%26aulast%3DRyder%26aufirst%3DH.%26aulast%3DMiro%26aufirst%3DX.%26aulast%3DBonet%26aufirst%3DC.%26aulast%3DCasacuberta%26aufirst%3DJ.%2BM.%26aulast%3DAzorin%26aufirst%3DF.%26aulast%3DPina%26aufirst%3DB.%26aulast%3DPuigdomenech%26aufirst%3DP.%26atitle%3DBenzyl%2520derivatives%2520of%25202%252C1%252C3-benzo-%2520and%2520benzothieno%255B3%252C2-a%255Dthiadiazine%25202%252C2-dioxides%253A%2520first%2520phosphodiesterase%25207%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D683%26epage%3D689%26doi%3D10.1021%2Fjm990382n" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kempson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carlsen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbosa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stebbins, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dodd, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nadler, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McKinnon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrish, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pitts, W. J.</span></span> <span> </span><span class="NLM_article-title">Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1935</span>– <span class="NLM_lpage">1938</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2009.02.060</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2009.02.060" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19272774" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjt1arsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1935-1938&author=J.+Guoauthor=A.+Watsonauthor=J.+Kempsonauthor=M.+Carlsenauthor=J.+Barbosaauthor=K.+Stebbinsauthor=D.+Leeauthor=J.+Doddauthor=S.+G.+Nadlerauthor=M.+McKinnonauthor=J.+Barrishauthor=W.+J.+Pitts&title=Identification+of+potent+pyrimidine+inhibitors+of+phosphodiesterase+7+%28PDE7%29+and+their+ability+to+inhibit+T+cell+proliferation&doi=10.1016%2Fj.bmcl.2009.02.060"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of potent pyrimidine inhibitors of phosphodiesterase 7 (PDE7) and their ability to inhibit T cell proliferation</span></div><div class="casAuthors">Guo, Junqing; Watson, Andrew; Kempson, James; Carlsen, Marianne; Barbosa, Joseph; Stebbins, Karen; Lee, Deborah; Dodd, John; Nadler, Steven G.; McKinnon, Murray; Barrish, Joel; Pitts, William J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1935-1938</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of pyrimidine based inhibitors of PDE7 are discussed.  The synthesis, structure-activity relationships (SAR) and selectivity against several other PDE family members as well as activity in T cells are presented.  These compds. were found to have effects on T cell proliferation, however it is not clear whether the mechanism is related to PDE7 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrOy2sf7uz1gbVg90H21EOLACvtfcHk0lhSk-ihDRmtjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjt1arsrg%253D&md5=fb37ad52040df80c4fc76d8f0c605f25</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.02.060&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.02.060%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DJ.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DKempson%26aufirst%3DJ.%26aulast%3DCarlsen%26aufirst%3DM.%26aulast%3DBarbosa%26aufirst%3DJ.%26aulast%3DStebbins%26aufirst%3DK.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DDodd%26aufirst%3DJ.%26aulast%3DNadler%26aufirst%3DS.%2BG.%26aulast%3DMcKinnon%26aufirst%3DM.%26aulast%3DBarrish%26aufirst%3DJ.%26aulast%3DPitts%26aufirst%3DW.%2BJ.%26atitle%3DIdentification%2520of%2520potent%2520pyrimidine%2520inhibitors%2520of%2520phosphodiesterase%25207%2520%2528PDE7%2529%2520and%2520their%2520ability%2520to%2520inhibit%2520T%2520cell%2520proliferation%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D1935%26epage%3D1938%26doi%3D10.1016%2Fj.bmcl.2009.02.060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vergne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proust, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mafroud, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Royer, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigglesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schellhaas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barvian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tertre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berna, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulard, P.</span></span> <span> </span><span class="NLM_article-title">Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4607</span>– <span class="NLM_lpage">4613</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.07.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2004.07.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15324874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4607-4613&author=F.+Vergneauthor=P.+Bernardelliauthor=E.+Lorthioisauthor=N.+Phamauthor=E.+Proustauthor=C.+Oliveiraauthor=A.+K.+Mafroudauthor=F.+Royerauthor=R.+Wrigglesworthauthor=J.+Schellhaasauthor=M.+Barvianauthor=F.+Moreauauthor=M.+Idrissiauthor=A.+Tertreauthor=B.+Bertinauthor=M.+Coupeauthor=P.+Bernaauthor=P.+Soulard&title=Discovery+of+thiadiazoles+as+a+novel+structural+class+of+potent+and+selective+PDE7+inhibitors.+Part+1%3A+design%2C+synthesis+and+structure-activity+relationship+studies&doi=10.1016%2Fj.bmcl.2004.07.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit65R"><div class="casContent"><span class="casTitleNuber">65</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of thiadiazoles as a novel structural class of potent and selective PDE7 inhibitors. Part 1: design, synthesis and structure-activity relationship studies</span></div><div class="casAuthors">Vergne, Fabrice; Bernardelli, Patrick; Lorthiois, Edwige; Pham, Nga; Proust, Emmanuelle; Oliveira, Chrystelle; Mafroud, Abdel-Kader; Royer, Frederique; Wrigglesworth, Roger; Schellhaas, Jennifer; Barvian, Mark; Moreau, Francois; Idrissi, Moulay; Tertre, Anita; Bertin, Bernadette; Coupe, Magali; Berna, Patrick; Soulard, Patricia</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4607-4613</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and SAR studies of a series of thiadiazoles, e.g., I, as inhibitors of PDE7 are discussed.  The best compds. from the series displayed low nanomolar inhibitory activity and are selective vs. PDE4.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDIZv5eu8DVLVg90H21EOLACvtfcHk0lhSk-ihDRmtjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbg%253D&md5=03e61c0f25cc278fa402d11c3c0e4d37</span></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.07.008%26sid%3Dliteratum%253Aachs%26aulast%3DVergne%26aufirst%3DF.%26aulast%3DBernardelli%26aufirst%3DP.%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DPham%26aufirst%3DN.%26aulast%3DProust%26aufirst%3DE.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DMafroud%26aufirst%3DA.%2BK.%26aulast%3DRoyer%26aufirst%3DF.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DSchellhaas%26aufirst%3DJ.%26aulast%3DBarvian%26aufirst%3DM.%26aulast%3DMoreau%26aufirst%3DF.%26aulast%3DIdrissi%26aufirst%3DM.%26aulast%3DTertre%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DB.%26aulast%3DCoupe%26aufirst%3DM.%26aulast%3DBerna%26aufirst%3DP.%26aulast%3DSoulard%26aufirst%3DP.%26atitle%3DDiscovery%2520of%2520thiadiazoles%2520as%2520a%2520novel%2520structural%2520class%2520of%2520potent%2520and%2520selective%2520PDE7%2520inhibitors.%2520Part%25201%253A%2520design%252C%2520synthesis%2520and%2520structure-activity%2520relationship%2520studies%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4607%26epage%3D4613%26doi%3D10.1016%2Fj.bmcl.2004.07.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lorthiois, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bernardelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergne, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliveira, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mafroud, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proust, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heuze, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idrissi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tertre, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bertin, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wrigglesworth, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Descours, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soulard, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berna, P.</span></span> <span> </span><span class="NLM_article-title">Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">4623</span>– <span class="NLM_lpage">4626</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2004.07.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2004.07.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15324876" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2004&pages=4623-4626&author=E.+Lorthioisauthor=P.+Bernardelliauthor=F.+Vergneauthor=C.+Oliveiraauthor=A.+K.+Mafroudauthor=E.+Proustauthor=L.+Heuzeauthor=F.+Moreauauthor=M.+Idrissiauthor=A.+Tertreauthor=B.+Bertinauthor=M.+Coupeauthor=R.+Wrigglesworthauthor=A.+Descoursauthor=P.+Soulardauthor=P.+Berna&title=Spiroquinazolinones+as+novel%2C+potent%2C+and+selective+PDE7+inhibitors.+Part+1&doi=10.1016%2Fj.bmcl.2004.07.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit66R"><div class="casContent"><span class="casTitleNuber">66</span><div class="casTitle"><span class="NLM_cas:atitle">Spiroquinazolinones as novel, potent, and selective PDE7 inhibitors. Part 1</span></div><div class="casAuthors">Lorthiois, Edwige; Bernardelli, Patrick; Vergne, Fabrice; Oliveira, Chrystelle; Mafroud, Abdel-Kader; Proust, Emmanuelle; Heuze, Lamia; Moreau, Francois; Idrissi, Moulay; Tertre, Anita; Bertin, Bernadette; Coupe, Magali; Wrigglesworth, Roger; Descours, Arnaud; Soulard, Patricia; Berna, Patrick</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">4623-4626</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The synthesis and SAR studies of spiroquinazolinones as novel PDE7 inhibitors are discussed.  The best compds. from the series displayed nanomolar inhibitory affinity and were selective vs. other PDE isoenzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoF8ehETjuUaLVg90H21EOLACvtfcHk0li5ZRdyZKfkzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmvV2hsbY%253D&md5=b9cfa3872dcb29f500c4754c8168e6c4</span></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2004.07.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2004.07.011%26sid%3Dliteratum%253Aachs%26aulast%3DLorthiois%26aufirst%3DE.%26aulast%3DBernardelli%26aufirst%3DP.%26aulast%3DVergne%26aufirst%3DF.%26aulast%3DOliveira%26aufirst%3DC.%26aulast%3DMafroud%26aufirst%3DA.%2BK.%26aulast%3DProust%26aufirst%3DE.%26aulast%3DHeuze%26aufirst%3DL.%26aulast%3DMoreau%26aufirst%3DF.%26aulast%3DIdrissi%26aufirst%3DM.%26aulast%3DTertre%26aufirst%3DA.%26aulast%3DBertin%26aufirst%3DB.%26aulast%3DCoupe%26aufirst%3DM.%26aulast%3DWrigglesworth%26aufirst%3DR.%26aulast%3DDescours%26aufirst%3DA.%26aulast%3DSoulard%26aufirst%3DP.%26aulast%3DBerna%26aufirst%3DP.%26atitle%3DSpiroquinazolinones%2520as%2520novel%252C%2520potent%252C%2520and%2520selective%2520PDE7%2520inhibitors.%2520Part%25201%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2004%26volume%3D14%26spage%3D4623%26epage%3D4626%26doi%3D10.1016%2Fj.bmcl.2004.07.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales-Garcia, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alonso-Gil, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gracia-Rubio, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ros-Simo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez-Castillo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valverde, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">Modulation of cAMP-specific PDE without emetogenic activity: new sulfide-like PDE7 inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">8590</span>– <span class="NLM_lpage">8607</span>, <span class="refDoi"> DOI: 10.1021/jm501090m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm501090m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref67/cit67&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=8590-8607&author=A.+M.+Garciaauthor=J.+Breaauthor=J.+A.+Morales-Garciaauthor=D.+I.+Perezauthor=A.+Gonzalezauthor=S.+Alonso-Gilauthor=I.+Gracia-Rubioauthor=C.+Ros-Simoauthor=S.+Condeauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=A.+Perez-Castilloauthor=O.+Valverdeauthor=A.+Martinezauthor=C.+Gil&title=Modulation+of+cAMP-specific+PDE+without+emetogenic+activity%3A+new+sulfide-like+PDE7+inhibitors&doi=10.1021%2Fjm501090m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit67R"><div class="casContent"><span class="casTitleNuber">67</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of cAMP-Specific PDE without Emetogenic Activity: New Sulfide-Like PDE7 Inhibitors</span></div><div class="casAuthors">Garcia, Ana M.; Brea, Jose; Morales-Garcia, Jose A.; Perez, Daniel I.; Gonzalez, Alejandro; Alonso-Gil, Sandra; Gracia-Rubio, Irene; Ros-Simo, Clara; Conde, Santiago; Cadavid, Maria Isabel; Loza, Maria Isabel; Perez-Castillo, Ana; Valverde, Olga; Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">8590-8607</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A forward chem. genetic approach was followed to discover new targets and lead compds. for Parkinson's disease (PD) treatment.  By anal. of the cell protection produced by some small mols., a di-Ph sulfide compd. was revealed to be a new phosphodiesterase 7 (PDE7) inhibitor and identified as a new hit.  This result allows us to confirm the utility of PDE7 inhibitors as a potential pharmacol. treatment of PD.  On the basis of these data, a diverse family of di-Ph sulfides has been developed and pharmacol. evaluated in the present work.  Moreover, to gain insight into the safety of PDE7 inhibitors for human chronic treatment, the authors evaluated the new compds. in a surrogate emesis model, showing nonemetic effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm1xLipgnyN7Vg90H21EOLACvtfcHk0li5ZRdyZKfkzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1CnsrjO&md5=4ab21e80ba3a2fa20177a3a91bfcdb95</span></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=10.1021%2Fjm501090m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm501090m%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DA.%2BM.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DMorales-Garcia%26aufirst%3DJ.%2BA.%26aulast%3DPerez%26aufirst%3DD.%2BI.%26aulast%3DGonzalez%26aufirst%3DA.%26aulast%3DAlonso-Gil%26aufirst%3DS.%26aulast%3DGracia-Rubio%26aufirst%3DI.%26aulast%3DRos-Simo%26aufirst%3DC.%26aulast%3DConde%26aufirst%3DS.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DPerez-Castillo%26aufirst%3DA.%26aulast%3DValverde%26aufirst%3DO.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DModulation%2520of%2520cAMP-specific%2520PDE%2520without%2520emetogenic%2520activity%253A%2520new%2520sulfide-like%2520PDE7%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D8590%26epage%3D8607%26doi%3D10.1021%2Fjm501090m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Endo, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amano, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asanuma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sawada, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueo, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonoda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamei, N.</span></span> <span> </span><span class="NLM_article-title">Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2014.11.090</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2014.11.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25529739" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVyksL3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=649-653&author=Y.+Endoauthor=K.+Kawaiauthor=T.+Asanoauthor=S.+Amanoauthor=Y.+Asanumaauthor=K.+Sawadaauthor=K.+Oguraauthor=N.+Nagataauthor=N.+Ueoauthor=N.+Takahashiauthor=Y.+Sonodaauthor=N.+Kamei&title=Discovery+and+SAR+study+of+2-%284-pyridylamino%29thieno%5B3%2C2-d%5Dpyrimidin-4%283H%29-ones+as+soluble+and+highly+potent+PDE7+inhibitors&doi=10.1016%2Fj.bmcl.2014.11.090"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and SAR study of 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-ones as soluble and highly potent PDE7 inhibitors</span></div><div class="casAuthors">Endo, Yusuke; Kawai, Kentaro; Asano, Takeshi; Amano, Seiji; Asanuma, Yoshihito; Sawada, Keisuke; Ogura, Keiji; Nagata, Naoya; Ueo, Noriko; Takahashi, Nobuaki; Sonoda, Yo; Kamei, Noriyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">649-653</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The discovery and SAR study of a new series of sol. and highly potent phosphodiesterase (PDE) 7 inhibitors are described herein.  The authors explored a new lead compd. with improved soly., which led to the discovery of a 2-(4-pyridylamino)thieno[3,2-d]pyrimidin-4(3H)-one series.  The introduction of 3-piperidines at the 7-position resulted in the significant enhancement of PDE7 activity.  In particular, compd. I also showed strong PDE7 inhibitory activity; good selectivity against PDE3, 4, and 5; and good aq. soly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1wFrTvh9FIbVg90H21EOLACvtfcHk0li5ZRdyZKfkzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVyksL3K&md5=ad8f5cce007ad0e86c8016d0845b13d0</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2014.11.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2014.11.090%26sid%3Dliteratum%253Aachs%26aulast%3DEndo%26aufirst%3DY.%26aulast%3DKawai%26aufirst%3DK.%26aulast%3DAsano%26aufirst%3DT.%26aulast%3DAmano%26aufirst%3DS.%26aulast%3DAsanuma%26aufirst%3DY.%26aulast%3DSawada%26aufirst%3DK.%26aulast%3DOgura%26aufirst%3DK.%26aulast%3DNagata%26aufirst%3DN.%26aulast%3DUeo%26aufirst%3DN.%26aulast%3DTakahashi%26aufirst%3DN.%26aulast%3DSonoda%26aufirst%3DY.%26aulast%3DKamei%26aufirst%3DN.%26atitle%3DDiscovery%2520and%2520SAR%2520study%2520of%25202-%25284-pyridylamino%2529thieno%255B3%252C2-d%255Dpyrimidin-4%25283H%2529-ones%2520as%2520soluble%2520and%2520highly%2520potent%2520PDE7%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D649%26epage%3D653%26doi%3D10.1016%2Fj.bmcl.2014.11.090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Elfeky, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobahi, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gineinah, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmed, N. S.</span></span> <span> </span><span class="NLM_article-title">Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors</span>. <i>Arch. Pharm.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>353</i></span>, <span class="NLM_elocation-id">1900211</span> <span class="refDoi"> DOI: 10.1002/ardp.201900211</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fardp.201900211" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitFWitrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=353&publication_year=2020&author=S.+M.+Elfekyauthor=T.+R.+Sobahiauthor=M.+M.+Gineinahauthor=N.+S.+Ahmed&title=Synthesis%2C+biological+screening%2C+and+molecular+docking+of+quinazolinone+and+quinazolinethione+as+phosphodiesterase+7+inhibitors&doi=10.1002%2Fardp.201900211"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, biological screening, and molecular docking of quinazolinone and quinazolinethione as phosphodiesterase 7 inhibitors</span></div><div class="casAuthors">Elfeky, Sherin M.; Sobahi, Tariq R.; Gineinah, Magdy M.; Ahmed, Nesreen S.</div><div class="citationInfo"><span class="NLM_cas:title">Archiv der Pharmazie (Weinheim, Germany)</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">353</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1900211</span>CODEN:
                <span class="NLM_cas:coden">ARPMAS</span>;
        ISSN:<span class="NLM_cas:issn">0365-6233</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">N-Substituted isatoic anhydrides were used as starting materials for the synthesis of compds. 5-16 through alkali hydrolysis, Schiff base reactions, and oxidn.  Compds. 18-23 were obtained by thionation of their oxo isosteres using Lawesson's reagent.  Cyclocondesation of anthranilic acid with thiourea afforded compds. 25-27, which were S-alkylated to afford compds. 28-30, which were thionated using Lawesson's reagent to afford 31-33.  The compds. were tested for their in vitro inhibitory activity against the phosphodiesterase 7A (PDE7A) enzyme compared with the selective PDE7 inhibitor BRL50481.  All the compds. showed the inhibitory activity on the enzyme at micromolar levels.  Compds. 9 and 25 showed the highest inhibitory activity on the enzyme: IC50 = 0.096 and 0.074μM, resp., comparable to BRL50481 (IC50 = 0.072μM).  The binding mode and binding affinity of the target compds. at the enzyme PDE7A-binding site were studied through mol. docking.  Compds. 9 and 25 showed good recognition at the enzyme-binding site and were capable of binding in an inhibitory mode similar to the ref. compd. BRL50481, forming the necessary interactions with the key amino acids.  Docking studies and enzyme assay were in agreement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGorclFgoUSpQrVg90H21EOLACvtfcHk0lgefN_t_9yZjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitFWitrjM&md5=25449bd4201f1792b67877280ed1dadd</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1002%2Fardp.201900211&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fardp.201900211%26sid%3Dliteratum%253Aachs%26aulast%3DElfeky%26aufirst%3DS.%2BM.%26aulast%3DSobahi%26aufirst%3DT.%2BR.%26aulast%3DGineinah%26aufirst%3DM.%2BM.%26aulast%3DAhmed%26aufirst%3DN.%2BS.%26atitle%3DSynthesis%252C%2520biological%2520screening%252C%2520and%2520molecular%2520docking%2520of%2520quinazolinone%2520and%2520quinazolinethione%2520as%2520phosphodiesterase%25207%2520inhibitors%26jtitle%3DArch.%2520Pharm.%26date%3D2020%26volume%3D353%26doi%3D10.1002%2Fardp.201900211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Servaes, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vazquez, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wyffels, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedeurwaerdere, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Veken, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joossens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustyns, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobants, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staelens, S.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of two novel radioligands for PDE7 imaging in the brain</span>. <i>The 21st International Symposium on Radiopharmaceutical Sciences.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_fpage">S295</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&pages=S295&author=D.+Thomaeauthor=S.+Servaesauthor=N.+Vazquezauthor=L.+Wyffelsauthor=S.+Dedeurwaerdereauthor=P.+Van+der+Vekenauthor=J.+Joossensauthor=K.+Augustynsauthor=S.+Stroobantsauthor=S.+Staelens&title=Synthesis+and+preclinical+evaluation+of+two+novel+radioligands+for+PDE7+imaging+in+the+brain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DServaes%26aufirst%3DS.%26aulast%3DVazquez%26aufirst%3DN.%26aulast%3DWyffels%26aufirst%3DL.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DVan%2Bder%2BVeken%26aufirst%3DP.%26aulast%3DJoossens%26aufirst%3DJ.%26aulast%3DAugustyns%26aufirst%3DK.%26aulast%3DStroobants%26aufirst%3DS.%26aulast%3DStaelens%26aufirst%3DS.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520two%2520novel%2520radioligands%2520for%2520PDE7%2520imaging%2520in%2520the%2520brain%26jtitle%3DThe%252021st%2520International%2520Symposium%2520on%2520Radiopharmaceutical%2520Sciences.%26date%3D2005%26spage%3DS295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Obokata, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maeda, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumura, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takakuwa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukuda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minamimoto, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.-R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakajima, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis and preclinical evaluation of [11C]MTP38 as a novel PET ligand for phosphodiesterase 7 in the brain</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1007/s00259-021-05269-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-021-05269-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref71/cit71&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32561969" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=1&author=N.+Obokataauthor=C.+Sekiauthor=T.+Hirataauthor=J.+Maedaauthor=H.+Ishiiauthor=Y.+Nagaiauthor=T.+Matsumuraauthor=M.+Takakuwaauthor=H.+Fukudaauthor=T.+Minamimotoauthor=K.+Kawamuraauthor=M.-R.+Zhangauthor=T.+Nakajimaauthor=T.+Saijoauthor=M.+Higuchi&title=Synthesis+and+preclinical+evaluation+of+%5B11C%5DMTP38+as+a+novel+PET+ligand+for+phosphodiesterase+7+in+the+brain&doi=10.1007%2Fs00259-021-05269-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1007%2Fs00259-021-05269-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-021-05269-4%26sid%3Dliteratum%253Aachs%26aulast%3DObokata%26aufirst%3DN.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DHirata%26aufirst%3DT.%26aulast%3DMaeda%26aufirst%3DJ.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DY.%26aulast%3DMatsumura%26aufirst%3DT.%26aulast%3DTakakuwa%26aufirst%3DM.%26aulast%3DFukuda%26aufirst%3DH.%26aulast%3DMinamimoto%26aufirst%3DT.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.-R.%26aulast%3DNakajima%26aufirst%3DT.%26aulast%3DSaijo%26aufirst%3DT.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DSynthesis%2520and%2520preclinical%2520evaluation%2520of%2520%255B11C%255DMTP38%2520as%2520a%2520novel%2520PET%2520ligand%2520for%2520phosphodiesterase%25207%2520in%2520the%2520brain%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2021%26spage%3D1%26doi%3D10.1007%2Fs00259-021-05269-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kubota, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seki, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takado, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuoka, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichise, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawamura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Higuchi, M.</span></span> <span> </span><span class="NLM_article-title">A first-in-human study of (11)C-MTP38, a novel PET ligand for phosphodiesterase 7</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2021</span>,  <span class="NLM_fpage">1</span>, <span class="refDoi"> DOI: 10.1007/s00259-021-05235-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-021-05235-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32561969" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2021&pages=1&author=M.+Kubotaauthor=C.+Sekiauthor=Y.+Kimuraauthor=K.+Takahataauthor=H.+Shimadaauthor=Y.+Takadoauthor=K.+Matsuokaauthor=K.+Tagaiauthor=Y.+Sanoauthor=Y.+Yamamotoauthor=M.+Okadaauthor=T.+Kikuchiauthor=M.+Ichiseauthor=K.+Kawamuraauthor=M.+R.+Zhangauthor=M.+Higuchi&title=A+first-in-human+study+of+%2811%29C-MTP38%2C+a+novel+PET+ligand+for+phosphodiesterase+7&doi=10.1007%2Fs00259-021-05235-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1007%2Fs00259-021-05235-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-021-05235-0%26sid%3Dliteratum%253Aachs%26aulast%3DKubota%26aufirst%3DM.%26aulast%3DSeki%26aufirst%3DC.%26aulast%3DKimura%26aufirst%3DY.%26aulast%3DTakahata%26aufirst%3DK.%26aulast%3DShimada%26aufirst%3DH.%26aulast%3DTakado%26aufirst%3DY.%26aulast%3DMatsuoka%26aufirst%3DK.%26aulast%3DTagai%26aufirst%3DK.%26aulast%3DSano%26aufirst%3DY.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DOkada%26aufirst%3DM.%26aulast%3DKikuchi%26aufirst%3DT.%26aulast%3DIchise%26aufirst%3DM.%26aulast%3DKawamura%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26aulast%3DHiguchi%26aufirst%3DM.%26atitle%3DA%2520first-in-human%2520study%2520of%2520%252811%2529C-MTP38%252C%2520a%2520novel%2520PET%2520ligand%2520for%2520phosphodiesterase%25207%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2021%26spage%3D1%26doi%3D10.1007%2Fs00259-021-05235-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heckman, P. R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E. P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations</span>. <i>Neurosci. Biobehav. Rev.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">233</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/j.neubiorev.2018.02.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neubiorev.2018.02.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29454746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref73/cit73&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjs1Wktbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2018&pages=233-254&author=P.+R.+A.+Heckmanauthor=A.+Bloklandauthor=E.+P.+P.+Bollenauthor=J.+Prickaerts&title=Phosphodiesterase+inhibition+and+modulation+of+corticostriatal+and+hippocampal+circuits%3A+Clinical+overview+and+translational+considerations&doi=10.1016%2Fj.neubiorev.2018.02.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit73R"><div class="casContent"><span class="casTitleNuber">73</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibition and modulation of corticostriatal and hippocampal circuits: Clinical overview and translational considerations</span></div><div class="casAuthors">Heckman, P. R. A.; Blokland, A.; Bollen, E. P. P.; Prickaerts, J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience & Biobehavioral Reviews</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">233-254</span>CODEN:
                <span class="NLM_cas:coden">NBREDE</span>;
        ISSN:<span class="NLM_cas:issn">0149-7634</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The corticostriatal and hippocampal circuits contribute to the neurobiol. underpinnings of several neuropsychiatric disorders, including Alzheimer's disease, Parkinson's disease and schizophrenia.  Based on biol. function, these circuits can be clustered into motor circuits, associative/cognitive circuits and limbic circuits.  Together, dysfunctions in these circuits produce the wide range of symptoms obsd. in related neuropsychiatric disorders.  Intracellular signaling in these circuits is largely mediated through the cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) pathway with an addnl. role for the cyclic guanosine monophosphate (cGMP)/ protein kinase G (PKG) pathway, both of which can be regulated by phosphodiesterase inhibitors (PDE inhibitors).  Through their effects on cAMP response element-binding protein (CREB) and Dopamine- and cAMP-Regulated PhosphoProtein MR 32kDa (DARPP-32), cyclic nucleotide pathways are involved in synaptic transmission, neuron excitability, neuroplasticity and neuroprotection.  In this clin. review, we provide an overview of the current clin. status, discuss the general mechanism of action of PDE inhibitors in relation to the corticostriatal and hippocampal circuits and consider several translational challenges.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpZ8E39qiE5ybVg90H21EOLACvtfcHk0lgUnZBRN6WkuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjs1Wktbw%253D&md5=22af530e8aaab77dd07baece8cb68bf6</span></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1016%2Fj.neubiorev.2018.02.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neubiorev.2018.02.007%26sid%3Dliteratum%253Aachs%26aulast%3DHeckman%26aufirst%3DP.%2BR.%2BA.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DE.%2BP.%2BP.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DPhosphodiesterase%2520inhibition%2520and%2520modulation%2520of%2520corticostriatal%2520and%2520hippocampal%2520circuits%253A%2520Clinical%2520overview%2520and%2520translational%2520considerations%26jtitle%3DNeurosci.%2520Biobehav.%2520Rev.%26date%3D2018%26volume%3D87%26spage%3D233%26epage%3D254%26doi%3D10.1016%2Fj.neubiorev.2018.02.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C. A.</span>; <span class="NLM_string-name">Nunes, A. K. S.</span>; <span class="NLM_string-name">Rapôso, C.</span></span> <span> </span><span class="NLM_article-title">The role of NO/cGMP signaling on neuroinflammation: A new therapeutic opportunity</span>. In  <i>Mechanisms of Neuroinflammation</i>, <span class="NLM_year">2017</span>, <span class="NLM_publisher-loc">United Kingdom</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.5772%2Fintechopen.68990" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2017&author=C.+A.+Peixoto&author=A.+K.+S.+Nunes&author=C.+Rap%C3%B4so&title=Mechanisms+of+Neuroinflammation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.5772%2Fintechopen.68990&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.5772%252Fintechopen.68990%26sid%3Dliteratum%253Aachs%26aulast%3DPeixoto%26aufirst%3DC.%2BA.%26atitle%3DThe%2520role%2520of%2520NO%252FcGMP%2520signaling%2520on%2520neuroinflammation%253A%2520A%2520new%2520therapeutic%2520opportunity%26btitle%3DMechanisms%2520of%2520Neuroinflammation%26date%3D2017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xin, Z. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lue, T. F.</span></span> <span> </span><span class="NLM_article-title">Expression, distribution and regulation of phosphodiesterase 5</span>. <i>Curr. Pharm. Des.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">3439</span>– <span class="NLM_lpage">3457</span>, <span class="refDoi"> DOI: 10.2174/138161206778343064</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2174%2F138161206778343064" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=17017938" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=3439-3457&author=C.+S.+Linauthor=G.+Linauthor=Z.+C.+Xinauthor=T.+F.+Lue&title=Expression%2C+distribution+and+regulation+of+phosphodiesterase+5&doi=10.2174%2F138161206778343064"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit75R"><div class="casContent"><span class="casTitleNuber">75</span><div class="casTitle"><span class="NLM_cas:atitle">Expression, distribution and regulation of phosphodiesterase 5</span></div><div class="casAuthors">Lin, Ching-Shwun; Lin, Guiting; Xin, Zhong-Cheng; Lue, Tom F.</div><div class="citationInfo"><span class="NLM_cas:title">Current Pharmaceutical Design</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">27</span>),
    <span class="NLM_cas:pages">3439-3457</span>CODEN:
                <span class="NLM_cas:coden">CPDEFP</span>;
        ISSN:<span class="NLM_cas:issn">1381-6128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 5 (PDE5) is 1 of 11 members of the mammalian phosphodiesterase family that hydrolyzes cGMP and cAMP.  Best known as the target of the impotence drug, sildenafil, PDE5 degrades cGMP in smooth muscle cells so as to maintain the contracted state of contractile organs such as the penis, blood vessels, uterus, and intestines.  In addn., it regulates numerous other physiol. processes such as neurogenesis and apoptosis.  Like all other PDEs, PDE5 is dimeric; each subunit is ∼100 kDa in size and has 2 allosteric cGMP-binding sites and a catalytic domain.  Protein kinase G (PKG)-mediated phosphorylation and allosteric cGMP binding up-regulate PDE5 activity, whereas PP1 phosphatase-mediated dephosphorylation down-regulates.  Sildenafil and other selective inhibitors inhibit PDE5 by binding to the catalytic site.  From 2 promoters a single PDE5A gene at human chromosome 4q26 encodes 3 alternatively spliced isoforms (PDE5A1-3) that differ in the N-terminus.  The PDE5A promoter is located upstream of the 3 isoform-specific 1st exons (in the order of A1-A3-A2) and consists of a 139-bp core, a 308-bp upstream enhancer, and a 156-bp downstream enhancer.  The weaker 182-bp PDE5A2 promoter is located between the A3- and A2-specific exons and contains an indispensable Sp1-binding sequence.  Both promoters are responsive to cGMP or cAMP stimulation, and several studies have demonstrated regulation of PDE5 expression possibly through these promoters.  Virtually all tissues and cell types express PDE5, with heart and cardiomyocytes being contentious.  PDE5A1 and PDE5A2 are ubiquitous, but PDE5A3 is specific to smooth muscle.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp50kF64plnCbVg90H21EOLACvtfcHk0lgUnZBRN6WkuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVGlt7%252FJ&md5=4e50e20562709050deb7cff9a38c73e5</span></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.2174%2F138161206778343064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F138161206778343064%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%2BS.%26aulast%3DLin%26aufirst%3DG.%26aulast%3DXin%26aufirst%3DZ.%2BC.%26aulast%3DLue%26aufirst%3DT.%2BF.%26atitle%3DExpression%252C%2520distribution%2520and%2520regulation%2520of%2520phosphodiesterase%25205%26jtitle%3DCurr.%2520Pharm.%2520Des.%26date%3D2006%26volume%3D12%26spage%3D3439%26epage%3D3457%26doi%3D10.2174%2F138161206778343064" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Giovannoni, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergelli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graziano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dal Piaz, V.</span></span> <span> </span><span class="NLM_article-title">PDE5 inhibitors and their applications</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2564</span>– <span class="NLM_lpage">2587</span>, <span class="refDoi"> DOI: 10.2174/092986710791859360</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2174%2F092986710791859360" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20491634" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2564-2587&author=M.+P.+Giovannoniauthor=C.+Vergelliauthor=A.+Grazianoauthor=V.+Dal+Piaz&title=PDE5+inhibitors+and+their+applications&doi=10.2174%2F092986710791859360"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">PDE5 inhibitors and their applications</span></div><div class="casAuthors">Giovannoni, M. P.; Vergelli, C.; Graziano, A.; Dal Piaz, V.</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">2564-2587</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  PDE5 belongs to a superfamily of enzymes that catalyzes the hydrolysis of cyclic nucleotides cAMP and cGMP to the corresponding 5-nucleoside monophosphate.  PDE5 takes part in many physiol. and pathol. functions, therefore selective PDE5 inhibitors are potentially useful for a variety of pathologies.  At the present, PDE5 inhibitors available on the market have been used for the treatment of erectile dysfunction but, at the same time, are in clin. trials investigating other pathologies such as pulmonary arterial hypertension, coronary vasospasm, benign prostatic hyperplasia etc.  This review analyzes the PDE5 inhibitors currently in clin. use, the drugs in clin. trials and the most representative chem. classes published in literature in this last decade.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvcIgBfP9AWbVg90H21EOLACvtfcHk0lgUnZBRN6WkuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaju7nJ&md5=d80cc3a18546e004b08ad22245849ce3</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.2174%2F092986710791859360&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710791859360%26sid%3Dliteratum%253Aachs%26aulast%3DGiovannoni%26aufirst%3DM.%2BP.%26aulast%3DVergelli%26aufirst%3DC.%26aulast%3DGraziano%26aufirst%3DA.%26aulast%3DDal%2BPiaz%26aufirst%3DV.%26atitle%3DPDE5%2520inhibitors%2520and%2520their%2520applications%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2564%26epage%3D2587%26doi%3D10.2174%2F092986710791859360" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sato, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marban, E.</span></span> <span> </span><span class="NLM_article-title">The role of mitochondrial K<sub>ATP</sub> channels in cardioprotection</span>. <i>Basic Res. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">285</span>– <span class="NLM_lpage">289</span>, <span class="refDoi"> DOI: 10.1007/s003950070047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs003950070047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11005583" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFSkt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2000&pages=285-289&author=T.+Satoauthor=E.+Marban&title=The+role+of+mitochondrial+KATP+channels+in+cardioprotection&doi=10.1007%2Fs003950070047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">The role of mitochondrial KATP channels in cardioprotection</span></div><div class="casAuthors">Sato, Toshiaki; Marban, Eduardo</div><div class="citationInfo"><span class="NLM_cas:title">Basic Research in Cardiology</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">285-289</span>CODEN:
                <span class="NLM_cas:coden">BRCAB7</span>;
        ISSN:<span class="NLM_cas:issn">0300-8428</span>.
    
            (<span class="NLM_cas:orgname">Dr. Dietrich Steinkopff Verlag GmbH & Co. KG</span>)
        </div><div class="casAbstract">A review with 51 refs.  Topics discussed include the pharmacol. of mitochondrial KATP channels, the connection between cardioprotection and mitochondrial KATP channels, the link between signaling in ischemic preconditioning (IPC) and the mitochondrial KATP channel, and the mechanism of cardioprotection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpuM0_I595rXrVg90H21EOLACvtfcHk0lgbRmSe-b9jEw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFSkt7s%253D&md5=e8682716af73393f0fe9faaac6754238</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1007%2Fs003950070047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs003950070047%26sid%3Dliteratum%253Aachs%26aulast%3DSato%26aufirst%3DT.%26aulast%3DMarban%26aufirst%3DE.%26atitle%3DThe%2520role%2520of%2520mitochondrial%2520KATP%2520channels%2520in%2520cardioprotection%26jtitle%3DBasic%2520Res.%2520Cardiol.%26date%3D2000%26volume%3D95%26spage%3D285%26epage%3D289%26doi%3D10.1007%2Fs003950070047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Peixoto, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunes, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-5 inhibitors: action on the signaling pathways of neuroinflammation, neurodegeneration, and cognition</span>. <i>Mediators Inflammation</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>2015</i></span>,  <span class="NLM_fpage">940207</span>, <span class="refDoi"> DOI: 10.1155/2015/940207</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1155%2F2015%2F940207" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26770022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC28ngslCjtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2015&publication_year=2015&pages=940207&author=C.+A.+Peixotoauthor=A.+K.+Nunesauthor=A.+Garcia-Osta&title=Phosphodiesterase-5+inhibitors%3A+action+on+the+signaling+pathways+of+neuroinflammation%2C+neurodegeneration%2C+and+cognition&doi=10.1155%2F2015%2F940207"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase-5 Inhibitors: Action on the Signaling Pathways of Neuroinflammation, Neurodegeneration, and Cognition</span></div><div class="casAuthors">Peixoto Christina Alves; Nunes Ana Karolina Santana; Garcia-Osta Ana</div><div class="citationInfo"><span class="NLM_cas:title">Mediators of inflammation</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">2015</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">940207</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphodiesterase type 5 inhibitors (PDE5-Is) have recently emerged as a potential therapeutic strategy for neuroinflammatory, neurodegenerative, and memory loss diseases.  Mechanistically, PDE5-Is produce an anti-inflammatory and neuroprotection effect by increasing expression of nitric oxide synthases and accumulation of cGMP and activating protein kinase G (PKG), the signaling pathway of which is thought to play an important role in the development of several neurodiseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and multiple sclerosis (MS).  The aim of this paper was to review present knowledge of the signaling pathways that underlie the use of PDE5-Is in neuroinflammation, neurogenesis, learning, and memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQyhEh7K_YIpSCEBeYuoi7AfW6udTcc2eYR3NTkD2lLErntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28ngslCjtw%253D%253D&md5=7117c842c4d9c185516fefbb66f09185</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1155%2F2015%2F940207&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2015%252F940207%26sid%3Dliteratum%253Aachs%26aulast%3DPeixoto%26aufirst%3DC.%2BA.%26aulast%3DNunes%26aufirst%3DA.%2BK.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26atitle%3DPhosphodiesterase-5%2520inhibitors%253A%2520action%2520on%2520the%2520signaling%2520pathways%2520of%2520neuroinflammation%252C%2520neurodegeneration%252C%2520and%2520cognition%26jtitle%3DMediators%2520Inflammation%26date%3D2015%26volume%3D2015%26spage%3D940207%26doi%3D10.1155%2F2015%2F940207" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodahl, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olsen, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, radiolabeling and in vivo evaluation of [<sup>11</sup>C]RAL-01, a potential phosphodiesterase 5 radioligand</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">593</span>– <span class="NLM_lpage">597</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2006.04.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2006.04.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16843833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XntFWrtrw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2006&pages=593-597&author=S.+Jakobsenauthor=G.+M.+Kodahlauthor=A.+K.+Olsenauthor=P.+Cumming&title=Synthesis%2C+radiolabeling+and+in+vivo+evaluation+of+%5B11C%5DRAL-01%2C+a+potential+phosphodiesterase+5+radioligand&doi=10.1016%2Fj.nucmedbio.2006.04.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, radiolabeling and in vivo evaluation of [11C]RAL-01, a potential phosphodiesterase 5 radioligand</span></div><div class="casAuthors">Jakobsen, Steen; Kodahl, Gitte Munkebo; Olsen, Aage Kristian; Cumming, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">593-597</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Very few tracers are available for imaging studies of second messenger systems.  We developed a radiosynthesis for the phosphodiesterase (PDE) 5 inhibitor [11C]RAL-01.  Whole body distribution studies using positron emission tomog. (PET) revealed a time-dependant passage through the liver and accumulation of radioactivity in the bile of the Landrace pig.  Displaceable binding was readily discerned in the myocardium, and traces of binding were seen in pulmonary tissue, consistent with the use of this class of drug in the treatment of pulmonary hypertension and heart failure.  [11C]RAL-01 readily entered the brain and obtained an equil. distribution vol. of 4-5 mL g-1.  Mean parametric images suggested the presence of a small displaceable binding component, but this binding was not significant in the present group of three pigs.  Thus, [11C]RAL-01 shows considerable promise for PET studies of biliary elimination and of PDE5 binding in the cardiovascular system.  However, analogs of higher affinity may be required for investigations of central nervous system binding sites.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPKVRbPHi74bVg90H21EOLACvtfcHk0ljJd5G2NqU3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntFWrtrw%253D&md5=f5c53dad2b47d7c536e8b2809791fb2b</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2006.04.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2006.04.006%26sid%3Dliteratum%253Aachs%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DKodahl%26aufirst%3DG.%2BM.%26aulast%3DOlsen%26aufirst%3DA.%2BK.%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DSynthesis%252C%2520radiolabeling%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255DRAL-01%252C%2520a%2520potential%2520phosphodiesterase%25205%2520radioligand%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2006%26volume%3D33%26spage%3D593%26epage%3D597%26doi%3D10.1016%2Fj.nucmedbio.2006.04.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chekol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheysens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleynhens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokreisz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoof, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Evaluation of PET radioligands for in vivo visualization of phosphodiesterase 5 (PDE5)</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">162</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2013.10.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2013.10.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24290227" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVKitrjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=155-162&author=R.+Chekolauthor=O.+Gheysensauthor=J.+Cleynhensauthor=P.+Pokreiszauthor=G.+Vanhoofauthor=M.+Ahamedauthor=S.+Janssensauthor=A.+Verbruggenauthor=G.+Bormans&title=Evaluation+of+PET+radioligands+for+in+vivo+visualization+of+phosphodiesterase+5+%28PDE5%29&doi=10.1016%2Fj.nucmedbio.2013.10.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit80R"><div class="casContent"><span class="casTitleNuber">80</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of PET radioligands for in vivo visualization of phosphodiesterase 5 (PDE5)</span></div><div class="casAuthors">Chekol, Rufael; Gheysens, Olivier; Cleynhens, Jan; Pokreisz, Peter; Vanhoof, Greet; Ahamed, Muneer; Janssens, Stefan; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">155-162</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) is considered to play an important role in various etiologies such as pulmonary arterial hypertension (PAH) and chronic heart failure.  This PDE5 modulation represents an important prognostic and/or therapeutic target; however, there is currently no method to non-invasively evaluate the PDE5 expression levels in vivo.  Radiolabeled tracers were prepd. by N-alkylation of the corresponding precursors with [11C]methyl trifluoromethanesulfonate ([11C]CH3OTf) or 2-[18 F]fluoroethyl trifluoromethanesulfonate ([18 F]FEtOTf).  Biodistribution of radiolabeled tracers was studied in NMRI mice and their specific binding to PDE5 was investigated by comparing their lung retention as the enzyme is abundantly expressed in this organ.The overall radiochem. yields ranged between 24% and 60% for labeled radiotracers with radiochem. purity of > 99%.  The highest retention in the lungs at 30 min post injection was obsd. for vardenafil derivs. [11C]-7 and [18 F]-11 and the retention of the ethoxyethyl pyrazolopyrimidine deriv. [11C]-37 was moderate.  The other investigated compds. [11C]-8, [11C]-14, [11C]-21 and [11C]-33 showed lower retention in lungs in agreement with their lower in-vitro affinity for PDE5.Among the different radiolabeled PDE5 inhibitors evaluated in this study, the vardenafil derivs. [11C]-7 and [18 F]-11 are found to be promising tracers for in vivo visualization of PDE5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobkmHPuwoB1bVg90H21EOLACvtfcHk0ljJd5G2NqU3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVKitrjE&md5=1bffbf456898cd836b28e8d506e7f44c</span></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2013.10.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2013.10.007%26sid%3Dliteratum%253Aachs%26aulast%3DChekol%26aufirst%3DR.%26aulast%3DGheysens%26aufirst%3DO.%26aulast%3DCleynhens%26aufirst%3DJ.%26aulast%3DPokreisz%26aufirst%3DP.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DAhamed%26aufirst%3DM.%26aulast%3DJanssens%26aufirst%3DS.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DEvaluation%2520of%2520PET%2520radioligands%2520for%2520in%2520vivo%2520visualization%2520of%2520phosphodiesterase%25205%2520%2528PDE5%2529%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D155%26epage%3D162%26doi%3D10.1016%2Fj.nucmedbio.2013.10.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez-Vallejo, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ugarte, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Barroso, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuadrado-Tejedor, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szczupak, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dopeso-Reyes, I. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lanciego, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garcia-Osta, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Llop, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyarzabal, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Franco, R.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">403</span>– <span class="NLM_lpage">415</span>, <span class="refDoi"> DOI: 10.1111/jnc.13454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fjnc.13454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26641206" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref81/cit81&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVKitw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2016&pages=403-415&author=V.+Gomez-Vallejoauthor=A.+Ugarteauthor=C.+Garcia-Barrosoauthor=M.+Cuadrado-Tejedorauthor=B.+Szczupakauthor=I.+G.+Dopeso-Reyesauthor=J.+L.+Lanciegoauthor=A.+Garcia-Ostaauthor=J.+Llopauthor=J.+Oyarzabalauthor=R.+Franco&title=Pharmacokinetic+investigation+of+sildenafil+using+positron+emission+tomography+and+determination+of+its+effect+on+cerebrospinal+fluid+cGMP+levels&doi=10.1111%2Fjnc.13454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit81R"><div class="casContent"><span class="casTitleNuber">81</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetic investigation of sildenafil using positron emission tomography and determination of its effect on cerebrospinal fluid cGMP levels</span></div><div class="casAuthors">Gomez-Vallejo, Vanessa; Ugarte, Ana; Garcia-Barroso, Carolina; Cuadrado-Tejedor, Mar; Szczupak, Boguslaw; Dopeso-Reyes, Iria G.; Lanciego, Jose L.; Garcia-Osta, Ana; Llop, Jordi; Oyarzabal, Julen; Franco, Rafael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">403-415</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Sildenafil (Viagra) is a selective inhibitor of phosphodiesterase type 5 (PDE5), which degrades cGMP to the linear nucleotide.  Sildenafil is acutely used in erectile dysfunction and chronically in pulmonary hypertension.  Evidence in the last decade shows that sildenafil may have potential as a therapeutic option for Alzheimer's disease or other neurodegenerative disorders.  The purpose of this work was to explore whether sildenafil crosses the blood-brain barrier.  Pharmacokinetic properties of sildenafil in rodents were investigated using 11C-radiolabeling followed by in vivo positron emission tomog. (PET) and ex vivo tissue dissection and gamma counting.  PET results in rats suggest penetration into the central nervous system.  Ex vivo data in perfused animals suggest that trapping of [11C]sildenafil within the cerebral vascular endothelium limits accumulation in the central nervous system parenchyma.  Peroral sildenafil administration to Macaca fascicularis and subsequent chem. anal. of plasma and cerebrospinal fluid (CSF) using liq. chromatog. coupled with tandem mass spectrometry showed that drug content in the CSF was high enough to achieve PDE5 inhibition, which was also demonstrated by the significant increases in CSF cGMP levels.  Central actions of sildenafil include both relaxation of the cerebral vasculature and inhibition of PDE5 in neurons and glia.  This central action of sildenafil may underlie its efficacy in neuroprotection models, and may justify the continued search for a PDE5 ligand suitable for PET imaging.  Sildenafil interacts with phosphodiesterase type 5 (PDE5) expressed in the endothelium and/or smooth muscle cells of brain vessels and also crosses the blood-brain barrier to interact with PDE5 expressed in brain cells.  At therapeutic doses, the concn. of sildenafil in the cerebrospinal fluid (CSF) is high enough to inhibit PDE5 in the neural cells (neurons and glia).  In turn, the concn. of cGMP likely increases in parenchymal cells and, as shown in the CSF.  Read the Editorial Highlight for this article on page 220.  Cover Image for this issue: doi: 10.1111/jnc.13302.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrNfPXruaaALVg90H21EOLACvtfcHk0ljJd5G2NqU3HA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVKitw%253D%253D&md5=6de24b35db0c575431eabc500fc87fbd</span></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13454%26sid%3Dliteratum%253Aachs%26aulast%3DGomez-Vallejo%26aufirst%3DV.%26aulast%3DUgarte%26aufirst%3DA.%26aulast%3DGarcia-Barroso%26aufirst%3DC.%26aulast%3DCuadrado-Tejedor%26aufirst%3DM.%26aulast%3DSzczupak%26aufirst%3DB.%26aulast%3DDopeso-Reyes%26aufirst%3DI.%2BG.%26aulast%3DLanciego%26aufirst%3DJ.%2BL.%26aulast%3DGarcia-Osta%26aufirst%3DA.%26aulast%3DLlop%26aufirst%3DJ.%26aulast%3DOyarzabal%26aufirst%3DJ.%26aulast%3DFranco%26aufirst%3DR.%26atitle%3DPharmacokinetic%2520investigation%2520of%2520sildenafil%2520using%2520positron%2520emission%2520tomography%2520and%2520determination%2520of%2520its%2520effect%2520on%2520cerebrospinal%2520fluid%2520cGMP%2520levels%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D136%26spage%3D403%26epage%3D415%26doi%3D10.1111%2Fjnc.13454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chekol, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gheysens, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahamed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cleynhens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pokreisz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoof, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssens, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Carbon-11 and fluorine-18 radiolabeled pyridopyrazinone derivatives for positron emission tomography (PET) imaging of phosphodiesterase-5 (PDE5)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">486</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01666</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01666" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVWms7zO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=486-496&author=R.+Chekolauthor=O.+Gheysensauthor=M.+Ahamedauthor=J.+Cleynhensauthor=P.+Pokreiszauthor=G.+Vanhoofauthor=S.+Janssensauthor=A.+Verbruggenauthor=G.+Bormans&title=Carbon-11+and+fluorine-18+radiolabeled+pyridopyrazinone+derivatives+for+positron+emission+tomography+%28PET%29+imaging+of+phosphodiesterase-5+%28PDE5%29&doi=10.1021%2Facs.jmedchem.6b01666"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Carbon-11 and Fluorine-18 Radiolabeled Pyridopyrazinone Derivatives for Positron Emission Tomography (PET) Imaging of Phosphodiesterase-5 (PDE5)</span></div><div class="casAuthors">Chekol, Rufael; Gheysens, Olivier; Ahamed, Muneer; Cleynhens, Jan; Pokreisz, Peter; Vanhoof, Greet; Janssens, Stefan; Verbruggen, Alfons; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">486-496</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The cyclic guanosine monophosphate (cGMP) specific phosphodiesterase type 5 (PDE5) plays an important role in various pathologies including pulmonary arterial hypertension and cardiomyopathy.  PDE5 represents an important therapeutic and/or prognostic target, but noninvasive assessment of PDE5 expression is lacking.  The purpose of this study was to develop and evaluate pyridopyrazinone derivs. labeled with carbon-11 or fluorine-18 as PDE5-specific PET tracers.  In biodistribution studies, highest PDE5-specific retention was obsd. for [11C]-12 and [18F]-17 in the lungs of wild-type mice and in the myocardium of transgenic mice with cardiomyocyte-specific PDE5 overexpression at 30 min postinjection.  In vivo dynamic microPET images in rats revealed that both tracers crossed the blood-brain barrier but brain retention was not PDE5-specific.  Both [11C]-12 and [18F]-17 showed specific binding to PDE5 in myocardium of transgenic mice; however [18F]-17 showed significantly higher PDE5-specific inhibitable binding than [11C]-12.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqztFgTc-Z9TrVg90H21EOLACvtfcHk0liMR6AhsKPzCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVWms7zO&md5=048a160400b14b316eaf1b4af802044c</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01666&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01666%26sid%3Dliteratum%253Aachs%26aulast%3DChekol%26aufirst%3DR.%26aulast%3DGheysens%26aufirst%3DO.%26aulast%3DAhamed%26aufirst%3DM.%26aulast%3DCleynhens%26aufirst%3DJ.%26aulast%3DPokreisz%26aufirst%3DP.%26aulast%3DVanhoof%26aufirst%3DG.%26aulast%3DJanssens%26aufirst%3DS.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DCarbon-11%2520and%2520fluorine-18%2520radiolabeled%2520pyridopyrazinone%2520derivatives%2520for%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520imaging%2520of%2520phosphodiesterase-5%2520%2528PDE5%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D486%26epage%3D496%26doi%3D10.1021%2Facs.jmedchem.6b01666" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chezal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial-Besset, A.</span></span> <span> </span><span class="NLM_article-title">Development of a new radiofluorinated quinoline analog for PET imaging of phosphodiesterase 5 (PDE5) in brain</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">22</span>, <span class="refDoi"> DOI: 10.3390/ph9020022</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fph9020022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXmvVKqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2016&pages=22&author=J.+Liuauthor=B.+Wenzelauthor=S.+Dukic-Stefanovicauthor=R.+Teodoroauthor=F.+A.+Ludwigauthor=W.+Deuther-Conradauthor=S.+Schroderauthor=J.+M.+Chezalauthor=E.+Moreauauthor=P.+Brustauthor=A.+Maisonial-Besset&title=Development+of+a+new+radiofluorinated+quinoline+analog+for+PET+imaging+of+phosphodiesterase+5+%28PDE5%29+in+brain&doi=10.3390%2Fph9020022"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new radiofluorinated quinoline analog for PET imaging of phosphodiesterase 5 (PDE5) in brain</span></div><div class="casAuthors">Liu, Jianrong; Wenzel, Barbara; Dukic-Stefanovic, Sladjana; Teodoro, Rodrigo; Ludwig, Friedrich-Alexander; Deuther-Conrad, Winnie; Schroeder, Susann; Chezal, Jean-Michel; Moreau, Emmanuel; Brust, Peter; Maisonial-Besset, Aurelie</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">22/1-22/15</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Phosphodiesterases (PDEs) are enzymes that play a major role in cell signalling by hydrolyzing the secondary messengers cyclic adenosine monophosphate (cAMP) and/or cyclic guanosine monophosphate (cGMP) throughout the body and brain.  Altered cyclic nucleotide-mediated signalling has been assocd. with a wide array of disorders, including neurodegenerative disorders.  Recently, PDE5 has been shown to be involved in neurodegenerative disorders such as Alzheimer's disease, but its precise role has not been elucidated yet.  To visualize and quantify the expression of this enzyme in brain, we developed a radiotracer for specific PET imaging of PDE5.  A quinoline-based lead compd. has been structurally modified resulting in the fluoroethoxymethyl deriv. ICF24027 with high inhibitory activity towards PDE5 (IC50 = 1.86 nM).  Radiolabelling with fluorine-18 was performed by a one-step nucleophilic substitution reaction using a tosylate precursor (RCY(EOB) = 12.9% ± 1.8%; RCP > 99%; SA(EOS) = 70-126 GBq/μmol).  In vitro autoradiog. studies of [18F]ICF24027 on different mouse tissue as well as on porcine brain slices demonstrated a moderate specific binding to PDE5.  In vivo studies in mice revealed that [18F]ICF24027 was metabolized under formation of brain penetrable radiometabolites making the radiotracer unsuitable for PET imaging of PDE5 in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGooSgVz7_FolrVg90H21EOLACvtfcHk0liMR6AhsKPzCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXmvVKqur8%253D&md5=2f1068c745deb16ee1326eaf65f3beb0</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.3390%2Fph9020022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph9020022%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DLudwig%26aufirst%3DF.%2BA.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DChezal%26aufirst%3DJ.%2BM.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DMaisonial-Besset%26aufirst%3DA.%26atitle%3DDevelopment%2520of%2520a%2520new%2520radiofluorinated%2520quinoline%2520analog%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520in%2520brain%26jtitle%3DPharmaceuticals%26date%3D2016%26volume%3D9%26spage%3D22%26doi%3D10.3390%2Fph9020022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer’s disease</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>154</i></span>,  <span class="NLM_fpage">108873</span>, <span class="refDoi"> DOI: 10.1016/j.apradiso.2019.108873</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.apradiso.2019.108873" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31470193" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1GktL7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=154&publication_year=2019&pages=108873&author=F.+Dongauthor=J.+Duauthor=C.+Miaoauthor=L.+Jiaauthor=W.+Liauthor=M.+Wangauthor=Q.+H.+Zhengauthor=Z.+Xu&title=Radiosynthesis+of+carbon-11+labeled+PDE5+inhibitors+as+new+potential+PET+radiotracers+for+imaging+of+Alzheimer%E2%80%99s+disease&doi=10.1016%2Fj.apradiso.2019.108873"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit84R"><div class="casContent"><span class="casTitleNuber">84</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis of carbon-11 labeled PDE5 inhibitors as new potential PET radiotracers for imaging of Alzheimer's disease</span></div><div class="casAuthors">Dong, Fugui; Du, Jie; Miao, Caihong; Jia, Limeng; Li, Wei; Wang, Min; Zheng, Qi-Huang; Xu, Zhidong</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">154</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">108873</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To develop PET tracers for imaging of Alzheimer's disease, new carbon-11 labeled potent and selective PDE5 inhibitors have been synthesized.  The ref. stds. (5) and (12), and their corresponding desmethylated precursors (6) and (13) were synthesized from Me 2-amino-5-bromobenzoate and (4-methoxyphenyl)methanamine in multiple steps with 2%, 1%, 1% and 0.2% overall chem. yield, resp.  The radiotracers ([11C]5) and ([11C]12) were prepd. from their corresponding precursors 6 and 13 with [11C]CH3OTf through O-11C-methylation and isolated by HPLC combined with SPE in 40-50% radiochem. yield, based on [11C]CO2 and decay cor. to EOB.  The radiochem. purity was >99%, and the molar activity (Am) at EOB was in a range of 370-740 GBq/μmol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzLcZ9vyLEuLVg90H21EOLACvtfcHk0liMR6AhsKPzCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1GktL7M&md5=c30f25f6570a5233a5343c4efb19c163</span></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2019.108873&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2019.108873%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DF.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DMiao%26aufirst%3DC.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DWang%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26aulast%3DXu%26aufirst%3DZ.%26atitle%3DRadiosynthesis%2520of%2520carbon-11%2520labeled%2520PDE5%2520inhibitors%2520as%2520new%2520potential%2520PET%2520radiotracers%2520for%2520imaging%2520of%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2019%26volume%3D154%26spage%3D108873%26doi%3D10.1016%2Fj.apradiso.2019.108873" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial-Besset, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canitrot, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baufond, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chezal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, E.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">548</span>– <span class="NLM_lpage">560</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejmech.2017.03.091" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28544981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXotlWmuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=548-560&author=J.+Liuauthor=A.+Maisonial-Bessetauthor=B.+Wenzelauthor=D.+Canitrotauthor=A.+Baufondauthor=J.+M.+Chezalauthor=P.+Brustauthor=E.+Moreau&title=Synthesis+and+in+vitro+evaluation+of+new+fluorinated+quinoline+derivatives+with+high+affinity+for+PDE5%3A+Towards+the+development+of+new+PET+neuroimaging+probes&doi=10.1016%2Fj.ejmech.2017.03.091"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit85R"><div class="casContent"><span class="casTitleNuber">85</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: Towards the development of new PET neuroimaging probes</span></div><div class="casAuthors">Liu, Jianrong; Maisonial-Besset, Aurelie; Wenzel, Barbara; Canitrot, Damien; Baufond, Ariane; Chezal, Jean-Michel; Brust, Peter; Moreau, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">548-560</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A new radiofluorinated quinoline derivs. I [R1 = Et, cyclopropyl; R2 = cyano, trifluoromethyl; R3 = fluoromethyl, hydroxy, 2-fluoroethoxy] for the visualization of PDE5 in brain using PET imaging was synthesized.  Based on currently known PDE5 inhibitors, a series of fluorinated compds. I bearing a quinoline core were synthesized via multi-steps reaction pathways.  Their affinity for PDE5 and selectivity over other PDE families were investigated.  According to the data collected from the in vitro screening, compd. I [R1 = ethyl/cyclopropyl, R2 = cyano, R3 = 2-fluoroethoxy] bearing a fluoroethoxy group at the C-3 position of the quinoline core appeared to be the most promising structures and was further radiolabeled with fluorine-18 for in vitro and in vivo evaluations as PET radiotracer for neuroimaging of PDE5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRBnUYEYe1P7Vg90H21EOLACvtfcHk0lhimn3Md5jkuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXotlWmuro%253D&md5=75ada3588ebf3ce711bcdcd850df6ffd</span></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.091%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DMaisonial-Besset%26aufirst%3DA.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DCanitrot%26aufirst%3DD.%26aulast%3DBaufond%26aufirst%3DA.%26aulast%3DChezal%26aufirst%3DJ.%2BM.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DMoreau%26aufirst%3DE.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520new%2520fluorinated%2520quinoline%2520derivatives%2520with%2520high%2520affinity%2520for%2520PDE5%253A%2520Towards%2520the%2520development%2520of%2520new%2520PET%2520neuroimaging%2520probes%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D136%26spage%3D548%26epage%3D560%26doi%3D10.1016%2Fj.ejmech.2017.03.091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chezal, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moreau, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial-Besset, A.</span></span> <span> </span><span class="NLM_article-title">Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18</span>. <i>Bioorg. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">346</span>– <span class="NLM_lpage">362</span>, <span class="refDoi"> DOI: 10.1016/j.bioorg.2019.01.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bioorg.2019.01.037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30753989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXivVansL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2019&pages=346-362&author=B.+Wenzelauthor=J.+Liuauthor=S.+Dukic-Stefanovicauthor=W.+Deuther-Conradauthor=R.+Teodoroauthor=F.+A.+Ludwigauthor=J.+M.+Chezalauthor=E.+Moreauauthor=P.+Brustauthor=A.+Maisonial-Besset&title=Targeting+cyclic+nucleotide+phosphodiesterase+5+%28PDE5%29+in+brain%3A+Toward+the+development+of+a+PET+radioligand+labeled+with+fluorine-18&doi=10.1016%2Fj.bioorg.2019.01.037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18</span></div><div class="casAuthors">Wenzel, Barbara; Liu, Jianrong; Dukic-Stefanovic, Sladjana; Deuther-Conrad, Winnie; Teodoro, Rodrigo; Ludwig, Friedrich-Alexander; Chezal, Jean-Michel; Moreau, Emmanuel; Brust, Peter; Maisonial-Besset, Aurelie</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">346-362</span>CODEN:
                <span class="NLM_cas:coden">BOCMBM</span>;
        ISSN:<span class="NLM_cas:issn">0045-2068</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">With the aim to develop a specific radioligand for imaging the cyclic nucleotide phosphodiesterase 5 (PDE5) in brain by positron emission tomog. (PET), seven new fluorinated inhibitors (3-9) were synthesized on the basis of a quinoline core.  The inhibitory activity for PDE5 together with a panel of other PDEs was detd. in vitro and two derivs. were selected for IC50 value detn.  The most promising compd. 7 (IC50 = 5.92 nM for PDE5A), contg. a 3-fluoroazetidine moiety, was further radiolabeled by aliph. nucleophilic substitution of two different leaving groups (nosylate and tosylate) using [18F]fluoride.  The use of the nosylate precursor and tetra-Bu ammonium [18F]fluoride ([18F]TBAF) in 3-methyl-3-pentanol combined with the addn. of a small amt. of water proved to be the best radiolabeling conditions achieving a RCY of 4.9 ± 1.5% in an automated procedure.  Preliminary biol. investigations in vitro and in vivo were performed to characterize this new PDE5 radioligand.  Metab. studies of [18F]7 in mice revealed a fast metabolic degrdn. with the formation of radiometabolites which have been detected in the brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-88BZ5aZD3rVg90H21EOLACvtfcHk0lhimn3Md5jkuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXivVansL4%253D&md5=4fd10c022a6303d6d782177d6b802b8d</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2Fj.bioorg.2019.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bioorg.2019.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DJ.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DLudwig%26aufirst%3DF.%2BA.%26aulast%3DChezal%26aufirst%3DJ.%2BM.%26aulast%3DMoreau%26aufirst%3DE.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DMaisonial-Besset%26aufirst%3DA.%26atitle%3DTargeting%2520cyclic%2520nucleotide%2520phosphodiesterase%25205%2520%2528PDE5%2529%2520in%2520brain%253A%2520Toward%2520the%2520development%2520of%2520a%2520PET%2520radioligand%2520labeled%2520with%2520fluorine-18%26jtitle%3DBioorg.%2520Chem.%26date%3D2019%26volume%3D86%26spage%3D346%26epage%3D362%26doi%3D10.1016%2Fj.bioorg.2019.01.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cumming, P.</span></span> <span> </span><span class="NLM_article-title">A business of some heat: molecular imaging of phosphodiesterase 5</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">220</span>– <span class="NLM_lpage">221</span>, <span class="refDoi"> DOI: 10.1111/jnc.13453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fjnc.13453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26990291" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XmtVKitg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2016&pages=220-221&author=P.+Cumming&title=A+business+of+some+heat%3A+molecular+imaging+of+phosphodiesterase+5&doi=10.1111%2Fjnc.13453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit87R"><div class="casContent"><span class="casTitleNuber">87</span><div class="casTitle"><span class="NLM_cas:atitle">A business of some heat: molecular imaging of phosphodiesterase 5</span></div><div class="casAuthors">Cumming, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">220-221</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcGW-tgajlyLVg90H21EOLACvtfcHk0lhimn3Md5jkuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmtVKitg%253D%253D&md5=0273552b82c661a77a79d652fb93ff1a</span></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13453%26sid%3Dliteratum%253Aachs%26aulast%3DCumming%26aufirst%3DP.%26atitle%3DA%2520business%2520of%2520some%2520heat%253A%2520molecular%2520imaging%2520of%2520phosphodiesterase%25205%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D136%26spage%3D220%26epage%3D221%26doi%3D10.1111%2Fjnc.13453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, Q. H.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [<sup>11</sup>C]TPN171 as a new potential PET heart imaging agent</span>. <i>Appl. Radiat. Isot.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>162</i></span>,  <span class="NLM_fpage">109190</span>, <span class="refDoi"> DOI: 10.1016/j.apradiso.2020.109190</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.apradiso.2020.109190" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32501230" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXos1Slt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=162&publication_year=2020&pages=109190&author=Z.+Xuauthor=L.+Jiaauthor=W.+Liuauthor=W.+Liauthor=Y.+Songauthor=Q.+H.+Zheng&title=Radiosynthesis+of+a+carbon-11+labeled+PDE5+inhibitor+%5B11C%5DTPN171+as+a+new+potential+PET+heart+imaging+agent&doi=10.1016%2Fj.apradiso.2020.109190"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis of a carbon-11 labeled PDE5 inhibitor [11C]TPN171 as a new potential PET heart imaging agent</span></div><div class="casAuthors">Xu, Zhidong; Jia, Limeng; Liu, Wenqing; Li, Wei; Song, Ying; Zheng, Qi-Huang</div><div class="citationInfo"><span class="NLM_cas:title">Applied Radiation and Isotopes</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">162</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">109190</span>CODEN:
                <span class="NLM_cas:coden">ARISEF</span>;
        ISSN:<span class="NLM_cas:issn">0969-8043</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">To develop PET tracers for imaging of heart disease, a new carbon-11 labeled potent and selective PDE5 inhibitor [11C]TPN171 ([11C]9) has been synthesized.  The ref. std. TPN171 (9) and its corresponding precursor desmethyl-TPN171 (11) were synthesized from Me 3-oxovalerate and 2-hydroxybenzonitrile in 9 and 10 steps with 31% and 25% overall chem. yield, resp.  The radiotracer [11C]TPN171 was prepd. from desmethyl-TPN171 with [11C]CH3OTf through N-11C-methylation and isolated by HPLC purifn. followed by SPE formulation in 45-55% radiochem. yield, based on [11C]CO2 and decay cor. to EOB.  The radiochem. purity was >99%, and the molar activity (Am) at EOB was in a range of 370-740 GBq/μmol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxER-ICt_sd7Vg90H21EOLACvtfcHk0lh_oPHkacXg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXos1Slt7k%253D&md5=cf4eb7007dbff64286684876edbfb047</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1016%2Fj.apradiso.2020.109190&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.apradiso.2020.109190%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DJia%26aufirst%3DL.%26aulast%3DLiu%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DSong%26aufirst%3DY.%26aulast%3DZheng%26aufirst%3DQ.%2BH.%26atitle%3DRadiosynthesis%2520of%2520a%2520carbon-11%2520labeled%2520PDE5%2520inhibitor%2520%255B11C%255DTPN171%2520as%2520a%2520new%2520potential%2520PET%2520heart%2520imaging%2520agent%26jtitle%3DAppl.%2520Radiat.%2520Isot.%26date%3D2020%26volume%3D162%26spage%3D109190%26doi%3D10.1016%2Fj.apradiso.2020.109190" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cote, R. H.</span></span> <span> </span><span class="NLM_article-title">Characteristics of photoreceptor PDE (PDE6): similarities and differences to PDE5</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">S28</span>– <span class="NLM_lpage">S33</span>, <span class="refDoi"> DOI: 10.1038/sj.ijir.3901212</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fsj.ijir.3901212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=15224133" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2004&pages=S28-S33&author=R.+H.+Cote&title=Characteristics+of+photoreceptor+PDE+%28PDE6%29%3A+similarities+and+differences+to+PDE5&doi=10.1038%2Fsj.ijir.3901212"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Characteristics of Photoreceptor PDE (PDE6): similarities and differences to PDE5</span></div><div class="casAuthors">Cote, R. H.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">Suppl. 1</span>),
    <span class="NLM_cas:pages">S28-S33</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 6 (PDE6) is highly concd. in the retina.  It is most abundant in the internal membranes of retinal photoreceptors, where it reduces cytoplasmic levels of cGMP in rod and cone outer segments in response to light.  The rod PDE6 holoenzyme comprises α and β catalytic subunits and two identical inhibitory γ subunits.  Each catalytic subunit contains three distinct globular domains corresponding to the catalytic domain and two GAF domains (responsible for allosteric cGMP binding).  The PDE6 catalytic subunits resemble PDE5 in amino-acid sequence as well as in three-dimensional structure of the catalytic dimer; preference for cGMP over cAMP (cAMP) as a substrate; and the ability to bind cGMP at the regulatory GAF domains.  Most PDE5 inhibitors inhibit PDE6 with similar potency, and electroretinogram studies show modest effects of PDE5 inhibitors on visual function-an observation potentially important in designing PDE5-specific therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwrGvfie0U1bVg90H21EOLACvtfcHk0lh_oPHkacXg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXlt1Sjsbs%253D&md5=7700b18905668782047be0bbdd461726</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901212%26sid%3Dliteratum%253Aachs%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DCharacteristics%2520of%2520photoreceptor%2520PDE%2520%2528PDE6%2529%253A%2520similarities%2520and%2520differences%2520to%2520PDE5%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2004%26volume%3D16%26spage%3DS28%26epage%3DS33%26doi%3D10.1038%2Fsj.ijir.3901212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tolone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Belhadj, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rentsch, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers</span>. <i>Genes</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">453</span>, <span class="refDoi"> DOI: 10.3390/genes10060453</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fgenes10060453" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhs1ehsrfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=453&author=A.+Toloneauthor=S.+Belhadjauthor=A.+Rentschauthor=F.+Schwedeauthor=F.+Paquet-Durand&title=The+cGMP+pathway+and+inherited+photoreceptor+degeneration%3A+targets%2C+compounds%2C+and+biomarkers&doi=10.3390%2Fgenes10060453"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">The cGMP pathway and inherited photoreceptor degeneration: targets, compounds, and biomarkers</span></div><div class="casAuthors">Tolone, Arianna; Belhadj, Soumaya; Rentsch, Andreas; Schwede, Frank; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">Genes</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">453</span>CODEN:
                <span class="NLM_cas:coden">GENEG9</span>;
        ISSN:<span class="NLM_cas:issn">2073-4425</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Photoreceptor physiol. and pathophysiol. is intricately linked to guanosine-3',5'-cyclic monophosphate (cGMP)-signaling.  Here, we discuss the importance of cGMP-signaling for the pathogenesis of hereditary retinal degeneration.  Excessive accumulation of cGMP in photoreceptors is a common denominator in cell death caused by a variety of di erent gene mutations.  The cGMP-dependent cell death pathway may be targeted for the treatment of inherited photoreceptor degeneration, using specifically designed and formulated inhibitory cGMP analogs.  Moreover, cGMP-signaling and its down-stream targets may be exploited for the development of novel biomarkers that could facilitate monitoring of disease progression and reveal the response to treatment in future clin. trials.  We then briefly present the importance of appropriate formulations for delivery to the retina, both for drug and biomarker applications.  Finally, the review touches on important aspects of future clin. translation, highlighting the need for interdisciplinary cooperation of researchers from a diverse range of fields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpnfVBgGiBOBLVg90H21EOLACvtfcHk0lh_oPHkacXg1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhs1ehsrfF&md5=e948169c60cb9150218e4adf8b231dc5</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.3390%2Fgenes10060453&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fgenes10060453%26sid%3Dliteratum%253Aachs%26aulast%3DTolone%26aufirst%3DA.%26aulast%3DBelhadj%26aufirst%3DS.%26aulast%3DRentsch%26aufirst%3DA.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DThe%2520cGMP%2520pathway%2520and%2520inherited%2520photoreceptor%2520degeneration%253A%2520targets%252C%2520compounds%252C%2520and%2520biomarkers%26jtitle%3DGenes%26date%3D2019%26volume%3D10%26spage%3D453%26doi%3D10.3390%2Fgenes10060453" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Irwin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gupta, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, X. Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cahill, K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cote, R. H.</span></span> <span> </span><span class="NLM_article-title">The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>294</i></span>,  <span class="NLM_fpage">19486</span>– <span class="NLM_lpage">19497</span>, <span class="refDoi"> DOI: 10.1074/jbc.RA119.011002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.RA119.011002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31690623" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB3MjlsFCnsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=294&publication_year=2019&pages=19486-19497&author=M.+J.+Irwinauthor=R.+Guptaauthor=X.+Z.+Gaoauthor=K.+B.+Cahillauthor=F.+Chuauthor=R.+H.+Cote&title=The+molecular+architecture+of+photoreceptor+phosphodiesterase+6+%28PDE6%29+with+activated+G+protein+elucidates+the+mechanism+of+visual+excitation&doi=10.1074%2Fjbc.RA119.011002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">The molecular architecture of photoreceptor phosphodiesterase 6 (PDE6) with activated G protein elucidates the mechanism of visual excitation</span></div><div class="casAuthors">Irwin Michael J; Gupta Richa; Gao Xiong-Zhuo; Cahill Karyn B; Chu Feixia; Cote Rick H</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">294</span>
        (<span class="NLM_cas:issue">51</span>),
    <span class="NLM_cas:pages">19486-19497</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Photoreceptor phosphodiesterase 6 (PDE6) is the central effector of the visual excitation pathway in both rod and cone photoreceptors, and PDE6 mutations that alter PDE6 structure or regulation can result in several human retinal diseases.  The rod PDE6 holoenzyme consists of two catalytic subunits (Pαβ) whose activity is suppressed in the dark by binding of two inhibitory γ-subunits (Pγ).  Upon photoactivation of rhodopsin, the heterotrimeric G protein (transducin) is activated, resulting in binding of the activated transducin α-subunit (Gtα) to PDE6, displacement of Pγ from the PDE6 active site, and enzyme activation.  Although the biochemistry of this pathway is understood, a lack of detailed structural information about the PDE6 activation mechanism hampers efforts to develop therapeutic interventions for managing PDE6-associated retinal diseases.  To address this gap, here we used a cross-linking MS-based approach to create a model of the entire interaction surface of Pγ with the regulatory and catalytic domains of Pαβ in its nonactivated state.  Following reconstitution of PDE6 and activated Gtα with liposomes and identification of cross-links between Gtα and PDE6 subunits, we determined that the PDE6-Gtα protein complex consists of two Gtα-binding sites per holoenzyme.  Each Gtα interacts with the catalytic domains of both catalytic subunits and induces major changes in the interaction sites of the Pγ subunit with the catalytic subunits.  These results provide the first structural model for the activated state of the transducin-PDE6 complex during visual excitation, enhancing our understanding of the molecular etiology of inherited retinal diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQod-4D8xoMrWx8TEN9K18QfW6udTcc2eY7oonniy1BF7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MjlsFCnsg%253D%253D&md5=8944b65b4420523af61fbf49629bd8d3</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1074%2Fjbc.RA119.011002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.RA119.011002%26sid%3Dliteratum%253Aachs%26aulast%3DIrwin%26aufirst%3DM.%2BJ.%26aulast%3DGupta%26aufirst%3DR.%26aulast%3DGao%26aufirst%3DX.%2BZ.%26aulast%3DCahill%26aufirst%3DK.%2BB.%26aulast%3DChu%26aufirst%3DF.%26aulast%3DCote%26aufirst%3DR.%2BH.%26atitle%3DThe%2520molecular%2520architecture%2520of%2520photoreceptor%2520phosphodiesterase%25206%2520%2528PDE6%2529%2520with%2520activated%2520G%2520protein%2520elucidates%2520the%2520mechanism%2520of%2520visual%2520excitation%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2019%26volume%3D294%26spage%3D19486%26epage%3D19497%26doi%3D10.1074%2Fjbc.RA119.011002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chabre, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigay, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruckert, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornancin, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deterre, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfister, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vuong, T. M.</span></span> <span> </span><span class="NLM_article-title">Visual signal transduction: the cycle of transducin shuttling between rhodopsin and cGMP phosphodiesterase</span>. <i>Cold Spring Harbor Symp. Quant. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1988</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">313</span>– <span class="NLM_lpage">324</span>, <span class="refDoi"> DOI: 10.1101/SQB.1988.053.01.038</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1101%2FSQB.1988.053.01.038" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=2855482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADyaK3cXls1OnsLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=1988&pages=313-324&author=M.+Chabreauthor=J.+Bigayauthor=F.+Bruckertauthor=F.+Bornancinauthor=P.+Deterreauthor=C.+Pfisterauthor=T.+M.+Vuong&title=Visual+signal+transduction%3A+the+cycle+of+transducin+shuttling+between+rhodopsin+and+cGMP+phosphodiesterase&doi=10.1101%2FSQB.1988.053.01.038"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit92R"><div class="casContent"><span class="casTitleNuber">92</span><div class="casTitle"><span class="NLM_cas:atitle">Visual signal transduction:  the cycle of transducin shuttling between rhodopsin and cGMP phosphodiesterase</span></div><div class="casAuthors">Chabre, M.; Bigay, J.; Bruckert, F.; Bornancin, F.; Deterre, P.; Pfister, C.; Vuong, T. M.</div><div class="citationInfo"><span class="NLM_cas:title">Cold Spring Harbor Symposia on Quantitative Biology</span>
        (<span class="NLM_cas:date">1988</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">Mol. Biol. Signal Transduction, Pt. 1</span>),
    <span class="NLM_cas:pages">313-24</span>CODEN:
                <span class="NLM_cas:coden">CSHSAZ</span>;
        ISSN:<span class="NLM_cas:issn">0091-7451</span>.
    </div><div class="casAbstract">A review, with ∼25 refs., on transducin as it shuttles between rhodopsin and phosphodiesterase.  Lateral diffusion of rhodopsin and GTP interaction with transducin as a model G-protein are included.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpET59p2U20p7Vg90H21EOLACvtfcHk0ljpN59QxiVKyw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3cXls1OnsLs%253D&md5=48e6f02cf219e4b86475fc5c3be2219c</span></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1101%2FSQB.1988.053.01.038&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252FSQB.1988.053.01.038%26sid%3Dliteratum%253Aachs%26aulast%3DChabre%26aufirst%3DM.%26aulast%3DBigay%26aufirst%3DJ.%26aulast%3DBruckert%26aufirst%3DF.%26aulast%3DBornancin%26aufirst%3DF.%26aulast%3DDeterre%26aufirst%3DP.%26aulast%3DPfister%26aufirst%3DC.%26aulast%3DVuong%26aufirst%3DT.%2BM.%26atitle%3DVisual%2520signal%2520transduction%253A%2520the%2520cycle%2520of%2520transducin%2520shuttling%2520between%2520rhodopsin%2520and%2520cGMP%2520phosphodiesterase%26jtitle%3DCold%2520Spring%2520Harbor%2520Symp.%2520Quant.%2520Biol.%26date%3D1988%26volume%3D53%26spage%3D313%26epage%3D324%26doi%3D10.1101%2FSQB.1988.053.01.038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Qureshi, B. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behrmann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schöneberg, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loerke, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bürger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mielke, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giesebrecht, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noé, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofmann, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spahn, C. M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, M.</span></span> <span> </span><span class="NLM_article-title">Asymmetric properties of rod cGMP Phosphodiesterase 6 (PDE6): structural and functional analysis</span>. <i>BMC Pharmacol. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">A76</span>, <span class="refDoi"> DOI: 10.1186/2050-6511-16-S1-A76</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1186%2F2050-6511-16-S1-A76" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2015&pages=A76&author=B.+M.+Qureshiauthor=E.+Behrmannauthor=J.+Sch%C3%B6nebergauthor=J.+Loerkeauthor=J.+B%C3%BCrgerauthor=T.+Mielkeauthor=J.+Giesebrechtauthor=F.+No%C3%A9author=K.+P.+Hofmannauthor=C.+M.+T.+Spahnauthor=M.+Heck&title=Asymmetric+properties+of+rod+cGMP+Phosphodiesterase+6+%28PDE6%29%3A+structural+and+functional+analysis&doi=10.1186%2F2050-6511-16-S1-A76"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1186%2F2050-6511-16-S1-A76&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2050-6511-16-S1-A76%26sid%3Dliteratum%253Aachs%26aulast%3DQureshi%26aufirst%3DB.%2BM.%26aulast%3DBehrmann%26aufirst%3DE.%26aulast%3DSch%25C3%25B6neberg%26aufirst%3DJ.%26aulast%3DLoerke%26aufirst%3DJ.%26aulast%3DB%25C3%25BCrger%26aufirst%3DJ.%26aulast%3DMielke%26aufirst%3DT.%26aulast%3DGiesebrecht%26aufirst%3DJ.%26aulast%3DNo%25C3%25A9%26aufirst%3DF.%26aulast%3DHofmann%26aufirst%3DK.%2BP.%26aulast%3DSpahn%26aufirst%3DC.%2BM.%2BT.%26aulast%3DHeck%26aufirst%3DM.%26atitle%3DAsymmetric%2520properties%2520of%2520rod%2520cGMP%2520Phosphodiesterase%25206%2520%2528PDE6%2529%253A%2520structural%2520and%2520functional%2520analysis%26jtitle%3DBMC%2520Pharmacol.%2520Toxicol.%26date%3D2015%26volume%3D16%26spage%3DA76%26doi%3D10.1186%2F2050-6511-16-S1-A76" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanhoutte, P. M.</span></span> <span> </span><span class="NLM_article-title">PDE and sGC hand in hand to see the light</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>111</i></span>,  <span class="NLM_fpage">17704</span>– <span class="NLM_lpage">17705</span>, <span class="refDoi"> DOI: 10.1073/pnas.1421161111</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1073%2Fpnas.1421161111" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25468979" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitFCrtL%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2014&pages=17704-17705&author=P.+M.+Vanhoutte&title=PDE+and+sGC+hand+in+hand+to+see+the+light&doi=10.1073%2Fpnas.1421161111"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">PDE and sGC hand in hand to see the light</span></div><div class="casAuthors">Vanhoutte, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">111</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">17704-17705</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">A review.  The title research of Sikka, G. et al. (ibid, pages 17977-17982) is reviewed with commentary.  Sikka et al. suggest that melanopsin, a non-image-forming opsin (opsin4, Opn4), may play a physiol. role in the regulation of vascular tone by mediating photorelaxation.  This means that light of a defined wavelength known to stimulate opsin4 in other systems induces relaxation of the vascular smooth muscle cells of melanopsin-contg. blood vessels.  This response is clearly eNOS-, NO-,and endothelium-independent but, as pointed out by the authors, may involve other components of the blood vessel wall.  The authors show that the response to light is due to hyperpolarization of the vascular smooth muscle cells resulting from the activation of sol. guanylyl cyclase (sGC), but does not involve protein kinase G (PKG).  In addn., Sikka et al. very convincingly demonstrate that phosphodiesterase 6 (PDE6) is present in their prepns. and that inhibitors of that enzyme prevent the response.  This study not only provides an intriguing mol. explanation for a phenomenon (photorelaxation) that has puzzled vascular biologists for more than half a century but also forces us to rethink the fate of the products generated by sGC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryAQMybosXl7Vg90H21EOLACvtfcHk0lgxnYOfnWagDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitFCrtL%252FL&md5=8d6a6a1f9c2e8d679b826213b246e28c</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.1073%2Fpnas.1421161111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.1421161111%26sid%3Dliteratum%253Aachs%26aulast%3DVanhoutte%26aufirst%3DP.%2BM.%26atitle%3DPDE%2520and%2520sGC%2520hand%2520in%2520hand%2520to%2520see%2520the%2520light%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2014%26volume%3D111%26spage%3D17704%26epage%3D17705%26doi%3D10.1073%2Fpnas.1421161111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Olshevskaya, E. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermilov, A. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dizhoor, A. M.</span></span> <span> </span><span class="NLM_article-title">Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration</span>. <i>Mol. Cell. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>230</i></span>,  <span class="NLM_fpage">139</span>– <span class="NLM_lpage">147</span>, <span class="refDoi"> DOI: 10.1023/A:1014248208584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1023%2FA%3A1014248208584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11952089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref95/cit95&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD38XislGhtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=230&publication_year=2002&pages=139-147&author=E.+V.+Olshevskayaauthor=A.+N.+Ermilovauthor=A.+M.+Dizhoor&title=Factors+that+affect+regulation+of+cGMP+synthesis+in+vertebrate+photoreceptors+and+their+genetic+link+to+human+retinal+degeneration&doi=10.1023%2FA%3A1014248208584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit95R"><div class="casContent"><span class="casTitleNuber">95</span><div class="casTitle"><span class="NLM_cas:atitle">Factors that affect regulation of cGMP synthesis in vertebrate photoreceptors and their genetic link to human retinal degeneration</span></div><div class="casAuthors">Olshevskaya, Elena V.; Ermilov, Alexandre N.; Dizhoor, Alexander M.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular and Cellular Biochemistry</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">230</span>
        (<span class="NLM_cas:issue">1&2</span>),
    <span class="NLM_cas:pages">139-147</span>CODEN:
                <span class="NLM_cas:coden">MCBIB8</span>;
        ISSN:<span class="NLM_cas:issn">0300-8177</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">A review.  CGMP is essential for the ability of rods and cones to respond to the light stimuli.  Light triggers hydrolysis of cGMP and stops the influx of sodium and calcium through the cGMP-gated ion channels.  The consequence of this event is 2-fold: first, the decrease in the inward sodium current plays the major role in an abrupt hyperpolarization of the cellular membrane: secondly, the decrease in the Ca2+ influx diminishes the free intracellular Ca2+ concn.  While the former constitutes the essence of the phototransduction pathway in rods and cones, the latter gives rise to a potent feedback mechanism that accelerates photoreceptor recovery and adaptation to background light.  One of the most important events by which Ca2+ feedback controls recovery and light adaptation is synthesis of cGMP by guanylyl cyclase.  Two isoenzymes of membrane photoreceptor guanylyl cyclase (retGC) have been identified in rods and cones that are regulated by Ca2+-binding proteins, GCAPs.  At low intracellular concns. of Ca2+ typical for light-adapted rods and cones GCAPs activate RetGC, but concns. above 500 nM typical for dark-adapted photoreceptors turn them into inhibitors of retGC.  A variety of mutations found in GCAP and retGC genes have been linked to several forms of human congenital retinal diseases, such as dominant cone degeneration, cone-rod dystrophy and Leber congenital amaurosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpaviMSMnCoBLVg90H21EOLACvtfcHk0lgxnYOfnWagDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XislGhtrk%253D&md5=7cf234dccffddb3b6972105123a8c74e</span></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=10.1023%2FA%3A1014248208584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1014248208584%26sid%3Dliteratum%253Aachs%26aulast%3DOlshevskaya%26aufirst%3DE.%2BV.%26aulast%3DErmilov%26aufirst%3DA.%2BN.%26aulast%3DDizhoor%26aufirst%3DA.%2BM.%26atitle%3DFactors%2520that%2520affect%2520regulation%2520of%2520cGMP%2520synthesis%2520in%2520vertebrate%2520photoreceptors%2520and%2520their%2520genetic%2520link%2520to%2520human%2520retinal%2520degeneration%26jtitle%3DMol.%2520Cell.%2520Biochem.%26date%3D2002%26volume%3D230%26spage%3D139%26epage%3D147%26doi%3D10.1023%2FA%3A1014248208584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arango-Gonzalez, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trifunovic, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sahaboglu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michalakis, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farinelli, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cottet, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Janssen-Bienhold, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zrenner, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euler, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekstrom, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ueffing, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet-Durand, F.</span></span> <span> </span><span class="NLM_article-title">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">e112142</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0112142</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1371%2Fjournal.pone.0112142" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25392995" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&author=B.+Arango-Gonzalezauthor=D.+Trifunovicauthor=A.+Sahabogluauthor=K.+Kranzauthor=S.+Michalakisauthor=P.+Farinelliauthor=S.+Kochauthor=F.+Kochauthor=S.+Cottetauthor=U.+Janssen-Bienholdauthor=K.+Dedekauthor=M.+Bielauthor=E.+Zrennerauthor=T.+Eulerauthor=P.+Ekstromauthor=M.+Ueffingauthor=F.+Paquet-Durand&title=Identification+of+a+common+non-apoptotic+cell+death+mechanism+in+hereditary+retinal+degeneration&doi=10.1371%2Fjournal.pone.0112142"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a common non-apoptotic cell death mechanism in hereditary retinal degeneration</span></div><div class="casAuthors">Arango-Gonzalez, Blanca; Trifunovic, Dragana; Sahaboglu, Ayse; Kranz, Katharina; Michalakis, Stylianos; Farinelli, Pietro; Koch, Susanne; Koch, Fred; Cottet, Sandra; Janssen-Bienhold, Ulrike; Dedek, Karin; Biel, Martin; Zrenner, Eberhart; Euler, Thomas; Ekstroem, Per; Ueffing, Marius; Paquet-Durand, Francois</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">e112142/1-e112142/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Cell death in neurodegenerative diseases is often thought to be governed by apoptosis; however, an increasing body of evidence suggests the involvement of alternative cell death mechanisms in neuronal degeneration.  We studied retinal neurodegeneration using 10 different animal models, covering all major groups of hereditary human blindness (rd1, rd2, rd10, Cngb1 KO, Rho KO, S334ter, P23H, Cnga3 KO, cpfl1, Rpe65 KO), by investigating metabolic processes relevant for different forms of cell death.  We show that apoptosis plays only a minor role in the inherited forms of retinal neurodegeneration studied, where instead, a non-apoptotic degenerative mechanism common to all mutants is of major importance.  Hallmark features of this pathway are activation of histone deacetylase, poly-ADP-ribose-polymerase, and calpain, as well as accumulation of cyclic guanosine monophosphate and poly-ADP-ribose.  Our work thus demonstrates the prevalence of alternative cell death mechanisms in inherited retinal degeneration and provides a rational basis for the design of mutation-independent treatments.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpYEcYvkyewtrVg90H21EOLACvtfcHk0lgxnYOfnWagDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvFyht7zL&md5=53c0c17980aa77b6c8addc7cff796a1a</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0112142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0112142%26sid%3Dliteratum%253Aachs%26aulast%3DArango-Gonzalez%26aufirst%3DB.%26aulast%3DTrifunovic%26aufirst%3DD.%26aulast%3DSahaboglu%26aufirst%3DA.%26aulast%3DKranz%26aufirst%3DK.%26aulast%3DMichalakis%26aufirst%3DS.%26aulast%3DFarinelli%26aufirst%3DP.%26aulast%3DKoch%26aufirst%3DS.%26aulast%3DKoch%26aufirst%3DF.%26aulast%3DCottet%26aufirst%3DS.%26aulast%3DJanssen-Bienhold%26aufirst%3DU.%26aulast%3DDedek%26aufirst%3DK.%26aulast%3DBiel%26aufirst%3DM.%26aulast%3DZrenner%26aufirst%3DE.%26aulast%3DEuler%26aufirst%3DT.%26aulast%3DEkstrom%26aufirst%3DP.%26aulast%3DUeffing%26aufirst%3DM.%26aulast%3DPaquet-Durand%26aufirst%3DF.%26atitle%3DIdentification%2520of%2520a%2520common%2520non-apoptotic%2520cell%2520death%2520mechanism%2520in%2520hereditary%2520retinal%2520degeneration%26jtitle%3DPLoS%2520One%26date%3D2014%26volume%3D9%26doi%3D10.1371%2Fjournal.pone.0112142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span> <span> </span><span class="NLM_article-title">Two pathways of rod photoreceptor cell death induced by elevated cGMP</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>26</i></span>,  <span class="NLM_fpage">2299</span>– <span class="NLM_lpage">2306</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddx121</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1093%2Fhmg%2Fddx121" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28379353" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFais7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2017&pages=2299-2306&author=T.+Wangauthor=S.+H.+Tsangauthor=J.+Chen&title=Two+pathways+of+rod+photoreceptor+cell+death+induced+by+elevated+cGMP&doi=10.1093%2Fhmg%2Fddx121"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Two pathways of rod photoreceptor cell death induced by elevated cGMP</span></div><div class="casAuthors">Wang, Tian; Tsang, Stephen H.; Chen, Jeannie</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2299-2306</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">1460-2083</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">CGMP is a second messenger in phototransduction, a G-protein signaling cascade that conveys photon absorption by rhodopsin to a change in current at the rod photoreceptor outer segment plasma membrane.  Basal cGMP level is strictly controlled by the opposing actions of phosphodiesterase (PDE6) and retinal guanylyl cyclases (GCs), and mutations in genes that disrupt cGMP homeostasis leads to retinal degeneration in humans through mechanisms that are incompletely understood.  The purpose of this study is to examine two distinct cellular targets of cGMP: the cGMP-gated (CNG) channels and protein kinase G (PRKG), and how each may contribute to rod cell death.  Using a mouse genetic approach, we found that abolishing expression of CNG channels prolongs rod survival caused by elevated cGMP in a PDE6 mutant mouse model.  This observation supports the use of channel blockers to delay rod death, which is expected to prolong useful vision through enhanced cone survival.  However, the absence of CNG channel alone also caused abnormal cGMP accumulation.  In a mouse model of CNG channel loss-of-function, abolishing PRKG1 expression had a long-lasting effect in promoting rod cell survival.  Our data strongly implicate two distinct cGMP-mediated cell death pathways, and suggest that therapeutic designs targeting both pathways will be more effective at slowing photoreceptor cell death caused by elevated cGMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrRFY3AluI1i7Vg90H21EOLACvtfcHk0lg7LA3KM_2Mlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFais7o%253D&md5=0a2d794d212b6ecd7b8df6c324091b63</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddx121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddx121%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DTsang%26aufirst%3DS.%2BH.%26aulast%3DChen%26aufirst%3DJ.%26atitle%3DTwo%2520pathways%2520of%2520rod%2520photoreceptor%2520cell%2520death%2520induced%2520by%2520elevated%2520cGMP%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2017%26volume%3D26%26spage%3D2299%26epage%3D2306%26doi%3D10.1093%2Fhmg%2Fddx121" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brocke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epstein, P. M.</span></span> <span> </span><span class="NLM_article-title">Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells</span>. <i>SpringerPlus</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">680</span>, <span class="refDoi"> DOI: 10.1186/2193-1801-2-680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1186%2F2193-1801-2-680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24683528" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXht1Whsr%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2013&pages=680&author=H.+Dongauthor=K.+P.+Claffeyauthor=S.+Brockeauthor=P.+M.+Epstein&title=Expression+of+phosphodiesterase+6+%28PDE6%29+in+human+breast+cancer+cells&doi=10.1186%2F2193-1801-2-680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of phosphodiesterase 6 (PDE6) in human breast cancer cells</span></div><div class="casAuthors">Dong, Hongli; Claffey, Kevin P.; Brocke, Stefan; Epstein, Paul M.</div><div class="citationInfo"><span class="NLM_cas:title">SpringerPlus</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">680/1-680/10, 10 pp.</span>CODEN:
                <span class="NLM_cas:coden">SPRIFB</span>;
        ISSN:<span class="NLM_cas:issn">2193-1801</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">Considerable epidemiol. evidence demonstrates a pos. assocn. between artificial light at night (LAN) levels and incidence rates of breast cancer, suggesting that exposure to LAN is a risk factor for breast cancer.  There is a 30-50 % higher risk of breast cancer in the highest LAN exposed countries compared to the lowest LAN countries, and studies showing higher incidence of breast cancer among shift workers exposed to more LAN have led the International Agency for Research on Cancer to classify shift work as a probable human carcinogen.  Nevertheless, the means by which light can affect breast cancer is still unknown.  In this study we examd. established human breast cancer cell lines and patients' primary breast cancer tissues for expression of genetic components of phosphodiesterase 6 (PDE6), a cGMP-specific PDE involved in transduction of the light signal, and previously thought to be selectively expressed in photoreceptors.  By microarray anal. we find highly significant expression of mRNA for the PDE6B, PDE6C, and PDE6D genes in both the cell lines and patients' tissues, minimal expression of PDE6A and PDE6G and no expression of PDE6H.  Using antibody specific for PDE6β, we find expression of PDE6B protein in a wide range of patients' tissues by immunohistochem., and in MCF-7 breast cancer cells by immunofluorescence and Western blot anal.  Considerable expression of key circadian genes, PERIOD 2, CLOCK, TIMELESS, CRYPTOCHROME 1, and CRYPTOCHROME 2 was also seen in all breast cancer cell lines and all patients' breast cancer tissues.  These studies indicate that genes for PDE6 and control of circadian rhythm are expressed in human breast cancer cells and tissues and may play a role in transducing the effects of light on breast cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZdjd-brp86LVg90H21EOLACvtfcHk0lg7LA3KM_2Mlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXht1Whsr%252FJ&md5=74cec2df2c22739690381ccb3553c733</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=10.1186%2F2193-1801-2-680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F2193-1801-2-680%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DH.%26aulast%3DClaffey%26aufirst%3DK.%2BP.%26aulast%3DBrocke%26aufirst%3DS.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26atitle%3DExpression%2520of%2520phosphodiesterase%25206%2520%2528PDE6%2529%2520in%2520human%2520breast%2520cancer%2520cells%26jtitle%3DSpringerPlus%26date%3D2013%26volume%3D2%26spage%3D680%26doi%3D10.1186%2F2193-1801-2-680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giovannini, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schanzle, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koros, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Runge, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fuchs, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reymann, K. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, U. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedele, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorner-Ciossek, C.</span></span> <span> </span><span class="NLM_article-title">The novel phosphodiesterase 9A inhibitor BI 409306 increases cyclic guanosine monophosphate levels in the brain, promotes synaptic plasticity, and enhances memory function in rodents</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>371</i></span>,  <span class="NLM_fpage">633</span>– <span class="NLM_lpage">641</span>, <span class="refDoi"> DOI: 10.1124/jpet.119.260059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fjpet.119.260059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31578258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXjt1Wltrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=371&publication_year=2019&pages=633-641&author=H.+Rosenbrockauthor=R.+Giovanniniauthor=G.+Schanzleauthor=E.+Korosauthor=F.+Rungeauthor=H.+Fuchsauthor=A.+Martiauthor=K.+G.+Reymannauthor=U.+H.+Schroderauthor=E.+Fedeleauthor=C.+Dorner-Ciossek&title=The+novel+phosphodiesterase+9A+inhibitor+BI+409306+increases+cyclic+guanosine+monophosphate+levels+in+the+brain%2C+promotes+synaptic+plasticity%2C+and+enhances+memory+function+in+rodents&doi=10.1124%2Fjpet.119.260059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">The novel phosphodiesterase 9A inhibitor BI 409306 increases cyclic guanosine monophosphate levels in the brain, promotes synaptic plasticity, and enhances memory function in rodents</span></div><div class="casAuthors">Rosenbrock, Holger; Giovannini, Riccardo; Schaenzle, Gerhard; Koros, Eliza; Runge, Frank; Fuchs, Holger; Marti, Anelise; Reymann, Klaus G.; Schroeder, Ulrich H.; Fedele, Ernesto; Dorner-Ciossek, Cornelia</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">371</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">633-646</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">N-methyl-d-aspartate (NMDA) receptor-dependent long-term potentiation (LTP) is an established cellular model underlying learning and memory, and involves intracellular signaling mediated by the second messenger cyclic guanosine monophosphate (cGMP).  As phosphodiesterase (PDE)9A selectively hydrolyzes cGMP in areas of the brain related to cognition, PDE9A inhibitors may improve cognitive function by enhancing NMDA receptor-dependent LTP.  This study aimed to pharmacol. characterize BI 409306, a novel PDE9A inhibitor, using in vitro assays and in vivo detn. of cGMP levels in the brain.  Further, the effects of BI 409306 on synaptic plasticity evaluated by LTP in ex vivo hippocampal slices and on cognitive performance in rodents were also investigated.  In vitro assays demonstrated that BI 409306 is a potent and selective inhibitor of human and rat PDE9A with mean concns. at half-maximal inhibition (IC50) of 65 and 168 nM.  BI 409306 increased cGMP levels in rat prefrontal cortex and cerebrospinal fluid and attenuated a redn. in mouse striatum cGMP induced by the NMDA-receptor antagonist MK-801.  In ex vivo rat brain slices, BI 409306 enhanced LTP induced by both weak and strong tetanic stimulation.  Treatment of mice with BI 409306 reversed MK-801-induced working memory deficits in a T-maze spontaneous-alternation task and improved long-term memory in an object recognition task.  These findings suggest that BI 409306 is a potent and selective inhibitor of PDE9A.  BI 409306 shows target engagement by increasing cGMP levels in brain, facilitates synaptic plasticity as demonstrated by enhancement of hippocampal LTP, and improves episodic and working memory function in rodents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFFF-k-V2uQ7Vg90H21EOLACvtfcHk0lg7LA3KM_2Mlg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXjt1Wltrc%253D&md5=8df2e014d7252294520c064daf206709</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1124%2Fjpet.119.260059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.119.260059%26sid%3Dliteratum%253Aachs%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DGiovannini%26aufirst%3DR.%26aulast%3DSchanzle%26aufirst%3DG.%26aulast%3DKoros%26aufirst%3DE.%26aulast%3DRunge%26aufirst%3DF.%26aulast%3DFuchs%26aufirst%3DH.%26aulast%3DMarti%26aufirst%3DA.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroder%26aufirst%3DU.%2BH.%26aulast%3DFedele%26aufirst%3DE.%26aulast%3DDorner-Ciossek%26aufirst%3DC.%26atitle%3DThe%2520novel%2520phosphodiesterase%25209A%2520inhibitor%2520BI%2520409306%2520increases%2520cyclic%2520guanosine%2520monophosphate%2520levels%2520in%2520the%2520brain%252C%2520promotes%2520synaptic%2520plasticity%252C%2520and%2520enhances%2520memory%2520function%2520in%2520rodents%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2019%26volume%3D371%26spage%3D633%26epage%3D641%26doi%3D10.1124%2Fjpet.119.260059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moschetti, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sand, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wunderlich, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Feifel, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boland, K.</span></span> <span> </span><span class="NLM_article-title">The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomised trials in healthy volunteers</span>. <i>Eur. Neuropsychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>28</i></span>,  <span class="NLM_fpage">643</span>– <span class="NLM_lpage">655</span>, <span class="refDoi"> DOI: 10.1016/j.euroneuro.2018.01.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.euroneuro.2018.01.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29567399" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVSgtL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2018&pages=643-655&author=V.+Moschettiauthor=M.+Kimauthor=M.+Sandauthor=G.+Wunderlichauthor=G.+Andersenauthor=U.+Feifelauthor=I.+J.+Jangauthor=W.+Timmerauthor=H.+Rosenbrockauthor=K.+Boland&title=The+safety%2C+tolerability+and+pharmacokinetics+of+BI+409306%2C+a+novel+and+potent+PDE9+inhibitor%3A+Overview+of+three+Phase+I+randomised+trials+in+healthy+volunteers&doi=10.1016%2Fj.euroneuro.2018.01.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">The safety, tolerability and pharmacokinetics of BI 409306, a novel and potent PDE9 inhibitor: Overview of three Phase I randomized trials in healthy volunteers</span></div><div class="casAuthors">Moschetti, Viktoria; Kim, Maria; Sand, Michael; Wunderlich, Glen; Andersen, Grit; Feifel, Ulrich; Jang, In-Jin; Timmer, Wolfgang; Rosenbrock, Holger; Boland, Katja</div><div class="citationInfo"><span class="NLM_cas:title">European Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">28</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">643-655</span>CODEN:
                <span class="NLM_cas:coden">EURNE8</span>;
        ISSN:<span class="NLM_cas:issn">0924-977X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Safety, tolerability and pharmacokinetics of BI 409306, a potent and selective phosphodiesterase 9A inhibitor, were assessed in healthy subjects in three Phase I, within-dose group, double-blind trials.  Trial 1 randomized young and elderly subjects to receive BI 409306 25, 50, 100 mg, placebo once daily (OD) or BI 409306 50 mg twice daily (young) for 14 days.  Trial 2 randomized young poor metabolizers (PM) of cytochrome P 450 isoform 2C19 (CYP2C19) and elderly subjects to receive BI 409306 25, 50 mg or placebo OD for 14 days.  Trial 3 randomized Chinese and Japanese extensive metabolizers of CYP2C19 to receive single doses (SD) of BI 409306 25, 50, 100 mg or placebo and Chinese (PM) to SD of BI 409306 100 mg or placebo (Part 1).  Japanese PM received SD of BI 409306 100 mg or placebo (Day 1) followed by BI 409306 100 mg or placebo OD for 7 days after a 48-h washout period (Part 2).  Reported adverse events (AE) were mild-to-moderate intensity and increased with BI 409306 dose.  Eye disorders were most commonly reported (Trial 1: 40.0-41.7%, Trial 2: 29.2-37.5%, Trial 3: 18.2-66.7%) and increased with dose and systemic exposure.  PM reported more AEs than other treatment groups, corresponding to higher systemic exposure to BI 409306.  Systemic exposure to BI 409306 produced dose-dependent increases and was slightly greater in elderly vs. young subgroups (Trial 1).  Steady state was achieved by Day 2-3.  Overall, BI 409306 demonstrated good safety, tolerability and minor accumulation after multiple dosing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYcPdm9PaZH7Vg90H21EOLACvtfcHk0lgf8TPhB8Ld8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVSgtL8%253D&md5=05bba157a7076beb48c216fbcff7deda</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1016%2Fj.euroneuro.2018.01.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.euroneuro.2018.01.003%26sid%3Dliteratum%253Aachs%26aulast%3DMoschetti%26aufirst%3DV.%26aulast%3DKim%26aufirst%3DM.%26aulast%3DSand%26aufirst%3DM.%26aulast%3DWunderlich%26aufirst%3DG.%26aulast%3DAndersen%26aufirst%3DG.%26aulast%3DFeifel%26aufirst%3DU.%26aulast%3DJang%26aufirst%3DI.%2BJ.%26aulast%3DTimmer%26aufirst%3DW.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DBoland%26aufirst%3DK.%26atitle%3DThe%2520safety%252C%2520tolerability%2520and%2520pharmacokinetics%2520of%2520BI%2520409306%252C%2520a%2520novel%2520and%2520potent%2520PDE9%2520inhibitor%253A%2520Overview%2520of%2520three%2520Phase%2520I%2520randomised%2520trials%2520in%2520healthy%2520volunteers%26jtitle%3DEur.%2520Neuropsychopharmacol.%26date%3D2018%26volume%3D28%26spage%3D643%26epage%3D655%26doi%3D10.1016%2Fj.euroneuro.2018.01.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Conran, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Torres, L.</span></span> <span> </span><span class="NLM_article-title">cGMP modulation therapeutics for sickle cell disease</span>. <i>Exp. Biol. Med. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>244</i></span>,  <span class="NLM_fpage">132</span>– <span class="NLM_lpage">146</span>, <span class="refDoi"> DOI: 10.1177/1535370219827276</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1177%2F1535370219827276" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXktlKrsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=244&publication_year=2019&pages=132-146&author=N.+Conranauthor=L.+Torres&title=cGMP+modulation+therapeutics+for+sickle+cell+disease&doi=10.1177%2F1535370219827276"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic GMP modulation therapeutics for sickle cell disease</span></div><div class="casAuthors">Conran, Nicola; Torres, Lidiane</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">244</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">132-146</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3699</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">A review.  Sickle cell disease (SCD) is an inherited disease caused by the prodn. of abnormal Hb (Hb) S, whose deoxygenation-induced polymn. results in red blood cell (RBC) sickling and numerous pathophysiol. consequences.  SCD affects approx. 300,000 newborns worldwide each year and is assocd. with acute and chronic complications, including frequent painful vaso-occlusive episodes that often require hospitalization.  Chronic intravascular hemolysis in SCD significantly reduces vascular nitric oxide (NO) bioavailability, consequently decreasing intracellular signaling via cyclic guanosine monophosphate (cGMP), in turn diminishing vasodilation and contributing to the inflammatory mechanisms that trigger vaso-occlusive processes.  Oxidative stress may further reduce NO bioavailability in SCD and can oxidize the intracellular enzyme target of NO, sol. guanylate cyclase (sGC), rendering it inactive.  Increasing intracellular cGMP-dependent signaling constitutes an important pharmacol. therapeutic approach for SCD with a view to augmenting vasodilation, and reducing inflammatory mechanisms, as well as for increasing the prodn. of anti-polymg. fetal Hb in erythroid cells.  Pharmacol. agents under pre-clin. and clin. investigation for SCD include NO-based therapeutics to augment NO bioavailability, as well as heme-dependent sGC stimulators and heme-independent sGC activators that directly stimulate native and oxidized sGC, resp., therefore bypassing the need for vascular NO delivery.  Addnl., the phosphodiesterases (PDEs) that degrade intracellular cyclic nucleotides with specific cellular distributions are attractive drug targets for SCD; PDE9 is highly expressed in hematopoietic cells, making the use of PDE9 inhibitors, originally developed for use in neurol. diseases, a potential approach that could rapidly amplify intracellular cGMP concns. in a relatively tissue-specific manner.  Impact statement: Sickle cell disease (SCD) is one of the most common inherited diseases and is assocd. with a reduced life expectancy and acute and chronic complications, including frequent painful vaso-occlusive episodes that often require hospitalization.  At present, treatment of SCD is limited to hematopoietic stem cell transplant, transfusion, and limited options for pharmacotherapy, based principally on hydroxyurea therapy.  This review highlights the importance of intracellular cGMP-dependent signaling pathways in SCD pathophysiol.; modulation of these pathways with sol. guanylate cyclase (sGC) stimulators or phosphodiesterase (PDE) inhibitors could potentially provide vasorelaxation and anti-inflammatory effects, as well as elevate levels of anti-sickling fetal Hb.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovV6MaRlwtwbVg90H21EOLACvtfcHk0lgf8TPhB8Ld8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXktlKrsr8%253D&md5=39addb6bc5181a92e916849a60dbcbaf</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1177%2F1535370219827276&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1177%252F1535370219827276%26sid%3Dliteratum%253Aachs%26aulast%3DConran%26aufirst%3DN.%26aulast%3DTorres%26aufirst%3DL.%26atitle%3DcGMP%2520modulation%2520therapeutics%2520for%2520sickle%2520cell%2520disease%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2019%26volume%3D244%26spage%3D132%26epage%3D146%26doi%3D10.1177%2F1535370219827276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karami-Tehrani, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moeinifard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aghaei, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atri, M.</span></span> <span> </span><span class="NLM_article-title">Evaluation of PDE5 and PDE9 expression in benign and malignant breast tumors</span>. <i>Arch. Med. Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">470</span>– <span class="NLM_lpage">475</span>, <span class="refDoi"> DOI: 10.1016/j.arcmed.2012.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.arcmed.2012.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22960860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsFGjur7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2012&pages=470-475&author=F.+Karami-Tehraniauthor=M.+Moeinifardauthor=M.+Aghaeiauthor=M.+Atri&title=Evaluation+of+PDE5+and+PDE9+expression+in+benign+and+malignant+breast+tumors&doi=10.1016%2Fj.arcmed.2012.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit102R"><div class="casContent"><span class="casTitleNuber">102</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of PDE5 and PDE9 Expression in Benign and Malignant Breast Tumors</span></div><div class="casAuthors">Karami-Tehrani, Fatemeh; Moeinifard, Marzieh; Aghaei, Mahmoud; Atri, Morteza</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Medical Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">470-475</span>CODEN:
                <span class="NLM_cas:coden">AEDEER</span>;
        ISSN:<span class="NLM_cas:issn">0188-4409</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterases 5 and 9 (PDE5, PDE9) are enzymes responsible for regulating second messenger signaling by hydrolyzing 3',5' cyclic guanosine monophosphate (cGMP).  PDE isoforms are deregulated in some types of human cancer.  The present study was carried out to evaluate the expression of phosphodiesterase isoenzymes, PDE5 and PDE9, in benign and malignant breast tumors.  The expression levels of PDE5 and PDE9 were assayed in malignant and benign breast tumors and corresponding normal breast tissues using quant. real-time RT-PCR.  Moreover, the correlation between PDE5, PDE9 relative expression and clinicopathol. characteristics were analyzed.  The relative expressions of PDE5 and PDE9 in malignant tumors were significantly higher than those of resp. normal breast tissues and benign tumors (5.5-fold, p <0.001 and 6-fold, p <0.001, resp.).  Furthermore, a significant pos. correlation was found between PDE5 and PDE9 overexpression and tumor grade, stage, and lymph node involvement.  However, a neg. correlation was obsd. with age.  Based on the present results, it is concluded that assessment of PDE5 and PDE9 expression may be useful in the differential diagnosis of benign and malignant breast disease and successful treatment of breast cancer.  To the best of our knowledge, this is the first study to show that PDE5 and PDE9 expression levels are higher in malignant breast tumors than those of normal and benign breast tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIGx8wlYEgibVg90H21EOLACvtfcHk0lgf8TPhB8Ld8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsFGjur7F&md5=b9c1346a0083c4edf25d887516939e34</span></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1016%2Fj.arcmed.2012.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.arcmed.2012.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DKarami-Tehrani%26aufirst%3DF.%26aulast%3DMoeinifard%26aufirst%3DM.%26aulast%3DAghaei%26aufirst%3DM.%26aulast%3DAtri%26aufirst%3DM.%26atitle%3DEvaluation%2520of%2520PDE5%2520and%2520PDE9%2520expression%2520in%2520benign%2520and%2520malignant%2520breast%2520tumors%26jtitle%3DArch.%2520Med.%2520Res.%26date%3D2012%26volume%3D43%26spage%3D470%26epage%3D475%26doi%3D10.1016%2Fj.arcmed.2012.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Claffey, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fors, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundesmann, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lui, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, A. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hajos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDowell, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Connor, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macdougall-Murphy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fonseca, K. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nelson, F. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span> <span> </span><span class="NLM_article-title">Application of structure-based drug design and parallel chemistry to identify selective, brain penetrant, in vivo active phosphodiesterase 9A inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">9055</span>– <span class="NLM_lpage">9068</span>, <span class="refDoi"> DOI: 10.1021/jm3009635</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm3009635" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=9055-9068&author=M.+M.+Claffeyauthor=C.+J.+Helalauthor=P.+R.+Verhoestauthor=Z.+Kangauthor=K.+S.+Forsauthor=S.+Jungauthor=J.+Zhongauthor=M.+W.+Bundesmannauthor=X.+Houauthor=S.+Luiauthor=R.+J.+Kleimanauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=F.+Mennitiauthor=C.+J.+Schmidtauthor=W.+E.+Hoffmanauthor=M.+Hajosauthor=L.+McDowellauthor=R.+E.+O%E2%80%99Connorauthor=M.+Macdougall-Murphyauthor=K.+R.+Fonsecaauthor=S.+L.+Beckerauthor=F.+R.+Nelsonauthor=S.+Liras&title=Application+of+structure-based+drug+design+and+parallel+chemistry+to+identify+selective%2C+brain+penetrant%2C+in+vivo+active+phosphodiesterase+9A+inhibitors&doi=10.1021%2Fjm3009635"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span></div><div class="casAuthors">Claffey, Michelle M.; Helal, Christopher J.; Verhoest, Patrick R.; Kang, Zhijun; Bundesmann, Mark W.; Hou, Xinjun; Lui, Shenping; Kleiman, Robin J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Menniti, Frank; Schmidt, Christopher J.; Hoffman, William E.; Hajos, Mihaly; McDowell, Laura; O'Connor, Rebecca E.; MacDougall-Murphy, Mary; Fonseca, Kari R.; Becker, Stacey L.; Nelson, Frederick R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">9055-9068</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 9A inhibitors have shown activity in preclin. models of cognition with potential application as novel therapies for treating Alzheimer's disease.  Our clin. candidate, PF-04447943 (2), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochem. properties outside the range assocd. with traditional CNS drugs.  To address the potential risk of restricted CNS penetration with 2 in human clin. trials, we sought to identify a preclin. candidate with no asymmetry in rat brain penetration and that could advance into development.  Merging the medicinal chem. strategies of structure-based design with parallel chem., a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C.  Optimization afforded preclin. candidate 19 that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with the ability to increase cyclic guanosine monophosphosphate levels in rat CSF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphK4OmJAu-pbVg90H21EOLACvtfcHk0liWLPQnRDC0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhsVejsrvJ&md5=5e3aea9b0bfd660973c1e5fd56b6d933</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1021%2Fjm3009635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3009635%26sid%3Dliteratum%253Aachs%26aulast%3DClaffey%26aufirst%3DM.%2BM.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DKang%26aufirst%3DZ.%26aulast%3DFors%26aufirst%3DK.%2BS.%26aulast%3DJung%26aufirst%3DS.%26aulast%3DZhong%26aufirst%3DJ.%26aulast%3DBundesmann%26aufirst%3DM.%2BW.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DLui%26aufirst%3DS.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DMenniti%26aufirst%3DF.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHoffman%26aufirst%3DW.%2BE.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DL.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%2BE.%26aulast%3DMacdougall-Murphy%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DApplication%2520of%2520structure-based%2520drug%2520design%2520and%2520parallel%2520chemistry%2520to%2520identify%2520selective%252C%2520brain%2520penetrant%252C%2520in%2520vivo%2520active%2520phosphodiesterase%25209A%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D9055%26epage%3D9068%26doi%3D10.1021%2Fjm3009635" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Meng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, P. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ke, H.</span></span> <span> </span><span class="NLM_article-title">Structure-based discovery of highly selective phosphodiesterase-9A inhibitors and implications for inhibitor design</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">8549</span>– <span class="NLM_lpage">8558</span>, <span class="refDoi"> DOI: 10.1021/jm301189c</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm301189c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=8549-8558&author=F.+Mengauthor=J.+Houauthor=Y.+X.+Shaoauthor=P.+Y.+Wuauthor=M.+Huangauthor=X.+Zhuauthor=Y.+Caiauthor=Z.+Liauthor=J.+Xuauthor=P.+Liuauthor=H.+B.+Luoauthor=Y.+Wanauthor=H.+Ke&title=Structure-based+discovery+of+highly+selective+phosphodiesterase-9A+inhibitors+and+implications+for+inhibitor+design&doi=10.1021%2Fjm301189c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit104R"><div class="casContent"><span class="casTitleNuber">104</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Discovery of Highly Selective Phosphodiesterase-9A Inhibitors and Implications for Inhibitor Design</span></div><div class="casAuthors">Meng, Fei; Hou, Jing; Shao, Yong-Xian; Wu, Pei-Ying; Huang, Manna; Zhu, Xinhai; Cai, Yonghong; Li, Zhe; Xu, Jie; Liu, Peiqing; Luo, Hai-Bin; Wan, Yiqian; Ke, Hengming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8549-8558</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A new series of phosphodiesterase-9 (PDE9) inhibitors that contain a scaffold of 6-amino-pyrazolopyrimidinone have been discovered by a combination of structure-based design and computational docking.  This procedure significantly saved the load of chem. synthesis and is an effective method for the discovery of inhibitors.  The best compd. 28 (I) has an IC50 of 21 nM and 3.3 μM, resp., for PDE9 and PDE5 and about 3 orders of magnitude of selectivity against other PDE families.  The crystal structure of the PDE9 catalytic domain in complex with 28 has been detd. and shows a hydrogen bond between 28 and Tyr424.  This hydrogen bond may account for the 860-fold selectivity of 28 against PDE1B, in comparison with about 30-fold selectivity of BAY73-6691.  Thus, our studies suggest that Tyr424, a unique residue of PDE8 and PDE9, is a potential target for improvement of selectivity of PDE9 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXPtJ-cQVCabVg90H21EOLACvtfcHk0liWLPQnRDC0QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlGktbzJ&md5=ed8c37d784c80b040c51c9e2b40e2d99</span></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1021%2Fjm301189c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm301189c%26sid%3Dliteratum%253Aachs%26aulast%3DMeng%26aufirst%3DF.%26aulast%3DHou%26aufirst%3DJ.%26aulast%3DShao%26aufirst%3DY.%2BX.%26aulast%3DWu%26aufirst%3DP.%2BY.%26aulast%3DHuang%26aufirst%3DM.%26aulast%3DZhu%26aufirst%3DX.%26aulast%3DCai%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26aulast%3DWan%26aufirst%3DY.%26aulast%3DKe%26aufirst%3DH.%26atitle%3DStructure-based%2520discovery%2520of%2520highly%2520selective%2520phosphodiesterase-9A%2520inhibitors%2520and%2520implications%2520for%2520inhibitor%2520design%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D8549%26epage%3D8558%26doi%3D10.1021%2Fjm301189c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshmikuttyamma, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Selvakumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shrivastav, A.</span></span> <span> </span><span class="NLM_article-title">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review</span>. <i>Int. J. Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.3892/ijmm.18.1.95</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3892%2Fijmm.18.1.95" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16786160" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=95-105&author=R.+K.+Sharmaauthor=S.+B.+Dasauthor=A.+Lakshmikuttyammaauthor=P.+Selvakumarauthor=A.+Shrivastav&title=Regulation+of+calmodulin-stimulated+cyclic+nucleotide+phosphodiesterase+%28PDE1%29%3A+review&doi=10.3892%2Fijmm.18.1.95"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit105R"><div class="casContent"><span class="casTitleNuber">105</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1): review</span></div><div class="casAuthors">Sharma, Rajendra K.; Das, Shankar B.; Lakshmikuttyamma, Ashakumary; Selvakumar, Ponniah; Shrivastav, Anuraag</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Medicine</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-105</span>CODEN:
                <span class="NLM_cas:coden">IJMMFG</span>;
        ISSN:<span class="NLM_cas:issn">1107-3756</span>.
    
            (<span class="NLM_cas:orgname">International Journal of Molecular Medicine</span>)
        </div><div class="casAbstract">A review.  The response of living cells to change in cell environment depends on the action of second messenger mols.  The two second messenger mols. cAMP and Ca2+ regulate a large no. of eukaryotic cellular events.  Calmodulin-stimulated cyclic nucleotide phosphodiesterase (PDE1) is one of the key enzymes involved in the complex interaction between cAMP and Ca2+ second messenger systems.  Some PDE1 isoenzymes have similar kinetic and immunol. properties but are differentially regulated by Ca2+ and calmodulin.  Accumulating evidence suggests that the activity of PDE1 is selectively regulated by cross-talk between Ca2+ and cAMP signaling pathways.  These isoenzymes are also further distinguished by various pharmacol. agents.  We have demonstrated a potentially novel regulation of PDE1 by calpain.  This study suggests that limited proteolysis by calpain could be an alternative mechanism for the activation of PDE1.  We have also shown PDE1 activity, expression and effect of calpain in the rat model in vitro of cardiac ischemia-reperfusion.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZnr-AhNApDLVg90H21EOLACvtfcHk0li-qu9xgnm46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xnt1CnsLo%253D&md5=671b71e77c39fcf4782b9d3e2bceebcd</span></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.3892%2Fijmm.18.1.95&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fijmm.18.1.95%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DR.%2BK.%26aulast%3DDas%26aufirst%3DS.%2BB.%26aulast%3DLakshmikuttyamma%26aufirst%3DA.%26aulast%3DSelvakumar%26aufirst%3DP.%26aulast%3DShrivastav%26aufirst%3DA.%26atitle%3DRegulation%2520of%2520calmodulin-stimulated%2520cyclic%2520nucleotide%2520phosphodiesterase%2520%2528PDE1%2529%253A%2520review%26jtitle%3DInt.%2520J.%2520Mol.%2520Med.%26date%3D2006%26volume%3D18%26spage%3D95%26epage%3D105%26doi%3D10.3892%2Fijmm.18.1.95" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bönöczk, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyás, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adam-Vizi, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nemes, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kárpáti, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kiss, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapás, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szántay, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koncz, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zelles, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vas, A.</span></span> <span> </span><span class="NLM_article-title">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span>. <i>Brain Res. Bull.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>53</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">254</span>, <span class="refDoi"> DOI: 10.1016/S0361-9230(00)00354-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2FS0361-9230%2800%2900354-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11113577" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2000&pages=245-254&author=P.+B%C3%B6n%C3%B6czkauthor=B.+Guly%C3%A1sauthor=V.+Adam-Viziauthor=A.+Nemesauthor=E.+K%C3%A1rp%C3%A1tiauthor=B.+Kissauthor=M.+Kap%C3%A1sauthor=C.+Sz%C3%A1ntayauthor=I.+Konczauthor=T.+Zellesauthor=A.+Vas&title=Role+of+sodium+channel+inhibition+in+neuroprotection%3A+effect+of+vinpocetine&doi=10.1016%2FS0361-9230%2800%2900354-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit106R"><div class="casContent"><span class="casTitleNuber">106</span><div class="casTitle"><span class="NLM_cas:atitle">Role of sodium channel inhibition in neuroprotection: effect of vinpocetine</span></div><div class="casAuthors">Bonoczk, P.; Gulyas, B.; Adam-Vizi, V.; Nemes, A.; Karpati, E.; Kiss, B.; Kapas, M.; Szantay, C.; Koncz, I.; Zelles, T.; Vas, A.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research Bulletin</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">245-254</span>CODEN:
                <span class="NLM_cas:coden">BRBUDU</span>;
        ISSN:<span class="NLM_cas:issn">0361-9230</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 111 refs.  Vinpocetine (Et apovincaminate) discovered during the late 1960s has successfully been used in the treatment of central nervous system disorders of cerebrovascular origin for decades.  The increase in the regional cerebral blood flow in response to vinpocetine administration is well established and strengthened by new diagnostical techniques (transcranial Doppler, near IR spectroscopy, positron emission tomog.).  The latest in vitro studies have revealed the effect of the compd. on Ca2+/calmodulin dependent cGMP-phosphodiesterase 1, voltage-operated Ca2+ channels, glutamate receptors and voltage dependent Na+-channels; the latest being esp. relevant to the neuroprotective action of vinpocetine.  The good brain penetration profile and heterogeneous brain distribution pattern (mainly in the thalamus, basal ganglia and visual cortex) of labeled vinpocetine were demonstrated by positron emission tomog. in primates and man.  Multicentric, randomized, placebo-controlled clin. studies proved the efficacy of orally administered vinpocetine in patients with org. psychosyndrome.  Recently positron emission tomog. studies have proved that vinpocetine is able to redistribute regional cerebral blood flow and enhance glucose supply of brain tissue in ischemic post-stroke patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNFVCMjshLcbVg90H21EOLACvtfcHk0li-qu9xgnm46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXoslGgtrY%253D&md5=656c03dd9e9cd41a7638c6eb8674c5e4</span></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1016%2FS0361-9230%2800%2900354-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0361-9230%252800%252900354-3%26sid%3Dliteratum%253Aachs%26aulast%3DB%25C3%25B6n%25C3%25B6czk%26aufirst%3DP.%26aulast%3DGuly%25C3%25A1s%26aufirst%3DB.%26aulast%3DAdam-Vizi%26aufirst%3DV.%26aulast%3DNemes%26aufirst%3DA.%26aulast%3DK%25C3%25A1rp%25C3%25A1ti%26aufirst%3DE.%26aulast%3DKiss%26aufirst%3DB.%26aulast%3DKap%25C3%25A1s%26aufirst%3DM.%26aulast%3DSz%25C3%25A1ntay%26aufirst%3DC.%26aulast%3DKoncz%26aufirst%3DI.%26aulast%3DZelles%26aufirst%3DT.%26aulast%3DVas%26aufirst%3DA.%26atitle%3DRole%2520of%2520sodium%2520channel%2520inhibition%2520in%2520neuroprotection%253A%2520effect%2520of%2520vinpocetine%26jtitle%3DBrain%2520Res.%2520Bull.%26date%3D2000%26volume%3D53%26spage%3D245%26epage%3D254%26doi%3D10.1016%2FS0361-9230%2800%2900354-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Deshmukh, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mehan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bedi, K. L.</span></span> <span> </span><span class="NLM_article-title">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span>. <i>Eur. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>620</i></span>,  <span class="NLM_fpage">49</span>– <span class="NLM_lpage">56</span>, <span class="refDoi"> DOI: 10.1016/j.ejphar.2009.08.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejphar.2009.08.027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19699735" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=620&publication_year=2009&pages=49-56&author=R.+Deshmukhauthor=V.+Sharmaauthor=S.+Mehanauthor=N.+Sharmaauthor=K.+L.+Bedi&title=Amelioration+of+intracerebroventricular+streptozotocin+induced+cognitive+dysfunction+and+oxidative+stress+by+vinpocetine+-+a+PDE1+inhibitor&doi=10.1016%2Fj.ejphar.2009.08.027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Amelioration of intracerebroventricular streptozotocin induced cognitive dysfunction and oxidative stress by vinpocetine - a PDE1 inhibitor</span></div><div class="casAuthors">Deshmukh, Rahul; Sharma, Vivek; Mehan, Sidharth; Sharma, Nidhi; Bedi, K. L.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">620</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">49-56</span>CODEN:
                <span class="NLM_cas:coden">EJPHAZ</span>;
        ISSN:<span class="NLM_cas:issn">0014-2999</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Enhancing cyclic nucleotides signaling by inhibition of phosphodiesterases (PDEs) is known to be beneficial in disorders assocd. with cognitive decline.  The present study was designed to investigate the effect of vinpocetine (PDE1 inhibitor) on intracerebroventricular (i.c.v.) streptozotocin induced exptl. sporadic dementia of Alzheimer's type.  Infusion of streptozotocin impaired learning and memory, increased oxidative-nitritive stress and induced cholinergic hypofunction in rats.  Chronic treatment with vinpocetine (5, 10 and 20 mg/kg i.p.) for 21 days following first i.c.v. streptozotocin infusion significantly improved learning and memory in Morris water maze and passive avoidance paradigms.  Further, vinpocetine significantly reduced the oxidative-nitritive stress, as evidenced by decrease in malondialdehyde (MDA) and nitrite levels, and restored the reduced glutathione (GSH) levels.  Significant increase in acetylcholinesterase activity and lactate dehydrogenase levels was obsd. in the present model indicating cholinergic hypofunction and increase in neuronal cell damage.  Chronic treatment with vinpocetine also reduced significantly the increase in acetylcholinesterase activity and lactate dehydrogenase levels indicating restorative capacity of vinpocetine with respect to cholinergic functions and preventing the neuronal damage.  The obsd. beneficial effects of vinpocetine on spatial memory may be due to its ability to favorably modulate cholinergic functions, prevent neuronal cell damage and possibly through its antioxidant mechanism also.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokMQmZ9Cf3ybVg90H21EOLACvtfcHk0li-qu9xgnm46g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFGlt73L&md5=59b849a1799de087fe52b8eb62605be5</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1016%2Fj.ejphar.2009.08.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejphar.2009.08.027%26sid%3Dliteratum%253Aachs%26aulast%3DDeshmukh%26aufirst%3DR.%26aulast%3DSharma%26aufirst%3DV.%26aulast%3DMehan%26aufirst%3DS.%26aulast%3DSharma%26aufirst%3DN.%26aulast%3DBedi%26aufirst%3DK.%2BL.%26atitle%3DAmelioration%2520of%2520intracerebroventricular%2520streptozotocin%2520induced%2520cognitive%2520dysfunction%2520and%2520oxidative%2520stress%2520by%2520vinpocetine%2520-%2520a%2520PDE1%2520inhibitor%26jtitle%3DEur.%2520J.%2520Pharmacol.%26date%3D2009%26volume%3D620%26spage%3D49%26epage%3D56%26doi%3D10.1016%2Fj.ejphar.2009.08.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Al-Kuraishy, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Gareeb, A. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naji, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Mamorry, F.</span></span> <span> </span><span class="NLM_article-title">Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review</span>. <i>Brain Circ.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">10</span>, <span class="refDoi"> DOI: 10.4103/bc.bc_46_19</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.4103%2Fbc.bc_46_19" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32166194" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB383ivVGiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2020&pages=1-10&author=H.+M.+Al-Kuraishyauthor=A.+I.+Al-Gareebauthor=M.+T.+Najiauthor=F.+Al-Mamorry&title=Role+of+vinpocetine+in+ischemic+stroke+and+poststroke+outcomes%3A+A+critical+review&doi=10.4103%2Fbc.bc_46_19"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit108R"><div class="casContent"><span class="casTitleNuber">108</span><div class="casTitle"><span class="NLM_cas:atitle">Role of vinpocetine in ischemic stroke and poststroke outcomes: A critical review</span></div><div class="casAuthors">Al-Kuraishy Hayder M; Al-Gareeb Ali I; Naji Marwa Thaier; Al-Mamorry Farah</div><div class="citationInfo"><span class="NLM_cas:title">Brain circulation</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-10</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Vinpocetine (VPN) is a synthetic ethyl-ester derivative of the alkaloid apovincamine from Vinca minor leaves.  VPN is a selective inhibitor of phosphodiesterase type 1 (PDE1) that has potential neurological effects through inhibition of voltage-gated sodium channel and reduction of neuronal calcium influx.  VPN has noteworthy antioxidant, anti-inflammatory, and anti-apoptotic effects with inhibitory effect on glial and astrocyte cells during and following ischemic stroke (IS).  VPN is effective as adjuvant therapy in the management of epilepsy; it reduces seizure frequency by 50% in a dose of 2 mg/kg/day.  VPN improves psychomotor performances through modulation of brain monoamine pathway mainly on dopamine and serotonin, which play an integral role in attenuation of depressive symptoms.  VPN recover cognitive functions and spatial memory through inhibition of hippocampal and cortical PDE1 with augmentation of cyclic adenosin monophosphate and cyclic guanosin monophosphate ratio, enhancement of cholinergic neurotransmission, and inhibition of neuronal inflammatory mediators.  Therefore, VPN is an effective agent in the management of IS and plays an integral role in the prevention and attenuation of poststroke epilepsy, depression, and cognitive deficit through direct cAMP/cGMP-dependent pathway or indirectly through anti-inflammatory and antioxidant effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQBCuQOoiVQZIxhnOQkIHOxfW6udTcc2ea5PJ1BxVKlRLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB383ivVGiuw%253D%253D&md5=fcb519bbc1909ba04a5734cb0ce1277a</span></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.4103%2Fbc.bc_46_19&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4103%252Fbc.bc_46_19%26sid%3Dliteratum%253Aachs%26aulast%3DAl-Kuraishy%26aufirst%3DH.%2BM.%26aulast%3DAl-Gareeb%26aufirst%3DA.%2BI.%26aulast%3DNaji%26aufirst%3DM.%2BT.%26aulast%3DAl-Mamorry%26aufirst%3DF.%26atitle%3DRole%2520of%2520vinpocetine%2520in%2520ischemic%2520stroke%2520and%2520poststroke%2520outcomes%253A%2520A%2520critical%2520review%26jtitle%3DBrain%2520Circ.%26date%3D2020%26volume%3D6%26spage%3D1%26epage%3D10%26doi%3D10.4103%2Fbc.bc_46_19" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shekarian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Komaki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shahidi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarihi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salehi, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raoufi, S.</span></span> <span> </span><span class="NLM_article-title">The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of Amyloid Beta (αβ) peptide</span>. <i>Behav. Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>383</i></span>,  <span class="NLM_fpage">112512</span>, <span class="refDoi"> DOI: 10.1016/j.bbr.2020.112512</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bbr.2020.112512" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31991177" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXitlCgsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=383&publication_year=2020&pages=112512&author=M.+Shekarianauthor=A.+Komakiauthor=S.+Shahidiauthor=A.+Sarihiauthor=I.+Salehiauthor=S.+Raoufi&title=The+protective+and+therapeutic+effects+of+vinpocetine%2C+a+PDE1+inhibitor%2C+on+oxidative+stress+and+learning+and+memory+impairment+induced+by+an+intracerebroventricular+%28ICV%29+injection+of+Amyloid+Beta+%28%CE%B1%CE%B2%29+peptide&doi=10.1016%2Fj.bbr.2020.112512"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit109R"><div class="casContent"><span class="casTitleNuber">109</span><div class="casTitle"><span class="NLM_cas:atitle">The protective and therapeutic effects of vinpocetine, a PDE1 inhibitor, on oxidative stress and learning and memory impairment induced by an intracerebroventricular (ICV) injection of amyloid beta (aβ) peptide</span></div><div class="casAuthors">Shekarian, Meysam; Komaki, Alireza; Shahidi, Siamak; Sarihi, Abdolrahman; Salehi, Iraj; Raoufi, Safoura</div><div class="citationInfo"><span class="NLM_cas:title">Behavioural Brain Research</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">383</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">112512</span>CODEN:
                <span class="NLM_cas:coden">BBREDI</span>;
        ISSN:<span class="NLM_cas:issn">0166-4328</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is a neurodegenerative disease leading to cognitive and memory impairment.  This study aimed at investigating the therapeutic and preserving effects of vinpocetine on amyloid beta (Aβ)-induced rat model of AD.  Sixty male adult Wistar rats were randomly divided into 6 groups (n = 10 per group) as follows: 1; control, 2; sham, 3; Aβ, 4; pre-treatment (vinpocetine + Aβ): oral gavage administration of vinpocetine at 4 mg/kg for 30 days followed by intracerebroventricular (ICV) injection of Aβ, 5; treatment (Aβ + vinpocetine): Aβ ICV injection followed by vinpocetine administration for 30 days, 6; pre-treatment + treatment (vinpocetine + Aβ + vinpocetine): vinpocetine administration for 30 days before and 30 days after AD induction.  Following treatments, the animals' learning and memory were investigated using passive avoidance learning (PAL) task, Morris water maze (MWM), and novel object recognition (NOR) tests.  The results demonstrated that Aβ significantly enhanced escape latency and the distance traveled in the MWM, decreased step-through latency, and increased time spent in the dark compartment in PAL.  Vinpocetine ameliorated the Aβ-infused memory deficits in both MWM and PAL tests.  Administration of vinpocetine in the Aβ rats increased the discrimination index of the NOR test.  It also significantly diminished the nitric oxide and malondialdehyde levels and restored the reduced glutathione (GSH) levels.  Vinpocetine can improve memory and learning impairment following Aβ infusion due to its different properties, including antioxidant effects, which indicates that vinpocetine administration can lead to the amelioration of cognitive dysfunction in AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGogIHcin7IhRLVg90H21EOLACvtfcHk0ljUCwCDAJo8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXitlCgsbo%253D&md5=3d398db734f39ac5c930850458cb0ea3</span></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1016%2Fj.bbr.2020.112512&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbr.2020.112512%26sid%3Dliteratum%253Aachs%26aulast%3DShekarian%26aufirst%3DM.%26aulast%3DKomaki%26aufirst%3DA.%26aulast%3DShahidi%26aufirst%3DS.%26aulast%3DSarihi%26aufirst%3DA.%26aulast%3DSalehi%26aufirst%3DI.%26aulast%3DRaoufi%26aufirst%3DS.%26atitle%3DThe%2520protective%2520and%2520therapeutic%2520effects%2520of%2520vinpocetine%252C%2520a%2520PDE1%2520inhibitor%252C%2520on%2520oxidative%2520stress%2520and%2520learning%2520and%2520memory%2520impairment%2520induced%2520by%2520an%2520intracerebroventricular%2520%2528ICV%2529%2520injection%2520of%2520Amyloid%2520Beta%2520%2528%25CE%25B1%25CE%25B2%2529%2520peptide%26jtitle%3DBehav.%2520Brain%2520Res.%26date%3D2020%26volume%3D383%26spage%3D112512%26doi%3D10.1016%2Fj.bbr.2020.112512" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beard, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ida, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snell, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sogabe, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heyser, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective inhibitors of phosphodiesterase 1 for the treatment of cognitive impairment associated with neurodegenerative and neuropsychiatric diseases</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">1149</span>– <span class="NLM_lpage">1164</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01751</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01751" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=1149-1164&author=P.+Liauthor=H.+L.+Zhengauthor=J.+Zhaoauthor=L.+Zhangauthor=W.+Yaoauthor=H.+W.+Zhuauthor=J.+D.+Beardauthor=K.+Idaauthor=W.+Laneauthor=G.+Snellauthor=S.+Sogabeauthor=C.+J.+Heyserauthor=G.+L.+Snyderauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+E.+Davisauthor=L.+P.+Wennogle&title=Discovery+of+potent+and+selective+inhibitors+of+phosphodiesterase+1+for+the+treatment+of+cognitive+impairment+associated+with+neurodegenerative+and+neuropsychiatric+diseases&doi=10.1021%2Facs.jmedchem.5b01751"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Inhibitors of Phosphodiesterase 1 for the Treatment of Cognitive Impairment Associated with Neurodegenerative and Neuropsychiatric Diseases</span></div><div class="casAuthors">Li, Peng; Zheng, Hailin; Zhao, Jun; Zhang, Lei; Yao, Wei; Zhu, Hongwen; Beard, J. David; Ida, Koh; Lane, Weston; Snell, Gyorgy; Sogabe, Satoshi; Heyser, Charles J.; Snyder, Gretchen L.; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert E.; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1149-1164</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A diverse set of 3-aminopyrazolo[3,4-d]pyrimidinones was designed and synthesized.  The structure-activity relationships of these polycyclic compds. as phosphodiesterase 1 (PDE1) inhibitors were studied along with their physicochem. and pharmacokinetic properties.  Systematic optimizations of this novel scaffold culminated in the identification of a clin. candidate I, which exhibited picomolar inhibitory potency for PDE1, demonstrated excellent selectivity against all other PDE families and showed good efficacy in vivo.  Currently, this investigational new drug is in Phase I clin. development and being considered for the treatment of several indications including cognitive deficits assocd. with schizophrenia and Alzheimer's disease, movement disorders, attention deficit and hyperactivity disorders, and other central nervous system (CNS) and non-CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqiqQuMoLsXnbVg90H21EOLACvtfcHk0ljUCwCDAJo8bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1aisLk%253D&md5=73741521722dc906869ffa3504ceaf2e</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01751&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01751%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26aulast%3DZheng%26aufirst%3DH.%2BL.%26aulast%3DZhao%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DZhu%26aufirst%3DH.%2BW.%26aulast%3DBeard%26aufirst%3DJ.%2BD.%26aulast%3DIda%26aufirst%3DK.%26aulast%3DLane%26aufirst%3DW.%26aulast%3DSnell%26aufirst%3DG.%26aulast%3DSogabe%26aufirst%3DS.%26aulast%3DHeyser%26aufirst%3DC.%2BJ.%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%2BE.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520inhibitors%2520of%2520phosphodiesterase%25201%2520for%2520the%2520treatment%2520of%2520cognitive%2520impairment%2520associated%2520with%2520neurodegenerative%2520and%2520neuropsychiatric%2520diseases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26spage%3D1149%26epage%3D1164%26doi%3D10.1021%2Facs.jmedchem.5b01751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, G. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wadenberg, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, H. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akkerman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendrick, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanover, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mates, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wennogle, L. P.</span></span> <span> </span><span class="NLM_article-title">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span>. <i>Psychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>233</i></span>,  <span class="NLM_fpage">3113</span>– <span class="NLM_lpage">3124</span>, <span class="refDoi"> DOI: 10.1007/s00213-016-4346-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00213-016-4346-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27342643" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=233&publication_year=2016&pages=3113-3124&author=G.+L.+Snyderauthor=J.+Prickaertsauthor=M.+L.+Wadenbergauthor=L.+Zhangauthor=H.+L.+Zhengauthor=W.+Yaoauthor=S.+Akkermanauthor=H.+W.+Zhuauthor=J.+P.+Hendrickauthor=K.+E.+Vanoverauthor=R.+Davisauthor=P.+Liauthor=S.+Matesauthor=L.+P.+Wennogle&title=Preclinical+profile+of+ITI-214%2C+an+inhibitor+of+phosphodiesterase+1%2C+for+enhancement+of+memory+performance+in+rats&doi=10.1007%2Fs00213-016-4346-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical profile of ITI-214, an inhibitor of phosphodiesterase 1, for enhancement of memory performance in rats</span></div><div class="casAuthors">Snyder, Gretchen L.; Prickaerts, Jos; Wadenberg, Marie-Louise; Zhang, Lei; Zheng, Hailin; Yao, Wei; Akkerman, Sven; Zhu, Hongwen; Hendrick, Joseph P.; Vanover, Kimberly E.; Davis, Robert; Li, Peng; Mates, Sharon; Wennogle, Lawrence P.</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Heidelberg, Germany)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">233</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3113-3124</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Rationale: Therapeutic agents for memory enhancement in psychiatric disorders, such as schizophrenia, are urgently needed.  Objective: The aim of this study is to characterize the preclin. profile of ITI-214, a potent inhibitor of phosphodiesterase 1 (PDE1).  Methods: ITI-214 was assayed for inhibition of PDE1 vs. other PDE enzyme families using recombinant human PDE enzymes and for off-target binding to 70 substrates (General SEP II diversity panel; Caliper Life Sciences).  Effects of ITI-214 (0.1-10 mg/kg, po) on memory performance were assayed in rats using the novel object recognition (NOR) paradigm, with drug given at specified time points prior to or following exposure to objects in an open field.  ITI-214 was evaluated for potential drug-drug interaction with risperidone in rats using conditioned avoidance response (CAR) and pharmacokinetic assessments.  Results: ITI-214 inhibited PDE1A (Ki = 33 pmol) with >1000-fold selectivity for the nearest other PDE family (PDE4D) and displayed minimal off-target binding interactions in a 70-substrate selectivity profile.  By using specific timing of oral ITI-214 administration, it was demonstrated in the NOR that ITI-214 is able to enhance acquisition, consolidation, and retrieval memory processes.  All memory effects were in the absence of effects on exploratory behavior.  ITI-214 did not disrupt the risperidone pharmacokinetic profile or effects in CAR.  Conclusions: ITI-214 improved the memory processes of acquisition, consolidation, and retrieval across a broad dose range (0.1-10 mg/kg, po) without disrupting the antipsychotic-like activity of a clin. antipsychotic medication, specifically risperidone.  Clin. development of ITI-214 is currently in progress.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7eUb8S0yISLVg90H21EOLACvtfcHk0lixinNnVgc1QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtVKnsLrF&md5=90f1653bd30aaf1ffe5a543f0181e4c1</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1007%2Fs00213-016-4346-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-016-4346-2%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DG.%2BL.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DWadenberg%26aufirst%3DM.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DZheng%26aufirst%3DH.%2BL.%26aulast%3DYao%26aufirst%3DW.%26aulast%3DAkkerman%26aufirst%3DS.%26aulast%3DZhu%26aufirst%3DH.%2BW.%26aulast%3DHendrick%26aufirst%3DJ.%2BP.%26aulast%3DVanover%26aufirst%3DK.%2BE.%26aulast%3DDavis%26aufirst%3DR.%26aulast%3DLi%26aufirst%3DP.%26aulast%3DMates%26aufirst%3DS.%26aulast%3DWennogle%26aufirst%3DL.%2BP.%26atitle%3DPreclinical%2520profile%2520of%2520ITI-214%252C%2520an%2520inhibitor%2520of%2520phosphodiesterase%25201%252C%2520for%2520enhancement%2520of%2520memory%2520performance%2520in%2520rats%26jtitle%3DPsychopharmacology%26date%3D2016%26volume%3D233%26spage%3D3113%26epage%3D3124%26doi%3D10.1007%2Fs00213-016-4346-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Laursen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mogensen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mow, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinilla, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knudsen, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hedegaard, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simonsen, U.</span></span> <span> </span><span class="NLM_article-title">Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">2563</span>– <span class="NLM_lpage">2575</span>, <span class="refDoi"> DOI: 10.1111/bph.13868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fbph.13868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28548283" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFSmu7%252FF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=2563-2575&author=M.+Laursenauthor=L.+Beckauthor=J.+Kehlerauthor=C.+T.+Christoffersenauthor=C.+Bundgaardauthor=S.+Mogensenauthor=T.+J.+Mowauthor=E.+Pinillaauthor=J.+S.+Knudsenauthor=E.+R.+Hedegaardauthor=M.+Grunnetauthor=U.+Simonsen&title=Novel+selective+PDE+type+1+inhibitors+cause+vasodilatation+and+lower+blood+pressure+in+rats&doi=10.1111%2Fbph.13868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Novel selective PDE type 1 inhibitors cause vasodilatation and lower blood pressure in rats</span></div><div class="casAuthors">Laursen, Morten; Beck, Lilliana; Kehler, Jan; Christoffersen, Claus Tornby; Bundgaard, Christoffer; Mogensen, Susie; Mow, Tomas Joachim; Pinilla, Estefano; Knudsen, Jakob Schoellhammer; Hedegaard, Elise Roge; Grunnet, Morten; Simonsen, Ulf</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">2563-2575</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Background and Purpose : The PDE enzymes (PDE1-11) hydrolyze and thus inactivate cyclic nucleotides and are important in the regulation of the cardiovascular system.  Here,we have investigated the effects on the cardiovascular system, of two novel selective PDE1 inhibitors, Lu AF41228 and Lu AF58027.  Exptl. Approach : We used rat mesenteric small arteries (internal diams. of 200-300 μm), RT-PCR and measured isometric wall tension.  Effects of Lu AF41228 and Lu AF58027 on heart rate and BP were assessed in both anesthetized and conscious male rats.  Key Results : Nanomolar concns. of Lu AF41228 and Lu AF58027 inhibited PDE1A, PDE1B and PDE1C enzyme activity, while micromolar concns. were required to observe inhibitory effects at other PDEs.  RT-PCR revealed expression of PDE1A, PDE1B and PDE1C in rat brain, heart and aorta, but only PDE1A and PDE1B in mesenteric arteries.  In rat isolated mesenteric arteries contracted with phenylephrine or U46619, Lu AF41228 and Lu AF58027 induced concn.-dependent relaxations which were markedly reduced by inhibitors of guanylate cyclase, ODQ, and adenylate cyclase, SQ22536, and in prepns. without endothelium.  In anesthetized rats, Lu AF41228 and Lu AF58027 dose-dependently lowered mean BP and increased heart rate.  In conscious rats with telemetric pressure transducers, repeated dosing with Lu AF41228 lowered mean arterial BP 10-15 mmHg and increased heart rate.  Conclusions and Implications : These novel PDE1 inhibitors induce vasodilation and lower BP, suggesting a potential use of these vasodilators in the treatment of hypertension and vasospasm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpW-SCH2nKBlrVg90H21EOLACvtfcHk0lixinNnVgc1QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFSmu7%252FF&md5=6379f7126cbddb332c41e5713e02427d</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1111%2Fbph.13868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.13868%26sid%3Dliteratum%253Aachs%26aulast%3DLaursen%26aufirst%3DM.%26aulast%3DBeck%26aufirst%3DL.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DMogensen%26aufirst%3DS.%26aulast%3DMow%26aufirst%3DT.%2BJ.%26aulast%3DPinilla%26aufirst%3DE.%26aulast%3DKnudsen%26aufirst%3DJ.%2BS.%26aulast%3DHedegaard%26aufirst%3DE.%2BR.%26aulast%3DGrunnet%26aufirst%3DM.%26aulast%3DSimonsen%26aufirst%3DU.%26atitle%3DNovel%2520selective%2520PDE%2520type%25201%2520inhibitors%2520cause%2520vasodilatation%2520and%2520lower%2520blood%2520pressure%2520in%2520rats%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D2563%26epage%3D2575%26doi%3D10.1111%2Fbph.13868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khammy, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dalsgaard, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsen, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Clausen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rasmussen, L. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkersen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grunnet, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kehler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aalkjr, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span> <span> </span><span class="NLM_article-title">PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>174</i></span>,  <span class="NLM_fpage">4186</span>– <span class="NLM_lpage">4198</span>, <span class="refDoi"> DOI: 10.1111/bph.14034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fbph.14034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28910498" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs1Glt7jI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=174&publication_year=2017&pages=4186-4198&author=M.+M.+Khammyauthor=T.+Dalsgaardauthor=P.+H.+Larsenauthor=C.+T.+Christoffersenauthor=D.+Clausenauthor=L.+K.+Rasmussenauthor=L.+Folkersenauthor=M.+Grunnetauthor=J.+Kehlerauthor=C.+Aalkjrauthor=J.+Nielsen&title=PDE1A+inhibition+elicits+cGMP-dependent+relaxation+of+rat+mesenteric+arteries&doi=10.1111%2Fbph.14034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">PDE1A inhibition elicits cGMP-dependent relaxation of rat mesenteric arteries</span></div><div class="casAuthors">Khammy, Makhala Michell; Dalsgaard, Thomas; Larsen, Peter Hjorringgaard; Christoffersen, Claus Tornby; Clausen, Dorte; Rasmussen, Lars Kyhn; Folkersen, Lasse; Grunnet, Morten; Kehler, Jan; Aalkjaer, Christian; Nielsen, Jacob</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">174</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4186-4198</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">PDE1, a subfamily of cyclic nucleotide PDEs consisting of three isoforms, PDE1A, PDE1B and PDE1C, has been implicated in the regulation of vascular tone.  The PDE1 isoform(s) responsible for tone regulation is unknown.  This study used isoform-preferring PDE1 inhibitors, Lu AF58027, Lu AF64196, Lu AF66896 and Lu AF67897, to investigate the relative contribution of PDE1 isoforms to regulation of vascular tone.  Exptl. Approach : In rat mesenteric arteries, expression and localization of Pde1 isoforms were detd. by quant. PCR and in situ hybridization, and physiol. impact of PDE1 inhibition was evaluated by isometric tension recordings.  Key Results : In rat mesenteric arteries, Pde1a mRNA expression was higher than Pde1b and Pde1c.  In situ hybridization revealed localization of Pde1a to vascular smooth muscle cells (VSMCs) and only minor appearance of Pde1b and Pde1c.  The potency of the PDE1 inhibitors at eliciting relaxation showed excellent correlation with their potency at inhibiting PDE1A.  Thus, Lu AF58027 was the most potent at inhibiting PDE1A and was also the most potent at eliciting relaxation in mesenteric arteries.  Inhibition of NOS with L-NAME, sol. GC with ODQ or PKG with Rp-8-Br-PET-cGMP all attenuated the inhibitory effect of PDE1 on relaxation, whereas PKA inhibition with H89 had no effect.  Conclusions and Implications : Pde1a is the dominant PDE1 isoform present in VSMCs, and relaxation mediated by PDE1A inhibition is predominantly driven by enhanced cGMP signalling.  These results imply that isoform-selective PDE1 inhibitors are powerful investigative tools allowing examn. of physiol. and pathol. roles of PDE1 isoforms.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpA0cqyoTWmrbVg90H21EOLACvtfcHk0lixinNnVgc1QQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs1Glt7jI&md5=3aa92761452be0e054b03ccb2a3724de</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1111%2Fbph.14034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fbph.14034%26sid%3Dliteratum%253Aachs%26aulast%3DKhammy%26aufirst%3DM.%2BM.%26aulast%3DDalsgaard%26aufirst%3DT.%26aulast%3DLarsen%26aufirst%3DP.%2BH.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DClausen%26aufirst%3DD.%26aulast%3DRasmussen%26aufirst%3DL.%2BK.%26aulast%3DFolkersen%26aufirst%3DL.%26aulast%3DGrunnet%26aufirst%3DM.%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DAalkjr%26aufirst%3DC.%26aulast%3DNielsen%26aufirst%3DJ.%26atitle%3DPDE1A%2520inhibition%2520elicits%2520cGMP-dependent%2520relaxation%2520of%2520rat%2520mesenteric%2520arteries%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2017%26volume%3D174%26spage%3D4186%26epage%3D4198%26doi%3D10.1111%2Fbph.14034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dyck, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Branstetter, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gharbaoui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudson, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botrous, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marrone, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barido, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allerston, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cedervall, E. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sridhar, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aertgeerts, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmelzer, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neul, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Massari, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andersen, C. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Petroski, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Limberis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Augustin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edwards, T. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabatabaei, A.</span></span> <span> </span><span class="NLM_article-title">Discovery of selective phosphodiesterase 1 inhibitors with memory enhancing properties</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">3472</span>– <span class="NLM_lpage">3483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00302</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00302" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=3472-3483&author=B.+Dyckauthor=B.+Branstetterauthor=T.+Gharbaouiauthor=A.+R.+Hudsonauthor=J.+G.+Breitenbucherauthor=L.+Gomezauthor=I.+Botrousauthor=T.+Marroneauthor=R.+Baridoauthor=C.+K.+Allerstonauthor=E.+P.+Cedervallauthor=R.+Xuauthor=V.+Sridharauthor=R.+Barkerauthor=K.+Aertgeertsauthor=K.+Schmelzerauthor=D.+Neulauthor=D.+Leeauthor=M.+E.+Massariauthor=C.+B.+Andersenauthor=K.+Sebringauthor=X.+B.+Zhouauthor=R.+Petroskiauthor=J.+Limberisauthor=M.+Augustinauthor=L.+E.+Chunauthor=T.+E.+Edwardsauthor=M.+Petersauthor=A.+Tabatabaei&title=Discovery+of+selective+phosphodiesterase+1+inhibitors+with+memory+enhancing+properties&doi=10.1021%2Facs.jmedchem.7b00302"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit114R"><div class="casContent"><span class="casTitleNuber">114</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties</span></div><div class="casAuthors">Dyck, Brian; Branstetter, Bryan; Gharbaoui, Tawfik; Hudson, Andrew R.; Breitenbucher, J. Guy; Gomez, Laurent; Botrous, Iriny; Marrone, Tami; Barido, Richard; Allerston, Charles K.; Cedervall, E. Peder; Xu, Rui; Sridhar, Vandana; Barker, Ryan; Aertgeerts, Kathleen; Schmelzer, Kara; Neul, David; Lee, Dong; Massari, Mark Eben; Andersen, Carsten B.; Sebring, Kristen; Zhou, Xianbo; Petroski, Robert; Limberis, James; Augustin, Martin; Chun, Lawrence E.; Edwards, Thomas E.; Peters, Marco; Tabatabaei, Ali</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3472-3483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of potent thienotriazolopyrimidinone-based PDE1 inhibitors was discovered.  X-ray crystal structures of example compds. from this series in complex with the catalytic domain of PDE1B and PDE10A were detd., allowing optimization of PDE1B potency and PDE selectivity.  Redn. of hERG affinity led to greater than a 3000-fold selectivity for PDE1B over hERG. 6-(4-Methoxybenzyl)-9-((tetrahydro-2H-pyran-4-yl)methyl)-8,9,10,11-tetrahydropyrido[4',3':4,5]thieno[3,2-e][1,2,4]triazolo[1,5-c]pyrimidin-5(6H)-one was identified as an orally bioavailable and brain penetrating PDE1B enzyme inhibitor with potent memory-enhancing effects in a rat model of object recognition memory.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqX2wxwLW-OPLVg90H21EOLACvtfcHk0lhB-cHZagCdgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvF2jsLk%253D&md5=ff7c3c08432646621c8d2cc32693e75f</span></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00302%26sid%3Dliteratum%253Aachs%26aulast%3DDyck%26aufirst%3DB.%26aulast%3DBranstetter%26aufirst%3DB.%26aulast%3DGharbaoui%26aufirst%3DT.%26aulast%3DHudson%26aufirst%3DA.%2BR.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DBotrous%26aufirst%3DI.%26aulast%3DMarrone%26aufirst%3DT.%26aulast%3DBarido%26aufirst%3DR.%26aulast%3DAllerston%26aufirst%3DC.%2BK.%26aulast%3DCedervall%26aufirst%3DE.%2BP.%26aulast%3DXu%26aufirst%3DR.%26aulast%3DSridhar%26aufirst%3DV.%26aulast%3DBarker%26aufirst%3DR.%26aulast%3DAertgeerts%26aufirst%3DK.%26aulast%3DSchmelzer%26aufirst%3DK.%26aulast%3DNeul%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DD.%26aulast%3DMassari%26aufirst%3DM.%2BE.%26aulast%3DAndersen%26aufirst%3DC.%2BB.%26aulast%3DSebring%26aufirst%3DK.%26aulast%3DZhou%26aufirst%3DX.%2BB.%26aulast%3DPetroski%26aufirst%3DR.%26aulast%3DLimberis%26aufirst%3DJ.%26aulast%3DAugustin%26aufirst%3DM.%26aulast%3DChun%26aufirst%3DL.%2BE.%26aulast%3DEdwards%26aufirst%3DT.%2BE.%26aulast%3DPeters%26aufirst%3DM.%26aulast%3DTabatabaei%26aufirst%3DA.%26atitle%3DDiscovery%2520of%2520selective%2520phosphodiesterase%25201%2520inhibitors%2520with%2520memory%2520enhancing%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D3472%26epage%3D3483%26doi%3D10.1021%2Facs.jmedchem.7b00302" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Movsesian, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Am Ende, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jenkinson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liras, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orozco, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pandit, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vajdos, F. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandeput, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span> <span> </span><span class="NLM_article-title">Discovery of potent and selective periphery-restricted quinazoline inhibitors of the cyclic nucleotide phosphodiesterase PDE1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">4635</span>– <span class="NLM_lpage">4640</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b00374</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b00374" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXovVCiu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=4635-4640&author=J.+M.+Humphreyauthor=M.+Movsesianauthor=C.+W.+Am+Endeauthor=S.+L.+Beckerauthor=T.+A.+Chappieauthor=S.+Jenkinsonauthor=J.+L.+Lirasauthor=S.+Lirasauthor=C.+Orozcoauthor=J.+Panditauthor=F.+F.+Vajdosauthor=F.+Vandeputauthor=E.+Yangauthor=F.+S.+Menniti&title=Discovery+of+potent+and+selective+periphery-restricted+quinazoline+inhibitors+of+the+cyclic+nucleotide+phosphodiesterase+PDE1&doi=10.1021%2Facs.jmedchem.8b00374"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1</span></div><div class="casAuthors">Humphrey, John M.; Movsesian, Matthew; am Ende, Christopher W.; Becker, Stacey L.; Chappie, Thomas A.; Jenkinson, Stephen; Liras, Jennifer L.; Liras, Spiros; Orozco, Christine; Pandit, Jayvardhan; Vajdos, Felix F.; Vandeput, Fabrice; Yang, Eddie; Menniti, Frank S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4635-4640</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We disclose the discovery and X-ray cocrystal data of potent, selective quinazoline inhibitors of PDE1.  Inhibitor (S)-3 readily attains free plasma concns. above PDE1 IC50 values and has restricted brain access.  The racemic compd. 3 inhibits >75% of PDE hydrolytic activity in sol. samples of human myocardium, consistent with heightened PDE1 activity in this tissue.  These compds. represent promising new tools to probe the value of PDE1 inhibition in the treatment of cardiovascular disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoyfBNdGu_yn7Vg90H21EOLACvtfcHk0lhB-cHZagCdgA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXovVCiu7k%253D&md5=733a5dbd18abb79d3522a6cce873df71</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b00374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b00374%26sid%3Dliteratum%253Aachs%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DMovsesian%26aufirst%3DM.%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DJenkinson%26aufirst%3DS.%26aulast%3DLiras%26aufirst%3DJ.%2BL.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DOrozco%26aufirst%3DC.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DVajdos%26aufirst%3DF.%2BF.%26aulast%3DVandeput%26aufirst%3DF.%26aulast%3DYang%26aufirst%3DE.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520selective%2520periphery-restricted%2520quinazoline%2520inhibitors%2520of%2520the%2520cyclic%2520nucleotide%2520phosphodiesterase%2520PDE1%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D4635%26epage%3D4640%26doi%3D10.1021%2Facs.jmedchem.8b00374" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, P.</span>; <span class="NLM_string-name">Wennogle, L. P.</span>; <span class="NLM_string-name">Zhao, J.</span>; <span class="NLM_string-name">Zheng, H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase-1-trageting tracers and methods</span>. WO <span class="NLM_patent">2011043816 A1</span>, <span class="NLM_year">2011</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2011&author=P.+Li&author=L.+P.+Wennogle&author=J.+Zhao&author=H.+Zheng&title=Phosphodiesterase-1-trageting+tracers+and+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DP.%26atitle%3DPhosphodiesterase-1-trageting%2520tracers%2520and%2520methods%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kealey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aigbirhio, F. I.</span></span> <span> </span><span class="NLM_article-title">Synthesis and radiolabelling of the first potential PET radiotracer for imaging PDE1</span>. <i>J. Labelled Comp Radiopharm</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">S111</span>– <span class="NLM_lpage">S640</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28502124" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=S111-S640&issue=1&author=S.+Kealeyauthor=F.+I.+Aigbirhio&title=Synthesis+and+radiolabelling+of+the+first+potential+PET+radiotracer+for+imaging+PDE1"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKealey%26aufirst%3DS.%26aulast%3DAigbirhio%26aufirst%3DF.%2BI.%26atitle%3DSynthesis%2520and%2520radiolabelling%2520of%2520the%2520first%2520potential%2520PET%2520radiotracer%2520for%2520imaging%2520PDE1%26jtitle%3DJ.%2520Labelled%2520Comp%2520Radiopharm%26date%3D2017%26volume%3D60%26issue%3D1%26spage%3DS111%26epage%3DS640" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuzhuppilly
Ramakrishnan, N.</span>; <span class="NLM_string-name">Kealey, S.</span>; <span class="NLM_string-name">Zhou, X.</span>; <span class="NLM_string-name">Williamson, D.</span>; <span class="NLM_string-name">Aigbirhio, F.</span></span> <span> </span><span class="NLM_article-title">In vivo PET evaluation of a potential PDE1 radiotracer - [11C](±)-PF04822163</span>. In  <i>The XII International Symposium of Functional Neuroreceptor Mapping of the Living Brain</i>, <span class="NLM_publisher-loc">London, UK</span>, <span class="NLM_year">2018</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=N.+Kuzhuppilly%0ARamakrishnan&author=S.+Kealey&author=X.+Zhou&author=D.+Williamson&author=F.+Aigbirhio&title=In+vivo+PET+evaluation+of+a+potential+PDE1+radiotracer+-+%5B11C%5D%28%C2%B1%29-PF04822163"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DKuzhuppilly%2BRamakrishnan%26aufirst%3DN.%26atitle%3DIn%2520vivo%2520PET%2520evaluation%2520of%2520a%2520potential%2520PDE1%2520radiotracer%2520-%2520%255B11C%255D%2528%25C2%25B1%2529-PF04822163%26jtitle%3DThe%2520XII%2520International%2520Symposium%2520of%2520Functional%2520Neuroreceptor%2520Mapping%2520of%2520the%2520Living%2520Brain%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zoidl, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koesling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, M.</span></span> <span> </span><span class="NLM_article-title">Dual acylation of PDE2A splice variant 3: targeting to synaptic membranes</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>284</i></span>,  <span class="NLM_fpage">25782</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1074/jbc.M109.017194</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.M109.017194" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19632989" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtr7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=284&publication_year=2009&pages=25782-90&author=C.+Russwurmauthor=G.+Zoidlauthor=D.+Koeslingauthor=M.+Russwurm&title=Dual+acylation+of+PDE2A+splice+variant+3%3A+targeting+to+synaptic+membranes&doi=10.1074%2Fjbc.M109.017194"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Dual acylation of PDE2A splice variant 3: Targeting to synaptic membranes</span></div><div class="casAuthors">Russwurm, Corina; Zoidl, Georg; Koesling, Doris; Russwurm, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">284</span>
        (<span class="NLM_cas:issue">38</span>),
    <span class="NLM_cas:pages">25782-25790</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The cGMP-stimulated PDE2A hydrolyzes both cyclic nucleotides, cGMP and cAMP.  Three splice variants have been cloned from several species.  Whereas PDE2A1 is sol., PDE2A2 and PDE2A3 are membrane-bound enzymes of rat and bovine origin, resp.  To date it is unclear whether one species expresses all three variants.  The splice variants only differ in their N termini, which likely det. the subcellular localization.  However, the mechanism for membrane attachment remains unknown.  Here, we show that myristoylation underlies membrane targeting of PDE2A3.  The myristoylated enzyme was bound to plasma membranes, whereas mutation of the myristoyl recipient Gly2 prevented incorporation of [3H]myristate and turned PDE2A3 completely sol.  Addnl., Cys5 and to a minor extent Cys11 are required for targeting of PDE2A3.  Substitution of the putatively palmitoylated cysteines partially solubilized the enzyme and led to an accumulation in the endoplasmic reticulum/Golgi compartment, as shown by fluorescence microscopy in HEK 293 and PC12 cells.  In vivo, PDE2A is expressed in many tissues.  By using newly generated antibodies selectively detecting the splice variants PDE2A3 or PDE2A1, resp., we demonstrate on the protein level PDE2A3 expression in mouse brain where it is entirely membrane-assocd. and a widespread expression of sol. PDE2A1 in mouse tissues.  We show that PDE2A localizes to synaptosomal membranes and in primary cultures of hippocampal neurons partially overlaps with the presynaptic marker synaptophysin as demonstrated by immunofluorescence.  In sum, these results demonstrate dual acylation as mechanism targeting neuronal PDE2A3 to synapses thereby ensuring local control of cyclic nucleotides.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoGAPRP71KIt7Vg90H21EOLACvtfcHk0lhKH-JkrI7TsA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtFWhtr7I&md5=b5a55f15e1bc5b15d7b74867e8160be2</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M109.017194&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M109.017194%26sid%3Dliteratum%253Aachs%26aulast%3DRusswurm%26aufirst%3DC.%26aulast%3DZoidl%26aufirst%3DG.%26aulast%3DKoesling%26aufirst%3DD.%26aulast%3DRusswurm%26aufirst%3DM.%26atitle%3DDual%2520acylation%2520of%2520PDE2A%2520splice%2520variant%25203%253A%2520targeting%2520to%2520synaptic%2520membranes%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2009%26volume%3D284%26spage%3D25782%26epage%3D90%26doi%3D10.1074%2Fjbc.M109.017194" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breitenbucher, J. G.</span></span> <span> </span><span class="NLM_article-title">PDE2 inhibition: potential for the treatment of cognitive disorders</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">6522</span>– <span class="NLM_lpage">6527</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2013.10.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2013.10.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24189054" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=6522-6527&author=L.+Gomezauthor=J.+G.+Breitenbucher&title=PDE2+inhibition%3A+potential+for+the+treatment+of+cognitive+disorders&doi=10.1016%2Fj.bmcl.2013.10.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit120R"><div class="casContent"><span class="casTitleNuber">120</span><div class="casTitle"><span class="NLM_cas:atitle">PDE2 inhibition: Potential for the treatment of cognitive disorders</span></div><div class="casAuthors">Gomez, Laurent; Breitenbucher, J. Guy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">6522-6527</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase inhibition has received much attention in the past 20 years for the potential treatment of CNS disorders.  A primary focus of this work is the enhancement of memory and/or cognitive functioning.  The role of PDEs in the augmentation of cyclic nucleotide signaling makes these enzymes attractive targets for enhancing the effects of neuronal communication.  This review focuses on recent findings with respect to the role of PDE2 inhibition in cognitive functioning.  Special attention is paid to recently disclosed, selective tool compds. and the use of these tool compds. to support the role of PDE2 inhibition in cognition.  Recently reported SAR and modeling work will be presented along with discussion of the entry of new PDE2 inhibitors into the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqGUUFzh2-kTrVg90H21EOLACvtfcHk0liNM3b5M2hkFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhslartbjL&md5=04ca2bdc35dc0b436a228ba62934b91e</span></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2013.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2013.10.014%26sid%3Dliteratum%253Aachs%26aulast%3DGomez%26aufirst%3DL.%26aulast%3DBreitenbucher%26aufirst%3DJ.%2BG.%26atitle%3DPDE2%2520inhibition%253A%2520potential%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2013%26volume%3D23%26spage%3D6522%26epage%3D6527%26doi%3D10.1016%2Fj.bmcl.2013.10.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Am Ende, C. W.</span>; <span class="NLM_string-name">Kormos, B.</span>; <span class="NLM_string-name">Humphrey, J. M.</span></span> <span> </span><span class="NLM_article-title">The state of the art in selective PDE2A inhibitor design</span>. In  <i>Phosphodiesterases and Their Inhibitors</i>; <span class="NLM_year">2014</span>; Chapter 6, p  <span class="NLM_fpage">83</span>. <span class="refDoi"> DOI: 10.1002/9783527682348.ch06</span> .</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2F9783527682348.ch06" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&pages=83&author=C.+W.+Am+Ende&author=B.+Kormos&author=J.+M.+Humphrey&title=Phosphodiesterases+and+Their+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1002%2F9783527682348.ch06&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9783527682348.ch06%26sid%3Dliteratum%253Aachs%26aulast%3DAm%2BEnde%26aufirst%3DC.%2BW.%26atitle%3DThe%2520state%2520of%2520the%2520art%2520in%2520selective%2520PDE2A%2520inhibitor%2520design%26btitle%3DPhosphodiesterases%2520and%2520Their%2520Inhibitors%26date%3D2014%26spage%3D83%26doi%3D10.1002%2F9783527682348.ch06" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Domek-Lopacinska, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strosznajder, J. B.</span></span> <span> </span><span class="NLM_article-title">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1216</i></span>,  <span class="NLM_fpage">68</span>– <span class="NLM_lpage">77</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2008.02.108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.brainres.2008.02.108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=18499090" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1216&publication_year=2008&pages=68-77&author=K.+Domek-Lopacinskaauthor=J.+B.+Strosznajder&title=The+effect+of+selective+inhibition+of+cyclic+GMP+hydrolyzing+phosphodiesterases+2+and+5+on+learning+and+memory+processes+and+nitric+oxide+synthase+activity+in+brain+during+aging&doi=10.1016%2Fj.brainres.2008.02.108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of selective inhibition of cyclic GMP hydrolyzing phosphodiesterases 2 and 5 on learning and memory processes and nitric oxide synthase activity in brain during aging</span></div><div class="casAuthors">Domek-Lopacinska, K.; Strosznajder, J. B.</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1216</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">68-77</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Our previous studies have shown that there is a lower cGMP concn. in the aged brain as well as an alteration in the activity of cGMP-hydrolyzing phosphodiesterases (PDEs) and nitric oxide synthase (NOS).  The aim of this study was to investigate the effect of specific inhibitors of selected PDEs on object recognition memory and locomotor activity during aging, and to correlate their action with NOS activity in the following brain regions: hippocampus, striatum, and cerebral cortex.  The study was carried out using 3, 12, and 24 mo-old rats.  Inhibitors of PDE2 and PDE5 (Bayer 60-7550 and zaprinast, resp.) were used.  Evaluation of memory and locomotor activity was carried out using an object recognition task and the open field test.  NOS activity was detd. using a radiochem. method after behavioral anal. in the cytosolic fraction from all brain areas investigated.  We have found that the inhibitor of PDE2, Bayer 60-7550, improves object recognition memory in all age groups investigated and increases basal constitutive NOS activity in the hippocampus and striatum.  Moreover, in 3 mo-old rats, addnl. inhibition of PDE5 by zaprinast improves object memory and elevates NOS activity in all brain regions studied.  Specific inhibition of nNOS eliminates the effect of Bayer 60-7550 on memory function and on NOS activity in 24 mo-old rats.  In summary, our results indicate that inhibition of PDE2 is able to improve cognition and memory function in 3, 12, and 24 mo-old rats through the enhancement of nNOS activity in the brain, whereas inhibition of PDE5 is effective only in 3 mo-old animals.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGroSn1Uayy6qrVg90H21EOLACvtfcHk0liNM3b5M2hkFQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXmvVKku7c%253D&md5=bbc77008c158141527bb046db313f6bf</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2008.02.108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2008.02.108%26sid%3Dliteratum%253Aachs%26aulast%3DDomek-Lopacinska%26aufirst%3DK.%26aulast%3DStrosznajder%26aufirst%3DJ.%2BB.%26atitle%3DThe%2520effect%2520of%2520selective%2520inhibition%2520of%2520cyclic%2520GMP%2520hydrolyzing%2520phosphodiesterases%25202%2520and%25205%2520on%2520learning%2520and%2520memory%2520processes%2520and%2520nitric%2520oxide%2520synthase%2520activity%2520in%2520brain%2520during%2520aging%26jtitle%3DBrain%2520Res.%26date%3D2008%26volume%3D1216%26spage%3D68%26epage%3D77%26doi%3D10.1016%2Fj.brainres.2008.02.108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rutten, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Donkelaar, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrington, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blokland, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bollen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbusch, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prickaerts, J. H.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span>. <i>Neuropsychopharmacology</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1914</span>– <span class="NLM_lpage">1925</span>, <span class="refDoi"> DOI: 10.1038/npp.2009.24</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fnpp.2009.24" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19262466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref123/cit123&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2009&pages=1914-1925&author=K.+Ruttenauthor=E.+L.+Van+Donkelaarauthor=L.+Ferringtonauthor=A.+Bloklandauthor=E.+Bollenauthor=H.+W.+Steinbuschauthor=P.+A.+Kellyauthor=J.+H.+Prickaerts&title=Phosphodiesterase+inhibitors+enhance+object+memory+independent+of+cerebral+blood+flow+and+glucose+utilization+in+rats&doi=10.1038%2Fnpp.2009.24"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit123R"><div class="casContent"><span class="casTitleNuber">123</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors enhance object memory independent of cerebral blood flow and glucose utilization in rats</span></div><div class="casAuthors">Rutten, Kris; Van Donkelaar, Eva L.; Ferrington, Linda; Blokland, Arjan; Bollen, Eva; Steinbusch, Harry W. M.; Kelly, Paul A. T.; Prickaerts, Jos H. H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Neuropsychopharmacology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1914-1925</span>CODEN:
                <span class="NLM_cas:coden">NEROEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-133X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors prevent the breakdown of the second messengers, cAMP (cAMP) and cyclic GMP (cGMP), and are currently studied as possible targets for cognitive enhancement.  Earlier studies indicated beneficial effects of PDE inhibitors in object recognition.  In this study we tested the effects of three PDE inhibitors on spatial memory as assessed in a place and object recognition task.  Furthermore, as both cAMP and cGMP are known vasodilators, the effects of PDE inhibition on cognitive functions could be explained by enhancement of cerebrovascular function.  We examd. this possibility by measuring the effects of PDE5 and PDE4 inhibitor treatment on local cerebral blood flow and glucose utilization in rats using [14C]-iodoantipyrine and [14C]-2-deoxyglucose quant. autoradiog., resp.  In the spatial location task, PDE5 inhibition (cGMP) with vardenafil enhanced only early phase consolidation, PDE4 inhibition (cAMP) with rolipram enhanced only late phase consolidation, and PDE2 inhibition (cAMP and cGMP) with Bay 60-7550 enhanced both consolidation processes.  Furthermore, PDE5 inhibition had no cerebrovascular effects in hippocampal or rhinal areas.  PDE4 inhibition increased rhinal, but not hippocampal blood flow, whereas it decreased glucose utilization in both areas.  In general, PDE5 inhibition decreased the ratio between blood flow and glucose utilization, indicative of general oligemia; whereas PDE4 inhibition increased this ratio, indicative of general hyperemia.  Both oligemic and hyperemic conditions are detrimental for brain function and do not explain memory enhancement.  These results underscore the specific effects of cAMP and cGMP on memory consolidation (object and spatial memory) and provide evidence that the underlying mechanisms of PDE inhibition on cognition are independent of cerebrovascular effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfAElwT0GL1rVg90H21EOLACvtfcHk0ljAPGOKzAz5yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXnsFSju7c%253D&md5=506d0fbcb1b4a7a0c25bf92ab08fc270</span></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=10.1038%2Fnpp.2009.24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnpp.2009.24%26sid%3Dliteratum%253Aachs%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DVan%2BDonkelaar%26aufirst%3DE.%2BL.%26aulast%3DFerrington%26aufirst%3DL.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DBollen%26aufirst%3DE.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%26aulast%3DKelly%26aufirst%3DP.%2BA.%26aulast%3DPrickaerts%26aufirst%3DJ.%2BH.%26atitle%3DPhosphodiesterase%2520inhibitors%2520enhance%2520object%2520memory%2520independent%2520of%2520cerebral%2520blood%2520flow%2520and%2520glucose%2520utilization%2520in%2520rats%26jtitle%3DNeuropsychopharmacology%26date%3D2009%26volume%3D34%26spage%3D1914%26epage%3D1925%26doi%3D10.1038%2Fnpp.2009.24" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruan, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reed, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klabnik, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, J. M.</span></span> <span> </span><span class="NLM_article-title">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">955</span>– <span class="NLM_lpage">970</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neurobiolaging.2014.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25442113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=955-970&author=Y.+Xuauthor=J.+Panauthor=J.+Sunauthor=L.+Dingauthor=L.+Ruanauthor=M.+Reedauthor=X.+Yuauthor=J.+Klabnikauthor=D.+Linauthor=J.+Liauthor=L.+Chenauthor=C.+Zhangauthor=H.+Zhangauthor=J.+M.+O%E2%80%99Donnell&title=Inhibition+of+phosphodiesterase+2+reverses+impaired+cognition+and+neuronal+remodeling+caused+by+chronic+stress&doi=10.1016%2Fj.neurobiolaging.2014.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of phosphodiesterase 2 reverses impaired cognition and neuronal remodeling caused by chronic stress</span></div><div class="casAuthors">Xu, Ying; Pan, Jianchun; Sun, Jiao; Ding, Lianshu; Ruan, Lina; Reed, Miranda; Yu, Xuefeng; Klabni, Jonathan; Lin, Dan; Li, Jianxin; Chen, Ling; Zhang, Chong; Zhang, Hanting; O'Donnell, James M.</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">955-970</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Chronic stress and neuronal vulnerability have recently been recognized as factors contributing to cognitive disorders.  One way to modify neuronal vulnerability is through mediation of phosphodiesterase 2 (PDE2), an enzyme that exerts its action on cognitive processes via the control of intracellular second messengers, cGMP and, to a lesser extent, cAMP.  This study explored the effects of a PDE2 inhibitor, Bay 60-7550, on stress-induced learning and memory dysfunction in terms of its ramification on behavioral, morphol., and mol. changes.  Bay 60-7550 reversed stress-induced cognitive impairment in the Morris water maze, novel object recognition, and location tasks (object recognition test and/or object location test), effects prevented by treatment with 7-NI, a selective inhibitor of neuronal nitric oxide synthase; MK801, a glutamate receptor (NMDAR) inhibitor; myr-AIP, a CaMKII inhibitor; and KT5823, a protein kinase G inhibitor.  Bay 60-7550 also ameliorated stress-induced structural remodeling in the CA1 of the hippocampus, leading to increases in dendritic branching, length, and spine d.  However, the neuroplasticity initiated by Bay 60-7550 was not seen in the presence of 7-NI, MK801, myr-AIP, or KT5823.  PDE2 inhibition reduced stress-induced extracellular-regulated protein kinase activation and attenuated stress-induced decreases in transcription factors (e.g., Elk-1, TORC1, and CREB phosphorylation) and plasticity-related proteins (e.g., Egr-1 and brain-derived neurotrophic factor).  Pretreatment with inhibitors of NMDA, CaMKII, neuronal nitric oxide synthase, and protein kinase G (or protein kinase A) blocked the effects of Bay 60-7550 on cGMP or cAMP signaling.  These findings indicate that the effect of PDE2 inhibition on stress-induced memory impairment is potentially mediated via modulation of neuroplasticity-related NMDAR-CaMKII-cGMP/cAMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqC4VvV9CfvU7Vg90H21EOLACvtfcHk0ljAPGOKzAz5yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsF2mu7rL&md5=bd201c08a67c20c036958d7ed02cd25f</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DJ.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DL.%26aulast%3DRuan%26aufirst%3DL.%26aulast%3DReed%26aufirst%3DM.%26aulast%3DYu%26aufirst%3DX.%26aulast%3DKlabnik%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DJ.%2BM.%26atitle%3DInhibition%2520of%2520phosphodiesterase%25202%2520reverses%2520impaired%2520cognition%2520and%2520neuronal%2520remodeling%2520caused%2520by%2520chronic%2520stress%26jtitle%3DNeurobiol.%2520Aging%26date%3D2015%26volume%3D36%26spage%3D955%26epage%3D970%26doi%3D10.1016%2Fj.neurobiolaging.2014.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, H. B.</span></span> <span> </span><span class="NLM_article-title">Novel phosphodiesterase inhibitors for cognitive improvement in Alzheimer’s disease</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">5467</span>– <span class="NLM_lpage">5483</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b01370</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b01370" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=5467-5483&author=Y.+Wuauthor=Z.+Liauthor=Y.+Y.+Huangauthor=D.+Wuauthor=H.+B.+Luo&title=Novel+phosphodiesterase+inhibitors+for+cognitive+improvement+in+Alzheimer%E2%80%99s+disease&doi=10.1021%2Facs.jmedchem.7b01370"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">Novel Phosphodiesterase Inhibitors for Cognitive Improvement in Alzheimer's Disease</span></div><div class="casAuthors">Wu, Yinuo; Li, Zhe; Huang, Yi-You; Wu, Deyan; Luo, Hai-Bin</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">5467-5483</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD) is one of the greatest public health challenges.  Phosphodiesterases (PDEs) are a superenzyme family responsible for the hydrolysis of two second messengers: cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP).  Since several PDE subfamilies are highly expressed in the human brain, the inhibition of PDEs is involved in neurodegenerative processes by regulating the concn. of cAMP and/or cGMP.  Currently, PDEs are considered as promising targets for the treatment of AD since many PDE inhibitors have exhibited remarkable cognitive improvement effects in preclin. studies and over 15 of them have been subjected to clin. trials.  The aim of this review is to summarize the outstanding progress that has been made by PDE inhibitors as anti-AD agents with encouraging results in preclin. studies and clin. trials.  The binding affinity, pharmacokinetics, underlying mechanisms, and limitations of these PDE inhibitors in the treatment of AD are also reviewed and discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGom1l9eMNKCt7Vg90H21EOLACvtfcHk0ljAPGOKzAz5yA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFGqu7w%253D&md5=87cd22fa21c661f4cb5dc2155368bd7c</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b01370&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b01370%26sid%3Dliteratum%253Aachs%26aulast%3DWu%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DY.%2BY.%26aulast%3DWu%26aufirst%3DD.%26aulast%3DLuo%26aufirst%3DH.%2BB.%26atitle%3DNovel%2520phosphodiesterase%2520inhibitors%2520for%2520cognitive%2520improvement%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2018%26volume%3D61%26spage%3D5467%26epage%3D5483%26doi%3D10.1021%2Facs.jmedchem.7b01370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Fernandez, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosenbrock, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kroker, K. S.</span></span> <span> </span><span class="NLM_article-title">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">484</span>– <span class="NLM_lpage">496</span>, <span class="refDoi"> DOI: 10.1002/syn.21840</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21840" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26178667" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=484-496&author=D.+Fernandez-Fernandezauthor=H.+Rosenbrockauthor=K.+S.+Kroker&title=Inhibition+of+PDE2A%2C+but+not+PDE9A%2C+modulates+presynaptic+short-term+plasticity+measured+by+paired-pulse+facilitation+in+the+CA1+region+of+the+hippocampus&doi=10.1002%2Fsyn.21840"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of PDE2A, but not PDE9A, modulates presynaptic short-term plasticity measured by paired-pulse facilitation in the CA1 region of the hippocampus</span></div><div class="casAuthors">Fernandez-Fernandez, Diego; Rosenbrock, Holger; Kroker, Katja S.</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">484-496</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) inhibitors are currently considered promising therapeutic targets for treatment of cognitive impairment in diseases such as Schizophrenia and Alzheimer's disease.  Inhibitors of PDE2A and PDE9A have emerged as potential candidates shown to improve synaptic plasticity and memory function in animals.  However, the functional relevance of their putative different localization in the neuron is not understood.  Thus, this study aims at elucidating potential presynaptic effects of PDE2A inhibition in comparison to the inhibition of PDE9A.  For this purpose, we used paired-pulse facilitation (PPF), a model of short-term synaptic plasticity related to presynaptic function.  First, we performed a series of expts. to validate the model in acute rat hippocampal slices using several ref. substances including calcium channel blockers, glutamatergic receptor antagonists, and GPCR agonists.  Second, we analyzed the effect of PDE2A and PDE9A inhibition and their role regulating the influence that the second messengers cAMP and cGMP exert on basal transmission.  Our results show that the interplay between the adenylyl cyclase activator forskolin, the sol. guanylyl cyclase activator BAY 41-8543 and the PDE2A inhibitor PF-999 reveals a primarily presynaptic mechanism of action of PDE2A inhibition.  On the contrary, inhibition of PDE9A did not alter PPF under similar conditions.  In conclusion, these data provide new evidence supporting a role of PDE2A modulating short-term synaptic plasticity.  Moreover, this function of PDE2A is suggested to rely on an active modulation of the cAMP hydrolysis as a response to changes in cGMP levels at the presynaptic level.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMx3KC2TNDKrVg90H21EOLACvtfcHk0lgyn0qI6gelYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1elu7vI&md5=990c6e54c53f4d8a08ae91d2fbdcef83</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21840&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21840%26sid%3Dliteratum%253Aachs%26aulast%3DFernandez-Fernandez%26aufirst%3DD.%26aulast%3DRosenbrock%26aufirst%3DH.%26aulast%3DKroker%26aufirst%3DK.%2BS.%26atitle%3DInhibition%2520of%2520PDE2A%252C%2520but%2520not%2520PDE9A%252C%2520modulates%2520presynaptic%2520short-term%2520plasticity%2520measured%2520by%2520paired-pulse%2520facilitation%2520in%2520the%2520CA1%2520region%2520of%2520the%2520hippocampus%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D484%26epage%3D496%26doi%3D10.1002%2Fsyn.21840" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Asano, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ujikawa, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukumoto, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of an orally bioavailable, brain-penetrating, in vivo active phosphodiesterase 2A inhibitor lead series for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7658</span>– <span class="NLM_lpage">7676</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00709</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00709" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7658-7676&author=S.+Mikamiauthor=S.+Sasakiauthor=Y.+Asanoauthor=O.+Ujikawaauthor=S.+Fukumotoauthor=K.+Nakashimaauthor=H.+Okiauthor=N.+Kamiguchiauthor=H.+Imadaauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+an+orally+bioavailable%2C+brain-penetrating%2C+in+vivo+active+phosphodiesterase+2A+inhibitor+lead+series+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00709"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit127R"><div class="casContent"><span class="casTitleNuber">127</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of an Orally Bioavailable, Brain-Penetrating, in Vivo Active Phosphodiesterase 2A Inhibitor Lead Series for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Sasaki, Shigekazu; Asano, Yasutomi; Ujikawa, Osamu; Fukumoto, Shoji; Nakashima, Kosuke; Oki, Hideyuki; Kamiguchi, Naomi; Imada, Haruka; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7658-7676</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein, the authors describe the discovery of a potent, selective, brain-penetrating, in vivo active phosphodiesterase (PDE) 2A inhibitor lead series.  To identify high-quality leads suitable for optimization and enable validation of the physiol. function of PDE2A in vivo, structural modifications of the high-throughput screening hit were performed.  The lead generation efforts revealed three key potency-enhancing functionalities with minimal increases in mol. wt. (MW) and no change in topol. polar surface area (TPSA).  Combining these structural elements led to the identification of 6-methyl-N-((1R)-1-(4-(trifluoromethoxy)phenyl)propyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide (38a), a mol. with the desired balance of preclin. properties.  Further characterization by cocrystal structure anal. of (38a) bound to PDE2A uncovered a unique binding mode and provided insights into its obsd. potency and PDE selectivity.  Compd. (38a) significantly elevated 3',5'-cGMP levels in mouse brain following oral administration, thus validating this compd. as a useful pharmacol. tool and an attractive lead for future optimization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoXk4ZjO3RKAbVg90H21EOLACvtfcHk0lgyn0qI6gelYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXht1GhurrO&md5=361f9ce22899da731673ed86ade3f8aa</span></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00709&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00709%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DAsano%26aufirst%3DY.%26aulast%3DUjikawa%26aufirst%3DO.%26aulast%3DFukumoto%26aufirst%3DS.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520an%2520orally%2520bioavailable%252C%2520brain-penetrating%252C%2520in%2520vivo%2520active%2520phosphodiesterase%25202A%2520inhibitor%2520lead%2520series%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7658%26epage%3D7676%26doi%3D10.1021%2Facs.jmedchem.7b00709" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mikami, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashizawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawasaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokubo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, I. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imada, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iwashita, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span> <span> </span><span class="NLM_article-title">Discovery of clinical candidate N-((1<i>S</i>)-1-(3-fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2, 3-dihydropyrido[2,3-<i>b</i>]pyrazine-4(1<i>H</i>)-carboxamide (TAK-915): A highly potent, selective, and brain-penetrating phosphodiesterase 2A inhibitor for the treatment of cognitive disorders</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">7677</span>– <span class="NLM_lpage">7702</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.7b00807</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.7b00807" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=7677-7702&author=S.+Mikamiauthor=S.+Nakamuraauthor=T.+Ashizawaauthor=I.+Nomuraauthor=M.+Kawasakiauthor=S.+Sasakiauthor=H.+Okiauthor=H.+Kokuboauthor=I.+D.+Hoffmanauthor=H.+Zouauthor=N.+Uchiyamaauthor=K.+Nakashimaauthor=N.+Kamiguchiauthor=H.+Imadaauthor=N.+Suzukiauthor=H.+Iwashitaauthor=T.+Taniguchi&title=Discovery+of+clinical+candidate+N-%28%281S%29-1-%283-fluoro-4-%28trifluoromethoxy%29phenyl%29-2-methoxyethyl%29-7-methoxy-2-oxo-2%2C+3-dihydropyrido%5B2%2C3-b%5Dpyrazine-4%281H%29-carboxamide+%28TAK-915%29%3A+A+highly+potent%2C+selective%2C+and+brain-penetrating+phosphodiesterase+2A+inhibitor+for+the+treatment+of+cognitive+disorders&doi=10.1021%2Facs.jmedchem.7b00807"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Clinical Candidate N-((1S)-1-(3-Fluoro-4-(trifluoromethoxy)phenyl)-2-methoxyethyl)-7-methoxy-2-oxo-2,3-dihydropyrido[2,3-b]pyrazine-4(1H)-carboxamide (TAK-915): A Highly Potent, Selective, and Brain-Penetrating Phosphodiesterase 2A Inhibitor for the Treatment of Cognitive Disorders</span></div><div class="casAuthors">Mikami, Satoshi; Nakamura, Shinji; Ashizawa, Tomoko; Nomura, Izumi; Kawasaki, Masanori; Sasaki, Shigekazu; Oki, Hideyuki; Kokubo, Hironori; Hoffman, Isaac D.; Zou, Hua; Uchiyama, Noriko; Nakashima, Kosuke; Kamiguchi, Naomi; Imada, Haruka; Suzuki, Noriko; Iwashita, Hiroki; Taniguchi, Takahiko</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">7677-7702</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 2A inhibitors have emerged as a novel mechanism with potential therapeutic option to ameliorate cognitive dysfunction in schizophrenia or Alzheimer's disease through upregulation of cyclic nucleotides in the brain, and thereby achieve potentiation of cyclic nucleotide signaling pathways.  This article details the expedited optimization of the authors' recently disclosed pyrazolo[1,5-a]pyrimidine lead compd. 4b, leading to the discovery of clin. candidate 36 (I) (TAK-915), which demonstrates an appropriate combination of potency, PDE selectivity, and favorable pharmacokinetic (PK) properties, including brain penetration.  Successful identification of 36 was realized through application of structure-based drug design (SBDD) to further improve potency and PDE selectivity, coupled with prospective design focused on physicochem. properties to deliver brain penetration.  Oral administration of 36 demonstrated significant elevation of 3',5'-cGMP levels in mouse brains, and improved cognitive performance in a novel object recognition task in rats.  Consequently, compd. 36 was advanced into human clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCUw5grC_66rVg90H21EOLACvtfcHk0lgyn0qI6gelYA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtlSmtL3I&md5=f87cb3ac86b6299fc90e336b88ea2a21</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.7b00807&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.7b00807%26sid%3Dliteratum%253Aachs%26aulast%3DMikami%26aufirst%3DS.%26aulast%3DNakamura%26aufirst%3DS.%26aulast%3DAshizawa%26aufirst%3DT.%26aulast%3DNomura%26aufirst%3DI.%26aulast%3DKawasaki%26aufirst%3DM.%26aulast%3DSasaki%26aufirst%3DS.%26aulast%3DOki%26aufirst%3DH.%26aulast%3DKokubo%26aufirst%3DH.%26aulast%3DHoffman%26aufirst%3DI.%2BD.%26aulast%3DZou%26aufirst%3DH.%26aulast%3DUchiyama%26aufirst%3DN.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DImada%26aufirst%3DH.%26aulast%3DSuzuki%26aufirst%3DN.%26aulast%3DIwashita%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26atitle%3DDiscovery%2520of%2520clinical%2520candidate%2520N-%2528%25281S%2529-1-%25283-fluoro-4-%2528trifluoromethoxy%2529phenyl%2529-2-methoxyethyl%2529-7-methoxy-2-oxo-2%252C%25203-dihydropyrido%255B2%252C3-b%255Dpyrazine-4%25281H%2529-carboxamide%2520%2528TAK-915%2529%253A%2520A%2520highly%2520potent%252C%2520selective%252C%2520and%2520brain-penetrating%2520phosphodiesterase%25202A%2520inhibitor%2520for%2520the%2520treatment%2520of%2520cognitive%2520disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D7677%26epage%3D7702%26doi%3D10.1021%2Facs.jmedchem.7b00807" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Andrös-Gil, J. I.</span>; <span class="NLM_string-name">Rombouts, F. J. R.</span>; <span class="NLM_string-name">Traban-Co-Suarez, A. A.</span>; <span class="NLM_string-name">Vanhoof, G. C. P.</span>; <span class="NLM_string-name">De Angelis, M.</span>; <span class="NLM_string-name">Buijnsters, P. J. J. A.</span>; <span class="NLM_string-name">Guillemont, J. E. G.</span>; <span class="NLM_string-name">Bormans, G. M. R.</span>; <span class="NLM_string-name">Celen, S. J. L.</span>; <span class="NLM_string-name">Vliegen, M.</span></span> <span> </span><span class="NLM_article-title">l-Aryl-4-methyl-[l,2,4]triazolo[4,3-a]quinoxaline derivatives</span>. WO <span class="NLM_patent">2013000924 A1</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=J.+I.+Andr%C3%B6s-Gil&author=F.+J.+R.+Rombouts&author=A.+A.+Traban-Co-Suarez&author=G.+C.+P.+Vanhoof&author=M.+De+Angelis&author=P.+J.+J.+A.+Buijnsters&author=J.+E.+G.+Guillemont&author=G.+M.+R.+Bormans&author=S.+J.+L.+Celen&author=M.+Vliegen&title=l-Aryl-4-methyl-%5Bl%2C2%2C4%5Dtriazolo%5B4%2C3-a%5Dquinoxaline+derivatives"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAndr%25C3%25B6s-Gil%26aufirst%3DJ.%2BI.%26atitle%3Dl-Aryl-4-methyl-%255Bl%252C2%252C4%255Dtriazolo%255B4%252C3-a%255Dquinoxaline%2520derivatives%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beck, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bocan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chappie, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heck, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humphrey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhoest, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wager, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span> <span> </span><span class="NLM_article-title">Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligand</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4568</span>– <span class="NLM_lpage">4579</span>, <span class="refDoi"> DOI: 10.1021/jm400312y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm400312y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2013&pages=4568-4579&author=L.+Zhangauthor=A.+Villalobosauthor=E.+M.+Beckauthor=T.+Bocanauthor=T.+A.+Chappieauthor=L.+Chenauthor=S.+Grimwoodauthor=S.+D.+Heckauthor=C.+J.+Helalauthor=X.+Houauthor=J.+M.+Humphreyauthor=J.+Luauthor=M.+B.+Skaddanauthor=T.+J.+McCarthyauthor=P.+R.+Verhoestauthor=T.+T.+Wagerauthor=K.+Zasadny&title=Design+and+selection+parameters+to+accelerate+the+discovery+of+novel+central+nervous+system+positron+emission+tomography+%28PET%29+ligands+and+their+application+in+the+development+of+a+novel+phosphodiesterase+2A+PET+ligand&doi=10.1021%2Fjm400312y"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Design and Selection Parameters to Accelerate the Discovery of Novel Central Nervous System Positron Emission Tomography (PET) Ligands and Their Application in the Development of a Novel Phosphodiesterase 2A PET Ligand</span></div><div class="casAuthors">Zhang, Lei; Villalobos, Anabella; Beck, Elizabeth M.; Bocan, Thomas; Chappie, Thomas A.; Chen, Laigao; Grimwood, Sarah; Heck, Steven D.; Helal, Christopher J.; Hou, Xinjun; Humphrey, John M.; Lu, Jiemin; Skaddan, Marc B.; McCarthy, Timothy J.; Verhoest, Patrick R.; Wager, Travis T.; Zasadny, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">4568-4579</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">To accelerate the discovery of novel small mol. central nervous system (CNS) positron emission tomog. (PET) ligands, we aimed to define a property space that would facilitate ligand design and prioritization, thereby providing a higher probability of success for novel PET ligand development.  Toward this end, we built a database consisting of 62 PET ligands that have successfully reached the clinic and 15 radioligands that failed in late-stage development as neg. controls.  A systematic anal. of these ligands identified a set of preferred parameters for physicochem. properties, brain permeability, and nonspecific binding (NSB).  These preferred parameters have subsequently been applied to several programs and have led to the successful development of novel PET ligands with reduced resources and timelines.  This strategy is illustrated here by the discovery of the novel phosphodiesterase 2A (PDE2A) PET ligand 4-(3-[18F]fluoroazetidin-1-yl)-7-methyl-5-{1-methyl-5-[4-(trifluoromethyl)phenyl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine, [18F]PF-05270430 (5).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpTCG9TZE0X-bVg90H21EOLACvtfcHk0lgvrIhANdkkUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXntFyhtro%253D&md5=ee7ce04829d7456a632c02c331c4edfa</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1021%2Fjm400312y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400312y%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DBeck%26aufirst%3DE.%2BM.%26aulast%3DBocan%26aufirst%3DT.%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHeck%26aufirst%3DS.%2BD.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DMcCarthy%26aufirst%3DT.%2BJ.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DZasadny%26aufirst%3DK.%26atitle%3DDesign%2520and%2520selection%2520parameters%2520to%2520accelerate%2520the%2520discovery%2520of%2520novel%2520central%2520nervous%2520system%2520positron%2520emission%2520tomography%2520%2528PET%2529%2520ligands%2520and%2520their%2520application%2520in%2520the%2520development%2520of%2520a%2520novel%2520phosphodiesterase%25202A%2520PET%2520ligand%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2013%26volume%3D56%26spage%3D4568%26epage%3D4579%26doi%3D10.1021%2Fjm400312y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabulsi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naganawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zasadny, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skaddan, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafzadeh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Helal, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boyden, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropchan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalobos, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-PF-05270430, a novel PET radioligand for the phosphodiesterase 2A enzyme</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1448</span>– <span class="NLM_lpage">1453</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.171454</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.115.171454" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27199356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaktbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1448-1453&author=L.+Chenauthor=N.+Nabulsiauthor=M.+Naganawaauthor=K.+Zasadnyauthor=M.+B.+Skaddanauthor=L.+Zhangauthor=S.+Najafzadehauthor=S.+F.+Linauthor=C.+J.+Helalauthor=T.+L.+Boydenauthor=C.+Changauthor=J.+Ropchanauthor=R.+E.+Carsonauthor=A.+Villalobosauthor=Y.+Huang&title=Preclinical+evaluation+of+18F-PF-05270430%2C+a+novel+PET+radioligand+for+the+phosphodiesterase+2A+enzyme&doi=10.2967%2Fjnumed.115.171454"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit131R"><div class="casContent"><span class="casTitleNuber">131</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of 18F-PF-05270430, a novel PET radioligand for the phosphodiesterase 2A enzyme</span></div><div class="casAuthors">Chen, Laigao; Nabulsi, Nabeel; Naganawa, Mika; Zasadny, Kenneth; Skaddan, Marc B.; Zhang, Lei; Najafzadeh, Soheila; Lin, Shu-fei; Helal, Christopher J.; Boyden, Tracey L.; Chang, Cheng; Ropchan, Jim; Carson, Richard E.; Villalobos, Anabella; Huang, Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1448-1453</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">The enzyme phosphodiesterase 2A (PF-05270430) is a potential target for development of novel therapeutic agents for the treatment of cognitive impairments.  The goal of the present study was to evaluate the PDE2A ligand 18F-PF-05270430, 4-(3-fluoroazetidin-1-yl)-7-methyl-5-(1-methyl-5-(4-(trifluoromethyl)phenyl)-1H-pyrazol-4-yl)imidazo[1,5-f][1,2,4]triazine, in nonhuman primates.  18F-PF-05270430 was radiolabeled by 2 methods via nucleophilic substitution of its tosylate precursor.  Tissue metabolite anal. in rodents and PET imaging in nonhuman primates under baseline and blocking conditions were performed to det. the pharmacokinetic and binding characteristics of the new radioligand.  Various kinetic modeling approaches were assessed to select the optimal method for anal. of imaging data.  18F-PF-05270430 was synthesized in greater than 98% radiochem. purity and high specific activity.  In the nonhuman primate brain, uptake of 18F-PF-05270430 was fast, with peak concn. (SUVs of 1.5-1.8 in rhesus monkeys) achieved within 7 min after injection.  The rank order of uptake was striatum > neocortical regions > cerebellum.  Regional time-activity curves were well fitted by the 2-tissuecompartment model and the multilinear anal.-1 (MA1) method to arrive at reliable ests. of regional distribution vol. (VT) and binding potential (BPND) with 120 min of scan data.  Regional VT values (MA1) ranged from 1.28 mL/cm3 in the cerebellum to 3.71 mL/cm3 in the putamen, with a BPND of 0.25 in the temporal cortex and 1.92 in the putamen.  Regional BPND values estd. by the simplified ref. tissue model (SRTM) were similar to those from MA1.  Test-retest variability in high-binding regions (striatum) was 4% ± 6% for MA1 VT, 13% ± 6% for MA1 BPND, and 13% ± 7% SRTM BPND, resp.  Pretreatment of animals with the PDE2A inhibitor PF-05180999 resulted in a dose-dependent redn. of 18F-PF-05270430 specific binding, with a half maximal effective concn. of 69.4 ng/mL in plasma PF-05180999 concn.  18F-PF-05270430 displayed fast and reversible kinetics in nonhuman primates, as well as specific binding blockable by a PDE2A inhibitor.  This is the first PET tracer with desirable imaging properties and demonstrated ability to image and quantify PDE2A in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonEqcoW7Fj7bVg90H21EOLACvtfcHk0lgvrIhANdkkUg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaktbzL&md5=7ef3b7de193aec4ce0b11d86c9104e73</span></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.171454&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.171454%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DL.%26aulast%3DNabulsi%26aufirst%3DN.%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DZasadny%26aufirst%3DK.%26aulast%3DSkaddan%26aufirst%3DM.%2BB.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DNajafzadeh%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DBoyden%26aufirst%3DT.%2BL.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DRopchan%26aufirst%3DJ.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-PF-05270430%252C%2520a%2520novel%2520PET%2520radioligand%2520for%2520the%2520phosphodiesterase%25202A%2520enzyme%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1448%26epage%3D1453%26doi%3D10.2967%2Fjnumed.115.171454" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Naganawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabulsi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ropchan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tarabar, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeMartinis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Banerjee, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span> <span> </span><span class="NLM_article-title">First-in-human assessment of the novel PDE2A PET radiotracer <sup>18</sup>F-PF-05270430</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">1388</span>– <span class="NLM_lpage">1395</span>, <span class="refDoi"> DOI: 10.2967/jnumed.115.166850</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.115.166850" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27103022" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslaktLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2016&pages=1388-1395&author=M.+Naganawaauthor=R.+N.+Waterhouseauthor=N.+Nabulsiauthor=S.+F.+Linauthor=D.+Labareeauthor=J.+Ropchanauthor=S.+Tarabarauthor=N.+DeMartinisauthor=A.+Ogdenauthor=A.+Banerjeeauthor=Y.+Huangauthor=R.+E.+Carson&title=First-in-human+assessment+of+the+novel+PDE2A+PET+radiotracer+18F-PF-05270430&doi=10.2967%2Fjnumed.115.166850"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">First-in-human assessment of the novel PDE2A PET radiotracer 18F-PF-05270430</span></div><div class="casAuthors">Naganawa, Mika; Waterhouse, Rikki N.; Nabulsi, Nabeel; Lin, Shu-Fei; Labaree, David; Ropchan, Jim; Tarabar, Sanela; De Martinis, Nicholas; Ogden, Adam; Banerjee, Anindita; Huang, Yiyun; Carson, Richard E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1388-1395</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">1535-5667</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">This was a first-in-human study of the novel phosphodiesterase-2A (PDE2A) PET ligand 18F-PF-05270430.  The primary goals were to det. the appropriate tracer kinetic model to quantify brain uptake and to examine the within-subject test-retest variability.  Methods: In advance of human studies, radiation dosimetry was detd. in nonhuman primates.  Six healthy male subjects participated in a test-retest protocol with dynamic scans and metabolite-cor. input functions.  Nine brain regions of interest were studied, including the striatum, white matter, neocortical regions, and cerebellum.  Multiple modeling methods were applied to calc. vol. of distribution (VT) and binding potentials relative to the nondisplaceable tracer in tissue (BPND), concn. of tracer in plasma (BPP), and free tracer in tissue (BPF).  The cerebellum was selected as a ref. region to calc. binding potentials.  Results: The dosimetry study provided an ED of less than 0.30 mSv/MBq, with the gallbladder as the crit. organ; the human target dose was 185 MBq.  There were no adverse events or clin. detectable pharmacol. effects reported.  Tracer uptake was highest in the striatum, followed by neocortical regions and white matter, and lowest in the cerebellum.  Regional time-activity curves were well fit by multilinear anal.-1, and a 70-min scan duration was sufficient to quantify VT and the binding potentials.  BPND, with mean values ranging from 0.3 to 0.8, showed the best intrasubject and intersubject variability and reliability.  Test-retest variability in the whole brain (excluding the cerebellum) of VT, BPND, and BPP were 8%, 16%, and 17%, resp.  Conclusion: 18F-PF-05270430 shows promise as a PDE2A PET ligand, albeit with low binding potential values.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPWWBE9u0cFLVg90H21EOLACvtfcHk0liPvcsnTLU1eA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslaktLbL&md5=1cf1e3dc43a79238626d2e49418acb5c</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.115.166850&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.115.166850%26sid%3Dliteratum%253Aachs%26aulast%3DNaganawa%26aufirst%3DM.%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26aulast%3DNabulsi%26aufirst%3DN.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DRopchan%26aufirst%3DJ.%26aulast%3DTarabar%26aufirst%3DS.%26aulast%3DDeMartinis%26aufirst%3DN.%26aulast%3DOgden%26aufirst%3DA.%26aulast%3DBanerjee%26aufirst%3DA.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26atitle%3DFirst-in-human%2520assessment%2520of%2520the%2520novel%2520PDE2A%2520PET%2520radiotracer%252018F-PF-05270430%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2016%26volume%3D57%26spage%3D1388%26epage%3D1395%26doi%3D10.2967%2Fjnumed.115.166850" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schröder, S.</span>; <span class="NLM_string-name">Wenzel, B.</span>; <span class="NLM_string-name">Deuther-Conrad, W.</span>; <span class="NLM_string-name">Teodoro, R.</span>; <span class="NLM_string-name">Egerland, U.</span>; <span class="NLM_string-name">Kranz, M.</span>; <span class="NLM_string-name">Fischer, S.</span>; <span class="NLM_string-name">Höfgen, N.</span>; <span class="NLM_string-name">Steinbach, J.</span>; <span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Novel <sup>18</sup>F-labelled triazine derivatives for PET imaging of phosphodiesterase 2A</span>. In  <i>21st International Symposium on Radiopharmaceutical Sciences · ISRS 2015 Columbia, USA</i>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=S.+Schr%C3%B6der&author=B.+Wenzel&author=W.+Deuther-Conrad&author=R.+Teodoro&author=U.+Egerland&author=M.+Kranz&author=S.+Fischer&author=N.+H%C3%B6fgen&author=J.+Steinbach&author=P.+Brust&title=Novel+18F-labelled+triazine+derivatives+for+PET+imaging+of+phosphodiesterase+2A"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DSchr%25C3%25B6der%26aufirst%3DS.%26atitle%3DNovel%252018F-labelled%2520triazine%2520derivatives%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase%25202A%26jtitle%3D21st%2520International%2520Symposium%2520on%2520Radiopharmaceutical%2520Sciences%2520%25C2%25B7%2520ISRS%25202015%2520Columbia%252C%2520USA%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis, <sup>18</sup>F-radiolabelling and biological characterization of novel fluoroalkylated triazine derivatives for in vivo imaging of phosphodiesterase 2A in brain via positron emission tomography</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">9591</span>– <span class="NLM_lpage">9615</span>, <span class="refDoi"> DOI: 10.3390/molecules20069591</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules20069591" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26016549" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2MfotVylsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2015&pages=9591-9615&author=S.+Schroderauthor=B.+Wenzelauthor=W.+Deuther-Conradauthor=R.+Teodoroauthor=U.+Egerlandauthor=M.+Kranzauthor=M.+Scheunemannauthor=N.+Hofgenauthor=J.+Steinbachauthor=P.+Brust&title=Synthesis%2C+18F-radiolabelling+and+biological+characterization+of+novel+fluoroalkylated+triazine+derivatives+for+in+vivo+imaging+of+phosphodiesterase+2A+in+brain+via+positron+emission+tomography&doi=10.3390%2Fmolecules20069591"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit134R"><div class="casContent"><span class="casTitleNuber">134</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis, 18F-Radiolabelling and Biological Characterization of Novel Fluoroalkylated Triazine Derivatives for in Vivo Imaging of Phosphodiesterase 2A in Brain via Positron Emission Tomography</span></div><div class="casAuthors">Schroder Susann; Wenzel Barbara; Deuther-Conrad Winnie; Teodoro Rodrigo; Kranz Mathias; Scheunemann Matthias; Steinbach Jorg; Brust Peter; Egerland Ute; Hofgen Norbert</div><div class="citationInfo"><span class="NLM_cas:title">Molecules (Basel, Switzerland)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">9591-615</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphodiesterase 2A (PDE2A) is highly and specifically expressed in particular brain regions that are affected by neurological disorders and in certain tumors.  Development of a specific PDE2A radioligand would enable molecular imaging of the PDE2A protein via positron emission tomography (PET).  Herein we report on the syntheses of three novel fluoroalkylated triazine derivatives (TA2-4) and on the evaluation of their effect on the enzymatic activity of human PDE2A.  The most potent PDE2A inhibitors were 18F-radiolabelled ([18F]TA3 and [18F]TA4) and investigated regarding their potential as PET radioligands for imaging of PDE2A in mouse brain.  In vitro autoradiography on rat brain displayed region-specific distribution of [18F]TA3 and [18F]TA4, which is consistent with the expression pattern of PDE2A protein.  Metabolism studies of both [18F]TA3 and [18F]TA4 in mice showed a significant accumulation of two major radiometabolites of each radioligand in brain as investigated by micellar radio-chromatography.  Small-animal PET/MR studies in mice using [18F]TA3 revealed a constantly increasing uptake of activity in the non-target region cerebellum, which may be caused by the accumulation of brain penetrating radiometabolites.  Hence, [18F]TA3 and [18F]TA4 are exclusively suitable for in vitro investigation of PDE2A.  Nevertheless, further structural modification of these promising radioligands might result in metabolically stable derivatives.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSYL82f4RkqVs25P7XSLhESfW6udTcc2eY7-vMxVEr4frntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfotVylsw%253D%253D&md5=ef2b8ab1e0551d41e098a35002a257e6</span></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.3390%2Fmolecules20069591&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules20069591%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DHofgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DSynthesis%252C%252018F-radiolabelling%2520and%2520biological%2520characterization%2520of%2520novel%2520fluoroalkylated%2520triazine%2520derivatives%2520for%2520in%2520vivo%2520imaging%2520of%2520phosphodiesterase%25202A%2520in%2520brain%2520via%2520positron%2520emission%2520tomography%26jtitle%3DMolecules%26date%3D2015%26volume%3D20%26spage%3D9591%26epage%3D9615%26doi%3D10.3390%2Fmolecules20069591" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schroder, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Investigation of an <sup>18</sup>F-labelled Imidazopyridotriazine for Molecular Imaging of Cyclic Nucleotide Phosphodiesterase 2A</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">556</span>, <span class="refDoi"> DOI: 10.3390/molecules23030556</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules23030556" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2018&pages=556&author=S.+Schroderauthor=B.+Wenzelauthor=W.+Deuther-Conradauthor=R.+Teodoroauthor=M.+Kranzauthor=M.+Scheunemannauthor=U.+Egerlandauthor=N.+Hofgenauthor=D.+Brielauthor=J.+Steinbachauthor=P.+Brust&title=Investigation+of+an+18F-labelled+Imidazopyridotriazine+for+Molecular+Imaging+of+Cyclic+Nucleotide+Phosphodiesterase+2A&doi=10.3390%2Fmolecules23030556"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.3390%2Fmolecules23030556&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules23030556%26sid%3Dliteratum%253Aachs%26aulast%3DSchroder%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DHofgen%26aufirst%3DN.%26aulast%3DBriel%26aufirst%3DD.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DInvestigation%2520of%2520an%252018F-labelled%2520Imidazopyridotriazine%2520for%2520Molecular%2520Imaging%2520of%2520Cyclic%2520Nucleotide%2520Phosphodiesterase%25202A%26jtitle%3DMolecules%26date%3D2018%26volume%3D23%26spage%3D556%26doi%3D10.3390%2Fmolecules23030556" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritawidya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toussaint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine: A Potential radioligand for in vivo phosphodiesterase 2A (PDE2A) PET imaging</span>. <i>23rd International Symposium on Radiopharmaceutical Sciences, Beijing, China</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_fpage">S162</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&pages=S162&author=R.+Ritawidyaauthor=R.+Teodoroauthor=B.+Wenzelauthor=M.+Kranzauthor=M.+Toussaintauthor=S.+Dukic-Stefanovicauthor=W.+Deuther-Conradauthor=M.+Scheunemannauthor=P.+Brust&title=Synthesis+and+biological+investigation+of+a+novel+fluorine-18+labeled+benzoimidazotriazine%3A+A+Potential+radioligand+for+in+vivo+phosphodiesterase+2A+%28PDE2A%29+PET+imaging"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRitawidya%26aufirst%3DR.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DToussaint%26aufirst%3DM.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DSynthesis%2520and%2520biological%2520investigation%2520of%2520a%2520novel%2520fluorine-18%2520labeled%2520benzoimidazotriazine%253A%2520A%2520Potential%2520radioligand%2520for%2520in%2520vivo%2520phosphodiesterase%25202A%2520%2528PDE2A%2529%2520PET%2520imaging%26jtitle%3D23rd%2520International%2520Symposium%2520on%2520Radiopharmaceutical%2520Sciences%252C%2520Beijing%252C%2520China%26date%3D2016%26spage%3DS162" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ritawidya, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toussaint, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dukic-Stefanovic, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ludwig, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine-based radioligand for the imaging of phosphodiesterase 2A with positron emission tomography</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">4149</span>, <span class="refDoi"> DOI: 10.3390/molecules24224149</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules24224149" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlyrsLfM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2019&pages=4149&author=R.+Ritawidyaauthor=B.+Wenzelauthor=R.+Teodoroauthor=M.+Toussaintauthor=M.+Kranzauthor=W.+Deuther-Conradauthor=S.+Dukic-Stefanovicauthor=F.+A.+Ludwigauthor=M.+Scheunemannauthor=P.+Brust&title=Radiosynthesis+and+biological+investigation+of+a+novel+fluorine-18+labeled+benzoimidazotriazine-based+radioligand+for+the+imaging+of+phosphodiesterase+2A+with+positron+emission+tomography&doi=10.3390%2Fmolecules24224149"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and biological investigation of a novel fluorine-18 labeled benzoimidazotriazine-based radioligand for the imaging of phosphodiesterase 2A with positron emission tomography</span></div><div class="casAuthors">Ritawidya, Rien; Wenzel, Barbara; Teodoro, Rodrigo; Toussaint, Magali; Kranz, Mathias; Deuther-Conrad, Winnie; Dukic-Stefanovic, Sladjana; Ludwig, Friedrich-Alexander; Scheunemann, Matthias; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">24</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">4149</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A specific radioligand for the imaging of cyclic nucleotide phosphodiesterase 2A (PDE2A) via positron emission tomog. (PET) would be helpful for research on the physiol. and disease-related changes in the expression of this enzyme in the brain.  In this report, the radiosynthesis of a novel PDE2A radioligand and the subsequent biol. evaluation were described.  Our prospective compd. 1-(2-chloro-5-methoxy phenyl)-8-(2-fluoropyridin-4-yl)-3-methylbenzo[e]imidazo[5,1-c][1,2,4]triazine, benzoimidazotriazine (BIT1) (IC50 PDE2A = 3.33 nM; 16-fold selectivity over PDE10A) was fluorine-18 labeled via arom. nucleophilic substitution of the corresponding nitro precursor using the K[18F]F-K2.2.2-carbonate complex system.  The new radioligand [18F]BIT1 was obtained with a high radiochem. yield (54 ± 2%, n = 3), a high radiochem. purity (≥99%), and high molar activities (155-175 GBq/μmol, n = 3).  In vitro autoradiog. on pig brain cryosections exhibited a heterogeneous spatial distribution of [18F]BIT1 corresponding to the known pattern of expression of PDE2A.  The investigation of in vivo metab. of [18F]BIT1 in a mouse revealed sufficient metabolic stability.  PET studies in mouse exhibited a moderate brain uptake of [18F]BIT1 with a max. standardized uptake value of ∼0.7 at 5 min p.i.  However, in vivo blocking studies revealed a non-target specific binding of [18F]BIT1.  Therefore, further structural modifications are needed to improve target selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEakGihEqbT7Vg90H21EOLACvtfcHk0ljaGHkwjLRXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlyrsLfM&md5=ae71f979c3026e1680feec4777810175</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.3390%2Fmolecules24224149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules24224149%26sid%3Dliteratum%253Aachs%26aulast%3DRitawidya%26aufirst%3DR.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DToussaint%26aufirst%3DM.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DDukic-Stefanovic%26aufirst%3DS.%26aulast%3DLudwig%26aufirst%3DF.%2BA.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DRadiosynthesis%2520and%2520biological%2520investigation%2520of%2520a%2520novel%2520fluorine-18%2520labeled%2520benzoimidazotriazine-based%2520radioligand%2520for%2520the%2520imaging%2520of%2520phosphodiesterase%25202A%2520with%2520positron%2520emission%2520tomography%26jtitle%3DMolecules%26date%3D2019%26volume%3D24%26spage%3D4149%26doi%3D10.3390%2Fmolecules24224149" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Movsesian, M.</span></span> <span> </span><span class="NLM_article-title">Novel approaches to targeting PDE3 in cardiovascular disease</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>163</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.03.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.pharmthera.2016.03.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27108947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=163&publication_year=2016&pages=74-81&author=M.+Movsesian&title=Novel+approaches+to+targeting+PDE3+in+cardiovascular+disease&doi=10.1016%2Fj.pharmthera.2016.03.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Novel approaches to targeting PDE3 in cardiovascular disease</span></div><div class="casAuthors">Movsesian, Matthew</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">163</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">74-81</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Inhibitors of PDE3, a family of dual-specificity cyclic nucleotide phosphodiesterases, are used clin. to increase cardiac contractility by raising intracellular cAMP content in cardiac myocytes and to reduce vascular resistance by increasing intracellular cGMP content in vascular smooth muscle myocytes.  When used in the treatment of patients with heart failure, PDE3 inhibitors are effective in the acute setting but increase sudden cardiac death with long-term administration, possibly reflecting pro-apoptotic and pro-hypertrophic consequences of increased cAMP-mediated signaling in cardiac myocytes.  CAMP-mediated signaling in cardiac myocytes is highly compartmentalized, and different phosphodiesterases, by controlling cAMP content in functionally discrete intracellular microcompartments, regulate different cAMP-mediated pathways.  Four variants/isoforms of PDE3 (PDE3A1, PDE3A2, PDE3A3, and PDE3B) are expressed in cardiac myocytes, and new exptl. results have demonstrated that these isoforms, which are differentially localized intracellularly through unique protein-protein interactions, control different physiol. responses.  While the catalytic regions of these isoforms may be too similar to allow the catalytic activity of each isoform to be selectively inhibited, targeting their unique protein-protein interactions may allow desired responses to be elicited without the adverse consequences that limit the usefulness of existing PDE3 inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpySUN0pntSI7Vg90H21EOLACvtfcHk0ljaGHkwjLRXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XntVOms7g%253D&md5=6e933dbd53f91fb96ad1664b273d8d99</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.03.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.03.014%26sid%3Dliteratum%253Aachs%26aulast%3DMovsesian%26aufirst%3DM.%26atitle%3DNovel%2520approaches%2520to%2520targeting%2520PDE3%2520in%2520cardiovascular%2520disease%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D163%26spage%3D74%26epage%3D81%26doi%3D10.1016%2Fj.pharmthera.2016.03.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beute, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ganesh, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nastiti, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoogenboom, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bos, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Folkerts, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreurs, M. W. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hockman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">KleinJan, A.</span></span> <span> </span><span class="NLM_article-title">PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells</span>. <i>Front. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">470</span>, <span class="refDoi"> DOI: 10.3389/fphar.2020.00470</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3389%2Ffphar.2020.00470" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32425769" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvFKktrzO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=470&author=J.+Beuteauthor=K.+Ganeshauthor=H.+Nastitiauthor=R.+Hoogenboomauthor=V.+Bosauthor=J.+Folkertsauthor=M.+W.+J.+Schreursauthor=S.+Hockmanauthor=R.+W.+Hendriksauthor=A.+KleinJan&title=PDE3+inhibition+reduces+epithelial+mast+cell+numbers+in+allergic+airway+inflammation+and+attenuates+degranulation+of+basophils+and+mast+cells&doi=10.3389%2Ffphar.2020.00470"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">PDE3 inhibition reduces epithelial mast cell numbers in allergic airway inflammation and attenuates degranulation of basophils and mast cells</span></div><div class="casAuthors">Beute, Jan; Ganesh, Keerthana; Nastiti, Hedwika; Hoogenboom, Robin; Bos, Vivica; Folkerts, Jelle; Schreurs, Marco W. J.; Hockman, Steve; Hendriks, Rudi W.; Jan, Alex Klein</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Pharmacology</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">00470</span>CODEN:
                <span class="NLM_cas:coden">FPRHAU</span>;
        ISSN:<span class="NLM_cas:issn">1663-9812</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">Epithelial mast cells are generally present in the airways of patients with allergic asthma that are inadequately controlled.  Airway mast cells (MCs) are critically involved in allergic airway inflammation and contribute directly to the main symptoms of allergic patients.  Phosphodiesterase 3 (PDE3) tailors signaling of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), which are crit. intracellular second messenger mols. in various signaling pathways.  This paper investigates the pathophysiol. role and disease-modifying effects of PDE3 in mouse bone marrowderived MCs (bmMCs), human LAD2- and HMC1 mast cell lines, human blood basophils, and peripheral blood-derived primary human MCs (HuMCs).  In a chronic house dust mite (HDM)-driven allergic airway inflammation mouse model, we obsd. that PDE3 deficiency or PDE3 inhibition (PDE3i) therapy reduced the nos. of epithelial MCs, when compared to control mice.  Mouse bone marrow-derived MCs (bmMCs) and the human HMC1 and LAD2 cell lines predominantly expressed PDE3B and PDE4A.  BmMCs from Pde3-/- mice showed reduced loss of the degranulation marker CD107b compared with wild-type BmMCs, when stimulated in an IgE (IgE)-dependent manner.  Following both IgE-mediated and substance P-mediated activation, PDE3i-pretreated basophils, LAD2 cells, and HuMCs, showed less degranulation than diluent controls, as measured by surface CD63 expression.  MCs lacking PDE3 or treated with the PDE3i enoximone exhibited a lower calcium flux upon stimulation with ionomycine.  In conclusion PDE3 plays a crit. role in basophil and mast cell degranulation and therefore its inhibition may be a treatment option in allergic disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPS1Ku6tG3B7Vg90H21EOLACvtfcHk0ljaGHkwjLRXzw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvFKktrzO&md5=7770ec4eee777eeb975a27681a174e30</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.3389%2Ffphar.2020.00470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffphar.2020.00470%26sid%3Dliteratum%253Aachs%26aulast%3DBeute%26aufirst%3DJ.%26aulast%3DGanesh%26aufirst%3DK.%26aulast%3DNastiti%26aufirst%3DH.%26aulast%3DHoogenboom%26aufirst%3DR.%26aulast%3DBos%26aufirst%3DV.%26aulast%3DFolkerts%26aufirst%3DJ.%26aulast%3DSchreurs%26aufirst%3DM.%2BW.%2BJ.%26aulast%3DHockman%26aufirst%3DS.%26aulast%3DHendriks%26aufirst%3DR.%2BW.%26aulast%3DKleinJan%26aufirst%3DA.%26atitle%3DPDE3%2520inhibition%2520reduces%2520epithelial%2520mast%2520cell%2520numbers%2520in%2520allergic%2520airway%2520inflammation%2520and%2520attenuates%2520degranulation%2520of%2520basophils%2520and%2520mast%2520cells%26jtitle%3DFront.%2520Pharmacol.%26date%3D2020%26volume%3D11%26spage%3D470%26doi%3D10.3389%2Ffphar.2020.00470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, T.</span></span> <span> </span><span class="NLM_article-title">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span>. <i>Am. J. Geriatr. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">354</span>, <span class="refDoi"> DOI: 10.1097/JGP.0b013e31819431ea</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1097%2FJGP.0b013e31819431ea" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=19307864" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2009&pages=353-354&author=H.+Araiauthor=T.+Takahashi&title=A+combination+therapy+of+donepezil+and+cilostazol+for+patients+with+moderate+Alzheimer+disease%3A+pilot+follow-up+study&doi=10.1097%2FJGP.0b013e31819431ea"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">A combination therapy of donepezil and cilostazol for patients with moderate Alzheimer disease: pilot follow-up study</span></div><div class="casAuthors">Arai Heii; Takahashi Tadashi</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">353-4</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQCx1PkgV5nGvEeosoOnpOLfW6udTcc2eZhWHHPO40qjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1M3ivVCgsw%253D%253D&md5=722b0e9a3896ed1fcc3161ff5ec31d93</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.1097%2FJGP.0b013e31819431ea&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJGP.0b013e31819431ea%26sid%3Dliteratum%253Aachs%26aulast%3DArai%26aufirst%3DH.%26aulast%3DTakahashi%26aufirst%3DT.%26atitle%3DA%2520combination%2520therapy%2520of%2520donepezil%2520and%2520cilostazol%2520for%2520patients%2520with%2520moderate%2520Alzheimer%2520disease%253A%2520pilot%2520follow-up%2520study%26jtitle%3DAm.%2520J.%2520Geriatr.%2520Psychiatry%26date%3D2009%26volume%3D17%26spage%3D353%26epage%3D354%26doi%3D10.1097%2FJGP.0b013e31819431ea" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yanai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, S.</span></span> <span> </span><span class="NLM_article-title">PDE3 inhibitors repurposed as treatments for age-related cognitive impairment</span>. <i>Mol. Neurobiol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">4306</span>– <span class="NLM_lpage">4316</span>, <span class="refDoi"> DOI: 10.1007/s12035-018-1374-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs12035-018-1374-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30311144" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhvV2qsLvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2019&pages=4306-4316&author=S.+Yanaiauthor=S.+Endo&title=PDE3+inhibitors+repurposed+as+treatments+for+age-related+cognitive+impairment&doi=10.1007%2Fs12035-018-1374-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit141R"><div class="casContent"><span class="casTitleNuber">141</span><div class="casTitle"><span class="NLM_cas:atitle">PDE3 Inhibitors Repurposed as Treatments for Age-Related Cognitive Impairment</span></div><div class="casAuthors">Yanai, Shuichi; Endo, Shogo</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Neurobiology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4306-4316</span>CODEN:
                <span class="NLM_cas:coden">MONBEW</span>;
        ISSN:<span class="NLM_cas:issn">0893-7648</span>.
    
            (<span class="NLM_cas:orgname">Humana Press Inc.</span>)
        </div><div class="casAbstract">A review.  As the population of older individuals grows worldwide, researchers have increasingly focused their attention on identifying key mol. targets of age-related cognitive impairments, with the aim of developing possible therapeutic interventions.  Two such mols. are the intracellular cyclic nucleotides, cAMP and cGMP.  These second messengers mediate fundamental aspects of brain function relevant to memory, learning, and cognitive function.  In this review, we provide an overview of different PDE inhibitors, and then we focus on pharmacol. and physiol. effects of PDE3 inhibitors in the CNS and peripheral tissues.  Finally, we discuss findings from exptl. and preliminary clin. studies and the potential beneficial effects of the PDE3 inhibitor cilostazol on age-related cognitive impairments.  In the innovation pipeline of pharmaceutical development, the antiplatelet agent cilostazol has come into the spotlight as a novel treatment for mild cognitive impairment.  Overall, the repurposing of cilostazol may represent a potentially promising way to treat mild cognitive impairment, Alzheimer's disease, and vascular dementia.  In this review, we present a brief summary of cAMP signaling and different PDE inhibitors, followed by a discussion of the pharmacol. and physiol. role of PDE3 inhibitors.  In this context, we discuss the repurposing of a PDE3 inhibitor, cilostazol, as a potential treatment for age-related cognitive impairment based on recent research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqndGKXeWmnBLVg90H21EOLACvtfcHk0lj7ql48QKJBOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhvV2qsLvM&md5=486846fb15c92bc158cadca2f74c4cca</span></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1007%2Fs12035-018-1374-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs12035-018-1374-4%26sid%3Dliteratum%253Aachs%26aulast%3DYanai%26aufirst%3DS.%26aulast%3DEndo%26aufirst%3DS.%26atitle%3DPDE3%2520inhibitors%2520repurposed%2520as%2520treatments%2520for%2520age-related%2520cognitive%2520impairment%26jtitle%3DMol.%2520Neurobiol.%26date%3D2019%26volume%3D56%26spage%3D4306%26epage%3D4316%26doi%3D10.1007%2Fs12035-018-1374-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takata, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasahara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishino, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stern, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okada, M.</span></span> <span> </span><span class="NLM_article-title">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span>. <i>Psychogeriatrics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">164</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1111/psyg.12021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fpsyg.12021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25707423" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref142/cit142&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2013&pages=164-169&author=A.+Taguchiauthor=Y.+Takataauthor=M.+Iharaauthor=Y.+Kasaharaauthor=M.+Tsujiauthor=M.+Nishinoauthor=D.+Sternauthor=M.+Okada&title=Cilostazol+improves+cognitive+function+in+patients+with+mild+cognitive+impairment%3A+a+retrospective+analysis&doi=10.1111%2Fpsyg.12021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit142R"><div class="casContent"><span class="casTitleNuber">142</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol improves cognitive function in patients with mild cognitive impairment: a retrospective analysis</span></div><div class="casAuthors">Taguchi Akihiko; Takata Yu; Ihara Masafumi; Kasahara Yukiko; Tsuji Masahiro; Nishino Madoka; Stern David; Okada Masahiro</div><div class="citationInfo"><span class="NLM_cas:title">Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">164-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND AND PURPOSE:  Cerebral ischemia and accumulation of amyloid β (Aβ) are major risk factors for the development of dementia, including vascular dementia and Alzheimer's disease.  Cilostazol, an antiplatelet drug, has been shown to improve cerebral circulation and reduce accumulation of Aβ.  In this study, the long-term effect of cilostazol on cognitive function was investigated retrospectively.  METHODS:  Medical records at Sumotoitsuki Hospital were surveyed to find all patients treated with cilostazol and evaluated by the Mini-Mental State Examination (MMSE) during at least two visits separated by an interval of more than 6 months.  Patients receiving anti-dementia drugs were excluded.  Temporal changes in MMSE scores were compared between patients treated with cilostazol (n = 70) and those who ceased administration of this drug (n = 22).  The mean follow-up period was 691 days.  RESULTS:  Decrease in MMSE score was significantly ameliorated by administration of cilostazol.  Subgroup analysis revealed that cilostazol significantly improved MMSE score in patients with mild cognitive impairment, though no significant effect was observed in patients with normal cognitive function or dementia.  CONCLUSIONS:  Although there are limitations to such a retrospective study, these results significantly encourage undertaking a prospective cohort study to determine the effect of cilostazol on mild cognitive impairment where no treatments currently exist.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTkwhSfdrbgnCXXDYhVZBdlfW6udTcc2eZhWHHPO40qjbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mrot1ajsw%253D%253D&md5=96c6a6e5803056c9a9c96d4f28376871</span></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=10.1111%2Fpsyg.12021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fpsyg.12021%26sid%3Dliteratum%253Aachs%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DTakata%26aufirst%3DY.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DKasahara%26aufirst%3DY.%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DNishino%26aufirst%3DM.%26aulast%3DStern%26aufirst%3DD.%26aulast%3DOkada%26aufirst%3DM.%26atitle%3DCilostazol%2520improves%2520cognitive%2520function%2520in%2520patients%2520with%2520mild%2520cognitive%2520impairment%253A%2520a%2520retrospective%2520analysis%26jtitle%3DPsychogeriatrics%26date%3D2013%26volume%3D13%26spage%3D164%26epage%3D169%26doi%3D10.1111%2Fpsyg.12021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiramatsu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takiguchi, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishiyama, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mori, H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol prevents amyloid β peptide<sub>25–35</sub>-induced memory impairment and oxidative stress in mice</span>. <i>Br. J. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>161</i></span>,  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1912</span>, <span class="refDoi"> DOI: 10.1111/j.1476-5381.2010.01014.x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fj.1476-5381.2010.01014.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20825411" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=161&publication_year=2010&pages=1899-1912&author=M.+Hiramatsuauthor=O.+Takiguchiauthor=A.+Nishiyamaauthor=H.+Mori&title=Cilostazol+prevents+amyloid+%CE%B2+peptide25%E2%80%9335-induced+memory+impairment+and+oxidative+stress+in+mice&doi=10.1111%2Fj.1476-5381.2010.01014.x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol prevents amyloid β peptide25-35-induced memory impairment and oxidative stress in mice</span></div><div class="casAuthors">Hiramatsu, Masayuki; Takiguchi, Osanao; Nishiyama, Aki; Mori, Hiromasa</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Pharmacology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">161</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1899-1912</span>CODEN:
                <span class="NLM_cas:coden">BJPCBM</span>;
        ISSN:<span class="NLM_cas:issn">1476-5381</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Cilostazol may be effective in dementia assocd. with a cerebral ischemia.  In this study, we examd. whether it exerts beneficial effects on learning and/or memory impairment induced by Aβ25-35 in mice, and compared its effects with those of aspirin.  Aβ25-35 (9 nmol) was administered to mice i.c.v.  Learning and memory behavior were evaluated by measuring spontaneous alternation in a Y-maze and a step-down type passive avoidance test, on the 5th and 8th days after injection resp.  Levels of lipid peroxidn. (malondialdehyde) and cytokines in the frontal cortex and hippocampus were measured 2, 3, 5 and 7 days after the Aβ25-35 injection.  The effects of repeated administration of cilostazol and aspirin (both at 30 and 100 mg/kg-1, p.o.) on any changes induced by Aβ25-35 were evaluated.  Repeated administration of cilostazol significantly attenuated the impairment of spontaneous alternation and the shortened step-down latency induced by Aβ25-35.  Aspirin did not show any beneficial effect.  A significant increase in the levels of malondialdehyde (MDA) and IL-1β (only measured in hippocampus) was obsd. 2, 3 and 5 days after the Aβ25-35 injection in the frontal cortex and hippocampus.  Repeated administration of cilostazol (100 mg/kg-1) completely prevented the increase in MDA levels but failed to antagonize the increase in the expression of IL-1β induced by Aβ25-35.  These results suggest that the protective effect of cilostazol on Aβ25-35-induced memory impairment may be related to oxidative stress in the frontal cortex and the hippocampus.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo29phkvEihHLVg90H21EOLACvtfcHk0ljpUBe_0Kl9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFWhsb%252FK&md5=d3e02a6445fdea4e98b023cf78f4c2a0</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1111%2Fj.1476-5381.2010.01014.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1476-5381.2010.01014.x%26sid%3Dliteratum%253Aachs%26aulast%3DHiramatsu%26aufirst%3DM.%26aulast%3DTakiguchi%26aufirst%3DO.%26aulast%3DNishiyama%26aufirst%3DA.%26aulast%3DMori%26aufirst%3DH.%26atitle%3DCilostazol%2520prevents%2520amyloid%2520%25CE%25B2%2520peptide25%25E2%2580%259335-induced%2520memory%2520impairment%2520and%2520oxidative%2520stress%2520in%2520mice%26jtitle%3DBr.%2520J.%2520Pharmacol.%26date%3D2010%26volume%3D161%26spage%3D1899%26epage%3D1912%26doi%3D10.1111%2Fj.1476-5381.2010.01014.x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bae, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, K. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leem, J. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, B. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, H. K.</span></span> <span> </span><span class="NLM_article-title">Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation</span>. <i>Biochem. Biophys. Res. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>408</i></span>,  <span class="NLM_fpage">602</span>– <span class="NLM_lpage">608</span>, <span class="refDoi"> DOI: 10.1016/j.bbrc.2011.04.068</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bbrc.2011.04.068" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21530492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmsVyrsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=408&publication_year=2011&pages=602-608&author=S.+H.+Parkauthor=J.+H.+Kimauthor=S.+S.+Baeauthor=K.+W.+Hongauthor=D.+S.+Leeauthor=J.+Y.+Leemauthor=B.+T.+Choiauthor=H.+K.+Shin&title=Protective+effect+of+the+phosphodiesterase+III+inhibitor+cilostazol+on+amyloid+%CE%B2-induced+cognitive+deficits+associated+with+decreased+amyloid+%CE%B2+accumulation&doi=10.1016%2Fj.bbrc.2011.04.068"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Protective effect of the phosphodiesterase III inhibitor cilostazol on amyloid β-induced cognitive deficits associated with decreased amyloid β accumulation</span></div><div class="casAuthors">Park, Sun Haeng; Kim, Ji Hyun; Bae, Sun Sik; Hong, Ki Whan; Lee, Dong-Seok; Leem, Jae Yoon; Choi, Byung Tae; Shin, Hwa Kyoung</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical and Biophysical Research Communications</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">408</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">602-608</span>CODEN:
                <span class="NLM_cas:coden">BBRCA9</span>;
        ISSN:<span class="NLM_cas:issn">0006-291X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Alzheimer's disease (AD), which is characterized by progressive cognitive impairment, is the most common neurodegenerative disease.  Here, the authors investigated the preventive effect of a phosphodiesterase III inhibitor, cilostazol against cognitive decline in AD mouse model.  In vitro studies using N2a cells stably expressing human amyloid precursor protein Swedish mutation (N2aSwe) showed that cilostazol decreased the amyloid β (Aβ) levels in the conditioned medium and cell lysates.  Cilostazol attenuated the expression of ApoE, which is responsible for Aβ aggregation, in N2aSwe.  Intracerebroventricular injection of Aβ25-35 in C57BL/6J mice resulted in increased immunoreactivity of Aβ and p-Tau, and microglia activation in the brain.  Oral administration of cilostazol for 2 wk before Aβ administration and once a day for 4 wk post-surgery almost completely prevented the Aβ-induced increases of Aβ and p-Tau immunoreactivity, as well as CD11b immunoreactivity.  However, post-treatment with cilostazol 4 wk after Aβ administration, when Aβ was already accumulated, did not prevent the Aβ-induced neuropathol. responses.  Furthermore, cilostazol did not affect the neprilysin and insulin degrading enzymes involved in the degrdn. of the Aβ peptide, but decreased ApoE levels in Aβ-injected brain.  In addn., cilostazol significantly improved spatial learning and memory in Aβ-injected mice.  The findings suggest that a phosphodiesterase III inhibitor, cilostazol significantly decreased Aβ accumulation and improved memory impairment induced by Aβ25-35.  The beneficial effects of cilostazol might be explained by the redn. of Aβ accumulation and tau phosphorylation, not through an increase in Aβ degrdn. but via a significant decrease in ApoE-mediated Aβ aggregation.  Cilostazol may be the basis of a novel strategy for the therapy of AD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoIK7eM16DWzLVg90H21EOLACvtfcHk0ljpUBe_0Kl9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmsVyrsLY%253D&md5=81e6fd05d6b4bff87ca77e926ec569e1</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1016%2Fj.bbrc.2011.04.068&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bbrc.2011.04.068%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DS.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DBae%26aufirst%3DS.%2BS.%26aulast%3DHong%26aufirst%3DK.%2BW.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DLeem%26aufirst%3DJ.%2BY.%26aulast%3DChoi%26aufirst%3DB.%2BT.%26aulast%3DShin%26aufirst%3DH.%2BK.%26atitle%3DProtective%2520effect%2520of%2520the%2520phosphodiesterase%2520III%2520inhibitor%2520cilostazol%2520on%2520amyloid%2520%25CE%25B2-induced%2520cognitive%2520deficits%2520associated%2520with%2520decreased%2520amyloid%2520%25CE%25B2%2520accumulation%26jtitle%3DBiochem.%2520Biophys.%2520Res.%2520Commun.%26date%3D2011%26volume%3D408%26spage%3D602%26epage%3D608%26doi%3D10.1016%2Fj.bbrc.2011.04.068" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tai, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chien, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y. H.</span></span> <span> </span><span class="NLM_article-title">Cilostazol use is associated with reduced risk of dementia: A nationwide cohort study</span>. <i>Neurotherapeutics</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">784</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1007/s13311-017-0512-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs13311-017-0512-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28194663" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2017&pages=784-791&author=S.+Y.+Taiauthor=C.+Y.+Chienauthor=Y.+H.+Changauthor=Y.+H.+Yang&title=Cilostazol+use+is+associated+with+reduced+risk+of+dementia%3A+A+nationwide+cohort+study&doi=10.1007%2Fs13311-017-0512-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit145R"><div class="casContent"><span class="casTitleNuber">145</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol Use Is Associated with Reduced Risk of Dementia: A Nationwide Cohort Study</span></div><div class="casAuthors">Tai, Shu-Yu; Chien, Chen-Yu; Chang, Yu-Han; Yang, Yuan-Han</div><div class="citationInfo"><span class="NLM_cas:title">Neurotherapeutics</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-791</span>CODEN:
                <span class="NLM_cas:coden">NEURNV</span>;
        ISSN:<span class="NLM_cas:issn">1878-7479</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Whether antiplatelet agents have a preventive effect on cognitive function remains unknown.  We examd. the potential assocn. between the use of cilostazol, an antiplatelet agent and cyclic adenosine monophosphate phosphodiesterase 3 inhibitor, and the risk of dementia in an Asian population.  Patients initiating cilostazol therapy between 1 Jan. 2004 and 31 Dec. 2009 without a prior history of dementia were identified from Taiwan's National Health Insurance database.  Participants were stratified by age, sex, comorbidities, and comedication.  The outcome of interest was all-cause dementia (ICD-9-CM codes 290.0, 290.4, 294.1, 331.0).  Cox regression models were used to est. the hazard ratio (HR) of dementia.  The cumulative cilostazol dosage was stratified by quartile of defined daily doses using no cilostazol use as a ref.  A total of 9148 participants 40 years of age or older and free of dementia at baseline were analyzed.  Patients using cilostazol (n = 2287) had a significantly decreased risk of incident dementia compared with patients not using the drug [n = 6861; adjusted HR (aHR) 0.75; 95% confidence interval (CI) 0.61-0.92].  Notably, cilostazol use was found to have a dose-dependent assocn. with reduced rate of dementia emergence (p for trend = 0.001).  Subgroup anal. identified a decline of dementia in cilostazol users with diagnosed ischemic heart disease (aHR 0.44, 95% CI 0.24-0.83) and cerebral vascular disease (aHR 0.34, 95% CI 0.21-0.54).  These observations suggest that cilostazol use may reduce the risk to develop dementia, and a high cumulative dose further decreases the risk of dementia.  These findings should be examd. further in randomized clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp6ZP4x682GkLVg90H21EOLACvtfcHk0ljpUBe_0Kl9aw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVaqs78%253D&md5=d5867d3221d14af26c08fe9d65fc8cca</span></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1007%2Fs13311-017-0512-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs13311-017-0512-4%26sid%3Dliteratum%253Aachs%26aulast%3DTai%26aufirst%3DS.%2BY.%26aulast%3DChien%26aufirst%3DC.%2BY.%26aulast%3DChang%26aufirst%3DY.%2BH.%26aulast%3DYang%26aufirst%3DY.%2BH.%26atitle%3DCilostazol%2520use%2520is%2520associated%2520with%2520reduced%2520risk%2520of%2520dementia%253A%2520A%2520nationwide%2520cohort%2520study%26jtitle%3DNeurotherapeutics%26date%3D2017%26volume%3D14%26spage%3D784%26epage%3D791%26doi%3D10.1007%2Fs13311-017-0512-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, D. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shin, C. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, O.</span></span> <span> </span><span class="NLM_article-title">The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms</span>. <i>J. Dermatol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>91</i></span>,  <span class="NLM_fpage">60</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.1016/j.jdermsci.2018.04.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.jdermsci.2018.04.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29678305" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXot1Cns7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=91&publication_year=2018&pages=60-68&author=H.+I.+Choiauthor=D.+Y.+Kimauthor=S.+J.+Choiauthor=C.+Y.+Shinauthor=S.+T.+Hwangauthor=K.+H.+Kimauthor=O.+Kwon&title=The+effect+of+cilostazol%2C+a+phosphodiesterase+3+%28PDE3%29+inhibitor%2C+on+human+hair+growth+with+the+dual+promoting+mechanisms&doi=10.1016%2Fj.jdermsci.2018.04.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit146R"><div class="casContent"><span class="casTitleNuber">146</span><div class="casTitle"><span class="NLM_cas:atitle">The effect of cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, on human hair growth with the dual promoting mechanisms</span></div><div class="casAuthors">Choi, Hye-In; Kim, Dong Young; Choi, Soon-Jin; Shin, Chang-Yup; Hwang, Sungjoo Tommy; Kim, Kyu Han; Kwon, Ohsang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Dermatological Science</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">91</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">60-68</span>CODEN:
                <span class="NLM_cas:coden">JDSCEI</span>;
        ISSN:<span class="NLM_cas:issn">0923-1811</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ireland Ltd.</span>)
        </div><div class="casAbstract">Cilostazol, a phosphodiesterase 3 (PDE3) inhibitor, increases the intracellular level of cyclic adenosine monophosphate to cause vasodilation.  Topical application of cilostazol is reported to improve local blood flow and enhance wound healing; however, its effect on human hair follicles is unknown.  The purpose of this study was to det. the effect of cilostazol on hair growth.  We investigated the expression of PDE3 in human dermal papilla cells (DPCs), outer root sheath cells (ORSCs), and hair follicles.  The effects of cilostazol on DPC and ORSC proliferation were evaluated using BrdU and WST-1 assays.  The expression of various growth factors in DPCs was investigated by growth factor antibody array.  Addnl., hair shaft elongation was measured using ex vivo hair follicle organ cultures, and anagen induction was evaluated in C57BL/6 mice.  Finally, the effects of cilostazol on vessel formation and activation of the mitogen-activated protein kinase pathway were evaluated.  We confirmed high mRNA and protein expression of PDE3 in human DPCs.  Cilostazol not only enhanced the proliferation of human DPCs but also regulated the secretion of several growth factors responsible for hair growth.  Furthermore, it promoted hair shaft elongation ex vivo, with increased proliferation of matrix keratinocytes.  Cilostazol also accelerated anagen induction by stimulating vessel formation and upregulating the levels of phosphorylated extracellular signal-regulated kinase, c-Jun N-terminal kinase, and P38 after its topical application in C57BL/6 mice.  Our results show that cilostazol promotes hair growth and may serve as a therapeutic agent for the treatment of alopecia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrx2LPJgK2EXLVg90H21EOLACvtfcHk0lh9uz3OT9ktjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXot1Cns7w%253D&md5=4131befac73c13e5bb21277748b1adec</span></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1016%2Fj.jdermsci.2018.04.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jdermsci.2018.04.005%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DH.%2BI.%26aulast%3DKim%26aufirst%3DD.%2BY.%26aulast%3DChoi%26aufirst%3DS.%2BJ.%26aulast%3DShin%26aufirst%3DC.%2BY.%26aulast%3DHwang%26aufirst%3DS.%2BT.%26aulast%3DKim%26aufirst%3DK.%2BH.%26aulast%3DKwon%26aufirst%3DO.%26atitle%3DThe%2520effect%2520of%2520cilostazol%252C%2520a%2520phosphodiesterase%25203%2520%2528PDE3%2529%2520inhibitor%252C%2520on%2520human%2520hair%2520growth%2520with%2520the%2520dual%2520promoting%2520mechanisms%26jtitle%3DJ.%2520Dermatol.%2520Sci.%26date%3D2018%26volume%3D91%26spage%3D60%26epage%3D68%26doi%3D10.1016%2Fj.jdermsci.2018.04.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tsuji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohshima, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saito, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hattori, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanaka, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taguchi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ihara, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, Y.</span></span> <span> </span><span class="NLM_article-title">Cilostazol, a phosphodiesterase 3 inhibitor, moderately attenuates behaviors depending on sex in the Ts65Dn mouse model of down syndrome</span>. <i>Front. Aging Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">106</span>, <span class="refDoi"> DOI: 10.3389/fnagi.2020.00106</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3389%2Ffnagi.2020.00106" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=32372946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1OlsrbO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2020&pages=106&author=M.+Tsujiauthor=M.+Ohshimaauthor=Y.+Yamamotoauthor=S.+Saitoauthor=Y.+Hattoriauthor=E.+Tanakaauthor=A.+Taguchiauthor=M.+Iharaauthor=Y.+Ogawa&title=Cilostazol%2C+a+phosphodiesterase+3+inhibitor%2C+moderately+attenuates+behaviors+depending+on+sex+in+the+Ts65Dn+mouse+model+of+down+syndrome&doi=10.3389%2Ffnagi.2020.00106"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit147R"><div class="casContent"><span class="casTitleNuber">147</span><div class="casTitle"><span class="NLM_cas:atitle">Cilostazol, a phosphodiesterase 3 inhibitor, moderately attenuates behaviors depending on sex in the Ts65Dn mouse model of down syndrome</span></div><div class="casAuthors">Tsuji, Masahiro; Ohshima, Makiko; Yamamoto, Yumi; Saito, Satoshi; Hattori, Yorito; Tanaka, Emi; Taguchi, Akihiko; Ihara, Masafumi; Ogawa, Yuko</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Aging Neuroscience</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">106</span>CODEN:
                <span class="NLM_cas:coden">FANRC5</span>;
        ISSN:<span class="NLM_cas:issn">1663-4365</span>.
    
            (<span class="NLM_cas:orgname">Frontiers Media S.A.</span>)
        </div><div class="casAbstract">People with Down syndrome, which is a trisomy of chromosome 21, exhibit intellectual disability from infancy and neuropathol. similar to Alzheimer's disease, such as amyloid plaques, from an early age.  Recently, we showed that cilostazol, a selective inhibitor of phosphodiesterase (PDE) 3, promotes the clearance of amyloid β and rescues cognitive deficits in a mouse model of Alzheimer's disease.  The objective of the present study was to examine whether cilostazol improves behaviors in the most widely used animal model of Down syndrome, i.e., Ts65Dn mice.  Mice were supplemented with cilostazol from the fetal period until young adulthood.  Supplementation significantly ameliorated novel-object recognition in Ts65Dn females and partially ameliorated sensorimotor function as detd. by the rotarod test in Ts65Dn females and hyperactive locomotion in Ts65Dn males.  Cilostazol supplementation significantly shortened swimming distance in Ts65Dn males in the Morris water maze test, suggesting that the drug improved cognitive function, although it did not shorten swimming duration, which was due to decreased swimming speed.  Thus, this study suggests that early supplementation with cilostazol partially rescues behavioral abnormalities seen in Down syndrome and indicates that the effects are sex-dependent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrgdf15YFRuXbVg90H21EOLACvtfcHk0lh9uz3OT9ktjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1OlsrbO&md5=566847b002963d79600afbf6a1738266</span></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.3389%2Ffnagi.2020.00106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3389%252Ffnagi.2020.00106%26sid%3Dliteratum%253Aachs%26aulast%3DTsuji%26aufirst%3DM.%26aulast%3DOhshima%26aufirst%3DM.%26aulast%3DYamamoto%26aufirst%3DY.%26aulast%3DSaito%26aufirst%3DS.%26aulast%3DHattori%26aufirst%3DY.%26aulast%3DTanaka%26aufirst%3DE.%26aulast%3DTaguchi%26aufirst%3DA.%26aulast%3DIhara%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DY.%26atitle%3DCilostazol%252C%2520a%2520phosphodiesterase%25203%2520inhibitor%252C%2520moderately%2520attenuates%2520behaviors%2520depending%2520on%2520sex%2520in%2520the%2520Ts65Dn%2520mouse%2520model%2520of%2520down%2520syndrome%26jtitle%3DFront.%2520Aging%2520Neurosci.%26date%3D2020%26volume%3D12%26spage%3D106%26doi%3D10.3389%2Ffnagi.2020.00106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bejaoui, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaouali, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakly, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ben Abdennebi, H.</span></span> <span> </span><span class="NLM_article-title">Olprinone protects the liver from ischemia-reperfusion injury through oxidative stress prevention and protein kinase Akt activation</span>. <i>Can. J. Physiol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">227</span>– <span class="NLM_lpage">231</span>, <span class="refDoi"> DOI: 10.1139/cjpp-2017-0153</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1139%2Fcjpp-2017-0153" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28675791" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXitlCgsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2018&pages=227-231&author=M.+Bejaouiauthor=M.+A.+Zaoualiauthor=R.+Saklyauthor=H.+Ben+Abdennebi&title=Olprinone+protects+the+liver+from+ischemia-reperfusion+injury+through+oxidative+stress+prevention+and+protein+kinase+Akt+activation&doi=10.1139%2Fcjpp-2017-0153"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Olprinone protects the liver from ischemia-reperfusion injury through oxidative stress prevention and protein kinase Akt activation</span></div><div class="casAuthors">Bejaoui, Mohamed; Zaouali, Mohamed Amine; Sakly, Rim; Ben Abdennebi, Hassen</div><div class="citationInfo"><span class="NLM_cas:title">Canadian Journal of Physiology and Pharmacology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">227-231</span>CODEN:
                <span class="NLM_cas:coden">CJPPA3</span>;
        ISSN:<span class="NLM_cas:issn">0008-4212</span>.
    
            (<span class="NLM_cas:orgname">Canadian Science Publishing</span>)
        </div><div class="casAbstract">Liver ischemia-reperfusion (IR) injury is inevitable in surgical procedures such as hepatic resection and liver transplantation.  It represents a leading cause of liver graft dysfunction and primary nonfunction after transplantation.  Phosphodiesterase (PDE) inhibitors are emerging as effective drugs able to reduce IR damage.  The aim of this study was to investigate the effect of selective PDE-3 inhibitor olprinone (Olp) against liver IR injury.  Male Wistar rats were subjected to 1 h of partial warm ischemia (70%) followed by 6 h of reperfusion.  Before ischemia, rats were treated with saline (IR group), Olp (Olp group), or Olp with Akt inhibitor LY294002 (Olp plus LY group).  After reperfusion, hepatic injury (transaminase activities), mitochondrial damage (glutamate dehydrogenase activity), oxidative stress (malondialdehyde and glutathione concns. and catalase and superoxide dismutase activities), and protein kinase Akt activation were evaluated.  Rat treatment with Olp reduced liver injury, prevented mitochondrial damage, decreased lipid peroxidn., and enhanced antioxidant enzymes.  Also, Olp induced a significant activation in protein kinase Akt.  Inhibition of Akt with LY294002 abolished all of the protective effects of Olp.  In conclusion, Olp treatment may be an effective strategy in reducing liver IR injury through oxidative stress prevention and Akt activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpNo7zUdO9H87Vg90H21EOLACvtfcHk0lh9uz3OT9ktjg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXitlCgsQ%253D%253D&md5=036751057a795420e2b172c3d717c7c3</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.1139%2Fcjpp-2017-0153&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1139%252Fcjpp-2017-0153%26sid%3Dliteratum%253Aachs%26aulast%3DBejaoui%26aufirst%3DM.%26aulast%3DZaouali%26aufirst%3DM.%2BA.%26aulast%3DSakly%26aufirst%3DR.%26aulast%3DBen%2BAbdennebi%26aufirst%3DH.%26atitle%3DOlprinone%2520protects%2520the%2520liver%2520from%2520ischemia-reperfusion%2520injury%2520through%2520oxidative%2520stress%2520prevention%2520and%2520protein%2520kinase%2520Akt%2520activation%26jtitle%3DCan.%2520J.%2520Physiol.%2520Pharmacol.%26date%3D2018%26volume%3D96%26spage%3D227%26epage%3D231%26doi%3D10.1139%2Fcjpp-2017-0153" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kosutova, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mikolka, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Balentova, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamkov, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calkovska, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mokra, D.</span></span> <span> </span><span class="NLM_article-title">Effects of PDE3 inhibitor olprinone on the respiratory parameters, inflammation, and apoptosis in an experimental model of acute respiratory distress syndrome</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">3382</span>, <span class="refDoi"> DOI: 10.3390/ijms21093382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fijms21093382" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhvVOjtrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=3382&author=P.+Kosutovaauthor=P.+Mikolkaauthor=S.+Balentovaauthor=M.+Adamkovauthor=A.+Calkovskaauthor=D.+Mokra&title=Effects+of+PDE3+inhibitor+olprinone+on+the+respiratory+parameters%2C+inflammation%2C+and+apoptosis+in+an+experimental+model+of+acute+respiratory+distress+syndrome&doi=10.3390%2Fijms21093382"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Effects of PDE3 inhibitor olprinone on the respiratory parameters, inflammation, and apoptosis in an experimental model of acute respiratory distress syndrome</span></div><div class="casAuthors">Kosutova, Petra; Mikolka, Pavol; Balentova, Sona; Adamkov, Marian; Calkovska, Andrea; Mokra, Daniela</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3382</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">This study aimed to investigate whether a selective phosphodiesterase-3 (PDE3) inhibitor olprinone can pos. influence the inflammation, apoptosis, and respiratory parameters in animals with acute respiratory distress syndrome (ARDS) model induced by repetitive saline lung lavage.  Adult rabbits were divided into 3 groups: ARDS without therapy (ARDS), ARDS treated with olprinone i.v. (1 mg/kg; ARDS/PDE3), and healthy ventilated controls (Control), and were oxygen-ventilated for the following 4 h.  Dynamic lung-thorax compliance (Cdyn), mean airway pressure (MAP), arterial oxygen satn. (SaO2), alveolar-arterial gradient (AAG), ratio between partial pressure of oxygen in arterial blood to a fraction of inspired oxygen (PaO2/FiO2), oxygenation index (OI), and ventilation efficiency index (VEI) were evaluated every hour.  Post mortem, inflammatory and oxidative markers interleukin (IL)-6, IL-1β, a receptor for advanced glycation end products (RAGE), IL-10, total antioxidant capacity (TAC), 3-nitrotyrosine (3NT), and malondialdehyde (MDA) and apoptosis (apoptotic index and caspase-3) were assessed in the lung tissue.  Treatment with olprinone reduced the release of inflammatory mediators and markers of oxidative damage decreased apoptosis of epithelial cells and improved respiratory parameters.  The results indicate a future potential of PDE3 inhibitors also in the therapy of ARDS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqug1lMVKPz_7Vg90H21EOLACvtfcHk0ligSlQb_Mj-IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhvVOjtrvO&md5=0f504f7a8894cf7d8df59264c2220a26</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.3390%2Fijms21093382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21093382%26sid%3Dliteratum%253Aachs%26aulast%3DKosutova%26aufirst%3DP.%26aulast%3DMikolka%26aufirst%3DP.%26aulast%3DBalentova%26aufirst%3DS.%26aulast%3DAdamkov%26aufirst%3DM.%26aulast%3DCalkovska%26aufirst%3DA.%26aulast%3DMokra%26aufirst%3DD.%26atitle%3DEffects%2520of%2520PDE3%2520inhibitor%2520olprinone%2520on%2520the%2520respiratory%2520parameters%252C%2520inflammation%252C%2520and%2520apoptosis%2520in%2520an%2520experimental%2520model%2520of%2520acute%2520respiratory%2520distress%2520syndrome%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D3382%26doi%3D10.3390%2Fijms21093382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coskran, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morton, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Menniti, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamowicz, W. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kleiman, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strick, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephenson, D. T.</span></span> <span> </span><span class="NLM_article-title">Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species</span>. <i>J. Histochem. Cytochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1205</span>– <span class="NLM_lpage">1213</span>, <span class="refDoi"> DOI: 10.1369/jhc.6A6930.2006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1369%2Fjhc.6A6930.2006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16864896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFWqurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=1205-1213&author=T.+M.+Coskranauthor=D.+Mortonauthor=F.+S.+Mennitiauthor=W.+O.+Adamowiczauthor=R.+J.+Kleimanauthor=A.+M.+Ryanauthor=C.+A.+Strickauthor=C.+J.+Schmidtauthor=D.+T.+Stephenson&title=Immunohistochemical+localization+of+phosphodiesterase+10A+in+multiple+mammalian+species&doi=10.1369%2Fjhc.6A6930.2006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit150R"><div class="casContent"><span class="casTitleNuber">150</span><div class="casTitle"><span class="NLM_cas:atitle">Immunohistochemical localization of phosphodiesterase 10A in multiple mammalian species</span></div><div class="casAuthors">Coskran, Timothy M.; Morton, Daniel; Menniti, Frank S.; Adamowicz, Wendy O.; Kleiman, Robin J.; Ryan, Anne M.; Strick, Christine A.; Schmidt, Christopher J.; Stephenson, Diane T.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Histochemistry and Cytochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1205-1213</span>CODEN:
                <span class="NLM_cas:coden">JHCYAS</span>;
        ISSN:<span class="NLM_cas:issn">0022-1554</span>.
    
            (<span class="NLM_cas:orgname">Histochemical Society, Inc.</span>)
        </div><div class="casAbstract">A monoclonal antibody directed against the N-terminal of rat phosphodiesterase 10A (PDE10A) was used to localize PDE10A in multiple central nervous system (CNS) and peripheral tissues from mouse, rat, dog, cynomolgus macaque, and human.  PDE10A immunoreactivity is strongly expressed in the CNS of these species with limited expression in peripheral tissues.  Within the brain, strong immunoreactivity is present in both neuronal cell bodies and neuropil of the striatum, in striatonigral and striatopallidal white matter tracks, and in the substantia nigra and globus pallidus.  Outside the brain, PDE10A immunoreactivity is less intense, and distribution is limited to few tissues such as the testis, epididymal sperm, and enteric ganglia.  These data demonstrate that PDE10A is an evolutionarily conserved phosphodiesterase highly expressed in the brain but with restricted distribution in the periphery in multiple mammalian species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoRfW0o5F66eLVg90H21EOLACvtfcHk0ligSlQb_Mj-IA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFWqurrJ&md5=03df0a34bb9e43ad63b84b734e6c1974</span></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1369%2Fjhc.6A6930.2006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1369%252Fjhc.6A6930.2006%26sid%3Dliteratum%253Aachs%26aulast%3DCoskran%26aufirst%3DT.%2BM.%26aulast%3DMorton%26aufirst%3DD.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DAdamowicz%26aufirst%3DW.%2BO.%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DRyan%26aufirst%3DA.%2BM.%26aulast%3DStrick%26aufirst%3DC.%2BA.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26atitle%3DImmunohistochemical%2520localization%2520of%2520phosphodiesterase%252010A%2520in%2520multiple%2520mammalian%2520species%26jtitle%3DJ.%2520Histochem.%2520Cytochem.%26date%3D2006%26volume%3D54%26spage%3D1205%26epage%3D1213%26doi%3D10.1369%2Fjhc.6A6930.2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jager, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwede, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genieser, H. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koesling, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russwurm, M.</span></span> <span> </span><span class="NLM_article-title">Activation of PDE10 and PDE11 phosphodiesterases</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>287</i></span>,  <span class="NLM_fpage">1210</span>– <span class="NLM_lpage">1219</span>, <span class="refDoi"> DOI: 10.1074/jbc.M111.263806</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.M111.263806" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22105073" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref151/cit151&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC387is1Crtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=287&publication_year=2012&pages=1210-1219&author=R.+Jagerauthor=C.+Russwurmauthor=F.+Schwedeauthor=H.+G.+Genieserauthor=D.+Koeslingauthor=M.+Russwurm&title=Activation+of+PDE10+and+PDE11+phosphodiesterases&doi=10.1074%2Fjbc.M111.263806"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit151R"><div class="casContent"><span class="casTitleNuber">151</span><div class="casTitle"><span class="NLM_cas:atitle">Activation of PDE10 and PDE11 phosphodiesterases</span></div><div class="casAuthors">Jager Ronald; Russwurm Corina; Schwede Frank; Genieser Hans-Gottfried; Koesling Doris; Russwurm Michael</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of biological chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">287</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">1210-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The most recently identified cyclic nucleotide phosphodiesterases, PDE10 and PDE11, contain a tandem of so-called GAF domains in their N-terminal regulatory regions.  In PDE2 and PDE5, the GAF domains mediate cGMP stimulation; however, their function in PDE10 and PDE11 remains controversial.  Although the GAF domains of PDE10 mediate cAMP-induced stimulation of chimeric adenylyl cyclases, cAMP binding did not stimulate the PDE10 holoenzyme.  Comparable data about cGMP and the PDE11 GAF domains exist.  Here, we identified synthetic ligands for the GAF domains of PDE10 and PDE11 to reduce interference of the GAF ligand with the catalytic reaction of PDE.  With these ligands, GAF-mediated stimulation of the PDE10 and PDE11 holoenzymes is demonstrated for the first time.  Furthermore, PDE10 is shown to be activated by cAMP, which paradoxically results in potent competitive inhibition of cGMP turnover by cAMP.  PDE11, albeit susceptible to GAF-dependent stimulation, is not activated by the native cyclic nucleotides cAMP and cGMP.  In summary, PDE11 can be stimulated by GAF domain ligands, but its native ligand remains to be identified, and PDE10 is the only PDE activated by cAMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRPLtDOMxj8oNTiMd2aNQVUfW6udTcc2eZ6hhIjyB2MXrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC387is1Crtw%253D%253D&md5=5557bf6173db79a35bd8ce0d7e937a37</span></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M111.263806&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M111.263806%26sid%3Dliteratum%253Aachs%26aulast%3DJager%26aufirst%3DR.%26aulast%3DRusswurm%26aufirst%3DC.%26aulast%3DSchwede%26aufirst%3DF.%26aulast%3DGenieser%26aufirst%3DH.%2BG.%26aulast%3DKoesling%26aufirst%3DD.%26aulast%3DRusswurm%26aufirst%3DM.%26atitle%3DActivation%2520of%2520PDE10%2520and%2520PDE11%2520phosphodiesterases%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2012%26volume%3D287%26spage%3D1210%26epage%3D1219%26doi%3D10.1074%2Fjbc.M111.263806" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zuccato, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ciammola, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rigamonti, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leavitt, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goffredo, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conti, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacDonald, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedlander, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silani, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayden, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmusk, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sipione, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cattaneo, E.</span></span> <span> </span><span class="NLM_article-title">Loss of huntingtin-mediated BDNF gene transcription in Huntington’s disease</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>293</i></span>,  <span class="NLM_fpage">493</span>– <span class="NLM_lpage">498</span>, <span class="refDoi"> DOI: 10.1126/science.1059581</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1126%2Fscience.1059581" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=11408619" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref152/cit152&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3MXlsFGjtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=293&publication_year=2001&pages=493-498&author=C.+Zuccatoauthor=A.+Ciammolaauthor=D.+Rigamontiauthor=B.+R.+Leavittauthor=D.+Goffredoauthor=L.+Contiauthor=M.+E.+MacDonaldauthor=R.+M.+Friedlanderauthor=V.+Silaniauthor=M.+R.+Haydenauthor=T.+Timmuskauthor=S.+Sipioneauthor=E.+Cattaneo&title=Loss+of+huntingtin-mediated+BDNF+gene+transcription+in+Huntington%E2%80%99s+disease&doi=10.1126%2Fscience.1059581"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit152R"><div class="casContent"><span class="casTitleNuber">152</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Huntingtin-mediated BDNF gene transcription in Huntington's disease</span></div><div class="casAuthors">Zuccato, Chiara; Ciammola, Andrea; Rigamonti, Dorotea; Leavitt, Blair R.; Goffredo, Donato; Conti, Luciano; MacDonald, Marcy E.; Friedlander, Robert M.; Silani, Vincenzo; Hayden, Michael R.; Timmusk, Tonis; Sipione, Simonetta; Cattaneo, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">293</span>
        (<span class="NLM_cas:issue">5529</span>),
    <span class="NLM_cas:pages">493-498</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Huntingtin is a 350-kDa protein of unknown function that is mutated in Huntington's disease (HD), a neurodegenerative disorder.  The mutant protein is presumed to acquire a toxic gain of function that is detrimental to striatal neurons in the brain.  However, loss of a beneficial activity of wild-type Huntingtin may also cause the death of striatal neurons.  Here we demonstrate that wild-type Huntingtin up-regulates transcription of brain-derived neurotrophic factor (BDNF), a pro-survival factor produced by cortical neurons that is necessary for survival of striatal neurons in the brain.  We show that this beneficial activity of Huntingtin is lost when the protein becomes mutated, resulting in decreased prodn. of cortical BDNF.  This leads to insufficient neurotrophic support for striatal neurons, which then die.  Restoring wild-type Huntingtin activity and increasing BDNF prodn. may be therapeutic approaches for treating HD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpM4Z_NQRioP7Vg90H21EOLACvtfcHk0ljACr5wPVXb0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXlsFGjtr0%253D&md5=aeb2de58b5782f2f08a9683556608d81</span></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=10.1126%2Fscience.1059581&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1059581%26sid%3Dliteratum%253Aachs%26aulast%3DZuccato%26aufirst%3DC.%26aulast%3DCiammola%26aufirst%3DA.%26aulast%3DRigamonti%26aufirst%3DD.%26aulast%3DLeavitt%26aufirst%3DB.%2BR.%26aulast%3DGoffredo%26aufirst%3DD.%26aulast%3DConti%26aufirst%3DL.%26aulast%3DMacDonald%26aufirst%3DM.%2BE.%26aulast%3DFriedlander%26aufirst%3DR.%2BM.%26aulast%3DSilani%26aufirst%3DV.%26aulast%3DHayden%26aufirst%3DM.%2BR.%26aulast%3DTimmusk%26aufirst%3DT.%26aulast%3DSipione%26aufirst%3DS.%26aulast%3DCattaneo%26aufirst%3DE.%26atitle%3DLoss%2520of%2520huntingtin-mediated%2520BDNF%2520gene%2520transcription%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DScience%26date%3D2001%26volume%3D293%26spage%3D493%26epage%3D498%26doi%3D10.1126%2Fscience.1059581" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Jicha, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weaver, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lane, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vianna, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kress, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockwood, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davies, P.</span></span> <span> </span><span class="NLM_article-title">cAMP-dependent protein kinase phosphorylations on Tau in Alzheimer’s disease</span>. <i>J. Neurosci.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">7486</span>– <span class="NLM_lpage">7494</span>, <span class="refDoi"> DOI: 10.1523/JNEUROSCI.19-17-07486.1999</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1523%2FJNEUROSCI.19-17-07486.1999" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10460255" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADyaK1MXlslWms74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=1999&pages=7486-7494&author=G.+A.+Jichaauthor=C.+Weaverauthor=E.+Laneauthor=C.+Viannaauthor=Y.+Kressauthor=J.+Rockwoodauthor=P.+Davies&title=cAMP-dependent+protein+kinase+phosphorylations+on+Tau+in+Alzheimer%E2%80%99s+disease&doi=10.1523%2FJNEUROSCI.19-17-07486.1999"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit153R"><div class="casContent"><span class="casTitleNuber">153</span><div class="casTitle"><span class="NLM_cas:atitle">cAMP-dependent protein kinase phosphorylations on Tau in Alzheimer's disease</span></div><div class="casAuthors">Jicha, Gregory A.; Weaver, Charles; Lane, Eric; Vianna, Cintia; Kress, Yvonne; Rockwood, Julia; Davies, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">7486-7494</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">To elucidate the role cAMP-dependent protein kinase (PKA) phosphorylations on tau play in Alzheimer's disease, we have generated highly specific monoclonal antibodies, CP-3 and PG-5, which recognize the PKA-dependent phosphorylations of ser214 and ser409 in tau resp.  The present study demonstrates by immunohistochem. anal., CP-3 and PG-5 immunoreactivity with neurofibrillary pathol. in both early and advanced Alzheimer's disease, but not in normal brain tissue and demonstrates that cAMP-dependent protein kinase phosphorylations on tau precede or are coincident with the initial appearance of filamentous aggregates of tau.  Studies using heat-stable prepns. demonstrate that neither site appears to be phosphorylated to any appreciable extent in normal rodent or human brain.  Further anal. demonstrates that the β catalytic subunit of PKA (Cβ), the β II regulatory subunit of PKA (RIIβ), and the 79 kDa A-kinase-anchoring-protein (AKAP79), are tightly assocd. with the neurofibrillary pathol., positioning cAMP-dependent protein kinase to participate directly in the pathol. hyperphosphorylation of tau seen in Alzheimer's disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo2-_aEtC_SIbVg90H21EOLACvtfcHk0ljACr5wPVXb0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlslWms74%253D&md5=d75b62fd8a29a0e611fcfc9fa7b13a38</span></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1523%2FJNEUROSCI.19-17-07486.1999&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1523%252FJNEUROSCI.19-17-07486.1999%26sid%3Dliteratum%253Aachs%26aulast%3DJicha%26aufirst%3DG.%2BA.%26aulast%3DWeaver%26aufirst%3DC.%26aulast%3DLane%26aufirst%3DE.%26aulast%3DVianna%26aufirst%3DC.%26aulast%3DKress%26aufirst%3DY.%26aulast%3DRockwood%26aufirst%3DJ.%26aulast%3DDavies%26aufirst%3DP.%26atitle%3DcAMP-dependent%2520protein%2520kinase%2520phosphorylations%2520on%2520Tau%2520in%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DJ.%2520Neurosci.%26date%3D1999%26volume%3D19%26spage%3D7486%26epage%3D7494%26doi%3D10.1523%2FJNEUROSCI.19-17-07486.1999" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McPhee, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, L. C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kewney, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Darroch, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stevens, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spinks, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cooreman, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">MacKenzie, S. J.</span></span> <span> </span><span class="NLM_article-title">Cyclic nucleotide signalling: a molecular approach to drug discovery for Alzheimer’s disease</span>. <i>Biochem. Soc. Trans.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">1330</span>– <span class="NLM_lpage">1332</span>, <span class="refDoi"> DOI: 10.1042/BST20051330</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1042%2FBST0331330" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16246111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsL3O" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2005&pages=1330-1332&author=I.+McPheeauthor=L.+C.+D.+Gibsonauthor=J.+Kewneyauthor=C.+Darrochauthor=P.+A.+Stevensauthor=D.+Spinksauthor=A.+Cooremanauthor=S.+J.+MacKenzie&title=Cyclic+nucleotide+signalling%3A+a+molecular+approach+to+drug+discovery+for+Alzheimer%E2%80%99s+disease&doi=10.1042%2FBST20051330"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclic nucleotide signaling: a molecular approach to drug discovery for Alzheimer's disease</span></div><div class="casAuthors">McPhee, I.; Gibson, L. C. D.; Kewney, J.; Darroch, C.; Stevens, P. A.; Spinks, D.; Cooreman, A.; MacKenzie, S. J.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Society Transactions</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1330-1332</span>CODEN:
                <span class="NLM_cas:coden">BCSTB5</span>;
        ISSN:<span class="NLM_cas:issn">0300-5127</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">The EPAC (exchange protein directly activated by cAMP) proteins are GEFs (guanine nucleotide-exchange factors) that activate Rap GTPases upon binding to cAMP.  The involvement of these proteins in a no. of diseases, neurodegenerative, inflammatory and metabolic, has started to show how they may prove to be important targets for therapeutic intervention.  We first became interested in EPAC when we discovered that the expression levels of both EPAC1 and EPAC2 were altered in those regions of the brain assocd. with Alzheimer's disease [McPhee, Breslin, Kewney, MacKenzie, Cooreman, Gibson and Hammond (2004) International Patent no. WO 2004/096199 A2].  It was known that compds. could be designed to be selective for EPAC over PKA (protein kinase A); however, these compds. were all based around the core structure of cAMP.  We decided to screen a small compd. library (10000 compds.) to investigate the possibility of developing a compd. series outside of the cAMP structure.  We subsequently developed a novel, high-throughput screen based on the displacement of [3H]cAMP from the EPAC cAMP-binding site and identified small mol. hits from the Scottish Biomedical Lead Generation Library.  These compds. selectively bind to the cAMP-binding sites of EPAC1 and EPAC2 and are structurally dissimilar to cAMP.  They have similar affinities for both EPAC1 and EPAC2 and have a high degree of specificity for EPAC over PKA.  We believe that these compds. provide a valuable starting point for a drug optimization program.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouyPDxphsRO7Vg90H21EOLACvtfcHk0ljACr5wPVXb0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtFCqsL3O&md5=a7bd75bee9d72e8a91883bbd698c0f80</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1042%2FBST0331330&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FBST0331330%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DI.%26aulast%3DGibson%26aufirst%3DL.%2BC.%2BD.%26aulast%3DKewney%26aufirst%3DJ.%26aulast%3DDarroch%26aufirst%3DC.%26aulast%3DStevens%26aufirst%3DP.%2BA.%26aulast%3DSpinks%26aufirst%3DD.%26aulast%3DCooreman%26aufirst%3DA.%26aulast%3DMacKenzie%26aufirst%3DS.%2BJ.%26atitle%3DCyclic%2520nucleotide%2520signalling%253A%2520a%2520molecular%2520approach%2520to%2520drug%2520discovery%2520for%2520Alzheimer%25E2%2580%2599s%2520disease%26jtitle%3DBiochem.%2520Soc.%2520Trans.%26date%3D2005%26volume%3D33%26spage%3D1330%26epage%3D1332%26doi%3D10.1042%2FBST20051330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garcia, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brea, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gonzalez-Garcia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cadavid, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loza, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gil, C.</span></span> <span> </span><span class="NLM_article-title">Targeting PDE10A GAF domain with small molecules: A way for allosteric modulation with anti-inflammatory effects</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1472</span>, <span class="refDoi"> DOI: 10.3390/molecules22091472</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fmolecules22091472" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhslWgsrzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1472&author=A.+M.+Garciaauthor=J.+Breaauthor=A.+Gonzalez-Garciaauthor=C.+Perezauthor=M.+I.+Cadavidauthor=M.+I.+Lozaauthor=A.+Martinezauthor=C.+Gil&title=Targeting+PDE10A+GAF+domain+with+small+molecules%3A+A+way+for+allosteric+modulation+with+anti-inflammatory+effects&doi=10.3390%2Fmolecules22091472"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit155R"><div class="casContent"><span class="casTitleNuber">155</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting PDE10A GAF domain with small molecules: a way for allosteric modulation with anti-inflammatory effects</span></div><div class="casAuthors">Garcia, Ana M.; Brea, Jose; Gonzalez-Garcia, Alejandro; Perez, Concepcion; Cadavid, Maria Isabel; Loza, Maria Isabel; Martinez, Ana; Gil, Carmen</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1472/1-1472/8</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) enzymes regulate the levels of cyclic nucleotides, cAMP, and/or cGMP, being attractive therapeutic targets.  In order to modulate PDE activity in a selective way, we focused our efforts on the search of allosteric modulators.  Based on the crystal structure of the PDE10A GAF-B domain, a virtual screening study allowed the discovery of new hits that were also tested exptl., showing inhibitory activities in the micromolar range.  Moreover, these new PDE10A inhibitors were able to decrease the nitrite prodn. in LPS-stimulated cells, thus demonstrating their potential as anti-inflammatory agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrt-1hKgjMtnLVg90H21EOLACvtfcHk0ljPsJSkboABOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhslWgsrzJ&md5=1665309bf5f8a224ee692a7b3c40e4ea</span></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.3390%2Fmolecules22091472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules22091472%26sid%3Dliteratum%253Aachs%26aulast%3DGarcia%26aufirst%3DA.%2BM.%26aulast%3DBrea%26aufirst%3DJ.%26aulast%3DGonzalez-Garcia%26aufirst%3DA.%26aulast%3DPerez%26aufirst%3DC.%26aulast%3DCadavid%26aufirst%3DM.%2BI.%26aulast%3DLoza%26aufirst%3DM.%2BI.%26aulast%3DMartinez%26aufirst%3DA.%26aulast%3DGil%26aufirst%3DC.%26atitle%3DTargeting%2520PDE10A%2520GAF%2520domain%2520with%2520small%2520molecules%253A%2520A%2520way%2520for%2520allosteric%2520modulation%2520with%2520anti-inflammatory%2520effects%26jtitle%3DMolecules%26date%3D2017%26volume%3D22%26spage%3D1472%26doi%3D10.3390%2Fmolecules22091472" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nawrocki, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodriguez, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toolan, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henry, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Szeto, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keohane, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance</span>. <i>Diabetes</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">300</span>– <span class="NLM_lpage">311</span>, <span class="refDoi"> DOI: 10.2337/db13-0247</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2337%2Fdb13-0247" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24101672" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2014&pages=300-311&author=A.+R.+Nawrockiauthor=C.+G.+Rodriguezauthor=D.+M.+Toolanauthor=O.+Priceauthor=M.+Henryauthor=G.+Forrestauthor=D.+Szetoauthor=C.+A.+Keohaneauthor=Y.+Panauthor=K.+M.+Smithauthor=I.+T.+Raheemauthor=C.+D.+Coxauthor=J.+Hwaauthor=J.+J.+Rengerauthor=S.+M.+Smith&title=Genetic+deletion+and+pharmacological+inhibition+of+phosphodiesterase+10A+protects+mice+from+diet-induced+obesity+and+insulin+resistance&doi=10.2337%2Fdb13-0247"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Genetic deletion and pharmacological inhibition of phosphodiesterase 10A protects mice from diet-induced obesity and insulin resistance</span></div><div class="casAuthors">Nawrocki, Andrea R.; Rodriguez, Carlos G.; Toolan, Dawn M.; Price, Olga; Henry, Melanie; Forrest, Gail; Szeto, Daphne; Keohane, Carol Ann; Pan, Yie; Smith, Karen M.; Raheem, Izzat T.; Cox, Christopher D.; Hwa, Joyce; Renger, John J.; Smith, Sean M.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">300-311</span>CODEN:
                <span class="NLM_cas:coden">DIAEAZ</span>;
        ISSN:<span class="NLM_cas:issn">0012-1797</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a novel therapeutic target for the treatment of schizophrenia.  Here we report a novel role of PDE10A in the regulation of caloric intake and energy homeostasis.  PDE10A-deficient mice are resistant to diet-induced obesity (DIO) and assocd. metabolic disturbances.  Inhibition of wt. gain is due to hypophagia after mice are fed a highly palatable diet rich in fats and sugar but not a std. diet.  PDE10A deficiency produces a decrease in caloric intake without affecting meal frequency, daytime vs. nighttime feeding behavior, or locomotor activity.  We tested THPP-6, a small mol. PDE10A inhibitor, in DIO mice.  THPP-6 treatment resulted in decreased food intake, body wt. loss, and reduced adiposity at doses that produced antipsychotic efficacy in behavioral models.  We show that PDE10A inhibition increased whole-body energy expenditure in DIO mice fed a Western-style diet, achieving wt. loss and reducing adiposity beyond the extent seen with food restriction alone.  Therefore, chronic THPP-6 treatment conferred improved insulin sensitivity and reversed hyperinsulinemia.  These data demonstrate that PDE10A inhibition represents a novel antipsychotic target that may have addnl. metabolic benefits over current medications for schizophrenia by suppressing food intake, alleviating wt. gain, and reducing the risk for the development of diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpXpKRCUJQfObVg90H21EOLACvtfcHk0ljPsJSkboABOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsFKqsQ%253D%253D&md5=64c728352a9482af90ddbf86acc68a58</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.2337%2Fdb13-0247&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252Fdb13-0247%26sid%3Dliteratum%253Aachs%26aulast%3DNawrocki%26aufirst%3DA.%2BR.%26aulast%3DRodriguez%26aufirst%3DC.%2BG.%26aulast%3DToolan%26aufirst%3DD.%2BM.%26aulast%3DPrice%26aufirst%3DO.%26aulast%3DHenry%26aufirst%3DM.%26aulast%3DForrest%26aufirst%3DG.%26aulast%3DSzeto%26aufirst%3DD.%26aulast%3DKeohane%26aufirst%3DC.%2BA.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DSmith%26aufirst%3DK.%2BM.%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DHwa%26aufirst%3DJ.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26atitle%3DGenetic%2520deletion%2520and%2520pharmacological%2520inhibition%2520of%2520phosphodiesterase%252010A%2520protects%2520mice%2520from%2520diet-induced%2520obesity%2520and%2520insulin%2520resistance%26jtitle%3DDiabetes%26date%3D2014%26volume%3D63%26spage%3D300%26epage%3D311%26doi%3D10.2337%2Fdb13-0247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hankir, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnad, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weiner, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronisch, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhoff, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luthardt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kloting, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabri, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heiker, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bluher, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pfeifer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fenske, W. K.</span></span> <span> </span><span class="NLM_article-title">A novel thermoregulatory role for PDE10A in mouse and human adipocytes</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">796</span>– <span class="NLM_lpage">812</span>, <span class="refDoi"> DOI: 10.15252/emmm.201506085</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.15252%2Femmm.201506085" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27247380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xosl2nu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2016&pages=796-812&author=M.+K.+Hankirauthor=M.+Kranzauthor=T.+Gnadauthor=J.+Weinerauthor=S.+Wagnerauthor=W.+Deuther-Conradauthor=F.+Bronischauthor=K.+Steinhoffauthor=J.+Luthardtauthor=N.+Klotingauthor=S.+Hesseauthor=J.+P.+Seibylauthor=O.+Sabriauthor=J.+T.+Heikerauthor=M.+Bluherauthor=A.+Pfeiferauthor=P.+Brustauthor=W.+K.+Fenske&title=A+novel+thermoregulatory+role+for+PDE10A+in+mouse+and+human+adipocytes&doi=10.15252%2Femmm.201506085"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">A novel thermoregulatory role for PDE10A in mouse and human adipocytes</span></div><div class="casAuthors">Hankir, Mohammed K.; Kranz, Mathias; Gnad, Thorsten; Weiner, Juliane; Wagner, Sally; Deuther-Conrad, Winnie; Bronisch, Felix; Steinhoff, Karen; Luthardt, Julia; Kloeting, Nora; Hesse, Swen; Seibyl, John P.; Sabri, Osama; Heiker, John T.; Blueher, Matthias; Pfeifer, Alexander; Brust, Peter; Fenske, Wiebke K.</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">796-812</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase type 10A (PDE10A) is highly enriched in striatum and is under evaluation as a drug target for several psychiatric/neurodegenerative diseases.  Preclin. studies implicate PDE10A in the regulation of energy homeostasis, but the mechanisms remain unclear.  By utilizing small-animal PET/MRI and the novel radioligand [18F]-AQ28A, we found marked levels of PDE10A in interscapular brown adipose tissue (BAT) of mice.  Pharmacol. inactivation of PDE10A with the highly selective inhibitor MP-10 recruited BAT and potentiated thermogenesis in vivo.  In diet-induced obese mice, chronic administration of MP-10 caused wt. loss assocd. with increased energy expenditure, browning of white adipose tissue, and improved insulin sensitivity.  Anal. of human PET data further revealed marked levels of PDE10A in the supraclavicular region where brown/beige adipocytes are clustered in adults.  Finally, the inhibition of PDE10A with MP-10 stimulated thermogenic gene expression in human brown adipocytes and induced browning of human white adipocytes.  Collectively, our findings highlight a novel thermoregulatory role for PDE10A in mouse and human adipocytes and promote PDE10A inhibitors as promising candidates for the treatment of obesity and diabetes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEqSV38fvPb7Vg90H21EOLACvtfcHk0ljPsJSkboABOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xosl2nu7o%253D&md5=f24b4ab2ae0805bcaae4df511f0be275</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.15252%2Femmm.201506085&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.15252%252Femmm.201506085%26sid%3Dliteratum%253Aachs%26aulast%3DHankir%26aufirst%3DM.%2BK.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DGnad%26aufirst%3DT.%26aulast%3DWeiner%26aufirst%3DJ.%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DBronisch%26aufirst%3DF.%26aulast%3DSteinhoff%26aufirst%3DK.%26aulast%3DLuthardt%26aufirst%3DJ.%26aulast%3DKloting%26aufirst%3DN.%26aulast%3DHesse%26aufirst%3DS.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DSabri%26aufirst%3DO.%26aulast%3DHeiker%26aufirst%3DJ.%2BT.%26aulast%3DBluher%26aufirst%3DM.%26aulast%3DPfeifer%26aufirst%3DA.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DFenske%26aufirst%3DW.%2BK.%26atitle%3DA%2520novel%2520thermoregulatory%2520role%2520for%2520PDE10A%2520in%2520mouse%2520and%2520human%2520adipocytes%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2016%26volume%3D8%26spage%3D796%26epage%3D812%26doi%3D10.15252%2Femmm.201506085" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramirez-Alcantara, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Canzoneri, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sigler, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gary, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moyer, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salter, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wierzbicki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keeton, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piazza, G. A.</span></span> <span> </span><span class="NLM_article-title">Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">27403</span>– <span class="NLM_lpage">27415</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.4741</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.18632%2Foncotarget.4741" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26299804" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC287lsVSktQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=27403-27415&author=N.+Liauthor=X.+Chenauthor=B.+Zhuauthor=V.+Ramirez-Alcantaraauthor=J.+C.+Canzoneriauthor=K.+Leeauthor=S.+Siglerauthor=B.+Garyauthor=Y.+Liauthor=W.+Zhangauthor=M.+P.+Moyerauthor=E.+A.+Salterauthor=A.+Wierzbickiauthor=A.+B.+Keetonauthor=G.+A.+Piazza&title=Suppression+of+%CE%B2-catenin%2FTCF+transcriptional+activity+and+colon+tumor+cell+growth+by+dual+inhibition+of+PDE5+and+10&doi=10.18632%2Foncotarget.4741"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of β-catenin/TCF transcriptional activity and colon tumor cell growth by dual inhibition of PDE5 and 10</span></div><div class="casAuthors">Li Nan; Chen Xi; Zhu Bing; Ramirez-Alcantara Veronica; Canzoneri Joshua C; Lee Kevin; Sigler Sara; Gary Bernard; Keeton Adam B; Piazza Gary A; Li Yonghe; Zhang Wei; Moyer Mary P; Salter E Alan; Wierzbicki Andrzej</div><div class="citationInfo"><span class="NLM_cas:title">Oncotarget</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">29</span>),
    <span class="NLM_cas:pages">27403-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Previous studies suggest the anti-inflammatory drug, sulindac inhibits tumorigenesis by a COX independent mechanism involving cGMP PDE inhibition.  Here we report that the cGMP PDE isozymes, PDE5 and 10, are elevated in colon tumor cells compared with normal colonocytes, and that inhibitors and siRNAs can selectively suppress colon tumor cell growth.  Combined treatment with inhibitors or dual knockdown suppresses tumor cell growth to a greater extent than inhibition from either isozyme alone.  A novel sulindac derivative, ADT-094 was designed to lack COX-1/-2 inhibitory activity but have improved potency to inhibit PDE5 and 10.  ADT-094 displayed >500 fold higher potency to inhibit colon tumor cell growth compared with sulindac by activating cGMP/PKG signaling to suppress proliferation and induce apoptosis.  Combined inhibition of PDE5 and 10 by treatment with ADT-094, PDE isozyme-selective inhibitors, or by siRNA knockdown also suppresses β-catenin, TCF transcriptional activity, and the levels of downstream targets, cyclin D1 and survivin.  These results suggest that dual inhibition of PDE5 and 10 represents novel strategy for developing potent and selective anticancer drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSZOcrzvUtxVNenUz0lpNqnfW6udTcc2ebMdEqacc72x7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC287lsVSktQ%253D%253D&md5=b141f2a8df2d86294a60f81bf37d6e6e</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.4741&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.4741%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DN.%26aulast%3DChen%26aufirst%3DX.%26aulast%3DZhu%26aufirst%3DB.%26aulast%3DRamirez-Alcantara%26aufirst%3DV.%26aulast%3DCanzoneri%26aufirst%3DJ.%2BC.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DSigler%26aufirst%3DS.%26aulast%3DGary%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DMoyer%26aufirst%3DM.%2BP.%26aulast%3DSalter%26aufirst%3DE.%2BA.%26aulast%3DWierzbicki%26aufirst%3DA.%26aulast%3DKeeton%26aufirst%3DA.%2BB.%26aulast%3DPiazza%26aufirst%3DG.%2BA.%26atitle%3DSuppression%2520of%2520%25CE%25B2-catenin%252FTCF%2520transcriptional%2520activity%2520and%2520colon%2520tumor%2520cell%2520growth%2520by%2520dual%2520inhibition%2520of%2520PDE5%2520and%252010%26jtitle%3DOncotarget%26date%3D2015%26volume%3D6%26spage%3D27403%26epage%3D27415%26doi%3D10.18632%2Foncotarget.4741" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeMartinis, N.,  3rd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickering, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walling, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogden, A.</span></span> <span> </span><span class="NLM_article-title">A roof-of-concept study evaluating the phosphodiesterase 10A inhibitor PF-02545920 in the adjunctive treatment of suboptimally controlled symptoms of schizophrenia</span>. <i>J. Clin. Psychopharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>39</i></span>,  <span class="NLM_fpage">318</span>– <span class="NLM_lpage">328</span>, <span class="refDoi"> DOI: 10.1097/JCP.0000000000001047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1097%2FJCP.0000000000001047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31205187" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref159/cit159&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXht1Kqtr3K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=39&publication_year=2019&pages=318-328&author=N.+DeMartinisauthor=R.+N.+Lopezauthor=E.+H.+Pickeringauthor=C.+J.+Schmidtauthor=L.+Gertsikauthor=D.+P.+Wallingauthor=A.+Ogden&title=A+roof-of-concept+study+evaluating+the+phosphodiesterase+10A+inhibitor+PF-02545920+in+the+adjunctive+treatment+of+suboptimally+controlled+symptoms+of+schizophrenia&doi=10.1097%2FJCP.0000000000001047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit159R"><div class="casContent"><span class="casTitleNuber">159</span><div class="casTitle"><span class="NLM_cas:atitle">A Proof-of-Concept Study Evaluating the Phosphodiesterase 10A Inhibitor PF-02545920 in the Adjunctive Treatment of Suboptimally Controlled Symptoms of Schizophrenia</span></div><div class="casAuthors">DeMartinis, Nicholas, III; Lopez, Rene N.; Pickering, Eve H.; Schmidt, Christopher J.; Gertsik, Lev; Walling, David P.; Ogden, Adam</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Psychopharmacology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">39</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">318-328</span>CODEN:
                <span class="NLM_cas:coden">JCPYDR</span>;
        ISSN:<span class="NLM_cas:issn">0271-0749</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Effective treatments for managing suboptimal clin. responses to current therapy for schizophrenia remain a crit. unmet need.  Phosphodiesterase 10A (PDE10A) inhibition represents a mechanistically novel approach to the treatment of schizophrenia, with preclin. studies suggesting improvements in partially responsive symptoms could be achieved through adjunctive use of the PDE10A inhibitor PF-02545920.  Therefore, the adjunctive safety, tolerability, pharmacokinetics, and efficacy of multiple repeat doses of PF-02545920 were investigated in a phase 1b study and subsequent phase 2 study.  The phase 1b study randomized 37 adult patients with stable symptomatol. and stable antipsychotic regimens within 3 cohorts.  Study participants received ascending doses of PF-02545920 or placebo for 10 to 18 days.  The phase 2 study randomized 240 outpatients with stable symptomatol. but suboptimal response to current antipsychotic regimens 1:1:1 to PF-02545920 5 mg, PF-02545920 15 mg, or placebo every 12 h for 12 wk.  The primary efficacy end point of the phase 2 study was change in the Pos. and Neg. Syndrome Scale total score from baseline to week 12, with changes in other clin. assessments as secondary end points.  Treatment was well tolerated, and obsd. PF-02545920 exposures were within the range predicted to be adequate for demonstrating efficacy.  However, no significant differences in the prespecified efficacy end points between the 2 PF-02545920 treatment arms and placebo were obsd.  Current data and results of a prior monotherapy study in which PF-02545920 failed to differentiate from placebo refute the hypothesis that PDE10A inhibitors have use as antipsychotic agents for schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQT0Fch8zyO7Vg90H21EOLACvtfcHk0lijyRFBAx4RHg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXht1Kqtr3K&md5=c0fcd49bf1bfb669f3d120285ff9b432</span></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=10.1097%2FJCP.0000000000001047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FJCP.0000000000001047%26sid%3Dliteratum%253Aachs%26aulast%3DDeMartinis%26aufirst%3DN.%26aulast%3DLopez%26aufirst%3DR.%2BN.%26aulast%3DPickering%26aufirst%3DE.%2BH.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DGertsik%26aufirst%3DL.%26aulast%3DWalling%26aufirst%3DD.%2BP.%26aulast%3DOgden%26aufirst%3DA.%26atitle%3DA%2520roof-of-concept%2520study%2520evaluating%2520the%2520phosphodiesterase%252010A%2520inhibitor%2520PF-02545920%2520in%2520the%2520adjunctive%2520treatment%2520of%2520suboptimally%2520controlled%2520symptoms%2520of%2520schizophrenia%26jtitle%3DJ.%2520Clin.%2520Psychopharmacol.%26date%3D2019%26volume%3D39%26spage%3D318%26epage%3D328%26doi%3D10.1097%2FJCP.0000000000001047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affinito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roepcke, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertsik, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, T. A.</span></span> <span> </span><span class="NLM_article-title">A randomized multiple dose pharmacokinetic study of a novel PDE10A inhibitor TAK-063 in subjects with stable schizophrenia and Japanese subjects and modeling of exposure relationships to adverse events</span>. <i>Drugs R&amp;D</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">631</span>– <span class="NLM_lpage">643</span>, <span class="refDoi"> DOI: 10.1007/s40268-017-0214-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs40268-017-0214-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29103081" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2017&pages=631-643&author=P.+Goldsmithauthor=J.+Affinitoauthor=M.+McCueauthor=M.+Tsaiauthor=S.+Roepckeauthor=J.+Xieauthor=L.+Gertsikauthor=T.+A.+Macek&title=A+randomized+multiple+dose+pharmacokinetic+study+of+a+novel+PDE10A+inhibitor+TAK-063+in+subjects+with+stable+schizophrenia+and+Japanese+subjects+and+modeling+of+exposure+relationships+to+adverse+events&doi=10.1007%2Fs40268-017-0214-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1007%2Fs40268-017-0214-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40268-017-0214-8%26sid%3Dliteratum%253Aachs%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DAffinito%26aufirst%3DJ.%26aulast%3DMcCue%26aufirst%3DM.%26aulast%3DTsai%26aufirst%3DM.%26aulast%3DRoepcke%26aufirst%3DS.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DGertsik%26aufirst%3DL.%26aulast%3DMacek%26aufirst%3DT.%2BA.%26atitle%3DA%2520randomized%2520multiple%2520dose%2520pharmacokinetic%2520study%2520of%2520a%2520novel%2520PDE10A%2520inhibitor%2520TAK-063%2520in%2520subjects%2520with%2520stable%2520schizophrenia%2520and%2520Japanese%2520subjects%2520and%2520modeling%2520of%2520exposure%2520relationships%2520to%2520adverse%2520events%26jtitle%3DDrugs%2520R%2526amp%253BD%26date%3D2017%26volume%3D17%26spage%3D631%26epage%3D643%26doi%3D10.1007%2Fs40268-017-0214-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Macek, T. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCue, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Affinito, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mahableshwarkar, A. R.</span></span> <span> </span><span class="NLM_article-title">A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia</span>. <i>Schizophr. Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>204</i></span>,  <span class="NLM_fpage">289</span>– <span class="NLM_lpage">294</span>, <span class="refDoi"> DOI: 10.1016/j.schres.2018.08.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.schres.2018.08.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30190165" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BB3c3mtlWmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=204&publication_year=2019&pages=289-294&author=T.+A.+Macekauthor=M.+McCueauthor=X.+Dongauthor=E.+Hansonauthor=P.+Goldsmithauthor=J.+Affinitoauthor=A.+R.+Mahableshwarkar&title=A+phase+2%2C+randomized%2C+placebo-controlled+study+of+the+efficacy+and+safety+of+TAK-063+in+subjects+with+an+acute+exacerbation+of+schizophrenia&doi=10.1016%2Fj.schres.2018.08.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">A phase 2, randomized, placebo-controlled study of the efficacy and safety of TAK-063 in subjects with an acute exacerbation of schizophrenia</span></div><div class="casAuthors">Macek Thomas A; Dong Xinxin; Hanson Elizabeth; Affinito John; Mahableshwarkar Atul R; McCue Maggie; Goldsmith Paul</div><div class="citationInfo"><span class="NLM_cas:title">Schizophrenia research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">204</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">289-294</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">INTRODUCTION:  TAK-063 is a potent, selective inhibitor of phosphodiesterase 10A, an enzyme selectively expressed in medium spiny neurons of the striatum.  This randomized, parallel-group study evaluated the efficacy and safety of 20-mg daily TAK-063 versus placebo in subjects with acutely exacerbated symptoms of schizophrenia (NCT02477020).  METHODS:  Adults aged 18 to 65 with diagnosed schizophrenia and psychotic symptoms that exacerbated within 60 days before screening were included.  Subjects who discontinued psychotropic medications before screening were randomized 1:1 to 6 weeks of placebo (n = 81) or 20-mg TAK-063 (n = 83).  Weekly efficacy visits were conducted during the treatment period, and dose de-escalation was allowed (blinded) to 10-mg TAK-063 for intolerability.  RESULTS:  The primary endpoint, change from baseline in the Positive and Negative Syndrome Scale total score at week 6, was not achieved (least-squares mean difference vs placebo [standard error] = -5.46 [3.44]; p = 0.115).  Secondary endpoints were generally supportive of antipsychotic efficacy.  Consistent with previous phase 1 studies, TAK-063 was safe and well tolerated, and most adverse events were mild or moderate in severity and did not result in discontinuation.  No deaths occurred, and the incidence of akathisia and dystonia, categories of extrapyramidal syndromes, was more frequent in the TAK-063 group than placebo.  CONCLUSIONS:  Although the study did not meet the primary endpoint (effect size = 0.308), the effects of TAK-063 on the primary and secondary endpoints may be suggestive of antipsychotic activity.  Interpretation of these results is confounded by a relatively high placebo effect and a lack of dose-ranging or active reference.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTvmehFgKXv78yail4HZd-ifW6udTcc2eZroVWw8S8Pprntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c3mtlWmtw%253D%253D&md5=5910ce3affa7412cc1b7b281fbe1bb61</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1016%2Fj.schres.2018.08.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.schres.2018.08.028%26sid%3Dliteratum%253Aachs%26aulast%3DMacek%26aufirst%3DT.%2BA.%26aulast%3DMcCue%26aufirst%3DM.%26aulast%3DDong%26aufirst%3DX.%26aulast%3DHanson%26aufirst%3DE.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DAffinito%26aufirst%3DJ.%26aulast%3DMahableshwarkar%26aufirst%3DA.%2BR.%26atitle%3DA%2520phase%25202%252C%2520randomized%252C%2520placebo-controlled%2520study%2520of%2520the%2520efficacy%2520and%2520safety%2520of%2520TAK-063%2520in%2520subjects%2520with%2520an%2520acute%2520exacerbation%2520of%2520schizophrenia%26jtitle%3DSchizophr.%2520Res.%26date%3D2019%26volume%3D204%26spage%3D289%26epage%3D294%26doi%3D10.1016%2Fj.schres.2018.08.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padakanti, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoghi, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mach, R. H.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and in vivo evaluation of [<sup>11</sup>C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1666</span>– <span class="NLM_lpage">1673</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2011.01.032</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmc.2011.01.032" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21315609" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXisFylt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2011&pages=1666-1673&author=Z.+Tuauthor=J.+Fanauthor=S.+Liauthor=L.+A.+Jonesauthor=J.+Cuiauthor=P.+K.+Padakantiauthor=J.+Xuauthor=D.+Zengauthor=K.+I.+Shoghiauthor=J.+S.+Perlmutterauthor=R.+H.+Mach&title=Radiosynthesis+and+in+vivo+evaluation+of+%5B11C%5DMP-10+as+a+PET+probe+for+imaging+PDE10A+in+rodent+and+non-human+primate+brain&doi=10.1016%2Fj.bmc.2011.01.032"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit162R"><div class="casContent"><span class="casTitleNuber">162</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and in vivo evaluation of [11C]MP-10 as a PET probe for imaging PDE10A in rodent and non-human primate brain</span></div><div class="casAuthors">Tu, Zhude; Fan, Jinda; Li, Shihong; Jones, Lynne A.; Cui, Jinquan; Padakanti, Prashanth K.; Xu, Jinbin; Zeng, Dexing; Shoghi, Kooresh I.; Perlmutter, Joel S.; Mach, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1666-1673</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">2-((4-(1-[11C]Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-quinoline (MP-10), a specific PDE10A inhibitor (IC50 = 0.18 nM with 100-fold selectivity over other PDEs), was radiosynthesized by alkylation of the desmethyl precursor with [11C]CH3I, ∼45% yield, >92% radiochem. purity, >370 GBq/μmol specific activity at end of bombardment (EOB).  Evaluation in Sprague-Dawley rats revealed that [11C]MP-10 had highest brain accumulation in the PDE10A enriched-striatum, the 30 min striatum: cerebellum ratio reached 6.55.  MicroPET studies of [11C]MP-10 in monkeys displayed selective uptake in striatum.  However, a radiolabeled metabolite capable of penetrating the blood-brain-barrier may limit the clin. utility of [11C]MP-10 as a PDE10A PET tracer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreVaHkkAyq4rVg90H21EOLACvtfcHk0ljBs8CygN_7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXisFylt7w%253D&md5=540b2a12c8c00307644df97a3d193d2a</span></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2011.01.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2011.01.032%26sid%3Dliteratum%253Aachs%26aulast%3DTu%26aufirst%3DZ.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DCui%26aufirst%3DJ.%26aulast%3DPadakanti%26aufirst%3DP.%2BK.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DZeng%26aufirst%3DD.%26aulast%3DShoghi%26aufirst%3DK.%2BI.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DMach%26aufirst%3DR.%2BH.%26atitle%3DRadiosynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255DMP-10%2520as%2520a%2520PET%2520probe%2520for%2520imaging%2520PDE10A%2520in%2520rodent%2520and%2520non-human%2520primate%2520brain%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2011%26volume%3D19%26spage%3D1666%26epage%3D1673%26doi%3D10.1016%2Fj.bmc.2011.01.032" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinzimmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiji, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and in vivo evaluation of [<sup>11</sup>C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>38</i></span>,  <span class="NLM_fpage">875</span>– <span class="NLM_lpage">884</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2011.02.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2011.02.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=21843784" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtVajsLrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2011&pages=875-884&author=C.+Plissonauthor=C.+Salinasauthor=D.+Weinzimmerauthor=D.+Labareeauthor=S.+F.+Linauthor=Y.+S.+Dingauthor=S.+Jakobsenauthor=P.+W.+Smithauthor=K.+Eijiauthor=R.+E.+Carsonauthor=R.+N.+Gunnauthor=E.+A.+Rabiner&title=Radiosynthesis+and+in+vivo+evaluation+of+%5B11C%5DMP-10+as+a+positron+emission+tomography+radioligand+for+phosphodiesterase+10A&doi=10.1016%2Fj.nucmedbio.2011.02.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit163R"><div class="casContent"><span class="casTitleNuber">163</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and in vivo evaluation of [11C]MP-10 as a positron emission tomography radioligand for phosphodiesterase 10A</span></div><div class="casAuthors">Plisson, Christophe; Salinas, Cristian; Weinzimmer, David; Labaree, David; Lin, Shu-Fei; Ding, Yu-Shin; Jakobsen, Steen; Smith, Paul W.; Eiji, Kawanishi; Carson, Richard E.; Gunn, Roger N.; Rabiner, Eugenii A.</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">38</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">875-884</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Introduction: The aim of this study was to evaluate a newly reported positron emission tomog. (PET) radioligand [11C]MP-10, a potent and selective inhibitor of the central phosphodiesterase 10A enzyme (PDE10A) in vivo, using PET.  Methods: A procedure was developed for labeling MP-10 with carbon-11. [11C]MP-10 was evaluated in vivo both in the pig and baboon brain.  Results: Alkylation of the corresponding desmethyl compd. with [11C]methyl iodide produced [11C]MP-10 with good radiochem. yield and specific activity.  PET studies in the pig showed that [11C]MP-10 rapidly entered the brain reaching peak tissue concn. at 1-2 min postadministration, followed by washout from the tissue.  Administration of a selective PDE10A inhibitor reduced the binding in all brain regions to the levels of the cerebellum, demonstrating the saturability and selectivity of [11C]MP-10 binding.  In the nonhuman primate, the brain tissue kinetics of [11C]MP-10 were slower, reaching peak tissue concns. at 30-60 min postadministration.  In both species, the obsd. rank order of regional brain signal was striatum>diencephalon>cortical regions=cerebellum, consistent with the known distribution and concn. of PDE10A. [11C]MP-10 brain kinetics were well described by a two-tissue compartment model, and ests. of total vol. of distribution (VT) were obtained.  Blocking studies with unlabeled MP-10 revealed the suitability of the cerebellum as a ref. tissue and enabled the estn. of regional binding potential (BP ND) as the outcome measure of specific binding.  Quantification of [11C]MP-10 binding using the simplified ref. tissue model with cerebellar input function produced BP ND ests. consistent with those obtained by the two-tissue compartment model.  Conclusion: We demonstrated that [11C]MP-10 possesses good characteristics for the in vivo quantification of the PDE10A in the brain by PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXXGU_U-Xg7rVg90H21EOLACvtfcHk0ljBs8CygN_7VA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtVajsLrO&md5=9dbea840abf1f40243929038b6cf5c8c</span></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2011.02.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2011.02.005%26sid%3Dliteratum%253Aachs%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DWeinzimmer%26aufirst%3DD.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DDing%26aufirst%3DY.%2BS.%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DSmith%26aufirst%3DP.%2BW.%26aulast%3DEiji%26aufirst%3DK.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26atitle%3DRadiosynthesis%2520and%2520in%2520vivo%2520evaluation%2520of%2520%255B11C%255DMP-10%2520as%2520a%2520positron%2520emission%2520tomography%2520radioligand%2520for%2520phosphodiesterase%252010A%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2011%26volume%3D38%26spage%3D875%26epage%3D884%26doi%3D10.1016%2Fj.nucmedbio.2011.02.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashworth, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kealey, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauridsen, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stensbol, T. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span> <span> </span><span class="NLM_article-title">Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [<sup>11</sup>C] MP-10 PET rodent imaging study with ex vivo confirmation</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>4</i></span>, <span class="NLM_elocation-id">e376</span> <span class="refDoi"> DOI: 10.1038/tp.2014.17</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Ftp.2014.17" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24690597" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXls1Khtb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2014&author=S.+Natesanauthor=S.+Ashworthauthor=J.+Nielsenauthor=S.+P.+Tangauthor=C.+Salinasauthor=S.+Kealeyauthor=J.+B.+Lauridsenauthor=T.+B.+Stensbolauthor=R.+N.+Gunnauthor=E.+A.+Rabinerauthor=S.+Kapur&title=Effect+of+chronic+antipsychotic+treatment+on+striatal+phosphodiesterase+10A+levels%3A+a+%5B11C%5D+MP-10+PET+rodent+imaging+study+with+ex+vivo+confirmation&doi=10.1038%2Ftp.2014.17"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit164R"><div class="casContent"><span class="casTitleNuber">164</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of chronic antipsychotic treatment on striatal phosphodiesterase 10A levels: a [11C]MP-10 PET rodent imaging study with ex vivo confirmation</span></div><div class="casAuthors">Natesan, S.; Ashworth, S.; Nielsen, J.; Tang, S.-P.; Salinas, C.; Kealey, S.; Lauridsen, J. B.; Stensboel, T. B.; Gunn, R. N.; Rabiner, E. A.; Kapur, S.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">e376</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A no. of phosphodiesterase 10A (PDE10) inhibitors are about to undergo clin. evaluation for their efficacy in treating schizophrenia.  As phosphodiesterases are in the same signalling pathway as dopamine D2 receptors, it is possible that prior antipsychotic treatment could influence these enzyme systems in patients.  Chronic, in contrast to acute, antipsychotic treatment has been reported to increase brain PDE10A levels in rodents.  The aim of this study was to confirm these findings in a manner that can be translated to human imaging studies to understand its consequences.  Positron emission tomog. (PET) scanning was used to evaluate PDE10A enzyme availability, after chronic haloperidol administration, using a specific PDE10A ligand ([11C]MP-10).  The binding of [11C]MP-10 in the striatum and the cerebellum was measured in rodents and a simplified ref. tissue model (SRTM) with cerebellum as the ref. region was used to det. the binding potential (BPND).  In rats treated chronically with haloperidol (2 mg kg-1 per day), there was no significant difference in PDE10A levels compared with the vehicle-treated group (BPND±s.d.: 3.57±0.64 vs. 2.86±0.71).  Following PET scans, ex vivo anal. of striatal brain tissue for PDE10A mRNA (Pde10a) and PDE10A enzyme activity showed no significant difference.  Similarly, the PDE10A protein content detd. by western blot anal. was similar between the two groups, contrary to an earlier finding.  The results of the study indicate that prior exposure to antipsychotic medication in rodents does not alter PDE10A levels.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGps1okMJG8N1LVg90H21EOLACvtfcHk0lgCW9bqzgR9Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXls1Khtb4%253D&md5=6bd49e8ed4c45b06b2a441ec9622d189</span></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1038%2Ftp.2014.17&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2014.17%26sid%3Dliteratum%253Aachs%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DAshworth%26aufirst%3DS.%26aulast%3DNielsen%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DS.%2BP.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DKealey%26aufirst%3DS.%26aulast%3DLauridsen%26aufirst%3DJ.%2BB.%26aulast%3DStensbol%26aufirst%3DT.%2BB.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DEffect%2520of%2520chronic%2520antipsychotic%2520treatment%2520on%2520striatal%2520phosphodiesterase%252010A%2520levels%253A%2520a%2520%255B11C%255D%2520MP-10%2520PET%2520rodent%2520imaging%2520study%2520with%2520ex%2520vivo%2520confirmation%26jtitle%3DTransl.%2520Psychiatry%26date%3D2014%26volume%3D4%26doi%3D10.1038%2Ftp.2014.17" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, M. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holden, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gallezot, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapinos, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Najafzadeh, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, Y.</span></span> <span> </span><span class="NLM_article-title">Further evaluation of [<sup>11</sup>C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">86</span>– <span class="NLM_lpage">95</span>, <span class="refDoi"> DOI: 10.1002/syn.21792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25450608" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVKmurfN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=86-95&author=S.+F.+Linauthor=D.+Labareeauthor=M.+K.+Chenauthor=D.+Holdenauthor=J.+D.+Gallezotauthor=M.+Kapinosauthor=J.+K.+Tengauthor=S.+Najafzadehauthor=C.+Plissonauthor=E.+A.+Rabinerauthor=R.+N.+Gunnauthor=R.+E.+Carsonauthor=Y.+Huang&title=Further+evaluation+of+%5B11C%5DMP-10+as+a+radiotracer+for+phosphodiesterase+10A%3A+PET+imaging+study+in+rhesus+monkeys+and+brain+tissue+metabolite+analysis&doi=10.1002%2Fsyn.21792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Further evaluation of [11C]MP-10 as a radiotracer for phosphodiesterase 10A: PET imaging study in rhesus monkeys and brain tissue metabolite analysis</span></div><div class="casAuthors">Lin, Shu-Fei; Labaree, David; Chen, Ming-Kai; Holden, Daniel; Gallezot, Jean-Dominique; Kapinos, Michael; Teng, Jo-Ku; Najafzadeh, Soheila; Plisson, Christophe; Rabiner, Eugenii A.; Gunn, Roger N.; Carson, Richard E.; Huang, Yiyun</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">86-95</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">[11C]MP-10 is a potent and specific PET tracer previously shown to be suitable for imaging the phosphodiesterase 10A (PDE10A) in baboons with reversible kinetics and high specific binding.  However, another report indicated that [11C]MP-10 displayed seemingly irreversible kinetics in rhesus monkeys, potentially due to the presence of a radiolabeled metabolite capable of penetrating the blood-brain-barrier (BBB) into the brain.  This study was designed to address the discrepancies between the species by re-evaluating [11C]MP-10 in vivo in rhesus monkey with baseline scans to assess tissue uptake kinetics and self-blocking scans with unlabeled MP-10 to det. binding specificity.  Ex vivo studies with one rhesus monkey and 4 Sprague-Dawley rats were also performed to investigate the presence of radiolabeled metabolites in the brain.  Our results indicated that [11C]MP-10 displayed reversible uptake kinetics in rhesus monkeys, albeit slower than in baboons.  Administration of unlabeled MP-10 reduced the binding of [11C]MP-10 in a dose-dependent manner in all brain regions including the cerebellum.  Consequently, the cerebellum appeared not to be a suitable ref. tissue in rhesus monkeys.  Regional vol. of distribution (VT) was mostly reliably derived with the multilinear anal. (MA1) method.  In ex vivo studies in the monkey and rats only negligible amt. of radiometabolites was seen in the brain of either species.  In summary, results from the present study strongly support the suitability of [11C]MP-10 as a radiotracer for PET imaging and quantification of PDE10A in nonhuman primates.  Synapse, 2014. © 2014 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRqsGsO2Aev7Vg90H21EOLACvtfcHk0lgCW9bqzgR9Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVKmurfN&md5=41cb1ab19cc0c097c65e84d7828a6f07</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21792%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DChen%26aufirst%3DM.%2BK.%26aulast%3DHolden%26aufirst%3DD.%26aulast%3DGallezot%26aufirst%3DJ.%2BD.%26aulast%3DKapinos%26aufirst%3DM.%26aulast%3DTeng%26aufirst%3DJ.%2BK.%26aulast%3DNajafzadeh%26aufirst%3DS.%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DHuang%26aufirst%3DY.%26atitle%3DFurther%2520evaluation%2520of%2520%255B11C%255DMP-10%2520as%2520a%2520radiotracer%2520for%2520phosphodiesterase%252010A%253A%2520PET%2520imaging%2520study%2520in%2520rhesus%2520monkeys%2520and%2520brain%2520tissue%2520metabolite%2520analysis%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D86%26epage%3D95%26doi%3D10.1002%2Fsyn.21792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rothfuss, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span> <span> </span><span class="NLM_article-title">Synthesis and <i>in vitro</i> biological evaluation of pyrazole group-containing analogues for PDE10A</span>. <i>MedChemComm</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">443</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1039/c2md20239e</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1039%2Fc2md20239e" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23585921" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVChsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2013&pages=443-449&author=J.+Liauthor=H.+Jinauthor=H.+Zhouauthor=J.+Rothfussauthor=Z.+Tu&title=Synthesis+and+in+vitro+biological+evaluation+of+pyrazole+group-containing+analogues+for+PDE10A&doi=10.1039%2Fc2md20239e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and in vitro biological evaluation of pyrazole group-containing analogues for PDE10A</span></div><div class="casAuthors">Li, Junfeng; Jin, Hongjun; Zhou, Haiying; Rothfuss, Justin; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">MedChemComm</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">443-449</span>CODEN:
                <span class="NLM_cas:coden">MCCEAY</span>;
        ISSN:<span class="NLM_cas:issn">2040-2503</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">Twenty eight new analogs were synthesized by optimizing the structure of MP-10 and their in vitro binding affinities towards PDE10 Å, PDE3A/B, and PDE4A/B were detd.  Among these new analogs are very potent towards PDE10 Å and have IC50 values of 0.40 ± 0.02, 0.28 ± 0.06, 1.82 ± 0.25, 0.24 ± 0.05, 0.36 ± 0.03 and 1.78 ± 0.03 nM, resp.; these six compds. displayed high selectivity for PDE10 Å vs. PDE3A/3B/4A/4B.  The promising compds. will be further validated in vivo to identify PDE10 Å imaging tracers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo4Q3Egx64AEbVg90H21EOLACvtfcHk0lgCW9bqzgR9Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVChsbk%253D&md5=f364b5c0215d910d60ac0d18a4dc4220</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1039%2Fc2md20239e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc2md20239e%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DZhou%26aufirst%3DH.%26aulast%3DRothfuss%26aufirst%3DJ.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DSynthesis%2520and%2520in%2520vitro%2520biological%2520evaluation%2520of%2520pyrazole%2520group-containing%2520analogues%2520for%2520PDE10A%26jtitle%3DMedChemComm%26date%3D2013%26volume%3D4%26spage%3D443%26epage%3D449%26doi%3D10.1039%2Fc2md20239e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padakanti, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span> <span> </span><span class="NLM_article-title">Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">2648</span>– <span class="NLM_lpage">2654</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2014.03.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmc.2014.03.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24721831" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlslSqu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2014&pages=2648-2654&author=J.+Fanauthor=X.+Zhangauthor=J.+Liauthor=H.+Jinauthor=P.+K.+Padakantiauthor=L.+A.+Jonesauthor=H.+P.+Floresauthor=Y.+Suauthor=J.+S.+Perlmutterauthor=Z.+Tu&title=Radiosyntheses+and+in+vivo+evaluation+of+carbon-11+PET+tracers+for+PDE10A+in+the+brain+of+rodent+and+nonhuman+primate&doi=10.1016%2Fj.bmc.2014.03.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit167R"><div class="casContent"><span class="casTitleNuber">167</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosyntheses and in vivo evaluation of carbon-11 PET tracers for PDE10A in the brain of rodent and nonhuman primate</span></div><div class="casAuthors">Fan, Jinda; Zhang, Xiang; Li, Junfeng; Jin, Hongjun; Padakanti, Prashanth K.; Jones, Lynne A.; Flores, Hubert P.; Su, Yi; Perlmutter, Joel S.; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">2648-2654</span>CODEN:
                <span class="NLM_cas:coden">BMECEP</span>;
        ISSN:<span class="NLM_cas:issn">0968-0896</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The radiosyntheses and in vivo evaluation of four carbon-11 labeled quinoline group-contg. radioligands are reported here.  Radiolabeling of [11C]1-4 was achieved by alkylation of their corresponding desmethyl precursors with [11C]CH3I.  Preliminary biodistribution evaluation in Sprague-Dawley rats demonstrated that [11C]1 and [11C]2 had high striatal accumulation (at peak time) for [11C]1 and [11C]2 were 6.0-fold and 4.5-fold at 60 min, resp.  Following MP-10 pretreatment, striatal uptake in rats of [11C]1 and [11C]2 was reduced, suggesting that the tracers bind specifically to PDE10A.  MicroPET studies of [11C]1 and [11C]2 in nonhuman primates (NHP) also showed good tracer retention in the striatum with rapid clearance from non-target brain regions.  Striatal uptake (SUV) of [11C]1 reached 1.8 at 30 min with a 3.5-fold striatum:cerebellum ratio.  In addn., HPLC anal. of solvent exts. from NHP plasma samples suggested that [11C]1 had a very favorable metabolic stability.  Our preclin. investigations suggest that [11C]1 is a promising candidate for quantification of PDE10A in vivo using PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrS2h3C-yQwb7Vg90H21EOLACvtfcHk0lgjxxHBzHYqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlslSqu7s%253D&md5=4c6ee08f881da1c4ea349d3952acd48b</span></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2014.03.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2014.03.028%26sid%3Dliteratum%253Aachs%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DPadakanti%26aufirst%3DP.%2BK.%26aulast%3DJones%26aufirst%3DL.%2BA.%26aulast%3DFlores%26aufirst%3DH.%2BP.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DRadiosyntheses%2520and%2520in%2520vivo%2520evaluation%2520of%2520carbon-11%2520PET%2520tracers%2520for%2520PDE10A%2520in%2520the%2520brain%2520of%2520rodent%2520and%2520nonhuman%2520primate%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2014%26volume%3D22%26spage%3D2648%26epage%3D2654%26doi%3D10.1016%2Fj.bmc.2014.03.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yue, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Perlmutter, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tu, Z.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2015.07.049</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2015.07.049" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26216275" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXht1yhtbvJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2015&pages=253-262&author=H.+Liuauthor=H.+Jinauthor=X.+Yueauthor=X.+Zhangauthor=H.+Yangauthor=J.+Liauthor=H.+Floresauthor=Y.+Suauthor=J.+S.+Perlmutterauthor=Z.+Tu&title=Preclinical+evaluation+of+a+promising+C-11+labeled+PET+tracer+for+imaging+phosphodiesterase+10A+in+the+brain+of+living+subject&doi=10.1016%2Fj.neuroimage.2015.07.049"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of a promising C-11 labeled PET tracer for imaging phosphodiesterase 10A in the brain of living subject</span></div><div class="casAuthors">Liu, Hui; Jin, Hongjun; Yue, Xuyi; Zhang, Xiang; Yang, Hao; Li, Junfeng; Flores, Hubert; Su, Yi; Perlmutter, Joel S.; Tu, Zhude</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">253-262</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) plays a key role in the regulation of brain striatal signaling.  A PET tracer for PDE10A may serve as a tool to evaluate PDE10A expression in vivo in central nervous system disorders with striatal pathol.  Here, we further characterized the binding properties of a previously reported radioligand we developed for PDE10A, [11C]TZ1964B, in rodents and nonhuman primates (NHPs).  The tritiated counterpart [3H]TZ1964B was used for in vitro binding characterizations in rat striatum homogenates and in vitro autoradiog. studies in rat brain slices.  The carbon-11 labeled [11C]TZ1964B was utilized in the ex vivo autoradiog. studies for the brain of rats and microPET imaging studies for the brain of NHPs.  MicroPET scans of [11C]TZ1964B in NHPs were conducted at baseline, as well as with using a selective PDE10A inhibitor MP-10 for either pretreatment or displacement.  The in vivo regional target occupancy (Occ) was obtained by pretreating with different doses of MP-10 (0.05-2.00 mg/kg).  Both in vitro binding assays and in vitro autoradiog. studies revealed a nanomolar binding affinity of [3H]TZ1964B to the rat striatum.  The striatal binding of [3H]TZ1964B and [11C]TZ1964B was either displaced or blocked by MP-10 in rats and NHPs.  Autoradiog. and microPET imaging confirmed that the specific binding of the radioligand was found in the striatum but not in the cerebellum.  Blocking studies also confirmed the suitability of the cerebellum as an appropriate ref. region.  The binding potentials (BPND) of [11C]TZ1964B in the NHP striatum that were calcd. using either the Logan ref. model (LoganREF, 3.96 ± 0.17) or the simplified ref. tissue model (SRTM, 4.64 ± 0.47), with the cerebellum as the ref. region, was high and had good reproducibility.  The occupancy studies indicated a MP-10 dose of 0.31 ± 0.09 mg/kg (LoganREF)/0.45 ± 0.17 mg/kg (SRTM) occupies 50% striatal PDE10A binding sites.  Studies in rats and NHPs demonstrated radiolabeled TZ1964B has a high binding affinity and good specificity for PDE10A, as well as favorable in vivo pharmacokinetic properties and binding profiles.  Our data suggests that [11C]TZ1964B is a promising radioligand for in vivo imaging PDE10A in the brain of living subject.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoN3uo0CfJYU7Vg90H21EOLACvtfcHk0lgjxxHBzHYqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXht1yhtbvJ&md5=09bcfb0fa42e4deaadc22344fdbf8061</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2015.07.049&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2015.07.049%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DJin%26aufirst%3DH.%26aulast%3DYue%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DFlores%26aufirst%3DH.%26aulast%3DSu%26aufirst%3DY.%26aulast%3DPerlmutter%26aufirst%3DJ.%2BS.%26aulast%3DTu%26aufirst%3DZ.%26atitle%3DPreclinical%2520evaluation%2520of%2520a%2520promising%2520C-11%2520labeled%2520PET%2520tracer%2520for%2520imaging%2520phosphodiesterase%252010A%2520in%2520the%2520brain%2520of%2520living%2520subject%26jtitle%3DNeuroImage%26date%3D2015%26volume%3D121%26spage%3D253%26epage%3D262%26doi%3D10.1016%2Fj.neuroimage.2015.07.049" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chitneni, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dedeurwaerdere, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moechars, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of <sup>18</sup>F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">1584</span>– <span class="NLM_lpage">1591</span>, <span class="refDoi"> DOI: 10.2967/jnumed.110.077040</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.110.077040" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=20847170" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrnL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2010&pages=1584-1591&author=S.+Celenauthor=M.+Kooleauthor=M.+De+Angelisauthor=I.+Sannenauthor=S.+K.+Chitneniauthor=J.+Alcazarauthor=S.+Dedeurwaerdereauthor=D.+Moecharsauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andresauthor=G.+Bormans&title=Preclinical+evaluation+of+18F-JNJ41510417+as+a+radioligand+for+PET+imaging+of+phosphodiesterase-10A+in+the+brain&doi=10.2967%2Fjnumed.110.077040"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET Imaging of phosphodiesterase-10A in the brain</span></div><div class="casAuthors">Celen, Sofie; Koole, Michel; De Angelis, Meri; Sannen, Ivan; Chitneni, Satish K.; Alcazar, Jesus; Dedeurwaerdere, Stefanie; Moechars, Dieder; Schmidt, Mark; Verbruggen, Alfons; Langlois, Xavier; Van Laere, Koen; Andres, Jose Ignacio; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1584-1591</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine</span>)
        </div><div class="casAbstract">Phosphodiesterases are enzymes that inactivate the intracellular second messengers 3',5'-cyclic adenosine-monophosphate and/or cyclic guanosine-monophosphate.  Of all 11 known phosphodiesterase families, phosphodiesterase-10A (PDE10A) has the most restricted distribution, with high expression in the striatum.  PDE10A inhibitors are pursued as drugs for treatment of neuropsychiatric disorders.  We have synthesized and evaluated 18F-JNJ41510417 as a selective and high-affinity radioligand for in vivo brain imaging of PDE10A using PET.  Methods: The biodistribution of 18F-JNJ41510417 was evaluated in rats.  Rat plasma and perfused brain homogenates were analyzed by high-performance liq. chromatog. to quantify radiometabolites.  Dynamic small-animal PET was performed in rats and in wild-type and PDE10A knock-out mice and compared with ex vivo autoradiog.  Blocking and displacement expts. were performed using the nonradioactive analog and other selective PDE10A inhibitors.  Results: Tissue distribution studies showed predominant hepatobiliary excretion, sufficient brain uptake (0.56 ± 0.00 percentage injected dose at 2 min after tracer injection), and continuous accumulation of the tracer in the striatum over time; rapid washout of nonspecific binding from other brain regions was obsd.  Polar radiometabolites were detected in plasma and brain tissue.  Dynamic small-animal PET showed continuous tracer accumulation in the striatum, with rapid decline in the cortex and cerebellum.  Pretreatment and chase expts. with PDE10A inhibitors showed that the tracer binding to PDE10A was specific and reversible.  Imaging in PDE10A knock-out and wild-type mice further confirmed that binding in the striatum was specific for PDE10A.  Conclusion: Expts. in rats and PDE10A knock-out mice indicate that 18F-JNJ41510417 binds specifically and reversibly to PDE10A in the striatum, suggesting that this new fluorinated quinoline deriv. is a promising candidate for in vivo imaging of PDE10A using PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYwofQ-1zM9rVg90H21EOLACvtfcHk0lgjxxHBzHYqiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtlKgtrnL&md5=4d40c29032952f223e1fc9df7e5f6b42</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.110.077040&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.110.077040%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DChitneni%26aufirst%3DS.%2BK.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DDedeurwaerdere%26aufirst%3DS.%26aulast%3DMoechars%26aufirst%3DD.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%252018F-JNJ41510417%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase-10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2010%26volume%3D51%26spage%3D1584%26epage%3D1591%26doi%3D10.2967%2Fjnumed.110.077040" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudyana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span> <span> </span><span class="NLM_article-title">Human biodistribution and dosimetry of <sup>18</sup>F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">254</span>– <span class="NLM_lpage">261</span>, <span class="refDoi"> DOI: 10.1007/s00259-012-2270-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-012-2270-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23160998" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC3s7kt1OgsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2013&pages=254-261&author=K.+Van+Laereauthor=R.+U.+Ahmadauthor=H.+Hudyanaauthor=S.+Celenauthor=K.+Duboisauthor=M.+E.+Schmidtauthor=G.+Bormansauthor=M.+Koole&title=Human+biodistribution+and+dosimetry+of+18F-JNJ42259152%2C+a+radioligand+for+phosphodiesterase+10A+imaging&doi=10.1007%2Fs00259-012-2270-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Human biodistribution and dosimetry of 18F-JNJ42259152, a radioligand for phosphodiesterase 10A imaging</span></div><div class="casAuthors">Van Laere Koen; Ahmad Rawaha U; Hudyana Hendra; Celen Sofie; Dubois Kristof; Schmidt Mark E; Bormans Guy; Koole Michel</div><div class="citationInfo"><span class="NLM_cas:title">European journal of nuclear medicine and molecular imaging</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">254-61</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">PURPOSE:  Phosphodiesterase 10A (PDE10A) is a cAMP/cGMP-hydrolysing enzyme with a central role in striatal signalling and implicated in neuropsychiatric disorders such as Huntington's disease, Parkinson's disease, schizophrenia and addiction.  We have developed a novel PDE10A PET ligand, (18)F-JNJ42259152, and describe here its human dynamic biodistribution, safety and dosimetry.  METHODS:  Six male subjects (age range 23-67 years) underwent ten dynamic whole-body PET/CT scans over 6 h after bolus injection of 175.5 ± 9.4 MBq (18)F-JNJ42259152.  Source organs were delineated on PET/CT and individual organ doses and effective dose were determined using the OLINDA software.  RESULTS:  F-JNJ42259152 was readily taken up by the brain and showed exclusive retention in the brain, especially in the striatum with good washout starting after 20 min.  The tracer was cleared through both the hepatobiliary and the urinary routes.  No defluorination was observed.  Organ absorbed doses were largest for the gallbladder (239 μSv/MBq) and upper large intestine (138 μSv/MBq).  The mean effective dose was 24.9 ± 4.1 μSv/MBq.  No adverse events were encountered.  CONCLUSION:  In humans, (18)F-JNJ42259152 has an appropriate distribution, brain kinetics and safety.  The estimated effective dose was within WHO class IIb with low interindividual variability.  Therefore, the tracer is suitable for further kinetic evaluation in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSG3cQLgkqOMjl5L8hwNX0fW6udTcc2ebllVtrua5ZMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3s7kt1OgsA%253D%253D&md5=168d719b36355388d5f8f99931b730db</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs00259-012-2270-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-012-2270-1%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAhmad%26aufirst%3DR.%2BU.%26aulast%3DHudyana%26aufirst%3DH.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DDubois%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DKoole%26aufirst%3DM.%26atitle%3DHuman%2520biodistribution%2520and%2520dosimetry%2520of%252018F-JNJ42259152%252C%2520a%2520radioligand%2520for%2520phosphodiesterase%252010A%2520imaging%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2013%26volume%3D40%26spage%3D254%26epage%3D261%26doi%3D10.1007%2Fs00259-012-2270-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">De Angelis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sannen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornelis, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alcazar, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langlois, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andres, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">Preclinical evaluation of [<sup>18</sup>F]JNJ42259152 as a PET tracer for PDE10A</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">13</span>– <span class="NLM_lpage">22</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2013.04.123</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2013.04.123" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23664955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtlyrsbvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2013&pages=13-22&author=S.+Celenauthor=M.+Kooleauthor=M.+Oomsauthor=M.+De+Angelisauthor=I.+Sannenauthor=J.+Cornelisauthor=J.+Alcazarauthor=M.+Schmidtauthor=A.+Verbruggenauthor=X.+Langloisauthor=K.+Van+Laereauthor=J.+I.+Andresauthor=G.+Bormans&title=Preclinical+evaluation+of+%5B18F%5DJNJ42259152+as+a+PET+tracer+for+PDE10A&doi=10.1016%2Fj.neuroimage.2013.04.123"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit171R"><div class="casContent"><span class="casTitleNuber">171</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical evaluation of [18F]JNJ42259152 as a PET tracer for PDE10A</span></div><div class="casAuthors">Celen, S.; Koole, M.; Ooms, M.; De Angelis, M.; Sannen, I.; Cornelis, J.; Alcazar, J.; Schmidt, M.; Verbruggen, A.; Langlois, X.; Van Laere, K.; Andres, J. I.; Bormans, G.</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13-22</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase-10A (PDE10A) is implicated in several neuropsychiatric disorders involving basal ganglia neurotransmission, such as schizophrenia, obsessive-compulsive disorder and Huntington's disease.  To confirm target engagement and exposure-occupancy relationships of clin. candidates for treatment, and to further explore the in vivo biol. of PDE10A, non-invasive imaging using a specific PET ligand is warranted.  Recently we have reported the in vivo evaluation of [18F]JNJ41510417 which showed specific binding to PDE10A in rat striatum, but with relatively slow kinetics.  A chem. related deriv. JNJ42259152 was found to have a similar in vivo occupancy, but lower lipophilicity and lower PDE10A in vitro inhibitory activity compared to JNJ41510417. 18F-labeled JNJ42259152 was therefore evaluated as a potential PDE10A PET radiotracer.  Baseline PET in rats and monkey showed specific retention in the PDE10A-rich striatum, and fast wash-out, with a good contrast to non-specific binding, in other brain regions.  Pretreatment and chase expts. in rats with the selective PDE10A inhibitor MP-10 showed that tracer binding was specific and reversible.  Absence of specific binding in PDE10A knock-out (KO) mice further confirmed PDE10A specificity.  In vivo radiometabolite anal. using high performance liq. chromatog. (HPLC) showed presence of polar radiometabolites in rat plasma and brain.  In vivo imaging in rat and monkey further showed faster brain kinetics, and higher striatum-to-cerebellum ratios for [18F]JNJ42259152 compared to [18F]JNJ41510417.  The arterial input function cor. for radiometabolites was detd. in rats and basic kinetic modeling was established.  For a 60-min acquisition time interval, striatal binding potential of the intact tracer referenced to the cerebellum showed good correlation with corresponding binding potential values of a Simplified Ref. Tissue Model and referenced Logan Plot, the latter using a population averaged ref. tissue-to-plasma clearance rate and offering the possibility to generate representative parametric binding potential images.  In conclusion we can state that in vivo imaging in PDE10A KO mice, rats and monkey demonstrates that [18F]JNJ42259152 provides a PDE10A-specific signal in the striatum with good pharmacokinetic properties.  Although presence of a polar radiometabolite in rat brain yielded a systematic but reproducible underestimation of the striatal BPND, a Logan ref. tissue model approach using 60 min acquisition data is appropriate for quantification.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqZPDGMkDaCELVg90H21EOLACvtfcHk0libdUZRvPskcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtlyrsbvN&md5=9e7b715690c4cacd7cc96cbbf235a41c</span></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2013.04.123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2013.04.123%26sid%3Dliteratum%253Aachs%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DDe%2BAngelis%26aufirst%3DM.%26aulast%3DSannen%26aufirst%3DI.%26aulast%3DCornelis%26aufirst%3DJ.%26aulast%3DAlcazar%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DLanglois%26aufirst%3DX.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAndres%26aufirst%3DJ.%2BI.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3DPreclinical%2520evaluation%2520of%2520%255B18F%255DJNJ42259152%2520as%2520a%2520PET%2520tracer%2520for%2520PDE10A%26jtitle%3DNeuroImage%26date%3D2013%26volume%3D82%26spage%3D13%26epage%3D22%26doi%3D10.1016%2Fj.neuroimage.2013.04.123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rietjens, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rangarajan, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vunckx, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valdeolivas, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himmelreich, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fernandez-Ruiz, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Casteels, C.</span></span> <span> </span><span class="NLM_article-title">Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice</span>. <i>Neurobiol. Aging</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">2858</span>– <span class="NLM_lpage">2869</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.06.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neurobiolaging.2014.06.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25018107" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtFCgu7zK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2014&pages=2858-2869&author=M.+Oomsauthor=R.+Rietjensauthor=J.+R.+Rangarajanauthor=K.+Vunckxauthor=S.+Valdeolivasauthor=F.+Maesauthor=U.+Himmelreichauthor=J.+Fernandez-Ruizauthor=G.+Bormansauthor=K.+Van+Laereauthor=C.+Casteels&title=Early+decrease+of+type+1+cannabinoid+receptor+binding+and+phosphodiesterase+10A+activity+in+vivo+in+R6%2F2+Huntington+mice&doi=10.1016%2Fj.neurobiolaging.2014.06.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Early decrease of type 1 cannabinoid receptor binding and phosphodiesterase 10A activity in vivo in R6/2 Huntington mice</span></div><div class="casAuthors">Ooms, Maarten; Rietjens, Roma; Rangarajan, Janaki Raman; Vunckx, Kathleen; Valdeolivas, Sara; Maes, Frederik; Himmelreich, Uwe; Fernandez-Ruiz, Javier; Bormans, Guy; Van Laere, Koen; Casteels, Cindy</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2858-2869</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Several lines of evidence imply early alterations in endocannabinoid and phosphodiesterase 10A (PDE10A) signaling in Huntington disease (HD).  Using [18F]MK-9470 and [18F]JNJ42259152 small-animal positron emission tomog. (PET), we investigated for the first time cerebral changes in type 1 cannabinoid (CB1) receptor binding and PDE10A levels in vivo in presymptomatic, early symptomatic, and late symptomatic HD (R6/2) mice, in relation to glucose metab. ([18F]FDG PET), brain morphol. (magnetic resonance imaging) and motor function.  Ten R6/2 and 16 wild-type (WT) mice were investigated at 3 different time points between the age of 4 and 13 wk.  Parametric CB1 receptor and PDE10A images were anatomically standardized to Paxinos space and analyzed voxelwise.  Volumetric microMRI imaging was performed to assess HD pathol.  In R6/2 mice, CB1 receptor binding was decreased in comparison with WT in a cluster comprising the bilateral caudate-putamen, globus pallidus, and thalamic nucleus at week 5 (-8.1% ± 2.6%, p = 1.7 × 10-5).  Longitudinal follow-up showed further progressive decline compared with controls in a cluster comprising the bilateral hippocampus, caudate-putamen, globus pallidus, superior colliculus, thalamic nucleus, and cerebellum (late vs. presymptomatic age: -13.7% ± 3.1% for R6/2 and +1.5% ± 4.0% for WT, p = 1.9 × 10-5).  In R6/2 mice, PDE10A binding potential also decreased over time to reach significance at early and late symptomatic HD (late vs. presymptomatic age: -79.1% ± 1.9% for R6/2 and +2.1% ± 2.7% for WT, p = 1.5 × 10-4).  The obsd. changes in CB1 receptor and PDE10A binding were correlated to anomalies exhibited by R6/2 animals in motor function, whereas no correlation was found with magnetic resonance imaging-based striatal vol.  Our findings point to early regional dysfunctions in endocannabinoid and PDE10A signaling, involving the caudate-putamen and lateral globus pallidus, which may play a role in the progression of the disease in R6/2 animals.  PET quantification of in vivo CB1 and/or PDE10A binding may thus be useful early biomarkers for HD.  Our results also provide evidence of subtle motor deficits at earlier stages than previously described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5XNTctrfkLbVg90H21EOLACvtfcHk0libdUZRvPskcQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtFCgu7zK&md5=c00883141f277d6a576e7d89537fb276</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.06.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.06.010%26sid%3Dliteratum%253Aachs%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DRietjens%26aufirst%3DR.%26aulast%3DRangarajan%26aufirst%3DJ.%2BR.%26aulast%3DVunckx%26aufirst%3DK.%26aulast%3DValdeolivas%26aufirst%3DS.%26aulast%3DMaes%26aufirst%3DF.%26aulast%3DHimmelreich%26aufirst%3DU.%26aulast%3DFernandez-Ruiz%26aufirst%3DJ.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DCasteels%26aufirst%3DC.%26atitle%3DEarly%2520decrease%2520of%2520type%25201%2520cannabinoid%2520receptor%2520binding%2520and%2520phosphodiesterase%252010A%2520activity%2520in%2520vivo%2520in%2520R6%252F2%2520Huntington%2520mice%26jtitle%3DNeurobiol.%2520Aging%26date%3D2014%26volume%3D35%26spage%3D2858%26epage%3D2869%26doi%3D10.1016%2Fj.neurobiolaging.2014.06.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourgeois, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Postnov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vandenberghe, W.</span></span> <span> </span><span class="NLM_article-title">PET imaging shows loss of striatal PDE10A in patients with Huntington disease</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">279</span>– <span class="NLM_lpage">281</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000000037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1212%2FWNL.0000000000000037" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24353339" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2c3ns12qsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=279-281&author=R.+Ahmadauthor=S.+Bourgeoisauthor=A.+Postnovauthor=M.+E.+Schmidtauthor=G.+Bormansauthor=K.+Van+Laereauthor=W.+Vandenberghe&title=PET+imaging+shows+loss+of+striatal+PDE10A+in+patients+with+Huntington+disease&doi=10.1212%2FWNL.0000000000000037"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">PET imaging shows loss of striatal PDE10A in patients with Huntington disease</span></div><div class="casAuthors">Ahmad Rawaha; Bourgeois Sophie; Postnov Andrey; Schmidt Mark E; Bormans Guy; Van Laere Koen; Vandenberghe Wim</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">82</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">279-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) belongs to a family of enzymes that hydrolyze cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate.(1) PDE10A is highly enriched in striatal medium spiny neurons (MSNs), where it regulates intracellular signaling.(1) PDE10A has been proposed as a therapeutic target for Huntington disease (HD), a disorder that preferentially affects MSNs, based on the observation that pharmacologic inhibition of PDE10A in transgenic HD mice significantly improved behavioral and neuropathologic abnormalities.(2) However, earlier work had shown that striatal PDE10A levels in HD mice already decline to minimal levels before onset of motor symptoms,(3) possibly because mutant huntingtin represses PDE10A transcription.  Also, postmortem analysis of striatum of 3 patients with HD revealed strong reduction of PDE10A levels.(3) Depletion of PDE10A in HD striatum would at first sight seem hard to reconcile with a beneficial effect of PDE10A inhibitors in HD.  However, a recent study reported a dramatic increase, rather than decrease, of PDE10A protein in MSNs of HD mice.(4) In light of these conflicting results and the strong interest in development of PDE10A inhibitors for clinical use in HD, it is important to determine whether PDE10A levels are affected in the striatum of patients with HD in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTseEUOb2KKAQaK-_ZudimnfW6udTcc2ebT4HxZOaCZ17ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2c3ns12qsQ%253D%253D&md5=dde2b872d2e565c5e675b51506326f26</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000000037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000000037%26sid%3Dliteratum%253Aachs%26aulast%3DAhmad%26aufirst%3DR.%26aulast%3DBourgeois%26aufirst%3DS.%26aulast%3DPostnov%26aufirst%3DA.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DVandenberghe%26aufirst%3DW.%26atitle%3DPET%2520imaging%2520shows%2520loss%2520of%2520striatal%2520PDE10A%2520in%2520patients%2520with%2520Huntington%2520disease%26jtitle%3DNeurology%26date%3D2014%26volume%3D82%26spage%3D279%26epage%3D281%26doi%3D10.1212%2FWNL.0000000000000037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ooms, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Attili, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verbruggen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span> <span> </span><span class="NLM_article-title">[<sup>18</sup>F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP</span>. <i>J. Neurochem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>139</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1111/jnc.13855</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1111%2Fjnc.13855" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27664396" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhslyktrvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=139&publication_year=2016&pages=897-906&author=M.+Oomsauthor=B.+Attiliauthor=S.+Celenauthor=M.+Kooleauthor=A.+Verbruggenauthor=K.+Van+Laereauthor=G.+Bormans&title=%5B18F%5DJNJ42259152+binding+to+phosphodiesterase+10A%2C+a+key+regulator+of+medium+spiny+neuron+excitability%2C+is+altered+in+the+presence+of+cyclic+AMP&doi=10.1111%2Fjnc.13855"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">[18F]JNJ42259152 binding to phosphodiesterase 10A, a key regulator of medium spiny neuron excitability, is altered in the presence of cyclic AMP</span></div><div class="casAuthors">Ooms, Maarten; Attili, Bala; Celen, Sofie; Koole, Michel; Verbruggen, Alfons; Van Laere, Koen; Bormans, Guy</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurochemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">139</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">897-906</span>CODEN:
                <span class="NLM_cas:coden">JONRA9</span>;
        ISSN:<span class="NLM_cas:issn">0022-3042</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a key regulator of medium spiny neuron excitability.  Therefore, it plays an important role in the regulation of motor, reward, and cognitive processes.  Despite the interest in PDE10A as a drug and positron emission tomog. (PET) imaging target, little is known about the regulation of PDE10A enzymic activity.  This study aimed to further investigate the role of cAMP in the regulation of PDE10A activity and PDE10A PET imaging.  Using [18F]JNJ42259152 as radioligand, we investigated alterations in PDE10A binding secondary to changes in cAMP levels.  An in vitro striatum homogenate binding assay was developed to det. KD and Bmax of [18F]JNJ42259152.  Homogenate binding was assessed after addn. of increasing concns. of exogenous cAMP (1, 10, and 100 μM).  Rats were treated using JNJ49137530 and rolipram to induce in vivo alterations of cAMP.  The effect of the induced cAMP alterations on PDE10A binding was assessed by comparing [18F]JNJ42259152 microPET studies after treatment to microPET studies acquired at baseline conditions prior to treatment.  In vitro binding affinity of [18F]JNJ42259152 was higher in the presence of cAMP compared to baseline conditions (KD = 3.17 ± 0.91 nM with 10 μM cAMP vs. KD = 6.62 ± 0.7 nM at baseline).  Inhibition of PDE4 using rolipram significantly increased [18F]JNJ42259152 binding (BPND = 2.61 ± 0.50 vs. 1.91 ± 0.36 at baseline).  Administration of the PDE2 inhibitor JNJ49137530 significantly increased PDE10A binding potential (BPND = 2.74 ± 0.22 vs. 2.05 ± 0.16 at baseline).  Our data indicate an important role for cAMP in the regulation of PDE10A activity.  Addnl., our data show a profound interaction between several PDEs in striatum.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpCws11u-3H-LVg90H21EOLACvtfcHk0lgpRZlCkAdzRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhslyktrvM&md5=6e4b6e91a7e91403d1a2e892ea54cb0d</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1111%2Fjnc.13855&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fjnc.13855%26sid%3Dliteratum%253Aachs%26aulast%3DOoms%26aufirst%3DM.%26aulast%3DAttili%26aufirst%3DB.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DKoole%26aufirst%3DM.%26aulast%3DVerbruggen%26aufirst%3DA.%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DBormans%26aufirst%3DG.%26atitle%3D%255B18F%255DJNJ42259152%2520binding%2520to%2520phosphodiesterase%252010A%252C%2520a%2520key%2520regulator%2520of%2520medium%2520spiny%2520neuron%2520excitability%252C%2520is%2520altered%2520in%2520the%2520presence%2520of%2520cyclic%2520AMP%26jtitle%3DJ.%2520Neurochem.%26date%3D2016%26volume%3D139%26spage%3D897%26epage%3D906%26doi%3D10.1111%2Fjnc.13855" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Van
Laere, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahmad, R. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudyana, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubois, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Celen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bormans, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koole, M.</span></span> <span> </span><span class="NLM_article-title">Quantification of <sup>18</sup>F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">1285</span>– <span class="NLM_lpage">1293</span>, <span class="refDoi"> DOI: 10.2967/jnumed.112.118679</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.112.118679" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=23843566" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsVaqu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2013&pages=1285-1293&author=K.+Van%0ALaereauthor=R.+U.+Ahmadauthor=H.+Hudyanaauthor=K.+Duboisauthor=M.+E.+Schmidtauthor=S.+Celenauthor=G.+Bormansauthor=M.+Koole&title=Quantification+of+18F-JNJ-42259152%2C+a+novel+phosphodiesterase+10A+PET+tracer%3A+kinetic+modeling+and+test-retest+study+in+human+brain&doi=10.2967%2Fjnumed.112.118679"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain</span></div><div class="casAuthors">Van Laere, Koen; Ahmad, Rawaha U.; Hudyana, Hendra; Dubois, Kristof; Schmidt, Mark E.; Celen, Sofie; Bormans, Guy; Koole, Michel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1285-1293</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) plays a central role in striatal signaling and is implicated in several neuropsychiatric disorders, such as movement disorders and schizophrenia.  We performed initial brain kinetic modeling of the novel PDE10A tracer 18F-JNJ-42259152 (2-[[4-[1-(2-18F-fluoroethyl)-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-3,5-dimethyl-pyridine) and studied test-retest reproducibility in healthy volunteers.  Methods: Twelve healthy volunteers (5 men, 7 women; age range, 42-77 y) were scanned dynamically up to 135 min after bolus injection of 172.5 ± 10.3 MBq of 18F-JNJ42259152.  Four volunteers (2 men, 2 women) underwent retest scanning, with a mean interscan interval of 37 d.  Input functions and tracer parent fractions were detd. using arterial sampling and high-performance liq. chromatog. anal.  Vols. of interest for the putamen, caudate nucleus, ventral striaturn, substantia nigra, thalamus, frontal cortex, and cerebellum were delineated using individual volumetric T1 MR imaging scans.  One-tissue (1T) and 2-tissue (2T) models were evaluated to calc. total distribution vol. (VT).  Simplified models were also tested to calc. binding potential (BPND), including the simplified ref. tissue model (SRTM) and multilinear ref. tissue model, using the frontal cortex as the optimal ref. tissue.  The stability of VT and BPND was assessed down to a 60-min scan time.  Results: The av. intact tracer half-life in blood was 90 min.  The 2T model VT values for the putamen, caudate nucleus, ventral striatum, substantia nigra, thalamus, frontal cortex, and cerebellum were 1.54 ± 0.37, 0.90 ± 0.24, 0.64 ± 0.18, 0.42 ± 0.09, 0.35 ± 0.09, 0.30 ± 0.07, and 0.36 ± 0.12, resp.  The 1T model provided significantly lower VT values, which were well correlated to the 2T VT.  SRTM BPND values referenced to the frontal cortex were 3.45 ± 0.43, 1.78 ± 0.35, 1.10 ± 0.31, and 0.44 ± 0.09 for the resp. target regions putamen, caudate nucleus, ventral striatum, and substantia nigra, with similar values for the multilinear ref. tissue model.  Good correlations were found for the target regions putamen, caudate nucleus, ventral striatum, and substantia nigra between the 2T-compartment model BPND and the SRTM BPND (r = 0.57, 0.82, 0.70, and 0.64, resp.).  SRTM BPND using a 90- and 60-min acquisition interval showed low bias.  Test-retest variability was 5%-19% for 2T VT and 5%-12% for BPND SRTM.  Conclusion: Kinetic modeling of 18F-JNJ-42259152 shows that PDE10A activity can be reliably quantified and simplified using a ref. tissue model with the frontal cortex as ref. and a 60-min acquisition period.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNPcD7IchsJrVg90H21EOLACvtfcHk0lgpRZlCkAdzRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsVaqu7jL&md5=309f0829c367346e1180a63bb771c2fe</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.112.118679&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.112.118679%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLaere%26aufirst%3DK.%26aulast%3DAhmad%26aufirst%3DR.%2BU.%26aulast%3DHudyana%26aufirst%3DH.%26aulast%3DDubois%26aufirst%3DK.%26aulast%3DSchmidt%26aufirst%3DM.%2BE.%26aulast%3DCelen%26aufirst%3DS.%26aulast%3DBormans%26aufirst%3DG.%26aulast%3DKoole%26aufirst%3DM.%26atitle%3DQuantification%2520of%252018F-JNJ-42259152%252C%2520a%2520novel%2520phosphodiesterase%252010A%2520PET%2520tracer%253A%2520kinetic%2520modeling%2520and%2520test-retest%2520study%2520in%2520human%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2013%26volume%3D54%26spage%3D1285%26epage%3D1293%26doi%3D10.2967%2Fjnumed.112.118679" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schwan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barbar Asskar, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hofgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kubicova, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Funke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahn, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieber, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strater, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briel, D.</span></span> <span> </span><span class="NLM_article-title">Fluorine-containing 6,7-dialkoxybiaryl-based inhibitors for phosphodiesterase 10 A: synthesis and in vitro evaluation of inhibitory potency, selectivity, and metabolism</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1476</span>– <span class="NLM_lpage">1487</span>, <span class="refDoi"> DOI: 10.1002/cmdc.201300522</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fcmdc.201300522" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24729456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmtVCgt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2014&pages=1476-1487&author=G.+Schwanauthor=G.+Barbar+Asskarauthor=N.+Hofgenauthor=L.+Kubicovaauthor=U.+Funkeauthor=U.+Egerlandauthor=M.+Zahnauthor=K.+Nieberauthor=M.+Scheunemannauthor=N.+Straterauthor=P.+Brustauthor=D.+Briel&title=Fluorine-containing+6%2C7-dialkoxybiaryl-based+inhibitors+for+phosphodiesterase+10+A%3A+synthesis+and+in+vitro+evaluation+of+inhibitory+potency%2C+selectivity%2C+and+metabolism&doi=10.1002%2Fcmdc.201300522"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Fluorine-containing 6,7-dialkoxybiaryl-based inhibitors for phosphodiesterase 10 A: Synthesis and in vitro evaluation of inhibitory potency, selectivity, and metabolism</span></div><div class="casAuthors">Schwan, Gregor; Barbar Asskar, Ghadir; Hoefgen, Norbert; Kubicova, Lenka; Funke, Uta; Egerland, Ute; Zahn, Michael; Nieber, Karen; Scheunemann, Matthias; Straeter, Norbert; Brust, Peter; Briel, Detlef</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1476-1487</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Various derivs. of the potent phosphodiesterase 10 A (PDE10A) inhibitor PQ-10 I (R = H, R1 = R2 = Me) were synthesized to det. relationships between their mol. structure and binding properties.  Their roles as potential positron emission tomog. (PET) ligands were evaluated, as well as their inhibitory potency toward PDE10A and other PDEs, and their metabolic stability was detd. in vitro.  Halo-alkyl substituents at position 2 of the quinazoline moiety and/or halo-alkyloxy substituents at positions 6 or 7 affect not only the compds.' affinity, but also their selectivity toward PDE10A.  As a result of substituting the MeO group for a monofluoroethoxy or difluoroethoxy group at position 6 of the quinazoline ring, the selectivity for PDE10A over PDE3A increased.  The same result was obtained by 6,7-difluoride substitution on the quinoxaline moiety.  Finally, fluoro compds., such as I [R = H, R1 = FCH2, R2 = Me; R = H, R1 = Me, R2 = FCH2, F(CH2)2, F2CHCH2; R = F, R1 = R2 = Me], showed the highest inhibitory potential (IC50 = 11-65 nM for PDE10A).  Further, fluoroethoxy substitution at position 7 of the quinazoline ring improved metabolic stability over that of the lead compd.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcfLu8wKjlkbVg90H21EOLACvtfcHk0lh-l4c7B1BQaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmtVCgt7Y%253D&md5=827806bd4dd9fc593f0a9a22da2a87c1</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.201300522&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.201300522%26sid%3Dliteratum%253Aachs%26aulast%3DSchwan%26aufirst%3DG.%26aulast%3DBarbar%2BAsskar%26aufirst%3DG.%26aulast%3DHofgen%26aufirst%3DN.%26aulast%3DKubicova%26aufirst%3DL.%26aulast%3DFunke%26aufirst%3DU.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DZahn%26aufirst%3DM.%26aulast%3DNieber%26aufirst%3DK.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DStrater%26aufirst%3DN.%26aulast%3DBrust%26aufirst%3DP.%26aulast%3DBriel%26aufirst%3DD.%26atitle%3DFluorine-containing%25206%252C7-dialkoxybiaryl-based%2520inhibitors%2520for%2520phosphodiesterase%252010%2520A%253A%2520synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%2520inhibitory%2520potency%252C%2520selectivity%252C%2520and%2520metabolism%26jtitle%3DChemMedChem%26date%3D2014%26volume%3D9%26spage%3D1476%26epage%3D1487%26doi%3D10.1002%2Fcmdc.201300522" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Funke, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maisonial, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Briel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and radiotracer properties of a 7-(2-[<sup>18</sup>F]fluoroethoxy)-6-methoxypyrrolidinylquinazoline for imaging of phosphodiesterase 10A with PET</span>. <i>Pharmaceuticals</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">169</span>– <span class="NLM_lpage">188</span>, <span class="refDoi"> DOI: 10.3390/ph5020169</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.3390%2Fph5020169" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24288087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38XivVKgtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2012&pages=169-188&author=U.+Funkeauthor=W.+Deuther-Conradauthor=G.+Schwanauthor=A.+Maisonialauthor=M.+Scheunemannauthor=S.+Fischerauthor=A.+Hillerauthor=D.+Brielauthor=P.+Brust&title=Radiosynthesis+and+radiotracer+properties+of+a+7-%282-%5B18F%5Dfluoroethoxy%29-6-methoxypyrrolidinylquinazoline+for+imaging+of+phosphodiesterase+10A+with+PET&doi=10.3390%2Fph5020169"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and radiotracer properties of a 7-(2-[18F]fluoroethoxy)-6-methoxypyrrolidinylquinazoline for imaging of phosphodiesterase 10A with PET</span></div><div class="casAuthors">Funke, Uta; Deuther-Conrad, Winnie; Schwan, Gregor; Maisonial, Aurelie; Scheunemann, Matthias; Fischer, Steffen; Hiller, Achim; Briel, Detlef; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Pharmaceuticals</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">169-188</span>CODEN:
                <span class="NLM_cas:coden">PHARH2</span>;
        ISSN:<span class="NLM_cas:issn">1424-8247</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a key enzyme of intracellular signal transduction which is involved in the regulation of neurotransmission.  The mol. imaging of PDE10A by PET is expected to allow a better understanding of physiol. and pathol. processes related to PDE10A expression and function in the brain.  The aim of this study was to develop a new 18F-labeled PDE10A ligand based on a 6,7-dimethoxy-4-pyrrolidinylquinazoline and to evaluate its properties in biodistribution studies.  Nucleophilic substitution of the 7-tosyloxy-analog led to the 7-[18F]fluoroethoxy-deriv. [18F]IV with radiochem. yields of 25% ± 9% (n = 9), high radiochem. purity of ≥99% and specific activities of 110-1,100 GBq/μmol.  [18F]IV showed moderate PDE10A affinity (KD,PDE10A = 14 nM) and high metabolic stability in the brain of female CD-1 mice, wherein the radioligand entered rapidly with a peak uptake of 2.3% ID/g in striatum at 5 min p.i.  However, ex vivo autoradiog. and in vivo blocking studies revealed no target specific accumulation and demonstrated [18F]IV to be inapplicable for imaging PDE10A with PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpo54WU6U6mjrVg90H21EOLACvtfcHk0lh-l4c7B1BQaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XivVKgtL4%253D&md5=ad3e963593f565c58e036b9965322c2b</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.3390%2Fph5020169&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fph5020169%26sid%3Dliteratum%253Aachs%26aulast%3DFunke%26aufirst%3DU.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DSchwan%26aufirst%3DG.%26aulast%3DMaisonial%26aufirst%3DA.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DHiller%26aufirst%3DA.%26aulast%3DBriel%26aufirst%3DD.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DRadiosynthesis%2520and%2520radiotracer%2520properties%2520of%2520a%25207-%25282-%255B18F%255Dfluoroethoxy%2529-6-methoxypyrrolidinylquinazoline%2520for%2520imaging%2520of%2520phosphodiesterase%252010A%2520with%2520PET%26jtitle%3DPharmaceuticals%26date%3D2012%26volume%3D5%26spage%3D169%26epage%3D188%26doi%3D10.3390%2Fph5020169" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tavares, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarthy, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G.</span></span> <span> </span><span class="NLM_article-title">In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: <sup>18</sup>F-MNI-659 and <sup>18</sup>F-MNI-654</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1297</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.2967/jnumed.113.122895</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.113.122895" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24898025" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1GnurjJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1297-1304&author=O.+Barretauthor=D.+Thomaeauthor=A.+Tavaresauthor=D.+Alagilleauthor=C.+Papinauthor=R.+Waterhouseauthor=T.+McCarthyauthor=D.+Jenningsauthor=K.+Marekauthor=D.+Russellauthor=J.+Seibylauthor=G.+Tamagnan&title=In+vivo+assessment+and+dosimetry+of+2+novel+PDE10A+PET+radiotracers+in+humans%3A+18F-MNI-659+and+18F-MNI-654&doi=10.2967%2Fjnumed.113.122895"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo assessment and dosimetry of 2 novel PDE10A PET radiotracers in humans: 18F-MNI-659 and 18F-MNI-654</span></div><div class="casAuthors">Barret, Olivier; Thomae, David; Tavares, Adriana; Alagille, David; Papin, Caroline; Waterhouse, Rikki; McCarthy, Timothy; Jennings, Danna; Marek, Ken; Russell, David; Seibyl, John; Tamagnan, Gilles</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1297-1304</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Phosphodiesterase (PDE) 10A is an enzyme involved in the regulation of cyclic adenosine monophosphate and cyclic guanosine monophosphate and is highly expressed in medium-sized spiny neurons of the striatum, making it an attractive target for novel therapies for a variety of neurol. and psychiatric disorders that involve striatal function.  Potential ligands for PET imaging of PDE10A have been reported.  Here, we report the first-in-human characterization of 2 new PDE10A radioligands, 2-(2-(3-(1-(2-fluoroethyl)-1H-indazol-6-yl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione (18F-MNI-654) and 2-(2-(3-(4-(2-fluoroethoxy)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione (18F-MNI-659), with the goal of selecting the best one for use in future studies interrogating pathophysiol. changes in neuropsychiatric disorders and aiding pharmaceutical development targeting PDE10A.  Methods: Eleven healthy volunteers participated in this study (18F-MNI-654 test-retest, 2 men; 18F-MNI-659 test-retest, 4 men and 1 woman; 18F-MNI-659 dosimetry, 2 men and 2 women).  Brain PET images were acquired over 5.5 h for 18F-MNI-654 and over 3.5 h for 18F-MNI-659, and pharmacokinetic modeling with plasma- and ref.-region (cerebellar cortex)-based methods was performed.  Whole-body PET images were acquired over 6 h for 18F-MNI-659 and radiation dosimetry estd. with OLINDA.  Results: Both radiotracers were similarly metabolized, with about 20% of intact parent remaining at 120 min after injection.  PET time-activity data demonstrated that 18F-MNI-654 kinetics were much slower than 18F-MNI-659 kinetics.  For 18F-MNI-659, there was good agreement between the Logan and simplified ref. tissue models for nondisplaceable binding potential (BPND), supporting non-invasive quantification, with test-retest variability less than 10% and intraclass correlation greater than 0.9.  The 18F-MNI-659 ED was estd. at 0.024 mSv/MBq.  Conclusion: PET imaging in the human brain with 2 novel PDE10A 18F tracers is being reported.  Noninvasive quantification of 18F-MNI-659 with the simplified ref. tissue model using the cerebellum as a ref. is possible.  In addn., 18F-MNI-659 kinetics are fast enough for a good est. of BPND with 90 min of data, with values around 3.0 in the basal ganglia.  Finally, 18F-MNI-659 dosimetry is favorable and consistent with values reported for other PET radiotracers currently used in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrUWk3vV3AyzbVg90H21EOLACvtfcHk0lhRVGrmhoG9Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1GnurjJ&md5=cd718c4e9137e4003c7179032342378b</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.122895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.122895%26sid%3Dliteratum%253Aachs%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DTavares%26aufirst%3DA.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DWaterhouse%26aufirst%3DR.%26aulast%3DMcCarthy%26aufirst%3DT.%26aulast%3DJennings%26aufirst%3DD.%26aulast%3DMarek%26aufirst%3DK.%26aulast%3DRussell%26aufirst%3DD.%26aulast%3DSeibyl%26aufirst%3DJ.%26aulast%3DTamagnan%26aufirst%3DG.%26atitle%3DIn%2520vivo%2520assessment%2520and%2520dosimetry%2520of%25202%2520novel%2520PDE10A%2520PET%2520radiotracers%2520in%2520humans%253A%252018F-MNI-659%2520and%252018F-MNI-654%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1297%26epage%3D1304%26doi%3D10.2967%2Fjnumed.113.122895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Friedman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papapetropoulos, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterhouse, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K. L.</span></span> <span> </span><span class="NLM_article-title">The phosphodiesterase 10 positron emission tomography tracer, [<sup>18</sup>F]MNI-659, as a novel biomarker for early Huntington disease</span>. <i>JAMA Neurol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>71</i></span>,  <span class="NLM_fpage">1520</span>– <span class="NLM_lpage">1528</span>, <span class="refDoi"> DOI: 10.1001/jamaneurol.2014.1954</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1001%2Fjamaneurol.2014.1954" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25322077" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC2M3htV2luw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=71&publication_year=2014&pages=1520-1528&author=D.+S.+Russellauthor=O.+Barretauthor=D.+L.+Jenningsauthor=J.+H.+Friedmanauthor=G.+D.+Tamagnanauthor=D.+Thomaeauthor=D.+Alagilleauthor=T.+J.+Morleyauthor=C.+Papinauthor=S.+Papapetropoulosauthor=R.+N.+Waterhouseauthor=J.+P.+Seibylauthor=K.+L.+Marek&title=The+phosphodiesterase+10+positron+emission+tomography+tracer%2C+%5B18F%5DMNI-659%2C+as+a+novel+biomarker+for+early+Huntington+disease&doi=10.1001%2Fjamaneurol.2014.1954"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">The phosphodiesterase 10 positron emission tomography tracer, [18F]MNI-659, as a novel biomarker for early Huntington disease</span></div><div class="casAuthors">Russell David S; Barret Olivier; Jennings Danna L; Tamagnan Gilles D; Alagille David; Morley Thomas J; Papin Caroline; Seibyl John P; Marek Kenneth L; Friedman Joseph H; Thomae David; Papapetropoulos Spyridon; Waterhouse Rikki N</div><div class="citationInfo"><span class="NLM_cas:title">JAMA neurology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">71</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1520-8</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">IMPORTANCE:  In Huntington disease (HD) striatal neuron loss precedes and predicts motor signs or symptoms.  Current imaging biomarkers lack adequate sensitivity for assessing the early stages of HD.  Developing an imaging biomarker for HD spanning the time of onset of motor signs remains a major unmet research need.  Intracellular proteins whose expression is altered by the mutant huntingtin protein may be superior markers for early HD stages.  OBJECTIVE:  To evaluate whether [18F]MNI-659 (2-(2-(3-(4-(2-[18F]fluoroethoxy)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione), a novel phosphodiesterase 10 positron emission tomography (PET) ligand, is a sensitive marker for striatal changes in early HD.  DESIGN, SETTING, AND PARTICIPANTS:  A cohort of individuals with HD, including premanifest (pre-HD) or manifest with motor signs (mHD), underwent clinical assessments, genetic determination, [18F]MNI-659 PET imaging, and brain magnetic resonance imaging.  Age-matched healthy volunteers (HVs) also received clinical assessments and PET and magnetic resonance imaging.  MAIN OUTCOMES AND MEASURES:  Binding potentials (BPnds) were estimated for brain regions of interest, specifically within the basal ganglia, and compared between participants with HD and the HVs and correlated with markers of HD severity and atrophy of basal ganglia nuclei.  RESULTS:  Eleven participants with HD (8 mHD and 3 pre-HD) and 9 HVs participated.  Ten of 11 HD participants had known huntingtin CAG repeat length, allowing determination of a burden of pathology (BOP) score.  One individual with HD declined CAG determination.  All participants with mHD had relatively early-stage disease (4 with stage 1 and 4 with stage 2) and a Unified Huntington's Disease Rating Scale (UHDRS) total Motor subscale score of less than 50.  The HD cohort had significantly lower striatal [18F]MNI-659 uptake than did the HV cohort (mean, -48.4%; P < .001).  The HD cohort as a whole had a reduction in the basal ganglia BPnd to approximately 50% of the level in the HVs (mean, -47.6%; P < .001).  The 3 pre-HD participants had intermediate basal ganglia BPnds.  Striatal [18F]MNI-659 uptake correlated strongly with the severity of disease measured by the clinical scale (UHDRS Motor subscale; R = 0.903; P < .001), the molecular marker (BOP; R = 0.908; P < .001), and regional atrophy (R = 0.667; P < .05).  CONCLUSIONS AND RELEVANCE:  As a promising striatal imaging biomarker, [18F]MNI-659 is potentially capable of assessing the extent of disease in early mHD.  Furthermore, [18F]MNI-659 may identify early changes in medium spiny neurons and serve as a marker to predict conversion to mHD.  Additional studies with larger, stratified cohorts of patients with HD and prospective studies of individuals with pre-HD are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRsGzrUWLbaY3yKPtYViAGfW6udTcc2eZH5trz5pwLubntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2M3htV2luw%253D%253D&md5=c312a59c902ca482c7ac6f9f699a8d05</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1001%2Fjamaneurol.2014.1954&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1001%252Fjamaneurol.2014.1954%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DD.%2BS.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DJennings%26aufirst%3DD.%2BL.%26aulast%3DFriedman%26aufirst%3DJ.%2BH.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DMorley%26aufirst%3DT.%2BJ.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DPapapetropoulos%26aufirst%3DS.%26aulast%3DWaterhouse%26aufirst%3DR.%2BN.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DMarek%26aufirst%3DK.%2BL.%26atitle%3DThe%2520phosphodiesterase%252010%2520positron%2520emission%2520tomography%2520tracer%252C%2520%255B18F%255DMNI-659%252C%2520as%2520a%2520novel%2520biomarker%2520for%2520early%2520Huntington%2520disease%26jtitle%3DJAMA%2520Neurol.%26date%3D2014%26volume%3D71%26spage%3D1520%26epage%3D1528%26doi%3D10.1001%2Fjamaneurol.2014.1954" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Russell, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jennings, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barret, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tamagnan, G. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carroll, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caille, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alagille, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morley, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seibyl, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marek, K. L.</span></span> <span> </span><span class="NLM_article-title">Change in PDE10 across early Huntington disease assessed by [<sup>18</sup>F]MNI-659 and PET imaging</span>. <i>Neurology</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>86</i></span>,  <span class="NLM_fpage">748</span>– <span class="NLM_lpage">754</span>, <span class="refDoi"> DOI: 10.1212/WNL.0000000000002391</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1212%2FWNL.0000000000002391" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26802091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xjt1ygtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=86&publication_year=2016&pages=748-754&author=D.+S.+Russellauthor=D.+L.+Jenningsauthor=O.+Barretauthor=G.+D.+Tamagnanauthor=V.+M.+Carrollauthor=F.+Cailleauthor=D.+Alagilleauthor=T.+J.+Morleyauthor=C.+Papinauthor=J.+P.+Seibylauthor=K.+L.+Marek&title=Change+in+PDE10+across+early+Huntington+disease+assessed+by+%5B18F%5DMNI-659+and+PET+imaging&doi=10.1212%2FWNL.0000000000002391"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Change in PDE10 across early Huntington disease assessed by [18F]MNI-659 and PET imaging</span></div><div class="casAuthors">Russell, David S.; Jennings, Danna L.; Barret, Olivier; Tamagnan, Gilles D.; Carroll, Vincent M.; Caille, Fabien; Alagille, David; Morley, Thomas J.; Papin, Caroline; Seibyl, John P.; Marek, Kenneth L.</div><div class="citationInfo"><span class="NLM_cas:title">Neurology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">86</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">748-754</span>CODEN:
                <span class="NLM_cas:coden">NEURAI</span>;
        ISSN:<span class="NLM_cas:issn">0028-3878</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Objective: To evaluate whether striatal [F]MNI-659 PET imaging of phosphodiesterase 10A (PDE10) serves as a sensitive and reliable biomarker of striatal neurodegeneration in a longitudinal cohort of participants with early Huntington disease (HD).  Methods: A cohort of participants with HD, including both participants premanifest or manifest with motor signs, underwent clin. assessments, genetic detn., and 2 [F]MNI-659 PET imaging sessions approx. 1 yr apart.  Eleven healthy control (HC) participants underwent clin. assessments and [F]MNI-659 PET imaging once.  Striatal binding potentials (BPnd) were estd. for brain regions of interest, specifically within the basal ganglia, and compared between baseline and follow-up imaging.  Clin. measures of HD severity were assessed at each visit.  Results: Eight participants with HD (6 manifest; 2 premanifest) participated.  Of those with manifest HD, all had relatively early stage disease (stage 1, n = 2; stage 2, n = 4) and a Unified Huntingtons Disease Rating Scale total motor score <45.  As expected, the HD cohort as a whole had a redn. in the basal ganglia BPnd to approx. 50% of that seen in HC.  Conclusion: Longitudinal data in this small cohort of participants with early HD support [F]MNI-659 PET imaging of PDE10 as a useful biomarker to track HD disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv-gGe_KOgy7Vg90H21EOLACvtfcHk0lhRVGrmhoG9Pw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xjt1ygtLc%253D&md5=715e32e75ae1fd223007380a92e6791c</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1212%2FWNL.0000000000002391&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1212%252FWNL.0000000000002391%26sid%3Dliteratum%253Aachs%26aulast%3DRussell%26aufirst%3DD.%2BS.%26aulast%3DJennings%26aufirst%3DD.%2BL.%26aulast%3DBarret%26aufirst%3DO.%26aulast%3DTamagnan%26aufirst%3DG.%2BD.%26aulast%3DCarroll%26aufirst%3DV.%2BM.%26aulast%3DCaille%26aufirst%3DF.%26aulast%3DAlagille%26aufirst%3DD.%26aulast%3DMorley%26aufirst%3DT.%2BJ.%26aulast%3DPapin%26aufirst%3DC.%26aulast%3DSeibyl%26aufirst%3DJ.%2BP.%26aulast%3DMarek%26aufirst%3DK.%2BL.%26atitle%3DChange%2520in%2520PDE10%2520across%2520early%2520Huntington%2520disease%2520assessed%2520by%2520%255B18F%255DMNI-659%2520and%2520PET%2520imaging%26jtitle%3DNeurology%26date%3D2016%26volume%3D86%26spage%3D748%26epage%3D754%26doi%3D10.1212%2FWNL.0000000000002391" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref181"><div class="reference"><strong class="refLabel"><a href="#ref181" class="rightTabRefNumLink">181</a></strong><div class="NLM_citation" id="rightTab-cit181"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fazio, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schain, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrzljak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nag, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Al-Tawil, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fitzer-Attas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronzova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Landwehrmeyer, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sampaio, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span> <span> </span><span class="NLM_article-title">Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with <sup>18</sup>F-MNI-659 and <sup>11</sup>C-raclopride with correction for partial volume effect</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>152</i></span>,  <span class="NLM_fpage">330</span>– <span class="NLM_lpage">339</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2017.02.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2017.02.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28254508" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref181/cit181&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkt1Ogsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=152&publication_year=2017&pages=330-339&author=P.+Fazioauthor=M.+Schainauthor=L.+Mrzljakauthor=N.+Aminiauthor=S.+Nagauthor=N.+Al-Tawilauthor=C.+J.+Fitzer-Attasauthor=J.+Bronzovaauthor=B.+Landwehrmeyerauthor=C.+Sampaioauthor=C.+Halldinauthor=A.+Varrone&title=Patterns+of+age+related+changes+for+phosphodiesterase+type-10A+in+comparison+with+dopamine+D2%2F3+receptors+and+sub-cortical+volumes+in+the+human+basal+ganglia%3A+A+PET+study+with+18F-MNI-659+and+11C-raclopride+with+correction+for+partial+volume+effect&doi=10.1016%2Fj.neuroimage.2017.02.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit181R"><div class="casContent"><span class="casTitleNuber">181</span><div class="casTitle"><span class="NLM_cas:atitle">Patterns of age related changes for phosphodiesterase type-10A in comparison with dopamine D2/3 receptors and sub-cortical volumes in the human basal ganglia: A PET study with 18F-MNI-659 and 11C-raclopride with correction for partial volume effect</span></div><div class="casAuthors">Fazio, Patrik; Schain, Martin; Mrzljak, Ladislav; Amini, Nahid; Nag, Sangram; Al-Tawil, Nabil; Fitzer-Attas, Cheryl J.; Bronzova, Juliana; Landwehrmeyer, Bernhard; Sampaio, Cristina; Halldin, Christer; Varrone, Andrea</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">152</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">330-339</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A enzyme (PDE10A) is an important striatal target that has been shown to be affected in patients with neurodegenerative disorders, particularly Huntington's disease (HD).  PDE10A is expressed on striatal neurons in basal ganglia where other known mol. targets are enriched such as dopamine D2/3 receptors (D2/3 R).  The aim of this study was to examine the availability of PDE10A enzyme in relation with age and gender and to compare those changes with those related to D2/3 R and vols. in different regions of the basal ganglia.  As a secondary objective we examd. the relative distribution of D2/3 R and PDE10A enzyme in the striatum and globus pallidus.  Forty control subjects (20F/20M; age: 44±11y, age range 27-69) from an ongoing positron emission tomog. (PET) study in HD gene expansion carriers were included.  Subjects were examd. with PET using the high-resoln. research tomograph (HRRT) and with 3T magnetic resonance imaging (MRI).  The PDE10A radioligand 18F-MNI-659 and D2/3 R radioligand 11C-raclopride were used.  The outcome measure was the binding potential (BPND) estd. with the two-tissue compartment model (18F-MNI-659) and the simplified ref. tissue model (11C-raclopride) using the cerebellum as ref. region.  The PET data were cor. for partial vol. effects.  In the striatum, PDE10A availability showed a significant age-related decline that was larger compared to the age-related decline of D2/3 R availability and to the age-related decline of vols. measured with MRI.  In the globus pallidus, a less pronounced decline of PDE10A availability was obsd., whereas D2/3 R availability and vols. seemed to be rather stable with aging.  The distribution of the PDE10A enzyme was different from the distribution of D2/3 R, with higher availability in the globus pallidus.  These results indicate that aging is assocd. with a considerable physiol. redn. of the availability of PDE10A enzyme in the striatum.  Moreover as result of the anal., in the striatum for both the mol. targets, we obsd. a gender effect with higher BPND the female group.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp3Y4kPL-SiJbVg90H21EOLACvtfcHk0libNoPlDWP5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkt1Ogsbg%253D&md5=7222e155c4af49f0c622d7dbf1247d12</span></div><a href="/servlet/linkout?suffix=cit181&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2017.02.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2017.02.047%26sid%3Dliteratum%253Aachs%26aulast%3DFazio%26aufirst%3DP.%26aulast%3DSchain%26aufirst%3DM.%26aulast%3DMrzljak%26aufirst%3DL.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DNag%26aufirst%3DS.%26aulast%3DAl-Tawil%26aufirst%3DN.%26aulast%3DFitzer-Attas%26aufirst%3DC.%2BJ.%26aulast%3DBronzova%26aufirst%3DJ.%26aulast%3DLandwehrmeyer%26aufirst%3DB.%26aulast%3DSampaio%26aufirst%3DC.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DVarrone%26aufirst%3DA.%26atitle%3DPatterns%2520of%2520age%2520related%2520changes%2520for%2520phosphodiesterase%2520type-10A%2520in%2520comparison%2520with%2520dopamine%2520D2%252F3%2520receptors%2520and%2520sub-cortical%2520volumes%2520in%2520the%2520human%2520basal%2520ganglia%253A%2520A%2520PET%2520study%2520with%252018F-MNI-659%2520and%252011C-raclopride%2520with%2520correction%2520for%2520partial%2520volume%2520effect%26jtitle%3DNeuroImage%26date%3D2017%26volume%3D152%26spage%3D330%26epage%3D339%26doi%3D10.1016%2Fj.neuroimage.2017.02.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref182"><div class="reference"><strong class="refLabel"><a href="#ref182" class="rightTabRefNumLink">182</a></strong><div class="NLM_citation" id="rightTab-cit182"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bertoglio, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verhaeghe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kosten, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomae, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van der Linden, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stroobants, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wityak, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dominguez, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrzljak, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staelens, S.</span></span> <span> </span><span class="NLM_article-title">MR-based spatial normalization improves [<sup>18</sup>F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington’s disease</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>13</i></span>, <span class="NLM_elocation-id">e0206613</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0206613</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1371%2Fjournal.pone.0206613" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30365550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref182/cit182&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXjtF2isb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2018&author=D.+Bertoglioauthor=J.+Verhaegheauthor=L.+Kostenauthor=D.+Thomaeauthor=A.+Van+der+Lindenauthor=S.+Stroobantsauthor=J.+Wityakauthor=C.+Dominguezauthor=L.+Mrzljakauthor=S.+Staelens&title=MR-based+spatial+normalization+improves+%5B18F%5DMNI-659+PET+regional+quantification+and+detectability+of+disease+effect+in+the+Q175+mouse+model+of+Huntington%E2%80%99s+disease&doi=10.1371%2Fjournal.pone.0206613"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit182R"><div class="casContent"><span class="casTitleNuber">182</span><div class="casTitle"><span class="NLM_cas:atitle">MR-based spatial normalization improves {18F]MNI-659 PET regional quantification and detectability of disease effect in the Q175 mouse model of Huntington's disease</span></div><div class="casAuthors">Bertoglio, Daniele; Verhaeghe, Jeroen; Kosten, Lauren; Thomae, David; Vander Linden, Annemie; Stroobants, Sigrid; Wityak, John; Dominguez, Celia; Mrzljak, Ladislav; Staelens, Steven</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">e0206613/1-e0206613/16</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">We performed [18F] MNI-659 PET imaging in six months old heterozygous (HET) Q175 mice and wild-type (WT) littermates, followed by X-ray computed tomog. (CT) scan.  In the same week, individual T2-weighted MRI were acquired.  Spatial normalization and regional quantification of the PET/CT images was performed on MRI, [18F]MNI-659 PET, or CT template and compared to binding potential (BPND) using vols. manually delineated on the individual MR images.  Striatal vol. was significantly reduced in HET mice (-7.7%, p<0.0001) compared to WT littermates. [18F]MNI-659 BPND in striatum of HET animals was significantly reduced (p<0.0001) when compared to WT littermates using all three templates.  However, BPND values were significantly higher for HET mice using the PET template compared to the MRI and CT ones (p<0.0001), with an overestimation at lower activities.  On the other hand, the CT template spatial normalization introduced larger variability reducing the effect size.  The PET and CT template-based approaches resulted in a lower accuracy in BPND quantification with consequent decrease in the detectability of disease effect.  This study demonstrates that for [18F]MNI-659 brain PET imaging in mice the use of an MRI-based spatial normalization is recommended to achieve accurate quantification and fully exploit the detectability of disease effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoogwCVMIQnvrVg90H21EOLACvtfcHk0libNoPlDWP5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXjtF2isb4%253D&md5=d2aef11115ccf6bc483217626e5f3526</span></div><a href="/servlet/linkout?suffix=cit182&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0206613&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0206613%26sid%3Dliteratum%253Aachs%26aulast%3DBertoglio%26aufirst%3DD.%26aulast%3DVerhaeghe%26aufirst%3DJ.%26aulast%3DKosten%26aufirst%3DL.%26aulast%3DThomae%26aufirst%3DD.%26aulast%3DVan%2Bder%2BLinden%26aufirst%3DA.%26aulast%3DStroobants%26aufirst%3DS.%26aulast%3DWityak%26aufirst%3DJ.%26aulast%3DDominguez%26aufirst%3DC.%26aulast%3DMrzljak%26aufirst%3DL.%26aulast%3DStaelens%26aufirst%3DS.%26atitle%3DMR-based%2520spatial%2520normalization%2520improves%2520%255B18F%255DMNI-659%2520PET%2520regional%2520quantification%2520and%2520detectability%2520of%2520disease%2520effect%2520in%2520the%2520Q175%2520mouse%2520model%2520of%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DPLoS%2520One%26date%3D2018%26volume%3D13%26doi%3D10.1371%2Fjournal.pone.0206613" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref183"><div class="reference"><strong class="refLabel"><a href="#ref183" class="rightTabRefNumLink">183</a></strong><div class="NLM_citation" id="rightTab-cit183"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Svedberg, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnas, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varrone, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitsios, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mulder, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beaumont, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Munoz-Sanjuan, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zaleska, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mrzljak, L.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [<sup>18</sup>F]MNI-659</span>. <i>Brain Res.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>1711</i></span>,  <span class="NLM_fpage">140</span>– <span class="NLM_lpage">145</span>, <span class="refDoi"> DOI: 10.1016/j.brainres.2019.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.brainres.2019.01.021" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30664847" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref183/cit183&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1711&publication_year=2019&pages=140-145&author=M.+M.+Svedbergauthor=K.+Varnasauthor=A.+Varroneauthor=N.+Mitsiosauthor=J.+Mulderauthor=B.+Gulyasauthor=V.+Beaumontauthor=I.+Munoz-Sanjuanauthor=M.+M.+Zaleskaauthor=C.+J.+Schmidtauthor=C.+Halldinauthor=L.+Mrzljak&title=In+vitro+phosphodiesterase+10A+%28PDE10A%29+binding+in+whole+hemisphere+human+brain+using+the+PET+radioligand+%5B18F%5DMNI-659&doi=10.1016%2Fj.brainres.2019.01.021"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit183R"><div class="casContent"><span class="casTitleNuber">183</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro phosphodiesterase 10A (PDE10A) binding in whole hemisphere human brain using the PET radioligand [18F]MNI-659</span></div><div class="casAuthors">Svedberg, Marie M.; Varnaes, Katarina; Varrone, Andrea; Mitsios, Nicholas; Mulder, Jan; Gulyas, Balazs; Beaumont, Vahri; Munoz-Sanjuan, Ignacio; Zaleska, Margaret M.; Schmidt, Christopher J.; Halldin, Christer; Mrzljak, Ladislav</div><div class="citationInfo"><span class="NLM_cas:title">Brain Research</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">1711</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">140-145</span>CODEN:
                <span class="NLM_cas:coden">BRREAP</span>;
        ISSN:<span class="NLM_cas:issn">0006-8993</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Highly specific and sensitive biomarkers for pathologies related to dysfunctions in the basal ganglia circuit are of great value to assess therapeutic efficacy not only clin. to establish an early diagnosis, but also in terms of monitoring the efficacy of therapeutic interventions and decelerated neurodegeneration.  The phosphodiesterase 10A (PDE10A) enzyme plays a central role in striatal signaling and is implicated in several neuropsychiatric disorders involving striatal pathol., such as Huntingtons disease (HD) and schizophrenia.  Inhibition of PDE10A activates the neurons in the striatum and consequently leads to alteration of behavioral aspects modulated by the striatal circuit. [18F]MNI-659, (2-(2-(3-(4-(2-[18F]fluoroethoxy)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione), is a newly developed PET radioligand that shows a high binding to PDE10A in the human brain in vivo.  In the present study, we examd. the in vitro binding of [18F]MNI-659 in human postmortem brain to gain a better understanding of the presence, d., disease-related alterations and therapy related to changes in PDE10A expression.  The results show high specific binding of [18F]MNI-659 in the caudate nucleus, putamen and the hippocampal formation.  Low specific [18F]MNI-659 binding was detected in nucleus accumbens in comparison to the caudate nucleus and putamen.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp45cuqYe-tiLVg90H21EOLACvtfcHk0libNoPlDWP5GQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCrtL4%253D&md5=8ec5f7836d96ac3a3611e11a2968706d</span></div><a href="/servlet/linkout?suffix=cit183&amp;dbid=16384&amp;doi=10.1016%2Fj.brainres.2019.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.brainres.2019.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DSvedberg%26aufirst%3DM.%2BM.%26aulast%3DVarnas%26aufirst%3DK.%26aulast%3DVarrone%26aufirst%3DA.%26aulast%3DMitsios%26aufirst%3DN.%26aulast%3DMulder%26aufirst%3DJ.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DBeaumont%26aufirst%3DV.%26aulast%3DMunoz-Sanjuan%26aufirst%3DI.%26aulast%3DZaleska%26aufirst%3DM.%2BM.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DMrzljak%26aufirst%3DL.%26atitle%3DIn%2520vitro%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520binding%2520in%2520whole%2520hemisphere%2520human%2520brain%2520using%2520the%2520PET%2520radioligand%2520%255B18F%255DMNI-659%26jtitle%3DBrain%2520Res.%26date%3D2019%26volume%3D1711%26spage%3D140%26epage%3D145%26doi%3D10.1016%2Fj.brainres.2019.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref184"><div class="reference"><strong class="refLabel"><a href="#ref184" class="rightTabRefNumLink">184</a></strong><div class="NLM_citation" id="rightTab-cit184"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mori, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujinaga, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogawa, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatori, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wakizaka, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurihara, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohkubo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nengaki, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M. R.</span></span> <span> </span><span class="NLM_article-title">Development of 2-(2-(3-(4-([<sup>18</sup>F]fluoromethoxy-<i>d</i>2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoli ne-1,3-dione for positron-emission-tomography imaging of phosphodiesterase 10A in the brain</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">688</span>– <span class="NLM_lpage">698</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01366</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01366" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref184/cit184&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisVens7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=688-698&author=W.+Moriauthor=T.+Yamasakiauthor=M.+Fujinagaauthor=M.+Ogawaauthor=Y.+Zhangauthor=A.+Hatoriauthor=L.+Xieauthor=K.+Kumataauthor=H.+Wakizakaauthor=Y.+Kuriharaauthor=T.+Ohkuboauthor=N.+Nengakiauthor=M.+R.+Zhang&title=Development+of+2-%282-%283-%284-%28%5B18F%5Dfluoromethoxy-d2%29phenyl%29-7-methyl-4-oxo-3%2C4-dihydroquinazolin-2-yl%29ethyl%29-4-isopropoxyisoindoli+ne-1%2C3-dione+for+positron-emission-tomography+imaging+of+phosphodiesterase+10A+in+the+brain&doi=10.1021%2Facs.jmedchem.8b01366"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit184R"><div class="casContent"><span class="casTitleNuber">184</span><div class="casTitle"><span class="NLM_cas:atitle">Development of 2-(2-(3-(4-([18F]Fluoromethoxy-d2)phenyl)-7-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione for Positron-Emission-Tomography Imaging of Phosphodiesterase 10A in the Brain</span></div><div class="casAuthors">Mori, Wakana; Yamasaki, Tomoteru; Fujinaga, Masayuki; Ogawa, Masanao; Zhang, Yiding; Hatori, Akiko; Xie, Lin; Kumata, Katsushi; Wakizaka, Hidekatsu; Kurihara, Yusuke; Ohkubo, Takayuki; Nengaki, Nobuki; Zhang, Ming-Rong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">688-698</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a newly identified therapeutic target for central-nervous-system disorders.  2-(2-(3-(4-([18F]Fluoroethoxy)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione ([18F]MNI-659, [18F]5) is a useful positron-emission-tomog. (PET) ligand for imaging of PDE10A in the human brain.  However, the radiolabeled metabolite of [18F]5 can accumulate in the brain.  In this study, using [18F]5 as a lead compd., we designed four new 18F-labeled ligands ([18F]6-9) to find one more suitable than [18F]5.  Of these, 2-(2-(3-(4-([18F]fluoromethoxy-d2)phenyl)-4-oxo-3,4-dihydroquinazolin-2-yl)ethyl)-4-isopropoxyisoindoline-1,3-dione ([18F]9) exhibited high in vitro binding affinity (Ki = 2.9 nM) to PDE10A and suitable lipophilicity (log D = 2.2).  In PET studies, the binding potential (BPND) of [18F]9 (5.8) to PDE10A in the striatum of rat brains was significantly higher than that of [18F]5 (4.6).  Furthermore, metabolite anal. showed much lower levels of contamination with radiolabeled metabolites in the brains of rats given [18F]9 than in those given [18F]5.  In conclusion, [18F]9 is a useful PET ligand for PDE10A imaging in brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNZBmRsqYtq7Vg90H21EOLACvtfcHk0lg-mQpbvSegqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisVens7vF&md5=f33639771fb1846d33104a564d9f9aab</span></div><a href="/servlet/linkout?suffix=cit184&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01366%26sid%3Dliteratum%253Aachs%26aulast%3DMori%26aufirst%3DW.%26aulast%3DYamasaki%26aufirst%3DT.%26aulast%3DFujinaga%26aufirst%3DM.%26aulast%3DOgawa%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DHatori%26aufirst%3DA.%26aulast%3DXie%26aufirst%3DL.%26aulast%3DKumata%26aufirst%3DK.%26aulast%3DWakizaka%26aufirst%3DH.%26aulast%3DKurihara%26aufirst%3DY.%26aulast%3DOhkubo%26aufirst%3DT.%26aulast%3DNengaki%26aufirst%3DN.%26aulast%3DZhang%26aufirst%3DM.%2BR.%26atitle%3DDevelopment%2520of%25202-%25282-%25283-%25284-%2528%255B18F%255Dfluoromethoxy-d2%2529phenyl%2529-7-methyl-4-oxo-3%252C4-dihydroquinazolin-2-yl%2529ethyl%2529-4-isopropoxyisoindoli%2520ne-1%252C3-dione%2520for%2520positron-emission-tomography%2520imaging%2520of%2520phosphodiesterase%252010A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D688%26epage%3D698%26doi%3D10.1021%2Facs.jmedchem.8b01366" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref185"><div class="reference"><strong class="refLabel"><a href="#ref185" class="rightTabRefNumLink">185</a></strong><div class="NLM_citation" id="rightTab-cit185"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hostetler, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evelhoch, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGaughey, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purcell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renger, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span> <span> </span><span class="NLM_article-title">Discovery of [<sup>11</sup>C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">4893</span>– <span class="NLM_lpage">4898</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.05.080</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.bmcl.2015.05.080" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26077491" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref185/cit185&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXpsF2itb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=4893-4898&author=C.+D.+Coxauthor=E.+D.+Hostetlerauthor=B.+A.+Floresauthor=J.+L.+Evelhochauthor=H.+Fanauthor=L.+Gantertauthor=M.+Holahanauthor=W.+Engauthor=A.+Joshiauthor=G.+McGaugheyauthor=X.+Mengauthor=M.+Purcellauthor=I.+T.+Raheemauthor=K.+Riffelauthor=Y.+Yanauthor=J.+J.+Rengerauthor=S.+M.+Smithauthor=P.+J.+Coleman&title=Discovery+of+%5B11C%5DMK-8193+as+a+PET+tracer+to+measure+target+engagement+of+phosphodiesterase+10A+%28PDE10A%29+inhibitors&doi=10.1016%2Fj.bmcl.2015.05.080"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit185R"><div class="casContent"><span class="casTitleNuber">185</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of [11C]MK-8193 as a PET tracer to measure target engagement of phosphodiesterase 10A (PDE10A) inhibitors</span></div><div class="casAuthors">Cox, Christopher D.; Hostetler, Eric D.; Flores, Broc A.; Evelhoch, Jeffrey L.; Fan, Hong; Gantert, Liza; Holahan, Marie; Eng, Waisi; Joshi, Aniket; McGaughey, Georgia; Meng, Xiangjun; Purcell, Mona; Raheem, Izzat T.; Riffel, Kerry; Yan, Youwei; Renger, John J.; Smith, Sean M.; Coleman, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">4893-4898</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) inhibition has recently been identified as a potential mechanism to treat multiple symptoms that manifest in schizophrenia.  In order to facilitate preclin. development and support key proof-of-concept clin. trials of novel PDE10A inhibitors, it is crit. to discover positron emission tomog. (PET) tracers that enable plasma concn./PDE10A occupancy relationships to be established across species with structurally diverse PDE10A inhibitors.  In this Letter, we describe how a high-throughput screening hit was optimized to provide [11C]MK-8193 (8j), a PET tracer that supports the detn. of plasma concn./PDE10A occupancy relationships for structurally diverse series of PDE10A inhibitors in both rat and rhesus monkey.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVYY9goOOHw7Vg90H21EOLACvtfcHk0lg-mQpbvSegqg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXpsF2itb8%253D&md5=73dc73294c0c6ace954a0ba7d1827cfc</span></div><a href="/servlet/linkout?suffix=cit185&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.05.080&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.05.080%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DFlores%26aufirst%3DB.%2BA.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DJoshi%26aufirst%3DA.%26aulast%3DMcGaughey%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DYan%26aufirst%3DY.%26aulast%3DRenger%26aufirst%3DJ.%2BJ.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26atitle%3DDiscovery%2520of%2520%255B11C%255DMK-8193%2520as%2520a%2520PET%2520tracer%2520to%2520measure%2520target%2520engagement%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitors%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D4893%26epage%3D4898%26doi%3D10.1016%2Fj.bmcl.2015.05.080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref186"><div class="reference"><strong class="refLabel"><a href="#ref186" class="rightTabRefNumLink">186</a></strong><div class="NLM_citation" id="rightTab-cit186"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hostetler, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joshi, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gantert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holahan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Malley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Purcell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riffel, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buist, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coleman, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cox, C. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flores, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Raheem, I. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cook, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evelhoch, J. L.</span></span> <span> </span><span class="NLM_article-title">Preclinical characterization of the phosphodiesterase 10A PET tracer [<sup>11</sup>C]MK-8193</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">579</span>– <span class="NLM_lpage">587</span>, <span class="refDoi"> DOI: 10.1007/s11307-015-0910-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs11307-015-0910-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26596571" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref186/cit186&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFCqu7%252FM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2016&pages=579-587&author=E.+D.+Hostetlerauthor=H.+Fanauthor=A.+D.+Joshiauthor=Z.+Zengauthor=W.+Engauthor=L.+Gantertauthor=M.+Holahanauthor=X.+Mengauthor=P.+Millerauthor=S.+O%E2%80%99Malleyauthor=M.+Purcellauthor=K.+Riffelauthor=C.+Salinasauthor=M.+Williamsauthor=B.+Maauthor=N.+Buistauthor=S.+M.+Smithauthor=P.+J.+Colemanauthor=C.+D.+Coxauthor=B.+A.+Floresauthor=I.+T.+Raheemauthor=J.+J.+Cookauthor=J.+L.+Evelhoch&title=Preclinical+characterization+of+the+phosphodiesterase+10A+PET+tracer+%5B11C%5DMK-8193&doi=10.1007%2Fs11307-015-0910-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit186R"><div class="casContent"><span class="casTitleNuber">186</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical Characterization of the Phosphodiesterase 10A PET Tracer [11C]MK-8193</span></div><div class="casAuthors">Hostetler, Eric D.; Fan, Hong; Joshi, Aniket D.; Zeng, Zhizhen; Eng, Waisi; Gantert, Liza; Holahan, Marie; Meng, Xianjun; Miller, Patricia; O'Malley, Stacey; Purcell, Mona; Riffel, Kerry; Salinas, Cristian; Williams, Mangay; Ma, Bennett; Buist, Nicole; Smith, Sean M.; Coleman, Paul J.; Cox, Christopher D.; Flores, Brock A.; Raheem, Izzat T.; Cook, Jacquelynn J.; Evelhoch, Jeffrey L.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging and Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">579-587</span>CODEN:
                <span class="NLM_cas:coden">MIBOCZ</span>;
        ISSN:<span class="NLM_cas:issn">1860-2002</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: A positron emission tomog. (PET) tracer for the enzyme phosphodiesterase 10A (PDE10A) is desirable to guide the discovery and development of PDE10A inhibitors as potential therapeutics.  The preclin. characterization of the PDE10A PET tracer [11C]MK-8193 is described.  Procedures: In vitro binding studies with [3H]MK-8193 were conducted in rat, monkey, and human brain tissue.  PET studies with [11C]MK-8193 were conducted in rats and rhesus monkeys at baseline and following administration of a PDE10A inhibitor.  Results: [3H]MK-8193 is a high-affinity, selective PDE10A radioligand in rat, monkey, and human brain tissue.  In vivo, [11C]MK-8193 displays rapid kinetics, low test-retest variability, and a large specific signal that is displaced by a structurally diverse PDE10A inhibitor, enabling the detn. of pharmacokinetic/enzyme occupancy relationships.  Conclusions: [11C]MK-8193 is a useful PET tracer for the preclin. characterization of PDE10A therapeutic candidates in rat and monkey.  Further evaluation of [11C]MK-8193 in humans is warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqwvkeZtq8g8bVg90H21EOLACvtfcHk0ljlLsN0tRJFpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFCqu7%252FM&md5=280beea4b1e031e3cf2a218ed9837903</span></div><a href="/servlet/linkout?suffix=cit186&amp;dbid=16384&amp;doi=10.1007%2Fs11307-015-0910-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-015-0910-0%26sid%3Dliteratum%253Aachs%26aulast%3DHostetler%26aufirst%3DE.%2BD.%26aulast%3DFan%26aufirst%3DH.%26aulast%3DJoshi%26aufirst%3DA.%2BD.%26aulast%3DZeng%26aufirst%3DZ.%26aulast%3DEng%26aufirst%3DW.%26aulast%3DGantert%26aufirst%3DL.%26aulast%3DHolahan%26aufirst%3DM.%26aulast%3DMeng%26aufirst%3DX.%26aulast%3DMiller%26aufirst%3DP.%26aulast%3DO%25E2%2580%2599Malley%26aufirst%3DS.%26aulast%3DPurcell%26aufirst%3DM.%26aulast%3DRiffel%26aufirst%3DK.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DMa%26aufirst%3DB.%26aulast%3DBuist%26aufirst%3DN.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DColeman%26aufirst%3DP.%2BJ.%26aulast%3DCox%26aufirst%3DC.%2BD.%26aulast%3DFlores%26aufirst%3DB.%2BA.%26aulast%3DRaheem%26aufirst%3DI.%2BT.%26aulast%3DCook%26aufirst%3DJ.%2BJ.%26aulast%3DEvelhoch%26aufirst%3DJ.%2BL.%26atitle%3DPreclinical%2520characterization%2520of%2520the%2520phosphodiesterase%252010A%2520PET%2520tracer%2520%255B11C%255DMK-8193%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2016%26volume%3D18%26spage%3D579%26epage%3D587%26doi%3D10.1007%2Fs11307-015-0910-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref187"><div class="reference"><strong class="refLabel"><a href="#ref187" class="rightTabRefNumLink">187</a></strong><div class="NLM_citation" id="rightTab-cit187"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kehler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilburn, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estrada, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christensen, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibblin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubberink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brennum, L. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiniger-Brach, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christoffersen, C. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timmermann, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kreilgaard, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of <sup>11</sup>C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">1513</span>– <span class="NLM_lpage">1518</span>, <span class="refDoi"> DOI: 10.2967/jnumed.114.140178</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.114.140178" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24994928" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref187/cit187&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVSrur3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=1513-1518&author=J.+Kehlerauthor=J.+P.+Kilburnauthor=S.+Estradaauthor=S.+R.+Christensenauthor=A.+Wallauthor=A.+Thibblinauthor=M.+Lubberinkauthor=C.+Bundgaardauthor=L.+T.+Brennumauthor=B.+Steiniger-Brachauthor=C.+T.+Christoffersenauthor=S.+Timmermannauthor=M.+Kreilgaardauthor=G.+Antoniauthor=B.+Bang-Andersenauthor=J.+Nielsen&title=Discovery+and+development+of+11C-Lu+AE92686+as+a+radioligand+for+PET+imaging+of+phosphodiesterase10A+in+the+brain&doi=10.2967%2Fjnumed.114.140178"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit187R"><div class="casContent"><span class="casTitleNuber">187</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of 11C-Lu AE92686 as a radioligand for PET imaging of phosphodiesterase10A in the brain</span></div><div class="casAuthors">Kehler, Jan; Kilburn, John Paul; Estrada, Sergio; Christensen, Soren Rahn; Wall, Anders; Thibblin, Alf; Lubberink, Mark; Bundgaard, Christoffer; Brennum, Lise Tourup; Steiniger-Brach, Bjorn; Christoffersen, Claus Tomby; Timmermann, Stine; Kreilgaard, Mads; Antoni, Gunnar; Bang-Andersen, Benny; Nielsen, Jacob</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1513-1518</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) plays a key role in the regulation of brain striatal signaling, and several pharmaceutical companies currently investigate PDE10A inhibitors in clin. trials for various central nervous system diseases.  A PDE10A PET ligand may provide evidence that a clin. drug candidate reaches and binds to the target.  Here we describe the successful discovery and initial validation of the novel radiolabeled PDE10A ligand 5,8-dimethyl-2-[2-((1-11C-methyl)-4-phenyl-1H-imidazol-2-yl)-ethyl]-[1,2,4]triazolo[1,5-a]pyridine (11C-Lu AE92686) and its tritiated analog 3H-Lu AE92686.  Methods: Initial in vitro expts. suggested Lu AE92686 as a promising radioligand, and the corresponding tritiated and 11C-labeled compds. were synthesized.  3H-Lu AE92686 was evaluated as a ligand for in vivo occupancy studies in mice and rats, and 11C-Lu AE92686 was evaluated as a PET tracer candidate in cynomolgus monkeys and in humans.  Results: 11C-Lu AE92686 displayed high specificity and selectivity for PDE10A-expressing regions in the brain of cynomolgus monkeys and humans.  Similar results were found in rodents using 3H-Lu AE92686.  The binding of 11C-Lu AE92686 and 3H-Lu AE92686 to striatum was completely and dose-dependently blocked by the structurally different PDE10A inhibitor 2-[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline (MP-10) in rodents and in monkeys.  In all species, specific binding of the radioligand was seen in the striatum but not in the cerebellum, supporting the use of the cerebellum as a ref. region.  The binding potentials (BPND) of 11C-Lu AE92686 in the striatum of both cynomolgus monkeys and humans were evaluated by the simplified ref. tissue model with the cerebellum as the ref. tissue, and BPND was found to be high and reproducible-i.e., BPNDs were 6.5 ± 0.3 (n = 3) and 7.5 ± 1.0 (n = 12) in monkeys and humans, resp.  Conclusion: Rodent, monkey, and human tests of labeled Lu AE92686 suggest that 11C-Lu AE92686 has great potential as a human PET tracer for the PDE10A enzyme.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojaLsSdAC7rbVg90H21EOLACvtfcHk0ljlLsN0tRJFpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVSrur3F&md5=a7a0842a56e497ae188e149a3488e620</span></div><a href="/servlet/linkout?suffix=cit187&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.114.140178&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.114.140178%26sid%3Dliteratum%253Aachs%26aulast%3DKehler%26aufirst%3DJ.%26aulast%3DKilburn%26aufirst%3DJ.%2BP.%26aulast%3DEstrada%26aufirst%3DS.%26aulast%3DChristensen%26aufirst%3DS.%2BR.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DThibblin%26aufirst%3DA.%26aulast%3DLubberink%26aufirst%3DM.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DBrennum%26aufirst%3DL.%2BT.%26aulast%3DSteiniger-Brach%26aufirst%3DB.%26aulast%3DChristoffersen%26aufirst%3DC.%2BT.%26aulast%3DTimmermann%26aufirst%3DS.%26aulast%3DKreilgaard%26aufirst%3DM.%26aulast%3DAntoni%26aufirst%3DG.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DNielsen%26aufirst%3DJ.%26atitle%3DDiscovery%2520and%2520development%2520of%252011C-Lu%2520AE92686%2520as%2520a%2520radioligand%2520for%2520PET%2520imaging%2520of%2520phosphodiesterase10A%2520in%2520the%2520brain%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D1513%26epage%3D1518%26doi%3D10.2967%2Fjnumed.114.140178" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref188"><div class="reference"><strong class="refLabel"><a href="#ref188" class="rightTabRefNumLink">188</a></strong><div class="NLM_citation" id="rightTab-cit188"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nielsen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bundgaard, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bang-Andersen, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimwood, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farde, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Finnema, S. J.</span></span> <span> </span><span class="NLM_article-title">Characterization of [<sup>11</sup>C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain</span>. <i>Eur. J. Nucl. Med. Mol. Imaging</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">308</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1007/s00259-016-3544-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs00259-016-3544-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27817159" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref188/cit188&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVaiu7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2017&pages=308-320&author=K.+C.+Yangauthor=V.+Stepanovauthor=N.+Aminiauthor=S.+Martinssonauthor=A.+Takanoauthor=J.+Nielsenauthor=C.+Bundgaardauthor=B.+Bang-Andersenauthor=S.+Grimwoodauthor=C.+Halldinauthor=L.+Fardeauthor=S.+J.+Finnema&title=Characterization+of+%5B11C%5DLu+AE92686+as+a+PET+radioligand+for+phosphodiesterase+10A+in+the+nonhuman+primate+brain&doi=10.1007%2Fs00259-016-3544-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit188R"><div class="casContent"><span class="casTitleNuber">188</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of [11C]Lu AE92686 as a PET radioligand for phosphodiesterase 10A in the nonhuman primate brain</span></div><div class="casAuthors">Yang, Kai-Chun; Stepanov, Vladimir; Amini, Nahid; Martinsson, Stefan; Takano, Akihiro; Nielsen, Jacob; Bundgaard, Christoffer; Bang-Andersen, Benny; Grimwood, Sarah; Halldin, Christer; Farde, Lars; Finnema, Sjoerd J.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Nuclear Medicine and Molecular Imaging</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">44</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">308-320</span>CODEN:
                <span class="NLM_cas:coden">EJNMA6</span>;
        ISSN:<span class="NLM_cas:issn">1619-7070</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: [11C]Lu AE92686 is a positron emission tomog. (PET) radioligand that has recently been validated for examg. phosphodiesterase 10A (PDE10A) in the human striatum.  [11C]Lu AE92686 has high affinity for PDE10A (IC50 = 0.39 nM) and may also be suitable for examn. of the substantia nigra, a region with low d. of PDE10A.  Here, we report characterization of regional [11C]Lu AE92686 binding to PDE10A in the nonhuman primate (NHP) brain.  Methods: A total of 11 PET measurements, seven baseline and four following pretreatment with unlabeled Lu AE92686 or the structurally unrelated PDE10A inhibitor MP-10, were performed in five NHPs using a high resoln. research tomograph (HRRT).  [11C]Lu AE92686 binding was quantified using a radiometabolite-cor. arterial input function and compartmental and graphical modeling approaches.  Results: Regional time-activity curves were best described with the two-tissue compartment model (2TCM).  However, the distribution vol. (VT) values for all regions were obtained by the Logan plot anal., as reliable cerebellar VT values could not be derived by the 2TCM.  For cerebellum, a proposed ref. region, VT values increased by ∼30 % with increasing PET measurement duration from 63 to 123 min, while VT values in target regions remained stable.  Both pretreatment drugs significantly decreased [11C]Lu AE92686 binding in target regions, while no significant effect on cerebellum was obsd.  Binding potential (BPND) values, derived with the simplified ref. tissue model (SRTM), were 13-17 in putamen and 3-5 in substantia nigra and correlated well to values from the Logan plot anal.  Conclusions: The method proposed for quantification of [11C]Lu AE92686 binding in applied studies in NHP is based on 63 min PET data and SRTM with cerebellum as a ref. region.  The study supports that [11C]Lu AE92686 can be used for PET examns. of PDE10A binding also in substantia nigra.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp-yWXVCDhoZ7Vg90H21EOLACvtfcHk0ljlLsN0tRJFpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVaiu7bI&md5=40a7c1aa947dec97ba54e6cd44787321</span></div><a href="/servlet/linkout?suffix=cit188&amp;dbid=16384&amp;doi=10.1007%2Fs00259-016-3544-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00259-016-3544-9%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DK.%2BC.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMartinsson%26aufirst%3DS.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNielsen%26aufirst%3DJ.%26aulast%3DBundgaard%26aufirst%3DC.%26aulast%3DBang-Andersen%26aufirst%3DB.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DFarde%26aufirst%3DL.%26aulast%3DFinnema%26aufirst%3DS.%2BJ.%26atitle%3DCharacterization%2520of%2520%255B11C%255DLu%2520AE92686%2520as%2520a%2520PET%2520radioligand%2520for%2520phosphodiesterase%252010A%2520in%2520the%2520nonhuman%2520primate%2520brain%26jtitle%3DEur.%2520J.%2520Nucl.%2520Med.%2520Mol.%2520Imaging%26date%3D2017%26volume%3D44%26spage%3D308%26epage%3D320%26doi%3D10.1007%2Fs00259-016-3544-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref189"><div class="reference"><strong class="refLabel"><a href="#ref189" class="rightTabRefNumLink">189</a></strong><div class="NLM_citation" id="rightTab-cit189"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boden, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wall, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lubberink, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ekselius, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Larsson, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antoni, G.</span></span> <span> </span><span class="NLM_article-title">Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study</span>. <i>Transl. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e1050</span> <span class="refDoi"> DOI: 10.1038/tp.2017.11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Ftp.2017.11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=28267149" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref189/cit189&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXkvVSnsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2017&author=R.+Bodenauthor=J.+Perssonauthor=A.+Wallauthor=M.+Lubberinkauthor=L.+Ekseliusauthor=E.+M.+Larssonauthor=G.+Antoni&title=Striatal+phosphodiesterase+10A+and+medial+prefrontal+cortical+thickness+in+patients+with+schizophrenia%3A+a+PET+and+MRI+study&doi=10.1038%2Ftp.2017.11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit189R"><div class="casContent"><span class="casTitleNuber">189</span><div class="casTitle"><span class="NLM_cas:atitle">Striatal phosphodiesterase 10A and medial prefrontal cortical thickness in patients with schizophrenia: a PET and MRI study</span></div><div class="casAuthors">Boden, R.; Persson, J.; Wall, A.; Lubberink, M.; Ekselius, L.; Larsson, E.-M.; Antoni, G.</div><div class="citationInfo"><span class="NLM_cas:title">Translational Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">e1050</span>CODEN:
                <span class="NLM_cas:coden">TPRSCF</span>;
        ISSN:<span class="NLM_cas:issn">2158-3188</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">The enzyme phosphodiesterase 10A (PDE10A) is abundant in striatal medium spiny neurons and has been implicated in the pathophysiol. of schizophrenia in animal models and is investigated as a possible new pharmacol. treatment target.  A redn. of prefrontal cortical thickness is common in schizophrenia, but how this relates to PDE10A expression is unknown.  Our study aim was to compare, we believe for the first time, the striatal non-displaceable binding potential (BPND) of the new validated PDE10A ligand [11C]Lu AE92686 between patients with schizophrenia and healthy controls.  Furthermore, we aimed to assess the correlation of PDE10A BPND to cortical thickness.  Sixteen healthy male controls and 10 male patients with schizophrenia treated with clozapine, olanzapine or quetiapine were investigated with positron emission tomog. (PET) and magnetic resonance imaging (MRI).  Striatal binding potential (BPND) of [11C]Lu AE92686 was acquired through dynamic PET scans and cortical thickness by structural MRI.  Clin. assessments of symptoms and cognitive function were performed and the antipsychotic dosage was recorded.  Patients with schizophrenia had a significantly lower BPND of [11C]Lu AE92686 in striatum (P=0.003) than healthy controls.  The striatal BPND significantly correlated to cortical thickness in the medial prefrontal cortex and superior frontal gyrus across patients with schizophrenia and healthy controls.  No significant correlation was obsd. between the BPND for [11C]Lu AE92686 in striatum and age, schizophrenia symptoms, antipsychotic dosage, coffee consumption, smoking, duration of illness or cognitive function in the patients.  In conclusion, PDE10A may be important for functioning in the striato-cortical interaction and in the pathophysiol. of schizophrenia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql31MnbvlqVLVg90H21EOLACvtfcHk0ljUgDLPZF-Ulw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXkvVSnsLY%253D&md5=c9443218293f591374f85ae5b6d2e076</span></div><a href="/servlet/linkout?suffix=cit189&amp;dbid=16384&amp;doi=10.1038%2Ftp.2017.11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Ftp.2017.11%26sid%3Dliteratum%253Aachs%26aulast%3DBoden%26aufirst%3DR.%26aulast%3DPersson%26aufirst%3DJ.%26aulast%3DWall%26aufirst%3DA.%26aulast%3DLubberink%26aufirst%3DM.%26aulast%3DEkselius%26aufirst%3DL.%26aulast%3DLarsson%26aufirst%3DE.%2BM.%26aulast%3DAntoni%26aufirst%3DG.%26atitle%3DStriatal%2520phosphodiesterase%252010A%2520and%2520medial%2520prefrontal%2520cortical%2520thickness%2520in%2520patients%2520with%2520schizophrenia%253A%2520a%2520PET%2520and%2520MRI%2520study%26jtitle%3DTransl.%2520Psychiatry%26date%3D2017%26volume%3D7%26doi%3D10.1038%2Ftp.2017.11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref190"><div class="reference"><strong class="refLabel"><a href="#ref190" class="rightTabRefNumLink">190</a></strong><div class="NLM_citation" id="rightTab-cit190"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakashima, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Development of a series of novel carbon-11 labeled PDE10A inhibitors</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">202</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3284</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.3284" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25891816" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref190/cit190&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXmslegsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=202-208&author=V.+Stepanovauthor=S.+Miuraauthor=A.+Takanoauthor=N.+Aminiauthor=R.+Nakaoauthor=T.+Hasuiauthor=K.+Nakashimaauthor=T.+Taniguchiauthor=H.+Kimuraauthor=T.+Kuroitaauthor=C.+Halldin&title=Development+of+a+series+of+novel+carbon-11+labeled+PDE10A+inhibitors&doi=10.1002%2Fjlcr.3284"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit190R"><div class="casContent"><span class="casTitleNuber">190</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a series of novel carbon-11 labeled PDE10A inhibitors</span></div><div class="casAuthors">Stepanov, Vladimir; Miura, Shotaro; Takano, Akihiro; Amini, Nahid; Nakao, Ryuji; Hasui, Tomoaki; Nakashima, Kosuke; Taniguchi, Takahiko; Kimura, Haruhide; Kuroita, Takanobu; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">202-208</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">A series of structurally related phosphodiesterase 10A (PDE10A) inhibitors with carbon-11 were synthesized and evaluated as potential positron emission tomog. (PET) radioligands for PDE10A using nonhuman primates.  The series consisted of seven compds. based on the 3-(1H-pyrazol-5-yl)pyridazin-4(1H)-one backbone.  These compds. were selected from the initial larger library based on a no. of parameters such as affinity, selectivity for hPDE10A in in-vitro tests, lipophilicity, and on the results of multidrug resistance protein 1 (MDR1)-LLCPK1 and the parallel artificial membrane permeability assays.  Seven radioligands were radiolabeled with carbon-11 employing O-methylation on the hydroxyl moiety using [11C]methyl triflate.  In-vivo examn. of each radioligand was performed using PET in rhesus monkeys; anal. of radiometabolites in plasma also was conducted using HPLC.  All seven radioligands were labeled with high (>90%) incorporation of [11C]methyl triflate into their appropriate precursors and with high specific radioactivity.  Carbon-11 labeled compds. I (X = CH, N) showed high accumulation in the striatum, consistent with the known anatomical distribution of PDE10A in brain, accompanied by fast washout and high specific binding ratio.  In particular compd. I (X = CH), was a promising PET tool for further examn. of PDE10A in human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp30BLNX0Ry7Vg90H21EOLACvtfcHk0ljUgDLPZF-Ulw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXmslegsbk%253D&md5=5a942473c561aa3cd691c3aa716bca1d</span></div><a href="/servlet/linkout?suffix=cit190&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3284&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3284%26sid%3Dliteratum%253Aachs%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DNakashima%26aufirst%3DK.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DKuroita%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520a%2520series%2520of%2520novel%2520carbon-11%2520labeled%2520PDE10A%2520inhibitors%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2015%26volume%3D58%26spage%3D202%26epage%3D208%26doi%3D10.1002%2Fjlcr.3284" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref191"><div class="reference"><strong class="refLabel"><a href="#ref191" class="rightTabRefNumLink">191</a></strong><div class="NLM_citation" id="rightTab-cit191"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Harada, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kamiguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuroita, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">146</span>– <span class="NLM_lpage">154</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.09.005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2014.09.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25451212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref191/cit191&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhvVamsLjI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2015&pages=146-154&author=A.+Haradaauthor=K.+Suzukiauthor=S.+Miuraauthor=T.+Hasuiauthor=N.+Kamiguchiauthor=T.+Ishiiauthor=T.+Taniguchiauthor=T.+Kuroitaauthor=A.+Takanoauthor=V.+Stepanovauthor=C.+Halldinauthor=H.+Kimura&title=Characterization+of+the+binding+properties+of+T-773+as+a+PET+radioligand+for+phosphodiesterase+10A&doi=10.1016%2Fj.nucmedbio.2014.09.005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit191R"><div class="casContent"><span class="casTitleNuber">191</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of the binding properties of T-773 as a PET radioligand for phosphodiesterase 10A</span></div><div class="casAuthors">Harada, Akina; Suzuki, Kazunori; Miura, Shotaro; Hasui, Tomoaki; Kamiguchi, Naomi; Ishii, Tsuyoshi; Taniguchi, Takahiko; Kuroita, Takanobu; Takano, Akihiro; Stepanov, Vladimir; Halldin, Christer; Kimura, Haruhide</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">146-154</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a dual-substrate PDE that hydrolyzes both cAMP and cGMP and is selectively expressed in striatal medium spiny neurons.  Recent studies have suggested that PDE10A inhibition is a novel approach for the treatment of disorders such as schizophrenia and Huntington's disease.  A positron emission tomog. (PET) occupancy study can provide useful information for the development of PDE10A inhibitors.  We discovered T-773 as a candidate PET radioligand for PDE10A and investigated its properties by in vitro autoradiog. and a PET study in a monkey.  Profiling of T-773 as a PET radioligand for PDE10A was conducted by in vitro enzyme inhibitory assay, in vitro autoradiog., and PET study in a monkey.  T-773 showed a high binding affinity and selectivity for human recombinant PDE10A2 in vitro; the IC50 value in an enzyme inhibitory assay was 0.77 nmol/L, and selectivity over other PDEs was more than 2500-fold.  In autoradiog. studies using mouse, rat, monkey, or human brain sections, radiolabeled T-773 selectively accumulated in the striatum.  This selective accumulation was not obsd. in the brain sections of Pde10a-KO mice.  The binding of [3H]T-773 to PDE10A in rat brain sections was competitively inhibited by MP-10, a selective PDE10A inhibitor.  In rat brain sections, [3H]T-773 bound to a single high affinity site of PDE10A with Kd values of 12.2 ± 2.2 and 4.7 ± 1.2 nmol/L in the caudate-putamen and nucleus accumbens, resp.  In a monkey PET study, [11C]T-773 showed good brain penetration and striatum-selective accumulation.  These results suggest that [11C]T-773 is a potential PET radioligand for PDE10A.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGokE5ArBExezrVg90H21EOLACvtfcHk0ljUgDLPZF-Ulw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhvVamsLjI&md5=464e0aa5d1610036958a9507dc42f58f</span></div><a href="/servlet/linkout?suffix=cit191&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.09.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.09.005%26sid%3Dliteratum%253Aachs%26aulast%3DHarada%26aufirst%3DA.%26aulast%3DSuzuki%26aufirst%3DK.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DKamiguchi%26aufirst%3DN.%26aulast%3DIshii%26aufirst%3DT.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DKuroita%26aufirst%3DT.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DKimura%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520the%2520binding%2520properties%2520of%2520T-773%2520as%2520a%2520PET%2520radioligand%2520for%2520phosphodiesterase%252010A%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2015%26volume%3D42%26spage%3D146%26epage%3D154%26doi%3D10.1016%2Fj.nucmedbio.2014.09.005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref192"><div class="reference"><strong class="refLabel"><a href="#ref192" class="rightTabRefNumLink">192</a></strong><div class="NLM_citation" id="rightTab-cit192"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Toth, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haggkvist, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Molecular imaging of PDE10A knockout mice with a novel PET radiotracer: [<sup>11</sup>C]T-773</span>. <i>Mol. Imaging Biol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">445</span>– <span class="NLM_lpage">449</span>, <span class="refDoi"> DOI: 10.1007/s11307-015-0822-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1007%2Fs11307-015-0822-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25622810" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref192/cit192&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1SmurfJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2015&pages=445-449&author=M.+Tothauthor=J.+Haggkvistauthor=V.+Stepanovauthor=A.+Takanoauthor=R.+Nakaoauthor=N.+Aminiauthor=S.+Miuraauthor=H.+Kimuraauthor=T.+Taniguchiauthor=B.+Gulyasauthor=C.+Halldin&title=Molecular+imaging+of+PDE10A+knockout+mice+with+a+novel+PET+radiotracer%3A+%5B11C%5DT-773&doi=10.1007%2Fs11307-015-0822-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit192R"><div class="casContent"><span class="casTitleNuber">192</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular Imaging of PDE10A Knockout Mice with a Novel PET Radiotracer: [11C]T-773</span></div><div class="casAuthors">Toth, Miklos; Haeggkvist, Jenny; Stepanov, Vladimir; Takano, Akihiro; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Kimura, Haruhide; Taniguchi, Takahiko; Gulyas, Balazs; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Imaging and Biology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">445-449</span>CODEN:
                <span class="NLM_cas:coden">MIBOCZ</span>;
        ISSN:<span class="NLM_cas:issn">1860-2002</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: [11C]T-773 is a new radioligand for positron emission tomog. (PET) targeting the phosphodiesterase 10A enzyme (PDE10A).  PDE10A is highly expressed in the striatum by medium spiny neurons, and it has been demonstrated to be involved in the regulation of striatal signaling through the redn. of medium spiny neuronal sensitivity towards glutamatergic excitation.  PDE10A is assocd. with Parkinson's disease and different neuropsychiatric disorders such as Huntington's disease, obsessive-compulsive disorders (OCD) and schizophrenia.  Studies have indicated that the inhibition of PDE10A may represent a novel therapeutic approach to the treatment of the aforementioned diseases characterized by the reduced activity of medium spiny neurons.  An appropriate PET radioligand for PDE10A would help to facilitate drug development and drug evaluation.  Procedures: We have evaluated the [11C]T-773 ligand in PDE10A knockout mice (heterozygous [HET] and homozygous [HOM]) as well as in normal control animals (WILD) with PET.  Results: The regional percent standardized uptake values (%SUV; mean ± SD) in the striatum were 48.2 ± 1.0 (HOM), 63.6 ± 5.3 (HET) and 85.1 ± 6.3 (WILD).  Between each animal group the striatal %SUV values were significantly different (p < 0.0001).  The striatal BPND values (mean ± SD) were 0.0 ± 0.0 (HOM), 0.14 ± 0.07 (HET) and 0.56 ± 0.15 (WILD).  The BPND values were significantly lower in homozygous and heterozygous animals compared to wild type (p < 0.0001).  Conclusions: The novel PDE10A radioligand [11C]T-773 shows increased signals with higher levels of PDE10A and acceptable binding in the striatum in control animals compared to knockout mice.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBr8ymNqXzHbVg90H21EOLACvtfcHk0lh__ouZaQwaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1SmurfJ&md5=587cc1056274405af54320865e01acd8</span></div><a href="/servlet/linkout?suffix=cit192&amp;dbid=16384&amp;doi=10.1007%2Fs11307-015-0822-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11307-015-0822-z%26sid%3Dliteratum%253Aachs%26aulast%3DToth%26aufirst%3DM.%26aulast%3DHaggkvist%26aufirst%3DJ.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DMolecular%2520imaging%2520of%2520PDE10A%2520knockout%2520mice%2520with%2520a%2520novel%2520PET%2520radiotracer%253A%2520%255B11C%255DT-773%26jtitle%3DMol.%2520Imaging%2520Biol.%26date%3D2015%26volume%3D17%26spage%3D445%26epage%3D449%26doi%3D10.1007%2Fs11307-015-0822-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref193"><div class="reference"><strong class="refLabel"><a href="#ref193" class="rightTabRefNumLink">193</a></strong><div class="NLM_citation" id="rightTab-cit193"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Evaluation of a novel PDE10A PET radioligand, [<sup>11</sup>C]T-773, in nonhuman primates: brain and whole body PET and brain autoradiography</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">345</span>– <span class="NLM_lpage">355</span>, <span class="refDoi"> DOI: 10.1002/syn.21821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25892433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref193/cit193&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXos1Okuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2015&pages=345-355&author=A.+Takanoauthor=V.+Stepanovauthor=B.+Gulyasauthor=R.+Nakaoauthor=N.+Aminiauthor=S.+Miuraauthor=H.+Kimuraauthor=T.+Taniguchiauthor=C.+Halldin&title=Evaluation+of+a+novel+PDE10A+PET+radioligand%2C+%5B11C%5DT-773%2C+in+nonhuman+primates%3A+brain+and+whole+body+PET+and+brain+autoradiography&doi=10.1002%2Fsyn.21821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit193R"><div class="casContent"><span class="casTitleNuber">193</span><div class="casTitle"><span class="NLM_cas:atitle">Evaluation of a novel PDE10A PET radioligand, [11C]T-773, in nonhuman primates: Brain and whole body PET and brain autoradiography</span></div><div class="casAuthors">Takano, Akihiro; Stepanov, Vladimir; Gulyas, Balazs; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Kimura, Haruhide; Taniguchi, Takahiko; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">345-355</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is considered to be a key target for the treatment of several neuropsychiatric diseases.  The characteristics of [11C]T-773, a novel positron emission tomog. (PET) radioligand with high binding affinity and selectivity for PDE10A, were evaluated in autoradiog. and in nonhuman primate (NHP) PET.  Brain PET measurements were performed under baseline conditions and after administration of a selective PDE10A inhibitor, MP-10.  Total distribution vol. (VT) and binding potential (BPND) were calcd. using various kinetic models.  Whole body PET measurements were performed to calc. the ED of [11C]T-773.  Autoradiog. studies in postmortem human and monkey brain sections showed high accumulation of [11C]T-773 in the striatum and substantia nigra which was blocked by MP-10.  Brain PET showed high accumulation of [11C]T-773 in the striatum, and the data could be fitted using a two tissue compartment model.  BPND was approx. 1.8 in the putamen when the cerebellum was used as the ref. region.  Approx. 70% of PDE10A binding was occupied by 1.8 mg/kg of MP-10.  Whole body PET showed high accumulation of [11C]T-773 in the liver, kidney, heart, and brain in the initial phase.  The radioligand was partly excreted via bile and the gastrointestinal tract, and partly excreted through the urinary tract.  The calcd. ED was 0.007 mSv/MBq.  In conclusion, [11C]T-773 was demonstrated to be a promising PET radioligand for PDE10A with favorable brain kinetics.  Dosimetry results support multiple PET measurements per person in human studies.  Further research is required with [11C]T-773 in order to test the radioligand's potential clin. applications.  Synapse, 2015. © 2015 Wiley Periodicals, Inc.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqRAv34x2bx9bVg90H21EOLACvtfcHk0lh__ouZaQwaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXos1Okuro%253D&md5=62b32f8095221719757b3e91498c6964</span></div><a href="/servlet/linkout?suffix=cit193&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21821%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DEvaluation%2520of%2520a%2520novel%2520PDE10A%2520PET%2520radioligand%252C%2520%255B11C%255DT-773%252C%2520in%2520nonhuman%2520primates%253A%2520brain%2520and%2520whole%2520body%2520PET%2520and%2520brain%2520autoradiography%26jtitle%3DSynapse%26date%3D2015%26volume%3D69%26spage%3D345%26epage%3D355%26doi%3D10.1002%2Fsyn.21821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref194"><div class="reference"><strong class="refLabel"><a href="#ref194" class="rightTabRefNumLink">194</a></strong><div class="NLM_citation" id="rightTab-cit194"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulyas, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [<sup>11</sup>C]T-773 in nonhuman primates</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">253</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.1002/syn.21896</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.21896" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26878349" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref194/cit194&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XjsFKrurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2016&pages=253-263&author=A.+Takanoauthor=V.+Stepanovauthor=R.+Nakaoauthor=N.+Aminiauthor=B.+Gulyasauthor=H.+Kimuraauthor=C.+Halldin&title=Brain+PET+measurement+of+PDE10A+occupancy+by+TAK-063%2C+a+new+PDE10A+inhibitor%2C+using+%5B11C%5DT-773+in+nonhuman+primates&doi=10.1002%2Fsyn.21896"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit194R"><div class="casContent"><span class="casTitleNuber">194</span><div class="casTitle"><span class="NLM_cas:atitle">Brain PET measurement of PDE10A occupancy by TAK-063, a new PDE10A inhibitor, using [11C]T-773 in nonhuman primates</span></div><div class="casAuthors">Takano, Akihiro; Stepanov, Vladimir; Nakao, Ryuji; Amini, Nahid; Gulyas, Balazs; Kimura, Haruhide; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Synapse (Hoboken, NJ, United States)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">70</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">253-263</span>CODEN:
                <span class="NLM_cas:coden">SYNAET</span>;
        ISSN:<span class="NLM_cas:issn">0887-4476</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Because phosphodiesterase 10A (PDE10A) degrades both cyclic adenosine monophosphate and cyclic guanosine monophosphate and is distributed mainly in the striatum, PDE10A inhibitors have been considered to potentially be useful therapeutic agents for psychiatric and neurodegenerative diseases such as schizophrenia and Huntington's disease.  We measured striatal PDE10A occupancy by TAK-063, a newly developed compd. with high affinity and selectivity for PDE10A, using PET with [11C]T-773 in nonhuman primates.  Two 123-min dynamic PET measurements were performed on three female rhesus monkeys, once at baseline and again after i.v. administration of different doses of TAK-063 (0.2-1.6 mg/kg).  Total distribution vol. (VT) was calcd. with a two-tissue compartment model using metabolite-cor. plasma input.  Although the in vitro autoradiog. did not show high specific binding to [11C]T-773 in the cerebellum, VT in the cerebellum decreased after TAK-063 treatment.  The specific binding to PDE10A (VS) was calcd. as the difference of the VT between the target regions and the cerebellum.  PDE10A occupancy was calcd. as the percent change of VS.  The av. PDE10A occupancy of the caudate nucleus and putamen was 35.2% at 0.2 mg/kg and 83.2% at 1.6 mg/kg.  In conclusion, this nonhuman primate PET study demonstrated that [11C]T-773 is useful to est. the PDE10A occupancy by TAK-063 in the striatum although there is in vivo interaction of the uptake between [11C]T-773 and TAK-063 in the cerebellum.  These results warrant further clin. occupancy study for TAK-063.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqKSzvhpfgFv7Vg90H21EOLACvtfcHk0lh__ouZaQwaUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XjsFKrurw%253D&md5=00c3ecbf2f6525fe871285d5da79adee</span></div><a href="/servlet/linkout?suffix=cit194&amp;dbid=16384&amp;doi=10.1002%2Fsyn.21896&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.21896%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DGulyas%26aufirst%3DB.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DBrain%2520PET%2520measurement%2520of%2520PDE10A%2520occupancy%2520by%2520TAK-063%252C%2520a%2520new%2520PDE10A%2520inhibitor%252C%2520using%2520%255B11C%255DT-773%2520in%2520nonhuman%2520primates%26jtitle%3DSynapse%26date%3D2016%26volume%3D70%26spage%3D253%26epage%3D263%26doi%3D10.1002%2Fsyn.21896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref195"><div class="reference"><strong class="refLabel"><a href="#ref195" class="rightTabRefNumLink">195</a></strong><div class="NLM_citation" id="rightTab-cit195"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stenkrona, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinsson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldsmith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macek, T. A.</span></span> <span> </span><span class="NLM_article-title">A human [<sup>11</sup>C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor</span>. <i>NeuroImage</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>141</i></span>,  <span class="NLM_fpage">10</span>– <span class="NLM_lpage">17</span>, <span class="refDoi"> DOI: 10.1016/j.neuroimage.2016.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroimage.2016.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27423256" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref195/cit195&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1ans7jM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=141&publication_year=2016&pages=10-17&author=A.+Takanoauthor=P.+Stenkronaauthor=V.+Stepanovauthor=N.+Aminiauthor=S.+Martinssonauthor=M.+Tsaiauthor=P.+Goldsmithauthor=J.+Xieauthor=J.+Wuauthor=T.+Uzauthor=C.+Halldinauthor=T.+A.+Macek&title=A+human+%5B11C%5DT-773+PET+study+of+PDE10A+binding+after+oral+administration+of+TAK-063%2C+a+PDE10A+inhibitor&doi=10.1016%2Fj.neuroimage.2016.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit195R"><div class="casContent"><span class="casTitleNuber">195</span><div class="casTitle"><span class="NLM_cas:atitle">A human [11C]T-773 PET study of PDE10A binding after oral administration of TAK-063, a PDE10A inhibitor</span></div><div class="casAuthors">Takano, Akihiro; Stenkrona, Per; Stepanov, Vladimir; Amini, Nahid; Martinsson, Stefan; Tsai, Max; Goldsmith, Paul; Xie, Jinhui; Wu, Jingtao; Uz, Tolga; Halldin, Christer; Macek, Thomas A.</div><div class="citationInfo"><span class="NLM_cas:title">NeuroImage</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">141</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">10-17</span>CODEN:
                <span class="NLM_cas:coden">NEIMEF</span>;
        ISSN:<span class="NLM_cas:issn">1053-8119</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is selectively expressed in the striatal regions in the brain and may play a role in modulating dopaminergic and glutamatergic second messenger pathways.  PDE10A inhibitors are expected to be useful in treating neuropsychiatric disorders such as schizophrenia and Huntington's disease.  In this study, the brain kinetics of [11C]T-773 in the human brain and test-retest reproducibility of the outcome measures were evaluated.  Subsequently, the occupancy of a novel PDE10A inhibitor, TAK-063, was measured using [11C]T-773.  Dynamic PET measurements were conducted three times for 12 healthy male subjects after i.v. bolus injection of [11C]T-773: two baseline PETs and one postdose PET (3 h) after oral administration of TAK-063 for four subjects, and one baseline PET and two postdose PET (3 h and 23 h) for eight subjects.  Kinetic model anal. was performed with arterial input functions.  PDE10A occupancy was calcd. as the percent change of the binding specific to PDE10A (Vs) total distribution vol. (VT), which was calcd. as the VT of the putamen minus the VT of the cerebellum.  Regional brain uptake was highest in the putamen.  Time-activity curves of the brain regions were described with two tissue-compartment (2TC) models.  The mean VT was 5.5 ± 0.7 in the putamen and 2.3 ± 0.5 in the cerebellum in the baseline PET.  Abs. VT variability between the two baseline scans was less than 7%.  Reproducibility of VT was excellent.  PDE10A occupancy in the putamen ranged from 2.8% to 72.1% at 3 h after a single administration of 3 to 1000 mg of TAK-063, and increased in a dose- and plasma concn.-dependent manner.  At 23 h postdose, PDE10A occupancy in the putamen was 0 to 42.8% following administration of 3 to 100 mg of TAK-063.  In conclusion, [11C]T-773 showed good characteristics as a PET radioligand for PDE10A in the human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphxQR4iFCU27Vg90H21EOLACvtfcHk0lio2Nkxa5phiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1ans7jM&md5=0022ca662d19f77cdef95352248f91e6</span></div><a href="/servlet/linkout?suffix=cit195&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroimage.2016.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroimage.2016.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DStenkrona%26aufirst%3DP.%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMartinsson%26aufirst%3DS.%26aulast%3DTsai%26aufirst%3DM.%26aulast%3DGoldsmith%26aufirst%3DP.%26aulast%3DXie%26aufirst%3DJ.%26aulast%3DWu%26aufirst%3DJ.%26aulast%3DUz%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26aulast%3DMacek%26aufirst%3DT.%2BA.%26atitle%3DA%2520human%2520%255B11C%255DT-773%2520PET%2520study%2520of%2520PDE10A%2520binding%2520after%2520oral%2520administration%2520of%2520TAK-063%252C%2520a%2520PDE10A%2520inhibitor%26jtitle%3DNeuroImage%26date%3D2016%26volume%3D141%26spage%3D10%26epage%3D17%26doi%3D10.1016%2Fj.neuroimage.2016.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref196"><div class="reference"><strong class="refLabel"><a href="#ref196" class="rightTabRefNumLink">196</a></strong><div class="NLM_citation" id="rightTab-cit196"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepanov, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amini, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hasui, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taniguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halldin, C.</span></span> <span> </span><span class="NLM_article-title">Development of two fluorine-18 labeled PET radioligands targeting PDE10A and <i>in vivo</i> PET evaluation in nonhuman primates</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>57</i></span>,  <span class="NLM_fpage">12</span>– <span class="NLM_lpage">19</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2017.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2017.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=29223715" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref196/cit196&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFCis7jP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2018&pages=12-19&author=V.+Stepanovauthor=A.+Takanoauthor=R.+Nakaoauthor=N.+Aminiauthor=S.+Miuraauthor=T.+Hasuiauthor=H.+Kimuraauthor=T.+Taniguchiauthor=C.+Halldin&title=Development+of+two+fluorine-18+labeled+PET+radioligands+targeting+PDE10A+and+in+vivo+PET+evaluation+in+nonhuman+primates&doi=10.1016%2Fj.nucmedbio.2017.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit196R"><div class="casContent"><span class="casTitleNuber">196</span><div class="casTitle"><span class="NLM_cas:atitle">Development of two fluorine-18 labeled PET radioligands targeting PDE10A and in vivo PET evaluation in nonhuman primates</span></div><div class="casAuthors">Stepanov, Vladimir; Takano, Akihiro; Nakao, Ryuji; Amini, Nahid; Miura, Shotaro; Hasui, Tomoaki; Kimura, Haruhide; Taniguchi, Takahiko; Halldin, Christer</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">57</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12-19</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is a member of the PDE enzyme family that degrades cyclic adenosine and guanosine monophosphates (cAMP and cGMP).  Based on the successful development of [11C]T-773 as PDE10A positron emission tomog. (PET) radioligand, in this study our aim was to develop and evaluate fluorine-18 analogs of [11C]T-773.[18F]FM-T-773-d2 and [18F]FE-T-773-d4 were synthesized from the same precursor used for 11C-labeling of T-773 in a two-step approach via 18F-fluoromethylation and 18F-fluoroethylation, resp., using corresponding deuterated synthons.  A total of 12 PET measurements were performed in seven non-human primates.  First, baseline PET measurements were performed using High Resoln. Research Tomograph system with both [18F]FM-T-773-d2 and [18F]FE-T-773-d4; the uptake in whole brain and sep. brain regions, as well as the specific binding and tissue ratio between putamen and cerebellum, was examd.  Second, baseline and pretreatment PET measurements using MP-10 as the blocker were performed for [18F]FM-T-773-d2 including arterial blood sampling with radiometabolite anal. in four NHPs.  Both [18F]FM-T-773-d2 and [18F]FE-T-773-d4 were successfully radiolabeled with an av. molar activity of 293 ±114 GBq/μmol (n = 8) for [18F]FM-T-773-d2 and 209 ± 26 GBq/μmol (n = 4) for [18F]FE-T-773-d4, and a radiochem. yield of 10% (EOB, n = 12, range 3%-16%).  Both radioligands displayed high brain uptake (∼ 5.5% of injected radioactivity for [18F]FM-T-773-d2 and ∼ 3.5% for [18F]FE-T-773-d4 at the peak) and a fast washout.  Specific binding reached max. within 30 min for [18F]FM-T-773-d2 and after approx. 45 min for [18F]FE-T-773-d4. [18F]FM-T-773-d2 data fitted well with kinetic compartment models.  BPND values obtained indirectly through compartment models were correlated well with those obtained by SRTM.  BPND calcd. with SRTM was 1.0-1.7 in the putamen.  The occupancy with 1.8 mg/kg of MP-10 was approx. 60%.[18F]FM-T-773-d2 and [18F]FE-T-773-d4 were developed as fluorine-18 PET radioligands for PDE10A, with the [18F]FM-T-773-d2 being the more promising PET radioligand warranting further evaluation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHBb1tHdjrGrVg90H21EOLACvtfcHk0lio2Nkxa5phiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFCis7jP&md5=8aa86e0a00c15ff2af65d29113ff2b67</span></div><a href="/servlet/linkout?suffix=cit196&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2017.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DStepanov%26aufirst%3DV.%26aulast%3DTakano%26aufirst%3DA.%26aulast%3DNakao%26aufirst%3DR.%26aulast%3DAmini%26aufirst%3DN.%26aulast%3DMiura%26aufirst%3DS.%26aulast%3DHasui%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DH.%26aulast%3DTaniguchi%26aufirst%3DT.%26aulast%3DHalldin%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520two%2520fluorine-18%2520labeled%2520PET%2520radioligands%2520targeting%2520PDE10A%2520and%2520in%2520vivo%2520PET%2520evaluation%2520in%2520nonhuman%2520primates%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2018%26volume%3D57%26spage%3D12%26epage%3D19%26doi%3D10.1016%2Fj.nucmedbio.2017.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref197"><div class="reference"><strong class="refLabel"><a href="#ref197" class="rightTabRefNumLink">197</a></strong><div class="NLM_citation" id="rightTab-cit197"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumfelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easwaramoorthy, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castrillon, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Dargham, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slifstein, M.</span></span> <span> </span><span class="NLM_article-title">Initial characterization of a PDE10A selective positron emission tomography tracer [<sup>11</sup>C]AMG 7980 in non-human primates</span>. <i>Nucl. Med. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">343</span>– <span class="NLM_lpage">349</span>, <span class="refDoi"> DOI: 10.1016/j.nucmedbio.2014.01.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.nucmedbio.2014.01.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24607437" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref197/cit197&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXjslKlu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2014&pages=343-349&author=D.+R.+Hwangauthor=E.+Huauthor=S.+Rumfeltauthor=B.+Easwaramoorthyauthor=J.+Castrillonauthor=C.+Davisauthor=J.+R.+Allenauthor=H.+Chenauthor=J.+Treanorauthor=A.+Abi-Darghamauthor=M.+Slifstein&title=Initial+characterization+of+a+PDE10A+selective+positron+emission+tomography+tracer+%5B11C%5DAMG+7980+in+non-human+primates&doi=10.1016%2Fj.nucmedbio.2014.01.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit197R"><div class="casContent"><span class="casTitleNuber">197</span><div class="casTitle"><span class="NLM_cas:atitle">Initial characterization of a PDE10A selective positron emission tomography tracer [11C]AMG 7980 in non-human primates</span></div><div class="casAuthors">Hwang, Dah-Ren; Hu, Essa; Rumfelt, Shannon; Easwaramoorthy, Balu; Castrillon, John; Davis, Carl; Allen, Jennifer R.; Chen, Hang; Treanor, James; Abi-Dargham, Anissa; Slifstein, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Nuclear Medicine and Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">343-349</span>CODEN:
                <span class="NLM_cas:coden">NMBIEO</span>;
        ISSN:<span class="NLM_cas:issn">0969-8051</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) is an intracellular enzyme responsible for the breakdown of cyclic nucleotides which are important secondary messengers in the central nervous system.  Inhibition of PDE10A has been identified as a potential therapeutic target for treatment of various neuropsychiatric disorders.  To assist the drug development program, we have identified a selective PDE10A PET tracer, [11C]AMG 7980, for imaging PDE10A distribution using positron emission tomog.  [11C]AMG 7980 was prepd. in a one-pot, two-step reaction.  Dynamic PET scans were performed in non-human primates following a bolus or bolus plus const. infusion tracer injection paradigm.  Regions-of-interest were defined on individuals' MRIs and transferred to the co-registered PET images.  Data were analyzed using Logan graphical anal. with metabolite-cor. input function, the simplified ref. tissue model (SRTM) method and occupancy plots.  A benchmark PDE10A inhibitor was used to demonstrate PDE10A-specific binding.  [11C]AMG 7980 was prepd. with a mean specific activity of 99 ± 74 GBq/μmol (n = 10) and a synthesis time of 45 min.  Specific binding of the tracer was localized to the striatum and globus pallidus (GP) and low in other brain regions.  Thalamus was used as the ref. tissue to derive binding potentials (BPND).  The BPND for caudate, putamen, and GP were 0.23, 0.65, 0.51, resp. by the graphical method, and 0.42, 0.76, and 0.75 from the SRTM method.  A dose dependent decrease of BPND was obsd. with the pre-treatment of a PDE10A inhibitor.  A bolus plus infusion injection paradigm yielded similar results.  [11C]AMG 7980 has been successfully used for imaging PDE10A in non-human primate brain.  Despite the fast brain kinetics it can be used to measure target occupancy of PDE10A inhibitors in non-human primates and potentially applicable to humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpl8JWDNIZ407Vg90H21EOLACvtfcHk0lio2Nkxa5phiw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXjslKlu7g%253D&md5=f07bf68932610a520e1238a3098ff598</span></div><a href="/servlet/linkout?suffix=cit197&amp;dbid=16384&amp;doi=10.1016%2Fj.nucmedbio.2014.01.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.nucmedbio.2014.01.007%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DD.%2BR.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DEaswaramoorthy%26aufirst%3DB.%26aulast%3DCastrillon%26aufirst%3DJ.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DAbi-Dargham%26aufirst%3DA.%26aulast%3DSlifstein%26aufirst%3DM.%26atitle%3DInitial%2520characterization%2520of%2520a%2520PDE10A%2520selective%2520positron%2520emission%2520tomography%2520tracer%2520%255B11C%255DAMG%25207980%2520in%2520non-human%2520primates%26jtitle%3DNucl.%2520Med.%2520Biol.%26date%3D2014%26volume%3D41%26spage%3D343%26epage%3D349%26doi%3D10.1016%2Fj.nucmedbio.2014.01.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref198"><div class="reference"><strong class="refLabel"><a href="#ref198" class="rightTabRefNumLink">198</a></strong><div class="NLM_citation" id="rightTab-cit198"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester-Zeiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaus, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Able, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biorn, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hill Della Puppa, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kazules, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dou, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talreja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rumfelt, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ye, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thiel, O. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williamson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Immke, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span> <span> </span><span class="NLM_article-title">AMG 580: a novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>352</i></span>,  <span class="NLM_fpage">327</span>– <span class="NLM_lpage">337</span>, <span class="refDoi"> DOI: 10.1124/jpet.114.220517</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1124%2Fjpet.114.220517" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=25502803" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref198/cit198&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFSqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=352&publication_year=2015&pages=327-337&author=H.+Chenauthor=D.+Lester-Zeinerauthor=J.+Shiauthor=S.+Millerauthor=C.+Glausauthor=E.+Huauthor=N.+Chenauthor=J.+Ableauthor=C.+Biornauthor=J.+Wongauthor=J.+Maauthor=K.+Michelsenauthor=G.+Hill+Della+Puppaauthor=T.+Kazulesauthor=H.+H.+Douauthor=S.+Talrejaauthor=X.+Zhaoauthor=A.+Chenauthor=S.+Rumfeltauthor=R.+K.+Kunzauthor=H.+Yeauthor=O.+R.+Thielauthor=T.+Williamsonauthor=C.+Davisauthor=A.+Porterauthor=D.+Immkeauthor=J.+R.+Allenauthor=J.+Treanor&title=AMG+580%3A+a+novel+small+molecule+phosphodiesterase+10A+%28PDE10A%29+positron+emission+tomography+tracer&doi=10.1124%2Fjpet.114.220517"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit198R"><div class="casContent"><span class="casTitleNuber">198</span><div class="casTitle"><span class="NLM_cas:atitle">AMG 580: A novel small molecule phosphodiesterase 10A (PDE10A) positron emission tomography tracer</span></div><div class="casAuthors">Chen, Hang; Lester-Zeiner, Dianna; Shi, Jianxia; Miller, Silke; Glaus, Charlie; Hu, Essa; Chen, Ning; Able, Jessica; Biorn, Christopher; Wong, Jamie; Ma, Ji; Michelsen, Klaus; Della Puppa, Geraldine Hill; Kazules, Tim; Dou, Hui Hannah; Talreja, Santosh; Zhao, Xiaoning; Chen, Ada; Rumfelt, Shannon; Kunz, Roxanne K.; Ye, Hu; Thiel, Oliver R.; Williamson, Toni; Davis, Carl; Porter, Amy; Immke, David; Allen, Jennifer R.; Treanor, James</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">352</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">327-337/1-327-337/11, 11 pp.</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Phosphodiesterase 10A (PDE10A) inhibitors have therapeutic potential for the treatment of psychiatric and neurol. disorders, such as schizophrenia and Huntington's disease.  One of the key requirements for successful central nervous system drug development is to demonstrate target coverage of therapeutic candidates in brain for lead optimization in the drug discovery phase and for assisting dose selection in clin. development.  Therefore, we identified AMG 580 [1-(4-(3-(4-(1H-benzo[d] imidazole-2-carbonyl)phenoxy)pyrazin-2-yl)piperidin-1-yl)-2- fluoropropan-1-one], a novel, selective small-mol. antagonist with subnanomolar affinity for rat, primate, and human PDE10A.  We showed that AMG580 is suitable as a tracer for lead optimization to det. target coverage by novel PDE10A inhibitors using triple-stage quadrupole liq. chromatog.-tandem mass spectrometry technol.  [3H]AMG 580 bound with high affinity in a specific and saturable manner to both striatal homogenates and brain slices from rats, baboons, and human in vitro.  Moreover, [18F]AMG 580 demonstrated prominent uptake by positron emission tomog. in rats, suggesting that radiolabeled AMG 580 may be suitable for further development as a noninvasive radiotracer for target coverage measurements in clin. studies.  These results indicate that AMG 580 is a potential imaging biomarker for mapping PDE10A distribution and ensuring target coverage by therapeutic PDE10A inhibitors in clin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozcuESxX7s_LVg90H21EOLACvtfcHk0lghP8US4m5c1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFSqtr0%253D&md5=60f3c102f60fb4c4822b9d9d3a997b52</span></div><a href="/servlet/linkout?suffix=cit198&amp;dbid=16384&amp;doi=10.1124%2Fjpet.114.220517&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.114.220517%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DH.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DMiller%26aufirst%3DS.%26aulast%3DGlaus%26aufirst%3DC.%26aulast%3DHu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DAble%26aufirst%3DJ.%26aulast%3DBiorn%26aufirst%3DC.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DHill%2BDella%2BPuppa%26aufirst%3DG.%26aulast%3DKazules%26aufirst%3DT.%26aulast%3DDou%26aufirst%3DH.%2BH.%26aulast%3DTalreja%26aufirst%3DS.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DA.%26aulast%3DRumfelt%26aufirst%3DS.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DYe%26aufirst%3DH.%26aulast%3DThiel%26aufirst%3DO.%2BR.%26aulast%3DWilliamson%26aufirst%3DT.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DPorter%26aufirst%3DA.%26aulast%3DImmke%26aufirst%3DD.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26aulast%3DTreanor%26aufirst%3DJ.%26atitle%3DAMG%2520580%253A%2520a%2520novel%2520small%2520molecule%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520positron%2520emission%2520tomography%2520tracer%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2015%26volume%3D352%26spage%3D327%26epage%3D337%26doi%3D10.1124%2Fjpet.114.220517" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref199"><div class="reference"><strong class="refLabel"><a href="#ref199" class="rightTabRefNumLink">199</a></strong><div class="NLM_citation" id="rightTab-cit199"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kunz, R. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michelsen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lester-Zeiner, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hungate, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Treanor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, J. R.</span></span> <span> </span><span class="NLM_article-title">Discovery of phosphodiesterase 10A (PDE10A) PET tracer AMG 580 to support clinical studies</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">719</span>– <span class="NLM_lpage">723</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00185</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00185" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref199/cit199&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xot1ektL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=719-723&author=E.+Huauthor=N.+Chenauthor=R.+K.+Kunzauthor=D.+R.+Hwangauthor=K.+Michelsenauthor=C.+Davisauthor=J.+Maauthor=J.+Shiauthor=D.+Lester-Zeinerauthor=R.+Hungateauthor=J.+Treanorauthor=H.+Chenauthor=J.+R.+Allen&title=Discovery+of+phosphodiesterase+10A+%28PDE10A%29+PET+tracer+AMG+580+to+support+clinical+studies&doi=10.1021%2Facsmedchemlett.6b00185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit199R"><div class="casContent"><span class="casTitleNuber">199</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Phosphodiesterase 10A (PDE10A) PET Tracer AMG 580 to Support Clinical Studies</span></div><div class="casAuthors">Hu, Essa; Chen, Ning; Kunz, Roxanne K.; Hwang, Dah-Ren; Michelsen, Klaus; Davis, Carl; Ma, Ji; Shi, Jianxia; Lester-Zeiner, Dianna; Hungate, Randall; Treanor, James; Chen, Hang; Allen, Jennifer R.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">719-723</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the discovery of PDE10A PET tracer AMG 580 developed to support proof of concept studies with PDE10A inhibitors in the clinic.  To find a tracer with higher binding potential (BPND) in NHP than our previously reported tracer 1, we implemented a surface plasmon resonance assay to measure the binding off-rate to identify candidates with slower washout rate in vivo.  Five candidates (2-6) from two structurally distinct scaffolds were identified that possessed both the in vitro characteristics that would favor central penetration and the structural features necessary for PET isotope radiolabeling.  Two cinnolines (2, 3) and one keto-benzimidazole (5) exhibited PDE10A target specificity and brain uptake comparable to or better than 1 in the in vivo LC-MS/MS kinetics distribution study in SD rats.  In NHP PET imaging study, [18F]-5 produced a significantly improved BPND of 3.1 and was nominated as PDE10A PET tracer clin. candidate for further studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzWYWmHhOKz7Vg90H21EOLACvtfcHk0lghP8US4m5c1A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xot1ektL8%253D&md5=342e1880548119b29ed28707d997aff4</span></div><a href="/servlet/linkout?suffix=cit199&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00185%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DN.%26aulast%3DKunz%26aufirst%3DR.%2BK.%26aulast%3DHwang%26aufirst%3DD.%2BR.%26aulast%3DMichelsen%26aufirst%3DK.%26aulast%3DDavis%26aufirst%3DC.%26aulast%3DMa%26aufirst%3DJ.%26aulast%3DShi%26aufirst%3DJ.%26aulast%3DLester-Zeiner%26aufirst%3DD.%26aulast%3DHungate%26aufirst%3DR.%26aulast%3DTreanor%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DAllen%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520PET%2520tracer%2520AMG%2520580%2520to%2520support%2520clinical%2520studies%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2016%26volume%3D7%26spage%3D719%26epage%3D723%26doi%3D10.1021%2Facsmedchemlett.6b00185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">200</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dipper, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoefgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and <i>in vitro</i> evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>107</i></span>,  <span class="NLM_fpage">97</span>– <span class="NLM_lpage">108</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2015.10.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ejmech.2015.10.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26562545" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=107&publication_year=2016&pages=97-108&author=S.+Wagnerauthor=M.+Scheunemannauthor=K.+Dipperauthor=U.+Egerlandauthor=N.+Hoefgenauthor=J.+Steinbachauthor=P.+Brust&title=Development+of+highly+potent+phosphodiesterase+10A+%28PDE10A%29+inhibitors%3A+Synthesis+and+in+vitro+evaluation+of+1%2C8-dipyridinyl-+and+1-pyridinyl-substituted+imidazo%5B1%2C5-a%5Dquinoxalines&doi=10.1016%2Fj.ejmech.2015.10.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Development of highly potent phosphodiesterase 10A (PDE10A) inhibitors: Synthesis and in vitro evaluation of 1,8-dipyridinyl- and 1-pyridinyl-substituted imidazo[1,5-a]quinoxalines</span></div><div class="casAuthors">Wagner, Sally; Scheunemann, Matthias; Dipper, Karolin; Egerland, Ute; Hoefgen, Norbert; Steinbach, Joerg; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">107</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">97-108</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Herein we report the synthesis of fluorinated inhibitors of phosphodiesterase 10A (PDE10A), which can be used potentially as a lead structure for the development of a 18F-labeled PDE10A imaging agent for positron emission tomog.  The use of o-fluoropyridines as residues could potentially enable the introduction of 18F through nucleophilic substitution for radiolabeling purposes.  2-Fluoropyridines are introduced by a Suzuki coupling at different positions of the mol.  The ref. compds., 1,8-dipyridinylimidazo[1,5-a]quinoxalines and 1-pyridinylimidazo[1,5-a]quinoxalines, show inhibitory potencies at best in the subnanomolar range and selectivity factors greater than 38 against other PDE's.  1,8-Dipyridinylimidazo[1,5-a]quinoxalines are more potent inhibitors than 1-pyridinylimidazo[1,5-a]quinoxalines.  Using 2-fluoro-3-pyridinyl as the residue provided the most potent inhibitors I (IC50 = 0.12 nM), II (IC50 = 0.048 nM), and III (IC50 = 0.037 nM).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGok5Llcb5Me3LVg90H21EOLACvtfcHk0liXZDaZSzlpnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvVWms7rL&md5=2f176dd7450db00bb2b9df696e2cef41</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2015.10.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2015.10.028%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DDipper%26aufirst%3DK.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DHoefgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DDevelopment%2520of%2520highly%2520potent%2520phosphodiesterase%252010A%2520%2528PDE10A%2529%2520inhibitors%253A%2520Synthesis%2520and%2520in%2520vitro%2520evaluation%2520of%25201%252C8-dipyridinyl-%2520and%25201-pyridinyl-substituted%2520imidazo%255B1%252C5-a%255Dquinoxalines%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2016%26volume%3D107%26spage%3D97%26epage%3D108%26doi%3D10.1016%2Fj.ejmech.2015.10.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref201"><div class="reference"><strong class="refLabel"><a href="#ref201" class="rightTabRefNumLink">201</a></strong><div class="NLM_citation" id="rightTab-cit201"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hankir, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.K. F. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hesse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Höfgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Evaluation of the new radioligand [<sup>18</sup>F]AQ-28A by small animal PET/MR demonstrates increase of PDE10A expression in striatum and brown adipose tissue (BAT) of obese mice</span>. <i>J. Label. Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">S52</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2015&pages=S52&author=S.+Wagnerauthor=M.+Kranzauthor=M.+Hankirauthor=W.+Deuther-Conradauthor=M.+Scheunemannauthor=R.+Teodoroauthor=B.+Wenzelauthor=S.+Fischerauthor=U.K.+F.+W.+Egerlandauthor=S.+Hesseauthor=N.+H%C3%B6fgenauthor=J.+Steinbachauthor=P.+Brust&title=Evaluation+of+the+new+radioligand+%5B18F%5DAQ-28A+by+small+animal+PET%2FMR+demonstrates+increase+of+PDE10A+expression+in+striatum+and+brown+adipose+tissue+%28BAT%29+of+obese+mice"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit201&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DHankir%26aufirst%3DM.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DEgerland%26aufirst%3DU.K.%2BF.%2BW.%26aulast%3DHesse%26aufirst%3DS.%26aulast%3DH%25C3%25B6fgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DEvaluation%2520of%2520the%2520new%2520radioligand%2520%255B18F%255DAQ-28A%2520by%2520small%2520animal%2520PET%252FMR%2520demonstrates%2520increase%2520of%2520PDE10A%2520expression%2520in%2520striatum%2520and%2520brown%2520adipose%2520tissue%2520%2528BAT%2529%2520of%2520obese%2520mice%26jtitle%3DJ.%2520Label.%2520Compd.%2520Radiopharm.%26date%3D2015%26volume%3D58%26spage%3DS52" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref202"><div class="reference"><strong class="refLabel"><a href="#ref202" class="rightTabRefNumLink">202</a></strong><div class="NLM_citation" id="rightTab-cit202"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teodoro, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deuther-Conrad, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kranz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheunemann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wenzel, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egerland, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoefgen, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brust, P.</span></span> <span> </span><span class="NLM_article-title">Radiosynthesis and biological evaluation of the new PDE10A radioligand [<sup>18</sup>F]AQ28A</span>. <i>J. Labelled Compd. Radiopharm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">36</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1002/jlcr.3471</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fjlcr.3471" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27896836" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref202/cit202&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7rM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=36-48&author=S.+Wagnerauthor=R.+Teodoroauthor=W.+Deuther-Conradauthor=M.+Kranzauthor=M.+Scheunemannauthor=S.+Fischerauthor=B.+Wenzelauthor=U.+Egerlandauthor=N.+Hoefgenauthor=J.+Steinbachauthor=P.+Brust&title=Radiosynthesis+and+biological+evaluation+of+the+new+PDE10A+radioligand+%5B18F%5DAQ28A&doi=10.1002%2Fjlcr.3471"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit202R"><div class="casContent"><span class="casTitleNuber">202</span><div class="casTitle"><span class="NLM_cas:atitle">Radiosynthesis and biological evaluation of the new PDE10A radioligand [18F]AQ28A</span></div><div class="casAuthors">Wagner, Sally; Teodoro, Rodrigo; Deuther-Conrad, Winnie; Kranz, Mathias; Scheunemann, Matthias; Fischer, Steffen; Wenzel, Barbara; Egerland, Ute; Hoefgen, Norbert; Steinbach, Joerg; Brust, Peter</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Labelled Compounds and Radiopharmaceuticals</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">36-48</span>CODEN:
                <span class="NLM_cas:coden">JLCRD4</span>;
        ISSN:<span class="NLM_cas:issn">0362-4803</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">In this study we developed, radiolabeled, and evaluated a new PDE10A radioligand, 8-bromo-1-(6-[18F]fluoropyridin-3-yl)-3,4-dimethylimidazo[1,5-a]quinoxaline ([18F]AQ28A).  Radiolabeling of[18F]AQ28A was done by both nucleophilic bromo-to-fluoro or nitro-to-fluoro exchange using K[18F]F-K2.2.2-carbonate complex with different yields.  Using the superior nitro precursor, we developed an automated synthesis on a Tracerlab FX F-N module and obtained [18F]AQ28A with high radiochem. yields (33 ± 6%) and specific activities (96-145 GBq.μmol-1) for further evaluation.  Initially, we investigated the binding of [18F]AQ28A to the brain of different species by autoradiog. and obsd. the highest d. of binding sites in striatum, the brain region with the highest PDE10A expression.  Subsequent dynamic PET studies in mice revealed a region-specific accumulation of [18F]AQ28A in this region, which could be blocked by preinjection of the selective PDE10A ligand MP-10.  In conclusion, the data suggested [18F]AQ28A was a suitable candidate for imaging of PDE10A in rodent brain by PET.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO4MFa_yebTbVg90H21EOLACvtfcHk0liXZDaZSzlpnw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvFGqu7rM&md5=0cc6ea11a660eac6e5fff7df7eea5795</span></div><a href="/servlet/linkout?suffix=cit202&amp;dbid=16384&amp;doi=10.1002%2Fjlcr.3471&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjlcr.3471%26sid%3Dliteratum%253Aachs%26aulast%3DWagner%26aufirst%3DS.%26aulast%3DTeodoro%26aufirst%3DR.%26aulast%3DDeuther-Conrad%26aufirst%3DW.%26aulast%3DKranz%26aufirst%3DM.%26aulast%3DScheunemann%26aufirst%3DM.%26aulast%3DFischer%26aufirst%3DS.%26aulast%3DWenzel%26aufirst%3DB.%26aulast%3DEgerland%26aufirst%3DU.%26aulast%3DHoefgen%26aufirst%3DN.%26aulast%3DSteinbach%26aufirst%3DJ.%26aulast%3DBrust%26aufirst%3DP.%26atitle%3DRadiosynthesis%2520and%2520biological%2520evaluation%2520of%2520the%2520new%2520PDE10A%2520radioligand%2520%255B18F%255DAQ28A%26jtitle%3DJ.%2520Labelled%2520Compd.%2520Radiopharm.%26date%3D2017%26volume%3D60%26spage%3D36%26epage%3D48%26doi%3D10.1002%2Fjlcr.3471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref203"><div class="reference"><strong class="refLabel"><a href="#ref203" class="rightTabRefNumLink">203</a></strong><div class="NLM_citation" id="rightTab-cit203"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinzimmer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jakobsen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salinas, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Labaree, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, M. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nabulsi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kawanishi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saijo, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carson, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 10A PET radioligand development program: from pig to human</span>. <i>J. Nucl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">601</span>, <span class="refDoi"> DOI: 10.2967/jnumed.113.131409</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.2967%2Fjnumed.113.131409" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=24614221" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref203/cit203&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOhtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2014&pages=595-601&author=C.+Plissonauthor=D.+Weinzimmerauthor=S.+Jakobsenauthor=S.+Natesanauthor=C.+Salinasauthor=S.+F.+Linauthor=D.+Labareeauthor=M.+Q.+Zhengauthor=N.+Nabulsiauthor=T.+R.+Marquesauthor=S.+Kapurauthor=E.+Kawanishiauthor=T.+Saijoauthor=R.+N.+Gunnauthor=R.+E.+Carsonauthor=E.+A.+Rabiner&title=Phosphodiesterase+10A+PET+radioligand+development+program%3A+from+pig+to+human&doi=10.2967%2Fjnumed.113.131409"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit203R"><div class="casContent"><span class="casTitleNuber">203</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 10A PET radioligand development program: from pig to human</span></div><div class="casAuthors">Plisson, Christophe; Weinzimmer, David; Jakobsen, Steen; Natesan, Sridhar; Salinas, Cristian; Lin, Shu-Fei; Labaree, David; Zheng, Ming-Qiang; Nabulsi, Nabeel; Marques, Tiago Reis; Kapur, Shitij; Kawanishi, Eiji; Saijo, Takeaki; Gunn, Roger N.; Carson, Richard E.; Rabiner, Eugenii A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Nuclear Medicine</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">595-601</span>CODEN:
                <span class="NLM_cas:coden">JNMEAQ</span>;
        ISSN:<span class="NLM_cas:issn">0161-5505</span>.
    
            (<span class="NLM_cas:orgname">Society of Nuclear Medicine and Molecular Imaging</span>)
        </div><div class="casAbstract">Four novel phosphodiesterase 10A (PDE10A) PET tracers have been synthesized, characterized in preclin. studies, and compared with the previously reported 11C-MP-10.  Methods: On the basis of in vitro data, IMA102, IMA104, IMA107, and IMA106 were identified as potential PDE10A radioligand candidates and labeled with either 11C via N-methylation or with 18F through an SN2 reaction, in the case of IMA102.  These candidates were compared with 11C-MP-10 in pilot in vivo studies in the pig brain.  On the basis of these data, 11C-IMA106 and 11C-IMA107 were taken into further evaluation and comparison with 11C-MP-10 in the primate brain.  Finally, the most promising radioligand candidate was progressed into human evaluation.  Results: All 5 tracers were produced with good radiochem. yield and specific activity.  All candidates readily entered the brain and demonstrated a heterogeneous distribution consistent with the known expression of PDE10A.  Baseline PET studies in the pig and baboon showed that 11C-IMA107 and 11C-MP-10 displayed the most favorable tissue kinetics and imaging properties.  The administration of selective PDE10A inhibitors reduced the binding of 11C-IMA107 and 11C-MP-10 in the PDE10A-rich brain regions, in a dose-dependent manner.  In the nonhuman primate brain, the tissue kinetics of 11C-IMA107 and 11C-MP-10 were well described by a 2-tissue-compartment model, allowing robust ests. of the regional total vol. of distribution.  Blockade with unlabeled MP-10 confirmed the suitability of the cerebellum as a ref. tissue and enabled the estn. of regional binding potential as the outcome measure of specific binding.  Conclusion: 11C-IMA107 was identified as the ligand with the highest binding potential while still possessing reversible kinetics.  The first human administration of 11C-IMA107 has demonstrated the expected regional distribution and suitably fast kinetics, indicating that 11C-IMA107 will be a useful tool for the investigation of PDE10A status in the living human brain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpm-Fd40QJWDLVg90H21EOLACvtfcHk0li5UXf6ZYlIww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOhtro%253D&md5=a0e5db2b744a2f49aac00507258f21b3</span></div><a href="/servlet/linkout?suffix=cit203&amp;dbid=16384&amp;doi=10.2967%2Fjnumed.113.131409&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2967%252Fjnumed.113.131409%26sid%3Dliteratum%253Aachs%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DWeinzimmer%26aufirst%3DD.%26aulast%3DJakobsen%26aufirst%3DS.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DSalinas%26aufirst%3DC.%26aulast%3DLin%26aufirst%3DS.%2BF.%26aulast%3DLabaree%26aufirst%3DD.%26aulast%3DZheng%26aufirst%3DM.%2BQ.%26aulast%3DNabulsi%26aufirst%3DN.%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DKawanishi%26aufirst%3DE.%26aulast%3DSaijo%26aufirst%3DT.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DCarson%26aufirst%3DR.%2BE.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26atitle%3DPhosphodiesterase%252010A%2520PET%2520radioligand%2520development%2520program%253A%2520from%2520pig%2520to%2520human%26jtitle%3DJ.%2520Nucl.%2520Med.%26date%3D2014%26volume%3D55%26spage%3D595%26epage%3D601%26doi%3D10.2967%2Fjnumed.113.131409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref204"><div class="reference"><strong class="refLabel"><a href="#ref204" class="rightTabRefNumLink">204</a></strong><div class="NLM_citation" id="rightTab-cit204"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reis Marques, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muhlert, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tziortzi, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span> <span> </span><span class="NLM_article-title">Altered PDE10A expression detectable early before symptomatic onset in Huntington’s disease</span>. <i>Brain</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">3016</span>– <span class="NLM_lpage">3029</span>, <span class="refDoi"> DOI: 10.1093/brain/awv214</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1093%2Fbrain%2Fawv214" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26198591" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref204/cit204&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC28%252Flt1KqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2015&pages=3016-3029&author=F.+Niccoliniauthor=S.+Haiderauthor=T.+Reis+Marquesauthor=N.+Muhlertauthor=A.+C.+Tziortziauthor=G.+E.+Searleauthor=S.+Natesanauthor=P.+Picciniauthor=S.+Kapurauthor=E.+A.+Rabinerauthor=R.+N.+Gunnauthor=S.+J.+Tabriziauthor=M.+Politis&title=Altered+PDE10A+expression+detectable+early+before+symptomatic+onset+in+Huntington%E2%80%99s+disease&doi=10.1093%2Fbrain%2Fawv214"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit204R"><div class="casContent"><span class="casTitleNuber">204</span><div class="casTitle"><span class="NLM_cas:atitle">Altered PDE10A expression detectable early before symptomatic onset in Huntington's disease</span></div><div class="casAuthors">Niccolini Flavia; Politis Marios; Haider Salman; Tabrizi Sarah J; Reis Marques Tiago; Natesan Sridhar; Kapur Shitij; Muhlert Nils; Tziortzi Andri C; Searle Graham E; Piccini Paola; Rabiner Eugenii A; Gunn Roger N</div><div class="citationInfo"><span class="NLM_cas:title">Brain : a journal of neurology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue">Pt 10</span>),
    <span class="NLM_cas:pages">3016-29</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">There is an urgent need for early biomarkers and novel disease-modifying therapies in Huntington's disease.  Huntington's disease pathology involves the toxic effect of mutant huntingtin primarily in striatal medium spiny neurons, which highly express phosphodiesterase 10A (PDE10A).  PDE10A hydrolyses cAMP/cGMP signalling cascades, thus having a key role in the regulation of striatal output, and in promoting neuronal survival.  PDE10A could be a key therapeutic target in Huntington's disease.  Here, we used combined positron emission tomography (PET) and multimodal magnetic resonance imaging to assess PDE10A expression in vivo in a unique cohort of 12 early premanifest Huntington's disease gene carriers with a mean estimated 90% probability of 25 years before the predicted onset of clinical symptoms.  We show bidirectional changes in PDE10A expression in premanifest Huntington's disease gene carriers, which are associated with the probability of symptomatic onset.  PDE10A expression in early premanifest Huntington's disease was decreased in striatum and pallidum and increased in motor thalamic nuclei, compared to a group of matched healthy controls.  Connectivity-based analysis revealed prominent PDE10A decreases confined in the sensorimotor-striatum and in striatonigral and striatopallidal projecting segments.  The ratio between higher PDE10A expression in motor thalamic nuclei and lower PDE10A expression in striatopallidal projecting striatum was the strongest correlate with higher probability of symptomatic conversion in early premanifest Huntington's disease gene carriers.  Our findings demonstrate in vivo, a novel and earliest pathophysiological mechanism underlying Huntington's disease with direct implications for the development of new pharmacological treatments, which can promote neuronal survival and improve outcome in Huntington's disease gene carriers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQt45D4d8YjXeWhZTslLrfffW6udTcc2eZ0YMNgDys7VLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28%252Flt1KqtA%253D%253D&md5=35244382e3e08926abebd5ce93bb061b</span></div><a href="/servlet/linkout?suffix=cit204&amp;dbid=16384&amp;doi=10.1093%2Fbrain%2Fawv214&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fbrain%252Fawv214%26sid%3Dliteratum%253Aachs%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DReis%2BMarques%26aufirst%3DT.%26aulast%3DMuhlert%26aufirst%3DN.%26aulast%3DTziortzi%26aufirst%3DA.%2BC.%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DTabrizi%26aufirst%3DS.%2BJ.%26aulast%3DPolitis%26aufirst%3DM.%26atitle%3DAltered%2520PDE10A%2520expression%2520detectable%2520early%2520before%2520symptomatic%2520onset%2520in%2520Huntington%25E2%2580%2599s%2520disease%26jtitle%3DBrain%26date%3D2015%26volume%3D138%26spage%3D3016%26epage%3D3029%26doi%3D10.1093%2Fbrain%2Fawv214" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref205"><div class="reference"><strong class="refLabel"><a href="#ref205" class="rightTabRefNumLink">205</a></strong><div class="NLM_citation" id="rightTab-cit205"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yousaf, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, N. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martino, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plisson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piccini, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foltynie, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span> <span> </span><span class="NLM_article-title">Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinson’s disease</span>. <i>Mov. Disord.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">1505</span>– <span class="NLM_lpage">1515</span>, <span class="refDoi"> DOI: 10.1002/mds.27733</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fmds.27733" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31158314" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref205/cit205&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhvFynsbzL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2019&pages=1505-1515&author=G.+Paganoauthor=F.+Niccoliniauthor=H.+Wilsonauthor=T.+Yousafauthor=N.+L.+Khanauthor=D.+Martinoauthor=C.+Plissonauthor=R.+N.+Gunnauthor=E.+A.+Rabinerauthor=P.+Picciniauthor=T.+Foltynieauthor=M.+Politis&title=Comparison+of+phosphodiesterase+10A+and+dopamine+transporter+levels+as+markers+of+disease+burden+in+early+Parkinson%E2%80%99s+disease&doi=10.1002%2Fmds.27733"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit205R"><div class="casContent"><span class="casTitleNuber">205</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of phosphodiesterase 10A and dopamine transporter levels as markers of disease burden in early Parkinsons disease</span></div><div class="casAuthors">Pagano, Gennaro; Niccolini, Flavia; Wilson, Heather; Yousaf, Tayyabah; Khan, Naheed L.; Martino, Davide; Plisson, Christophe; Gunn, Roger N.; Rabiner, Eugenii A.; Piccini, Paola; Foltynie, Thomas; Politis, Marios</div><div class="citationInfo"><span class="NLM_cas:title">Movement Disorders</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1505-1515</span>CODEN:
                <span class="NLM_cas:coden">MOVDEA</span>;
        ISSN:<span class="NLM_cas:issn">0885-3185</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">To assess phosphodiesterase 10A levels in early PD and compare with loss of dopamine transporter as markers of disease burden.  Seventy-eight subjects were included in this study (17 early de novo, 15 early L-dopa-treated, 24 moderate-advanced L-dopa-treated patients with PD, and 22 healthy controls).  Early de novo PD patients showed loss of [11C]IMA107 and of [11C]PE2I binding in caudate and putamen (P < 0.001); early L-dopa-treated PD patients showed addnl. loss of [11C]IMA107 in the caudate (P < 0.001; annual decline 3.6%) and putamen (P < 0.001; annual decline 2.8%), but loss of [11C]PE2I only in the putamen (P < 0.001; annual decline 6.8%).  Lower [11C]IMA107 correlated with lower [11C]PE2I in the caudate and putamen.  Longer disease duration correlated with lower [11C]IMA107 in the caudate and putamen and with lower [11C]PE2I only in the putamen.  Higher burden of motor symptoms correlated with lower [11C]IMA107 in the caudate and putamen and with lower [11C]PE2I only in the putamen.  Our findings demonstrate loss of phosphodiesterase 10A levels very early in the course of PD and is assocd. with the gradual and progressive increase of motor symptoms.  Phosphodiesterase 10A imaging shows similar potential with dopamine transporter imaging to follow disease progression.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpfPliKYC0FRrVg90H21EOLACvtfcHk0li5UXf6ZYlIww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhvFynsbzL&md5=b3f0d3717324e9d9b0a667742a744c97</span></div><a href="/servlet/linkout?suffix=cit205&amp;dbid=16384&amp;doi=10.1002%2Fmds.27733&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmds.27733%26sid%3Dliteratum%253Aachs%26aulast%3DPagano%26aufirst%3DG.%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DWilson%26aufirst%3DH.%26aulast%3DYousaf%26aufirst%3DT.%26aulast%3DKhan%26aufirst%3DN.%2BL.%26aulast%3DMartino%26aufirst%3DD.%26aulast%3DPlisson%26aufirst%3DC.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DPiccini%26aufirst%3DP.%26aulast%3DFoltynie%26aufirst%3DT.%26aulast%3DPolitis%26aufirst%3DM.%26atitle%3DComparison%2520of%2520phosphodiesterase%252010A%2520and%2520dopamine%2520transporter%2520levels%2520as%2520markers%2520of%2520disease%2520burden%2520in%2520early%2520Parkinson%25E2%2580%2599s%2520disease%26jtitle%3DMov.%2520Disord.%26date%3D2019%26volume%3D34%26spage%3D1505%26epage%3D1515%26doi%3D10.1002%2Fmds.27733" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref206"><div class="reference"><strong class="refLabel"><a href="#ref206" class="rightTabRefNumLink">206</a></strong><div class="NLM_citation" id="rightTab-cit206"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Searle, G. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 10A in schizophrenia: A PET study using [<sup>11</sup>C]IMA107</span>. <i>Am. J. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">714</span>– <span class="NLM_lpage">721</span>, <span class="refDoi"> DOI: 10.1176/appi.ajp.2015.15040518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1176%2Fappi.ajp.2015.15040518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=26892941" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref206/cit206&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A280%3ADC%252BC28jit1GltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2016&pages=714-721&author=T.+R.+Marquesauthor=S.+Natesanauthor=F.+Niccoliniauthor=M.+Politisauthor=R.+N.+Gunnauthor=G.+E.+Searleauthor=O.+Howesauthor=E.+A.+Rabinerauthor=S.+Kapur&title=Phosphodiesterase+10A+in+schizophrenia%3A+A+PET+study+using+%5B11C%5DIMA107&doi=10.1176%2Fappi.ajp.2015.15040518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit206R"><div class="casContent"><span class="casTitleNuber">206</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 10A in Schizophrenia: A PET Study Using [(11)C]IMA107</span></div><div class="casAuthors">Marques Tiago Reis; Natesan Sridhar; Niccolini Flavia; Politis Marios; Gunn Roger N; Searle Graham E; Howes Oliver; Rabiner Eugenii A; Kapur Shitij</div><div class="citationInfo"><span class="NLM_cas:title">The American journal of psychiatry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">714-21</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  Phosphodiesterase 10A (PDE10A) is an enzyme present in striatal medium spiny neurons that degrades the intracellular second messengers triggered by dopamine signaling.  The pharmaceutical industry has considerable interest in PDE10A inhibitors because they have been shown to have an antipsychotic-like effect in animal models.  However, the status of PDE10A in schizophrenia is unknown.  Using a newly developed and validated radioligand, [(11)C]IMA107, the authors report the first in vivo assessment of PDE10A brain expression in patients with schizophrenia.  METHOD:  The authors compared PDE10A availability in the brains of 12 patients with chronic schizophrenia and 12 matched healthy comparison subjects using [(11)C]IMA107 positron emission tomography (PET).  Regional estimates of the binding potential (BPND) of [(11)C]IMA107 were generated from dynamic PET scans using the simplified reference tissue model with the cerebellum as the reference tissue for nonspecific binding.  RESULTS:  There was no significant difference in [(11)C]IMA107 BPND between schizophrenia patients and comparison subjects in any of the brain regions studied (thalamus, caudate, putamen, nucleus accumbens, globus pallidus, and substantia nigra).  There was also no significant correlation between [(11)C]IMA107 BPND and the severity of psychotic symptoms or antipsychotic dosage.  CONCLUSIONS:  Patients with schizophrenia have normal availability of PDE10A in brain regions thought to be involved in the pathophysiology of this disorder.  The findings do not support the proposal of an altered PDE10A availability in schizophrenia.  The implication of this finding for future drug development is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT5qxqBomUfwWhHGZei4OW9fW6udTcc2ebPXjY-Ukw_Tbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28jit1GltA%253D%253D&md5=98c324f9f9df3fb3521fb5a1e96b7af0</span></div><a href="/servlet/linkout?suffix=cit206&amp;dbid=16384&amp;doi=10.1176%2Fappi.ajp.2015.15040518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1176%252Fappi.ajp.2015.15040518%26sid%3Dliteratum%253Aachs%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DPolitis%26aufirst%3DM.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DSearle%26aufirst%3DG.%2BE.%26aulast%3DHowes%26aufirst%3DO.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DKapur%26aufirst%3DS.%26atitle%3DPhosphodiesterase%252010A%2520in%2520schizophrenia%253A%2520A%2520PET%2520study%2520using%2520%255B11C%255DIMA107%26jtitle%3DAm.%2520J.%2520Psychiatry%26date%3D2016%26volume%3D173%26spage%3D714%26epage%3D721%26doi%3D10.1176%2Fappi.ajp.2015.15040518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref207"><div class="reference"><strong class="refLabel"><a href="#ref207" class="rightTabRefNumLink">207</a></strong><div class="NLM_citation" id="rightTab-cit207"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niccolini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Haider, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pagano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coello, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Natesan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kapur, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rabiner, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gunn, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tabrizi, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span> <span> </span><span class="NLM_article-title">Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington’s disease gene carriers</span>. <i>J. Neurol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>368</i></span>,  <span class="NLM_fpage">243</span>– <span class="NLM_lpage">248</span>, <span class="refDoi"> DOI: 10.1016/j.jns.2016.07.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.jns.2016.07.033" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27538642" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref207/cit207&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Slt7zI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=368&publication_year=2016&pages=243-248&author=H.+Wilsonauthor=F.+Niccoliniauthor=S.+Haiderauthor=T.+R.+Marquesauthor=G.+Paganoauthor=C.+Coelloauthor=S.+Natesanauthor=S.+Kapurauthor=E.+A.+Rabinerauthor=R.+N.+Gunnauthor=S.+J.+Tabriziauthor=M.+Politis&title=Loss+of+extra-striatal+phosphodiesterase+10A+expression+in+early+premanifest+Huntington%E2%80%99s+disease+gene+carriers&doi=10.1016%2Fj.jns.2016.07.033"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit207R"><div class="casContent"><span class="casTitleNuber">207</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of extra-striatal phosphodiesterase 10A expression in early premanifest Huntington's disease gene carriers</span></div><div class="casAuthors">Wilson, Heather; Niccolini, Flavia; Haider, Salman; Marques, Tiago Reis; Pagano, Gennaro; Coello, Christopher; Natesan, Sridhar; Kapur, Shitij; Rabiner, Eugenii A.; Gunn, Roger N.; Tabrizi, Sarah J.; Politis, Marios</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the Neurological Sciences</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">368</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">243-248</span>CODEN:
                <span class="NLM_cas:coden">JNSCAG</span>;
        ISSN:<span class="NLM_cas:issn">0022-510X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Huntington's disease (HD) is a monogenic neurodegenerative disorder with an underlying pathol. involving the toxic effect of mutant huntingtin protein primarily in striatal and cortical neurons.  Phosphodiesterase 10A (PDE10A) regulates intracellular signalling cascades, thus having a key role in promoting neuronal survival.  Using positron emission tomog. (PET) with [11C]IMA107, we investigated the in vivo extra-striatal expression of PDE10A in 12 early premanifest HD gene carriers.  Image processing and kinetic modeling was performed using MIAKAT.  Parametric images of [11C]IMA107 non-displaceable binding potential (BPND) were generated from the dynamic [11C]IMA107 scans using the simplified ref. tissue model with the cerebellum as the ref. tissue for nonspecific binding.  We set a threshold criterion for meaningful quantification of [11C]IMA107 BPND at 0.30 in healthy control data; regions meeting this criterion were designated as regions of interest (ROIs).  MRI-based volumetric anal. showed no atrophy in ROIs.  We found significant differences in mean ROIs [11C]IMA107 BPND between HD gene carriers and healthy controls.  HD gene carriers had significant loss of PDE10A within the insular cortex and occipital fusiform gyrus compared to healthy controls.  Insula and occipital fusiform gyrus are important brain areas for the regulation of cognitive and limbic function that is impaired in HD.  Our findings suggest that dysregulation of PDE10A-mediated intracellular signalling could be an early phenomenon in the course of HD with relevance also for extra-striatal brain areas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOzyDHr5CCa7Vg90H21EOLACvtfcHk0lhWHwxH4ZCTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Slt7zI&md5=fc19f1fe2787af794e526f1cade12e6f</span></div><a href="/servlet/linkout?suffix=cit207&amp;dbid=16384&amp;doi=10.1016%2Fj.jns.2016.07.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jns.2016.07.033%26sid%3Dliteratum%253Aachs%26aulast%3DWilson%26aufirst%3DH.%26aulast%3DNiccolini%26aufirst%3DF.%26aulast%3DHaider%26aufirst%3DS.%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DPagano%26aufirst%3DG.%26aulast%3DCoello%26aufirst%3DC.%26aulast%3DNatesan%26aufirst%3DS.%26aulast%3DKapur%26aufirst%3DS.%26aulast%3DRabiner%26aufirst%3DE.%2BA.%26aulast%3DGunn%26aufirst%3DR.%2BN.%26aulast%3DTabrizi%26aufirst%3DS.%2BJ.%26aulast%3DPolitis%26aufirst%3DM.%26atitle%3DLoss%2520of%2520extra-striatal%2520phosphodiesterase%252010A%2520expression%2520in%2520early%2520premanifest%2520Huntington%25E2%2580%2599s%2520disease%2520gene%2520carriers%26jtitle%3DJ.%2520Neurol.%2520Sci.%26date%3D2016%26volume%3D368%26spage%3D243%26epage%3D248%26doi%3D10.1016%2Fj.jns.2016.07.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref208"><div class="reference"><strong class="refLabel"><a href="#ref208" class="rightTabRefNumLink">208</a></strong><div class="NLM_citation" id="rightTab-cit208"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Diggle, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sukoff Rizzo, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiolek, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinttala, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schulke, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurian, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carr, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Markham, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonthron, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharif, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinhart, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">James, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanase-Frawley, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charych, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harms, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pysden, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strick, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vieira, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mankinen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kokkonen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kallioinen, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sormunen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinne, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johansson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alakurtti, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huilaja, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurskainen, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tasanen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anttila, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marques, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Howes, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Politis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fahiminiya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nguyen, K. Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Majewski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uusimaa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sheridan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brandon, N. J.</span></span> <span> </span><span class="NLM_article-title">Biallelic mutations in PDE10A lead to loss of striatal PDE10A and a hyperkinetic movement disorder with onset in infancy</span>. <i>Am. J. Hum. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>98</i></span>,  <span class="NLM_fpage">735</span>– <span class="NLM_lpage">43</span>, <span class="refDoi"> DOI: 10.1016/j.ajhg.2016.03.015</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.ajhg.2016.03.015" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27058446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref208/cit208&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XltFKht78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=98&publication_year=2016&pages=735-43&author=C.+P.+Diggleauthor=S.+J.+Sukoff+Rizzoauthor=M.+Popiolekauthor=R.+Hinttalaauthor=J.+P.+Schulkeauthor=M.+A.+Kurianauthor=I.+M.+Carrauthor=A.+F.+Markhamauthor=D.+T.+Bonthronauthor=C.+Watsonauthor=S.+M.+Sharifauthor=V.+Reinhartauthor=L.+C.+Jamesauthor=M.+A.+Vanase-Frawleyauthor=E.+Charychauthor=M.+Allenauthor=J.+Harmsauthor=C.+J.+Schmidtauthor=J.+Ngauthor=K.+Pysdenauthor=C.+Strickauthor=P.+Vieiraauthor=K.+Mankinenauthor=H.+Kokkonenauthor=M.+Kallioinenauthor=R.+Sormunenauthor=J.+O.+Rinneauthor=J.+Johanssonauthor=K.+Alakurttiauthor=L.+Huilajaauthor=T.+Hurskainenauthor=K.+Tasanenauthor=E.+Anttilaauthor=T.+R.+Marquesauthor=O.+Howesauthor=M.+Politisauthor=S.+Fahiminiyaauthor=K.+Q.+Nguyenauthor=J.+Majewskiauthor=J.+Uusimaaauthor=E.+Sheridanauthor=N.+J.+Brandon&title=Biallelic+mutations+in+PDE10A+lead+to+loss+of+striatal+PDE10A+and+a+hyperkinetic+movement+disorder+with+onset+in+infancy&doi=10.1016%2Fj.ajhg.2016.03.015"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit208R"><div class="casContent"><span class="casTitleNuber">208</span><div class="casTitle"><span class="NLM_cas:atitle">Biallelic Mutations in PDE10A Lead to Loss of Striatal PDE10A and a Hyperkinetic Movement Disorder with Onset in Infancy</span></div><div class="casAuthors">Diggle, Christine P.; Sukoff-Rizzo, Stacey J.; Popiolek, Michael; Hinttala, Reetta; Schulke, Jan-Philip; Kurian, Manju A.; Carr, Ian M.; Markham, Alexander F.; Bonthron, David T.; Watson, Christopher; Sharif, Saghira Malik; Reinhart, Veronica; James, Larry C.; Vanase-Frawley, Michelle A.; Charych, Erik; Allen, Melanie; Harms, John; Schmidt, Christopher J.; Ng, Joanne; Pysden, Karen; Strick, Christine; Vieira, Paivi; Mankinen, Katariina; Kokkonen, Hannaleena; Kallioinen, Matti; Sormunen, Raija; Rinne, Juha O.; Johansson, Jarkko; Alakurtti, Kati; Huilaja, Laura; Hurskainen, Tiina; Tasanen, Kaisa; Anttila, Eija; Marques, Tiago Reis; Howes, Oliver; Politis, Marius; Fahiminiya, Somayyeh; Nguyen, Khanh Q.; Majewski, Jacek; Uusimaa, Johanna; Sheridan, Eamonn; Brandon, Nicholas J.</div><div class="citationInfo"><span class="NLM_cas:title">American Journal of Human Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">98</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">735-743</span>CODEN:
                <span class="NLM_cas:coden">AJHGAG</span>;
        ISSN:<span class="NLM_cas:issn">0002-9297</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Deficits in the basal ganglia pathways modulating cortical motor activity underlie both Parkinson disease (PD) and Huntington disease (HD).  Phosphodiesterase 10A (PDE10A) is enriched in the striatum, and animal data suggest that it is a key regulator of this circuitry.  Here, we report on germline PDE10A mutations in eight individuals from two families affected by a hyperkinetic movement disorder due to homozygous mutations c.320A>G (p.Tyr107Cys) and c.346G>C (p.Ala116Pro).  Both mutations lead to a redn. in PDE10A levels in recombinant cellular systems, and critically, positron-emission-tomog. (PET) studies with a specific PDE10A ligand confirmed that the p.Tyr107Cys variant also reduced striatal PDE10A levels in one of the affected individuals.  A knock-in mouse model carrying the homologous p.Tyr97Cys variant had decreased striatal PDE10A and also displayed motor abnormalities.  Striatal prepns. from this animal had an impaired capacity to degrade cyclic adenosine monophosphate (cAMP) and a blunted pharmacol. response to PDE10A inhibitors.  These observations highlight the crit. role of PDE10A in motor control across species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp_vISP0guOL7Vg90H21EOLACvtfcHk0lhWHwxH4ZCTSQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XltFKht78%253D&md5=79585b919e71c6c401bfe469435d65ca</span></div><a href="/servlet/linkout?suffix=cit208&amp;dbid=16384&amp;doi=10.1016%2Fj.ajhg.2016.03.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ajhg.2016.03.015%26sid%3Dliteratum%253Aachs%26aulast%3DDiggle%26aufirst%3DC.%2BP.%26aulast%3DSukoff%2BRizzo%26aufirst%3DS.%2BJ.%26aulast%3DPopiolek%26aufirst%3DM.%26aulast%3DHinttala%26aufirst%3DR.%26aulast%3DSchulke%26aufirst%3DJ.%2BP.%26aulast%3DKurian%26aufirst%3DM.%2BA.%26aulast%3DCarr%26aufirst%3DI.%2BM.%26aulast%3DMarkham%26aufirst%3DA.%2BF.%26aulast%3DBonthron%26aufirst%3DD.%2BT.%26aulast%3DWatson%26aufirst%3DC.%26aulast%3DSharif%26aufirst%3DS.%2BM.%26aulast%3DReinhart%26aufirst%3DV.%26aulast%3DJames%26aufirst%3DL.%2BC.%26aulast%3DVanase-Frawley%26aufirst%3DM.%2BA.%26aulast%3DCharych%26aufirst%3DE.%26aulast%3DAllen%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DNg%26aufirst%3DJ.%26aulast%3DPysden%26aufirst%3DK.%26aulast%3DStrick%26aufirst%3DC.%26aulast%3DVieira%26aufirst%3DP.%26aulast%3DMankinen%26aufirst%3DK.%26aulast%3DKokkonen%26aufirst%3DH.%26aulast%3DKallioinen%26aufirst%3DM.%26aulast%3DSormunen%26aufirst%3DR.%26aulast%3DRinne%26aufirst%3DJ.%2BO.%26aulast%3DJohansson%26aufirst%3DJ.%26aulast%3DAlakurtti%26aufirst%3DK.%26aulast%3DHuilaja%26aufirst%3DL.%26aulast%3DHurskainen%26aufirst%3DT.%26aulast%3DTasanen%26aufirst%3DK.%26aulast%3DAnttila%26aufirst%3DE.%26aulast%3DMarques%26aufirst%3DT.%2BR.%26aulast%3DHowes%26aufirst%3DO.%26aulast%3DPolitis%26aufirst%3DM.%26aulast%3DFahiminiya%26aufirst%3DS.%26aulast%3DNguyen%26aufirst%3DK.%2BQ.%26aulast%3DMajewski%26aufirst%3DJ.%26aulast%3DUusimaa%26aufirst%3DJ.%26aulast%3DSheridan%26aufirst%3DE.%26aulast%3DBrandon%26aufirst%3DN.%2BJ.%26atitle%3DBiallelic%2520mutations%2520in%2520PDE10A%2520lead%2520to%2520loss%2520of%2520striatal%2520PDE10A%2520and%2520a%2520hyperkinetic%2520movement%2520disorder%2520with%2520onset%2520in%2520infancy%26jtitle%3DAm.%2520J.%2520Hum.%2520Genet.%26date%3D2016%26volume%3D98%26spage%3D735%26epage%3D43%26doi%3D10.1016%2Fj.ajhg.2016.03.015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref209"><div class="reference"><strong class="refLabel"><a href="#ref209" class="rightTabRefNumLink">209</a></strong><div class="NLM_citation" id="rightTab-cit209"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tollefson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gertler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Himes, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paris, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kendro, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopresti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott Mason, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Narendran, R.</span></span> <span> </span><span class="NLM_article-title">Imaging phosphodiesterase-10a availability in cocaine use disorder with [<sup>11</sup>C]IMA107 and PET</span>. <i>Synapse</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>73</i></span>, <span class="NLM_elocation-id">e22070</span> <span class="refDoi"> DOI: 10.1002/syn.22070</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1002%2Fsyn.22070" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref209/cit209&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=30240027" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=73&publication_year=2019&author=S.+Tollefsonauthor=J.+Gertlerauthor=M.+L.+Himesauthor=J.+Parisauthor=S.+Kendroauthor=B.+Loprestiauthor=N.+Scott+Masonauthor=R.+Narendran&title=Imaging+phosphodiesterase-10a+availability+in+cocaine+use+disorder+with+%5B11C%5DIMA107+and+PET&doi=10.1002%2Fsyn.22070"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit209&amp;dbid=16384&amp;doi=10.1002%2Fsyn.22070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fsyn.22070%26sid%3Dliteratum%253Aachs%26aulast%3DTollefson%26aufirst%3DS.%26aulast%3DGertler%26aufirst%3DJ.%26aulast%3DHimes%26aufirst%3DM.%2BL.%26aulast%3DParis%26aufirst%3DJ.%26aulast%3DKendro%26aufirst%3DS.%26aulast%3DLopresti%26aufirst%3DB.%26aulast%3DScott%2BMason%26aufirst%3DN.%26aulast%3DNarendran%26aufirst%3DR.%26atitle%3DImaging%2520phosphodiesterase-10a%2520availability%2520in%2520cocaine%2520use%2520disorder%2520with%2520%255B11C%255DIMA107%2520and%2520PET%26jtitle%3DSynapse%26date%3D2019%26volume%3D73%26doi%3D10.1002%2Fsyn.22070" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref210"><div class="reference"><strong class="refLabel"><a href="#ref210" class="rightTabRefNumLink">210</a></strong><div class="NLM_citation" id="rightTab-cit210"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Makhlouf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kshirsagar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niederberger, C.</span></span> <span> </span><span class="NLM_article-title">Phosphodiesterase 11: a brief review of structure, expression and function</span>. <i>Int. J. Impotence Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">501</span>– <span class="NLM_lpage">509</span>, <span class="refDoi"> DOI: 10.1038/sj.ijir.3901441</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fsj.ijir.3901441" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=16395323" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref210/cit210&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFChsrvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2006&pages=501-509&author=A.+Makhloufauthor=A.+Kshirsagarauthor=C.+Niederberger&title=Phosphodiesterase+11%3A+a+brief+review+of+structure%2C+expression+and+function&doi=10.1038%2Fsj.ijir.3901441"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit210R"><div class="casContent"><span class="casTitleNuber">210</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 11: a brief review of structure, expression and function</span></div><div class="casAuthors">Makhlouf, A.; Kshirsagar, A.; Niederberger, C.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Impotence Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">501-509</span>CODEN:
                <span class="NLM_cas:coden">IJIRFB</span>;
        ISSN:<span class="NLM_cas:issn">0955-9930</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Phosphodiesterase 11 (PDE11) is the latest isoform of the phosphodiesterase family to be identified.  Interest in PDE11 has increased recently because tadalafil, an oral phosphodiesterase 5 inhibitor, cross-reacts with PDE11.  The function of PDE11 remains largely unknown, but growing evidence points to a possible role in male reprodn.  Here, the published literature on PDE11 structure, function, and expression is reviewed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQHo7j_8684LVg90H21EOLACvtfcHk0lizuyKkNvMPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFChsrvO&md5=b33fb2263603bc5efae8472a6bdfecf8</span></div><a href="/servlet/linkout?suffix=cit210&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijir.3901441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijir.3901441%26sid%3Dliteratum%253Aachs%26aulast%3DMakhlouf%26aufirst%3DA.%26aulast%3DKshirsagar%26aufirst%3DA.%26aulast%3DNiederberger%26aufirst%3DC.%26atitle%3DPhosphodiesterase%252011%253A%2520a%2520brief%2520review%2520of%2520structure%252C%2520expression%2520and%2520function%26jtitle%3DInt.%2520J.%2520Impotence%2520Res.%26date%3D2006%26volume%3D18%26spage%3D501%26epage%3D509%26doi%3D10.1038%2Fsj.ijir.3901441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref211"><div class="reference"><strong class="refLabel"><a href="#ref211" class="rightTabRefNumLink">211</a></strong><div class="NLM_citation" id="rightTab-cit211"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yuasa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kotera, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fujishige, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Michibata, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Omori, K.</span></span> <span> </span><span class="NLM_article-title">Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">31469</span>– <span class="NLM_lpage">31479</span>, <span class="refDoi"> DOI: 10.1074/jbc.M003041200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1074%2Fjbc.M003041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10906126" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref211/cit211&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXntlCitLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=31469-31479&author=K.+Yuasaauthor=J.+Koteraauthor=K.+Fujishigeauthor=H.+Michibataauthor=T.+Sasakiauthor=K.+Omori&title=Isolation+and+characterization+of+two+novel+phosphodiesterase+PDE11A+variants+showing+unique+structure+and+tissue-specific+expression&doi=10.1074%2Fjbc.M003041200"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit211R"><div class="casContent"><span class="casTitleNuber">211</span><div class="casTitle"><span class="NLM_cas:atitle">Isolation and characterization of two novel phosphodiesterase PDE11A variants showing unique structure and tissue-specific expression</span></div><div class="casAuthors">Yuasa, Keizo; Kotera, Jun; Fujishige, Kotomi; Michibata, Hideo; Sasaki, Takashi; Omori, Kenji</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">31469-31479</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">CDNAs encoding a novel phosphodiesterase, phosphodiesterase 11A (PDE11A), were isolated by a combination of reverse transcriptase-polymerase chain reaction using degenerate oligonucleotide primers and rapid amplification of cDNA ends.  Their catalytic domain was identical to that of PDE11A1 (490 amino acids) reported during the course of this study.  However, the cDNAs we isolated had N termini distinct from PDE11A1, indicating two novel N-terminal variants of PDE11A.  PDE11A3 cDNA encoded a 684-amino acid protein including one complete and one incomplete GAF domain in the N-terminal region.  PDE11A4 was composed of 934 amino acids including two complete GAF domains and shared 630 C-terminal amino acids with PDE11A3 but had a distinct N terminus contg. the putative phosphorylation sites for cAMP- and cGMP-dependent protein kinases.  PDE11A3 transcripts were specifically expressed in testis, whereas PDE11A4 transcripts were particularly abundant in prostate.  Recombinant PDE11A4 expressed in COS-7 cells hydrolyzed cAMP and cGMP with Km values of 3.0 and 1.4 μM, resp., and the Vmax value with cAMP was almost twice that with cGMP.  Although PDE11A3 showed the same Km values as PDE11A4, the relative Vmax values of PDE11A3 were approx. one-sixth of those of PDE11A4.  PDE11A4, but not PDE11A3, was phosphorylated by both cAMP- and cGMP-dependent protein kinases in vitro.  Thus, the PDE11A gene undergoes tissue-specific alternative splicing that generates structurally and functionally distinct gene products.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqP-mE2wlBKDLVg90H21EOLACvtfcHk0lizuyKkNvMPAw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXntlCitLo%253D&md5=45ada9686385e445f515327b4c1e3777</span></div><a href="/servlet/linkout?suffix=cit211&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M003041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M003041200%26sid%3Dliteratum%253Aachs%26aulast%3DYuasa%26aufirst%3DK.%26aulast%3DKotera%26aufirst%3DJ.%26aulast%3DFujishige%26aufirst%3DK.%26aulast%3DMichibata%26aufirst%3DH.%26aulast%3DSasaki%26aufirst%3DT.%26aulast%3DOmori%26aufirst%3DK.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520two%2520novel%2520phosphodiesterase%2520PDE11A%2520variants%2520showing%2520unique%2520structure%2520and%2520tissue-specific%2520expression%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D31469%26epage%3D31479%26doi%3D10.1074%2Fjbc.M003041200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref212"><div class="reference"><strong class="refLabel"><a href="#ref212" class="rightTabRefNumLink">212</a></strong><div class="NLM_citation" id="rightTab-cit212"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fawcett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baxendale, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stacey, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McGrouther, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harrow, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soderling, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hetman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beavo, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, S. C.</span></span> <span> </span><span class="NLM_article-title">Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3702</span>– <span class="NLM_lpage">3707</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.7.3702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1073%2Fpnas.97.7.3702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10725373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref212/cit212&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlajsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3702-3707&author=L.+Fawcettauthor=R.+Baxendaleauthor=P.+Staceyauthor=C.+McGroutherauthor=I.+Harrowauthor=S.+Soderlingauthor=J.+Hetmanauthor=J.+A.+Beavoauthor=S.+C.+Phillips&title=Molecular+cloning+and+characterization+of+a+distinct+human+phosphodiesterase+gene+family%3A+PDE11A&doi=10.1073%2Fpnas.97.7.3702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit212R"><div class="casContent"><span class="casTitleNuber">212</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular cloning and characterization of a distinct human phosphodiesterase gene family: PDE11A</span></div><div class="casAuthors">Fawcett, Lindsay; Baxendale, Rhona; Stacey, Peter; McGrouther, Collette; Harrow, Ian; Soderling, Scott; Hetman, Joanna; Beavo, Joseph A.; Phillips, Stephen C.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3702-3707</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">The cloning, expression, and characterization of human PDE11A1, a member of a distinct cyclic nucleotide phosphodiesterase (PDE) family, is reported.  PDE11A exhibits ≤50% amino acid identity with the catalytic domains of all other PDEs, being most similar to PDE5, and has distinct biochem. properties.  The human PDE11A1 cDNA isolated contains a complete open reading frame encoding a 490-amino acid enzyme with a predicted mol. mass of 55,786 Da.  At the N-terminus PDE11A1 has a single GAF domain homologous to that found in other signaling mols., including PDE2, PDE5, PDE6, and PDE10, which constitutes a potential allosteric binding site for cGMP or another small ligand.  Tissue distribution studies indicate that PDE11A mRNA occurs at highest levels in skeletal muscle, prostate, kidney, liver, pituitary, and salivary glands and testis.  PDE11A is expressed as at least three major transcripts of ≈10.5, ≈8.5, and ≈6.0 kb, thus suggesting the existence of multiple subtypes.  This possibility is further supported by the detection of three distinct proteins of ≈78, ≈65, and ≈56 kDa by Western blotting of human tissues for PDE11A isoforms.  Recombinant human PDE11A1 hydrolyzes both cGMP and cAMP with Km values of 0.52 μM and 1.04 μM, resp., and similar Vmax values.  Therefore, PDE11A represents a dual-substrate PDE that may regulate both cGMP and cAMP under physiol. conditions.  PDE11A is sensitive to the nonselective PDE inhibitor 3-isobutyl-1-methylxanthine (IBMX) as well as zaprinast and dipyridamole, inhibitors that are generally considered relatively specific for the cGMP-selective PDEs, with IC50 values of 49.8 μM, 12.0 μM, and 0.37 μM, resp.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_VJWznJpR_bVg90H21EOLACvtfcHk0ljgop5IVODwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlajsr4%253D&md5=3c163b17327e91096fd2bcd7c7772918</span></div><a href="/servlet/linkout?suffix=cit212&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.7.3702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.7.3702%26sid%3Dliteratum%253Aachs%26aulast%3DFawcett%26aufirst%3DL.%26aulast%3DBaxendale%26aufirst%3DR.%26aulast%3DStacey%26aufirst%3DP.%26aulast%3DMcGrouther%26aufirst%3DC.%26aulast%3DHarrow%26aufirst%3DI.%26aulast%3DSoderling%26aufirst%3DS.%26aulast%3DHetman%26aufirst%3DJ.%26aulast%3DBeavo%26aufirst%3DJ.%2BA.%26aulast%3DPhillips%26aufirst%3DS.%2BC.%26atitle%3DMolecular%2520cloning%2520and%2520characterization%2520of%2520a%2520distinct%2520human%2520phosphodiesterase%2520gene%2520family%253A%2520PDE11A%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D3702%26epage%3D3707%26doi%3D10.1073%2Fpnas.97.7.3702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref213"><div class="reference"><strong class="refLabel"><a href="#ref213" class="rightTabRefNumLink">213</a></strong><div class="NLM_citation" id="rightTab-cit213"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oliver, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Poupore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shtutman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>335</i></span>,  <span class="NLM_fpage">151</span>– <span class="NLM_lpage">169</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2016.08.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.neuroscience.2016.08.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27544407" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref213/cit213&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVWmsL7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=335&publication_year=2016&pages=151-169&author=S.+Hegdeauthor=H.+Jiauthor=D.+Oliverauthor=N.+S.+Patelauthor=N.+Pouporeauthor=M.+Shtutmanauthor=M.+P.+Kelly&title=PDE11A+regulates+social+behaviors+and+is+a+key+mechanism+by+which+social+experience+sculpts+the+brain&doi=10.1016%2Fj.neuroscience.2016.08.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit213R"><div class="casContent"><span class="casTitleNuber">213</span><div class="casTitle"><span class="NLM_cas:atitle">PDE11A regulates social behaviors and is a key mechanism by which social experience sculpts the brain</span></div><div class="casAuthors">Hegde, Shweta; Ji, Hao; Oliver, David; Patel, Neema S.; Poupore, Nicolas; Shtutman, Michael; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">335</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">151-169</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Despite the fact that appropriate social behaviors are vital to thriving in one's environment, little is understood of the mol. mechanisms controlling social behaviors or how social experience sculpts these signaling pathways.  Here, we det. if Phosphodiesterase 11A (PDE11A), an enzyme that is enriched in the ventral hippocampal formation (VHIPP) and that breaks down cAMP and cGMP, regulates social behaviors.  PDE11 wild-type (WT), heterozygous (HT), and knockout (KO) mice were tested in various social approach assays and gene expression differences were measured by RNA sequencing.  The effect of social isolation on PDE11A4 compartmentalization and subsequent social interactions and social memory was also assessed.  Deletion of PDE11A triggered age- and sex-dependent deficits in social approach in specific social contexts but not others.  Mice appear to detect altered social behaviors of PDE11A KO mice, because C57BL/6J mice prefer to spend time with a sex-matched PDE11A WT vs. its KO littermate; whereas, a PDE11A KO prefers to spend time with a novel PDE11A KO vs. its WT littermate.  Not only is PDE11A required for intact social interactions, we found that 1 mo of social isolation vs. group housing decreased PDE11A4 protein expression specifically within the membrane fraction of VHIPP.  This isolation-induced decrease in PDE11A4 expression appears functional because social isolation impairs subsequent social approach behavior and social memory in a PDE11A genotype-dependent manner.  Pathway analyses following RNA sequencing suggests PDE11A is a key regulator of the oxytocin pathway and membrane signaling, consistent with its pivotal role in regulating social behavior.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqgvzxUXhd9CLVg90H21EOLACvtfcHk0ljgop5IVODwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVWmsL7I&md5=009789c35e20016c597bdc4dd2156ce4</span></div><a href="/servlet/linkout?suffix=cit213&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2016.08.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2016.08.019%26sid%3Dliteratum%253Aachs%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DOliver%26aufirst%3DD.%26aulast%3DPatel%26aufirst%3DN.%2BS.%26aulast%3DPoupore%26aufirst%3DN.%26aulast%3DShtutman%26aufirst%3DM.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DPDE11A%2520regulates%2520social%2520behaviors%2520and%2520is%2520a%2520key%2520mechanism%2520by%2520which%2520social%2520experience%2520sculpts%2520the%2520brain%26jtitle%3DNeuroscience%26date%3D2016%26volume%3D335%26spage%3D151%26epage%3D169%26doi%3D10.1016%2Fj.neuroscience.2016.08.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref214"><div class="reference"><strong class="refLabel"><a href="#ref214" class="rightTabRefNumLink">214</a></strong><div class="NLM_citation" id="rightTab-cit214"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pilarzyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klett, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pena, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porcher, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">Loss of function of phosphodiesterase 11A4 shows that recent and remote long-term memories can be uncoupled</span>. <i>Curr. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">2307</span>– <span class="NLM_lpage">2321</span>, <span class="refDoi"> DOI: 10.1016/j.cub.2019.06.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.cub.2019.06.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=31303492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref214/cit214&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7jL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2019&pages=2307-2321&author=K.+Pilarzykauthor=J.+Klettauthor=E.+A.+Penaauthor=L.+Porcherauthor=A.+J.+Smithauthor=M.+P.+Kelly&title=Loss+of+function+of+phosphodiesterase+11A4+shows+that+recent+and+remote+long-term+memories+can+be+uncoupled&doi=10.1016%2Fj.cub.2019.06.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit214R"><div class="casContent"><span class="casTitleNuber">214</span><div class="casTitle"><span class="NLM_cas:atitle">Loss of Function of Phosphodiesterase 11A4 Shows that Recent and Remote Long-Term Memories Can Be Uncoupled</span></div><div class="casAuthors">Pilarzyk, Katy; Klett, Jennifer; Pena, Edsel A.; Porcher, Latarsha; Smith, Abigail J.; Kelly, Michy P.</div><div class="citationInfo"><span class="NLM_cas:title">Current Biology</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">14</span>),
    <span class="NLM_cas:pages">2307-2321.e5</span>CODEN:
                <span class="NLM_cas:coden">CUBLE2</span>;
        ISSN:<span class="NLM_cas:issn">0960-9822</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Systems consolidation is a process by which memories initially require the hippocampus for recent long-term memory (LTM) but then become increasingly independent of the hippocampus and more dependent on the cortex for remote LTM.  Here, we study the role of phosphodiesterase 11A4 (PDE11A4) in systems consolidation.  PDE11A4, which degrades cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP), is preferentially expressed in neurons of CA1, the subiculum, and the adjacently connected amygdalohippocampal region.  In male and female mice, deletion of PDE11A enhances remote LTM for social odor recognition and social transmission of food preference (STFP) despite eliminating or silencing recent LTM for those same social events.  Measurement of a surrogate marker of neuronal activation (i.e., Arc mRNA) suggests the recent LTM deficits obsd. in Pde11 knockout mice correspond with decreased activation of ventral CA1 relative to wild-type littermates.  In contrast, the enhanced remote LTM obsd. in Pde11a knockout mice corresponds with increased activation and altered functional connectivity of anterior cingulate cortex, frontal assocn. cortex, parasubiculum, and the superficial layer of medial entorhinal cortex.  The apparent increased neural activation obsd. in prefrontal cortex of Pde11a knockout mice during remote LTM retrieval may be related to an upregulation of the N-methyl-D-aspartate receptor subunits NR1 and NR2A.  Viral restoration of PDE11A4 to vCA1 alone is sufficient to rescue both the LTM phenotypes and upregulation of NR1 exhibited by Pde11a knockout mice.  Together, our findings suggest remote LTM can be decoupled from recent LTM, which may have relevance for cognitive deficits assocd. with aging, temporal lobe epilepsy, or transient global amnesia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWjPjh6XZaGrVg90H21EOLACvtfcHk0ljgop5IVODwUQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlKlu7jL&md5=83996a6341e03b3419cc4af7ccc016e1</span></div><a href="/servlet/linkout?suffix=cit214&amp;dbid=16384&amp;doi=10.1016%2Fj.cub.2019.06.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.cub.2019.06.018%26sid%3Dliteratum%253Aachs%26aulast%3DPilarzyk%26aufirst%3DK.%26aulast%3DKlett%26aufirst%3DJ.%26aulast%3DPena%26aufirst%3DE.%2BA.%26aulast%3DPorcher%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DA.%2BJ.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DLoss%2520of%2520function%2520of%2520phosphodiesterase%252011A4%2520shows%2520that%2520recent%2520and%2520remote%2520long-term%2520memories%2520can%2520be%2520uncoupled%26jtitle%3DCurr.%2520Biol.%26date%3D2019%26volume%3D29%26spage%3D2307%26epage%3D2321%26doi%3D10.1016%2Fj.cub.2019.06.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref215"><div class="reference"><strong class="refLabel"><a href="#ref215" class="rightTabRefNumLink">215</a></strong><div class="NLM_citation" id="rightTab-cit215"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pathak, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Agostino, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishara, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capell, W. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fisher, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hegde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibrahim, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pilarzyk, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabin, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuczkewycz, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelly, M. P.</span></span> <span> </span><span class="NLM_article-title">PDE11A negatively regulates lithium responsivity</span>. <i>Mol. Psychiatry</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1714</span>– <span class="NLM_lpage">1724</span>, <span class="refDoi"> DOI: 10.1038/mp.2016.155</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1038%2Fmp.2016.155" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=27646265" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref215/cit215&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsFenu7bM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2017&pages=1714-1724&author=G.+Pathakauthor=M.+J.+Agostinoauthor=K.+Bisharaauthor=W.+R.+Capellauthor=J.+L.+Fisherauthor=S.+Hegdeauthor=B.+A.+Ibrahimauthor=K.+Pilarzykauthor=C.+Sabinauthor=T.+Tuczkewyczauthor=S.+Wilsonauthor=M.+P.+Kelly&title=PDE11A+negatively+regulates+lithium+responsivity&doi=10.1038%2Fmp.2016.155"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit215R"><div class="casContent"><span class="casTitleNuber">215</span><div class="casTitle"><span class="NLM_cas:atitle">PDE11A negatively regulates lithium responsivity</span></div><div class="casAuthors">Pathak, G.; Agostino, M. J.; Bishara, K.; Capell, W. R.; Fisher, J. L.; Hegde, S.; Ibrahim, B. A.; Pilarzyk, K.; Sabin, C.; Tuczkewycz, T.; Wilson, S.; Kelly, M. P.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Psychiatry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1714-1724</span>CODEN:
                <span class="NLM_cas:coden">MOPSFQ</span>;
        ISSN:<span class="NLM_cas:issn">1359-4184</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Lithium responsivity in patients with bipolar disorder has been genetically assocd. with Phosphodiesterase 11A (PDE11A), and lithium decreases PDE11A mRNA in induced pluripotent stem cell-derived hippocampal neurons originating from lithium-responsive patients.  PDE11 is an enzyme uniquely enriched in the hippocampus that breaks down cAMP and cyclic GMP.  Here we detd. whether decreasing PDE11A expression is sufficient to increase lithium responsivity in mice.  In dorsal hippocampus and ventral hippocampus (VHIPP), lithium-responsive C57BL/6J and 129S6/SvEvTac mice show decreased PDE11A4 protein expression relative to lithium-unresponsive BALB/cJ mice.  In VHIPP, C57BL/6J mice also show differences in PDE11A4 compartmentalization relative to BALB/cJ mice.  In contrast, neither PDE2A nor PDE10A expression differ among the strains.  The compartment-specific differences in PDE11A4 protein expression are explained by a coding single-nucleotide polymorphism (SNP) at amino acid 499, which falls within the GAF-B homodimerization domain.  Relative to the BALB/cJ 499T, the C57BL/6J 499A decreases PDE11A4 homodimerization, which removes PDE11A4 from the membrane.  Consistent with the observation that lower PDE11A4 expression correlates with better lithium responsiveness, we found that Pde11a knockout mice (KO) given 0.4% lithium chow for 3+ weeks exhibit greater lithium responsivity relative to wild-type (WT) littermates in tail suspension, an antidepressant-predictive assay, and amphetamine hyperlocomotion, an anti-manic predictive assay.  Reduced PDE11A4 expression may represent a lithium-sensitive pathophysiol., because both C57BL/6J and Pde11a KO mice show increased expression of the pro-inflammatory cytokine interleukin-6 (IL-6) relative to BALB/cJ and PDE11A WT mice, resp.  Our finding that PDE11A4 neg. regulates lithium responsivity in mice suggests that the PDE11A SNPs identified in patients may be functionally relevant.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBXAGJmh3H97Vg90H21EOLACvtfcHk0ljEWCCRRtMXwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsFenu7bM&md5=2641fddb991559003159ef79b0284c27</span></div><a href="/servlet/linkout?suffix=cit215&amp;dbid=16384&amp;doi=10.1038%2Fmp.2016.155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fmp.2016.155%26sid%3Dliteratum%253Aachs%26aulast%3DPathak%26aufirst%3DG.%26aulast%3DAgostino%26aufirst%3DM.%2BJ.%26aulast%3DBishara%26aufirst%3DK.%26aulast%3DCapell%26aufirst%3DW.%2BR.%26aulast%3DFisher%26aufirst%3DJ.%2BL.%26aulast%3DHegde%26aufirst%3DS.%26aulast%3DIbrahim%26aufirst%3DB.%2BA.%26aulast%3DPilarzyk%26aufirst%3DK.%26aulast%3DSabin%26aufirst%3DC.%26aulast%3DTuczkewycz%26aufirst%3DT.%26aulast%3DWilson%26aufirst%3DS.%26aulast%3DKelly%26aufirst%3DM.%2BP.%26atitle%3DPDE11A%2520negatively%2520regulates%2520lithium%2520responsivity%26jtitle%3DMol.%2520Psychiatry%26date%3D2017%26volume%3D22%26spage%3D1714%26epage%3D1724%26doi%3D10.1038%2Fmp.2016.155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref216"><div class="reference"><strong class="refLabel"><a href="#ref216" class="rightTabRefNumLink">216</a></strong><div class="NLM_citation" id="rightTab-cit216"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ceyhan, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birsoy, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, C. S.</span></span> <span> </span><span class="NLM_article-title">Identification of biologically active PDE11-selective inhibitors using a yeast-based high-throughput screen</span>. <i>Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">155</span>– <span class="NLM_lpage">163</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2011.12.010</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=10.1016%2Fj.chembiol.2011.12.010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=22284362" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref216/cit216&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1Ggt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2012&pages=155-163&author=O.+Ceyhanauthor=K.+Birsoyauthor=C.+S.+Hoffman&title=Identification+of+biologically+active+PDE11-selective+inhibitors+using+a+yeast-based+high-throughput+screen&doi=10.1016%2Fj.chembiol.2011.12.010"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit216R"><div class="casContent"><span class="casTitleNuber">216</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Biologically Active PDE11-Selective Inhibitors Using a Yeast-Based High-Throughput Screen</span></div><div class="casAuthors">Ceyhan, Ozge; Birsoy, Kivanc; Hoffman, Charles S.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Oxford, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">155-163</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The biol. roles of cyclic nucleotide phosphodiesterase 11 (PDE11) enzymes are poorly understood, in part due to the lack of selective inhibitors.  To address the need for such compds., we completed an ∼200,000 compd. high-throughput screen (HTS) for PDE11 inhibitors using a yeast-based growth assay, and identified 4 potent and selective PDE11 inhibitors.  One compd., along with two structural analogs, elevates cAMP and cortisol levels in human adrenocortical cells, consistent with gene assocn. studies that link PDE11 activity to adrenal function.  As such, these compds. can immediately serve as chem. tools to study PDE11 function in cell culture, and as leads to develop therapeutics for the treatment of adrenal insufficiencies.  Our results further validate this yeast-based HTS platform for the discovery of potent, selective, and biol. active PDE inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosoLwWtx7yMbVg90H21EOLACvtfcHk0ljEWCCRRtMXwA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1Ggt7w%253D&md5=6aa6eb3c95290e8991a83a0cfe989789</span></div><a href="/servlet/linkout?suffix=cit216&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2011.12.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2011.12.010%26sid%3Dliteratum%253Aachs%26aulast%3DCeyhan%26aufirst%3DO.%26aulast%3DBirsoy%26aufirst%3DK.%26aulast%3DHoffman%26aufirst%3DC.%2BS.%26atitle%3DIdentification%2520of%2520biologically%2520active%2520PDE11-selective%2520inhibitors%2520using%2520a%2520yeast-based%2520high-throughput%2520screen%26jtitle%3DChem.%2520Biol.%26date%3D2012%26volume%3D19%26spage%3D155%26epage%3D163%26doi%3D10.1016%2Fj.chembiol.2011.12.010" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00115&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00115%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-11%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00115" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                11MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67995b868cb33cd0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
